ID AMRSAP1 PN TP4 SO Oreochromis niloticus PL 25 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 12%, 'I': 20%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO K, S BA 14 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2981.598 AI 117.2 II 130.236 HP -0.128 HM 0.967 IP 13.201 NC 7.27 SF 0.36, 0.16, 0.16 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC = 16 μG/mL TO MBC = 32 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10040 SQ SEQUENCE 2981.598 DA MW 25AA FIHHIIGGLF SAGKAIHRLI RRRRR // ID AMRSAP2 PN F1A/I2A SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 3, 'I': 4, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4%, 'G': 12%, 'H': 12%, 'I': 16%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO F, K, S BA 14 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2863.42 AI 109.6 II 121.904 HP -0.276 HM 0.967 IP 13.201 NC 7.27 SF 0.28, 0.16, 0.24 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10041 SQ SEQUENCE 2863.42 DA MW 25AA AAHHIIGGLF SAGKAIHRLI RRRRR // ID AMRSAP3 PN H3A/H4A SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 1, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 4%, 'I': 20%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO H, K, S BA 16 LA 9 AA 0 BC 8 MC 0 MF 0 XX MM 2849.474 AI 125.2 II 107.724 HP 0.272 HM 0.967 IP 13.201 NC 7.089 SF 0.36, 0.16, 0.24 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC = 128 μG/mL TO MBC = 256 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10042 SQ SEQUENCE 2849.474 DA MW 25AA FIAAIIGGLF SAGKAIHRLI RRRRR // ID AMRSAP4 PN I5A/I6A SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 3, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 12%, 'I': 12%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO K, S BA 14 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2897.437 AI 94 II 112.66 HP -0.344 HM 0.967 IP 13.201 NC 7.27 SF 0.28, 0.16, 0.24 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10043 SQ SEQUENCE 2897.437 DA MW 25AA FIHHAAGGLF SAGKAIHRLI RRRRR // ID AMRSAP5 PN L9A/F10A SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 3, 'I': 5, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4%, 'G': 12%, 'H': 12%, 'I': 20%, 'K': 4%, 'L': 4%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO F, K, L, S BA 14 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2863.42 AI 109.6 II 126.84 HP -0.248 HM 0.967 IP 13.201 NC 7.27 SF 0.28, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10044 SQ SEQUENCE 2863.42 DA MW 25AA FIHHIIGGAA SAGKAIHRLI RRRRR // ID AMRSAP6 PN I16R SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 4, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 7, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 12%, 'I': 16%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO K, S BA 13 LA 12 AA 0 BC 11 MC 0 MF 0 XX MM 3024.626 AI 101.6 II 133.004 HP -0.488 HM 0.611 IP 13.28 NC 8.27 SF 0.32, 0.16, 0.16 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10045 SQ SEQUENCE 3024.626 DA MW 25AA FIHHIIGGLF SAGKARHRLI RRRRR // ID AMRSAP7 PN I16E SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 2, 'G': 3, 'H': 3, 'I': 4, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 8%, 'G': 12%, 'H': 12%, 'I': 16%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, M, N, P, Q, T, V, W, Y MO R LO E, K, S BA 13 LA 12 AA 1 BC 10 MC 0 MF 0 XX MM 2997.554 AI 101.6 II 122.284 HP -0.448 HM 0.774 IP 12.804 NC 6.272 SF 0.32, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10046 SQ SEQUENCE 2997.554 DA MW 25AA FIHHIIGGLF SAGKAEHRLI RRRRR // ID AMRSAP8 PN I16A SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 4, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 12%, 'I': 16%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO K, S BA 14 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2939.518 AI 105.6 II 121.904 HP -0.236 HM 0.898 IP 13.201 NC 7.27 SF 0.32, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC = 64 μG/mL TO MBC = 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10047 SQ SEQUENCE 2939.518 DA MW 25AA FIHHIIGGLF SAGKAAHRLI RRRRR // ID AMRSAP9 PN L19H/I20H SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 5, 'I': 4, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 20%, 'I': 16%, 'K': 4%, 'L': 4%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO K, L, S BA 12 LA 13 AA 0 BC 12 MC 0 MF 0 XX MM 3029.562 AI 86 II 137.94 HP -0.716 HM 0.776 IP 13.201 NC 7.452 SF 0.28, 0.16, 0.12 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC alpha XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10048 SQ SEQUENCE 3029.562 DA MW 25AA FIHHIIGGLF SAGKAIHRHH RRRRR // ID AMRSAP10 PN DN2 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 3, 'I': 4, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8.7%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.35%, 'G': 13.04%, 'H': 13.04%, 'I': 17.39%, 'K': 4.35%, 'L': 8.7%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 26.09%, 'S': 4.35%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO F, K, S BA 12 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2721.262 AI 110.435 II 135.326 HP -0.457 HM 0.967 IP 13.201 NC 7.27 SF 0.304, 0.174, 0.174 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC >= 512 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10049 SQ SEQUENCE 2721.262 DA MW 23AA HHIIGGLFSA GKAIHRLIRR RRR // ID AMRSAP11 PN DN4 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 1, 'I': 4, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 14.29%, 'H': 4.76%, 'I': 19.05%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 4.76%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO R LO F, H, K, S BA 12 LA 9 AA 0 BC 8 MC 0 MF 0 XX MM 2446.98 AI 120.952 II 126.338 HP -0.195 HM 0.967 IP 13.201 NC 7.089 SF 0.333, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC = 64 μG/mL TO MBC = 256 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10050 SQ SEQUENCE 2446.98 DA MW 21AA IIGGLFSAGK AIHRLIRRRR R // ID AMRSAP12 PN DC2 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8.7%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.7%, 'G': 13.04%, 'H': 13.04%, 'I': 21.74%, 'K': 4.35%, 'L': 8.7%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 17.39%, 'S': 4.35%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO I LO K, S BA 14 LA 9 AA 0 BC 8 MC 0 MF 0 XX MM 2669.223 AI 127.391 II 90.883 HP 0.252 HM 0.967 IP 12.981 NC 5.27 SF 0.391, 0.174, 0.174 [Helix, Turn, Sheet] AR 0.087 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA (MIC = 32 μG/mL TO MBC = 32 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10051 SQ SEQUENCE 2669.223 DA MW 23AA FIHHIIGGLF SAGKAIHRLI RRR // ID AMRSAP13 PN DC4 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 14.29%, 'H': 14.29%, 'I': 23.81%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 9.52%, 'S': 4.76%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO I LO K, S BA 14 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2356.848 AI 139.524 II 44.033 HP 0.705 HM 0.887 IP 12.516 NC 3.27 SF 0.429, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.095 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA (MIC = 256 μG/mL TO MBC = 256 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10052 SQ SEQUENCE 2356.848 DA MW 21AA FIHHIIGGLF SAGKAIHRLI R // ID AMRSAP14 PN A12V/A15H SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 20%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 4%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, T, W, Y MO R LO K, S, V BA 13 LA 12 AA 0 BC 11 MC 0 MF 0 XX MM 3075.714 AI 120.8 II 144.416 HP -0.232 HM 1.016 IP 13.201 NC 7.361 SF 0.4, 0.16, 0.08 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC = 32 μG/mL TO MBC = 64 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10053 SQ SEQUENCE 3075.714 DA MW 25AA FIHHIIGGLF SVGKHIHRLI RRRRR // ID AMRSAP15 PN A12I/A15I SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 3, 'I': 7, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 12%, 'I': 28%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 24%, 'S': 4%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, T, V, W, Y MO I LO K, S BA 14 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 3065.759 AI 140.4 II 126.84 HP 0.088 HM 1.015 IP 13.201 NC 7.27 SF 0.44, 0.16, 0.08 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA (MIC = 64 μG/mL TO MBC = 256 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10054 SQ SEQUENCE 3065.759 DA MW 25AA FIHHIIGGLF SIGKIIHRLI RRRRR // ID AMRSAP16 PN R18S/R21H SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 2, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 20%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16%, 'S': 8%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, T, V, W, Y MO I LO K BA 14 LA 11 AA 0 BC 9 MC 0 MF 0 XX MM 2893.442 AI 117.2 II 112.26 HP 0.072 HM 0.619 IP 12.981 NC 5.361 SF 0.36, 0.2, 0.16 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA (MIC = 32 μG/mL TO MBC = 32 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10055 SQ SEQUENCE 2893.442 DA MW 25AA FIHHIIGGLF SAGKAIHSLI HRRRR // ID AMRSAP17 PN VHSH SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 5, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 20%, 'I': 20%, 'K': 4%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16%, 'S': 8%, 'T': 0%, 'V': 4%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, T, W, Y MO H; I LO K, V BA 13 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 2987.559 AI 120.8 II 126.44 HP -0.032 HM 0.674 IP 12.981 NC 5.452 SF 0.4, 0.2, 0.08 [Helix, Turn, Sheet] AR 0.08 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA (MIC = 16 μG/mL TO MBC = 32 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10056 SQ SEQUENCE 2987.559 DA MW 25AA FIHHIIGGLF SVGKHIHSLI HRRRR // ID AMRSAP18 PN TP3 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 6, 'I': 5, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.7%, 'G': 17.39%, 'H': 26.09%, 'I': 21.74%, 'K': 4.35%, 'L': 8.7%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 8.7%, 'T': 0%, 'V': 4.35%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, R, T, W, Y MO H LO K, V BA 14 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2557.002 AI 131.304 II 57.343 HP 0.591 HM 0.569 IP 9.712 NC 1.543 SF 0.435, 0.261, 0.087 [Helix, Turn, Sheet] AR 0.087 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (MIC = 256 μG/mL TO MBC > 512 μM) XX XR PubMed: 29040295 XR CAMP R4: CAMPSQ10057 SQ SEQUENCE 2557.002 DA MW 23AA FIHHIIGGLF SVGKHIHSLI HGH // ID AMRSAP19 PN Peptide 69L SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, Y MO R LO W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1665.07 AI 137.5 II 145.292 HP -0.525 HM 0.464 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 36.120774 XX SC beta XX TO MRSA (MIC= 2 μG/mL) XX XR PubMed: 31616307 XR CAMP R4: CAMPSQ10083 SQ SEQUENCE 1665.07 DA MW 12AA RRWRIVVIRV RR // ID AMRSAP20 PN Peptide 14L SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, S, T, Y MO W LO F, I, K, V BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1376.673 AI 75.556 II 53.667 HP -0.456 HM 0.524 IP 12.516 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.444 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC= 0.5 μG/mL) XX XR PubMed: 31616307 XR CAMP R4: CAMPSQ10084 SQ SEQUENCE 1376.673 DA MW 9AA WKIVFWWRR // ID AMRSAP21 PN CA SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 33.33%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, Y MO K LO A, F, G, I, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1771.309 AI 149.333 II -28.987 HP 0.54 HM 0.687 IP 11.403 NC 4.997 SF 0.533, 0.067, 0.267 [Helix, Turn, Sheet] AR 0.133 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 3730529 (MIC = 4 μM) XX XR PubMed: 31448597 XR CAMP R4: CAMPSQ1019 SQ SEQUENCE 1771.309 DA MW 15AA KWKLFKKIGA VLKVL // ID AMRSAP22 PN Hfp1 SO Likely of sticklefish origin PL 21 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 0, 'I': 1, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 0%, 'I': 4.76%, 'K': 28.57%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 4.76%, 'T': 0%, 'V': 4.76%, 'W': 9.52%, 'Y': 0% MA C, D, E, H, L, M, N, P, Q, T, Y MO K LO I, R, S, V BA 13 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 2426.939 AI 41.905 II -11.476 HP -0.543 HM 0.758 IP 12.102 NC 6.996 SF 0.333, 0.238, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 11000, 11000 MS 42.140903 XX SC alpha_beta XX TO S.aureus MRSA-16 (MIC = 32 μM) XX XR PubMed: 22188679 XR CAMP R4: CAMPSQ10239 SQ SEQUENCE 2426.939 DA MW 21AA SFKKFWGGVK AIFKGARKGW K // ID AMRSAP23 PN Hfp1 SO Likely of sticklefish origin PL 21 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 0, 'I': 1, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 0%, 'I': 4.76%, 'K': 28.57%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 4.76%, 'T': 0%, 'V': 4.76%, 'W': 9.52%, 'Y': 0% MA C, D, E, H, L, M, N, P, Q, T, Y MO K LO I, R, S, V BA 13 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 2426.939 AI 41.905 II -11.476 HP -0.543 HM 0.758 IP 12.102 NC 6.996 SF 0.333, 0.238, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 11000, 11000 MS 42.140903 XX SC alpha_beta XX TO S.aureus MRSA-G1 (MIC = 32 μM) XX XR PubMed: 22188679 XR CAMP R4: CAMPSQ10239 SQ SEQUENCE 2426.939 DA MW 21AA SFKKFWGGVK AIFKGARKGW K // ID AMRSAP24 PN Hfp2 SO Likely of sticklefish origin PL 21 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 0, 'I': 1, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 19.05%, 'G': 19.05%, 'H': 0%, 'I': 4.76%, 'K': 28.57%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 9.52%, 'Y': 0% MA C, D, E, H, L, M, N, P, Q, S, T, Y MO K LO I, R, V BA 14 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2487.037 AI 41.905 II -11.476 HP -0.371 HM 0.758 IP 12.102 NC 6.996 SF 0.381, 0.19, 0.095 [Helix, Turn, Sheet] AR 0.286 ME 11000, 11000 MS 42.140903 XX SC alpha_beta XX TO S.aureus MRSA-16 (MIC =4 μM) XX XR PubMed: 22188679 XR CAMP R4: CAMPSQ10240 SQ SEQUENCE 2487.037 DA MW 21AA FFKKFWGGVK AIFKGARKGW K // ID AMRSAP25 PN Hfp2 SO Likely of sticklefish origin PL 21 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 0, 'I': 1, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 19.05%, 'G': 19.05%, 'H': 0%, 'I': 4.76%, 'K': 28.57%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 9.52%, 'Y': 0% MA C, D, E, H, L, M, N, P, Q, S, T, Y MO K LO I, R, V BA 14 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2487.037 AI 41.905 II -11.476 HP -0.371 HM 0.758 IP 12.102 NC 6.996 SF 0.381, 0.19, 0.095 [Helix, Turn, Sheet] AR 0.286 ME 11000, 11000 MS 42.140903 XX SC alpha_beta XX TO S.aureus MRSA-G (MIC = 4 μM) XX XR PubMed: 22188679 XR CAMP R4: CAMPSQ10240 SQ SEQUENCE 2487.037 DA MW 21AA FFKKFWGGVK AIFKGARKGW K // ID AMRSAP26 PN GGH-CM15 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 1, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 5.56%, 'I': 5.56%, 'K': 27.78%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 5.56%, 'Y': 0% MA C, D, E, M, N, P, Q, R, S, T, Y MO K LO A, F, H, I, W BA 12 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2022.554 AI 124.444 II -2.478 HP 0.228 HM 0.687 IP 11.403 NC 5.087 SF 0.444, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (3730529) (MIC = 2 μM) XX XR PubMed: 31448597 XR CAMP R4: CAMPSQ10261 SQ SEQUENCE 2022.554 DA MW 18AA GGHKWKLFKK IGAVLKVL // ID AMRSAP27 PN VIH-CM15 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 2, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 5.56%, 'H': 5.56%, 'I': 11.11%, 'K': 27.78%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 5.56%, 'Y': 0% MA C, D, E, M, N, P, Q, R, S, T, Y MO K LO A, F, G, H, W BA 12 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2120.742 AI 162.222 II -2.478 HP 0.756 HM 0.687 IP 11.403 NC 5.087 SF 0.556, 0.056, 0.222 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA (3730529) (MIC = 2 μM) XX XR PubMed: 31448597 XR CAMP R4: CAMPSQ10262 SQ SEQUENCE 2120.742 DA MW 18AA VIHKWKLFKK IGAVLKVL // ID AMRSAP28 PN Cit1.1 SO Litoria citropa PL 16 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1615.977 AI 158.125 II 14.188 HP 1.281 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (3730529) (MIC = 10 μM) XX XR PubMed: 31448597 XR CAMP R4: CAMPSQ10263 SQ SEQUENCE 1615.977 DA MW 16AA GLFDVIKKVA SVIGGL // ID AMRSAP29 PN GGH-Cit1.1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 5, 'H': 1, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 0%, 'D': 5.26%, 'E': 0%, 'F': 5.26%, 'G': 26.32%, 'H': 5.26%, 'I': 10.53%, 'K': 10.53%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 5.26%, 'T': 0%, 'V': 15.79%, 'W': 0%, 'Y': 0% MA C, E, M, N, P, Q, R, T, W, Y MO G LO A, D, F, H, S BA 14 LA 5 AA 1 BC 3 MC 0 MF 0 XX MM 1867.222 AI 133.158 II 14.563 HP 0.868 HM 0.642 IP 9.539 NC 1.089 SF 0.421, 0.316, 0.158 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (3730529) (MIC = 17 μM) XX XR PubMed: 31448597 XR CAMP R4: CAMPSQ10264 SQ SEQUENCE 1867.222 DA MW 19AA GGHGLFDVIK KVASVIGGL // ID AMRSAP30 PN VIH-Cit1.1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 1, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 0%, 'D': 5.26%, 'E': 0%, 'F': 5.26%, 'G': 15.79%, 'H': 5.26%, 'I': 15.79%, 'K': 10.53%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 5.26%, 'T': 0%, 'V': 21.05%, 'W': 0%, 'Y': 0% MA C, E, M, N, P, Q, R, T, W, Y MO V LO A, D, F, H, S BA 14 LA 5 AA 1 BC 3 MC 0 MF 0 XX MM 1965.41 AI 168.947 II 14.563 HP 1.368 HM 0.678 IP 9.539 NC 1.089 SF 0.526, 0.211, 0.158 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (3730529) (MIC = 16 μM) XX XR PubMed: 31448597 XR CAMP R4: CAMPSQ10265 SQ SEQUENCE 1965.41 DA MW 19AA VIHGLFDVIK KVASVIGGL // ID AMRSAP31 PN Ranalexin SO Rana catesbeiana PL 20 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 3, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 15%, 'K': 15%, 'L': 10%, AF 'M': 5%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 5%, 'V': 10%, 'W': 0%, 'Y': 0% MA D, E, H, N, Q, R, S, W, Y MO I; K LO F, M, P, T BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2105.73 AI 136.5 II 17.95 HP 1.4 HM 0.396 IP 9.668 NC 2.873 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 125 MS 18.060387 XX SC alpha_beta XX TO S. aureus NCTC 10442 MRSA (MIC = 3.8 μM) XX XR PubMed: 31426494 XR CAMP R4: CAMPSQ10371 SQ SEQUENCE 2105.73 DA MW 20AA FLGGLIKIVP AMICAVTKKC // ID AMRSAP32 PN Der-PS4 SO Phyllomedusa sauvagii PL 28 TX Animalia PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 4, 'L': 4, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 2, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 21.43%, 'C': 0%, 'D': 3.57%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 3.57%, 'I': 0%, 'K': 14.29%, 'L': 14.29%, AF 'M': 3.57%, 'N': 7.14%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 10.71%, 'W': 3.57%, 'Y': 0% MA C, E, F, I, P, R, S, Y MO A LO D, H, M, Q, W BA 17 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 2949.508 AI 108.214 II 0.246 HP 0.164 HM 0.645 IP 10.803 NC 3.088 SF 0.286, 0.143, 0.393 [Helix, Turn, Sheet] AR 0.036 ME 5500, 5500 MS 24.080516 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC =8 μM) XX XR PubMed: 31426323 XR CAMP R4: CAMPSQ10372 SQ SEQUENCE 2949.508 DA MW 28AA ALWKTLLKHV GKAAGKAALN AVTDMVNQ // ID AMRSAP33 PN RP557 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 11.76%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 29.41%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.88%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA A, D, E, H, L, M, N, P, Q, S, T MO K LO G, I, R, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2140.715 AI 40 II -0.482 HP -0.135 HM 0.532 IP 10.013 NC 5.748 SF 0.353, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 6990, 7240 MS 36.120774 XX SC beta XX TO MRSA 6313 (MIC = 2.0 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ10382 SQ SEQUENCE 2140.715 DA MW 17AA RFCWKVCYKG ICFKKCK // ID AMRSAP34 PN RP557 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 11.76%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 29.41%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.88%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA A, D, E, H, L, M, N, P, Q, S, T MO K LO G, I, R, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2140.715 AI 40 II -0.482 HP -0.135 HM 0.532 IP 10.013 NC 5.748 SF 0.353, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 6990, 7240 MS 36.120774 XX SC beta XX TO MRSA 6381 (MIC = 2.0 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ10382 SQ SEQUENCE 2140.715 DA MW 17AA RFCWKVCYKG ICFKKCK // ID AMRSAP35 PN RP557 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 11.76%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 29.41%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.88%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA A, D, E, H, L, M, N, P, Q, S, T MO K LO G, I, R, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2140.715 AI 40 II -0.482 HP -0.135 HM 0.532 IP 10.013 NC 5.748 SF 0.353, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 6990, 7240 MS 36.120774 XX SC beta XX TO MRSA ATCC 33592 (MIC = 2.0 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ10382 SQ SEQUENCE 2140.715 DA MW 17AA RFCWKVCYKG ICFKKCK // ID AMRSAP36 PN Tachyplesin 1 SO Tachypleus tridentatus PL 18 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 0%, 'I': 5.56%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 5.56%, 'Y': 11.11% MA A, D, E, H, K, L, M, N, P, Q, S, T MO R LO G, I, V, W BA 6 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2443.958 AI 37.778 II 26.2 HP -0.367 HM 0.634 IP 10.171 NC 5.748 SF 0.389, 0.056, 0 [Helix, Turn, Sheet] AR 0.278 ME 8480, 8730 MS 36.120774 XX SC beta XX TO MRSA 6313 (MIC = 3.5 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ10383 SQ SEQUENCE 2443.958 DA MW 18AA RFCWFRVCYR GICYRRCR // ID AMRSAP37 PN Tachyplesin 1 SO Tachypleus tridentatus PL 18 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 0%, 'I': 5.56%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 5.56%, 'Y': 11.11% MA A, D, E, H, K, L, M, N, P, Q, S, T MO R LO G, I, V, W BA 6 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2443.958 AI 37.778 II 26.2 HP -0.367 HM 0.634 IP 10.171 NC 5.748 SF 0.389, 0.056, 0 [Helix, Turn, Sheet] AR 0.278 ME 8480, 8730 MS 36.120774 XX SC beta XX TO MRSA 6381 (MIC = 3.5 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ10383 SQ SEQUENCE 2443.958 DA MW 18AA RFCWFRVCYR GICYRRCR // ID AMRSAP38 PN Tachyplesin 1 SO Tachypleus tridentatus PL 18 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 0%, 'I': 5.56%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 5.56%, 'Y': 11.11% MA A, D, E, H, K, L, M, N, P, Q, S, T MO R LO G, I, V, W BA 6 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2443.958 AI 37.778 II 26.2 HP -0.367 HM 0.634 IP 10.171 NC 5.748 SF 0.389, 0.056, 0 [Helix, Turn, Sheet] AR 0.278 ME 8480, 8730 MS 36.120774 XX SC beta XX TO MRSA ATCC 33592 (MIC = 3.5 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ10383 SQ SEQUENCE 2443.958 DA MW 18AA RFCWFRVCYR GICYRRCR // ID AMRSAP39 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 10.8 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10395 SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP40 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 19.2 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10396 SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP41 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 14.0 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10397 SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP42 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 4.4 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10398 SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP43 PN D37 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -3.446 HP 0.608 HM 0.687 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus (8 MRSA) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10399 SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS KAAAAALKTL LKALSK // ID AMRSAP44 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 12.3 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10400 SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP45 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 5.2 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10401 SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP46 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus (8 MRSA)(MIC = 8.4 μM) XX XR PubMed: 28636788 XR CAMP R4: CAMPSQ10402 SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP47 PN Pap12-1 SO Papilio xuthus PL 12 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 8.33%, 'F': 8.33%, 'G': 8.33%, 'H': 0%, 'I': 16.67%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, H, L, M, N, P, Q, S, T, Y MO K LO E, F, G, R, V, W BA 6 LA 6 AA 1 BC 5 MC 0 MF 0 XX MM 1531.908 AI 89.167 II 52.692 HP -0.742 HM 0.739 IP 11.248 NC 3.999 SF 0.417, 0.083, 0.083 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 3126 (MIC = 64 μM) XX XR PubMed: 30846839 XR CAMP R4: CAMPSQ10404 SQ SEQUENCE 1531.908 DA MW 12AA RWKIFKKIEK VG // ID AMRSAP48 PN Pap12-2 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA C, D, E, H, L, M, N, P, Q, S, T, V, Y MO K LO F, G, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1460.832 AI 49.167 II 30.225 HP -1.2 HM 0.714 IP 12.055 NC 5.997 SF 0.25, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3126 (MIC = 16 μM) XX XR PubMed: 30846839 XR CAMP R4: CAMPSQ10405 SQ SEQUENCE 1460.832 DA MW 12AA RWKIFKKAAK KG // ID AMRSAP49 PN Pap12-3 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, H, L, M, N, P, Q, S, T, Y MO K LO F, G, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1516.94 AI 80.833 II 20.75 HP -0.8 HM 0.768 IP 12.055 NC 5.997 SF 0.417, 0.083, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3126 (MIC = 16 μM) XX XR PubMed: 30846839 XR CAMP R4: CAMPSQ10406 SQ SEQUENCE 1516.94 DA MW 12AA RWKIFKKVVK KG // ID AMRSAP50 PN Pap12-4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA C, D, E, G, H, L, M, N, P, Q, S, T, V, Y MO K LO F, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1474.859 AI 57.5 II 37.3 HP -1.017 HM 0.727 IP 12.055 NC 5.997 SF 0.25, 0, 0.25 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3126 (MIC = 32 μM) XX XR PubMed: 30846839 XR CAMP R4: CAMPSQ10407 SQ SEQUENCE 1474.859 DA MW 12AA RWKIFKKAAK KA // ID AMRSAP51 PN Pap12-5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 8.33%, 'Y': 0% MA C, D, E, G, H, L, M, N, P, Q, S, T, Y MO K LO A, F, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1530.966 AI 89.167 II 27.825 HP -0.617 HM 0.78 IP 12.055 NC 5.997 SF 0.417, 0, 0.083 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3126 (MIC = 16 μM) XX XR PubMed: 30846839 XR CAMP R4: CAMPSQ10408 SQ SEQUENCE 1530.966 DA MW 12AA RWKIFKKVVK KA // ID AMRSAP52 PN Pap12-6 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, S, T, Y MO K LO F, I, R BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1646.101 AI 80.833 II 27.825 HP -0.842 HM 0.798 IP 12.055 NC 5.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO MRSA 3126 (MIC = 8 μM) XX XR PubMed: 30846839 XR CAMP R4: CAMPSQ10409 SQ SEQUENCE 1646.101 DA MW 12AA RWKIFKKVVK KW // ID AMRSAP53 PN Pilosulin P1 SO Myrmecia pilosula PL 20 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 5%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, T, W, Y MO G LO A, F, K, P, S BA 15 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 2108.605 AI 146 II 13.445 HP 0.81 HM 0.916 IP 12.807 NC 3.998 SF 0.45, 0.3, 0.2 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA XX XR PubMed: 15639237 XR CAMP R4: CAMPSQ10446 SQ SEQUENCE 2108.605 DA MW 20AA GLGSVFGRLA RILGRVIPKV // ID AMRSAP54 PN Ranatuerin-2Pb SO Rana pipiens PL 34 TX Animalia PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 4, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 7, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 8.82%, 'C': 5.88%, 'D': 2.94%, 'E': 0%, 'F': 2.94%, 'G': 8.82%, 'H': 0%, 'I': 5.88%, 'K': 11.76%, 'L': 11.76%, AF 'M': 0%, 'N': 2.94%, 'P': 0%, 'Q': 0%, 'R': 2.94%, 'S': 2.94%, 'T': 20.59%, 'V': 11.76%, 'W': 0%, 'Y': 0% MA E, H, M, P, Q, W, Y MO T LO D, F, N, R, S BA 17 LA 17 AA 1 BC 5 MC 0 MF 0 XX MM 3524.239 AI 111.765 II -13.832 HP 0.594 HM 0.556 IP 10.345 NC 3.873 SF 0.324, 0.147, 0.206 [Helix, Turn, Sheet] AR 0.029 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA (MIC = 16 μM TO MBC = 32 μM) XX XR PubMed: 31242693 XR CAMP R4: CAMPSQ10451 SQ SEQUENCE 3524.239 DA MW 34AA SFLTTVKKLV TNLAALAGTV IDTIKCKVTG GCRT // ID AMRSAP55 PN Rpa SO Rana pipiens PL 32 TX Animalia PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 4, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 6, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 9.38%, 'C': 6.25%, 'D': 3.13%, 'E': 0%, 'F': 3.13%, 'G': 9.38%, 'H': 0%, 'I': 6.25%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 3.13%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 3.13%, 'T': 18.75%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA E, H, M, P, Q, R, W, Y MO T LO D, F, N, S BA 17 LA 15 AA 1 BC 4 MC 0 MF 0 XX MM 3266.946 AI 118.75 II -15.322 HP 0.794 HM 0.556 IP 9.601 NC 2.873 SF 0.344, 0.156, 0.219 [Helix, Turn, Sheet] AR 0.031 ME 0, 125 MS 24.080516 XX SC beta XX TO MRSA (MIC > 256 μM TO MBC > 256 μM) XX XR PubMed: 31242693 XR CAMP R4: CAMPSQ10452 SQ SEQUENCE 3266.946 DA MW 32AA SFLTTVKKLV TNLAALAGTV IDTIKCKVTG GC // ID AMRSAP56 PN Rpb SO Rana pipiens PL 16 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 3, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 12.5%, 'L': 25%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 18.75%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, M, P, Q, R, W, Y MO L LO F, N, S BA 9 LA 7 AA 0 BC 2 MC 0 MF 0 XX MM 1719.098 AI 146.25 II -12.431 HP 0.988 HM 0.556 IP 10.805 NC 1.997 SF 0.438, 0.125, 0.375 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 16 μM TO MBC = 32 μM) XX XR PubMed: 31242693 XR CAMP R4: CAMPSQ10453 SQ SEQUENCE 1719.098 DA MW 16AA SFLTTVKKLV TNLAAL // ID AMRSAP57 PN G8P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 4%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO P, W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2932.522 AI 105.6 II 81.556 HP -0.048 HM 0.562 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700698 MRSA) (MIC = 1.6 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10517 SQ SEQUENCE 2932.522 DA MW 25AA FFGWLIKPAI HAGKAIHGLI HRRRH // ID AMRSAP58 PN G8P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 4%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO P, W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2932.522 AI 105.6 II 81.556 HP -0.048 HM 0.562 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700699 MRSA) (MIC = 1.6 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10517 SQ SEQUENCE 2932.522 DA MW 25AA FFGWLIKPAI HAGKAIHGLI HRRRH // ID AMRSAP59 PN G13P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 4%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO P, W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2932.522 AI 105.6 II 81.176 HP -0.048 HM 0.545 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700698 MRSA) (MIC = 3 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10518 SQ SEQUENCE 2932.522 DA MW 25AA FFGWLIKGAI HAPKAIHGLI HRRRH // ID AMRSAP60 PN G13P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 4%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO P, W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2932.522 AI 105.6 II 81.176 HP -0.048 HM 0.545 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700699 MRSA) (MIC = 1.6 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10518 SQ SEQUENCE 2932.522 DA MW 25AA FFGWLIKGAI HAPKAIHGLI HRRRH // ID AMRSAP61 PN G18P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 4%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO P, W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2932.522 AI 105.6 II 73.072 HP -0.048 HM 0.593 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700698 MRSA) (MIC = 3 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10519 SQ SEQUENCE 2932.522 DA MW 25AA FFGWLIKGAI HAGKAIHPLI HRRRH // ID AMRSAP62 PN G18P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 3, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 12%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 4%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO P, W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2932.522 AI 105.6 II 73.072 HP -0.048 HM 0.593 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700699 MRSA) (MIC = 3 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10519 SQ SEQUENCE 2932.522 DA MW 25AA FFGWLIKGAI HAGKAIHPLI HRRRH // ID AMRSAP63 PN G13,18P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 8%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2972.587 AI 105.6 II 84.172 HP -0.096 HM 0.576 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700698 MRSA) (MIC = 3 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10520 SQ SEQUENCE 2972.587 DA MW 25AA FFGWLIKGAI HAPKAIHPLI HRRRH // ID AMRSAP64 PN G13,18P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 8%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2972.587 AI 105.6 II 84.172 HP -0.096 HM 0.576 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700699 MRSA) (MIC = 1.6 μM) XX XR PubMed: 28611397 XR CAMP R4: CAMPSQ10520 SQ SEQUENCE 2972.587 DA MW 25AA FFGWLIKGAI HAPKAIHPLI HRRRH // ID AMRSAP65 PN Fowlicidin-2 , Myeloid antimicrobial peptide 27 SO Gallus gallus PL 32 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 8, 'S': 1, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 3.13%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 9.38%, 'K': 6.25%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 3.13%, 'Q': 6.25%, 'R': 25%, 'S': 3.13%, 'T': 6.25%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, W, Y MO R LO A, P, S BA 17 LA 15 AA 0 BC 10 MC 0 MF 0 XX MM 3818.585 AI 82.188 II 29.013 HP -0.428 HM 1.064 IP 13.348 NC 9.997 SF 0.344, 0.188, 0.094 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA ATCC BAA-39 (MIC = 0.66 μM at 0 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: CAMPSQ1054 SQ SEQUENCE 3818.585 DA MW 32AA LVQRGRFGRF LRKIRRFRPK VTITIQGSAR FG // ID AMRSAP66 PN Fowlicidin-2 , Myeloid antimicrobial peptide 27 SO Gallus gallus PL 32 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 8, 'S': 1, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 3.13%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 9.38%, 'K': 6.25%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 3.13%, 'Q': 6.25%, 'R': 25%, 'S': 3.13%, 'T': 6.25%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, W, Y MO R LO A, P, S BA 17 LA 15 AA 0 BC 10 MC 0 MF 0 XX MM 3818.585 AI 82.188 II 29.013 HP -0.428 HM 1.064 IP 13.348 NC 9.997 SF 0.344, 0.188, 0.094 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA ATCC 43300 (MIC = 0.33 μM at 100 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: CAMPSQ1054 SQ SEQUENCE 3818.585 DA MW 32AA LVQRGRFGRF LRKIRRFRPK VTITIQGSAR FG // ID AMRSAP67 PN Fowlicidin-2 , Myeloid antimicrobial peptide 27 SO Gallus gallus PL 32 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 8, 'S': 1, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 3.13%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 9.38%, 'K': 6.25%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 3.13%, 'Q': 6.25%, 'R': 25%, 'S': 3.13%, 'T': 6.25%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, W, Y MO R LO A, P, S BA 17 LA 15 AA 0 BC 10 MC 0 MF 0 XX MM 3818.585 AI 82.188 II 29.013 HP -0.428 HM 1.064 IP 13.348 NC 9.997 SF 0.344, 0.188, 0.094 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA ATCC BAA-39 (MIC = 1.33 μM at 0 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: CAMPSQ1054 SQ SEQUENCE 3818.585 DA MW 32AA LVQRGRFGRF LRKIRRFRPK VTITIQGSAR FG // ID AMRSAP68 PN Fowlicidin-2 , Myeloid antimicrobial peptide 27 SO Gallus gallus PL 32 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 4, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 8, 'S': 1, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 3.13%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 9.38%, 'K': 6.25%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 3.13%, 'Q': 6.25%, 'R': 25%, 'S': 3.13%, 'T': 6.25%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, W, Y MO R LO A, P, S BA 17 LA 15 AA 0 BC 10 MC 0 MF 0 XX MM 3818.585 AI 82.188 II 29.013 HP -0.428 HM 1.064 IP 13.348 NC 9.997 SF 0.344, 0.188, 0.094 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA ATCC 43300 (MIC = 2.66 μM at 100 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: CAMPSQ1054 SQ SEQUENCE 3818.585 DA MW 32AA LVQRGRFGRF LRKIRRFRPK VTITIQGSAR FG // ID AMRSAP69 PN NBC2253 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 17.65%, 'K': 17.65%, 'L': 23.53%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.88%, 'S': 11.76%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 5.88% MA A, D, E, F, H, M, N, P, Q, T, W MO L LO C, G, R, V, Y BA 9 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 1947.497 AI 177.647 II 0.341 HP 0.935 HM 0.644 IP 10.64 NC 3.934 SF 0.529, 0.176, 0.235 [Helix, Turn, Sheet] AR 0.059 ME 1490, 1490 MS 24.080516 XX SC beta XX TO Methicillin Resistant Staphylococcus aureus (MRSA) (MIC50 = 6.7 � 0.02 μM) XX XR PubMed: 31119600 XR CAMP R4: CAMPSQ10547 SQ SEQUENCE 1947.497 DA MW 17AA CGIYRSLKLI KSLVLIK // ID AMRSAP70 PN NBC2254 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 23.53%, 'L': 17.65%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.76%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA D, E, H, M, N, P, Q, S, W, Y MO K LO C, F, G, I, T, V BA 9 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 1945.487 AI 120.588 II 13.606 HP 0.194 HM 0.861 IP 11.823 NC 5.935 SF 0.353, 0.059, 0.294 [Helix, Turn, Sheet] AR 0.059 ME 0, 0 MS 36.120774 XX SC beta XX TO Methicillin Resistant Staphylococcus aureus (MRSA) (MIC50 = 73 � 0.02 μM) XX XR PubMed: 31119600 XR CAMP R4: CAMPSQ10548 SQ SEQUENCE 1945.487 DA MW 17AA CALKLTKAKR LVRKIGF // ID AMRSAP71 PN LDP SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 30%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 10%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, S, T, V, Y MO K LO W BA 3 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1411.806 AI 78 II 60.07 HP -2.24 HM 0.644 IP 12.826 NC 6.997 SF 0.3, 0, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 5500, 5500 MS 42.140903 XX SC alpha_beta XX TO MRSA (MIC = 5-10 μM) XX XR PubMed: 29329747 XR CAMP R4: CAMPSQ10562 SQ SEQUENCE 1411.806 DA MW 10AA KWRRKLKKLR // ID AMRSAP72 PN LDP-NLS SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 47.06%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 5.88%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, S, T, Y MO K LO P, V, W BA 5 LA 12 AA 0 BC 12 MC 0 MF 0 XX MM 2276.939 AI 62.941 II 64.965 HP -2.347 HM 0.575 IP 13.006 NC 11.996 SF 0.235, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.059 ME 5500, 5500 MS 72.241548 XX SC alpha_beta XX TO MRSA (MIC = 2.5-5 μM) XX XR PubMed: 29329747 XR CAMP R4: CAMPSQ10563 SQ SEQUENCE 2276.939 DA MW 17AA KWRRKLKKLR PKKKRKV // ID AMRSAP73 PN Mut-LDP-NLS SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 29.41%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 29.41%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 5.88%, 'Q': 0%, 'R': 11.76%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, Q, S, T, Y MO A; K LO P, V, W BA 10 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1935.436 AI 92.353 II 50.782 HP -0.6 HM 0.529 IP 12.572 NC 6.997 SF 0.235, 0.059, 0.412 [Helix, Turn, Sheet] AR 0.059 ME 5500, 5500 MS 42.140903 XX SC alpha_beta XX TO MRSA (MIC = 25-30 μM) XX XR PubMed: 29329747 XR CAMP R4: CAMPSQ10564 SQ SEQUENCE 1935.436 DA MW 17AA AWRRKLKALA PAKKAKV // ID AMRSAP74 PN NLS SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 57.14%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 14.29%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Q, S, T, W, Y MO K LO P, R, V BA 2 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 883.148 AI 41.429 II 43.014 HP -2.5 HM 0.458 IP 11.997 NC 4.997 SF 0.143, 0.143, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO MRSA (MIC > 50 μM) XX XR PubMed: 29329747 XR CAMP R4: CAMPSQ10565 SQ SEQUENCE 883.148 DA MW 7AA PKKKRKV // ID AMRSAP75 PN H27 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, N, P, Q, R, S, T, V, Y MO K LO G, I, M, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1485.981 AI 130 II 9.575 HP -0.25 HM 0.836 IP 11.403 NC 4.997 SF 0.417, 0.083, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 6271 (MIC = 6.3 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10604 SQ SEQUENCE 1485.981 DA MW 12AA GKWMKLLKKI LK // ID AMRSAP76 PN H27D SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, N, P, Q, R, S, T, V, Y MO K LO G, I, M, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1485.981 AI 130 II 9.575 HP -0.25 HM 0.836 IP 11.403 NC 4.997 SF 0.417, 0.083, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 6271 (MIC = 11.3 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10605 SQ SEQUENCE 1485.981 DA MW 12AA GKWMKLLKKI LK // ID AMRSAP77 PN H39 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 6271 (MIC = 9.0 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10606 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAP78 PN H39D SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 6271 (MIC = 22.0 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10607 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAP79 PN H39LD SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, T, Y MO K LO G, I, V, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1453.921 AI 154.167 II -19.633 HP -0.058 HM 0.845 IP 11.403 NC 4.997 SF 0.5, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 6271 (MIC >= 100 μM/L) XX XR PubMed: 31107198 XR CAMP R4: CAMPSQ10608 SQ SEQUENCE 1453.921 DA MW 12AA GKWVKLLKKI LK // ID AMRSAP80 PN Cg-BigDef1 SO Crassostrea gigas PL 93 TX Animalia PE Experimentally validated XX AC 'A': 10, 'C': 6, 'D': 4, 'E': 2, 'F': 3, 'G': 5, 'H': 3, 'I': 3, 'K': 0, 'L': 5, AC 'M': 0, 'N': 6, 'P': 4, 'Q': 2, 'R': 12, 'S': 8, 'T': 4, 'V': 5, 'W': 2, 'Y': 8 AF 'A': 10.87%, 'C': 6.52%, 'D': 4.35%, 'E': 2.17%, 'F': 3.26%, 'G': 5.43%, 'H': 3.26%, 'I': 3.26%, 'K': 0%, 'L': 5.43%, AF 'M': 0%, 'N': 6.52%, 'P': 4.35%, 'Q': 2.17%, 'R': 13.04%, 'S': 8.7%, 'T': 4.35%, 'V': 5.43%, 'W': 2.17%, 'Y': 8.7% MA K, M MO R LO Z BA 37 LA 55 AA 6 BC 15 MC {'Z': 1} MF {'Z': 0.010752688172043012} XX MM 10587.854 AI 59.892 II 50.347 HP -0.511 HM 0.713 IP 9.034 NC 5.897 SF 0.28, 0.247, 0.183 [Helix, Turn, Sheet] AR 0.14 ME 22920, 23295 MS 72.241548 XX SC beta XX TO Staphylococcus aureus (MRSA) strain 7877 (MIC = 2.5 μM TO MBC = 5 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10610 SQ SEQUENCE 10587.854 DA MW 93AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RENSYQRIRS DHDSHSCANN RGWCRPTCFS HEYTDWFNND VCGSYRCCRP GRR // ID AMRSAP81 PN Cg-BigDef1 SO Crassostrea gigas PL 93 TX Animalia PE Experimentally validated XX AC 'A': 10, 'C': 6, 'D': 4, 'E': 2, 'F': 3, 'G': 5, 'H': 3, 'I': 3, 'K': 0, 'L': 5, AC 'M': 0, 'N': 6, 'P': 4, 'Q': 2, 'R': 12, 'S': 8, 'T': 4, 'V': 5, 'W': 2, 'Y': 8 AF 'A': 10.87%, 'C': 6.52%, 'D': 4.35%, 'E': 2.17%, 'F': 3.26%, 'G': 5.43%, 'H': 3.26%, 'I': 3.26%, 'K': 0%, 'L': 5.43%, AF 'M': 0%, 'N': 6.52%, 'P': 4.35%, 'Q': 2.17%, 'R': 13.04%, 'S': 8.7%, 'T': 4.35%, 'V': 5.43%, 'W': 2.17%, 'Y': 8.7% MA K, M MO R LO Z BA 37 LA 55 AA 6 BC 15 MC {'Z': 1} MF {'Z': 0.010752688172043012} XX MM 10587.854 AI 59.892 II 50.347 HP -0.511 HM 0.713 IP 9.034 NC 5.897 SF 0.28, 0.247, 0.183 [Helix, Turn, Sheet] AR 0.14 ME 22920, 23295 MS 72.241548 XX SC beta XX TO Staphylococcus aureus (MRSA) strain 53863 (MIC = 2.5 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10610 SQ SEQUENCE 10587.854 DA MW 93AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RENSYQRIRS DHDSHSCANN RGWCRPTCFS HEYTDWFNND VCGSYRCCRP GRR // ID AMRSAP82 PN Cg-BigDef1 SO Crassostrea gigas PL 93 TX Animalia PE Experimentally validated XX AC 'A': 10, 'C': 6, 'D': 4, 'E': 2, 'F': 3, 'G': 5, 'H': 3, 'I': 3, 'K': 0, 'L': 5, AC 'M': 0, 'N': 6, 'P': 4, 'Q': 2, 'R': 12, 'S': 8, 'T': 4, 'V': 5, 'W': 2, 'Y': 8 AF 'A': 10.87%, 'C': 6.52%, 'D': 4.35%, 'E': 2.17%, 'F': 3.26%, 'G': 5.43%, 'H': 3.26%, 'I': 3.26%, 'K': 0%, 'L': 5.43%, AF 'M': 0%, 'N': 6.52%, 'P': 4.35%, 'Q': 2.17%, 'R': 13.04%, 'S': 8.7%, 'T': 4.35%, 'V': 5.43%, 'W': 2.17%, 'Y': 8.7% MA K, M MO R LO Z BA 37 LA 55 AA 6 BC 15 MC {'Z': 1} MF {'Z': 0.010752688172043012} XX MM 10587.854 AI 59.892 II 50.347 HP -0.511 HM 0.713 IP 9.034 NC 5.897 SF 0.28, 0.247, 0.183 [Helix, Turn, Sheet] AR 0.14 ME 22920, 23295 MS 72.241548 XX SC beta XX TO Staphylococcus aureus (MRSA) 31/01/14-B-5284 (MIC = 1.25 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10610 SQ SEQUENCE 10587.854 DA MW 93AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RENSYQRIRS DHDSHSCANN RGWCRPTCFS HEYTDWFNND VCGSYRCCRP GRR // ID AMRSAP83 PN Cg-BigDef1 SO Crassostrea gigas PL 93 TX Animalia PE Experimentally validated XX AC 'A': 10, 'C': 6, 'D': 4, 'E': 2, 'F': 3, 'G': 5, 'H': 3, 'I': 3, 'K': 0, 'L': 5, AC 'M': 0, 'N': 6, 'P': 4, 'Q': 2, 'R': 12, 'S': 8, 'T': 4, 'V': 5, 'W': 2, 'Y': 8 AF 'A': 10.87%, 'C': 6.52%, 'D': 4.35%, 'E': 2.17%, 'F': 3.26%, 'G': 5.43%, 'H': 3.26%, 'I': 3.26%, 'K': 0%, 'L': 5.43%, AF 'M': 0%, 'N': 6.52%, 'P': 4.35%, 'Q': 2.17%, 'R': 13.04%, 'S': 8.7%, 'T': 4.35%, 'V': 5.43%, 'W': 2.17%, 'Y': 8.7% MA K, M MO R LO Z BA 37 LA 55 AA 6 BC 15 MC {'Z': 1} MF {'Z': 0.010752688172043012} XX MM 10587.854 AI 59.892 II 50.347 HP -0.511 HM 0.713 IP 9.034 NC 5.897 SF 0.28, 0.247, 0.183 [Helix, Turn, Sheet] AR 0.14 ME 22920, 23295 MS 72.241548 XX SC beta XX TO Staphylococcus aureus (MRSA) 24/11/08-B-1347 (MIC = 2.5 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10610 SQ SEQUENCE 10587.854 DA MW 93AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RENSYQRIRS DHDSHSCANN RGWCRPTCFS HEYTDWFNND VCGSYRCCRP GRR // ID AMRSAP84 PN Cg-BigDef1 SO Crassostrea gigas PL 42 TX Animalia PE Experimentally validated XX AC 'A': 9, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 1, 'R': 4, 'S': 2, 'T': 2, 'V': 4, 'W': 0, 'Y': 5 AF 'A': 21.95%, 'C': 0%, 'D': 0%, 'E': 2.44%, 'F': 2.44%, 'G': 4.88%, 'H': 0%, 'I': 4.88%, 'K': 0%, 'L': 12.2%, AF 'M': 0%, 'N': 2.44%, 'P': 4.88%, 'Q': 2.44%, 'R': 9.76%, 'S': 4.88%, 'T': 4.88%, 'V': 9.76%, 'W': 0%, 'Y': 12.2% MA C, D, H, K, M, W MO A LO E, F, N, Q, Z BA 25 LA 16 AA 1 BC 4 MC {'Z': 1} MF {'Z': 0.023809523809523808} XX MM 4490.231 AI 114.048 II 58.852 HP 0.519 HM 0.427 IP 9.936 NC 2.995 SF 0.405, 0.167, 0.357 [Helix, Turn, Sheet] AR 0.143 ME 7450, 7450 MS 24.080516 XX SC beta XX TO Staphylococcus aureus (MRSA) strain 7877 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10611 SQ SEQUENCE 4490.231 DA MW 42AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RE // ID AMRSAP85 PN Cg-BigDef1 SO Crassostrea gigas PL 42 TX Animalia PE Experimentally validated XX AC 'A': 9, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 1, 'R': 4, 'S': 2, 'T': 2, 'V': 4, 'W': 0, 'Y': 5 AF 'A': 21.95%, 'C': 0%, 'D': 0%, 'E': 2.44%, 'F': 2.44%, 'G': 4.88%, 'H': 0%, 'I': 4.88%, 'K': 0%, 'L': 12.2%, AF 'M': 0%, 'N': 2.44%, 'P': 4.88%, 'Q': 2.44%, 'R': 9.76%, 'S': 4.88%, 'T': 4.88%, 'V': 9.76%, 'W': 0%, 'Y': 12.2% MA C, D, H, K, M, W MO A LO E, F, N, Q, Z BA 25 LA 16 AA 1 BC 4 MC {'Z': 1} MF {'Z': 0.023809523809523808} XX MM 4490.231 AI 114.048 II 58.852 HP 0.519 HM 0.427 IP 9.936 NC 2.995 SF 0.405, 0.167, 0.357 [Helix, Turn, Sheet] AR 0.143 ME 7450, 7450 MS 24.080516 XX SC beta XX TO Staphylococcus aureus (MRSA) strain 53863 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10611 SQ SEQUENCE 4490.231 DA MW 42AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RE // ID AMRSAP86 PN Cg-BigDef1 SO Crassostrea gigas PL 42 TX Animalia PE Experimentally validated XX AC 'A': 9, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 1, 'R': 4, 'S': 2, 'T': 2, 'V': 4, 'W': 0, 'Y': 5 AF 'A': 21.95%, 'C': 0%, 'D': 0%, 'E': 2.44%, 'F': 2.44%, 'G': 4.88%, 'H': 0%, 'I': 4.88%, 'K': 0%, 'L': 12.2%, AF 'M': 0%, 'N': 2.44%, 'P': 4.88%, 'Q': 2.44%, 'R': 9.76%, 'S': 4.88%, 'T': 4.88%, 'V': 9.76%, 'W': 0%, 'Y': 12.2% MA C, D, H, K, M, W MO A LO E, F, N, Q, Z BA 25 LA 16 AA 1 BC 4 MC {'Z': 1} MF {'Z': 0.023809523809523808} XX MM 4490.231 AI 114.048 II 58.852 HP 0.519 HM 0.427 IP 9.936 NC 2.995 SF 0.405, 0.167, 0.357 [Helix, Turn, Sheet] AR 0.143 ME 7450, 7450 MS 24.080516 XX SC beta XX TO Staphylococcus aureus (MRSA) 31/01/14-B-5284 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10611 SQ SEQUENCE 4490.231 DA MW 42AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RE // ID AMRSAP87 PN Cg-BigDef1 SO Crassostrea gigas PL 42 TX Animalia PE Experimentally validated XX AC 'A': 9, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 1, 'R': 4, 'S': 2, 'T': 2, 'V': 4, 'W': 0, 'Y': 5 AF 'A': 21.95%, 'C': 0%, 'D': 0%, 'E': 2.44%, 'F': 2.44%, 'G': 4.88%, 'H': 0%, 'I': 4.88%, 'K': 0%, 'L': 12.2%, AF 'M': 0%, 'N': 2.44%, 'P': 4.88%, 'Q': 2.44%, 'R': 9.76%, 'S': 4.88%, 'T': 4.88%, 'V': 9.76%, 'W': 0%, 'Y': 12.2% MA C, D, H, K, M, W MO A LO E, F, N, Q, Z BA 25 LA 16 AA 1 BC 4 MC {'Z': 1} MF {'Z': 0.023809523809523808} XX MM 4490.231 AI 114.048 II 58.852 HP 0.519 HM 0.427 IP 9.936 NC 2.995 SF 0.405, 0.167, 0.357 [Helix, Turn, Sheet] AR 0.143 ME 7450, 7450 MS 24.080516 XX SC beta XX TO Staphylococcus aureus (MRSA) 24/11/08-B-1347 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10611 SQ SEQUENCE 4490.231 DA MW 42AA ZAQALLPIAS YAGLTVSAPV FAALVTVYGA YALYRYNIRR RE // ID AMRSAP88 PN Cg-BigDef1 SO Crassostrea gigas PL 50 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 4, 'E': 1, 'F': 2, 'G': 3, 'H': 3, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 4, 'P': 2, 'Q': 1, 'R': 8, 'S': 6, 'T': 2, 'V': 1, 'W': 2, 'Y': 3 AF 'A': 2%, 'C': 12%, 'D': 8%, 'E': 2%, 'F': 4%, 'G': 6%, 'H': 6%, 'I': 2%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 8%, 'P': 4%, 'Q': 2%, 'R': 16%, 'S': 12%, 'T': 4%, 'V': 2%, 'W': 4%, 'Y': 6% MA K, L, M MO R LO A, E, I, Q, V BA 12 LA 38 AA 5 BC 11 MC 0 MF 0 XX MM 6001.534 AI 15.6 II 43.81 HP -1.316 HM 0.713 IP 8.384 NC 2.9 SF 0.18, 0.3, 0.04 [Helix, Turn, Sheet] AR 0.14 ME 15470, 15845 MS 48.161032 XX SC beta XX TO Staphylococcus aureus (MRSA) strain 7877 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10612 SQ SEQUENCE 6001.534 DA MW 50AA SYQRIRSDHD SHSCANNRGW CRPTCFSHEY TDWFNNDVCG SYRCCRPGRR // ID AMRSAP89 PN Cg-BigDef1 SO Crassostrea gigas PL 50 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 4, 'E': 1, 'F': 2, 'G': 3, 'H': 3, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 4, 'P': 2, 'Q': 1, 'R': 8, 'S': 6, 'T': 2, 'V': 1, 'W': 2, 'Y': 3 AF 'A': 2%, 'C': 12%, 'D': 8%, 'E': 2%, 'F': 4%, 'G': 6%, 'H': 6%, 'I': 2%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 8%, 'P': 4%, 'Q': 2%, 'R': 16%, 'S': 12%, 'T': 4%, 'V': 2%, 'W': 4%, 'Y': 6% MA K, L, M MO R LO A, E, I, Q, V BA 12 LA 38 AA 5 BC 11 MC 0 MF 0 XX MM 6001.534 AI 15.6 II 43.81 HP -1.316 HM 0.713 IP 8.384 NC 2.9 SF 0.18, 0.3, 0.04 [Helix, Turn, Sheet] AR 0.14 ME 15470, 15845 MS 48.161032 XX SC beta XX TO Staphylococcus aureus (MRSA) strain 53863 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10612 SQ SEQUENCE 6001.534 DA MW 50AA SYQRIRSDHD SHSCANNRGW CRPTCFSHEY TDWFNNDVCG SYRCCRPGRR // ID AMRSAP90 PN Cg-BigDef1 SO Crassostrea gigas PL 50 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 4, 'E': 1, 'F': 2, 'G': 3, 'H': 3, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 4, 'P': 2, 'Q': 1, 'R': 8, 'S': 6, 'T': 2, 'V': 1, 'W': 2, 'Y': 3 AF 'A': 2%, 'C': 12%, 'D': 8%, 'E': 2%, 'F': 4%, 'G': 6%, 'H': 6%, 'I': 2%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 8%, 'P': 4%, 'Q': 2%, 'R': 16%, 'S': 12%, 'T': 4%, 'V': 2%, 'W': 4%, 'Y': 6% MA K, L, M MO R LO A, E, I, Q, V BA 12 LA 38 AA 5 BC 11 MC 0 MF 0 XX MM 6001.534 AI 15.6 II 43.81 HP -1.316 HM 0.713 IP 8.384 NC 2.9 SF 0.18, 0.3, 0.04 [Helix, Turn, Sheet] AR 0.14 ME 15470, 15845 MS 48.161032 XX SC beta XX TO Staphylococcus aureus (MRSA) 31/01/14-B-5284 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10612 SQ SEQUENCE 6001.534 DA MW 50AA SYQRIRSDHD SHSCANNRGW CRPTCFSHEY TDWFNNDVCG SYRCCRPGRR // ID AMRSAP91 PN Cg-BigDef1 SO Crassostrea gigas PL 50 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 4, 'E': 1, 'F': 2, 'G': 3, 'H': 3, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 4, 'P': 2, 'Q': 1, 'R': 8, 'S': 6, 'T': 2, 'V': 1, 'W': 2, 'Y': 3 AF 'A': 2%, 'C': 12%, 'D': 8%, 'E': 2%, 'F': 4%, 'G': 6%, 'H': 6%, 'I': 2%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 8%, 'P': 4%, 'Q': 2%, 'R': 16%, 'S': 12%, 'T': 4%, 'V': 2%, 'W': 4%, 'Y': 6% MA K, L, M MO R LO A, E, I, Q, V BA 12 LA 38 AA 5 BC 11 MC 0 MF 0 XX MM 6001.534 AI 15.6 II 43.81 HP -1.316 HM 0.713 IP 8.384 NC 2.9 SF 0.18, 0.3, 0.04 [Helix, Turn, Sheet] AR 0.14 ME 15470, 15845 MS 48.161032 XX SC beta XX TO Staphylococcus aureus (MRSA) 24/11/08-B-1347 (MIC > 10 μM TO MBC > 10 μM) XX XR PubMed: 31641083 XR CAMP R4: CAMPSQ10612 SQ SEQUENCE 6001.534 DA MW 50AA SYQRIRSDHD SHSCANNRGW CRPTCFSHEY TDWFNNDVCG SYRCCRPGRR // ID AMRSAP92 PN Dermaseptin-PT9 SO Phyllomedusa tarsius PL 25 TX Animalia PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 1, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 1, 'K': 4, 'L': 2, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 4%, 'E': 4%, 'F': 4%, 'G': 12%, 'H': 0%, 'I': 4%, 'K': 16%, 'L': 8%, AF 'M': 4%, 'N': 4%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 4%, 'V': 8%, 'W': 4%, 'Y': 0% MA C, H, P, Q, R, Y MO A LO D, E, F, I, M, N, S, T, W BA 16 LA 9 AA 2 BC 4 MC 0 MF 0 XX MM 2606.078 AI 90 II 8.884 HP 0.18 HM 0.654 IP 10.333 NC 1.999 SF 0.28, 0.2, 0.36 [Helix, Turn, Sheet] AR 0.08 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12493 (MIC = 32 μM TO MBC = 64 μM) XX XR PubMed: 31635388 XR CAMP R4: CAMPSQ10755 SQ SEQUENCE 2606.078 DA MW 25AA GLWSKIKDAA KTAGKAALGF VNEMV // ID AMRSAP93 PN Dermaseptin-PT9 SO Phyllomedusa tarsius PL 25 TX Animalia PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 1, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 1, 'K': 4, 'L': 2, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 4%, 'E': 4%, 'F': 4%, 'G': 12%, 'H': 0%, 'I': 4%, 'K': 16%, 'L': 8%, AF 'M': 4%, 'N': 4%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 4%, 'V': 8%, 'W': 4%, 'Y': 0% MA C, H, P, Q, R, Y MO A LO D, E, F, I, M, N, S, T, W BA 16 LA 9 AA 2 BC 4 MC 0 MF 0 XX MM 2606.078 AI 90 II 8.884 HP 0.18 HM 0.654 IP 10.333 NC 1.999 SF 0.28, 0.2, 0.36 [Helix, Turn, Sheet] AR 0.08 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12493 (MBIC = 32 μM TO MBEC = 64 μM) XX XR PubMed: 31635388 XR CAMP R4: CAMPSQ10755 SQ SEQUENCE 2606.078 DA MW 25AA GLWSKIKDAA KTAGKAALGF VNEMV // ID AMRSAP94 PN K8, 23-DPT9 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 1, 'K': 6, 'L': 2, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4%, 'G': 12%, 'H': 0%, 'I': 4%, 'K': 24%, 'L': 8%, AF 'M': 4%, 'N': 4%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 4%, 'V': 8%, 'W': 4%, 'Y': 0% MA C, D, E, H, P, Q, R, Y MO K LO F, I, M, N, S, T, W BA 16 LA 9 AA 0 BC 6 MC 0 MF 0 XX MM 2618.222 AI 90 II 31.396 HP 0.148 HM 0.696 IP 11.5 NC 5.996 SF 0.28, 0.2, 0.32 [Helix, Turn, Sheet] AR 0.08 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA NCTC 12493 (MIC = 2 μM TO MBC = 4 μM) XX XR PubMed: 31635388 XR CAMP R4: CAMPSQ10756 SQ SEQUENCE 2618.222 DA MW 25AA GLWSKIKKAA KTAGKAALGF VNKMV // ID AMRSAP95 PN K8, 23-DPT9 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 1, 'K': 6, 'L': 2, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4%, 'G': 12%, 'H': 0%, 'I': 4%, 'K': 24%, 'L': 8%, AF 'M': 4%, 'N': 4%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 4%, 'V': 8%, 'W': 4%, 'Y': 0% MA C, D, E, H, P, Q, R, Y MO K LO F, I, M, N, S, T, W BA 16 LA 9 AA 0 BC 6 MC 0 MF 0 XX MM 2618.222 AI 90 II 31.396 HP 0.148 HM 0.696 IP 11.5 NC 5.996 SF 0.28, 0.2, 0.32 [Helix, Turn, Sheet] AR 0.08 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA NCTC 12493 (MBIC = 2 μM TO MBEC = 4 μM) XX XR PubMed: 31635388 XR CAMP R4: CAMPSQ10756 SQ SEQUENCE 2618.222 DA MW 25AA GLWSKIKKAA KTAGKAALGF VNKMV // ID AMRSAP96 PN Pap12-7 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, S, T, Y MO K LO F, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1559.02 AI 105 II 20.75 HP -0.417 HM 0.822 IP 12.055 NC 5.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3090 (MIC = 16 μM) XX XR PubMed: 31546301 XR CAMP R4: CAMPSQ10763 SQ SEQUENCE 1559.02 DA MW 12AA RWKIFKKVVK KV // ID AMRSAP97 PN Pap12-7 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, S, T, Y MO K LO F, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1559.02 AI 105 II 20.75 HP -0.417 HM 0.822 IP 12.055 NC 5.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3114 (MIC = 16 μM) XX XR PubMed: 31546301 XR CAMP R4: CAMPSQ10763 SQ SEQUENCE 1559.02 DA MW 12AA RWKIFKKVVK KV // ID AMRSAP98 PN Pap12-7 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 41.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, S, T, Y MO K LO F, I, R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1559.02 AI 105 II 20.75 HP -0.417 HM 0.822 IP 12.055 NC 5.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3126 (MIC = 16 μM) XX XR PubMed: 31546301 XR CAMP R4: CAMPSQ10763 SQ SEQUENCE 1559.02 DA MW 12AA RWKIFKKVVK KV // ID AMRSAP99 PN PMAP-36 SO Sus scrofa PL 34 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 4, 'K': 7, 'L': 4, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 2.94%, 'G': 11.76%, 'H': 0%, 'I': 11.76%, 'K': 20.59%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 8.82%, 'Q': 0%, 'R': 17.65%, 'S': 2.94%, 'T': 2.94%, 'V': 5.88%, 'W': 2.94%, 'Y': 0% MA A, C, D, E, H, M, N, Q, Y MO K LO F, S, T, W BA 19 LA 15 AA 0 BC 13 MC 0 MF 0 XX MM 3997.03 AI 108.824 II 28.297 HP -0.55 HM 0.756 IP 13.213 NC 12.996 SF 0.353, 0.235, 0.118 [Helix, Turn, Sheet] AR 0.059 ME 5500, 5500 MS 78.261677 XX SC alpha_beta XX TO S. aureus SA-62 (MRSA) (MIC= 4 μM) XX XR PubMed: 16128809 XR CAMP R4: CAMPSQ10812 SQ SEQUENCE 3997.03 DA MW 34AA GRFRRLRKKT RKRLKKIGKV LKWIPPIVGS IPLG // ID AMRSAP100 PN PMAP-36 SO Sus scrofa PL 35 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 4, 'K': 7, 'L': 4, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 2.86%, 'D': 0%, 'E': 0%, 'F': 2.86%, 'G': 11.43%, 'H': 0%, 'I': 11.43%, 'K': 20%, 'L': 11.43%, AF 'M': 0%, 'N': 0%, 'P': 8.57%, 'Q': 0%, 'R': 17.14%, 'S': 2.86%, 'T': 2.86%, 'V': 5.71%, 'W': 2.86%, 'Y': 0% MA A, D, E, H, M, N, Q, Y MO K LO C, F, S, T, W BA 19 LA 16 AA 0 BC 13 MC 0 MF 0 XX MM 4100.169 AI 105.714 II 27.774 HP -0.463 HM 0.756 IP 12.823 NC 12.934 SF 0.343, 0.229, 0.114 [Helix, Turn, Sheet] AR 0.057 ME 5500, 5500 MS 78.261677 XX SC alpha XX TO S. aureus SA-62 (MRSA) (MIC= 4 μM) XX XR PubMed: 16128809 XR CAMP R4: CAMPSQ10813 SQ SEQUENCE 4100.169 DA MW 35AA GRFRRLRKKT RKRLKKIGKV LKWIPPIVGS IPLGC // ID AMRSAP101 PN Pep-1 SO Simian virus PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 14.29%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.81%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, F, G, H, I, L, M, N, Y MO K; W LO P, Q, R, S, V BA 7 LA 14 AA 3 BC 6 MC 0 MF 0 XX MM 2848.259 AI 13.81 II 19.89 HP -2.038 HM 0.378 IP 10.623 NC 3.002 SF 0.286, 0.095, 0.143 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 1 (CCARM 3001) (MIC > 64 μM) XX XR PubMed: 16945333 XR CAMP R4: CAMPSQ10841 SQ SEQUENCE 2848.259 DA MW 21AA KETWWETWWT EWSQPKKKRK V // ID AMRSAP102 PN Pep-1 SO Simian virus PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 14.29%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.81%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, F, G, H, I, L, M, N, Y MO K; W LO P, Q, R, S, V BA 7 LA 14 AA 3 BC 6 MC 0 MF 0 XX MM 2848.259 AI 13.81 II 19.89 HP -2.038 HM 0.378 IP 10.623 NC 3.002 SF 0.286, 0.095, 0.143 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 2 (CCARM 3089) (MIC > 64 μM) XX XR PubMed: 16945333 XR CAMP R4: CAMPSQ10841 SQ SEQUENCE 2848.259 DA MW 21AA KETWWETWWT EWSQPKKKRK V // ID AMRSAP103 PN Pep-1 SO Simian virus PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 14.29%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.81%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, F, G, H, I, L, M, N, Y MO K; W LO P, Q, R, S, V BA 7 LA 14 AA 3 BC 6 MC 0 MF 0 XX MM 2848.259 AI 13.81 II 19.89 HP -2.038 HM 0.378 IP 10.623 NC 3.002 SF 0.286, 0.095, 0.143 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3 (CCARM 3543) (MIC > 64 μM) XX XR PubMed: 16945333 XR CAMP R4: CAMPSQ10841 SQ SEQUENCE 2848.259 DA MW 21AA KETWWETWWT EWSQPKKKRK V // ID AMRSAP104 PN PPF-BBI SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 4, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 12.5%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 6.25%, 'K': 12.5%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 25%, 'Q': 0%, 'R': 6.25%, 'S': 6.25%, 'T': 6.25%, 'V': 0%, 'W': 6.25%, 'Y': 0% MA D, E, F, H, M, N, Q, V, Y MO P LO A, G, I, L, R, S, T, W BA 9 LA 7 AA 0 BC 3 MC 0 MF 0 XX MM 1754.141 AI 55 II 34.363 HP -0.4 HM 0.235 IP 9.76 NC 2.873 SF 0.188, 0.375, 0.125 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5625 MS 18.060387 XX SC alpha XX TO MRSA (MIC/MBC > 512 μM) XX XR PubMed: 31337113 XR CAMP R4: CAMPSQ10880 SQ SEQUENCE 1754.141 DA MW 16AA ALRGCWTKSI PPKPCP // ID AMRSAP105 PN F8-PPF-BBI SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 4, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 12.5%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 6.25%, 'H': 0%, 'I': 6.25%, 'K': 6.25%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 25%, 'Q': 0%, 'R': 6.25%, 'S': 6.25%, 'T': 6.25%, 'V': 0%, 'W': 6.25%, 'Y': 0% MA D, E, H, M, N, Q, V, Y MO P LO A, F, G, I, K, L, R, S, T, W BA 10 LA 6 AA 0 BC 2 MC 0 MF 0 XX MM 1773.144 AI 55 II 42.075 HP 0.019 HM 0.267 IP 8.828 NC 1.874 SF 0.25, 0.375, 0.125 [Helix, Turn, Sheet] AR 0.125 ME 5500, 5625 MS 12.040258 XX SC alpha XX TO MRSA (MIC/MBC > 512 μM) XX XR PubMed: 31337113 XR CAMP R4: CAMPSQ10881 SQ SEQUENCE 1773.144 DA MW 16AA ALRGCWTFSI PPKPCP // ID AMRSAP106 PN K16-PPF-BBI SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 12.5%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 6.25%, 'K': 18.75%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 18.75%, 'Q': 0%, 'R': 6.25%, 'S': 6.25%, 'T': 6.25%, 'V': 0%, 'W': 6.25%, 'Y': 0% MA D, E, F, H, M, N, Q, V, Y MO K; P LO A, G, I, L, R, S, T, W BA 8 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 1785.199 AI 55 II 22.325 HP -0.544 HM 0.341 IP 10.513 NC 3.873 SF 0.188, 0.313, 0.125 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5625 MS 24.080516 XX SC alpha XX TO MRSA (MIC = 512 μM TO MBC = 512 μM) XX XR PubMed: 31337113 XR CAMP R4: CAMPSQ10882 SQ SEQUENCE 1785.199 DA MW 16AA ALRGCWTKSI PPKPCK // ID AMRSAP107 PN Tat-loop SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 1, 'R': 6, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 5%, 'K': 20%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 15%, 'Q': 5%, 'R': 30%, 'S': 5%, 'T': 5%, 'V': 0%, 'W': 5%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, V, Y MO R LO I, Q, S, T, W BA 5 LA 15 AA 0 BC 10 MC 0 MF 0 XX MM 2581.151 AI 19.5 II 126.325 HP -2.19 HM 0.477 IP 12.522 NC 9.873 SF 0.1, 0.2, 0 [Helix, Turn, Sheet] AR 0.05 ME 5500, 5625 MS 60.20129 XX SC alpha+beta XX TO MRSA (MIC = 256 μM TO MBC = 512 μM) XX XR PubMed: 31337113 XR CAMP R4: CAMPSQ10883 SQ SEQUENCE 2581.151 DA MW 20AA RKKRRQRRRC WTKSIPPKPC // ID AMRSAP108 PN TIL SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 18.18%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 18.18%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 27.27%, 'Q': 0%, 'R': 0%, 'S': 9.09%, 'T': 9.09%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, R, V, Y MO P LO I, S, T, W BA 5 LA 6 AA 0 BC 2 MC 0 MF 0 XX MM 1259.547 AI 35.455 II 18.136 HP -0.5 HM 0.204 IP 8.822 NC 1.873 SF 0.182, 0.364, 0 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5625 MS 12.040258 XX SC alpha XX TO MRSA (MIC > 512 μM) XX XR PubMed: 31337113 XR CAMP R4: CAMPSQ10884 SQ SEQUENCE 1259.547 DA MW 11AA CWTKSIPPKP C // ID AMRSAP109 PN CAP-18 SO Oryctolagus cuniculus PL 37 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 3, 'K': 9, 'L': 6, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 2, 'R': 5, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 2.7%, 'C': 0%, 'D': 2.7%, 'E': 2.7%, 'F': 2.7%, 'G': 8.11%, 'H': 0%, 'I': 8.11%, 'K': 24.32%, 'L': 16.22%, AF 'M': 0%, 'N': 2.7%, 'P': 5.41%, 'Q': 5.41%, 'R': 13.51%, 'S': 0%, 'T': 2.7%, 'V': 0%, 'W': 0%, 'Y': 2.7% MA C, H, M, S, V, W MO K LO A, D, E, F, N, T, Y BA 16 LA 21 AA 2 BC 14 MC 0 MF 0 XX MM 4433.449 AI 97.568 II 30.997 HP -1.097 HM 0.672 IP 12.105 NC 11.997 SF 0.297, 0.162, 0.216 [Helix, Turn, Sheet] AR 0.054 ME 1490, 1490 MS 84.281806 XX SC alpha+beta XX TO MRSA ATCC 33591 (MIC = 1.24 μM) XX XR PubMed: 11557478 XR CAMP R4: CAMPSQ10941 SQ SEQUENCE 4433.449 DA MW 37AA GLRKRLRKFR NKIKEKLKKI GQKIQGLLPK LAPRTDY // ID AMRSAP110 PN CP10A SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 23.08%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1829.186 AI 83.077 II 44.985 HP -0.285 HM 0.546 IP 12.516 NC 2.998 SF 0.538, 0, 0.308 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO MRSA XX XR PubMed: 11294848 XR CAMP R4: CAMPSQ10985 SQ SEQUENCE 1829.186 DA MW 13AA ILAWKWAWWA WRR // ID AMRSAP111 PN CycloCP-11 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 13.33%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 6.67%, 'K': 20%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 13.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 26.67%, 'Y': 0% MA A, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, L BA 8 LA 7 AA 0 BC 5 MC 0 MF 0 XX MM 2086.595 AI 52 II 50.86 HP -0.947 HM 0.464 IP 11.062 NC 4.873 SF 0.4, 0.133, 0.067 [Helix, Turn, Sheet] AR 0.267 ME 22000, 22125 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 14640680 XR CAMP R4: CAMPSQ10986 SQ SEQUENCE 2086.595 DA MW 15AA ICLKKWPWWP WRRCK // ID AMRSAP112 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20009 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP113 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20010 (MIC = 0.9 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP114 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20013 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP115 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20015 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP116 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20018 (MIC = 0.9 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP117 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20023 (MIC = 0.23 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP118 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20024 (MIC = 0.23 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP119 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20027 (MIC = 0.45 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP120 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20032 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP121 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20033 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP122 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20035 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP123 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20040 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP124 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20045 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP125 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20047 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP126 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20055 (MIC = 0.11 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP127 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20049 (MIC = 0.23 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP128 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20056 (MIC = 0.23 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP129 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20064 (MIC = 0.23 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP130 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU20057 (MIC = 0.45 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP131 PN RNZ2114 SO Synthetic construct PL 42 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.38%, 'C': 14.29%, 'D': 4.76%, 'E': 2.38%, 'F': 4.76%, 'G': 19.05%, 'H': 4.76%, 'I': 2.38%, 'K': 14.29%, 'L': 2.38%, AF 'M': 0%, 'N': 7.14%, 'P': 2.38%, 'Q': 0%, 'R': 4.76%, 'S': 2.38%, 'T': 0%, 'V': 2.38%, 'W': 2.38%, 'Y': 7.14% MA M, Q, T MO G LO A, E, I, L, P, S, V, W BA 16 LA 26 AA 3 BC 10 MC 0 MF 0 XX MM 4701.389 AI 27.857 II 30.495 HP -0.84 HM 0.358 IP 8.849 NC 4.806 SF 0.214, 0.31, 0.071 [Helix, Turn, Sheet] AR 0.143 ME 9970, 10345 MS 48.161032 XX SC beta XX TO MRSA SJU05P157 (MIC = 0.45 μM) XX XR PubMed: 23624708 XR CAMP R4: CAMPSQ11077 SQ SEQUENCE 4701.389 DA MW 42AA KRGFGCNGPW NEDDLRCHNH CKSIKGYKGG YCAKGGFVCK CY // ID AMRSAP132 PN YD1 SO Bacillus amyloliquefaciens CBSYD1 PL 10 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 30%, 'H': 0%, 'I': 0%, 'K': 10%, 'L': 0%, AF 'M': 0%, 'N': 10%, 'P': 20%, 'Q': 10%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, I, L, M, R, S, T, W, Y MO G LO A, K, N, Q, V BA 7 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 924.024 AI 39 II 4.74 HP -0.93 HM 0.311 IP 9.7 NC 0.998 SF 0.1, 0.6, 0.1 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha_beta XX TO S.aureus MRSA B15 (MIC = 32 μG/mL) XX XR PubMed: 28050849 XR CAMP R4: CAMPSQ11123 SQ SEQUENCE 924.024 DA MW 10AA APKGVQGPNG // ID AMRSAP133 PN R2PLx SO Rana palustris PL 28 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 4, 'C': 2, 'D': 2, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 5, 'L': 4, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 2, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 7.14%, 'D': 7.14%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 7.14%, 'K': 17.86%, 'L': 14.29%, AF 'M': 3.57%, 'N': 7.14%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 3.57%, 'W': 0%, 'Y': 0% MA E, F, H, P, R, S, W, Y MO K LO M, Q, V BA 14 LA 14 AA 2 BC 5 MC 0 MF 0 XX MM 2961.59 AI 108.214 II 3.779 HP 0.118 HM 0.636 IP 9.549 NC 2.873 SF 0.25, 0.143, 0.321 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA (ATCC 12493) (MIC = 256 μM) XX XR PubMed: 30279210 XR CAMP R4: CAMPSQ11243 SQ SEQUENCE 2961.59 DA MW 28AA GIMDTVKNAA KNLAGQLLDK LKCKITAC // ID AMRSAP134 PN Triintsin SO Trichophyton interdigitale PL 38 TX Fungi PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 3, 'F': 2, 'G': 7, 'H': 2, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 3, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 15.79%, 'D': 0%, 'E': 7.89%, 'F': 5.26%, 'G': 18.42%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 7.89%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 2.63%, 'R': 7.89%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 2.63% MA A, D, M, V, W MO G LO N, P, Q, Y BA 15 LA 23 AA 3 BC 7 MC 0 MF 0 XX MM 4161.795 AI 51.316 II 46.139 HP -0.339 HM 0.547 IP 8.125 NC 1.812 SF 0.211, 0.289, 0.158 [Helix, Turn, Sheet] AR 0.079 ME 1490, 1865 MS 30.100645 XX SC beta XX TO MRSA RM329 (MIC = 32 μM TO MBC = 32 μM) XX XR PubMed: 30102941 XR CAMP R4: CAMPSQ11245 SQ SEQUENCE 4161.795 DA MW 38AA GFGCPLNERE CHSHCQSIGR KFGYCGGTLR LTCICGKE // ID AMRSAP135 PN Triintsin SO Trichophyton interdigitale PL 38 TX Fungi PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 3, 'F': 2, 'G': 7, 'H': 2, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 3, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 15.79%, 'D': 0%, 'E': 7.89%, 'F': 5.26%, 'G': 18.42%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 7.89%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 2.63%, 'R': 7.89%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 2.63% MA A, D, M, V, W MO G LO N, P, Q, Y BA 15 LA 23 AA 3 BC 7 MC 0 MF 0 XX MM 4161.795 AI 51.316 II 46.139 HP -0.339 HM 0.547 IP 8.125 NC 1.812 SF 0.211, 0.289, 0.158 [Helix, Turn, Sheet] AR 0.079 ME 1490, 1865 MS 30.100645 XX SC beta XX TO MRSA P1374 (MIC = 32 μM TO MBC = 32 μM) XX XR PubMed: 30102941 XR CAMP R4: CAMPSQ11245 SQ SEQUENCE 4161.795 DA MW 38AA GFGCPLNERE CHSHCQSIGR KFGYCGGTLR LTCICGKE // ID AMRSAP136 PN Japonicin-2LF SO Limnonectes fujianensis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 3, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 15%, 'K': 20%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, N, Q, R, T, W, Y MO K LO P, S, V BA 13 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2282.961 AI 141.5 II 16.025 HP 1.405 HM 0.498 IP 10.349 NC 3.873 SF 0.5, 0.1, 0.25 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) NCTC 12493 (MIC= 4 μM) XX XR PubMed: 30802593 XR CAMP R4: CAMPSQ11276 SQ SEQUENCE 2282.961 DA MW 20AA FIVPSIFLLK KAFCIALKKC // ID AMRSAP137 PN Japonicin-2LF SO Limnonectes fujianensis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 3, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 15%, 'K': 20%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, N, Q, R, T, W, Y MO K LO P, S, V BA 13 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2282.961 AI 141.5 II 16.025 HP 1.405 HM 0.498 IP 10.349 NC 3.873 SF 0.5, 0.1, 0.25 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 24.080516 XX SC alpha_beta XX TO MRSA B038 V1S1 A (MIC= 8 μM) XX XR PubMed: 30802593 XR CAMP R4: CAMPSQ11276 SQ SEQUENCE 2282.961 DA MW 20AA FIVPSIFLLK KAFCIALKKC // ID AMRSAP138 PN Japonicin-2LF SO Limnonectes fujianensis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 3, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 15%, 'K': 20%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, N, Q, R, T, W, Y MO K LO P, S, V BA 13 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2282.961 AI 141.5 II 16.025 HP 1.405 HM 0.498 IP 10.349 NC 3.873 SF 0.5, 0.1, 0.25 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 24.080516 XX SC alpha_beta XX TO MRSA B042 V2E1 A (MIC= 8 μM) XX XR PubMed: 30802593 XR CAMP R4: CAMPSQ11276 SQ SEQUENCE 2282.961 DA MW 20AA FIVPSIFLLK KAFCIALKKC // ID AMRSAP139 PN Dicentracin-like SO Lates calcarifer PL 22 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 1, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.55%, 'G': 18.18%, 'H': 0%, 'I': 4.55%, 'K': 4.55%, 'L': 13.64%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.73%, 'S': 4.55%, 'T': 0%, 'V': 0%, 'W': 4.55%, 'Y': 4.55% MA C, D, E, H, M, N, P, Q, T, V MO R LO F, I, K, S, W, Y BA 14 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 2475.931 AI 89.091 II 25.655 HP -0.232 HM 0.935 IP 12.682 NC 5.997 SF 0.318, 0.227, 0.318 [Helix, Turn, Sheet] AR 0.136 ME 6990, 6990 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus(MRSA) (MIC = 4.68 μG/mL) XX XR PubMed: 30365554 XR CAMP R4: CAMPSQ11298 SQ SEQUENCE 2475.931 DA MW 22AA FLRSLLRGAK AIYRGARAGW RG // ID AMRSAP140 PN Moronecidin SO Lates calcarifer PL 22 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 3, 'H': 4, 'I': 3, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 13.64%, 'H': 18.18%, 'I': 13.64%, 'K': 4.55%, 'L': 4.55%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 9.09%, 'S': 0%, 'T': 9.09%, 'V': 13.64%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, S, W, Y MO H LO K, L BA 13 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2572.06 AI 110.455 II 8.114 HP 0.455 HM 0.729 IP 12.516 NC 3.361 SF 0.455, 0.136, 0.045 [Helix, Turn, Sheet] AR 0.136 ME 0, 0 MS 18.060387 XX SC alpha XX TO Staphylococcus aureus(MRSA) (MIC = 2.34 μG/mL) XX XR PubMed: 30365554 XR CAMP R4: CAMPSQ11299 SQ SEQUENCE 2572.06 DA MW 22AA FFHHIFRGIV HVGKTIHRLV TG // ID AMRSAP141 PN Lp-I SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 629.763 AI 97.5 II 7.5 HP -1.35 HM 1.452 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11310 SQ SEQUENCE 629.763 DA MW 4AA RIWR // ID AMRSAP142 PN Lp-I SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 629.763 AI 97.5 II 7.5 HP -1.35 HM 1.452 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11310 SQ SEQUENCE 629.763 DA MW 4AA RIWR // ID AMRSAP143 PN Lp-I SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 629.763 AI 97.5 II 7.5 HP -1.35 HM 1.452 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11310 SQ SEQUENCE 629.763 DA MW 4AA RIWR // ID AMRSAP144 PN Lp-M SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 25%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, N, P, Q, S, T, V, Y MO R LO M, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 647.796 AI 0 II 7.5 HP -2 HM 1.329 IP 12.5 NC 1.998 SF 0.25, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 6.25 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11312 SQ SEQUENCE 647.796 DA MW 4AA RMWR // ID AMRSAP145 PN Lp-M SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 25%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, N, P, Q, S, T, V, Y MO R LO M, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 647.796 AI 0 II 7.5 HP -2 HM 1.329 IP 12.5 NC 1.998 SF 0.25, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 6.25 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11312 SQ SEQUENCE 647.796 DA MW 4AA RMWR // ID AMRSAP146 PN Lp-M SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 25%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, N, P, Q, S, T, V, Y MO R LO M, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 647.796 AI 0 II 7.5 HP -2 HM 1.329 IP 12.5 NC 1.998 SF 0.25, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 6.25 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11312 SQ SEQUENCE 647.796 DA MW 4AA RMWR // ID AMRSAP147 PN Lp-R SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 75%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO W BA 1 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 672.791 AI 0 II 293.9 HP -3.6 HM 1.039 IP 12.801 NC 2.998 SF 0.25, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11313 SQ SEQUENCE 672.791 DA MW 4AA RRWR // ID AMRSAP148 PN Lp-R SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 75%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO W BA 1 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 672.791 AI 0 II 293.9 HP -3.6 HM 1.039 IP 12.801 NC 2.998 SF 0.25, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11313 SQ SEQUENCE 672.791 DA MW 4AA RRWR // ID AMRSAP149 PN Lp-R SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 75%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO W BA 1 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 672.791 AI 0 II 293.9 HP -3.6 HM 1.039 IP 12.801 NC 2.998 SF 0.25, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11313 SQ SEQUENCE 672.791 DA MW 4AA RRWR // ID AMRSAP150 PN Lp-FRR SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 66.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO F, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 976.155 AI 0 II 199.267 HP -2.683 HM 1.234 IP 12.977 NC 3.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11316 SQ SEQUENCE 976.155 DA MW 6AA RRFWRR // ID AMRSAP151 PN Lp-FRR SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 66.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO F, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 976.155 AI 0 II 199.267 HP -2.683 HM 1.234 IP 12.977 NC 3.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11316 SQ SEQUENCE 976.155 DA MW 6AA RRFWRR // ID AMRSAP152 PN Lp-FRR SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 66.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO F, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 976.155 AI 0 II 199.267 HP -2.683 HM 1.234 IP 12.977 NC 3.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11316 SQ SEQUENCE 976.155 DA MW 6AA RRFWRR // ID AMRSAP153 PN Lp-IRR SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 66.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 942.138 AI 65 II 199.267 HP -2.4 HM 1.256 IP 12.977 NC 3.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11317 SQ SEQUENCE 942.138 DA MW 6AA RRIWRR // ID AMRSAP154 PN Lp-IRR SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 66.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 942.138 AI 65 II 199.267 HP -2.4 HM 1.256 IP 12.977 NC 3.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11317 SQ SEQUENCE 942.138 DA MW 6AA RRIWRR // ID AMRSAP155 PN Lp-IRR SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 66.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 942.138 AI 65 II 199.267 HP -2.4 HM 1.256 IP 12.977 NC 3.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 6.25 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11317 SQ SEQUENCE 942.138 DA MW 6AA RRIWRR // ID AMRSAP156 PN Lau-RRIWb SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 25%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO F, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 663.78 AI 0 II 150.7 HP -1.775 HM 1.141 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11318 SQ SEQUENCE 663.78 DA MW 4AA RRFW // ID AMRSAP157 PN Lau-RRIWb SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 25%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO F, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 663.78 AI 0 II 150.7 HP -1.775 HM 1.141 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11318 SQ SEQUENCE 663.78 DA MW 4AA RRFW // ID AMRSAP158 PN Lau-RRIWb SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 25%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO F, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 663.78 AI 0 II 150.7 HP -1.775 HM 1.141 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 6.25-3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11318 SQ SEQUENCE 663.78 DA MW 4AA RRFW // ID AMRSAP159 PN Lau-RRFWb SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 629.763 AI 97.5 II 150.7 HP -1.35 HM 1.181 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus G (MRSA) (MIC = 6.25 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11319 SQ SEQUENCE 629.763 DA MW 4AA RRIW // ID AMRSAP160 PN Lau-RRFWb SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 629.763 AI 97.5 II 150.7 HP -1.35 HM 1.181 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus E (MRSA) (MIC = 3.125 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11319 SQ SEQUENCE 629.763 DA MW 4AA RRIW // ID AMRSAP161 PN Lau-RRFWb SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO R LO I, W BA 2 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 629.763 AI 97.5 II 150.7 HP -1.35 HM 1.181 IP 12.5 NC 1.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus 11 (MRSA) (MIC = 6.25 μG/mL) XX XR PubMed: 30789942 XR CAMP R4: CAMPSQ11319 SQ SEQUENCE 629.763 DA MW 4AA RRIW // ID AMRSAP162 PN Aborycin SO Streptomyces�sp. SCSIO ZS0098 PL 21 TX Monera PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 1, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 9.52%, 'C': 19.05%, 'D': 4.76%, 'E': 0%, 'F': 9.52%, 'G': 19.05%, 'H': 0%, 'I': 4.76%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 0%, 'V': 9.52%, 'W': 4.76%, 'Y': 4.76% MA E, H, K, M, P, Q, R, T MO C; G LO D, I, L, N, S, W, Y BA 13 LA 8 AA 1 BC 0 MC 0 MF 0 XX MM 2185.533 AI 74.286 II 33.819 HP 1.157 HM 0.281 IP 3.75 NC -1.25 SF 0.381, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.19 ME 6990, 7240 MS 0 XX SC beta XX TO S.aureus MRSA GDE4P037P (MIC >= 128 μG/mL) XX XR PubMed: 30795576 XR CAMP R4: CAMPSQ11320 SQ SEQUENCE 2185.533 DA MW 21AA CLGIGSCNDF AGCGYAVVCF W // ID AMRSAP163 PN Cnd-m3a SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 7, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.55%, 'G': 18.18%, 'H': 0%, 'I': 0%, 'K': 31.82%, 'L': 13.64%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.55%, 'S': 0%, 'T': 4.55%, 'V': 13.64%, 'W': 4.55%, 'Y': 4.55% MA A, C, D, E, H, I, M, N, P, Q, S MO K LO F, R, T, W, Y BA 12 LA 10 AA 0 BC 8 MC 0 MF 0 XX MM 2534.176 AI 92.727 II -35.491 HP -0.432 HM 0.691 IP 11.546 NC 7.995 SF 0.409, 0.182, 0.136 [Helix, Turn, Sheet] AR 0.136 ME 6990, 6990 MS 48.161032 XX SC alpha_beta XX TO Staphylococcus aureus MRSA (MIC = 25-50 μG/mL TO MBC = 50-50 μG/mL) XX XR PubMed: 30790604 XR CAMP R4: CAMPSQ11324 SQ SEQUENCE 2534.176 DA MW 22AA WFGKLYRGKT KVVKKVKGLL KG // ID AMRSAP164 PN Sub5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 8.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 41.67%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, Y MO R LO K BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1724.137 AI 113.333 II 185.95 HP -0.9 HM 0.425 IP 13.105 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO MRSA 43300(MIC = 2 μM) XX XR PubMed: 30742402 XR CAMP R4: CAMPSQ11347 SQ SEQUENCE 1724.137 DA MW 12AA RRWKIVVIRW RR // ID AMRSAP165 PN Cu-1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 1, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 13.33%, 'H': 6.67%, 'I': 13.33%, 'K': 6.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 13.33%, 'Y': 0% MA A, C, D, E, F, L, M, N, P, Q, S, T, Y MO R LO H, K BA 8 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1975.382 AI 90.667 II 158.987 HP -0.987 HM 0.463 IP 13.105 NC 6.089 SF 0.4, 0.133, 0 [Helix, Turn, Sheet] AR 0.133 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO MRSA 43300(MIC = 1 μM) XX XR PubMed: 30742402 XR CAMP R4: CAMPSQ11348 SQ SEQUENCE 1975.382 DA MW 15AA GGHRRWKIVV IRWRR // ID AMRSAP166 PN Cu-2 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 1, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 18.75%, 'H': 6.25%, 'I': 12.5%, 'K': 6.25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 31.25%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, L, M, N, P, Q, S, T, Y MO R LO H, K BA 9 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2032.434 AI 85 II 143.194 HP -0.95 HM 0.528 IP 13.105 NC 6.089 SF 0.375, 0.188, 0 [Helix, Turn, Sheet] AR 0.125 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO MRSA 43300(MIC = 1.3 μM) XX XR PubMed: 30742402 XR CAMP R4: CAMPSQ11349 SQ SEQUENCE 2032.434 DA MW 16AA GGHGRRWKIV VIRWRR // ID AMRSAP167 PN WLBU2 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA (MIC = 3.2 � 1.1 μM) XX XR PubMed: 30702120 XR CAMP R4: CAMPSQ11389 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAP168 PN D8 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 13, 'S': 0, 'T': 0, 'V': 8, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.17%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 12.5%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R LO W BA 11 LA 13 AA 0 BC 13 MC 0 MF 0 XX MM 3400.153 AI 96.667 II 213.771 HP -1.15 HM 1.185 IP 13.579 NC 12.998 SF 0.458, 0, 0 [Helix, Turn, Sheet] AR 0.125 ME 16500, 16500 MS 78.261677 XX SC beta XX TO MRSA (MIC = 3.2 � 1.1 μM) XX XR PubMed: 30702120 XR CAMP R4: CAMPSQ11390 SQ SEQUENCE 3400.153 DA MW 24AA RRWVRRVRRW VRRVVRVVRR WVRR // ID AMRSAP169 PN Myeloid antimicrobial peptide BMAP-27 SO Bos taurus PL 18 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 38.89%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 5.56%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, M, N, P, Q, T, V, W, Y MO K LO G, S BA 7 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2342.952 AI 43.333 II -6.928 HP -1.289 HM 0.825 IP 12.843 NC 9.996 SF 0.333, 0.111, 0.111 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA (MIC = 4 μM) XX XR PubMed: 8910461 XR CAMP R4: CAMPSQ114 SQ SEQUENCE 2342.952 DA MW 18AA GRFKRFRKKF KKLFKKLS // ID AMRSAP170 PN Nigrocin-HLM SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 26.67%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, T, W, Y MO G LO A, F, S, V BA 12 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1472.834 AI 156 II -6.127 HP 1.267 HM 0.483 IP 10.805 NC 1.997 SF 0.467, 0.333, 0.267 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (NCTC12493) (MIC = 5.89 μG/L) XX XR PubMed: 30555431 XR CAMP R4: CAMPSQ11602 SQ SEQUENCE 1472.834 DA MW 15AA GLLSGILGAG KKIVF // ID AMRSAP171 PN Nigrocin-HLM SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 26.67%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, T, W, Y MO G LO A, F, S, V BA 12 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1472.834 AI 156 II -6.127 HP 1.267 HM 0.483 IP 10.805 NC 1.997 SF 0.467, 0.333, 0.267 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (ATCC43300) (MIC = 1.47 μG/L) XX XR PubMed: 30555431 XR CAMP R4: CAMPSQ11602 SQ SEQUENCE 1472.834 DA MW 15AA GLLSGILGAG KKIVF // ID AMRSAP172 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-1 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP173 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-2 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP174 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-3 (MIC = 32 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP175 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-4 (MIC = 8 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP176 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-5 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP177 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-6 (MIC = 8 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP178 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-7 (MIC = 8 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP179 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-8 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP180 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-9 (MIC = 32 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP181 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-10 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP182 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-11 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP183 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-12 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP184 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-13 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP185 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-14 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP186 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-15 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP187 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-16 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP188 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-17 (MIC = 8 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP189 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-18 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP190 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-19 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP191 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-20 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP192 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-21 (MIC = 16 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP193 PN Epinecidin-1 SO Epinephelus coioides PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 2, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 19.05%, 'H': 14.29%, 'I': 19.05%, 'K': 9.52%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, N, P, Q, R, S, T, W, Y MO G; I LO A, M, V BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2335.885 AI 130 II 34.781 HP 1.09 HM 0.586 IP 10.806 NC 2.27 SF 0.476, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 12.040258 XX SC alpha XX TO Bacterial isolate MRSA-22 (MIC = 8 mg/L) XX XR PubMed: 35052952 XR CAMP R4: CAMPSQ11604 SQ SEQUENCE 2335.885 DA MW 21AA GFIFHIIKGL FHAGKMIHGL V // ID AMRSAP194 PN FALL-39 SO Homo sapiens PL 39 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 2, 'E': 3, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 2.56%, 'C': 0%, 'D': 5.13%, 'E': 7.69%, 'F': 12.82%, 'G': 5.13%, 'H': 0%, 'I': 7.69%, 'K': 15.38%, 'L': 10.26%, AF 'M': 0%, 'N': 2.56%, 'P': 2.56%, 'Q': 2.56%, 'R': 12.82%, 'S': 5.13%, 'T': 2.56%, 'V': 5.13%, 'W': 0%, 'Y': 0% MA C, H, M, W, Y MO K LO A, N, P, Q, T BA 18 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4711.58 AI 87.436 II 22.659 HP -0.569 HM 0.966 IP 11.347 NC 6.002 SF 0.359, 0.154, 0.205 [Helix, Turn, Sheet] AR 0.128 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 XX XR PubMed: 7529412 XR CAMP R4: CAMPSQ1161 SQ SEQUENCE 4711.58 DA MW 39AA FALLGDFFRK SKEKIGKEFK RIVQRIKDFL RNLVPRTES // ID AMRSAP195 PN Peptide 5 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 3, 'L': 2, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.09%, 'H': 4.55%, 'I': 0%, 'K': 13.64%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 4.55%, 'Q': 0%, 'R': 18.18%, 'S': 0%, 'T': 4.55%, 'V': 4.55%, 'W': 4.55%, 'Y': 9.09% MA A, D, E, F, I, M, Q, S MO R LO H, P, T, V, W BA 7 LA 15 AA 0 BC 8 MC 0 MF 0 XX MM 2749.256 AI 48.636 II 37.35 HP -1.35 HM 0.48 IP 11.117 NC 6.962 SF 0.273, 0.227, 0.091 [Helix, Turn, Sheet] AR 0.136 ME 8480, 8605 MS 42.140903 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus CMRSA-1 (MIC = 8.1 μM) XX XR PubMed: 30540905 XR CAMP R4: CAMPSQ11612 SQ SEQUENCE 2749.256 DA MW 22AA KRKKHRCRVY NNGLPTGLYR WC // ID AMRSAP196 PN Peptide 5 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 3, 'L': 2, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.09%, 'H': 4.55%, 'I': 0%, 'K': 13.64%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 4.55%, 'Q': 0%, 'R': 18.18%, 'S': 0%, 'T': 4.55%, 'V': 4.55%, 'W': 4.55%, 'Y': 9.09% MA A, D, E, F, I, M, Q, S MO R LO H, P, T, V, W BA 7 LA 15 AA 0 BC 8 MC 0 MF 0 XX MM 2749.256 AI 48.636 II 37.35 HP -1.35 HM 0.48 IP 11.117 NC 6.962 SF 0.273, 0.227, 0.091 [Helix, Turn, Sheet] AR 0.136 ME 8480, 8605 MS 42.140903 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus CMRSA-2 (MIC = 2.0 μM) XX XR PubMed: 30540905 XR CAMP R4: CAMPSQ11612 SQ SEQUENCE 2749.256 DA MW 22AA KRKKHRCRVY NNGLPTGLYR WC // ID AMRSAP197 PN Peptide 5 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 3, 'L': 2, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.09%, 'H': 4.55%, 'I': 0%, 'K': 13.64%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 4.55%, 'Q': 0%, 'R': 18.18%, 'S': 0%, 'T': 4.55%, 'V': 4.55%, 'W': 4.55%, 'Y': 9.09% MA A, D, E, F, I, M, Q, S MO R LO H, P, T, V, W BA 7 LA 15 AA 0 BC 8 MC 0 MF 0 XX MM 2749.256 AI 48.636 II 37.35 HP -1.35 HM 0.48 IP 11.117 NC 6.962 SF 0.273, 0.227, 0.091 [Helix, Turn, Sheet] AR 0.136 ME 8480, 8605 MS 42.140903 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus CMRSA-3 (MIC = 4.1 μM) XX XR PubMed: 30540905 XR CAMP R4: CAMPSQ11612 SQ SEQUENCE 2749.256 DA MW 22AA KRKKHRCRVY NNGLPTGLYR WC // ID AMRSAP198 PN KR-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 8.33%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, E, G, H, M, N, P, S, T, W, Y MO R LO D, F, L, Q, V BA 5 LA 7 AA 1 BC 5 MC 0 MF 0 XX MM 1571.933 AI 121.667 II 31.95 HP -0.708 HM 0.966 IP 12.244 NC 3.998 SF 0.417, 0, 0.083 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA ATCC 33591 XX XR PubMed: 18818205 XR CAMP R4: CAMPSQ1162 SQ SEQUENCE 1571.933 DA MW 12AA KRIVQRIKDF LR // ID AMRSAP199 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 0706C0025 (MIC = 2 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP200 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 11004533801 (MIC = 2 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP201 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 11004691801 (MIC = 2 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP202 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 11004787401 (MIC = 2 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP203 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 11006153901 (MIC = 4 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP204 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 070170095 (MIC = 2 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP205 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA 0702E0196 (MIC = 2 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP206 PN AP138 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 10%, 'L': 2.5%, AF 'M': 0%, 'N': 2.5%, 'P': 2.5%, 'Q': 0%, 'R': 7.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, N, P, V, W BA 16 LA 24 AA 3 BC 9 MC 0 MF 0 XX MM 4460.099 AI 29.25 II 21.89 HP -0.645 HM 0.459 IP 8.613 NC 3.807 SF 0.225, 0.3, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 42.140903 XX SC beta XX TO MRSA XX XR PubMed: 30532539 XR CAMP R4: CAMPSQ11656 SQ SEQUENCE 4460.099 DA MW 40AA GFGCNGPWSE DDLRCHRHCK SIKGYRGGYC AKGGFVCKCY // ID AMRSAP207 PN MBjAMP-re SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 4.76%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2483.944 AI 65.238 II 55.762 HP -0.79 HM 0.636 IP 12.334 NC 5.965 SF 0.19, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 36.120774 XX SC alpha XX TO MRSA CCARM 3089 (MIC = 12.5 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11724 SQ SEQUENCE 2483.944 DA MW 21AA NLCASLRARH TIPQCRKFGR R // ID AMRSAP208 PN MBjAMP-re SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 4.76%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2483.944 AI 65.238 II 55.762 HP -0.79 HM 0.636 IP 12.334 NC 5.965 SF 0.19, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 36.120774 XX SC alpha XX TO MRSA CCARM 3090 (MIC = 25 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11724 SQ SEQUENCE 2483.944 DA MW 21AA NLCASLRARH TIPQCRKFGR R // ID AMRSAP209 PN MBjAMP-re SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 4.76%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2483.944 AI 65.238 II 55.762 HP -0.79 HM 0.636 IP 12.334 NC 5.965 SF 0.19, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 36.120774 XX SC alpha XX TO MRSA CCARM 3095 (MIC = 12.5 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11724 SQ SEQUENCE 2483.944 DA MW 21AA NLCASLRARH TIPQCRKFGR R // ID AMRSAP210 PN MBjAMP-ox SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 4.76%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2483.944 AI 65.238 II 55.762 HP -0.79 HM 0.636 IP 12.334 NC 5.965 SF 0.19, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 36.120774 XX SC alpha XX TO MRSA CCARM 3089 (MIC = 12.5 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11725 SQ SEQUENCE 2483.944 DA MW 21AA NLCASLRARH TIPQCRKFGR R // ID AMRSAP211 PN MBjAMP-ox SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 4.76%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2483.944 AI 65.238 II 55.762 HP -0.79 HM 0.636 IP 12.334 NC 5.965 SF 0.19, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 36.120774 XX SC alpha XX TO MRSA CCARM 3090 (MIC = 25 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11725 SQ SEQUENCE 2483.944 DA MW 21AA NLCASLRARH TIPQCRKFGR R // ID AMRSAP212 PN MBjAMP-ox SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 4.76%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2483.944 AI 65.238 II 55.762 HP -0.79 HM 0.636 IP 12.334 NC 5.965 SF 0.19, 0.19, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 36.120774 XX SC alpha XX TO MRSA CCARM 3095 (MIC = 12.5 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11725 SQ SEQUENCE 2483.944 DA MW 21AA NLCASLRARH TIPQCRKFGR R // ID AMRSAP213 PN MBjAMP-ser SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2451.823 AI 65.238 II 89.448 HP -1.105 HM 0.593 IP 13.105 NC 6.089 SF 0.19, 0.286, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA CCARM 3089 (MIC = 25 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11726 SQ SEQUENCE 2451.823 DA MW 21AA NLSASLRARH TIPQSRKFGR R // ID AMRSAP214 PN MBjAMP-ser SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2451.823 AI 65.238 II 89.448 HP -1.105 HM 0.593 IP 13.105 NC 6.089 SF 0.19, 0.286, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA CCARM 3090 (MIC = 50 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11726 SQ SEQUENCE 2451.823 DA MW 21AA NLSASLRARH TIPQSRKFGR R // ID AMRSAP215 PN MBjAMP-ser SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.52%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 4.76%, 'H': 4.76%, 'I': 4.76%, 'K': 4.76%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 4.76%, 'Q': 4.76%, 'R': 23.81%, 'S': 14.29%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, T BA 8 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2451.823 AI 65.238 II 89.448 HP -1.105 HM 0.593 IP 13.105 NC 6.089 SF 0.19, 0.286, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA CCARM 3095 (MIC = 25 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11726 SQ SEQUENCE 2451.823 DA MW 21AA NLSASLRARH TIPQSRKFGR R // ID AMRSAP216 PN MBjAMP-del SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 5.26%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 10.53%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 5.26%, 'R': 26.32%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2277.667 AI 72.105 II 64.547 HP -1.137 HM 0.427 IP 13.105 NC 6.089 SF 0.211, 0.211, 0.211 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA CCARM 3089 (MIC = 12.5 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11727 SQ SEQUENCE 2277.667 DA MW 19AA NLASLRARHT IPQRKFGRR // ID AMRSAP217 PN MBjAMP-del SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 5.26%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 10.53%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 5.26%, 'R': 26.32%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2277.667 AI 72.105 II 64.547 HP -1.137 HM 0.427 IP 13.105 NC 6.089 SF 0.211, 0.211, 0.211 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA CCARM 3090 (MIC = 25 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11727 SQ SEQUENCE 2277.667 DA MW 19AA NLASLRARHT IPQRKFGRR // ID AMRSAP218 PN MBjAMP-del SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 5.26%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 10.53%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 5.26%, 'R': 26.32%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO R LO F, G, H, I, K, N, P, Q, S, T BA 8 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2277.667 AI 72.105 II 64.547 HP -1.137 HM 0.427 IP 13.105 NC 6.089 SF 0.211, 0.211, 0.211 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA CCARM 3095 (MIC = 25 μM) XX XR PubMed: 30475621 XR CAMP R4: CAMPSQ11727 SQ SEQUENCE 2277.667 DA MW 19AA NLASLRARHT IPQRKFGRR // ID AMRSAP219 PN CopW SO Copris tripartitus PL 9 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC >= 80 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11773 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP220 PN CopW3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 5 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11774 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP221 PN DCopW SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 40 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11775 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP222 PN DCopW1 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 20 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11776 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP223 PN DCopW2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 2.5 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11777 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP224 PN DCopW3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 1.25 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11778 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP225 PN DCopW4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 5 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11779 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP226 PN DCopW5 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 80 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11780 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP227 PN DCopW6 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 56.6 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC >= 80 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11781 SQ SEQUENCE 1140.481 DA MW 9AA LLWIALRKK // ID AMRSAP228 PN Retro-dCopW3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO L LO A, I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1140.481 AI 184.444 II 58.822 HP 0.5 HM 0.209 IP 11.823 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO MRSA (KCCM 40510) (MIC = 1.25 μM) XX XR PubMed: 30393205 XR CAMP R4: CAMPSQ11782 SQ SEQUENCE 1140.481 DA MW 9AA KKRLAIWLL // ID AMRSAP229 PN MS-1 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 25%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, M, N, P, Q, S, W, Y MO K LO F, T, V BA 6 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1514.964 AI 154.167 II 54.283 HP 0.183 HM 0.346 IP 12.546 NC 4.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO Gentamicin-resistant MRSA (MIC=4 μM) XX XR PubMed: 28479275 XR CAMP R4: CAMPSQ11787 SQ SEQUENCE 1514.964 DA MW 12AA KRKIFLRTKI LV // ID AMRSAP230 PN MS-2 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 25%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, M, N, P, Q, S, W, Y MO K LO F, T, V BA 6 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1514.964 AI 154.167 II 54.283 HP 0.183 HM 0.346 IP 12.546 NC 4.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO Gentamicin-resistant MRSA (MIC=6 μM) XX XR PubMed: 28479275 XR CAMP R4: CAMPSQ11788 SQ SEQUENCE 1514.964 DA MW 12AA KRKIFLRTKI LV // ID AMRSAP231 PN MS-3 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 25%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, M, N, P, Q, S, W, Y MO K LO F, T, V BA 6 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1514.964 AI 154.167 II 22.183 HP 0.183 HM 0.346 IP 12.546 NC 4.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO Gentamicin-resistant MRSA (MIC=8 μM) XX XR PubMed: 28479275 XR CAMP R4: CAMPSQ11789 SQ SEQUENCE 1514.964 DA MW 12AA VLIKTRLFIK RK // ID AMRSAP232 PN MS-4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 25%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, M, N, P, Q, S, W, Y MO K LO F, T, V BA 6 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1514.964 AI 154.167 II 22.183 HP 0.183 HM 0.346 IP 12.546 NC 4.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO Gentamicin-resistant MRSA (MIC=8 μM) XX XR PubMed: 28479275 XR CAMP R4: CAMPSQ11790 SQ SEQUENCE 1514.964 DA MW 12AA VLIKTRLFIK RK // ID AMRSAP233 PN MS-5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 25%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, M, N, P, Q, S, W, Y MO K LO F, T, V BA 6 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1514.964 AI 154.167 II 54.283 HP 0.183 HM 0.346 IP 12.546 NC 4.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO Gentamicin-resistant MRSA (MIC=3 μM) XX XR PubMed: 28479275 XR CAMP R4: CAMPSQ11791 SQ SEQUENCE 1514.964 DA MW 12AA KRKIFLRTKI LV // ID AMRSAP234 PN MS-6 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 25%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, M, N, P, Q, S, W, Y MO K LO F, T, V BA 6 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1514.964 AI 154.167 II 22.183 HP 0.183 HM 0.346 IP 12.546 NC 4.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO Gentamicin-resistant MRSA (MIC=4 μM) XX XR PubMed: 28479275 XR CAMP R4: CAMPSQ11792 SQ SEQUENCE 1514.964 DA MW 12AA VLIKTRLFIK RK // ID AMRSAP235 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 0706C0025 (MIC = 4 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP236 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 11004533801 (MIC = 4 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP237 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 11004691801 (MIC = 4 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP238 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 11004787401 (MIC = 8 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP239 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 11006153901 (MIC = 8 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP240 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 070170095 (MIC = 4 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP241 PN AP114 SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 2, 'E': 1, 'F': 2, 'G': 8, 'H': 2, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 3 AF 'A': 2.5%, 'C': 15%, 'D': 5%, 'E': 2.5%, 'F': 5%, 'G': 20%, 'H': 5%, 'I': 2.5%, 'K': 12.5%, 'L': 2.5%, AF 'M': 0%, 'N': 7.5%, 'P': 2.5%, 'Q': 0%, 'R': 2.5%, 'S': 2.5%, 'T': 0%, 'V': 2.5%, 'W': 2.5%, 'Y': 7.5% MA M, Q, T MO G LO A, E, I, L, P, R, S, V, W BA 16 LA 24 AA 3 BC 8 MC 0 MF 0 XX MM 4417.027 AI 29.25 II 25.493 HP -0.673 HM 0.358 IP 8.377 NC 2.807 SF 0.225, 0.325, 0.075 [Helix, Turn, Sheet] AR 0.15 ME 9970, 10345 MS 36.120774 XX SC beta XX TO MRSA 0702E0196 (MIC = 4 μG/mL) XX XR PubMed: 28848347 XR CAMP R4: CAMPSQ11796 SQ SEQUENCE 4417.027 DA MW 40AA GFGCNGPWNE DDLRCHNHCK SIKGYKGGYC AKGGFVCKCY // ID AMRSAP242 PN Medusin-PT SO Phyllomedusa tarsius PL 18 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 1, 'L': 4, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 16.67%, 'K': 5.56%, 'L': 22.22%, AF 'M': 5.56%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 0%, 'S': 11.11%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, N, Q, R, W, Y MO L LO G, K, M, P, T, V BA 14 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 1811.297 AI 184.444 II 13.828 HP 1.778 HM 0.391 IP 9.7 NC 0.998 SF 0.444, 0.222, 0.444 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (MIC > 512 μG/mL) XX XR PubMed: 28469603 XR CAMP R4: CAMPSQ11802 SQ SEQUENCE 1811.297 DA MW 18AA LLGMIPVAIT AISALSKL // ID AMRSAP243 PN Medusin-PT1 SO Phyllomedusa tarsius PL 18 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 2, 'L': 4, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 16.67%, 'K': 11.11%, 'L': 22.22%, AF 'M': 5.56%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 0%, 'S': 11.11%, 'T': 0%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, N, Q, R, T, W, Y MO L LO G, M, P, V BA 14 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1838.366 AI 184.444 II 9.111 HP 1.6 HM 0.512 IP 10.805 NC 1.997 SF 0.444, 0.222, 0.444 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 16 μG/mL) XX XR PubMed: 28469603 XR CAMP R4: CAMPSQ11803 SQ SEQUENCE 1838.366 DA MW 18AA LLGMIPVAIK AISALSKL // ID AMRSAP244 PN Medusin-PT1a SO Phyllomedusa tarsius PL 18 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 2, 'L': 4, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 16.67%, 'K': 11.11%, 'L': 22.22%, AF 'M': 5.56%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 0%, 'S': 11.11%, 'T': 0%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, N, Q, R, T, W, Y MO L LO G, M, P, V BA 14 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1838.366 AI 184.444 II 9.111 HP 1.6 HM 0.512 IP 10.805 NC 1.997 SF 0.444, 0.222, 0.444 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 16 μG/mL) XX XR PubMed: 28469603 XR CAMP R4: CAMPSQ11804 SQ SEQUENCE 1838.366 DA MW 18AA LLGMIPVAIK AISALSKL // ID AMRSAP245 PN Medusin-PT2 SO Phyllomedusa tarsius PL 17 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 2, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 17.65%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 17.65%, 'K': 11.76%, 'L': 17.65%, AF 'M': 5.88%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.76%, 'T': 5.88%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, N, P, Q, R, W, Y MO A; I; L LO G, M, T, V BA 12 LA 5 AA 0 BC 2 MC 0 MF 0 XX MM 1729.195 AI 172.353 II -0.576 HP 1.524 HM 0.413 IP 10.805 NC 1.997 SF 0.412, 0.176, 0.412 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 32 μG/mL) XX XR PubMed: 28469603 XR CAMP R4: CAMPSQ11805 SQ SEQUENCE 1729.195 DA MW 17AA LLGMIKVAIT AISALSK // ID AMRSAP246 PN GVF27 SO Homo Sapiens PL 27 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 7, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 1 AF 'A': 3.7%, 'C': 3.7%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 3.7%, 'H': 0%, 'I': 3.7%, 'K': 0%, 'L': 18.52%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 25.93%, 'S': 0%, 'T': 0%, 'V': 3.7%, 'W': 11.11%, 'Y': 3.7% MA D, E, H, K, M, N, Q, S, T MO R LO A, C, G, I, V, Y BA 18 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 3575.382 AI 101.111 II 95.156 HP -0.011 HM 0.714 IP 12.626 NC 6.935 SF 0.519, 0.148, 0.222 [Helix, Turn, Sheet] AR 0.259 ME 17990, 17990 MS 42.140903 XX SC alpha_beta XX TO MRSA WKZ-2 (MIC = 5 μM) XX XR PubMed: 28454736 XR CAMP R4: CAMPSQ11819 SQ SEQUENCE 3575.382 DA MW 27AA GVFYPWRFRL LCLLRRWLPR PRAWFIR // ID AMRSAP247 PN DiPGLa-H SO Xenopus laevis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 30%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10%, 'K': 30%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, R, S, T, W, Y MO A; K LO I, V BA 14 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2090.754 AI 176 II -20.215 HP 1 HM 0.714 IP 11.5 NC 5.996 SF 0.4, 0, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC=2 μG/mL) XX XR PubMed: 28426232 XR CAMP R4: CAMPSQ11844 SQ SEQUENCE 2090.754 DA MW 20AA KIAKVALKAL KIAKVALKAL // ID AMRSAP248 PN Kiadin SO Xenopus laevis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 30%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5%, 'H': 0%, 'I': 10%, 'K': 30%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, T, W, Y MO A; K LO G, V BA 14 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2048.674 AI 161.5 II -24.46 HP 0.77 HM 0.714 IP 11.5 NC 5.996 SF 0.35, 0.05, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC=16 μG/mL) XX XR PubMed: 28426232 XR CAMP R4: CAMPSQ11845 SQ SEQUENCE 2048.674 DA MW 20AA KIAKVALKAL KIAKGALKAL // ID AMRSAP249 PN LL-37 SO Homo sapiens PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA 6313 (MIC > 28.5 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ11864 SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP250 PN LL-37 SO Homo sapiens PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA 6381 (MIC > 28.5 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ11864 SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP251 PN LL-37 SO Homo sapiens PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33592 (MIC > 28.5 μM) XX XR PubMed: 31396193 XR CAMP R4: CAMPSQ11864 SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP252 PN GIBIM-P5S9K SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 17.65%, 'H': 0%, 'I': 11.76%, 'K': 29.41%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA D, E, H, M, N, P, Q, R, S, W, Y MO K LO A, C, F, T, V BA 10 LA 7 AA 0 BC 5 MC 0 MF 0 XX MM 1804.311 AI 114.706 II -18.065 HP 0.382 HM 0.696 IP 10.979 NC 4.935 SF 0.353, 0.176, 0.176 [Helix, Turn, Sheet] AR 0.059 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA (MIC = 1.0�10.0 μM TO MBC = 75 μM) XX XR PubMed: 28266350 XR CAMP R4: CAMPSQ11910 SQ SEQUENCE 1804.311 DA MW 17AA ATKKCGLFKI LKGVGKI // ID AMRSAP253 PN Saha-CATH1 SO Sarcophilus harrisii PL 30 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 2, 'F': 1, 'G': 1, 'H': 1, 'I': 3, 'K': 6, 'L': 2, AC 'M': 1, 'N': 1, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 3, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 6.67%, 'D': 3.33%, 'E': 6.67%, 'F': 3.33%, 'G': 3.33%, 'H': 3.33%, 'I': 10%, 'K': 20%, 'L': 6.67%, AF 'M': 3.33%, 'N': 3.33%, 'P': 3.33%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA Q, S, V, W, Y MO K LO D, F, G, H, M, N, P BA 12 LA 18 AA 3 BC 9 MC 0 MF 0 XX MM 3445.163 AI 75 II 47.667 HP -0.583 HM 0.418 IP 10.503 NC 4.967 SF 0.2, 0.1, 0.267 [Helix, Turn, Sheet] AR 0.033 ME 0, 125 MS 48.161032 XX SC beta XX TO Methicillin resistant S. aureus (MRSA) (MIC > 64 μG/mL) XX XR PubMed: 27725697 XR CAMP R4: CAMPSQ12009 SQ SEQUENCE 3445.163 DA MW 30AA GIKHILFMAK TKLPRATCTA EIKENCDRKK // ID AMRSAP254 PN Saha-CATH2 SO Sarcophilus harrisii PL 36 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 5, 'H': 1, 'I': 1, 'K': 6, 'L': 3, AC 'M': 1, 'N': 3, 'P': 2, 'Q': 0, 'R': 3, 'S': 3, 'T': 1, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 2.78%, 'F': 2.78%, 'G': 13.89%, 'H': 2.78%, 'I': 2.78%, 'K': 16.67%, 'L': 8.33%, AF 'M': 2.78%, 'N': 8.33%, 'P': 5.56%, 'Q': 0%, 'R': 8.33%, 'S': 8.33%, 'T': 2.78%, 'V': 2.78%, 'W': 0%, 'Y': 5.56% MA C, D, Q, W MO K LO E, F, H, I, M, T, V BA 16 LA 20 AA 1 BC 10 MC 0 MF 0 XX MM 4004.672 AI 56.944 II 43.858 HP -1.017 HM 0.445 IP 11.428 NC 8.087 SF 0.222, 0.361, 0.194 [Helix, Turn, Sheet] AR 0.083 ME 2980, 2980 MS 54.181161 XX SC alpha XX TO Methicillin resistant S. aureus (MRSA) (MIC > 64 μG/mL) XX XR PubMed: 27725697 XR CAMP R4: CAMPSQ12010 SQ SEQUENCE 4004.672 DA MW 36AA TFKRKNGSRK NGHRPGGYSL IALGNKKVLK APYMES // ID AMRSAP255 PN Saha-CATH4 SO Sarcophilus harrisii PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 5, 'E': 2, 'F': 4, 'G': 1, 'H': 0, 'I': 4, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 2, 'R': 8, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 0%, 'D': 13.51%, 'E': 5.41%, 'F': 10.81%, 'G': 2.7%, 'H': 0%, 'I': 10.81%, 'K': 8.11%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 0%, 'Q': 5.41%, 'R': 21.62%, 'S': 2.7%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 5.41% MA A, C, H, M, P, T, V, W MO R LO G, N, S BA 13 LA 24 AA 7 BC 11 MC 0 MF 0 XX MM 4820.54 AI 84.324 II 43.176 HP -1.138 HM 0.886 IP 10.684 NC 4.001 SF 0.378, 0.081, 0.162 [Helix, Turn, Sheet] AR 0.162 ME 2980, 2980 MS 66.221419 XX SC beta XX TO Methicillin resistant S. aureus (MRSA) (MIC > 64 μG/mL) XX XR PubMed: 27725697 XR CAMP R4: CAMPSQ12012 SQ SEQUENCE 4820.54 DA MW 37AA KREDFLDQII RDFRNFIYQK YRRLRDEFRK LRDILSG // ID AMRSAP256 PN Saha-CATH5 SO Sarcophilus harrisii PL 20 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 4, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 20%, 'K': 10%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, S, T, V, W, Y MO L; R LO K BA 13 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2301.943 AI 175.5 II 70.595 HP 0.255 HM 0.975 IP 13.107 NC 6.997 SF 0.45, 0.2, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO Methicillin resistant S. aureus (MRSA) (MIC = 32 μG/mL) XX XR PubMed: 27725697 XR CAMP R4: CAMPSQ12013 SQ SEQUENCE 2301.943 DA MW 20AA KRIGLIRLIG KILRGLRRLG // ID AMRSAP257 PN Saha-CATH6 SO Sarcophilus harrisii PL 29 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 3, 'E': 1, 'F': 4, 'G': 1, 'H': 0, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 9, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 10.34%, 'E': 3.45%, 'F': 13.79%, 'G': 3.45%, 'H': 0%, 'I': 13.79%, 'K': 6.9%, 'L': 6.9%, AF 'M': 0%, 'N': 6.9%, 'P': 0%, 'Q': 0%, 'R': 31.03%, 'S': 3.45%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, H, M, P, Q, T, V, W, Y MO R LO E, G, S BA 11 LA 18 AA 4 BC 11 MC 0 MF 0 XX MM 3794.433 AI 80.69 II 16.483 HP -1.162 HM 0.845 IP 12.412 NC 7 SF 0.345, 0.138, 0.103 [Helix, Turn, Sheet] AR 0.138 ME 0, 0 MS 66.221419 XX SC beta XX TO Methicillin resistant S. aureus (MRSA) (MIC > 64 μG/mL) XX XR PubMed: 27725697 XR CAMP R4: CAMPSQ12014 SQ SEQUENCE 3794.433 DA MW 29AA KRIRFFERIR DRLRDLGNRI KNRIRDFFS // ID AMRSAP258 PN Persulcatusin SO Ixodes persulcatus PL 38 TX Animalia (Insect ) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MR-1 (MRSA) (MIC = 2 μG/mL) XX XR PubMed: 27531221 XR CAMP R4: CAMPSQ12017 SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP259 PN IR SO Ixodes ricinus PL 37 TX Animalia (Insect ) PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 1, 'E': 0, 'F': 4, 'G': 6, 'H': 2, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 3 AF 'A': 2.7%, 'C': 16.22%, 'D': 2.7%, 'E': 0%, 'F': 10.81%, 'G': 16.22%, 'H': 5.41%, 'I': 2.7%, 'K': 10.81%, 'L': 2.7%, AF 'M': 0%, 'N': 0%, 'P': 2.7%, 'Q': 2.7%, 'R': 8.11%, 'S': 2.7%, 'T': 2.7%, 'V': 2.7%, 'W': 0%, 'Y': 8.11% MA E, M, N, W MO C; G LO A, D, I, L, P, Q, S, T, V BA 15 LA 22 AA 1 BC 9 MC 0 MF 0 XX MM 4237.984 AI 31.622 II 50.027 HP -0.308 HM 0.804 IP 9.129 NC 5.805 SF 0.27, 0.216, 0.054 [Helix, Turn, Sheet] AR 0.189 ME 4470, 4845 MS 42.140903 XX SC beta XX TO MR-1 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 27531221 XR CAMP R4: CAMPSQ12018 SQ SEQUENCE 4237.984 DA MW 37AA GGYYCPFFQD KCHRHCRSFG RKAGYCGGFL KKTCICV // ID AMRSAP260 PN HAE SO Haemaphysalis longicornis PL 36 TX Animalia (Insect) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 0, 'G': 6, 'H': 2, 'I': 3, 'K': 2, 'L': 1, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 2, 'R': 4, 'S': 1, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.56%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 16.67%, 'H': 5.56%, 'I': 8.33%, 'K': 5.56%, 'L': 2.78%, AF 'M': 0%, 'N': 5.56%, 'P': 2.78%, 'Q': 5.56%, 'R': 11.11%, 'S': 2.78%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA D, E, F, M, V, W MO C; G LO L, P, S BA 13 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 3926.561 AI 48.889 II 71.506 HP -0.531 HM 0.649 IP 9.175 NC 5.806 SF 0.167, 0.278, 0.083 [Helix, Turn, Sheet] AR 0.056 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MR-1 (MRSA) (MIC > 32 μG/mL) XX XR PubMed: 27531221 XR CAMP R4: CAMPSQ12019 SQ SEQUENCE 3926.561 DA MW 36AA GCPLNQGACH NHCRSIGRRG GYCAGIIKQT CTCYRK // ID AMRSAP261 PN OMBAC SO Ornithodoros moubata PL 37 TX Animalia (Insect ) PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 0, 'E': 1, 'F': 3, 'G': 7, 'H': 2, 'I': 0, 'K': 3, 'L': 1, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 2, 'R': 0, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 4 AF 'A': 2.7%, 'C': 16.22%, 'D': 0%, 'E': 2.7%, 'F': 8.11%, 'G': 18.92%, 'H': 5.41%, 'I': 0%, 'K': 8.11%, 'L': 2.7%, AF 'M': 0%, 'N': 5.41%, 'P': 5.41%, 'Q': 5.41%, 'R': 0%, 'S': 2.7%, 'T': 2.7%, 'V': 2.7%, 'W': 0%, 'Y': 10.81% MA D, I, M, R, W MO G LO A, E, L, S, T, V BA 15 LA 22 AA 1 BC 5 MC 0 MF 0 XX MM 4068.622 AI 21.081 II 33.341 HP -0.408 HM 0.403 IP 8.116 NC 1.805 SF 0.243, 0.324, 0.081 [Helix, Turn, Sheet] AR 0.189 ME 5960, 6335 MS 18.060387 XX SC beta XX TO MR-1 (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 27531221 XR CAMP R4: CAMPSQ12020 SQ SEQUENCE 4068.622 DA MW 37AA GFGCPFNQYE CHAHCSGVPG YKGGYCKGLF KQTCNCY // ID AMRSAP262 PN BMAP28 SO Bos taurus PL 27 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 6, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 3.7%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.81%, 'H': 0%, 'I': 22.22%, 'K': 14.81%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 7.41%, 'Q': 0%, 'R': 11.11%, 'S': 3.7%, 'T': 0%, 'V': 3.7%, 'W': 3.7%, 'Y': 3.7% MA C, D, E, F, H, M, N, Q, T MO I LO A, S, V, W, Y BA 18 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 3046.829 AI 144.444 II 46.43 HP 0.278 HM 0.871 IP 12.284 NC 6.996 SF 0.444, 0.259, 0.148 [Helix, Turn, Sheet] AR 0.074 ME 6990, 6990 MS 42.140903 XX SC alpha_beta XX TO MR-1 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 27531221 XR CAMP R4: CAMPSQ12021 SQ SEQUENCE 3046.829 DA MW 27AA GGLRSLGKKI LRAWKKYGPI IVPIIRI // ID AMRSAP263 PN BcDef1 SO Brugmansia x candida PL 17 TX Plantae (Dicotyledonae) PE Experimentally validated XX AC 'A': 0, 'C': 3, 'D': 1, 'E': 0, 'F': 2, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 17.65%, 'D': 5.88%, 'E': 0%, 'F': 11.76%, 'G': 17.65%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 5.88%, 'T': 5.88%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, E, H, I, K, M, N, P, Q, V, W, Y MO R LO D, L, S, T BA 6 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 1990.309 AI 22.941 II 109.571 HP -0.694 HM 0.547 IP 10.465 NC 3.812 SF 0.176, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 0, 125 MS 30.100645 XX SC alpha XX TO MRSA ATCC 43300 (MIC>= 251.21 μM) XX XR PubMed: 30071099 XR CAMP R4: CAMPSQ12079 SQ SEQUENCE 1990.309 DA MW 17AA FSGGDCRGLR RRCFCTR // ID AMRSAP264 PN Gomesin AgGom SO Acanthoscurria gomesiana PL 19 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 11.11%, 'R': 27.78%, 'S': 0%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 11.11% MA A, D, E, F, H, I, M, N, P, S, W MO R LO G, K, L, T, V, Z BA 3 LA 15 AA 0 BC 6 MC {'Z': 1} MF {'Z': 0.05263157894736842} XX MM 2292.744 AI 35.789 II 35.211 HP -1.005 HM 0.47 IP 10.068 NC 5.748 SF 0.211, 0.053, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 2980, 3230 MS 36.120774 XX SC beta XX TO Staphylococcus aureus ATCC 43300 MRSA (MIC > 28 μM TO MBC > 28 μM) XX XR PubMed: 30068931 XR CAMP R4: CAMPSQ12085 SQ SEQUENCE 2292.744 DA MW 19AA ZQCRRLCYKQ RCVTYCRGR // ID AMRSAP265 PN Gomesin AgGom SO Acanthoscurria gomesiana PL 19 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 11.11%, 'R': 27.78%, 'S': 0%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 11.11% MA A, D, E, F, H, I, M, N, P, S, W MO R LO G, K, L, T, V, Z BA 3 LA 15 AA 0 BC 6 MC {'Z': 1} MF {'Z': 0.05263157894736842} XX MM 2292.744 AI 35.789 II 35.211 HP -1.005 HM 0.47 IP 10.068 NC 5.748 SF 0.211, 0.053, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 2980, 3230 MS 36.120774 XX SC beta XX TO Staphylococcus aureus ATCC 29213 MRSA (MIC > 28 μM TO MBC > 28 μM) XX XR PubMed: 30068931 XR CAMP R4: CAMPSQ12085 SQ SEQUENCE 2292.744 DA MW 19AA ZQCRRLCYKQ RCVTYCRGR // ID AMRSAP266 PN HiGom SO Hadronyche infensa PL 19 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 6, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 5.56%, 'R': 33.33%, 'S': 0%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 11.11% MA A, D, E, F, H, I, K, M, P, S, W MO R LO G, L, N, Q, T, V, Z BA 3 LA 15 AA 0 BC 6 MC {'Z': 1} MF {'Z': 0.05263157894736842} XX MM 2306.731 AI 35.789 II 20.342 HP -1.037 HM 0.447 IP 10.171 NC 5.748 SF 0.211, 0.105, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 2980, 3230 MS 36.120774 XX SC beta XX TO Staphylococcus aureus ATCC 43300 MRSA (MIC > 28 μM TO MBC > 28 μM) XX XR PubMed: 30068931 XR CAMP R4: CAMPSQ12086 SQ SEQUENCE 2306.731 DA MW 19AA ZQCRRLCYRN RCVTYCRGR // ID AMRSAP267 PN HiGom SO Hadronyche infensa PL 19 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 6, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 5.56%, 'R': 33.33%, 'S': 0%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 11.11% MA A, D, E, F, H, I, K, M, P, S, W MO R LO G, L, N, Q, T, V, Z BA 3 LA 15 AA 0 BC 6 MC {'Z': 1} MF {'Z': 0.05263157894736842} XX MM 2306.731 AI 35.789 II 20.342 HP -1.037 HM 0.447 IP 10.171 NC 5.748 SF 0.211, 0.105, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 2980, 3230 MS 36.120774 XX SC beta XX TO Staphylococcus aureus ATCC 29213 MRSA (MIC > 28 μM TO MBC > 28 μM) XX XR PubMed: 30068931 XR CAMP R4: CAMPSQ12086 SQ SEQUENCE 2306.731 DA MW 19AA ZQCRRLCYRN RCVTYCRGR // ID AMRSAP268 PN OLAP-1 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 16, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 76.19%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 9.52%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 21 AA 0 BC 5 MC 0 MF 0 XX MM 2393.147 AI 0 II 36.8 HP 0.89 HM 0.262 IP 8.125 NC 4.006 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1000 MS 30.100645 XX SC beta XX TO MRSA DM9808R (MIC = 12.5 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12088 SQ SEQUENCE 2393.147 DA MW 21AA CCCCCCCCR- CCCCCCCCRR KK // ID AMRSAP269 PN OLAP-2 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 14, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 73.68%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 10.53%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.79%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 19 AA 0 BC 5 MC 0 MF 0 XX MM 2186.869 AI 0 II 39.621 HP 0.721 HM 0.262 IP 8.205 NC 4.13 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 875 MS 30.100645 XX SC beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12089 SQ SEQUENCE 2186.869 DA MW 19AA CCCCCCR-CC CCCCCCRRKK // ID AMRSAP270 PN OLAP- 3 SO Synthetic construct PL 30 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 24, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 80%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 6.67%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 13.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 30 AA 0 BC 6 MC 0 MF 0 XX MM 3374.445 AI 0 II 28.76 HP 1.14 HM 0.262 IP 8.003 NC 4.51 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1500 MS 36.120774 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 6.25 μG/mL XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12090 SQ SEQUENCE 3374.445 DA MW 30AA CCCCCCCCR- CCCCCCCCRC CCCCCCCRRK K // ID AMRSAP271 PN OLAP- 4 SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 32, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 84.21%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.26%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10.53%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 38 AA 0 BC 6 MC 0 MF 0 XX MM 4199.555 AI 0 II 24.811 HP 1.426 HM 0.33 IP 7.849 NC 4.014 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 2000 MS 36.120774 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 25 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12091 SQ SEQUENCE 4199.555 DA MW 38AA CCCCCCCCR- CCCCCCCCCC CCRCCCCCCC CCCCCRRKK // ID AMRSAP272 PN OLAP- 5 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 18, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 78.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.7%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 13.04%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 23 AA 0 BC 5 MC 0 MF 0 XX MM 2599.424 AI 0 II 34.47 HP 1.03 HM 0.262 IP 8.057 NC 3.882 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1125 MS 30.100645 XX SC beta XX TO MRSA DM9808R (MIC = 12.5 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12092 SQ SEQUENCE 2599.424 DA MW 23AA CCCCCCCCCC R-CCCCCCCC RRKK // ID AMRSAP273 PN OLAP- 6 SO Synthetic construct PL 51 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 44, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 86.27%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 3.92%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 9.8%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 51 AA 0 BC 7 MC 0 MF 0 XX MM 5593.408 AI 0 II 21.035 HP 1.563 HM 0.33 IP 7.767 NC 4.27 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 2750 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12093 SQ SEQUENCE 5593.408 DA MW 51AA CCCCCCCCR- CCCCCCCCCC CCRCCCCCCC CCCCCRCCCC CCCCCCCCRR KK // ID AMRSAP274 PN OLAP - 7 SO Synthetic construct PL 27 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 22, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 81.48%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 7.41%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 27 AA 0 BC 5 MC 0 MF 0 XX MM 3011.98 AI 0 II 30.844 HP 1.248 HM 0.33 IP 7.947 NC 3.634 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1375 MS 30.100645 XX SC alpha+beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12094 SQ SEQUENCE 3011.98 DA MW 27AA CCCCCCCCCC R-CCCCCCCC CCCCRRKK // ID AMRSAP275 PN OLAP- 8 SO Synthetic construct PL 32 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 26, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 81.25%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 6.25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 32 AA 0 BC 6 MC 0 MF 0 XX MM 3580.722 AI 0 II 27.588 HP 1.225 HM 0.262 IP 7.959 NC 4.386 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1625 MS 36.120774 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 6.25 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12095 SQ SEQUENCE 3580.722 DA MW 32AA CCCCCCCCCC R-CCCCCCCC RCCCCCCCCR RKK // ID AMRSAP276 PN OLAP- 9 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 20, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 80%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 25 AA 0 BC 5 MC 0 MF 0 XX MM 2805.702 AI 0 II 32.512 HP 1.148 HM 0.33 IP 7.999 NC 3.758 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1250 MS 30.100645 XX SC beta XX TO MRSA DM9808R (MIC = 6.25 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12096 SQ SEQUENCE 2805.702 DA MW 25AA CCCCCCCCR- CCCCCCCCCC CCRRKK // ID AMRSAP277 PN OLAP- 10 SO Synthetic construct PL 41 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 34, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 82.93%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 4.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.2%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 41 AA 0 BC 7 MC 0 MF 0 XX MM 4562.02 AI 0 II 23.727 HP 1.334 HM 0.262 IP 7.9 NC 4.89 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 2125 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 12.5 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12097 SQ SEQUENCE 4562.02 DA MW 41AA CCCCCCCCCC R-CCCCCCCC RCCCCCCCCR CCCCCCCCRR KK // ID AMRSAP278 PN OLAP- 11 SO Synthetic construct PL 39 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 32, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 82.05%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.13%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.82%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 39 AA 0 BC 7 MC 0 MF 0 XX MM 4355.743 AI 0 II 24.431 HP 1.274 HM 0.262 IP 7.933 NC 5.014 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 2000 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 6.25 μG/mL XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12098 SQ SEQUENCE 4355.743 DA MW 39AA CCCCCCCCR- CCCCCCCCRC CCCCCCCRCC CCCCCCRRKK // ID AMRSAP279 PN OLAP- 12 SO Synthetic construct PL 43 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 36, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 83.72%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 4.65%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.63%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 43 AA 0 BC 7 MC 0 MF 0 XX MM 4768.298 AI 0 II 23.088 HP 1.388 HM 0.262 IP 7.87 NC 4.766 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 2250 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12099 SQ SEQUENCE 4768.298 DA MW 43AA CCCCCCCCCC CCR-CCCCCC CCRCCCCCCC CRCCCCCCCC RRKK // ID AMRSAP280 PN OLAP- 13 SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 32, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 84.21%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.26%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10.53%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 38 AA 0 BC 6 MC 0 MF 0 XX MM 4199.555 AI 0 II 9.737 HP 1.426 HM 0.262 IP 7.849 NC 4.014 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 2000 MS 36.120774 XX SC alpha+beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12100 SQ SEQUENCE 4199.555 DA MW 38AA RCCCCCCCC- RCCCCCCCC- RCCCCCCCC- RCCCCCCCC2 KK // ID AMRSAP281 PN OLAP - 14 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 12, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 70.59%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 11.76%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 17.65%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 17 AA 0 BC 5 MC 0 MF 0 XX MM 1980.592 AI 0 II 43.106 HP 0.512 HM 0.568 IP 8.302 NC 4.254 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 750 MS 30.100645 XX SC beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12101 SQ SEQUENCE 1980.592 DA MW 17AA CCCCCCR-CC CCCCRRKK // ID AMRSAP282 PN OLAP- 15 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 18, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 75%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 24 AA 0 BC 6 MC 0 MF 0 XX MM 2755.612 AI 0 II 33.45 HP 0.8 HM 0.568 IP 8.169 NC 4.882 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1125 MS 36.120774 XX SC beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12102 SQ SEQUENCE 2755.612 DA MW 24AA CCCCCCR-CC CCCCRCCCCC CRRKK // ID AMRSAP283 PN OLAP- 16 SO Synthetic construct PL 31 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 24, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 77.42%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 6.45%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.13%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 31 AA 0 BC 7 MC 0 MF 0 XX MM 3530.632 AI 0 II 28.155 HP 0.958 HM 0.568 IP 8.093 NC 5.51 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1500 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12103 SQ SEQUENCE 3530.632 DA MW 31AA CCCCCCR-CC CCCCRCCCCC CRCCCCCCRR KK // ID AMRSAP284 PN OLAP- 17 SO Synthetic construct PL 28 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 22, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 78.57%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 7.14%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 28 AA 0 BC 6 MC 0 MF 0 XX MM 3168.167 AI 0 II 30.1 HP 1.043 HM 0.262 IP 8.051 NC 4.634 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1375 MS 36.120774 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12104 SQ SEQUENCE 3168.167 DA MW 28AA CCCCCCR-CC CCCCCCRCCC CCCCCRRKK // ID AMRSAP285 PN OLAP - 18 SO Synthetic construct PL 33 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 26, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 78.79%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 6.06%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.15%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 33 AA 0 BC 7 MC 0 MF 0 XX MM 3736.91 AI 0 II 27.055 HP 1.052 HM 0.568 IP 8.047 NC 5.386 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1625 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 12.5 μG/mL XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12105 SQ SEQUENCE 3736.91 DA MW 33AA CCCCCCCCR- CCCCCCRCCC CCCR-CCCCC CRRKK // ID AMRSAP286 PN OLAP- 19 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 18, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 72%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 25 AA 0 BC 7 MC 0 MF 0 XX MM 2911.799 AI 0 II 32.512 HP 0.588 HM 0.255 IP 8.27 NC 5.882 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1125 MS 42.140903 XX SC beta XX TO MRSA DM9808R (MIC >= 50 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12106 SQ SEQUENCE 2911.799 DA MW 25AA CCCCCCR-CC CCRCCCCRCC CCRRKK // ID AMRSAP287 PN OLAP - 20 SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 30, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 81.08%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.41%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 13.51%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 37 AA 0 BC 7 MC 0 MF 0 XX MM 4149.465 AI 0 II 25.211 HP 1.208 HM 0.262 IP 7.968 NC 5.138 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 1875 MS 42.140903 XX SC alpha+beta XX TO MRSA DM9808R (MIC = 12.5 μG/mL) XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12107 SQ SEQUENCE 4149.465 DA MW 37AA CCCCCCR-CC CCCCCCRCCC CCCCCRCCCC CCCCRRKK // ID AMRSAP288 PN OLAP- 21 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 8, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 53.33%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 13.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, W, Y MO C LO K BA 0 LA 15 AA 0 BC 7 MC 0 MF 0 XX MM 1880.411 AI 0 II 162.08 HP -0.687 HM 0.312 IP 9.046 NC 6.502 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 500 MS 42.140903 XX SC beta XX TO MRSA DM9808R (MIC = 6.25 μG/mL XX XR PubMed: 30066172 XR CAMP R4: CAMPSQ12108 SQ SEQUENCE 1880.411 DA MW 15AA CCCCCCCC-R RRRRKK // ID AMRSAP289 PN Teixobactin derivative 3 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 4, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 36.36%, 'K': 27.27%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 18.18%, 'T': 9.09%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, R, V, W, Y MO I LO F, T BA 5 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 1277.613 AI 141.818 II -6.345 HP 0.618 HM 0.239 IP 11.103 NC 2.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 18.060387 XX SC alpha XX TO Methicillin-resistant S. aureus MRSA - S. aureus B11970 (MIC = 32μG/mL) XX XR PubMed: 30050518 XR CAMP R4: CAMPSQ12134 SQ SEQUENCE 1277.613 DA MW 11AA FISKIISTKK I // ID AMRSAP290 PN Teixobactin derivative 4 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 4, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 36.36%, 'K': 27.27%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 0%, 'S': 9.09%, 'T': 9.09%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, R, V, W, Y MO I LO F, Q, S, T BA 5 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 1318.666 AI 141.818 II 11.164 HP 0.373 HM 0.341 IP 11.103 NC 2.997 SF 0.455, 0.091, 0 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 18.060387 XX SC alpha XX TO Methicillin-resistant S. aureus MRSA - S. aureus B11970 (MIC = 2μG/mL) XX XR PubMed: 30050518 XR CAMP R4: CAMPSQ12135 SQ SEQUENCE 1318.666 DA MW 11AA FISQIIKTKK I // ID AMRSAP291 PN Teixobactin derivative 5 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 4, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 36.36%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 9.09%, 'T': 9.09%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, L, M, N, P, Q, R, V, W, Y MO I; K LO F, S, T BA 5 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1318.709 AI 141.818 II -14.064 HP 0.336 HM 0.352 IP 11.278 NC 3.997 SF 0.455, 0.091, 0 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC alpha XX TO Methicillin-resistant S. aureus MRSA - S. aureus B11970 (MIC = 2μG/mL) XX XR PubMed: 30050518 XR CAMP R4: CAMPSQ12136 SQ SEQUENCE 1318.709 DA MW 11AA FIKKIISTKK I // ID AMRSAP292 PN Moronecidin-like SO Hippocampus comes PL 22 TX Animalia PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 2, 'H': 1, 'I': 0, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 31.82%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 9.09%, 'H': 4.55%, 'I': 0%, 'K': 9.09%, 'L': 4.55%, AF 'M': 0%, 'N': 4.55%, 'P': 0%, 'Q': 0%, 'R': 13.64%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA C, D, E, I, M, P, Q, S, T, V, Y MO A LO H, L, N BA 15 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2532.942 AI 49.545 II 18.2 HP -0.264 HM 0.718 IP 12.814 NC 5.088 SF 0.273, 0.136, 0.364 [Helix, Turn, Sheet] AR 0.227 ME 11000, 11000 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA (MIC = 3.12 μG/mL) XX XR PubMed: 30039186 XR CAMP R4: CAMPSQ12153 SQ SEQUENCE 2532.942 DA MW 22AA FFRNLWKGAK AAFRAGHAAW RA // ID AMRSAP293 PN Mastoparan-C SO Vespa crabro PL 14 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 21.43%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.14%, 'K': 21.43%, 'L': 35.71%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, P, Q, R, S, T, W, Y MO L LO I, N, V BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1507.967 AI 209.286 II 10.914 HP 1.279 HM 0.576 IP 11.103 NC 2.997 SF 0.5, 0.071, 0.571 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO S.aureus MRSA ATCC 12493 (MIC = 4 μM TO MBC = 4 μM) XX XR PubMed: 29904274 XR CAMP R4: CAMPSQ12278 SQ SEQUENCE 1507.967 DA MW 14AA LNLKALLAVA KKIL // ID AMRSAP294 PN Mastoparan-C derived cMP-C SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 18.75%, 'C': 12.5%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 6.25%, 'K': 18.75%, 'L': 31.25%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA D, E, F, G, H, M, P, Q, R, S, T, W, Y MO L LO I, N, V BA 10 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 1714.244 AI 183.125 II 22.838 HP 1.431 HM 0.576 IP 9.668 NC 2.873 SF 0.438, 0.063, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 18.060387 XX SC beta XX TO S.aureus MRSA ATCC 12493 (MIC = 128 μM TO MBC = 128 μM) XX XR PubMed: 29904274 XR CAMP R4: CAMPSQ12279 SQ SEQUENCE 1714.244 DA MW 16AA CLNLKALLAV AKKILC // ID AMRSAP295 PN Mastoparan-C tMP-C SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 6, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.04%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 4.35%, 'K': 21.74%, 'L': 21.74%, AF 'M': 0%, 'N': 4.35%, 'P': 0%, 'Q': 4.35%, 'R': 26.09%, 'S': 0%, 'T': 0%, 'V': 4.35%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, P, S, T, W, Y MO R LO I, N, Q, V BA 10 LA 13 AA 0 BC 11 MC 0 MF 0 XX MM 2829.571 AI 127.391 II 107.817 HP -0.887 HM 0.576 IP 13.209 NC 10.996 SF 0.304, 0.043, 0.348 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 66.221419 XX SC beta XX TO S.aureus MRSA ATCC 12493 (MIC = 4 μM TO MBC = 8 μM) XX XR PubMed: 29904274 XR CAMP R4: CAMPSQ12280 SQ SEQUENCE 2829.571 DA MW 23AA RKKRRQRRRL NLKALLAVAK KIL // ID AMRSAP296 PN Megicin-18 SO Mesobuthus gibbosus PL 18 TX Animalia (Scorpion) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, V, W, Y MO F LO G, P, R, S, T BA 13 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 2069.564 AI 119.444 II -3.956 HP 1.078 HM 0.667 IP 11.823 NC 2.997 SF 0.5, 0.167, 0.278 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 18.060387 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus (MRSA) P1374 (MIC = 3.0 μM) XX XR PubMed: 29896190 XR CAMP R4: CAMPSQ12306 SQ SEQUENCE 2069.564 DA MW 18AA FFGALFKLAT KIIPSLFR // ID AMRSAP297 PN Megicin-18 SO Mesobuthus gibbosus PL 18 TX Animalia (Scorpion) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, V, W, Y MO F LO G, P, R, S, T BA 13 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 2069.564 AI 119.444 II -3.956 HP 1.078 HM 0.667 IP 11.823 NC 2.997 SF 0.5, 0.167, 0.278 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 18.060387 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus (MRSA) P1381 (MIC = 3.0 μM) XX XR PubMed: 29896190 XR CAMP R4: CAMPSQ12306 SQ SEQUENCE 2069.564 DA MW 18AA FFGALFKLAT KIIPSLFR // ID AMRSAP298 PN Marcin-18 SO Mesobuthus martensii PL 18 TX Animalia (Scorpion) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 1, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 5.56%, 'I': 11.11%, 'K': 11.11%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, Q, V, W, Y MO F LO A, G, H, P, R, S, T BA 12 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2135.626 AI 113.889 II 0.761 HP 0.8 HM 0.667 IP 11.823 NC 3.088 SF 0.5, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 18.060387 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus (MRSA) P1374 (MIC = 2.9 μM) XX XR PubMed: 29896190 XR CAMP R4: CAMPSQ12308 SQ SEQUENCE 2135.626 DA MW 18AA FFGHLFKLAT KIIPSLFR // ID AMRSAP299 PN Marcin-18 SO Mesobuthus martensii PL 18 TX Animalia (Scorpion) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 1, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 5.56%, 'I': 11.11%, 'K': 11.11%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, Q, V, W, Y MO F LO A, G, H, P, R, S, T BA 12 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2135.626 AI 113.889 II 0.761 HP 0.8 HM 0.667 IP 11.823 NC 3.088 SF 0.5, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 18.060387 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus (MRSA) P1381 (MIC = 1.5 μM) XX XR PubMed: 29896190 XR CAMP R4: CAMPSQ12308 SQ SEQUENCE 2135.626 DA MW 18AA FFGHLFKLAT KIIPSLFR // ID AMRSAP300 PN Apolipoprotein-E derived 133-150 SO Homo sapiens PL 18 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 3, 'R': 1, 'S': 1, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 16.67%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 11.11%, AF 'M': 5.56%, 'N': 0%, 'P': 0%, 'Q': 16.67%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA C, D, F, H, I, K, N, P, W MO E; Q LO A, M, R, S, T, Y BA 8 LA 10 AA 3 BC 1 MC 0 MF 0 XX MM 2038.26 AI 81.111 II 40.178 HP -0.522 HM 0.243 IP 3.98 NC -1.998 SF 0.278, 0.167, 0.389 [Helix, Turn, Sheet] AR 0.056 ME 1490, 1490 MS 6.020129 XX SC beta XX TO MRSA WKZ-2 (MIC = 10 μM) XX XR PubMed: 29900637 XR CAMP R4: CAMPSQ12316 SQ SEQUENCE 2038.26 DA MW 18AA LVQYRGEVQA MLGQSTEE // ID AMRSAP301 PN Apolipoprotein-E derived 133-167 SO Homo sapiens PL 35 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 2, 'L': 8, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 3, 'R': 6, 'S': 2, 'T': 1, 'V': 3, 'W': 0, 'Y': 1 AF 'A': 5.71%, 'C': 0%, 'D': 0%, 'E': 8.57%, 'F': 0%, 'G': 5.71%, 'H': 2.86%, 'I': 0%, 'K': 5.71%, 'L': 22.86%, AF 'M': 2.86%, 'N': 0%, 'P': 0%, 'Q': 8.57%, 'R': 17.14%, 'S': 5.71%, 'T': 2.86%, 'V': 8.57%, 'W': 0%, 'Y': 2.86% MA C, D, F, I, N, P, W MO L LO H, M, T, Y BA 16 LA 19 AA 3 BC 9 MC 0 MF 0 XX MM 4148.933 AI 119.714 II 48.917 HP -0.426 HM 0.636 IP 11.884 NC 5.093 SF 0.343, 0.114, 0.4 [Helix, Turn, Sheet] AR 0.029 ME 1490, 1490 MS 48.161032 XX SC alpha_beta XX TO MRSA WKZ-2 (MIC = 5 μM) XX XR PubMed: 29900637 XR CAMP R4: CAMPSQ12317 SQ SEQUENCE 4148.933 DA MW 35AA LVQYRGEVQA MLGQSTEELR VRLASHLRKL RKRLL // ID AMRSAP302 PN Dermaseptin-PH SO Pithecopus hypochondrialis PL 44 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 3, 'E': 10, 'F': 2, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 6, AC 'M': 3, 'N': 1, 'P': 0, 'Q': 2, 'R': 2, 'S': 4, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 2.27%, 'D': 6.82%, 'E': 22.73%, 'F': 4.55%, 'G': 2.27%, 'H': 0%, 'I': 6.82%, 'K': 9.09%, 'L': 13.64%, AF 'M': 6.82%, 'N': 2.27%, 'P': 0%, 'Q': 4.55%, 'R': 4.55%, 'S': 9.09%, 'T': 0%, 'V': 4.55%, 'W': 0%, 'Y': 0% MA A, H, P, T, W, Y MO E LO C, G, N BA 17 LA 27 AA 13 BC 6 MC 0 MF 0 XX MM 5263.007 AI 92.955 II 88.548 HP -0.584 HM 0.421 IP 4.024 NC -7.046 SF 0.295, 0.136, 0.432 [Helix, Turn, Sheet] AR 0.045 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA (MIC > 512 μM) XX XR PubMed: 29064402 XR CAMP R4: CAMPSQ12447 SQ SEQUENCE 5263.007 DA MW 44AA MDILKKSLFL ILFLGVVSLS ICEEEKRENE EEMEQDDEQS EMKR // ID AMRSAP303 PN Bombinin HL SO Bombina variegata PL 18 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 0, 'I': 0, 'K': 0, 'L': 7, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 27.78%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 38.89%, AF 'M': 0%, 'N': 5.56%, 'P': 5.56%, 'Q': 0%, 'R': 0%, 'S': 5.56%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, K, M, Q, R, T, W, Y MO L LO N, P, S BA 16 LA 2 AA 0 BC 0 MC 0 MF 0 XX MM 1691.087 AI 200 II 27 HP 1.739 HM 0.35 IP 6.1 NC -0.002 SF 0.556, 0.444, 0.389 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC alpha XX TO MRSA (MIC = 16 mg/L) XX XR PubMed: 28894024 XR CAMP R4: CAMPSQ12465 SQ SEQUENCE 1691.087 DA MW 18AA LLGPVLGLVS NVLGGLLG // ID AMRSAP304 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 15 (MIC = 16 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP305 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 16 (MIC = 32 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP306 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 17 (MIC = 32 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP307 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 18 (MIC = 32 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP308 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 19 (MIC = 64 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP309 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 20 (MIC = 8 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP310 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 21 (MIC = 512 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP311 PN ASP-1 SO Bacillus subtilis URID 12.1 PL 7 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 40%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 20%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, W, Y MO F LO A, B, T, V, X BA 4 LA 1 AA 0 BC 0 MC {'B': 1, 'X': 1} MF {'B': 0.14285714285714285, 'X': 0.14285714285714285} XX MM 583.685 AI 55.714 II 8.571 HP 1.557 HM 0.071 IP 6.1 NC -0.002 SF 0.429, 0, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 0, 0 MS 0 XX SC alpha XX TO MRSA 22 (MIC = 32 μG/mL) XX XR PubMed: 28887200 XR CAMP R4: CAMPSQ12475 SQ SEQUENCE 583.685 DA MW 7AA FTAVBFX // ID AMRSAP312 PN Phylloseptin-PTa SO Phyllomedusa tarsius PL 19 TX Animalia (Amphibia) PE Predicted XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 1, 'I': 3, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 10.53%, 'H': 5.26%, 'I': 15.79%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 0%, 'R': 0%, 'S': 5.26%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, Q, R, T, V, W, Y MO A; L LO F, H, P, S BA 15 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1933.411 AI 164.737 II 5.516 HP 1.289 HM 0.475 IP 10.805 NC 2.088 SF 0.421, 0.211, 0.421 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA NCTC 12493 (MIC = 64 μG/mL) XX XR PubMed: 28850103 XR CAMP R4: CAMPSQ12512 SQ SEQUENCE 1933.411 DA MW 19AA FLSLIPKIAG GIAALAKHL // ID AMRSAP313 PN Phylloseptin-PHa SO Phyllomedusa hypochondrialis PL 19 TX Animalia (Amphibia) PE Predicted XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 1, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 3, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 26.32%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10.53%, 'G': 0%, 'H': 5.26%, 'I': 10.53%, 'K': 0%, 'L': 15.79%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 0%, 'S': 15.79%, 'T': 0%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA C, D, E, G, K, M, Q, R, T, W, Y MO A LO H, N, P, V BA 14 LA 5 AA 0 BC 1 MC 0 MF 0 XX MM 1942.288 AI 144.211 II 12.637 HP 1.5 HM 0.391 IP 7.55 NC 0.089 SF 0.421, 0.263, 0.421 [Helix, Turn, Sheet] AR 0.105 ME 0, 0 MS 0 XX SC alpha XX TO MRSA NCTC 12493 (MIC = 8 μG/mL) XX XR PubMed: 28850103 XR CAMP R4: CAMPSQ12513 SQ SEQUENCE 1942.288 DA MW 19AA FLSLIPAAIS AVSALANHF // ID AMRSAP314 PN ASU014 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 2, 'F': 2, 'G': 3, 'H': 1, 'I': 1, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.26%, 'E': 10.53%, 'F': 10.53%, 'G': 15.79%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 5.26%, AF 'M': 5.26%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 10.53%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, N, Q, V, W, Y MO G LO D, H, I, K, L, M, S, T BA 10 LA 9 AA 3 BC 4 MC 0 MF 0 XX MM 2174.462 AI 41.053 II 31.284 HP -0.879 HM 0.376 IP 7.551 NC 0.093 SF 0.211, 0.316, 0.211 [Helix, Turn, Sheet] AR 0.105 ME 0, 0 MS 18.060387 XX SC alpha_beta XX TO MRSA-USA100 (MIC = 100 μM) XX XR PubMed: 28835801 XR CAMP R4: CAMPSQ12531 SQ SEQUENCE 2174.462 DA MW 19AA IMKPFETHRL GPERFDGSG // ID AMRSAP315 PN ASU014 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 2, 'F': 2, 'G': 3, 'H': 1, 'I': 1, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.26%, 'E': 10.53%, 'F': 10.53%, 'G': 15.79%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 5.26%, AF 'M': 5.26%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 10.53%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, N, Q, V, W, Y MO G LO D, H, I, K, L, M, S, T BA 10 LA 9 AA 3 BC 4 MC 0 MF 0 XX MM 2174.462 AI 41.053 II 31.284 HP -0.879 HM 0.376 IP 7.551 NC 0.093 SF 0.211, 0.316, 0.211 [Helix, Turn, Sheet] AR 0.105 ME 0, 0 MS 18.060387 XX SC alpha_beta XX TO MRSA-USA300-HI168 (MIC = 100 μM) XX XR PubMed: 28835801 XR CAMP R4: CAMPSQ12531 SQ SEQUENCE 2174.462 DA MW 19AA IMKPFETHRL GPERFDGSG // ID AMRSAP316 PN ASU014 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 2, 'F': 2, 'G': 3, 'H': 1, 'I': 1, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.26%, 'E': 10.53%, 'F': 10.53%, 'G': 15.79%, 'H': 5.26%, 'I': 5.26%, 'K': 5.26%, 'L': 5.26%, AF 'M': 5.26%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 10.53%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, N, Q, V, W, Y MO G LO D, H, I, K, L, M, S, T BA 10 LA 9 AA 3 BC 4 MC 0 MF 0 XX MM 2174.462 AI 41.053 II 31.284 HP -0.879 HM 0.376 IP 7.551 NC 0.093 SF 0.211, 0.316, 0.211 [Helix, Turn, Sheet] AR 0.105 ME 0, 0 MS 18.060387 XX SC alpha_beta XX TO MRSA -USA300-LAC (MIC = 25 μM) XX XR PubMed: 28835801 XR CAMP R4: CAMPSQ12531 SQ SEQUENCE 2174.462 DA MW 19AA IMKPFETHRL GPERFDGSG // ID AMRSAP317 PN Chensinin-1b SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 4, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 22.22%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 5.56%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA C, D, E, G, I, M, N, P, Q, T, Y MO R LO A, F, K, L, S, V BA 7 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2551.956 AI 43.333 II 54.089 HP -1.672 HM 0.923 IP 13.105 NC 6.361 SF 0.333, 0.056, 0.111 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO S. aureus MRSA0910 (MIC = 3.13 μM) XX XR PubMed: 28756209 XR CAMP R4: CAMPSQ12621 SQ SEQUENCE 2551.956 DA MW 18AA SKVWRHWRRF WHRAHRLH // ID AMRSAP318 PN I7R SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 37.5%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO W LO L BA 5 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1344.59 AI 48.75 II 263.05 HP -1.663 HM 0.377 IP 12.801 NC 2.998 SF 0.625, 0, 0.125 [Helix, Turn, Sheet] AR 0.5 ME 22000, 22000 MS 18.060387 XX SC alpha_beta XX TO MRSA T144 (MIC = 8 μG/mL) XX XR PubMed: 33804947 XR CAMP R4: CAMPSQ12667 SQ SEQUENCE 1344.59 DA MW 8AA WWWLRRRW // ID AMRSAP319 PN Hypeptin SO Lysobacter sp. K5869 PL 8 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, V, W, Y MO X LO A, B, I, L, R, Z BA 3 LA 1 AA 0 BC 1 MC {'B': 1, 'Z': 1, 'X': 2} MF {'B': 0.125, 'Z': 0.125, 'X': 0.25} XX MM 471.6 AI 110 II 32.825 HP 0.7 HM 0.544 IP 10.55 NC 0.998 SF 0.25, 0, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC beta XX TO S. aureus LT 1334 (MRSA) (MIC = 0.25 μG/mL) XX XR PubMed: 33768646 XR CAMP R4: CAMPSQ12712 SQ SEQUENCE 471.6 DA MW 8AA ALRXXZBI // ID AMRSAP320 PN Temporin-PF SO Pelophylax fukienensis PL 13 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 23.08%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 7.69%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, R, S, T, V, W, Y MO F; L LO A, K, P BA 12 LA 1 AA 0 BC 1 MC 0 MF 0 XX MM 1435.815 AI 157.692 II 10.985 HP 1.869 HM 0.399 IP 9.7 NC 0.998 SF 0.615, 0.231, 0.308 [Helix, Turn, Sheet] AR 0.231 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (MIC = 4 μM TO MBC = 4 μM) XX XR PubMed: 33925935 XR CAMP R4: CAMPSQ12713 SQ SEQUENCE 1435.815 DA MW 13AA FLPLIAGLFG KIF // ID AMRSAP321 PN Des-Phe1 TPF SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 16.67%, 'H': 0%, 'I': 16.67%, 'K': 8.33%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, R, S, T, V, W, Y MO L LO A, K, P BA 11 LA 1 AA 0 BC 1 MC 0 MF 0 XX MM 1288.639 AI 170.833 II 11.067 HP 1.792 HM 0.399 IP 9.7 NC 0.998 SF 0.583, 0.25, 0.333 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 6.020129 XX SC alpha+beta XX TO MRSA (MIC = 32 μM TO MBC = 32 μM) XX XR PubMed: 33925935 XR CAMP R4: CAMPSQ12714 SQ SEQUENCE 1288.639 DA MW 12AA LPLIAGLFGK IF // ID AMRSAP322 PN W-des-Phe1 TPF SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 16.67%, 'H': 0%, 'I': 16.67%, 'K': 8.33%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA C, D, E, F, H, M, N, Q, R, S, T, V, Y MO L LO A, K, P BA 11 LA 1 AA 0 BC 1 MC 0 MF 0 XX MM 1366.712 AI 170.833 II 22.158 HP 1.175 HM 0.367 IP 9.7 NC 0.998 SF 0.583, 0.25, 0.333 [Helix, Turn, Sheet] AR 0.167 ME 11000, 11000 MS 6.020129 XX SC alpha_beta XX TO MRSA (MIC = 128 μM TO MBC = 128 μM) XX XR PubMed: 33925935 XR CAMP R4: CAMPSQ12715 SQ SEQUENCE 1366.712 DA MW 12AA LPLIAGLWGK IW // ID AMRSAP323 PN DW-des-Phe1 TPF SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 16.67%, 'H': 0%, 'I': 16.67%, 'K': 8.33%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 16.67%, 'Y': 0% MA C, D, E, F, H, M, N, Q, R, S, T, V, Y MO L LO A, K, P BA 11 LA 1 AA 0 BC 1 MC 0 MF 0 XX MM 1366.712 AI 170.833 II 22.158 HP 1.175 HM 0.367 IP 9.7 NC 0.998 SF 0.583, 0.25, 0.333 [Helix, Turn, Sheet] AR 0.167 ME 11000, 11000 MS 6.020129 XX SC alpha_beta XX TO MRSA (MIC > 128 μM TO MBC > 128 μM) XX XR PubMed: 33925935 XR CAMP R4: CAMPSQ12716 SQ SEQUENCE 1366.712 DA MW 12AA LPLIAGLWGK IW // ID AMRSAP324 PN Esculentin 2 HYba1 SO H. bahuvistara PL 37 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 8, 'C': 2, 'D': 0, 'E': 1, 'F': 2, 'G': 4, 'H': 0, 'I': 1, 'K': 6, 'L': 4, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 2, 'R': 0, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 21.62%, 'C': 5.41%, 'D': 0%, 'E': 2.7%, 'F': 5.41%, 'G': 10.81%, 'H': 0%, 'I': 2.7%, 'K': 16.22%, 'L': 10.81%, AF 'M': 2.7%, 'N': 2.7%, 'P': 0%, 'Q': 5.41%, 'R': 0%, 'S': 5.41%, 'T': 5.41%, 'V': 0%, 'W': 0%, 'Y': 2.7% MA D, H, P, R, V, W MO A LO E, I, M, N, Y BA 20 LA 17 AA 1 BC 6 MC 0 MF 0 XX MM 3820.542 AI 74.324 II 19.543 HP 0.089 HM 0.581 IP 10.299 NC 4.873 SF 0.216, 0.189, 0.378 [Helix, Turn, Sheet] AR 0.081 ME 1490, 1615 MS 36.120774 XX SC beta XX TO MRSA ATCC 43300 (MIC = 5 μM) XX XR PubMed: 31328553 XR CAMP R4: CAMPSQ12793 SQ SEQUENCE 3820.542 DA MW 37AA SIFSLFKMGA KALGKTLLKQ AGKAGAEYAA CKATNQC // ID AMRSAP325 PN E2/1-NH2 SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 8, 'C': 2, 'D': 0, 'E': 1, 'F': 2, 'G': 4, 'H': 0, 'I': 1, 'K': 6, 'L': 4, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 2, 'R': 0, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 21.62%, 'C': 5.41%, 'D': 0%, 'E': 2.7%, 'F': 5.41%, 'G': 10.81%, 'H': 0%, 'I': 2.7%, 'K': 16.22%, 'L': 10.81%, AF 'M': 2.7%, 'N': 2.7%, 'P': 0%, 'Q': 5.41%, 'R': 0%, 'S': 5.41%, 'T': 5.41%, 'V': 0%, 'W': 0%, 'Y': 2.7% MA D, H, P, R, V, W MO A LO E, I, M, N, Y BA 20 LA 17 AA 1 BC 6 MC 0 MF 0 XX MM 3820.542 AI 74.324 II 19.543 HP 0.089 HM 0.581 IP 10.299 NC 4.873 SF 0.216, 0.189, 0.378 [Helix, Turn, Sheet] AR 0.081 ME 1490, 1615 MS 36.120774 XX SC beta XX TO MRSA ATCC 43300 (MIC = 3 μM) XX XR PubMed: 31328553 XR CAMP R4: CAMPSQ12794 SQ SEQUENCE 3820.542 DA MW 37AA SIFSLFKMGA KALGKTLLKQ AGKAGAEYAA CKATNQC // ID AMRSAP326 PN Esculentin 2 HYba2 SO H. bahuvistara PL 37 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 7, 'C': 2, 'D': 0, 'E': 1, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 2, 'R': 0, 'S': 2, 'T': 2, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 18.92%, 'C': 5.41%, 'D': 0%, 'E': 2.7%, 'F': 2.7%, 'G': 10.81%, 'H': 0%, 'I': 5.41%, 'K': 16.22%, 'L': 10.81%, AF 'M': 2.7%, 'N': 2.7%, 'P': 0%, 'Q': 5.41%, 'R': 0%, 'S': 5.41%, 'T': 5.41%, 'V': 2.7%, 'W': 0%, 'Y': 2.7% MA D, H, P, R, W MO A LO E, F, M, N, V, Y BA 20 LA 17 AA 1 BC 6 MC 0 MF 0 XX MM 3814.578 AI 90 II 18.349 HP 0.2 HM 0.596 IP 10.299 NC 4.873 SF 0.243, 0.189, 0.351 [Helix, Turn, Sheet] AR 0.054 ME 1490, 1615 MS 36.120774 XX SC beta XX TO MRSA ATCC 43300 (MIC = 6 μM) XX XR PubMed: 31328553 XR CAMP R4: CAMPSQ12795 SQ SEQUENCE 3814.578 DA MW 37AA SILSLFKMGA KALGKTLIKQ AGKAGAEYVA CKATNQC // ID AMRSAP327 PN E2/2-NH2 SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 2, 'D': 0, 'E': 1, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 2, 'R': 0, 'S': 2, 'T': 2, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 18.92%, 'C': 5.41%, 'D': 0%, 'E': 2.7%, 'F': 2.7%, 'G': 10.81%, 'H': 0%, 'I': 5.41%, 'K': 16.22%, 'L': 10.81%, AF 'M': 2.7%, 'N': 2.7%, 'P': 0%, 'Q': 5.41%, 'R': 0%, 'S': 5.41%, 'T': 5.41%, 'V': 2.7%, 'W': 0%, 'Y': 2.7% MA D, H, P, R, W MO A LO E, F, M, N, V, Y BA 20 LA 17 AA 1 BC 6 MC 0 MF 0 XX MM 3814.578 AI 90 II 18.349 HP 0.2 HM 0.596 IP 10.299 NC 4.873 SF 0.243, 0.189, 0.351 [Helix, Turn, Sheet] AR 0.054 ME 1490, 1615 MS 36.120774 XX SC beta XX TO MRSA ATCC 43300 (MIC = 3 μM) XX XR PubMed: 31328553 XR CAMP R4: CAMPSQ12796 SQ SEQUENCE 3814.578 DA MW 37AA SILSLFKMGA KALGKTLIKQ AGKAGAEYVA CKATNQC // ID AMRSAP328 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 4 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 929.135 AI 130 II 8.333 HP -0.3 HM 0.856 IP 12.5 NC 1.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA 75 (MIC = 128 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12857 SQ SEQUENCE 929.135 DA MW 6AA WRIWRI // ID AMRSAP329 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 4 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 929.135 AI 130 II 8.333 HP -0.3 HM 0.856 IP 12.5 NC 1.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA 113 (MIC = 128 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12857 SQ SEQUENCE 929.135 DA MW 6AA WRIWRI // ID AMRSAP330 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1384.696 AI 130 II 8.889 HP -0.3 HM 0.659 IP 12.801 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA 75 (MIC = 8 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12858 SQ SEQUENCE 1384.696 DA MW 9AA WRIWRIWRI // ID AMRSAP331 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1384.696 AI 130 II 8.889 HP -0.3 HM 0.659 IP 12.801 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA 113 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12858 SQ SEQUENCE 1384.696 DA MW 9AA WRIWRIWRI // ID AMRSAP332 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1840.256 AI 130 II 9.167 HP -0.3 HM 0.586 IP 12.977 NC 3.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO MRSA 75 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12859 SQ SEQUENCE 1840.256 DA MW 12AA WRIWRIWRIW RI // ID AMRSAP333 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1840.256 AI 130 II 9.167 HP -0.3 HM 0.586 IP 12.977 NC 3.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO MRSA 113 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12859 SQ SEQUENCE 1840.256 DA MW 12AA WRIWRIWRIW RI // ID AMRSAP334 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2295.816 AI 130 II 9.333 HP -0.3 HM 0.685 IP 13.102 NC 4.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO MRSA 75 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12860 SQ SEQUENCE 2295.816 DA MW 15AA WRIWRIWRIW RIWRI // ID AMRSAP335 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, Y MO I; R; W LO I, R, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2295.816 AI 130 II 9.333 HP -0.3 HM 0.685 IP 13.102 NC 4.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12860 SQ SEQUENCE 2295.816 DA MW 15AA WRIWRIWRIW RIWRI // ID AMRSAP336 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 4 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 929.135 AI 130 II 47.8 HP -0.533 HM 0.827 IP 12.5 NC 1.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA 75 (MIC = 128 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12861 SQ SEQUENCE 929.135 DA MW 6AA WRLWRL // ID AMRSAP337 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 4 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 929.135 AI 130 II 47.8 HP -0.533 HM 0.827 IP 12.5 NC 1.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA 113 (MIC = 128 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12861 SQ SEQUENCE 929.135 DA MW 6AA WRLWRL // ID AMRSAP338 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1384.696 AI 130 II 61.511 HP -0.533 HM 0.637 IP 12.801 NC 2.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA 75 (MIC = 8 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12862 SQ SEQUENCE 1384.696 DA MW 9AA WRLWRLWRL // ID AMRSAP339 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1384.696 AI 130 II 61.511 HP -0.533 HM 0.637 IP 12.801 NC 2.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA 113 (MIC = 16 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12862 SQ SEQUENCE 1384.696 DA MW 9AA WRLWRLWRL // ID AMRSAP340 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1840.256 AI 130 II 68.367 HP -0.533 HM 0.545 IP 12.977 NC 3.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO MRSA 75 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12863 SQ SEQUENCE 1840.256 DA MW 12AA WRLWRLWRLW RL // ID AMRSAP341 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1840.256 AI 130 II 68.367 HP -0.533 HM 0.545 IP 12.977 NC 3.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12863 SQ SEQUENCE 1840.256 DA MW 12AA WRLWRLWRLW RL // ID AMRSAP342 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2295.816 AI 130 II 72.48 HP -0.533 HM 0.65 IP 13.102 NC 4.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO MRSA 75 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12864 SQ SEQUENCE 2295.816 DA MW 15AA WRLWRLWRLW RLWRL // ID AMRSAP343 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, Y MO L; R; W LO L, R, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2295.816 AI 130 II 72.48 HP -0.533 HM 0.65 IP 13.102 NC 4.998 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12864 SQ SEQUENCE 2295.816 DA MW 15AA WRLWRLWRLW RLWRL // ID AMRSAP344 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 4 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 997.17 AI 0 II 8.333 HP -0.867 HM 0.838 IP 12.5 NC 1.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA 75 (MIC = 32 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12865 SQ SEQUENCE 997.17 DA MW 6AA WRFWRF // ID AMRSAP345 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 4 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 997.17 AI 0 II 8.333 HP -0.867 HM 0.838 IP 12.5 NC 1.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA 113 (MIC = 32 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12865 SQ SEQUENCE 997.17 DA MW 6AA WRFWRF // ID AMRSAP346 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1486.747 AI 0 II 8.889 HP -0.867 HM 0.645 IP 12.801 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA 75 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12866 SQ SEQUENCE 1486.747 DA MW 9AA WRFWRFWRF // ID AMRSAP347 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1486.747 AI 0 II 8.889 HP -0.867 HM 0.645 IP 12.801 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12866 SQ SEQUENCE 1486.747 DA MW 9AA WRFWRFWRF // ID AMRSAP348 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1976.324 AI 0 II 9.167 HP -0.867 HM 0.561 IP 12.977 NC 3.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO MRSA 75 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12867 SQ SEQUENCE 1976.324 DA MW 12AA WRFWRFWRFW RF // ID AMRSAP349 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1976.324 AI 0 II 9.167 HP -0.867 HM 0.561 IP 12.977 NC 3.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12867 SQ SEQUENCE 1976.324 DA MW 12AA WRFWRFWRFW RF // ID AMRSAP350 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2465.902 AI 0 II 9.333 HP -0.867 HM 0.664 IP 13.102 NC 4.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO MRSA 75 (MIC = 8 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12868 SQ SEQUENCE 2465.902 DA MW 15AA WRFWRFWRFW RFWRF // ID AMRSAP351 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 33.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO F; R; W LO F, R, W BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2465.902 AI 0 II 9.333 HP -0.867 HM 0.664 IP 13.102 NC 4.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO MRSA 113 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12868 SQ SEQUENCE 2465.902 DA MW 15AA WRFWRFWRFW RFWRF // ID AMRSAP352 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1603.857 AI 0 II 199.822 HP -2.1 HM 0.625 IP 12.801 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 33000, 33000 MS 18.060387 XX SC alpha_beta XX TO MRSA 75 (MIC = 8 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12869 SQ SEQUENCE 1603.857 DA MW 9AA WRWWRWWRW // ID AMRSAP353 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1603.857 AI 0 II 199.822 HP -2.1 HM 0.625 IP 12.801 NC 2.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 33000, 33000 MS 18.060387 XX SC alpha_beta XX TO MRSA 113 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12869 SQ SEQUENCE 1603.857 DA MW 9AA WRWWRWWRW // ID AMRSAP354 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 8, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 2132.471 AI 0 II 200.1 HP -2.1 HM 0.515 IP 12.977 NC 3.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 44000, 44000 MS 24.080516 XX SC alpha_beta XX TO MRSA 75 (MIC = 8 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12870 SQ SEQUENCE 2132.471 DA MW 12AA WRWWRWWRWW RW // ID AMRSAP355 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 8, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 2132.471 AI 0 II 200.1 HP -2.1 HM 0.515 IP 12.977 NC 3.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 44000, 44000 MS 24.080516 XX SC alpha_beta XX TO MRSA 113 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12870 SQ SEQUENCE 2132.471 DA MW 12AA WRWWRWWRWW RW // ID AMRSAP356 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 10, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2661.085 AI 0 II 200.267 HP -2.1 HM 0.624 IP 13.102 NC 4.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 55000, 55000 MS 30.100645 XX SC alpha_beta XX TO MRSA 75 (MIC = 8 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12871 SQ SEQUENCE 2661.085 DA MW 15AA WRWWRWWRWW RWWRW // ID AMRSAP357 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 10, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 10 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2661.085 AI 0 II 200.267 HP -2.1 HM 0.624 IP 13.102 NC 4.998 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 55000, 55000 MS 30.100645 XX SC alpha_beta XX TO MRSA 113 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12871 SQ SEQUENCE 2661.085 DA MW 15AA WRWWRWWRWW RWWRW // ID AMRSAP358 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 959.165 AI 0 II 8.333 HP -3.1 HM 0.957 IP 12.532 NC 3.997 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO MRSA 75 (MIC > 128 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12872 SQ SEQUENCE 959.165 DA MW 6AA WRKWRK // ID AMRSAP359 PN SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 2 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 959.165 AI 0 II 8.333 HP -3.1 HM 0.957 IP 12.532 NC 3.997 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO MRSA 113 (MIC > 128 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12872 SQ SEQUENCE 959.165 DA MW 6AA WRKWRK // ID AMRSAP360 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 3 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1429.74 AI 0 II 8.889 HP -3.1 HM 0.736 IP 12.82 NC 5.997 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA 75 (MIC = 64 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12873 SQ SEQUENCE 1429.74 DA MW 9AA WRKWRKWRK // ID AMRSAP361 PN SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 3 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1429.74 AI 0 II 8.889 HP -3.1 HM 0.736 IP 12.82 NC 5.997 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA 113 (MIC = 32 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12873 SQ SEQUENCE 1429.74 DA MW 9AA WRKWRKWRK // ID AMRSAP362 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 4 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1900.314 AI 0 II 9.167 HP -3.1 HM 0.569 IP 12.992 NC 7.997 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 48.161032 XX SC alpha_beta XX TO MRSA 75 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12874 SQ SEQUENCE 1900.314 DA MW 12AA WRKWRKWRKW RK // ID AMRSAP363 PN SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 4 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1900.314 AI 0 II 9.167 HP -3.1 HM 0.569 IP 12.992 NC 7.997 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 48.161032 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12874 SQ SEQUENCE 1900.314 DA MW 12AA WRKWRKWRKW RK // ID AMRSAP364 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 5 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 2370.889 AI 0 II 9.333 HP -3.1 HM 0.569 IP 13.115 NC 9.996 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 60.20129 XX SC alpha_beta XX TO MRSA 75 (MIC = 4 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12875 SQ SEQUENCE 2370.889 DA MW 15AA WRKWRKWRKW RKWRK // ID AMRSAP365 PN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, V, Y MO K; R; W LO K, R, W BA 5 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 2370.889 AI 0 II 9.333 HP -3.1 HM 0.569 IP 13.115 NC 9.996 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 60.20129 XX SC alpha_beta XX TO MRSA 113 (MIC = 2 μM) XX XR PubMed: 33829758 XR CAMP R4: CAMPSQ12875 SQ SEQUENCE 2370.889 DA MW 15AA WRKWRKWRKW RKWRK // ID AMRSAP366 PN Ripcin SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 0, AC 'M': 1, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 0%, AF 'M': 5.56%, 'N': 5.56%, 'P': 5.56%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 11.11%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, F, H, L, Q, S, W MO R LO C, M, N, P, Y BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2092.552 AI 75.556 II 20.472 HP -0.45 HM 0.338 IP 11.577 NC 4.935 SF 0.278, 0.222, 0.056 [Helix, Turn, Sheet] AR 0.056 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC >= 256 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12965 SQ SEQUENCE 2092.552 DA MW 18AA GRVPIIYTNR KTGVCKRM // ID AMRSAP367 PN Ripcin B SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 0, 'I': 4, 'K': 3, 'L': 2, AC 'M': 2, 'N': 2, 'P': 2, 'Q': 0, 'R': 3, 'S': 2, 'T': 5, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 2.63%, 'C': 10.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 13.16%, 'H': 0%, 'I': 10.53%, 'K': 7.89%, 'L': 5.26%, AF 'M': 5.26%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 7.89%, 'S': 5.26%, 'T': 13.16%, 'V': 5.26%, 'W': 0%, 'Y': 2.63% MA D, E, F, H, Q, W MO G; T LO A, Y BA 18 LA 20 AA 0 BC 6 MC 0 MF 0 XX MM 4044.899 AI 79.474 II 15.116 HP 0.153 HM 0.338 IP 10.163 NC 5.748 SF 0.237, 0.289, 0.132 [Helix, Turn, Sheet] AR 0.026 ME 1490, 1740 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 4 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12966 SQ SEQUENCE 4044.899 DA MW 38AA ITSISLCTPG CKTGALMGCN GRVPIIYTNR KTGVCKRM // ID AMRSAP368 PN Ripcin C SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 4, 'K': 3, 'L': 2, AC 'M': 2, 'N': 2, 'P': 2, 'Q': 0, 'R': 3, 'S': 2, 'T': 5, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 2.7%, 'C': 10.81%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.81%, 'H': 0%, 'I': 10.81%, 'K': 8.11%, 'L': 5.41%, AF 'M': 5.41%, 'N': 5.41%, 'P': 5.41%, 'Q': 0%, 'R': 8.11%, 'S': 5.41%, 'T': 13.51%, 'V': 5.41%, 'W': 0%, 'Y': 2.7% MA D, E, F, H, Q, W MO T LO A, Y BA 17 LA 20 AA 0 BC 6 MC 0 MF 0 XX MM 3987.847 AI 81.622 II 19.316 HP 0.168 HM 0.338 IP 10.163 NC 5.748 SF 0.243, 0.27, 0.135 [Helix, Turn, Sheet] AR 0.027 ME 1490, 1740 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 2 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12967 SQ SEQUENCE 3987.847 DA MW 37AA ITSISLCTPG CKTGALMGCN RVPIIYTNRK TGVCKRM // ID AMRSAP369 PN Ripcin D SO Synthetic construct PL 36 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 4, 'K': 3, 'L': 2, AC 'M': 2, 'N': 2, 'P': 2, 'Q': 0, 'R': 2, 'S': 2, 'T': 5, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 2.78%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 11.11%, 'K': 8.33%, 'L': 5.56%, AF 'M': 5.56%, 'N': 5.56%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 13.89%, 'V': 5.56%, 'W': 0%, 'Y': 2.78% MA D, E, F, H, Q, W MO T LO A, Y BA 17 LA 19 AA 0 BC 5 MC 0 MF 0 XX MM 3831.66 AI 83.889 II 19.575 HP 0.297 HM 0.338 IP 9.578 NC 4.748 SF 0.25, 0.278, 0.139 [Helix, Turn, Sheet] AR 0.028 ME 1490, 1740 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 8 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12968 SQ SEQUENCE 3831.66 DA MW 36AA ITSISLCTPG CKTGALMGCN VPIIYTNRKT GVCKRM // ID AMRSAP370 PN Ripcin E SO Synthetic construct PL 35 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 4, 'K': 3, 'L': 2, AC 'M': 2, 'N': 2, 'P': 2, 'Q': 0, 'R': 2, 'S': 2, 'T': 5, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 2.86%, 'C': 11.43%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.43%, 'H': 0%, 'I': 11.43%, 'K': 8.57%, 'L': 5.71%, AF 'M': 5.71%, 'N': 5.71%, 'P': 5.71%, 'Q': 0%, 'R': 5.71%, 'S': 5.71%, 'T': 14.29%, 'V': 2.86%, 'W': 0%, 'Y': 2.86% MA D, E, F, H, Q, W MO T LO A, V, Y BA 16 LA 19 AA 0 BC 5 MC 0 MF 0 XX MM 3732.527 AI 78 II 13.523 HP 0.186 HM 0.381 IP 9.578 NC 4.748 SF 0.229, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.029 ME 1490, 1740 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 4 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12969 SQ SEQUENCE 3732.527 DA MW 35AA ITSISLCTPG CKTGALMGCN PIIYTNRKTG VCKRM // ID AMRSAP371 PN Ripcin F SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 4, 'K': 3, 'L': 2, AC 'M': 2, 'N': 2, 'P': 1, 'Q': 0, 'R': 2, 'S': 2, 'T': 5, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 2.94%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.76%, 'H': 0%, 'I': 11.76%, 'K': 8.82%, 'L': 5.88%, AF 'M': 5.88%, 'N': 5.88%, 'P': 2.94%, 'Q': 0%, 'R': 5.88%, 'S': 5.88%, 'T': 14.71%, 'V': 2.94%, 'W': 0%, 'Y': 2.94% MA D, E, F, H, Q, W MO T LO A, P, V, Y BA 15 LA 19 AA 0 BC 5 MC 0 MF 0 XX MM 3635.411 AI 80.294 II 27.397 HP 0.238 HM 0.346 IP 9.578 NC 4.748 SF 0.235, 0.265, 0.147 [Helix, Turn, Sheet] AR 0.029 ME 1490, 1740 MS 30.100645 XX SC beta XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 4 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12970 SQ SEQUENCE 3635.411 DA MW 34AA ITSISLCTPG CKTGALMGCN IIYTNRKTGV CKRM // ID AMRSAP372 PN Ripcin G SO Synthetic construct PL 33 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 3, 'K': 3, 'L': 2, AC 'M': 2, 'N': 2, 'P': 1, 'Q': 0, 'R': 2, 'S': 2, 'T': 5, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 3.03%, 'C': 12.12%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.12%, 'H': 0%, 'I': 9.09%, 'K': 9.09%, 'L': 6.06%, AF 'M': 6.06%, 'N': 6.06%, 'P': 3.03%, 'Q': 0%, 'R': 6.06%, 'S': 6.06%, 'T': 15.15%, 'V': 3.03%, 'W': 0%, 'Y': 3.03% MA D, E, F, H, Q, W MO T LO A, P, V, Y BA 14 LA 19 AA 0 BC 5 MC 0 MF 0 XX MM 3522.251 AI 70.909 II 27.924 HP 0.109 HM 0.338 IP 9.578 NC 4.748 SF 0.212, 0.273, 0.152 [Helix, Turn, Sheet] AR 0.03 ME 1490, 1740 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 4 μM) XX XR PubMed: 34156232 XR CAMP R4: CAMPSQ12971 SQ SEQUENCE 3522.251 DA MW 33AA ITSISLCTPG CKTGALMGCN IYTNRKTGVC KRM // ID AMRSAP373 PN RA2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 22.22%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 22.22%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 5.56%, 'Y': 0% MA D, E, F, G, H, L, M, N, Q, V, Y MO A; R LO K, S, T, W BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2056.481 AI 65.556 II 61.067 HP -0.35 HM 0.582 IP 12.053 NC 4.874 SF 0.167, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.056 ME 5500, 5625 MS 30.100645 XX SC beta XX TO MRSA 43300 (MIC = ND) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12992 SQ SEQUENCE 2056.481 DA MW 18AA RARAWRARAC TKSIPPIC // ID AMRSAP374 PN RI2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 6, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 33.33%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 22.22%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 5.56%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, V, Y MO I LO K, S, T, W BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2224.803 AI 130 II 36.656 HP 0.25 HM 0.604 IP 12.053 NC 4.874 SF 0.389, 0.167, 0 [Helix, Turn, Sheet] AR 0.056 ME 5500, 5625 MS 30.100645 XX SC beta XX TO MRSA 43300 (MIC = 16 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12993 SQ SEQUENCE 2224.803 DA MW 18AA RIRIWRIRIC TKSIPPIC // ID AMRSAP375 PN RL2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 22.22%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 5.56%, 'Y': 0% MA A, D, E, F, G, H, M, N, Q, V, Y MO L; R LO K, S, T, W BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2224.803 AI 130 II 71.211 HP 0.094 HM 0.595 IP 12.053 NC 4.874 SF 0.389, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.056 ME 5500, 5625 MS 30.100645 XX SC beta XX TO MRSA 43300 (MIC = 32 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12994 SQ SEQUENCE 2224.803 DA MW 18AA RLRLWRLRLC TKSIPPIC // ID AMRSAP376 PN RV2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 22.22%, 'S': 5.56%, 'T': 5.56%, 'V': 22.22%, 'W': 5.56%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, Y MO R; V LO K, S, T, W BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2168.696 AI 107.778 II 36.656 HP 0.183 HM 0.595 IP 12.053 NC 4.874 SF 0.389, 0.167, 0 [Helix, Turn, Sheet] AR 0.056 ME 5500, 5625 MS 30.100645 XX SC beta XX TO MRSA 43300 (MIC = 128 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12995 SQ SEQUENCE 2168.696 DA MW 18AA RVRVWRVRVC TKSIPPIC // ID AMRSAP377 PN RF2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 22.22%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 5.56%, 'Y': 0% MA A, D, E, G, H, L, M, N, Q, V, Y MO F; R LO K, S, T, W BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2360.872 AI 43.333 II 36.656 HP -0.128 HM 0.599 IP 12.053 NC 4.874 SF 0.389, 0.167, 0 [Helix, Turn, Sheet] AR 0.278 ME 5500, 5625 MS 30.100645 XX SC alpha XX TO MRSA 43300 (MIC = 4 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12996 SQ SEQUENCE 2360.872 DA MW 18AA RFRFWRFRFC TKSIPPIC // ID AMRSAP378 PN RW2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 22.22%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 27.78%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, V, Y MO W LO K, S, T BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2517.018 AI 43.333 II 163.944 HP -0.95 HM 0.587 IP 12.053 NC 4.874 SF 0.389, 0.167, 0 [Helix, Turn, Sheet] AR 0.278 ME 27500, 27625 MS 30.100645 XX SC alpha_beta XX TO MRSA 43300 (MIC = 4 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12997 SQ SEQUENCE 2517.018 DA MW 18AA RWRWWRWRWC TKSIPPIC // ID AMRSAP379 PN RA3 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 27.27%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 4.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 27.27%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 4.55%, 'Y': 0% MA D, E, F, G, H, L, M, N, Q, V, Y MO A; R LO K, S, T, W BA 11 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2511.013 AI 62.727 II 51.782 HP -0.532 HM 0.582 IP 12.506 NC 6.874 SF 0.136, 0.136, 0.273 [Helix, Turn, Sheet] AR 0.045 ME 5500, 5625 MS 42.140903 XX SC alpha XX TO MRSA 43300 (MIC = ND) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12998 SQ SEQUENCE 2511.013 DA MW 22AA RARARAWRAR ARACTKSIPP IC // ID AMRSAP380 PN RI3 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 8, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 36.36%, 'K': 4.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 27.27%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 4.55%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, V, Y MO I LO K, S, T, W BA 11 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2763.497 AI 141.818 II 31.809 HP 0.205 HM 0.604 IP 12.506 NC 6.874 SF 0.409, 0.136, 0 [Helix, Turn, Sheet] AR 0.045 ME 5500, 5625 MS 42.140903 XX SC beta XX TO MRSA 43300 (MIC = 32 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ12999 SQ SEQUENCE 2763.497 DA MW 22AA RIRIRIWRIR IRICTKSIPP IC // ID AMRSAP381 PN RL3 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 6, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 4.55%, 'L': 27.27%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 27.27%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 4.55%, 'Y': 0% MA A, D, E, F, G, H, M, N, Q, V, Y MO L; R LO K, S, T, W BA 11 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2763.497 AI 141.818 II 77.591 HP 0.014 HM 0.595 IP 12.506 NC 6.874 SF 0.409, 0.136, 0.273 [Helix, Turn, Sheet] AR 0.045 ME 5500, 5625 MS 42.140903 XX SC beta XX TO MRSA 43300 (MIC = 16 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ13000 SQ SEQUENCE 2763.497 DA MW 22AA RLRLRLWRLR LRLCTKSIPP IC // ID AMRSAP382 PN RV3 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 6, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 4.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 27.27%, 'S': 4.55%, 'T': 4.55%, 'V': 27.27%, 'W': 4.55%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, Y MO R; V LO K, S, T, W BA 11 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2679.336 AI 114.545 II 31.809 HP 0.123 HM 0.595 IP 12.506 NC 6.874 SF 0.409, 0.136, 0 [Helix, Turn, Sheet] AR 0.045 ME 5500, 5625 MS 42.140903 XX SC beta XX TO MRSA 43300 (MIC = 2 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ13001 SQ SEQUENCE 2679.336 DA MW 22AA RVRVRVWRVR VRVCTKSIPP IC // ID AMRSAP383 PN RF3 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 6, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 27.27%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 4.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 27.27%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 4.55%, 'Y': 0% MA A, D, E, G, H, L, M, N, Q, V, Y MO F; R LO K, S, T, W BA 11 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2967.6 AI 35.455 II 31.809 HP -0.259 HM 0.599 IP 12.506 NC 6.874 SF 0.409, 0.136, 0 [Helix, Turn, Sheet] AR 0.318 ME 5500, 5625 MS 42.140903 XX SC alpha XX TO MRSA 43300 (MIC = 4 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ13002 SQ SEQUENCE 2967.6 DA MW 22AA RFRFRFWRFR FRFCTKSIPP IC // ID AMRSAP384 PN RW3 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 6, 'S': 1, 'T': 1, 'V': 0, 'W': 7, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 4.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 27.27%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 31.82%, 'Y': 0% MA A, D, E, F, G, H, L, M, N, Q, V, Y MO W LO K, S, T BA 11 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 3201.82 AI 35.455 II 188.027 HP -1.268 HM 0.587 IP 12.506 NC 6.874 SF 0.409, 0.136, 0 [Helix, Turn, Sheet] AR 0.318 ME 38500, 38625 MS 42.140903 XX SC alpha_beta XX TO MRSA 43300 (MIC = 4 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ13003 SQ SEQUENCE 3201.82 DA MW 22AA RWRWRWWRWR WRWCTKSIPP IC // ID AMRSAP385 PN RV SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 6, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 46.15%, 'S': 0%, 'T': 0%, 'V': 46.15%, 'W': 7.69%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R; V LO W BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1736.149 AI 133.846 II 9.231 HP -0.208 HM 0.25 IP 13.199 NC 5.998 SF 0.538, 0, 0 [Helix, Turn, Sheet] AR 0.077 ME 5500, 5500 MS 36.120774 XX SC beta XX TO MRSA 43300 (MIC = 2 μM) XX XR PubMed: 33508505 XR CAMP R4: CAMPSQ13004 SQ SEQUENCE 1736.149 DA MW 13AA RVRVRVWRVR VRV // ID AMRSAP386 PN Tachyplesin-1 SO Tachypleus tridentatus PL 17 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA A, D, E, H, L, M, N, P, Q, S, T MO R LO F, G, I, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2268.768 AI 40 II 13.224 HP -0.518 HM 0.652 IP 10.068 NC 5.748 SF 0.353, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC 43300 (MRSA) (MIC = 0.25 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ132 SQ SEQUENCE 2268.768 DA MW 17AA KWCFRVCYRG ICYRRCR // ID AMRSAP387 PN TB2U SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 2, 'H': 1, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.74%, 'C': 0%, 'D': 4.35%, 'E': 4.35%, 'F': 0%, 'G': 8.7%, 'H': 4.35%, 'I': 8.7%, 'K': 13.04%, 'L': 13.04%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.35%, 'S': 0%, 'T': 8.7%, 'V': 8.7%, 'W': 0%, 'Y': 0% MA C, F, M, N, P, Q, S, W, Y MO A LO D, E, H, R BA 14 LA 9 AA 2 BC 5 MC 0 MF 0 XX MM 2375.84 AI 131.739 II -3.361 HP 0.4 HM 0.549 IP 10.501 NC 2.09 SF 0.304, 0.087, 0.391 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13267 SQ SEQUENCE 2375.84 DA MW 23AA GVIIDTLKGA AKTVAAELLR KAH // ID AMRSAP388 PN TB2U SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 2, 'H': 1, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.74%, 'C': 0%, 'D': 4.35%, 'E': 4.35%, 'F': 0%, 'G': 8.7%, 'H': 4.35%, 'I': 8.7%, 'K': 13.04%, 'L': 13.04%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.35%, 'S': 0%, 'T': 8.7%, 'V': 8.7%, 'W': 0%, 'Y': 0% MA C, F, M, N, P, Q, S, W, Y MO A LO D, E, H, R BA 14 LA 9 AA 2 BC 5 MC 0 MF 0 XX MM 2375.84 AI 131.739 II -3.361 HP 0.4 HM 0.549 IP 10.501 NC 2.09 SF 0.304, 0.087, 0.391 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13267 SQ SEQUENCE 2375.84 DA MW 23AA GVIIDTLKGA AKTVAAELLR KAH // ID AMRSAP389 PN TB2U-μ SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 5.26%, 'E': 5.26%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 10.53%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.53%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, F, H, M, N, P, Q, R, S, W, Y MO A LO D, E BA 13 LA 6 AA 2 BC 2 MC 0 MF 0 XX MM 1883.259 AI 154.211 II -11.842 HP 1 HM 0.549 IP 6.493 NC -0 SF 0.368, 0.105, 0.421 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13268 SQ SEQUENCE 1883.259 DA MW 19AA GVIIDTLKGA AKTVAAELL // ID AMRSAP390 PN TB2U-μ SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 5.26%, 'E': 5.26%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 10.53%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.53%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, F, H, M, N, P, Q, R, S, W, Y MO A LO D, E BA 13 LA 6 AA 2 BC 2 MC 0 MF 0 XX MM 1883.259 AI 154.211 II -11.842 HP 1 HM 0.549 IP 6.493 NC -0 SF 0.368, 0.105, 0.421 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13268 SQ SEQUENCE 1883.259 DA MW 19AA GVIIDTLKGA AKTVAAELL // ID AMRSAP391 PN TB2U-K SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.53%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, W, Y MO A; K LO G, I, T, V BA 13 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1895.403 AI 154.211 II -12.868 HP 0.958 HM 0.604 IP 11.278 NC 3.997 SF 0.368, 0.105, 0.368 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (MIC = 128 μM TO MBC = 128 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13269 SQ SEQUENCE 1895.403 DA MW 19AA GVIIKTLKGA AKTVAAKLL // ID AMRSAP392 PN TB2U-K SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.53%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, W, Y MO A; K LO G, I, T, V BA 13 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1895.403 AI 154.211 II -12.868 HP 0.958 HM 0.604 IP 11.278 NC 3.997 SF 0.368, 0.105, 0.368 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC > 512) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13269 SQ SEQUENCE 1895.403 DA MW 19AA GVIIKTLKGA AKTVAAKLL // ID AMRSAP393 PN 7-tB2U-K 1 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 2, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 28.57%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, W, Y MO I LO G, K, L, T, V BA 5 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 742.957 AI 208.571 II -3.557 HP 1.714 HM 0.455 IP 9.7 NC 0.998 SF 0.571, 0.143, 0.143 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC beta XX TO MRSA (MIC = 256 μM TO MBC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13270 SQ SEQUENCE 742.957 DA MW 7AA GVIIKTL // ID AMRSAP394 PN 7-tB2U-K 1 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 2, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 28.57%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, W, Y MO I LO G, K, L, T, V BA 5 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 742.957 AI 208.571 II -3.557 HP 1.714 HM 0.455 IP 9.7 NC 0.998 SF 0.571, 0.143, 0.143 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13270 SQ SEQUENCE 742.957 DA MW 7AA GVIIKTL // ID AMRSAP395 PN 14-tB2U-K SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, W, Y MO K LO L BA 9 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1398.753 AI 139.286 II -14.971 HP 0.779 HM 0.604 IP 11.103 NC 2.997 SF 0.357, 0.143, 0.214 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13271 SQ SEQUENCE 1398.753 DA MW 14AA GVIIKTLKGA AKTV // ID AMRSAP396 PN 14-tB2U-K SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, W, Y MO K LO L BA 9 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1398.753 AI 139.286 II -14.971 HP 0.779 HM 0.604 IP 11.103 NC 2.997 SF 0.357, 0.143, 0.214 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13271 SQ SEQUENCE 1398.753 DA MW 14AA GVIIKTLKGA AKTV // ID AMRSAP397 PN TB2U-6K SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 31.58%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, T, W, Y MO K LO G, I, V BA 13 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1949.541 AI 154.211 II -21.805 HP 0.621 HM 0.634 IP 11.5 NC 5.996 SF 0.368, 0.105, 0.368 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA (MIC = 64 μM TO MBC = 128 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13272 SQ SEQUENCE 1949.541 DA MW 19AA GVIIKKLKGA AKKVAAKLL // ID AMRSAP398 PN TB2U-6K SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 31.58%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, R, S, T, W, Y MO K LO G, I, V BA 13 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1949.541 AI 154.211 II -21.805 HP 0.621 HM 0.634 IP 11.5 NC 5.996 SF 0.368, 0.105, 0.368 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC = 256 μM TO MBC = 256 μM) XX XR PubMed: 34438945 XR CAMP R4: CAMPSQ13272 SQ SEQUENCE 1949.541 DA MW 19AA GVIIKKLKGA AKKVAAKLL // ID AMRSAP399 PN MRumC1 SO Ruminococcus gnavus E1 PL 67 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 11, 'C': 4, 'D': 2, 'E': 1, 'F': 1, 'G': 10, 'H': 1, 'I': 1, 'K': 4, 'L': 1, AC 'M': 2, 'N': 7, 'P': 1, 'Q': 1, 'R': 2, 'S': 4, 'T': 4, 'V': 7, 'W': 1, 'Y': 2 AF 'A': 16.42%, 'C': 5.97%, 'D': 2.99%, 'E': 1.49%, 'F': 1.49%, 'G': 14.93%, 'H': 1.49%, 'I': 1.49%, 'K': 5.97%, 'L': 1.49%, AF 'M': 2.99%, 'N': 10.45%, 'P': 1.49%, 'Q': 1.49%, 'R': 2.99%, 'S': 5.97%, 'T': 5.97%, 'V': 10.45%, 'W': 1.49%, 'Y': 2.99% MA MO A LO E, F, H, I, L, P, Q, W BA 35 LA 32 AA 3 BC 7 MC 0 MF 0 XX MM 6723.543 AI 58.358 II -0.531 HP -0.109 HM 0.398 IP 8.663 NC 2.841 SF 0.194, 0.328, 0.224 [Helix, Turn, Sheet] AR 0.06 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S. aureus MRSA ATCC BAA-1717 (MIC = 50 μM) XX XR PubMed: 31579822 XR CAMP R4: CAMPSQ13290 SQ SEQUENCE 6723.543 DA MW 67AA GAMDMRKIVA GKLQTGADFE GSKWGCVCSG STAVANSHNA GPAYCVGYCG NNGVVTRNAN ANVAKTA // ID AMRSAP400 PN Gj-CATH2 SO Gekko japonicus PL 48 TX Animalia (Reptilia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 9, 'H': 2, 'I': 7, 'K': 13, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 2, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 2.08%, 'F': 2.08%, 'G': 18.75%, 'H': 4.17%, 'I': 14.58%, 'K': 27.08%, 'L': 4.17%, AF 'M': 0%, 'N': 2.08%, 'P': 2.08%, 'Q': 0%, 'R': 8.33%, 'S': 4.17%, 'T': 0%, 'V': 4.17%, 'W': 0%, 'Y': 0% MA C, D, M, Q, T, W, Y MO K LO E, F, N, P BA 25 LA 23 AA 1 BC 19 MC 0 MF 0 XX MM 5188.383 AI 91.458 II 35.569 HP -0.692 HM 0.948 IP 12.59 NC 16.178 SF 0.25, 0.271, 0.125 [Helix, Turn, Sheet] AR 0.021 ME 0, 0 MS 102.342193 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC = 64 μG/mL) XX XR PubMed: 34237581 XR CAMP R4: CAMPSQ13357 SQ SEQUENCE 5188.383 DA MW 48AA RRGIKKFIKK VKKVKKAIKE GIKKGIKKLL SGGGSNIAHG PGGRRHIA // ID AMRSAP401 PN Sarconesin III SO Sarconesiopsis magellanica PL 11 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 2, 'K': 3, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 9.09%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 9.09%, 'I': 18.18%, 'K': 27.27%, 'L': 0%, AF 'M': 0%, 'N': 9.09%, 'P': 9.09%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 9.09%, 'W': 0%, 'Y': 9.09% MA A, C, E, F, G, L, M, Q, R, S, T, W MO K LO D, H, N, P, V, Y BA 4 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 1354.615 AI 97.273 II 40.555 HP -1.055 HM 0.257 IP 10.12 NC 2.088 SF 0.364, 0.182, 0 [Helix, Turn, Sheet] AR 0.091 ME 1490, 1490 MS 18.060387 XX SC beta XX TO S. aureus MRSA ATCC 43300 (MIC = 171.8 μM) XX XR PubMed: 34287503 XR CAMP R4: CAMPSQ13574 SQ SEQUENCE 1354.615 DA MW 11AA PKINIKHVYD K // ID AMRSAP402 PN Sarconesin IV SO Sarconesiopsis magellanica PL 8 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 1, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 37.5%, 'H': 12.5%, 'I': 12.5%, 'K': 0%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 25%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, K, M, N, P, Q, R, S, V, W, Y MO G LO H, I, L BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 754.841 AI 97.5 II 83.913 HP 0.313 HM 0.144 IP 7.55 NC 0.089 SF 0.25, 0.375, 0.125 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO S. aureus MRSA ATCC 43300 (MIC = 182.9.8 μM) XX XR PubMed: 34287503 XR CAMP R4: CAMPSQ13575 SQ SEQUENCE 754.841 DA MW 8AA HITGGGLT // ID AMRSAP403 PN Sarconesin VI SO Sarconesiopsis magellanica PL 16 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 1, AC 'M': 1, 'N': 2, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 6.25%, AF 'M': 6.25%, 'N': 12.5%, 'P': 12.5%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 6.25%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, Q, R, W, Y MO A; I; K; N; P; V LO L, M, S, T BA 10 LA 6 AA 0 BC 2 MC 0 MF 0 XX MM 1696.081 AI 121.875 II 14.306 HP 0.45 HM 0.357 IP 10.805 NC 1.997 SF 0.313, 0.313, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha_beta XX TO S. aureus MRSA ATCC 43300 (MIC = 171.8 μM) XX XR PubMed: 34287503 XR CAMP R4: CAMPSQ13577 SQ SEQUENCE 1696.081 DA MW 16AA ATAKNPINVV SMKLPI // ID AMRSAP404 PN Dermaseptin-TO SO Phyllomedusa tomopterna PL 28 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 2, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 4, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 17.86%, 'C': 0%, 'D': 7.14%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 3.57%, 'K': 14.29%, 'L': 14.29%, AF 'M': 3.57%, 'N': 10.71%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 0%, 'T': 3.57%, 'V': 10.71%, 'W': 3.57%, 'Y': 0% MA C, E, F, H, P, R, S, Y MO A LO I, M, Q, T, W BA 17 LA 11 AA 2 BC 4 MC 0 MF 0 XX MM 2982.534 AI 118.571 II 5.671 HP 0.15 HM 0.595 IP 10.333 NC 1.998 SF 0.321, 0.179, 0.357 [Helix, Turn, Sheet] AR 0.036 ME 5500, 5500 MS 24.080516 XX SC beta XX TO MRSA (MIC = 64 μM TO MBC > 512 μM) XX XR PubMed: 33582221 XR CAMP R4: CAMPSQ13596 SQ SEQUENCE 2982.534 DA MW 28AA ALWKDLLKNV GIAAGKAALN KVTDMVNQ // ID AMRSAP405 PN Dermaseptin-PS2 SO Phyllomedusa sauvagii PL 28 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 4, 'L': 4, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 2, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 17.86%, 'C': 0%, 'D': 3.57%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 14.29%, AF 'M': 3.57%, 'N': 10.71%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 14.29%, 'W': 3.57%, 'Y': 0% MA C, E, F, H, I, P, R, S, Y MO A LO D, M, Q, W BA 17 LA 11 AA 1 BC 4 MC 0 MF 0 XX MM 2954.524 AI 115 II 0.246 HP 0.239 HM 0.65 IP 10.803 NC 2.997 SF 0.321, 0.179, 0.357 [Helix, Turn, Sheet] AR 0.036 ME 5500, 5500 MS 24.080516 XX SC beta XX TO MRSA (MIC = 16 μM TO MBC = 32 μM) XX XR PubMed: 33582221 XR CAMP R4: CAMPSQ13597 SQ SEQUENCE 2954.524 DA MW 28AA ALWKTLLKNV GKAAGKAVLN AVTDMVNQ // ID AMRSAP406 PN Brevibacillin 2V SO Brevibacillus laterosporus�DSM 25 PL 14 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 6, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 54.55%, 'W': 0%, 'Y': 9.09% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, W MO V LO J, O, X, Y BA 8 LA 3 AA 0 BC 2 MC {'O': 1, 'J': 1, 'X': 1} MF {'O': 0.07142857142857142, 'J': 0.07142857142857142, 'X': 0.07142857142857142} XX MM 1495.956 AI 207.857 II -0.893 HP 1.693 HM 0.549 IP 10.248 NC 1.997 SF 0.643, 0, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 1490, 1490 MS 12.040258 XX SC beta XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 2 mg/L) XX XR PubMed: 34220785 XR CAMP R4: CAMPSQ13696 SQ SEQUENCE 1495.956 DA MW 14AA XJLOVVVKVV KYLV // ID AMRSAP407 PN Brevibacillin V SO Brevibacillus laterosporus�DSM 26 PL 14 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 5, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 45.45%, 'W': 0%, 'Y': 9.09% MA A, C, D, E, F, G, H, M, N, P, Q, R, S, T, W MO V LO I, J, O, X, Y BA 8 LA 3 AA 0 BC 2 MC {'O': 1, 'J': 1, 'X': 1} MF {'O': 0.07142857142857142, 'J': 0.07142857142857142, 'X': 0.07142857142857142} XX MM 1509.982 AI 215 II -6.957 HP 1.714 HM 0.546 IP 10.248 NC 1.997 SF 0.643, 0, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 1490, 1490 MS 12.040258 XX SC beta XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 1-2 mg/L) XX XR PubMed: 34220785 XR CAMP R4: CAMPSQ13697 SQ SEQUENCE 1509.982 DA MW 14AA XJLOIVVKVV KYLV // ID AMRSAP408 PN Brevibacillin SO Brevibacillus laterosporus�DSM 27 PL 14 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 36.36%, 'W': 0%, 'Y': 9.09% MA A, C, D, E, F, G, H, M, N, P, Q, R, S, T, W MO V LO J, O, X, Y BA 8 LA 3 AA 0 BC 2 MC {'O': 1, 'J': 1, 'X': 1} MF {'O': 0.07142857142857142, 'J': 0.07142857142857142, 'X': 0.07142857142857142} XX MM 1524.009 AI 222.143 II -6.957 HP 1.736 HM 0.574 IP 10.248 NC 1.997 SF 0.643, 0, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 1490, 1490 MS 12.040258 XX SC beta XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 2 mg/L) XX XR PubMed: 34220785 XR CAMP R4: CAMPSQ13698 SQ SEQUENCE 1524.009 DA MW 14AA XJLOIIVKVV KYLV // ID AMRSAP409 PN Brevibacillin I SO Brevibacillus laterosporus�DSM 28 PL 14 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 27.27%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 27.27%, 'W': 0%, 'Y': 9.09% MA A, C, D, E, F, G, H, M, N, P, Q, R, S, T, W MO I; V LO J, O, X, Y BA 8 LA 3 AA 0 BC 2 MC {'O': 1, 'J': 1, 'X': 1} MF {'O': 0.07142857142857142, 'J': 0.07142857142857142, 'X': 0.07142857142857142} XX MM 1538.036 AI 229.286 II -13.021 HP 1.757 HM 0.59 IP 10.248 NC 1.997 SF 0.643, 0, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 1490, 1490 MS 12.040258 XX SC beta XX TO Staphylococcus aureus ATCC15975 (MRSA) (MIC = 2 mg/L) XX XR PubMed: 34220785 XR CAMP R4: CAMPSQ13699 SQ SEQUENCE 1538.036 DA MW 14AA XJLOIIVKIV KYLV // ID AMRSAP410 PN Caerin 1.9 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 2, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 5, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 4%, 'G': 12%, 'H': 8%, 'I': 8%, 'K': 8%, 'L': 16%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, M, N, Q, R, T, W, Y MO V LO E, F, S BA 19 LA 6 AA 1 BC 4 MC 0 MF 0 XX MM 2594.182 AI 159.6 II 29.316 HP 1.148 HM 0.435 IP 9.541 NC 1.181 SF 0.48, 0.24, 0.28 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ13707 SQ SEQUENCE 2594.182 DA MW 25AA GLFGVLGSIA KHVLPHVVPV IAEKL // ID AMRSAP411 PN Caerin 1.9 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 2, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 5, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 4%, 'G': 12%, 'H': 8%, 'I': 8%, 'K': 8%, 'L': 16%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, M, N, Q, R, T, W, Y MO V LO E, F, S BA 19 LA 6 AA 1 BC 4 MC 0 MF 0 XX MM 2594.182 AI 159.6 II 29.316 HP 1.148 HM 0.435 IP 9.541 NC 1.181 SF 0.48, 0.24, 0.28 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA1 (Clincial isolate) (MIC = 7.5 μG/mL) XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ13707 SQ SEQUENCE 2594.182 DA MW 25AA GLFGVLGSIA KHVLPHVVPV IAEKL // ID AMRSAP412 PN Caerin 1.9 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 2, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 5, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 4%, 'G': 12%, 'H': 8%, 'I': 8%, 'K': 8%, 'L': 16%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, M, N, Q, R, T, W, Y MO V LO E, F, S BA 19 LA 6 AA 1 BC 4 MC 0 MF 0 XX MM 2594.182 AI 159.6 II 29.316 HP 1.148 HM 0.435 IP 9.541 NC 1.181 SF 0.48, 0.24, 0.28 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA2 (Clincial isolate) (MIC = 7.5 μG/mL) XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ13707 SQ SEQUENCE 2594.182 DA MW 25AA GLFGVLGSIA KHVLPHVVPV IAEKL // ID AMRSAP413 PN Caerin 1.9 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 2, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 5, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 4%, 'G': 12%, 'H': 8%, 'I': 8%, 'K': 8%, 'L': 16%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, D, M, N, Q, R, T, W, Y MO V LO E, F, S BA 19 LA 6 AA 1 BC 4 MC 0 MF 0 XX MM 2594.182 AI 159.6 II 29.316 HP 1.148 HM 0.435 IP 9.541 NC 1.181 SF 0.48, 0.24, 0.28 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA3 (Clincial isolate) (MIC = 7.5 μG/mL) XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ13707 SQ SEQUENCE 2594.182 DA MW 25AA GLFGVLGSIA KHVLPHVVPV IAEKL // ID AMRSAP414 PN R SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 2, 'I': 2, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 5, 'Q': 0, 'R': 1, 'S': 3, 'T': 4, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 2.63%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 2.63%, 'G': 7.89%, 'H': 5.26%, 'I': 5.26%, 'K': 15.79%, 'L': 15.79%, AF 'M': 0%, 'N': 2.63%, 'P': 13.16%, 'Q': 0%, 'R': 2.63%, 'S': 7.89%, 'T': 10.53%, 'V': 7.89%, 'W': 0%, 'Y': 0% MA C, D, E, M, Q, W, Y MO K; L LO A, F, N, R BA 21 LA 17 AA 0 BC 9 MC 0 MF 0 XX MM 4074.956 AI 107.632 II 29.192 HP -0.084 HM 0.553 IP 12.102 NC 7.178 SF 0.316, 0.316, 0.184 [Helix, Turn, Sheet] AR 0.026 ME 0, 0 MS 42.140903 XX SC alpha_beta XX TO Staphylococcus aureus MRSA WKZ-2 (MIC = 5-10 μM) XX XR PubMed: 34209895 XR CAMP R4: CAMPSQ13711 SQ SEQUENCE 4074.956 DA MW 38AA PHVALKPGKL KFIIPSPKRP VKLLSGGNTL HLVSTTKT // ID AMRSAP415 PN R SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 2, 'I': 2, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 4, 'Q': 0, 'R': 1, 'S': 3, 'T': 4, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 2.63%, 'G': 7.89%, 'H': 5.26%, 'I': 5.26%, 'K': 15.79%, 'L': 15.79%, AF 'M': 0%, 'N': 2.63%, 'P': 10.53%, 'Q': 0%, 'R': 2.63%, 'S': 7.89%, 'T': 10.53%, 'V': 7.89%, 'W': 0%, 'Y': 0% MA C, D, E, M, Q, W, Y MO K; L LO F, N, R BA 21 LA 17 AA 0 BC 9 MC 0 MF 0 XX MM 4048.918 AI 110.263 II 31.176 HP 0.005 HM 0.553 IP 12.102 NC 7.178 SF 0.316, 0.289, 0.211 [Helix, Turn, Sheet] AR 0.026 ME 0, 0 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA WKZ-2 (MIC = 2.5 μM) XX XR PubMed: 34209895 XR CAMP R4: CAMPSQ13712 SQ SEQUENCE 4048.918 DA MW 38AA PHVALKAGKL KFIIPSPKRP VKLLSGGNTL HLVSTTKT // ID AMRSAP416 PN WW307 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 37.5%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO W LO V BA 5 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1330.563 AI 36.25 II 212.938 HP -1.613 HM 0.337 IP 12.801 NC 2.998 SF 0.625, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 22000, 22000 MS 18.060387 XX SC alpha_beta XX TO MRSA T144 (MIC = 4 μG/mL) XX XR PubMed: 33804947 XR CAMP R4: CAMPSQ13715 SQ SEQUENCE 1330.563 DA MW 8AA RRRWWWWV // ID AMRSAP417 PN PinA SO Triticum aestivum PL 18 TX Plantae PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.56%, 'E': 0%, 'F': 5.56%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 16.67%, 'L': 0%, AF 'M': 5.56%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 0%, 'T': 11.11%, 'V': 5.56%, 'W': 27.78%, 'Y': 0% MA A, C, E, H, I, L, N, Q, S, Y MO W LO D, F, M, P, R, V BA 11 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2395.812 AI 16.111 II 47.55 HP -1.061 HM 0.502 IP 11.08 NC 2.998 SF 0.389, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 24.080516 XX SC alpha_beta XX TO MRSA (MIC = 128 μG/mL) XX XR PubMed: 34276635 XR CAMP R4: CAMPSQ13721 SQ SEQUENCE 2395.812 DA MW 18AA TMKDFPVTWR WWKWWKGG // ID AMRSAP418 PN PinB SO Triticum aestivum PL 17 TX Plantae PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 3, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.88%, 'E': 0%, 'F': 5.88%, 'G': 11.76%, 'H': 0%, 'I': 0%, 'K': 17.65%, 'L': 0%, AF 'M': 5.88%, 'N': 0%, 'P': 11.76%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 17.65%, 'V': 5.88%, 'W': 17.65%, 'Y': 0% MA A, C, E, H, I, L, N, Q, R, S, Y MO K; T; W LO D, F, M, V BA 10 LA 7 AA 1 BC 3 MC 0 MF 0 XX MM 2065.42 AI 17.059 II 16.065 HP -0.888 HM 0.411 IP 10.507 NC 1.998 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC > 512 μG/mL) XX XR PubMed: 34276635 XR CAMP R4: CAMPSQ13722 SQ SEQUENCE 2065.42 DA MW 17AA TMKDFPVTWP TKWWKGG // ID AMRSAP419 PN PinA mutant SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.56%, 'E': 0%, 'F': 5.56%, 'G': 22.22%, 'H': 0%, 'I': 0%, 'K': 16.67%, 'L': 0%, AF 'M': 5.56%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 0%, 'T': 11.11%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA A, C, E, H, I, L, N, Q, S, Y MO G LO D, F, M, P, R, V BA 11 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2137.49 AI 16.111 II 26.594 HP -1.006 HM 0.473 IP 11.08 NC 2.998 SF 0.278, 0.278, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO MRSA (MIC > 512 μG/mL) XX XR PubMed: 34276635 XR CAMP R4: CAMPSQ13723 SQ SEQUENCE 2137.49 DA MW 18AA TMKDFPVTWR WGKWGKGG // ID AMRSAP420 PN PinB mutant SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 3, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.88%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 5.88%, 'N': 0%, 'P': 11.76%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 17.65%, 'V': 5.88%, 'W': 17.65%, 'Y': 0% MA A, C, E, H, I, L, N, Q, R, S, Y MO G LO D, F, K, M, V BA 12 LA 5 AA 1 BC 1 MC 0 MF 0 XX MM 1923.176 AI 17.059 II 24.482 HP -0.476 HM 0.295 IP 6.337 NC -0.002 SF 0.294, 0.353, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 16500, 16500 MS 6.020129 XX SC alpha_beta XX TO MRSA (MIC > 512 μG/mL) XX XR PubMed: 34276635 XR CAMP R4: CAMPSQ13724 SQ SEQUENCE 1923.176 DA MW 17AA TMKDFPVTWP TGWWGGG // ID AMRSAP421 PN HBD3 SO Synthetic construct PL 46 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 0, 'E': 2, 'F': 0, 'G': 5, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 1, 'N': 1, 'P': 1, 'Q': 2, 'R': 7, 'S': 2, 'T': 2, 'V': 2, 'W': 0, 'Y': 2 AF 'A': 2.17%, 'C': 13.04%, 'D': 0%, 'E': 4.35%, 'F': 0%, 'G': 10.87%, 'H': 0%, 'I': 6.52%, 'K': 13.04%, 'L': 6.52%, AF 'M': 2.17%, 'N': 2.17%, 'P': 2.17%, 'Q': 4.35%, 'R': 15.22%, 'S': 4.35%, 'T': 4.35%, 'V': 4.35%, 'W': 0%, 'Y': 4.35% MA D, F, H, W MO R LO A, M, N, P BA 16 LA 30 AA 2 BC 13 MC 0 MF 0 XX MM 5292.389 AI 65.652 II 52.193 HP -0.643 HM 0.631 IP 10.629 NC 10.626 SF 0.217, 0.196, 0.152 [Helix, Turn, Sheet] AR 0.043 ME 2980, 3355 MS 78.261677 XX SC beta XX TO MRSA SAP0017 (MIC = 64 μG/mL) XX XR PubMed: 33865931 XR CAMP R4: CAMPSQ13746 SQ SEQUENCE 5292.389 DA MW 46AA MGIINTLQKY YCRVRGGRCA VLSCLPKEEQ IGKCSTRGRK CCRRKK // ID AMRSAP422 PN PST11-RK, SYM11KK SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 18.18%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, Q, R, S, T, V, Y MO K LO F, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1577.938 AI 0 II 27.827 HP -1.445 HM 0.136 IP 11.278 NC 3.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 1 (MRSA 1) (MIC = 4 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: CAMPSQ13764 SQ SEQUENCE 1577.938 DA MW 11AA KKFPWWWPFK K // ID AMRSAP423 PN PST11-RK, SYM11KK SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 18.18%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, Q, R, S, T, V, Y MO K LO F, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1577.938 AI 0 II 27.827 HP -1.445 HM 0.136 IP 11.278 NC 3.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 2 (MRSA 2) (MIC = 8 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: CAMPSQ13764 SQ SEQUENCE 1577.938 DA MW 11AA KKFPWWWPFK K // ID AMRSAP424 PN PST11-RK, SYM11KK SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 18.18%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, Q, R, S, T, V, Y MO K LO F, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1577.938 AI 0 II 27.827 HP -1.445 HM 0.136 IP 11.278 NC 3.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 1 (MRSA 1) (MIC = 4 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: CAMPSQ13765 SQ SEQUENCE 1577.938 DA MW 11AA KKFPWWWPFK K // ID AMRSAP425 PN PST11-RK, SYM11KK SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 18.18%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, Q, R, S, T, V, Y MO K LO F, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1577.938 AI 0 II 27.827 HP -1.445 HM 0.136 IP 11.278 NC 3.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 2 (MRSA 2) (MIC = 8 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: CAMPSQ13765 SQ SEQUENCE 1577.938 DA MW 11AA KKFPWWWPFK K // ID AMRSAP426 PN Pep-1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 8, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 13.33%, 'H': 0%, 'I': 0%, 'K': 53.33%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, T, V, W, Y MO K LO G BA 7 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1723.309 AI 130 II -35.947 HP -0.867 HM 0.853 IP 11.646 NC 7.996 SF 0.333, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA (MIC >> 500 � 10 μG/mL) XX XR PubMed: 21300831 XR CAMP R4: CAMPSQ13804 SQ SEQUENCE 1723.309 DA MW 15AA GKKLLKKLKK LLKKG // ID AMRSAP427 PN MA-d SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 8, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 13.33%, 'H': 0%, 'I': 0%, 'K': 53.33%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, T, V, W, Y MO K LO G BA 7 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1723.309 AI 130 II -35.947 HP -0.867 HM 0.853 IP 11.646 NC 7.996 SF 0.333, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA (MIC > 1000 μG/mL) XX XR PubMed: 21300831 XR CAMP R4: CAMPSQ13805 SQ SEQUENCE 1723.309 DA MW 15AA GKKLLKKLKK LLKKG // ID AMRSAP428 PN MAw-1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 8, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 53.33%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 6.67%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, T, V, Y MO K LO G, W BA 7 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1852.47 AI 130 II -30.287 HP -0.9 HM 0.853 IP 11.646 NC 7.996 SF 0.4, 0.067, 0.333 [Helix, Turn, Sheet] AR 0.067 ME 5500, 5500 MS 48.161032 XX SC alpha_beta XX TO MRSA (MIC <= 100 � 10 μG/mL) XX XR PubMed: 21300831 XR CAMP R4: CAMPSQ13806 SQ SEQUENCE 1852.47 DA MW 15AA GKKLLKKLKK LLKKW // ID AMRSAP429 PN MAw-2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 8, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 53.33%, 'L': 26.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 13.33%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, T, V, Y MO K LO G BA 7 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1925.524 AI 104 II -8.84 HP -1.213 HM 0.836 IP 11.646 NC 7.996 SF 0.4, 0.067, 0.267 [Helix, Turn, Sheet] AR 0.133 ME 11000, 11000 MS 48.161032 XX SC alpha_beta XX TO MRSA (MIC > 1000 μG/mL) XX XR PubMed: 21300831 XR CAMP R4: CAMPSQ13807 SQ SEQUENCE 1925.524 DA MW 15AA GKKLLKKLKK LWKKW // ID AMRSAP430 PN MAw-3 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 8, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 53.33%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 20%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, T, V, Y MO K LO G BA 7 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1998.578 AI 78 II 2.48 HP -1.527 HM 0.813 IP 11.646 NC 7.996 SF 0.4, 0.067, 0.2 [Helix, Turn, Sheet] AR 0.2 ME 16500, 16500 MS 48.161032 XX SC alpha_beta XX TO MRSA (MIC > 1000 μG/mL) XX XR PubMed: 21300831 XR CAMP R4: CAMPSQ13808 SQ SEQUENCE 1998.578 DA MW 15AA GKKLLKKWKK LWKKW // ID AMRSAP431 PN Defb14-1CV SO Synthetic construct PL 45 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 3, 'G': 5, 'H': 0, 'I': 2, 'K': 7, 'L': 4, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 7, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.33%, 'C': 2.22%, 'D': 0%, 'E': 4.44%, 'F': 6.67%, 'G': 11.11%, 'H': 0%, 'I': 4.44%, 'K': 15.56%, 'L': 8.89%, AF 'M': 0%, 'N': 4.44%, 'P': 2.22%, 'Q': 2.22%, 'R': 15.56%, 'S': 4.44%, 'T': 2.22%, 'V': 2.22%, 'W': 0%, 'Y': 0% MA D, H, M, W, Y MO K; R LO C, P, Q, T, V BA 22 LA 23 AA 2 BC 14 MC 0 MF 0 XX MM 5029.984 AI 71.778 II 28.831 HP -0.713 HM 0.759 IP 12.417 NC 11.937 SF 0.222, 0.222, 0.267 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 84.281806 XX SC alpha XX TO MRSA J2918 (MBC = 1.2 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13951 SQ SEQUENCE 5029.984 DA MW 45AA FLPKTLRKFF ARIRGGRAAV LNALGKEEQI GRASNSGRKC ARKKK // ID AMRSAP432 PN Defb14-1CV SO Synthetic construct PL 45 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 3, 'G': 5, 'H': 0, 'I': 2, 'K': 7, 'L': 4, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 7, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.33%, 'C': 2.22%, 'D': 0%, 'E': 4.44%, 'F': 6.67%, 'G': 11.11%, 'H': 0%, 'I': 4.44%, 'K': 15.56%, 'L': 8.89%, AF 'M': 0%, 'N': 4.44%, 'P': 2.22%, 'Q': 2.22%, 'R': 15.56%, 'S': 4.44%, 'T': 2.22%, 'V': 2.22%, 'W': 0%, 'Y': 0% MA D, H, M, W, Y MO K; R LO C, P, Q, T, V BA 22 LA 23 AA 2 BC 14 MC 0 MF 0 XX MM 5029.984 AI 71.778 II 28.831 HP -0.713 HM 0.759 IP 12.417 NC 11.937 SF 0.222, 0.222, 0.267 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 84.281806 XX SC alpha XX TO MRSA J2918 (MBC = 0.6 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13951 SQ SEQUENCE 5029.984 DA MW 45AA FLPKTLRKFF ARIRGGRAAV LNALGKEEQI GRASNSGRKC ARKKK // ID AMRSAP433 PN Defb14-1CVμ SO Synthetic construct PL 44 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 7, 'L': 4, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 7, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.64%, 'C': 2.27%, 'D': 0%, 'E': 4.55%, 'F': 4.55%, 'G': 11.36%, 'H': 0%, 'I': 4.55%, 'K': 15.91%, 'L': 9.09%, AF 'M': 0%, 'N': 4.55%, 'P': 2.27%, 'Q': 2.27%, 'R': 15.91%, 'S': 4.55%, 'T': 2.27%, 'V': 2.27%, 'W': 0%, 'Y': 0% MA D, H, M, W, Y MO K; R LO C, P, Q, T, V BA 21 LA 23 AA 2 BC 14 MC 0 MF 0 XX MM 4882.807 AI 73.409 II 29.259 HP -0.793 HM 0.759 IP 12.417 NC 11.937 SF 0.205, 0.227, 0.273 [Helix, Turn, Sheet] AR 0.045 ME 0, 0 MS 84.281806 XX SC alpha XX TO MRSA J2918 (MBC = 0.7 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13952 SQ SEQUENCE 4882.807 DA MW 44AA LPKTLRKFFA RIRGGRAAVL NALGKEEQIG RASNSGRKCA RKKK // ID AMRSAP434 PN Defb14-1CVμ SO Synthetic construct PL 43 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 7, 'L': 3, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 7, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.95%, 'C': 2.33%, 'D': 0%, 'E': 4.65%, 'F': 4.65%, 'G': 11.63%, 'H': 0%, 'I': 4.65%, 'K': 16.28%, 'L': 6.98%, AF 'M': 0%, 'N': 4.65%, 'P': 2.33%, 'Q': 2.33%, 'R': 16.28%, 'S': 4.65%, 'T': 2.33%, 'V': 2.33%, 'W': 0%, 'Y': 0% MA D, H, M, W, Y MO K; R LO C, P, Q, T, V BA 20 LA 23 AA 2 BC 14 MC 0 MF 0 XX MM 4769.648 AI 66.047 II 25.228 HP -0.9 HM 0.759 IP 12.417 NC 11.937 SF 0.186, 0.233, 0.256 [Helix, Turn, Sheet] AR 0.047 ME 0, 0 MS 84.281806 XX SC alpha XX TO MRSA J2918 (MBC = 2.1 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13953 SQ SEQUENCE 4769.648 DA MW 43AA PKTLRKFFAR IRGGRAAVLN ALGKEEQIGR ASNSGRKCAR KKK // ID AMRSAP435 PN Defb14-1CVμ SO Synthetic construct PL 43 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 7, 'L': 3, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 7, 'S': 2, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.95%, 'C': 2.33%, 'D': 0%, 'E': 4.65%, 'F': 4.65%, 'G': 11.63%, 'H': 0%, 'I': 4.65%, 'K': 16.28%, 'L': 6.98%, AF 'M': 0%, 'N': 4.65%, 'P': 2.33%, 'Q': 2.33%, 'R': 16.28%, 'S': 4.65%, 'T': 2.33%, 'V': 2.33%, 'W': 0%, 'Y': 0% MA D, H, M, W, Y MO K; R LO C, P, Q, T, V BA 20 LA 23 AA 2 BC 14 MC 0 MF 0 XX MM 4769.648 AI 66.047 II 25.228 HP -0.9 HM 0.759 IP 12.417 NC 11.937 SF 0.186, 0.233, 0.256 [Helix, Turn, Sheet] AR 0.047 ME 0, 0 MS 84.281806 XX SC alpha XX TO MRSA J2918 (MBC = 0.8 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13953 SQ SEQUENCE 4769.648 DA MW 43AA PKTLRKFFAR IRGGRAAVLN ALGKEEQIGR ASNSGRKCAR KKK // ID AMRSAP436 PN Defb14-1CVμ SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 6, 'L': 3, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 7, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 15%, 'C': 2.5%, 'D': 0%, 'E': 5%, 'F': 5%, 'G': 12.5%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 7.5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 2.5%, 'R': 17.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 0%, 'Y': 0% MA D, H, M, P, T, W, Y MO R LO C, Q, V BA 19 LA 21 AA 2 BC 13 MC 0 MF 0 XX MM 4443.252 AI 71 II 26.37 HP -0.813 HM 0.759 IP 12.411 NC 10.938 SF 0.2, 0.225, 0.275 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 78.261677 XX SC alpha XX TO MRSA J2918 (MBC = 2.5 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13954 SQ SEQUENCE 4443.252 DA MW 40AA LRKFFARIRG GRAAVLNALG KEEQIGRASN SGRKCARKKK // ID AMRSAP437 PN Defb14-1CVμ SO Synthetic construct PL 40 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 6, 'L': 3, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 7, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 15%, 'C': 2.5%, 'D': 0%, 'E': 5%, 'F': 5%, 'G': 12.5%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 7.5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 2.5%, 'R': 17.5%, 'S': 5%, 'T': 0%, 'V': 2.5%, 'W': 0%, 'Y': 0% MA D, H, M, P, T, W, Y MO R LO C, Q, V BA 19 LA 21 AA 2 BC 13 MC 0 MF 0 XX MM 4443.252 AI 71 II 26.37 HP -0.813 HM 0.759 IP 12.411 NC 10.938 SF 0.2, 0.225, 0.275 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 78.261677 XX SC alpha XX TO MRSA J2918 (MBC = 1.7 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13954 SQ SEQUENCE 4443.252 DA MW 40AA LRKFFARIRG GRAAVLNALG KEEQIGRASN SGRKCARKKK // ID AMRSAP438 PN Defb14-1CVμ SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 6, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.22%, 'C': 2.7%, 'D': 0%, 'E': 5.41%, 'F': 5.41%, 'G': 13.51%, 'H': 0%, 'I': 5.41%, 'K': 13.51%, 'L': 5.41%, AF 'M': 0%, 'N': 5.41%, 'P': 0%, 'Q': 2.7%, 'R': 16.22%, 'S': 5.41%, 'T': 0%, 'V': 2.7%, 'W': 0%, 'Y': 0% MA D, H, M, P, T, W, Y MO A; R LO C, Q, V BA 18 LA 19 AA 2 BC 11 MC 0 MF 0 XX MM 4045.731 AI 66.216 II 22.492 HP -0.754 HM 0.759 IP 12.253 NC 8.938 SF 0.189, 0.243, 0.27 [Helix, Turn, Sheet] AR 0.054 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA J2918 (MBC = 2.2 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13955 SQ SEQUENCE 4045.731 DA MW 37AA FFARIRGGRA AVLNALGKEE QIGRASNSGR KCARKKK // ID AMRSAP439 PN Defb14-1CVμ SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 1, 'D': 0, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 6, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.22%, 'C': 2.7%, 'D': 0%, 'E': 5.41%, 'F': 5.41%, 'G': 13.51%, 'H': 0%, 'I': 5.41%, 'K': 13.51%, 'L': 5.41%, AF 'M': 0%, 'N': 5.41%, 'P': 0%, 'Q': 2.7%, 'R': 16.22%, 'S': 5.41%, 'T': 0%, 'V': 2.7%, 'W': 0%, 'Y': 0% MA D, H, M, P, T, W, Y MO A; R LO C, Q, V BA 18 LA 19 AA 2 BC 11 MC 0 MF 0 XX MM 4045.731 AI 66.216 II 22.492 HP -0.754 HM 0.759 IP 12.253 NC 8.938 SF 0.189, 0.243, 0.27 [Helix, Turn, Sheet] AR 0.054 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA J2918 (MBC = 1.3 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13955 SQ SEQUENCE 4045.731 DA MW 37AA FFARIRGGRA AVLNALGKEE QIGRASNSGR KCARKKK // ID AMRSAP440 PN Defb14-1CVμ SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 6, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 14.71%, 'C': 2.94%, 'D': 0%, 'E': 5.88%, 'F': 0%, 'G': 14.71%, 'H': 0%, 'I': 5.88%, 'K': 14.71%, 'L': 5.88%, AF 'M': 0%, 'N': 5.88%, 'P': 0%, 'Q': 2.94%, 'R': 17.65%, 'S': 5.88%, 'T': 0%, 'V': 2.94%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, W, Y MO R LO C, Q, V BA 15 LA 19 AA 2 BC 11 MC 0 MF 0 XX MM 3680.299 AI 69.118 II 23.594 HP -1.038 HM 0.759 IP 12.253 NC 8.938 SF 0.147, 0.265, 0.265 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA J2918 (MBC > 10 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13956 SQ SEQUENCE 3680.299 DA MW 34AA RIRGGRAAVL NALGKEEQIG RASNSGRKCA RKKK // ID AMRSAP441 PN Defb14-1CVμ SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 6, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 14.71%, 'C': 2.94%, 'D': 0%, 'E': 5.88%, 'F': 0%, 'G': 14.71%, 'H': 0%, 'I': 5.88%, 'K': 14.71%, 'L': 5.88%, AF 'M': 0%, 'N': 5.88%, 'P': 0%, 'Q': 2.94%, 'R': 17.65%, 'S': 5.88%, 'T': 0%, 'V': 2.94%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, W, Y MO R LO C, Q, V BA 15 LA 19 AA 2 BC 11 MC 0 MF 0 XX MM 3680.299 AI 69.118 II 23.594 HP -1.038 HM 0.759 IP 12.253 NC 8.938 SF 0.147, 0.265, 0.265 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA J2918 (MBC = 1.5 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13956 SQ SEQUENCE 3680.299 DA MW 34AA RIRGGRAAVL NALGKEEQIG RASNSGRKCA RKKK // ID AMRSAP442 PN Defb14-1CVμ SO Synthetic construct PL 31 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 5, 'H': 0, 'I': 1, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 4, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.13%, 'C': 3.23%, 'D': 0%, 'E': 6.45%, 'F': 0%, 'G': 16.13%, 'H': 0%, 'I': 3.23%, 'K': 16.13%, 'L': 6.45%, AF 'M': 0%, 'N': 6.45%, 'P': 0%, 'Q': 3.23%, 'R': 12.9%, 'S': 6.45%, 'T': 0%, 'V': 3.23%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, W, Y MO A; G; K LO C, I, Q, V BA 14 LA 17 AA 2 BC 9 MC 0 MF 0 XX MM 3254.765 AI 63.226 II 27.648 HP -0.994 HM 0.759 IP 11.706 NC 6.938 SF 0.129, 0.29, 0.29 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 54.181161 XX SC alpha XX TO MRSA J2918 (MBC > 10 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13957 SQ SEQUENCE 3254.765 DA MW 31AA GGRAAVLNAL GKEEQIGRAS NSGRKCARKK K // ID AMRSAP443 PN Defb14-1CVμ SO Synthetic construct PL 31 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 5, 'H': 0, 'I': 1, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 4, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.13%, 'C': 3.23%, 'D': 0%, 'E': 6.45%, 'F': 0%, 'G': 16.13%, 'H': 0%, 'I': 3.23%, 'K': 16.13%, 'L': 6.45%, AF 'M': 0%, 'N': 6.45%, 'P': 0%, 'Q': 3.23%, 'R': 12.9%, 'S': 6.45%, 'T': 0%, 'V': 3.23%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, W, Y MO A; G; K LO C, I, Q, V BA 14 LA 17 AA 2 BC 9 MC 0 MF 0 XX MM 3254.765 AI 63.226 II 27.648 HP -0.994 HM 0.759 IP 11.706 NC 6.938 SF 0.129, 0.29, 0.29 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 54.181161 XX SC alpha XX TO MRSA J2918 (MBC = 6.7 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13957 SQ SEQUENCE 3254.765 DA MW 31AA GGRAAVLNAL GKEEQIGRAS NSGRKCARKK K // ID AMRSAP444 PN Defb14-1CVμ SO Synthetic construct PL 28 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 17.86%, 'C': 3.57%, 'D': 0%, 'E': 7.14%, 'F': 0%, 'G': 10.71%, 'H': 0%, 'I': 3.57%, 'K': 17.86%, 'L': 7.14%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 3.57%, 'R': 10.71%, 'S': 7.14%, 'T': 0%, 'V': 3.57%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, W, Y MO A; K LO C, I, Q, V BA 12 LA 16 AA 2 BC 8 MC 0 MF 0 XX MM 2984.473 AI 70 II 25.132 HP -0.911 HM 0.759 IP 11.311 NC 5.938 SF 0.143, 0.25, 0.321 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA J2918 (MBC > 10 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13958 SQ SEQUENCE 2984.473 DA MW 28AA AAVLNALGKE EQIGRASNSG RKCARKKK // ID AMRSAP445 PN Defb14-1CVμ SO Synthetic construct PL 28 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 17.86%, 'C': 3.57%, 'D': 0%, 'E': 7.14%, 'F': 0%, 'G': 10.71%, 'H': 0%, 'I': 3.57%, 'K': 17.86%, 'L': 7.14%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 3.57%, 'R': 10.71%, 'S': 7.14%, 'T': 0%, 'V': 3.57%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, W, Y MO A; K LO C, I, Q, V BA 12 LA 16 AA 2 BC 8 MC 0 MF 0 XX MM 2984.473 AI 70 II 25.132 HP -0.911 HM 0.759 IP 11.311 NC 5.938 SF 0.143, 0.25, 0.321 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA J2918 (MBC > 5 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13958 SQ SEQUENCE 2984.473 DA MW 28AA AAVLNALGKE EQIGRASNSG RKCARKKK // ID AMRSAP446 PN Defb14-1CVμ SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 3, 'S': 2, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 4.55%, 'D': 0%, 'E': 9.09%, 'F': 0%, 'G': 13.64%, 'H': 0%, 'I': 4.55%, 'K': 22.73%, 'L': 4.55%, AF 'M': 0%, 'N': 4.55%, 'P': 0%, 'Q': 4.55%, 'R': 13.64%, 'S': 9.09%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, V, W, Y MO K LO C, I, L, N, Q BA 7 LA 15 AA 2 BC 8 MC 0 MF 0 XX MM 2444.841 AI 44.545 II 29.259 HP -1.609 HM 0.759 IP 11.311 NC 5.938 SF 0.091, 0.273, 0.227 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA J2918 (MIC > 20.5 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13959 SQ SEQUENCE 2444.841 DA MW 22AA LGKEEQIGRA SNSGRKCARK KK // ID AMRSAP447 PN Defb14-1CVμ SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 2, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 3, 'S': 2, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 4.55%, 'D': 0%, 'E': 9.09%, 'F': 0%, 'G': 13.64%, 'H': 0%, 'I': 4.55%, 'K': 22.73%, 'L': 4.55%, AF 'M': 0%, 'N': 4.55%, 'P': 0%, 'Q': 4.55%, 'R': 13.64%, 'S': 9.09%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, F, H, M, P, T, V, W, Y MO K LO C, I, L, N, Q BA 7 LA 15 AA 2 BC 8 MC 0 MF 0 XX MM 2444.841 AI 44.545 II 29.259 HP -1.609 HM 0.759 IP 11.311 NC 5.938 SF 0.091, 0.273, 0.227 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA J2918 (MIC > 10 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13959 SQ SEQUENCE 2444.841 DA MW 22AA LGKEEQIGRA SNSGRKCARK KK // ID AMRSAP448 PN Defb14-1CV SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 30%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 20%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, Q, S, V, W, Y MO F LO P, R, T BA 6 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1296.621 AI 78 II 47.52 HP 0.14 HM 0.707 IP 11.823 NC 2.997 SF 0.5, 0.1, 0.2 [Helix, Turn, Sheet] AR 0.3 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA J2918 (MIC = 38.6 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13960 SQ SEQUENCE 1296.621 DA MW 10AA FLPKTLRKFF // ID AMRSAP449 PN Defb14-1CV SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 16.67%, 'H': 0%, 'I': 8.33%, 'K': 8.33%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, S, T, V, W, Y MO R LO A, I, K, L BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1476.794 AI 73.333 II 28.425 HP -0.583 HM 0.587 IP 12.981 NC 4.998 SF 0.333, 0.167, 0.167 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA J2918 (MIC = 4.8 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13961 SQ SEQUENCE 1476.794 DA MW 12AA LRKFFARIRG GR // ID AMRSAP450 PN Defb14-1CV SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 30%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 10%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, I, K, M, P, Q, S, T, W, Y MO A LO L, N, V BA 7 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 984.126 AI 98 II 12.85 HP 0.01 HM 0.479 IP 12.5 NC 1.998 SF 0.2, 0.3, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA J2918 (MIC > 48 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13963 SQ SEQUENCE 984.126 DA MW 10AA RGGRAAVLNA // ID AMRSAP451 PN Defb14-1CV SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 2, 'F': 0, 'G': 4, 'H': 0, 'I': 2, 'K': 1, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 9.09%, 'F': 0%, 'G': 18.18%, 'H': 0%, 'I': 9.09%, 'K': 4.55%, 'L': 9.09%, AF 'M': 0%, 'N': 4.55%, 'P': 0%, 'Q': 4.55%, 'R': 13.64%, 'S': 4.55%, 'T': 0%, 'V': 4.55%, 'W': 0%, 'Y': 0% MA C, D, F, H, M, P, T, W, Y MO A; G LO K, N, Q, S, V BA 13 LA 9 AA 2 BC 4 MC 0 MF 0 XX MM 2266.589 AI 102.273 II 31.009 HP -0.264 HM 0.443 IP 11.378 NC 2.001 SF 0.227, 0.273, 0.364 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA J2918 (MIC > 22 μM) XX XR PubMed: 20176896 XR CAMP R4: CAMPSQ13965 SQ SEQUENCE 2266.589 DA MW 22AA IRGGRAAVLN ALGKEEQIGR AS // ID AMRSAP452 PN OptP7 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 22.22%, 'K': 11.11%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 22.22%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, Y MO R LO K, V BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1312.63 AI 118.889 II 172.4 HP -0.667 HM 0.504 IP 12.807 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus epidemic Methicillin-resistant EMRSA-15 (MIC = 6 μM) XX XR PubMed: 34201398 XR CAMP R4: CAMPSQ14040 SQ SEQUENCE 1312.63 DA MW 9AA KRRVRWIIW // ID AMRSAP453 PN AMPR-11 SO Homo sapiens PL 21 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 1, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 23.81%, 'H': 0%, 'I': 9.52%, 'K': 4.76%, 'L': 0%, AF 'M': 19.05%, 'N': 0%, 'P': 0%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, V, W, Y MO G LO A, K, Q, R, S BA 14 LA 7 AA 0 BC 2 MC 0 MF 0 XX MM 2222.682 AI 41.905 II 36.862 HP 0.343 HM 0.373 IP 11.652 NC 1.998 SF 0.19, 0.286, 0.238 [Helix, Turn, Sheet] AR 0.095 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA ATCC33591 (MBC = 100 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14057 SQ SEQUENCE 2222.682 DA MW 21AA KTMMQSGGTF GTFMAIGMGI R // ID AMRSAP454 PN AMPR-11 K2 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 3, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 23.81%, 'H': 0%, 'I': 9.52%, 'K': 14.29%, 'L': 0%, AF 'M': 19.05%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 4.76%, 'T': 9.52%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, V, W, Y MO G LO A, R, S BA 14 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2249.794 AI 41.905 II 35.052 HP 0.171 HM 0.51 IP 11.925 NC 3.997 SF 0.19, 0.286, 0.238 [Helix, Turn, Sheet] AR 0.095 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA ATCC33591 (MBC = 64 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14058 SQ SEQUENCE 2249.794 DA MW 21AA KKMMKSGGTF GTFMAIGMGI R // ID AMRSAP455 PN AMPR-11 K3 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 4, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 23.81%, 'H': 0%, 'I': 9.52%, 'K': 19.05%, 'L': 0%, AF 'M': 19.05%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 0%, 'T': 9.52%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G LO A, R BA 14 LA 7 AA 0 BC 5 MC 0 MF 0 XX MM 2290.89 AI 41.905 II 31.01 HP 0.024 HM 0.528 IP 11.997 NC 4.997 SF 0.19, 0.238, 0.238 [Helix, Turn, Sheet] AR 0.095 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA ATCC33591 (MBC = 32 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14059 SQ SEQUENCE 2290.89 DA MW 21AA KKMMKKGGTF GTFMAIGMGI R // ID AMRSAP456 PN AMPR-11 K4 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 23.81%, 'H': 0%, 'I': 9.52%, 'K': 23.81%, 'L': 0%, AF 'M': 19.05%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.76%, 'S': 0%, 'T': 4.76%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, R, T BA 14 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2317.959 AI 41.905 II 25.133 HP -0.129 HM 0.657 IP 12.055 NC 5.997 SF 0.19, 0.238, 0.238 [Helix, Turn, Sheet] AR 0.095 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 8 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14060 SQ SEQUENCE 2317.959 DA MW 21AA KKMMKKGGKF GTFMAIGMGI R // ID AMRSAP457 PN AMPR-11 d58K SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 4, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G LO A, R, T BA 14 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2189.785 AI 44 II 25.89 HP 0.06 HM 0.621 IP 11.997 NC 4.997 SF 0.2, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA ATCC33591 (MBC = 2 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14061 SQ SEQUENCE 2189.785 DA MW 20AA KMMKKGGKFG TFMAIGMGIR // ID AMRSAP458 PN AMPR-11 d60M SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 3, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 15%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2186.766 AI 44 II 27.33 HP -0.23 HM 0.55 IP 12.055 NC 5.997 SF 0.2, 0.25, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 1 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14062 SQ SEQUENCE 2186.766 DA MW 20AA KKMKKGGKFG TFMAIGMGIR // ID AMRSAP459 PN AMPR-11 d62K SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 4, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G LO A, R, T BA 14 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2189.785 AI 44 II 25.89 HP 0.06 HM 0.474 IP 11.997 NC 4.997 SF 0.2, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA ATCC33591 (MBC = 8 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14063 SQ SEQUENCE 2189.785 DA MW 20AA KKMMKGGKFG TFMAIGMGIR // ID AMRSAP460 PN AMPR-11 d64G SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2260.907 AI 44 II 19.72 HP -0.115 HM 0.408 IP 12.055 NC 5.997 SF 0.2, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 1 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14064 SQ SEQUENCE 2260.907 DA MW 20AA KKMMKKGKFG TFMAIGMGIR // ID AMRSAP461 PN AMPR-11 d66K SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 4, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G LO A, R, T BA 14 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2189.785 AI 44 II 30.135 HP 0.06 HM 0.353 IP 11.997 NC 4.997 SF 0.2, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14065 SQ SEQUENCE 2189.785 DA MW 20AA KKMMKKGGFG TFMAIGMGIR // ID AMRSAP462 PN AMPR-11 d67F SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, F, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2170.782 AI 44 II 21.645 HP -0.275 HM 0.593 IP 12.055 NC 5.997 SF 0.15, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14066 SQ SEQUENCE 2170.782 DA MW 20AA KKMMKKGGKG TFMAIGMGIR // ID AMRSAP463 PN AMPR-11 d68G SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2260.907 AI 44 II 30.135 HP -0.115 HM 0.616 IP 12.055 NC 5.997 SF 0.2, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14067 SQ SEQUENCE 2260.907 DA MW 20AA KKMMKKGGKF TFMAIGMGIR // ID AMRSAP464 PN AMPR-11 d69T SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, T, V, W, Y MO G; K LO A, R BA 14 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2216.854 AI 44 II 23.965 HP -0.1 HM 0.657 IP 12.055 NC 5.997 SF 0.2, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 1 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14068 SQ SEQUENCE 2216.854 DA MW 20AA KKMMKKGGKF GFMAIGMGIR // ID AMRSAP465 PN AMPR-11 d70F SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, F, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2170.782 AI 44 II 19.72 HP -0.275 HM 0.657 IP 12.055 NC 5.997 SF 0.15, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 128 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14069 SQ SEQUENCE 2170.782 DA MW 20AA KKMMKKGGKF GTMAIGMGIR // ID AMRSAP466 PN AMPR-11 d71M SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 3, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 15%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2186.766 AI 44 II 19.72 HP -0.23 HM 0.657 IP 12.055 NC 5.997 SF 0.2, 0.25, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14070 SQ SEQUENCE 2186.766 DA MW 20AA KKMMKKGGKF GTFAIGMGIR // ID AMRSAP467 PN AMPR-11 d72A SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2246.88 AI 39 II 19.72 HP -0.225 HM 0.657 IP 12.055 NC 5.997 SF 0.2, 0.25, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 2 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14071 SQ SEQUENCE 2246.88 DA MW 20AA KKMMKKGGKF GTFMIGMGIR // ID AMRSAP468 PN AMPR-11 d73I SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 5%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, I, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2204.8 AI 24.5 II 25.89 HP -0.36 HM 0.657 IP 12.055 NC 5.997 SF 0.15, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC >= 256 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14072 SQ SEQUENCE 2204.8 DA MW 20AA KKMMKKGGKF GTFMAGMGIR // ID AMRSAP469 PN AMPR-11 d74G SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2260.907 AI 44 II 25.89 HP -0.115 HM 0.657 IP 12.055 NC 5.997 SF 0.2, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14073 SQ SEQUENCE 2260.907 DA MW 20AA KKMMKKGGKF GTFMAIMGIR // ID AMRSAP470 PN AMPR-11 d75M SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 3, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 15%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2186.766 AI 44 II 32.06 HP -0.23 HM 0.657 IP 12.055 NC 5.997 SF 0.2, 0.25, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 2 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14074 SQ SEQUENCE 2186.766 DA MW 20AA KKMMKKGGKF GTFMAIGGIR // ID AMRSAP471 PN AMPR-11 d76G SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO K LO A, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2260.907 AI 44 II 30.135 HP -0.115 HM 0.657 IP 12.055 NC 5.997 SF 0.2, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14075 SQ SEQUENCE 2260.907 DA MW 20AA KKMMKKGGKF GTFMAIGMIR // ID AMRSAP472 PN AMPR-11 d77I SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 1, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 5%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, S, V, W, Y MO G; K LO A, I, R, T BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2204.8 AI 24.5 II 30.135 HP -0.36 HM 0.657 IP 12.055 NC 5.997 SF 0.15, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14076 SQ SEQUENCE 2204.8 DA MW 20AA KKMMKKGGKF GTFMAIGMGR // ID AMRSAP473 PN AMPR-11 d78R SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 4, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 25%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 0%, AF 'M': 20%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, L, N, P, Q, R, S, V, W, Y MO G; K LO A, T BA 14 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2161.772 AI 44 II 25.89 HP 0.09 HM 0.657 IP 11.403 NC 4.997 SF 0.2, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA ATCC33591 (MBC = 4 μG/mL) XX XR PubMed: 34361008 XR CAMP R4: CAMPSQ14077 SQ SEQUENCE 2161.772 DA MW 20AA KKMMKKGGKF GTFMAIGMGI // ID AMRSAP474 PN CeHS-1 GP SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 1, 'E': 2, 'F': 1, 'G': 6, 'H': 1, 'I': 5, 'K': 7, 'L': 2, AC 'M': 1, 'N': 3, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.89%, 'C': 0%, 'D': 2.63%, 'E': 5.26%, 'F': 2.63%, 'G': 15.79%, 'H': 2.63%, 'I': 13.16%, 'K': 18.42%, 'L': 5.26%, AF 'M': 2.63%, 'N': 7.89%, 'P': 2.63%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 2.63%, 'Y': 0% MA C, R, S, T, Y MO K LO D, F, H, M, P, W BA 22 LA 16 AA 3 BC 8 MC 0 MF 0 XX MM 4131.895 AI 95 II 38.253 HP -0.389 HM 0.693 IP 10.677 NC 4.091 SF 0.289, 0.263, 0.211 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 42.140903 XX SC alpha_beta XX TO MRSA (MIC = 128 μG/mL TO MBC = 128 μG/mL) XX XR PubMed: 34641415 XR CAMP R4: CAMPSQ14175 SQ SEQUENCE 4131.895 DA MW 38AA GWINKIQKKI DEKIGNNILG GMAKAGPVVH KLAKGEFQ // ID AMRSAP475 PN CeHS-1 GPK SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 1, 'E': 2, 'F': 1, 'G': 6, 'H': 1, 'I': 5, 'K': 8, 'L': 2, AC 'M': 1, 'N': 2, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.89%, 'C': 0%, 'D': 2.63%, 'E': 5.26%, 'F': 2.63%, 'G': 15.79%, 'H': 2.63%, 'I': 13.16%, 'K': 21.05%, 'L': 5.26%, AF 'M': 2.63%, 'N': 5.26%, 'P': 2.63%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 2.63%, 'Y': 0% MA C, R, S, T, Y MO K LO D, F, H, M, P, W BA 22 LA 16 AA 3 BC 9 MC 0 MF 0 XX MM 4145.966 AI 95 II 30.687 HP -0.4 HM 0.693 IP 10.801 NC 5.091 SF 0.289, 0.237, 0.211 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 48.161032 XX SC alpha_beta XX TO MRSA (MIC = 128 μG/mL TO MBC = 128 μG/mL) XX XR PubMed: 34641415 XR CAMP R4: CAMPSQ14176 SQ SEQUENCE 4145.966 DA MW 38AA GWINKIQKKI DEKIGNKILG GMAKAGPVVH KLAKGEFQ // ID AMRSAP476 PN Chem-1 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 28.57%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, S, T, W, Y MO L; V LO G, K, R BA 5 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 784.013 AI 194.286 II -3.557 HP 1.029 HM 0.85 IP 11.652 NC 1.998 SF 0.571, 0.143, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus�(ATCC�33591�MRSA) (MIC >=100 μM) XX XR PubMed: 34662112 XR CAMP R4: CAMPSQ14204 SQ SEQUENCE 784.013 DA MW 7AA KVLGRLV // ID AMRSAP477 PN Chem-KVL SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 28.57%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, S, T, W, Y MO L; V LO G, K, R BA 10 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1550.01 AI 194.286 II -4.9 HP 1.029 HM 0.843 IP 12.532 NC 3.997 SF 0.571, 0.143, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus�(ATCC�33591�MRSA) (MIC = 1 μM) XX XR PubMed: 34662112 XR CAMP R4: CAMPSQ14205 SQ SEQUENCE 1550.01 DA MW 14AA KVLGRLVKVL GRLV // ID AMRSAP478 PN Chem-1dK SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 28.57%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, S, T, W, Y MO L; V LO G, K, R BA 10 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1550.01 AI 194.286 II -4.9 HP 1.029 HM 0.843 IP 12.532 NC 3.997 SF 0.571, 0.143, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus�(ATCC�33591�MRSA) (MIC = 1 μM) XX XR PubMed: 34662112 XR CAMP R4: CAMPSQ14206 SQ SEQUENCE 1550.01 DA MW 14AA KVLGRLVKVL GRLV // ID AMRSAP479 PN Chem-8dK SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 28.57%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, S, T, W, Y MO L; V LO G, K, R BA 10 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1550.01 AI 194.286 II -4.9 HP 1.029 HM 0.843 IP 12.532 NC 3.997 SF 0.571, 0.143, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus�(ATCC�33591�MRSA) (MIC = 2 μM) XX XR PubMed: 34662112 XR CAMP R4: CAMPSQ14207 SQ SEQUENCE 1550.01 DA MW 14AA KVLGRLVKVL GRLV // ID AMRSAP480 PN Chem1,8dK SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 28.57%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, S, T, W, Y MO L; V LO G, K, R BA 10 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1550.01 AI 194.286 II -4.9 HP 1.029 HM 0.843 IP 12.532 NC 3.997 SF 0.571, 0.143, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus�(ATCC�33591�MRSA) (MIC = 2 μM) XX XR PubMed: 34662112 XR CAMP R4: CAMPSQ14208 SQ SEQUENCE 1550.01 DA MW 14AA KVLGRLVKVL GRLV // ID AMRSAP481 PN CaD23 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 5.56%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 11.11%, 'Y': 0% MA A, E, F, G, H, M, N, P, S, T, Y MO K LO C, D, Q, V BA 7 LA 11 AA 1 BC 8 MC 0 MF 0 XX MM 2398.003 AI 102.778 II 30.961 HP -1.028 HM 0.952 IP 11.777 NC 6.935 SF 0.389, 0, 0.111 [Helix, Turn, Sheet] AR 0.111 ME 11000, 11000 MS 48.161032 XX SC alpha_beta XX TO MRSA (ATCC MRSA43300) (MIC = 25 μG/mL) XX XR PubMed: 34690770 XR CAMP R4: CAMPSQ14228 SQ SEQUENCE 2398.003 DA MW 18AA KRIVQRIKDW LRKLCKKW // ID AMRSAP482 PN Antimicrobial peptide SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 54.55%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 18.18%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, M, N, P, Q, S, T, V, W, Y MO K LO C BA 2 LA 9 AA 0 BC 8 MC 0 MF 0 XX MM 1428.892 AI 70.909 II 18.882 HP -2.027 HM 0.498 IP 11.924 NC 7.934 SF 0.182, 0, 0.182 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC alpha+beta XX TO MRSA (MIC = 2.50 mg/mL) XX XR PubMed: 34497894 XR CAMP R4: CAMPSQ14261 SQ SEQUENCE 1428.892 DA MW 11AA RKKKKLLRKK C // ID AMRSAP483 PN CS-HP-P SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 54.55%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 18.18%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, M, N, P, Q, S, T, V, W, Y MO K LO C BA 2 LA 9 AA 0 BC 8 MC 0 MF 0 XX MM 1428.892 AI 70.909 II 18.882 HP -2.027 HM 0.498 IP 11.924 NC 7.934 SF 0.182, 0, 0.182 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC alpha+beta XX TO MRSA (MIC = 0.26 mg/mL) XX XR PubMed: 34497894 XR CAMP R4: CAMPSQ14262 SQ SEQUENCE 1428.892 DA MW 11AA RKKKKLLRKK C // ID AMRSAP484 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DM21455 (MIC = 8 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP485 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR09808R (MIC = 4 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP486 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB21595 (MIC = 4 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP487 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR42412 (MIC = 8 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP488 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB68004 (MIC = 8 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP489 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB57964/04 (MIC = 4 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP490 PN BTT1 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 46.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, V, W, Y MO L LO G, T BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1737.333 AI 182 II -64.247 HP 0.14 HM 0.324 IP 11.5 NC 5.996 SF 0.467, 0.067, 0.467 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA ATCC43300 (MIC = 4 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14264 SQ SEQUENCE 1737.333 DA MW 15AA LKLKLKLTGK LKLKL // ID AMRSAP491 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DM21455 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP492 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR09808R (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP493 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB21595 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP494 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR42412 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP495 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB68004 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP496 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB57964/04 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP497 PN BTT2 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 6.67%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, R, S, W, Y MO K LO T, V BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1747.328 AI 149.333 II -21.587 HP -0.273 HM 0.139 IP 11.5 NC 5.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA ATCC43300 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14265 SQ SEQUENCE 1747.328 DA MW 15AA LKLKLKVPPT KLKLK // ID AMRSAP498 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DM21455 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP499 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR09808R (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP500 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB21595 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP501 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR42412 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP502 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB68004 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP503 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB57964/04 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP504 PN BTT3 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, Q, R, S, T, V, W, Y MO K; L LO G, P BA 8 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1620.185 AI 167.143 II -62.807 HP -0.186 HM 0.117 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA ATCC43300 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14266 SQ SEQUENCE 1620.185 DA MW 14AA LKLKLKPGKL KLKL // ID AMRSAP505 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DM21455 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP506 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR09808R (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP507 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB21595 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP508 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR42412 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP509 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB68004 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP510 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB57964/04 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP511 PN BTT4 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 46.67%, 'L': 33.33%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, R, S, T, V, W, Y MO K LO G, I, N BA 7 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 1765.346 AI 156 II -62.947 HP -0.513 HM 0.19 IP 11.579 NC 6.996 SF 0.4, 0.133, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA ATCC43300 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14267 SQ SEQUENCE 1765.346 DA MW 15AA LKLKLKINGK KLKLK // ID AMRSAP512 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DM21455 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP513 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR09808R (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP514 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB21595 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP515 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR42412 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP516 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB68004 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP517 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB57964/04 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP518 PN BTT5 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, P, Q, R, S, T, V, W, Y MO K; L LO G, N BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1637.172 AI 167.143 II -68.157 HP -0.321 HM 0.128 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA ATCC43300 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14268 SQ SEQUENCE 1637.172 DA MW 14AA LKLKLKNGKL KLKL // ID AMRSAP519 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DM21455 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP520 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR09808R (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP521 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB21595 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP522 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR42412 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP523 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB68004 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP524 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB57964/04 (MIC = 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP525 PN BTT6 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, Q, R, S, T, V, W, Y MO K; L LO N, P BA 7 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 1677.237 AI 167.143 II -39.829 HP -0.407 HM 0.097 IP 11.5 NC 5.996 SF 0.429, 0.143, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA ATCC43300 (MIC = 16 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14269 SQ SEQUENCE 1677.237 DA MW 14AA LKLKLKPNKL KLKL // ID AMRSAP526 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DM21455 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP527 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR09808R (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP528 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB21595 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP529 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR42412 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP530 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB68004 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP531 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB57964/04 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP532 PN BTT7 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, N, P, Q, S, T, V, W, Y MO K; L LO D, G, R BA 7 LA 8 AA 1 BC 7 MC 0 MF 0 XX MM 1794.344 AI 156 II -31.193 HP -0.6 HM 0.458 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA ATCC43300 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14270 SQ SEQUENCE 1794.344 DA MW 15AA LKLKLKRDGK LKLKL // ID AMRSAP533 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DM21455 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP534 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR09808R (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP535 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB21595 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP536 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DR42412 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP537 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB68004 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP538 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA DB57964/04 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP539 PN BTT8 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, H, I, M, Q, R, S, T, V, W, Y MO K; L LO D, G, N, P BA 8 LA 8 AA 1 BC 6 MC 0 MF 0 XX MM 1849.377 AI 146.25 II -55.506 HP -0.6 HM 0.169 IP 11.102 NC 4.997 SF 0.375, 0.188, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA ATCC43300 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14271 SQ SEQUENCE 1849.377 DA MW 16AA LKLKLKNPDG KLKLKL // ID AMRSAP540 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DM21455 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP541 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR09808R (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP542 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB21595 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP543 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR42412 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP544 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB68004 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP545 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB57964/04 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP546 PN BTT9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 43.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, F, H, I, M, P, Q, R, S, T, V, W, Y MO K LO E, G, N BA 7 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1894.462 AI 146.25 II -34.194 HP -0.744 HM 0.374 IP 11.199 NC 5.998 SF 0.375, 0.125, 0.438 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA ATCC43300 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14272 SQ SEQUENCE 1894.462 DA MW 16AA LKLKLKEGNK KLKLKL // ID AMRSAP547 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DM21455 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP548 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR09808R (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP549 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB21595 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP550 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DR42412 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP551 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB68004 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP552 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA DB57964/04 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP553 PN BTT10 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 6, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, E, F, G, H, I, M, P, Q, S, T, V, W, Y MO K; L LO D, N, R BA 6 LA 9 AA 1 BC 7 MC 0 MF 0 XX MM 1851.396 AI 156 II -9.747 HP -0.807 HM 0.373 IP 11.458 NC 5.997 SF 0.4, 0.067, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA ATCC43300 (MIC >= 32 μM) XX XR PubMed: 34506975 XR CAMP R4: CAMPSQ14273 SQ SEQUENCE 1851.396 DA MW 15AA LKLKLKRDNK LKLKL // ID AMRSAP554 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO Staphylococcus aureus ATCC 33591 (MRSA) (MIC = 2 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAP555 PN Ba49 SO Bacillus subtilis subsp. spizizenii PL 32 TX Monera PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 4.17%, 'C': 20.83%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 16.67%, AF 'M': 0%, 'N': 4.17%, 'P': 4.17%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.17%, 'W': 4.17%, 'Y': 0% MA D, H, M, R, S, T, Y MO C; O LO A, E, F, I, N, P, V, W BA 12 LA 12 AA 1 BC 3 MC {'O': 5, 'J': 3} MF {'O': 0.15625, 'J': 0.09375} XX MM 3884.84 AI 109.688 II 21.5 HP 0.375 HM 0.348 IP 8.213 NC 1.689 SF 0.25, 0.125, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO Staphylococcus aureus ATCC 43300 (MRSA) (MIC = 2 μM) XX XR PubMed: 33427970 XR CAMP R4: CAMPSQ14322 SQ SEQUENCE 3884.84 DA MW 32AA WKJEJLCOPG CVOGALQOCF LQOLOCNCKI JK // ID AMRSAP556 PN Ca12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 8.33%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, E, G, H, M, N, P, S, T, W, Y MO R LO D, F, L, Q, V BA 5 LA 7 AA 1 BC 5 MC 0 MF 0 XX MM 1571.933 AI 121.667 II 31.95 HP -0.708 HM 0.966 IP 12.244 NC 3.998 SF 0.417, 0, 0.083 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA-OS (MIC >= 127.2 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14330 SQ SEQUENCE 1571.933 DA MW 12AA KRIVQRIKDF LR // ID AMRSAP557 PN BD2 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 16.67%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, H, I, L, M, N, Q, R, S, T, V, W, Y MO K LO P BA 1 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 705.932 AI 0 II -4.233 HP -1.383 HM 0.643 IP 9.668 NC 2.873 SF 0, 0.167, 0 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 18.060387 XX SC beta XX TO MRSA-OS (MIC = 283.3 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14331 SQ SEQUENCE 705.932 DA MW 6AA KCCKKP // ID AMRSAP558 PN BD3 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 20%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 0%, 'K': 30%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 40%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, I, L, M, N, P, Q, S, T, V, W, Y MO R LO G BA 1 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 1290.617 AI 0 II 57.79 HP -2.51 HM 0.467 IP 12.102 NC 6.873 SF 0, 0.1, 0 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 42.140903 XX SC alpha XX TO MRSA-OS (MIC >= 154.9 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14332 SQ SEQUENCE 1290.617 DA MW 10AA RGRKCCRRKK // ID AMRSAP559 PN DD12 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 25%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.5%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 6.25%, 'Q': 0%, 'R': 6.25%, 'S': 0%, 'T': 6.25%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, I, L, M, N, Q, S, V, W, Y MO K LO A, P, R, T BA 4 LA 12 AA 0 BC 7 MC 0 MF 0 XX MM 1739.207 AI 6.25 II -16.563 HP -1.2 HM 0.462 IP 10.512 NC 6.748 SF 0, 0.188, 0.063 [Helix, Turn, Sheet] AR 0 ME 0, 250 MS 42.140903 XX SC beta XX TO MRSA-OS (MIC >= 115 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14333 SQ SEQUENCE 1739.207 DA MW 16AA RGKAKCCKGT KCCKKP // ID AMRSAP560 PN DD13 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.56%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, I, L, M, N, P, Q, S, T, V, W, Y MO K LO A BA 3 LA 15 AA 0 BC 11 MC 0 MF 0 XX MM 2165.735 AI 5.556 II 45.228 HP -1.939 HM 0.74 IP 11.696 NC 10.748 SF 0, 0.111, 0.056 [Helix, Turn, Sheet] AR 0 ME 0, 250 MS 66.221419 XX SC alpha XX TO MRSA-OS (MIC >= 92.3 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14334 SQ SEQUENCE 2165.735 DA MW 18AA RGKAKCCKRG RKCCRRKK // ID AMRSAP561 PN DD32 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 25%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 6.25%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, I, L, M, N, Q, S, T, V, W, Y MO K LO G, P BA 2 LA 14 AA 0 BC 10 MC 0 MF 0 XX MM 1978.534 AI 0 II 35.156 HP -2.088 HM 0.581 IP 11.371 NC 9.748 SF 0, 0.125, 0 [Helix, Turn, Sheet] AR 0 ME 0, 250 MS 60.20129 XX SC beta XX TO MRSA-OS (MIC >= 101 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14335 SQ SEQUENCE 1978.534 DA MW 16AA RGRKCCRRKK KCCKKP // ID AMRSAP562 PN CaD1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 0%, 'D': 5.88%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 11.76%, 'K': 23.53%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, S, T, W, Y MO K; R LO A, D, F, G, L, Q, V BA 7 LA 10 AA 1 BC 8 MC 0 MF 0 XX MM 2112.599 AI 91.765 II 49.2 HP -1.141 HM 0.966 IP 12.532 NC 6.997 SF 0.294, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.059 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA-OS (MIC >= 94.7 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14336 SQ SEQUENCE 2112.599 DA MW 17AA KRIVQRIKDF LRRGKAK // ID AMRSAP563 PN CaD2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 5.56%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 5.56%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA A, E, G, H, M, N, S, T, W, Y MO K LO D, F, L, P, Q, V BA 6 LA 12 AA 1 BC 8 MC 0 MF 0 XX MM 2259.849 AI 81.111 II 20.444 HP -0.933 HM 0.966 IP 11.311 NC 6.873 SF 0.278, 0.056, 0.056 [Helix, Turn, Sheet] AR 0.056 ME 0, 125 MS 48.161032 XX SC beta XX TO MRSA-OS (MIC >= 88.5 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14337 SQ SEQUENCE 2259.849 DA MW 18AA KRIVQRIKDF LRKCCKKP // ID AMRSAP564 PN CaD3 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 11.76%, 'D': 5.88%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 23.53%, 'L': 5.88%, AF 'M': 0%, 'N': 5.88%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, E, H, M, P, Q, S, T, V, W, Y MO R LO D, F, G, I, L, N BA 4 LA 13 AA 1 BC 9 MC 0 MF 0 XX MM 2177.666 AI 45.882 II 43.424 HP -1.729 HM 0.905 IP 12.014 NC 7.873 SF 0.176, 0.118, 0.059 [Helix, Turn, Sheet] AR 0.059 ME 0, 125 MS 54.181161 XX SC beta XX TO MRSA-OS (MIC >= 91.8 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14338 SQ SEQUENCE 2177.666 DA MW 17AA RIKDFLRNGR KCCRRKK // ID AMRSAP565 PN CaD21 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5.56%, 'C': 5.56%, 'D': 5.56%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 5.56%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA E, G, H, M, N, S, T, W, Y MO K LO A, C, D, F, L, P, Q, V BA 7 LA 11 AA 1 BC 8 MC 0 MF 0 XX MM 2227.789 AI 86.667 II 44.856 HP -0.972 HM 0.966 IP 11.777 NC 6.935 SF 0.278, 0.056, 0.111 [Helix, Turn, Sheet] AR 0.056 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA-OS (MIC >= 89.8 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14339 SQ SEQUENCE 2227.789 DA MW 18AA KRIVQRIKDF LRKACKKP // ID AMRSAP566 PN CaD22 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 11.11%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 5.56%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 5.56%, 'Y': 0% MA A, E, F, G, H, M, N, S, T, Y MO K LO D, L, P, Q, V, W BA 6 LA 12 AA 1 BC 8 MC 0 MF 0 XX MM 2298.886 AI 81.111 II 31.489 HP -1.139 HM 0.952 IP 11.311 NC 6.873 SF 0.278, 0.056, 0.056 [Helix, Turn, Sheet] AR 0.056 ME 5500, 5625 MS 48.161032 XX SC beta XX TO MRSA-OS (MIC >= 87 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14340 SQ SEQUENCE 2298.886 DA MW 18AA KRIVQRIKDW LRKCCKKP // ID AMRSAP567 PN CaD23 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 5.56%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 11.11%, 'Y': 0% MA A, E, F, G, H, M, N, P, S, T, Y MO K LO C, D, Q, V BA 7 LA 11 AA 1 BC 8 MC 0 MF 0 XX MM 2398.003 AI 102.778 II 30.961 HP -1.028 HM 0.952 IP 11.777 NC 6.935 SF 0.389, 0, 0.111 [Helix, Turn, Sheet] AR 0.111 ME 11000, 11000 MS 48.161032 XX SC alpha_beta XX TO MRSA-OS (MIC = 25 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14341 SQ SEQUENCE 2398.003 DA MW 18AA KRIVQRIKDW LRKLCKKW // ID AMRSAP568 PN CaD23 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 5.56%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 11.11%, 'Y': 0% MA A, E, F, G, H, M, N, P, S, T, Y MO K LO C, D, Q, V BA 7 LA 11 AA 1 BC 8 MC 0 MF 0 XX MM 2398.003 AI 102.778 II 30.961 HP -1.028 HM 0.952 IP 11.777 NC 6.935 SF 0.389, 0, 0.111 [Helix, Turn, Sheet] AR 0.111 ME 11000, 11000 MS 48.161032 XX SC alpha_beta XX TO MRSA ATCC 43300 (MIC = 25 μM) XX XR PubMed: 34526600 XR CAMP R4: CAMPSQ14341 SQ SEQUENCE 2398.003 DA MW 18AA KRIVQRIKDW LRKLCKKW // ID AMRSAP569 PN B1OS SO Odorrana schmackeri PL 23 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 3, 'K': 3, 'L': 2, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 8.7%, 'C': 8.7%, 'D': 0%, 'E': 0%, 'F': 8.7%, 'G': 4.35%, 'H': 0%, 'I': 13.04%, 'K': 13.04%, 'L': 8.7%, AF 'M': 0%, 'N': 4.35%, 'P': 8.7%, 'Q': 0%, 'R': 4.35%, 'S': 4.35%, 'T': 4.35%, 'V': 8.7%, 'W': 0%, 'Y': 0% MA D, E, H, M, Q, W, Y MO I; K LO G, N, R, S, T BA 14 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 2519.148 AI 118.696 II 29.413 HP 0.822 HM 0.714 IP 10.513 NC 3.873 SF 0.391, 0.217, 0.174 [Helix, Turn, Sheet] AR 0.087 ME 0, 125 MS 24.080516 XX SC beta XX TO MRSA NCTC 12493 (MIC = 64 μM TO MBC = 128 μM) XX XR PubMed: 34564615 XR CAMP R4: CAMPSQ14342 SQ SEQUENCE 2519.148 DA MW 23AA FPLIASLAGN VVPKIFCKIT KRC // ID AMRSAP570 PN B1OS-L SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 3, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 8.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 4.17%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 4.17%, 'P': 8.33%, 'Q': 0%, 'R': 4.17%, 'S': 4.17%, 'T': 4.17%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA D, E, H, M, Q, W, Y MO I; K; L LO G, N, R, S, T BA 15 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 2632.307 AI 130 II 28.604 HP 0.946 HM 0.714 IP 10.513 NC 3.873 SF 0.417, 0.208, 0.208 [Helix, Turn, Sheet] AR 0.083 ME 0, 125 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12493 (MIC = 4 μM TO MBC = 8 μM) XX XR PubMed: 34564615 XR CAMP R4: CAMPSQ14343 SQ SEQUENCE 2632.307 DA MW 24AA FLPLIASLAG NVVPKIFCKI TKRC // ID AMRSAP571 PN B1OS-D-L SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 3, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 8.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 4.17%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 4.17%, 'P': 8.33%, 'Q': 0%, 'R': 4.17%, 'S': 4.17%, 'T': 4.17%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA D, E, H, M, Q, W, Y MO I; K; L LO G, N, R, S, T BA 15 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 2632.307 AI 130 II 28.604 HP 0.946 HM 0.714 IP 10.513 NC 3.873 SF 0.417, 0.208, 0.208 [Helix, Turn, Sheet] AR 0.083 ME 0, 125 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12493 (MIC = 4 μM TO MBC = 4 μM) XX XR PubMed: 34564615 XR CAMP R4: CAMPSQ14344 SQ SEQUENCE 2632.307 DA MW 24AA FLPLIASLAG NVVPKIFCKI TKRC // ID AMRSAP572 PN Temporin-FL SO Pelophylax nigromaculatus PL 13 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 15.38%, 'T': 0%, 'V': 7.69%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, N, Q, R, T, W, Y MO L LO G, I, K, P, V BA 10 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1433.797 AI 172.308 II 0.485 HP 1.692 HM 0.401 IP 9.7 NC 0.998 SF 0.615, 0.308, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA NCTC 12493 (MIC = 32 μM TO MBC = 64 μM TO MBIC = 32 μM TO MBEC = 64 μM) XX XR PubMed: 34738013 XR CAMP R4: CAMPSQ14431 SQ SEQUENCE 1433.797 DA MW 13AA FIPLVSGLFS KLL // ID AMRSAP573 PN Temporin-FL SO Pelophylax nigromaculatus PL 13 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 15.38%, 'T': 0%, 'V': 7.69%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, N, Q, R, T, W, Y MO L LO G, I, K, P, V BA 10 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1433.797 AI 172.308 II 0.485 HP 1.692 HM 0.401 IP 9.7 NC 0.998 SF 0.615, 0.308, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA ATCC 43300 (MIC = 32 μM TO MBC = 32 μM TO MBIC = 32 μM TO MBEC = 64 μM) XX XR PubMed: 34738013 XR CAMP R4: CAMPSQ14431 SQ SEQUENCE 1433.797 DA MW 13AA FIPLVSGLFS KLL // ID AMRSAP574 PN Temporin-FLa SO Pelophylax nigromaculatus PL 12 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 8.33%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 0%, 'S': 8.33%, 'T': 0%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, N, Q, R, T, W, Y MO L LO G, I, K, P, S, V BA 10 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 1346.719 AI 186.667 II -12.833 HP 1.9 HM 0.454 IP 9.7 NC 0.998 SF 0.667, 0.25, 0.333 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA NCTC 12493 (MIC = 4 μM TO MBC = 16 μM TO MBIC = 8 μM TO MBEC = 32 μM) XX XR PubMed: 34738013 XR CAMP R4: CAMPSQ14432 SQ SEQUENCE 1346.719 DA MW 12AA FIPLVSGLFK LL // ID AMRSAP575 PN Temporin-FLa SO Pelophylax nigromaculatus PL 12 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 8.33%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 0%, 'S': 8.33%, 'T': 0%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, N, Q, R, T, W, Y MO L LO G, I, K, P, S, V BA 10 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 1346.719 AI 186.667 II -12.833 HP 1.9 HM 0.454 IP 9.7 NC 0.998 SF 0.667, 0.25, 0.333 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA ATCC 43300 (MIC = 4 μM TO MBC = 8 μM TO MBIC = 4 μM TO MBEC = 8 μM) XX XR PubMed: 34738013 XR CAMP R4: CAMPSQ14432 SQ SEQUENCE 1346.719 DA MW 12AA FIPLVSGLFK LL // ID AMRSAP576 PN Temporin-FLb SO Pelophylax nigromaculatus PL 11 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 9.09%, 'H': 0%, 'I': 9.09%, 'K': 9.09%, 'L': 27.27%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 0%, 'S': 9.09%, 'T': 0%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, N, Q, R, T, W, Y MO L LO G, I, K, P, S, V BA 9 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 1233.56 AI 168.182 II 2.6 HP 1.727 HM 0.299 IP 9.7 NC 0.998 SF 0.636, 0.273, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA NCTC 12493 (MIC = 16 μM TO MBC = 32 μM TO MBIC = 64 μM TO MBEC = 128 μM) XX XR PubMed: 34738013 XR CAMP R4: CAMPSQ14433 SQ SEQUENCE 1233.56 DA MW 11AA FIPVSGLFKL L // ID AMRSAP577 PN Temporin-FLb SO Pelophylax nigromaculatus PL 11 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 9.09%, 'H': 0%, 'I': 9.09%, 'K': 9.09%, 'L': 27.27%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 0%, 'S': 9.09%, 'T': 0%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, N, Q, R, T, W, Y MO L LO G, I, K, P, S, V BA 9 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 1233.56 AI 168.182 II 2.6 HP 1.727 HM 0.299 IP 9.7 NC 0.998 SF 0.636, 0.273, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA ATCC 43300 (MIC = 64 μM TO MBC = 128 μM TO MBIC = 64 μM TO MBEC = 128 μM) XX XR PubMed: 34738013 XR CAMP R4: CAMPSQ14433 SQ SEQUENCE 1233.56 DA MW 11AA FIPVSGLFKL L // ID AMRSAP578 PN VL1 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, S, T, W, Y MO K LO A, L BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1808.415 AI 133.75 II -8.438 HP -0.2 HM 0.762 IP 11.646 NC 7.996 SF 0.375, 0, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA 43300 (MIC >= 64 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14467 SQ SEQUENCE 1808.415 DA MW 16AA VKKLVKKAVK KLVKKA // ID AMRSAP579 PN VL2 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, S, T, W, Y MO K LO A, L BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1808.415 AI 133.75 II -8.438 HP -0.2 HM 0.776 IP 11.646 NC 7.996 SF 0.375, 0, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA 43300 (MIC >= 64 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14468 SQ SEQUENCE 1808.415 DA MW 16AA VKKLVKKLVK KAVKKA // ID AMRSAP580 PN VL3 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 18.75%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, S, T, W, Y MO K LO A BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1850.495 AI 151.875 II -13.744 HP -0.075 HM 0.781 IP 11.646 NC 7.996 SF 0.438, 0, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA 43300 (MIC = 32 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14469 SQ SEQUENCE 1850.495 DA MW 16AA VKKLVKKLVK KLVKKA // ID AMRSAP581 PN VL4 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 18.75%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, S, T, W, Y MO K LO A BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1850.495 AI 151.875 II -13.744 HP -0.075 HM 0.776 IP 11.646 NC 7.996 SF 0.438, 0, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA 43300 (MIC = 32 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14470 SQ SEQUENCE 1850.495 DA MW 16AA VKKLVKKLVK KAVKKL // ID AMRSAP582 PN VL5 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, W, Y MO K LO L, V BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1892.576 AI 170 II -19.05 HP 0.05 HM 0.781 IP 11.646 NC 7.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA 43300 (MIC = 8 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14471 SQ SEQUENCE 1892.576 DA MW 16AA VKKLVKKLVK KLVKKL // ID AMRSAP583 PN VW1 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 2, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 12.5%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, Y MO K LO A, W BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1954.522 AI 85 II -8.438 HP -0.788 HM 0.743 IP 11.646 NC 7.996 SF 0.375, 0, 0.125 [Helix, Turn, Sheet] AR 0.125 ME 11000, 11000 MS 48.161032 XX SC alpha_beta XX TO MRSA 43300 (MIC >= 64 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14472 SQ SEQUENCE 1954.522 DA MW 16AA VKKWVKKAVK KWVKKA // ID AMRSAP584 PN VW2 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 2, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 12.5%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, Y MO K LO A, W BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1954.522 AI 85 II -8.438 HP -0.788 HM 0.748 IP 11.646 NC 7.996 SF 0.375, 0, 0.125 [Helix, Turn, Sheet] AR 0.125 ME 11000, 11000 MS 48.161032 XX SC alpha_beta XX TO MRSA 43300 (MIC = 64 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14473 SQ SEQUENCE 1954.522 DA MW 16AA VKKWVKKWVK KAVKKA // ID AMRSAP585 PN VW3 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 3, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 18.75%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, Y MO K LO A BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2069.657 AI 78.75 II -8.438 HP -0.956 HM 0.748 IP 11.646 NC 7.996 SF 0.438, 0, 0.063 [Helix, Turn, Sheet] AR 0.188 ME 16500, 16500 MS 48.161032 XX SC alpha_beta XX TO MRSA 43300 (MIC = 8 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14474 SQ SEQUENCE 2069.657 DA MW 16AA VKKWVKKWVK KAVKKW // ID AMRSAP586 PN VW4 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 3, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 18.75%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, Y MO K LO A BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2069.657 AI 78.75 II -13.744 HP -0.956 HM 0.748 IP 11.646 NC 7.996 SF 0.438, 0, 0.063 [Helix, Turn, Sheet] AR 0.188 ME 16500, 16500 MS 48.161032 XX SC alpha_beta XX TO MRSA 43300 (MIC = 4 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14475 SQ SEQUENCE 2069.657 DA MW 16AA VKKWVKKWVK KWVKKA // ID AMRSAP587 PN VW5 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, Y MO K LO V, W BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2184.791 AI 72.5 II -13.744 HP -1.125 HM 0.748 IP 11.646 NC 7.996 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.25 ME 22000, 22000 MS 48.161032 XX SC alpha_beta XX TO MRSA 43300 (MIC = 2 μM) XX XR PubMed: 34721331 XR CAMP R4: CAMPSQ14476 SQ SEQUENCE 2184.791 DA MW 16AA VKKWVKKWVK KWVKKW // ID AMRSAP588 PN Anoplin SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.5%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 37.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, S, V, W, Y MO L LO G, R, T BA 4 LA 4 AA 0 BC 3 MC {'O': 2} MF {'O': 0.2} XX MM 1402.79 AI 117 II 33.11 HP -0.2 HM 0.377 IP 11.823 NC 2.997 SF 0.3, 0.1, 0.3 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO S. aureus�ATCC BAA1720 MRSA (MIC = 8 μM) XX XR PubMed: 34966367 XR CAMP R4: CAMPSQ14478 SQ SEQUENCE 1402.79 DA MW 10AA GOLKROKTLL // ID AMRSAP589 PN Anoplin SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 25%, 'L': 37.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, V, W, Y MO L LO G, I, T BA 5 LA 3 AA 0 BC 2 MC {'O': 2} MF {'O': 0.2} XX MM 1359.762 AI 156 II -7.98 HP 0.7 HM 0.507 IP 10.805 NC 1.997 SF 0.4, 0.1, 0.3 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus�ATCC BAA1720 MRSA (MIC = 4 μM) XX XR PubMed: 34966367 XR CAMP R4: CAMPSQ14479 SQ SEQUENCE 1359.762 DA MW 10AA GLLKOIKTOL // ID AMRSAP590 PN AnoplinS5 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 25%, 'L': 37.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, R, S, V, W, Y MO L LO G, I, T BA 5 LA 3 AA 0 BC 2 MC {'O': 2} MF {'O': 0.2} XX MM 1359.762 AI 156 II -7.98 HP 0.7 HM 0.507 IP 10.805 NC 1.997 SF 0.4, 0.1, 0.3 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus�ATCC BAA1720 MRSA (MIC = 64 μM) XX XR PubMed: 34966367 XR CAMP R4: CAMPSQ14480 SQ SEQUENCE 1359.762 DA MW 10AA GLLKOIKTOL // ID AMRSAP591 PN T-DPH1 SO Phyllomedusa hypochondrialis PL 21 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 33.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 4.76%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 0%, 'V': 4.76%, 'W': 4.76%, 'Y': 0% MA C, D, E, F, H, M, P, Q, R, T, Y MO A LO I, N, S, V, W BA 16 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 2010.41 AI 121.429 II 4.629 HP 0.695 HM 0.488 IP 11.103 NC 2.997 SF 0.286, 0.238, 0.476 [Helix, Turn, Sheet] AR 0.048 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO Methicillin-resistant�Staphylococcus aureus�(MRSA) NCTC 12493 (MIC = 16 μM TO MBC = 32 μM TO MBIC = 32 μM TO MBEC > 256 μM) XX XR PubMed: 34943741 XR CAMP R4: CAMPSQ14548 SQ SEQUENCE 2010.41 DA MW 21AA GLWSKIKNVA AAAGKAALGA L // ID AMRSAP592 PN T-DPH1-K4 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 33.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 4.76%, 'K': 19.05%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 4.76%, 'Y': 0% MA C, D, E, F, H, M, P, Q, R, S, T, Y MO A LO I, N, V, W BA 16 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 2051.506 AI 121.429 II 4.629 HP 0.548 HM 0.506 IP 11.278 NC 3.997 SF 0.286, 0.19, 0.476 [Helix, Turn, Sheet] AR 0.048 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant�Staphylococcus aureus�(MRSA) NCTC 12493 (MIC = 2 μM TO MBC = 4 μM TO MBIC = 8 μM TO MBEC > 256 μM) XX XR PubMed: 34943741 XR CAMP R4: CAMPSQ14549 SQ SEQUENCE 2051.506 DA MW 21AA GLWKKIKNVA AAAGKAALGA L // ID AMRSAP593 PN T-DPH1-5K SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 28.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 4.76%, 'K': 23.81%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 4.76%, 'Y': 0% MA C, D, E, F, H, M, P, Q, R, S, T, Y MO A LO I, N, V, W BA 15 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2108.601 AI 116.667 II 4.629 HP 0.276 HM 0.679 IP 11.403 NC 4.997 SF 0.286, 0.19, 0.429 [Helix, Turn, Sheet] AR 0.048 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO Methicillin-resistant�Staphylococcus aureus�(MRSA) NCTC 12493 (MIC = 2 μM TO MBC = 4 μM TO MBIC = 4 μM TO MBEC > 256 μM) XX XR PubMed: 34943741 XR CAMP R4: CAMPSQ14550 SQ SEQUENCE 2108.601 DA MW 21AA GLWKKIKNVA KAAGKAALGA L // ID AMRSAP594 PN T-DPH1-6K SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 6, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 28.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 4.76%, 'K': 28.57%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 4.76%, 'Y': 0% MA C, D, E, F, H, M, P, Q, R, S, T, Y MO A; K LO I, N, V, W BA 14 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2123.616 AI 98.095 II 0.586 HP -0.09 HM 0.679 IP 11.5 NC 5.996 SF 0.238, 0.19, 0.381 [Helix, Turn, Sheet] AR 0.048 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO Methicillin-resistant�Staphylococcus aureus�(MRSA) NCTC 12493 (MIC = 32 μM TO MBC = 64 μM TO MBIC = 64 μM TO MBEC > 256 μM) XX XR PubMed: 34943741 XR CAMP R4: CAMPSQ14551 SQ SEQUENCE 2123.616 DA MW 21AA GLWKKIKNVA KAAGKAAKGA L // ID AMRSAP595 PN T-DPH1-6KW SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 6, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 28.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 28.57%, 'L': 9.52%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.76%, 'W': 9.52%, 'Y': 0% MA C, D, E, F, H, M, P, Q, R, S, T, Y MO A; K LO I, N, V BA 14 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2252.777 AI 98.095 II 6.462 HP -0.114 HM 0.679 IP 11.5 NC 5.996 SF 0.286, 0.143, 0.381 [Helix, Turn, Sheet] AR 0.095 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Methicillin-resistant�Staphylococcus aureus�(MRSA) NCTC 12493 (MIC = 128 μM TO MBC = 256 μM TO MBIC > 256 μM TO MBEC > 256 μM) XX XR PubMed: 34943741 XR CAMP R4: CAMPSQ14552 SQ SEQUENCE 2252.777 DA MW 21AA WLWKKIKNVA KAAGKAAKGA L // ID AMRSAP596 PN Dermaseptin-AC SO Agalychnis callidryas PL 26 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 5, 'H': 0, 'I': 1, 'K': 4, 'L': 4, AC 'M': 2, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 3.85%, 'G': 19.23%, 'H': 0%, 'I': 3.85%, 'K': 15.38%, 'L': 15.38%, AF 'M': 7.69%, 'N': 3.85%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 7.69%, 'V': 3.85%, 'W': 0%, 'Y': 0% MA C, D, E, H, P, Q, R, S, W, Y MO A; G LO F, I, N, V BA 19 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2562.171 AI 105.385 II -20.131 HP 0.654 HM 0.667 IP 11.278 NC 3.997 SF 0.269, 0.231, 0.423 [Helix, Turn, Sheet] AR 0.038 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA�ATCC 43300 (MIC = 2 μG/mL) XX XR PubMed: 34908502 XR CAMP R4: CAMPSQ14630 SQ SEQUENCE 2562.171 DA MW 26AA GMFTNMLKGI GKLAGKAALG AVKTLA // ID AMRSAP597 PN Hybrid peptide R23F SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 5, 'H': 1, 'I': 1, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 6, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 23.81%, 'H': 4.76%, 'I': 4.76%, 'K': 14.29%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 4.76%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, C, D, E, L, M, N, P, S, T, W, Y MO R LO F, H, I, J, O, Q BA 10 LA 11 AA 0 BC 10 MC {'O': 1, 'J': 1} MF {'O': 0.043478260869565216, 'J': 0.043478260869565216} XX MM 2685.229 AI 71.739 II 129.278 HP -1.196 HM 0.506 IP 13.205 NC 9.088 SF 0.217, 0.217, 0 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 54.181161 XX SC beta XX TO MRSA ATCC 43300 XX XR PubMed: 35008951 XR CAMP R4: CAMPSQ14672 SQ SEQUENCE 2685.229 DA MW 23AA RKKRRQRRRG GJGVVVHIOG GKF // ID AMRSAP598 PN Hybrid peptide R23DI SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 2, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 6, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.55%, 'C': 0%, 'D': 4.55%, 'E': 0%, 'F': 9.09%, 'G': 18.18%, 'H': 0%, 'I': 9.09%, 'K': 9.09%, 'L': 4.55%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 27.27%, 'S': 0%, 'T': 4.55%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, S, V, W, Y MO R LO A, D, J, L, T BA 10 LA 12 AA 1 BC 8 MC {'J': 1} MF {'J': 0.043478260869565216} XX MM 2617.061 AI 72.174 II 98.252 HP -1.191 HM 0.61 IP 12.807 NC 6.998 SF 0.217, 0.174, 0.087 [Helix, Turn, Sheet] AR 0.087 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA ATCC 43300 XX XR PubMed: 35008951 XR CAMP R4: CAMPSQ14673 SQ SEQUENCE 2617.061 DA MW 23AA RKKRRQRRRG GJGLTQFGAF IDI // ID AMRSAP599 PN Hybrid peptide R23EI SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 4, 'H': 1, 'I': 2, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 6, 'S': 1, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 4.55%, 'F': 0%, 'G': 18.18%, 'H': 4.55%, 'I': 9.09%, 'K': 9.09%, 'L': 4.55%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 27.27%, 'S': 4.55%, 'T': 0%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA A, C, D, F, M, N, P, T, W, Y MO R LO E, H, J, L, S BA 9 LA 13 AA 1 BC 9 MC {'J': 1} MF {'J': 0.043478260869565216} XX MM 2587.036 AI 93.043 II 144.352 HP -1.291 HM 0.568 IP 12.807 NC 7.09 SF 0.217, 0.217, 0.087 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA ATCC 43300 XX XR PubMed: 35008951 XR CAMP R4: CAMPSQ14674 SQ SEQUENCE 2587.036 DA MW 23AA RKKRRQRRRG GJGVQGLVHI SEI // ID AMRSAP600 PN QUB-1641 SO Kassina senegalensis PL 15 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.67%, 'C': 0%, 'D': 0%, 'E': 6.67%, 'F': 6.67%, 'G': 0%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 26.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 6.67%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, G, H, M, N, P, R, S, T, V, W, Y MO A; L LO E, F, Q BA 11 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1642.058 AI 182.667 II 10.853 HP 1.293 HM 0.434 IP 9.537 NC 0.999 SF 0.467, 0, 0.6 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA NCTC 12493 (MIC = 64 μM TO MBC = 128 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15073 SQ SEQUENCE 1642.058 DA MW 15AA FLALALIQEA IAKLK // ID AMRSAP601 PN QUB-1599 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.67%, 'C': 0%, 'D': 0%, 'E': 6.67%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 20%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 6.67%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, P, R, S, T, V, W, Y MO A LO E, F, G, I, Q BA 10 LA 5 AA 1 BC 3 MC 0 MF 0 XX MM 1600.965 AI 130.667 II 20.98 HP 0.453 HM 0.232 IP 10.507 NC 1.999 SF 0.333, 0.067, 0.533 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA NCTC 12493 (MIC > 128 μM TO MBC > 128 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15074 SQ SEQUENCE 1600.965 DA MW 15AA FLALAGKQEA IAKLK // ID AMRSAP602 PN QUB-1585 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.67%, 'C': 0%, 'D': 0%, 'E': 6.67%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 6.67%, 'K': 20%, 'L': 26.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, P, Q, R, S, T, V, W, Y MO A; L LO E, F, G, I BA 11 LA 4 AA 1 BC 3 MC 0 MF 0 XX MM 1585.994 AI 156.667 II -7.647 HP 0.94 HM 0.352 IP 10.507 NC 1.999 SF 0.4, 0.067, 0.6 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA NCTC 12493 (MIC = 64 μM TO MBC = 128 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15075 SQ SEQUENCE 1585.994 DA MW 15AA FLALALGKEA IAKLK // ID AMRSAP603 PN QUB-1570 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 13.33%, 'K': 20%, 'L': 26.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, V, W, Y MO A; L LO F, G BA 12 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1570.038 AI 182.667 II -7.647 HP 1.473 HM 0.528 IP 11.103 NC 2.997 SF 0.467, 0.067, 0.533 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA NCTC 12493 (MIC = 4 μM TO MBC = 8 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15076 SQ SEQUENCE 1570.038 DA MW 15AA FLALALIGKA IAKLK // ID AMRSAP604 PN QUB-1643 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 6.67%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 13.33%, 'K': 20%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 6.67%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, P, R, S, T, V, W, Y MO A; K; L LO E, F, G, Q BA 10 LA 5 AA 1 BC 3 MC 0 MF 0 XX MM 1643.046 AI 150 II -0.467 HP 0.633 HM 0.575 IP 10.507 NC 1.999 SF 0.4, 0.067, 0.467 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA NCTC 12493 (MIC = 64 μM TO MBC = 128 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15077 SQ SEQUENCE 1643.046 DA MW 15AA FLAGKLIQEA IAKLK // ID AMRSAP605 PN QUB-1498 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 13.33%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 26.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, V, W, Y MO A; L LO F BA 13 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 1498.915 AI 182.667 II 0.58 HP 1.707 HM 0.351 IP 10.805 NC 1.997 SF 0.467, 0.133, 0.533 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA NCTC 12493 (MIC = 128 μM TO MBC > 128 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15078 SQ SEQUENCE 1498.915 DA MW 15AA FLALALIGGA IAKLK // ID AMRSAP606 PN QUB-1609 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 0%, 'H': 0%, 'I': 13.33%, 'K': 20%, 'L': 26.67%, AF 'M': 0%, 'N': 0%, 'P': 6.67%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, M, N, Q, R, S, T, V, W, Y MO A; L LO F, P BA 12 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1610.102 AI 182.667 II -3.907 HP 1.393 HM 0.518 IP 11.103 NC 2.997 SF 0.467, 0.067, 0.533 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 18.060387 XX SC alpha+beta XX TO MRSA NCTC 12493 (MIC = 8 μM TO MBC = 16 μM) XX XR PubMed: 35203845 XR CAMP R4: CAMPSQ15079 SQ SEQUENCE 1610.102 DA MW 15AA FLALALIPKA IAKLK // ID AMRSAP607 PN LfcinB6 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 16.67%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, S, T, V, Y MO R LO Q BA 2 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 987.135 AI 0 II 199.267 HP -3.133 HM 0.537 IP 12.801 NC 2.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO MRSA CCARM 3089 (MIC >64 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15081 SQ SEQUENCE 987.135 DA MW 6AA RRWQWR // ID AMRSAP608 PN LfcinB6 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 16.67%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, S, T, V, Y MO R LO Q BA 2 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 987.135 AI 0 II 199.267 HP -3.133 HM 0.537 IP 12.801 NC 2.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO MRSA CCARM 3090 (MIC >64 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15081 SQ SEQUENCE 987.135 DA MW 6AA RRWQWR // ID AMRSAP609 PN LfcinB6 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 16.67%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 33.33%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, S, T, V, Y MO R LO Q BA 2 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 987.135 AI 0 II 199.267 HP -3.133 HM 0.537 IP 12.801 NC 2.998 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO MRSA CCARM 3095 (MIC >64 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15081 SQ SEQUENCE 987.135 DA MW 6AA RRWQWR // ID AMRSAP610 PN KR-12-a4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 33.33%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, S, T, Y MO K LO V, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1581.07 AI 154.167 II 39.042 HP -0.392 HM 1.022 IP 12.56 NC 5.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA CCARM 3089 (MIC = 64 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15082 SQ SEQUENCE 1581.07 DA MW 12AA KRIVKLIKKW LR // ID AMRSAP611 PN KR-12-a4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 33.33%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, S, T, Y MO K LO V, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1581.07 AI 154.167 II 39.042 HP -0.392 HM 1.022 IP 12.56 NC 5.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA CCARM 3090 (MIC >64 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15082 SQ SEQUENCE 1581.07 DA MW 12AA KRIVKLIKKW LR // ID AMRSAP612 PN KR-12-a4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 33.33%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, S, T, Y MO K LO V, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1581.07 AI 154.167 II 39.042 HP -0.392 HM 1.022 IP 12.56 NC 5.997 SF 0.5, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO MRSA CCARM 3095 (MIC >64 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15082 SQ SEQUENCE 1581.07 DA MW 12AA KRIVKLIKKW LR // ID AMRSAP613 PN Lf-KR SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 5.26%, 'R': 26.32%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 15.79%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, S, T, Y MO R LO P, Q, V BA 9 LA 10 AA 0 BC 9 MC 0 MF 0 XX MM 2647.306 AI 97.368 II 98.774 HP -1.321 HM 1.022 IP 13.113 NC 8.997 SF 0.421, 0.053, 0.105 [Helix, Turn, Sheet] AR 0.158 ME 16500, 16500 MS 54.181161 XX SC alpha_beta XX TO MRSA CCARM 3089 (MIC = 8 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15083 SQ SEQUENCE 2647.306 DA MW 19AA RRWQWRPKRI VKLIKKWLR // ID AMRSAP614 PN Lf-KR SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 5.26%, 'R': 26.32%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 15.79%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, S, T, Y MO R LO P, Q, V BA 9 LA 10 AA 0 BC 9 MC 0 MF 0 XX MM 2647.306 AI 97.368 II 98.774 HP -1.321 HM 1.022 IP 13.113 NC 8.997 SF 0.421, 0.053, 0.105 [Helix, Turn, Sheet] AR 0.158 ME 16500, 16500 MS 54.181161 XX SC alpha_beta XX TO MRSA CCARM 3090 (MIC = 8 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15083 SQ SEQUENCE 2647.306 DA MW 19AA RRWQWRPKRI VKLIKKWLR // ID AMRSAP615 PN Lf-KR SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 5.26%, 'R': 26.32%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 15.79%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, S, T, Y MO R LO P, Q, V BA 9 LA 10 AA 0 BC 9 MC 0 MF 0 XX MM 2647.306 AI 97.368 II 98.774 HP -1.321 HM 1.022 IP 13.113 NC 8.997 SF 0.421, 0.053, 0.105 [Helix, Turn, Sheet] AR 0.158 ME 16500, 16500 MS 54.181161 XX SC alpha_beta XX TO MRSA CCARM 3095 (MIC = 8 μM) XX XR PubMed: 35288606 XR CAMP R4: CAMPSQ15083 SQ SEQUENCE 2647.306 DA MW 19AA RRWQWRPKRI VKLIKKWLR // ID AMRSAP616 PN OL-1 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, I, K, L, M, N, P, Q, S, T, Y MO V LO H, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1137.356 AI 96.667 II 59.9 HP -0.156 HM 0.122 IP 12.5 NC 2.089 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA (MIC = 50 μG/mL) XX XR PubMed: 35268850 XR CAMP R4: CAMPSQ15088 SQ SEQUENCE 1137.356 DA MW 9AA XVHWVRWRV // ID AMRSAP617 PN OL-2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, I, K, L, M, N, P, Q, S, T, Y MO V LO H, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1137.356 AI 96.667 II 59.9 HP -0.156 HM 0.122 IP 12.5 NC 2.089 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO MRSA (MIC = 12.5 μG/mL) XX XR PubMed: 35268850 XR CAMP R4: CAMPSQ15089 SQ SEQUENCE 1137.356 DA MW 9AA XVHWVRWRV // ID AMRSAP618 PN OL-3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 2, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 25%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, I, K, L, M, N, P, Q, S, T, Y MO V LO R, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1118.309 AI 96.667 II -6.944 HP -0.011 HM 0.259 IP 10.554 NC 1.18 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 6.020129 XX SC alpha_beta XX TO MRSA (MIC = 12.5 μG/mL) XX XR PubMed: 35268850 XR CAMP R4: CAMPSQ15090 SQ SEQUENCE 1118.309 DA MW 9AA XVHWVHWRV // ID AMRSAP619 PN OL-4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 2, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 25%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, I, K, L, M, N, P, Q, S, T, Y MO V LO R, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1118.309 AI 96.667 II -6.944 HP -0.011 HM 0.259 IP 10.554 NC 1.18 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 6.020129 XX SC alpha_beta XX TO MRSA (MIC = 6.25 μG/mL) XX XR PubMed: 35268850 XR CAMP R4: CAMPSQ15091 SQ SEQUENCE 1118.309 DA MW 9AA XVHWVHWRV // ID AMRSAP620 PN OL-5 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 37.5%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, Y MO R; V LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1156.402 AI 96.667 II 126.744 HP -0.3 HM 0.351 IP 12.801 NC 2.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC = 6.25 μG/mL) XX XR PubMed: 35268850 XR CAMP R4: CAMPSQ15092 SQ SEQUENCE 1156.402 DA MW 9AA XVRWVRWRV // ID AMRSAP621 PN Mini-ChBac7.5N alpha SO Capra hircus PL 22 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 8, 'Q': 0, 'R': 12, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 36.36%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, Q, S, T, V, W, Y MO R LO L BA 10 LA 12 AA 0 BC 12 MC 0 MF 0 XX MM 2895.518 AI 35.455 II 112.991 HP -2.691 HM 0.382 IP 13.541 NC 11.998 SF 0.091, 0.364, 0.091 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 72.241548 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC >= 64 μM) XX XR PubMed: 27795854 XR CAMP R4: CAMPSQ15198 SQ SEQUENCE 2895.518 DA MW 22AA RRLRPRRPRL PRPRPRPRPR PR // ID AMRSAP622 PN Mini-ChBac7.5N beta SO Capra hircus PL 21 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 8, 'Q': 0, 'R': 11, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 9.52%, AF 'M': 0%, 'N': 0%, 'P': 38.1%, 'Q': 0%, 'R': 52.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, Q, S, T, V, W, Y MO R LO L BA 10 LA 11 AA 0 BC 11 MC 0 MF 0 XX MM 2739.33 AI 37.143 II 121.486 HP -2.605 HM 0.382 IP 13.5 NC 10.998 SF 0.095, 0.381, 0.095 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 66.221419 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC >= 64 μM) XX XR PubMed: 27795854 XR CAMP R4: CAMPSQ15199 SQ SEQUENCE 2739.33 DA MW 21AA RRLRPRRPRL PRPRPRPRPR P // ID AMRSAP623 PN MCRAMP SO Rattus norvegicus PL 39 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 3, 'F': 2, 'G': 5, 'H': 0, 'I': 4, 'K': 8, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 4, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 2.56%, 'C': 0%, 'D': 0%, 'E': 7.69%, 'F': 5.13%, 'G': 12.82%, 'H': 0%, 'I': 10.26%, 'K': 20.51%, 'L': 12.82%, AF 'M': 0%, 'N': 2.56%, 'P': 5.13%, 'Q': 10.26%, 'R': 5.13%, 'S': 2.56%, 'T': 0%, 'V': 2.56%, 'W': 0%, 'Y': 0% MA C, D, H, M, T, W, Y MO K LO A, N, S, V BA 20 LA 19 AA 3 BC 10 MC 0 MF 0 XX MM 4419.326 AI 100 II 21.859 HP -0.656 HM 0.76 IP 11.248 NC 7.001 SF 0.308, 0.231, 0.231 [Helix, Turn, Sheet] AR 0.051 ME 0, 0 MS 60.20129 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC = 2.42 μM [Low] TO MIC = 17.9 []) XX XR PubMed: 10768969 XR CAMP R4: CAMPSQ15200 SQ SEQUENCE 4419.326 DA MW 39AA ISRLAGLLRK GGEKIGEKLK KIGQKIKNFF QKLVPQPEQ // ID AMRSAP624 PN SMAP34 SO Ovis aries PL 34 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 2, 'E': 2, 'F': 2, 'G': 5, 'H': 0, 'I': 4, 'K': 4, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 5, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 2.94%, 'C': 2.94%, 'D': 5.88%, 'E': 5.88%, 'F': 5.88%, 'G': 14.71%, 'H': 0%, 'I': 11.76%, 'K': 11.76%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 14.71%, 'S': 2.94%, 'T': 0%, 'V': 0%, 'W': 2.94%, 'Y': 0% MA H, M, N, P, T, V, Y MO G; R LO A, C, S, W BA 17 LA 17 AA 4 BC 9 MC 0 MF 0 XX MM 3988.716 AI 94.706 II 27.432 HP -0.579 HM 0.856 IP 11.161 NC 4.939 SF 0.324, 0.176, 0.206 [Helix, Turn, Sheet] AR 0.088 ME 5500, 5500 MS 54.181161 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4.00 μM [Low] TO MIC = 13.3 []) XX XR PubMed: 10768969 XR CAMP R4: CAMPSQ15201 SQ SEQUENCE 3988.716 DA MW 34AA GLFGRLRDSL QRGGQKILEK AERIWCKIKD IFRG // ID AMRSAP625 PN OH-CATH30 SO Ophiophagus hannah PL 30 TX Animalia (Reptiles) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 1, 'H': 0, 'I': 2, 'K': 10, 'L': 1, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 2, 'S': 2, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 3.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 3.33%, 'H': 0%, 'I': 6.67%, 'K': 33.33%, 'L': 3.33%, AF 'M': 0%, 'N': 3.33%, 'P': 6.67%, 'Q': 0%, 'R': 6.67%, 'S': 6.67%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, Q, T, W, Y MO K LO A, G, L, N BA 15 LA 15 AA 0 BC 12 MC 0 MF 0 XX MM 3595.515 AI 71.333 II 4.327 HP -0.517 HM 0.756 IP 12.628 NC 11.995 SF 0.367, 0.2, 0.067 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 72.241548 XX SC alpha_beta XX TO S. aureus ATCC 43300 MRSA (MIC = 6.25 μG/mL) XX XR PubMed: 22491685 XR CAMP R4: CAMPSQ15233 SQ SEQUENCE 3595.515 DA MW 30AA KFFKKLKNSV KKRAKKFFKK PRVIGVSIPF // ID AMRSAP626 PN D-OH-CATH30 SO Ophiophagus hannah PL 30 TX Animalia (Reptiles) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 1, 'H': 0, 'I': 2, 'K': 10, 'L': 1, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 2, 'S': 2, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 3.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 3.33%, 'H': 0%, 'I': 6.67%, 'K': 33.33%, 'L': 3.33%, AF 'M': 0%, 'N': 3.33%, 'P': 6.67%, 'Q': 0%, 'R': 6.67%, 'S': 6.67%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, Q, T, W, Y MO K LO A, G, L, N BA 15 LA 15 AA 0 BC 12 MC 0 MF 0 XX MM 3595.515 AI 71.333 II 4.327 HP -0.517 HM 0.756 IP 12.628 NC 11.995 SF 0.367, 0.2, 0.067 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 72.241548 XX SC alpha_beta XX TO S. aureus ATCC 43300 MRSA (MIC = 6.25 μG/mL) XX XR PubMed: 22491685 XR CAMP R4: CAMPSQ15234 SQ SEQUENCE 3595.515 DA MW 30AA KFFKKLKNSV KKRAKKFFKK PRVIGVSIPF // ID AMRSAP627 PN OH-CM6 SO Ophiophagus hannah PL 20 TX Animalia (Reptiles) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 0, 'I': 0, 'K': 10, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 20%, 'G': 5%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, H, I, M, N, P, Q, R, S, T, W, Y MO K LO G, L BA 10 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 2399.097 AI 58.5 II -23.95 HP -0.62 HM 0.85 IP 11.755 NC 9.995 SF 0.35, 0.05, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus ATCC 43300 MRSA (MIC = 3.125 μG/mL) XX XR PubMed: 22491685 XR CAMP R4: CAMPSQ15235 SQ SEQUENCE 2399.097 DA MW 20AA KFFKKLKKAV KKGFKKFAKV // ID AMRSAP628 PN D-OH-CM6 SO Ophiophagus hannah PL 20 TX Animalia (Reptiles) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 0, 'I': 0, 'K': 10, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 20%, 'G': 5%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, H, I, M, N, P, Q, R, S, T, W, Y MO K LO G, L BA 10 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 2399.097 AI 58.5 II -23.95 HP -0.62 HM 0.85 IP 11.755 NC 9.995 SF 0.35, 0.05, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus ATCC 43300 MRSA (MIC = 6.25 μG/mL) XX XR PubMed: 22491685 XR CAMP R4: CAMPSQ15236 SQ SEQUENCE 2399.097 DA MW 20AA KFFKKLKKAV KKGFKKFAKV // ID AMRSAP629 PN Ib-AMP1 SO Impatiens balsamina PL 20 TX Plantae PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 1, 'F': 0, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 1 AF 'A': 0%, 'C': 20%, 'D': 0%, 'E': 5%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 5%, 'W': 15%, 'Y': 5% MA A, D, F, H, I, K, L, M, N, Q, S, T MO R LO E, P, V, Y BA 9 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 2486.896 AI 14.5 II 76.165 HP -0.95 HM 0.461 IP 9.077 NC 3.751 SF 0.25, 0.25, 0.05 [Helix, Turn, Sheet] AR 0.2 ME 17990, 18240 MS 30.100645 XX SC beta XX TO MRSA (CCARM 3543) (MIC = 16 μM) XX XR PubMed: 19778562 XR CAMP R4: CAMPSQ15247 SQ SEQUENCE 2486.896 DA MW 20AA EWGRRCCGWG PGRRYCVRWC // ID AMRSAP630 PN Analog-1 SO Impatiens balsamina PL 18 TX Plantae PE Experimentally validated XX AC 'A': 0, 'C': 3, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 1 AF 'A': 0%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 22.22%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 5.56% MA A, D, E, F, H, I, K, L, M, N, Q, S, T MO R LO P, V, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2254.642 AI 16.111 II 91.867 HP -1 HM 0.461 IP 10.953 NC 4.811 SF 0.278, 0.278, 0 [Helix, Turn, Sheet] AR 0.222 ME 17990, 18115 MS 30.100645 XX SC alpha_beta XX TO MRSA (CCARM 3543) (MIC = 2 μM) XX XR PubMed: 19778562 XR CAMP R4: CAMPSQ15248 SQ SEQUENCE 2254.642 DA MW 18AA WGRRCCGWGP GRRYCVRW // ID AMRSAP631 PN Analog-2 SO Impatiens balsamina PL 18 TX Plantae PE Experimentally validated XX AC 'A': 0, 'C': 3, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 1 AF 'A': 0%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 22.22%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 5.56% MA A, D, E, F, H, I, K, L, M, N, Q, S, T MO R LO P, V, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2254.642 AI 16.111 II 91.867 HP -1 HM 0.461 IP 10.953 NC 4.811 SF 0.278, 0.278, 0 [Helix, Turn, Sheet] AR 0.222 ME 17990, 18115 MS 30.100645 XX SC alpha_beta XX TO MRSA (CCARM 3543) (MIC = 2 μM) XX XR PubMed: 19778562 XR CAMP R4: CAMPSQ15249 SQ SEQUENCE 2254.642 DA MW 18AA WGRRCCGWGP GRRYCVRW // ID AMRSAP632 PN Analog-3 SO Impatiens balsamina PL 18 TX Plantae PE Experimentally validated XX AC 'A': 1, 'C': 3, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 1 AF 'A': 5.56%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 22.22%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 5.56% MA D, E, F, H, I, K, L, M, N, P, Q, S, T MO R LO A, V, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2228.604 AI 21.667 II 87.15 HP -0.811 HM 0.44 IP 10.953 NC 4.811 SF 0.278, 0.222, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 17990, 18115 MS 30.100645 XX SC beta XX TO MRSA (CCARM 3543) (MIC = 2 μM) XX XR PubMed: 19778562 XR CAMP R4: CAMPSQ15250 SQ SEQUENCE 2228.604 DA MW 18AA WGRRCCGWGA GRRYCVRW // ID AMRSAP633 PN Analog-4 SO Impatiens balsamina PL 18 TX Plantae PE Experimentally validated XX AC 'A': 0, 'C': 3, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 1 AF 'A': 0%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 22.22%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 5.56% MA A, D, E, F, H, I, L, M, N, P, Q, S, T MO R LO K, V, Y BA 8 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2285.699 AI 16.111 II 82.433 HP -1.128 HM 0.549 IP 11.308 NC 5.811 SF 0.278, 0.222, 0 [Helix, Turn, Sheet] AR 0.222 ME 17990, 18115 MS 36.120774 XX SC alpha_beta XX TO MRSA (CCARM 3543) (MIC = 2 μM) XX XR PubMed: 19778562 XR CAMP R4: CAMPSQ15251 SQ SEQUENCE 2285.699 DA MW 18AA WGRRCCGWGK GRRYCVRW // ID AMRSAP634 PN Tatritin SO Tachypleus tridentatus PL 47 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 1, 'E': 1, 'F': 1, 'G': 5, 'H': 1, 'I': 1, 'K': 2, 'L': 5, AC 'M': 0, 'N': 2, 'P': 3, 'Q': 0, 'R': 9, 'S': 2, 'T': 2, 'V': 0, 'W': 2, 'Y': 3 AF 'A': 2.13%, 'C': 12.77%, 'D': 2.13%, 'E': 2.13%, 'F': 2.13%, 'G': 10.64%, 'H': 2.13%, 'I': 2.13%, 'K': 4.26%, 'L': 10.64%, AF 'M': 0%, 'N': 4.26%, 'P': 6.38%, 'Q': 0%, 'R': 19.15%, 'S': 4.26%, 'T': 4.26%, 'V': 0%, 'W': 4.26%, 'Y': 6.38% MA M, Q, V MO R LO A, D, E, F, H, I BA 18 LA 29 AA 2 BC 12 MC 0 MF 0 XX MM 5620.579 AI 51.915 II 36.057 HP -0.806 HM 0.682 IP 10.208 NC 8.716 SF 0.255, 0.255, 0.149 [Helix, Turn, Sheet] AR 0.128 ME 15470, 15845 MS 66.221419 XX SC beta XX TO S. aureus�(MRSA) XX XR PubMed: 35401525 XR CAMP R4: CAMPSQ16230 SQ SEQUENCE 5620.579 DA MW 47AA SLLDHKITER SLRCAGYGGR CNPWRYPRCC WPLKCTRLRC YRGFRNG // ID AMRSAP635 PN GHaR6R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, I, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1546.882 AI 127.692 II 21.246 HP 0.423 HM 0.612 IP 12.801 NC 2.998 SF 0.462, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA(MIC=6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16264 SQ SEQUENCE 1546.882 DA MW 13AA FLQRIRGALG RLF // ID AMRSAP636 PN GHaR6R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, I, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1546.882 AI 127.692 II 21.246 HP 0.423 HM 0.612 IP 12.801 NC 2.998 SF 0.462, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-1 (MIC = 12.5 μM TO MBC = 25 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16264 SQ SEQUENCE 1546.882 DA MW 13AA FLQRIRGALG RLF // ID AMRSAP637 PN GHaR6R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, I, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1546.882 AI 127.692 II 21.246 HP 0.423 HM 0.612 IP 12.801 NC 2.998 SF 0.462, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-2 (MIC = 12.5 μM TO MBC = 25 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16264 SQ SEQUENCE 1546.882 DA MW 13AA FLQRIRGALG RLF // ID AMRSAP638 PN GHaR6R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, I, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1546.882 AI 127.692 II 21.246 HP 0.423 HM 0.612 IP 12.801 NC 2.998 SF 0.462, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-3 (MIC = 6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16264 SQ SEQUENCE 1546.882 DA MW 13AA FLQRIRGALG RLF // ID AMRSAP639 PN GHaR6R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, I, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1546.882 AI 127.692 II 21.246 HP 0.423 HM 0.612 IP 12.801 NC 2.998 SF 0.462, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-4 (MIC = 12.5 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16264 SQ SEQUENCE 1546.882 DA MW 13AA FLQRIRGALG RLF // ID AMRSAP640 PN GHaR6R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, I, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1546.882 AI 127.692 II 21.246 HP 0.423 HM 0.612 IP 12.801 NC 2.998 SF 0.462, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-5 (MIC = 12.5 μM TO MBC = 25 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16264 SQ SEQUENCE 1546.882 DA MW 13AA FLQRIRGALG RLF // ID AMRSAP641 PN GHaR7R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, G, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.989 AI 157.692 II 34.308 HP 0.8 HM 1.025 IP 12.801 NC 2.998 SF 0.538, 0.077, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA (MIC = 3.1 μM TO MBC = 6.2 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16265 SQ SEQUENCE 1602.989 DA MW 13AA FLQRIIRALG RLF // ID AMRSAP642 PN GHaR7R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, G, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.989 AI 157.692 II 34.308 HP 0.8 HM 1.025 IP 12.801 NC 2.998 SF 0.538, 0.077, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-1 (MIC = 6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16265 SQ SEQUENCE 1602.989 DA MW 13AA FLQRIIRALG RLF // ID AMRSAP643 PN GHaR7R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, G, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.989 AI 157.692 II 34.308 HP 0.8 HM 1.025 IP 12.801 NC 2.998 SF 0.538, 0.077, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-2 (MIC = 3.1 μM TO MBC = 6.2 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16265 SQ SEQUENCE 1602.989 DA MW 13AA FLQRIIRALG RLF // ID AMRSAP644 PN GHaR7R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, G, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.989 AI 157.692 II 34.308 HP 0.8 HM 1.025 IP 12.801 NC 2.998 SF 0.538, 0.077, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-3 (MIC = 6.2 μM TO MBC = 6.2 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16265 SQ SEQUENCE 1602.989 DA MW 13AA FLQRIIRALG RLF // ID AMRSAP645 PN GHaR7R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, G, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.989 AI 157.692 II 34.308 HP 0.8 HM 1.025 IP 12.801 NC 2.998 SF 0.538, 0.077, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-4 (MIC = 3.1 μM TO MBC = 3.1 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16265 SQ SEQUENCE 1602.989 DA MW 13AA FLQRIIRALG RLF // ID AMRSAP646 PN GHaR7R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 7.69%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO A, G, Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.989 AI 157.692 II 34.308 HP 0.8 HM 1.025 IP 12.801 NC 2.998 SF 0.538, 0.077, 0.308 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-5 (MIC = 12.5 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16265 SQ SEQUENCE 1602.989 DA MW 13AA FLQRIIRALG RLF // ID AMRSAP647 PN GHaR8R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1588.962 AI 150 II 34.308 HP 0.631 HM 0.929 IP 12.801 NC 2.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA (MIC = 3.1 μM TO MBC = 3.1 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16266 SQ SEQUENCE 1588.962 DA MW 13AA FLQRIIGRLG RLF // ID AMRSAP648 PN GHaR8R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1588.962 AI 150 II 34.308 HP 0.631 HM 0.929 IP 12.801 NC 2.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-1 (MIC = 6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16266 SQ SEQUENCE 1588.962 DA MW 13AA FLQRIIGRLG RLF // ID AMRSAP649 PN GHaR8R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1588.962 AI 150 II 34.308 HP 0.631 HM 0.929 IP 12.801 NC 2.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-2 (MIC = 3.1 μM TO MBC = 6.2 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16266 SQ SEQUENCE 1588.962 DA MW 13AA FLQRIIGRLG RLF // ID AMRSAP650 PN GHaR8R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1588.962 AI 150 II 34.308 HP 0.631 HM 0.929 IP 12.801 NC 2.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-3 (MIC = 6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16266 SQ SEQUENCE 1588.962 DA MW 13AA FLQRIIGRLG RLF // ID AMRSAP651 PN GHaR8R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1588.962 AI 150 II 34.308 HP 0.631 HM 0.929 IP 12.801 NC 2.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-4 (MIC = 6.2 μM TO MBC = 6.2 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16266 SQ SEQUENCE 1588.962 DA MW 13AA FLQRIIGRLG RLF // ID AMRSAP652 PN GHaR8R SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 23.08%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, P, S, T, V, W, Y MO L; R LO Q BA 9 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1588.962 AI 150 II 34.308 HP 0.631 HM 0.929 IP 12.801 NC 2.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA-5 (MIC = 12.5 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16266 SQ SEQUENCE 1588.962 DA MW 13AA FLQRIIGRLG RLF // ID AMRSAP653 PN GHaR9W SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 7.69%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, Y MO F; G; I; L; R LO A, Q, W BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1576.908 AI 127.692 II 19.8 HP 0.754 HM 0.757 IP 12.5 NC 1.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.231 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16267 SQ SEQUENCE 1576.908 DA MW 13AA FLQRIIGAWG RLF // ID AMRSAP654 PN GHaR9W SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 7.69%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, Y MO F; G; I; L; R LO A, Q, W BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1576.908 AI 127.692 II 19.8 HP 0.754 HM 0.757 IP 12.5 NC 1.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.231 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA-1 (MIC = 12.5 μM TO MBC = 25 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16267 SQ SEQUENCE 1576.908 DA MW 13AA FLQRIIGAWG RLF // ID AMRSAP655 PN GHaR9W SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 7.69%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, Y MO F; G; I; L; R LO A, Q, W BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1576.908 AI 127.692 II 19.8 HP 0.754 HM 0.757 IP 12.5 NC 1.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.231 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA-2 (MIC = 12.5 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16267 SQ SEQUENCE 1576.908 DA MW 13AA FLQRIIGAWG RLF // ID AMRSAP656 PN GHaR9W SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 7.69%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, Y MO F; G; I; L; R LO A, Q, W BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1576.908 AI 127.692 II 19.8 HP 0.754 HM 0.757 IP 12.5 NC 1.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.231 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA-3 (MIC = 6.2 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16267 SQ SEQUENCE 1576.908 DA MW 13AA FLQRIIGAWG RLF // ID AMRSAP657 PN GHaR9W SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 7.69%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, Y MO F; G; I; L; R LO A, Q, W BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1576.908 AI 127.692 II 19.8 HP 0.754 HM 0.757 IP 12.5 NC 1.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.231 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA-4 (MIC = 6.2 μM TO MBC = 6.2 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16267 SQ SEQUENCE 1576.908 DA MW 13AA FLQRIIGAWG RLF // ID AMRSAP658 PN GHaR9W SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 15.38%, 'H': 0%, 'I': 15.38%, 'K': 0%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 7.69%, 'Y': 0% MA C, D, E, H, K, M, N, P, S, T, V, Y MO F; G; I; L; R LO A, Q, W BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1576.908 AI 127.692 II 19.8 HP 0.754 HM 0.757 IP 12.5 NC 1.998 SF 0.538, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.231 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA-5 (MIC = 12.5 μM TO MBC = 12.5 μM) XX XR PubMed: 35538042 XR CAMP R4: CAMPSQ16267 SQ SEQUENCE 1576.908 DA MW 13AA FLQRIIGAWG RLF // ID AMRSAP659 PN TPk SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 7.69%, 'Q': 0%, 'R': 30.77%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, Q, S, T, Y MO R LO F, L, P, V BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1914.338 AI 52.308 II 126.985 HP -1.485 HM 0.627 IP 12.985 NC 5.997 SF 0.462, 0.077, 0.077 [Helix, Turn, Sheet] AR 0.308 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA1 (CCARM 3001) (MIC = 1 μM) XX XR PubMed: 17604338 XR CAMP R4: CAMPSQ16479 SQ SEQUENCE 1914.338 DA MW 13AA VRRPKWWWKF LRR // ID AMRSAP660 PN STPk SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 54.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K LO F BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1640.053 AI 0 II -18.236 HP -1.864 HM 0.413 IP 11.5 NC 5.996 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA1 (CCARM 3001) (MIC = 2 μM) XX XR PubMed: 17604338 XR CAMP R4: CAMPSQ16480 SQ SEQUENCE 1640.053 DA MW 11AA KKFKWWWKFK K // ID AMRSAP661 PN Ink SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 30.77%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO W LO I, L BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2000.471 AI 60 II 61.577 HP -1.6 HM 0.432 IP 12.56 NC 5.997 SF 0.538, 0, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA1 (CCARM 3001) (MIC= 2 μM) XX XR PubMed: 17604338 XR CAMP R4: CAMPSQ16481 SQ SEQUENCE 2000.471 DA MW 13AA ILKWKWKWWK WRR // ID AMRSAP662 PN Syn-BNP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 4, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 30%, 'G': 0%, 'H': 0%, 'I': 20%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 40%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, K, L, M, N, P, Q, R, T, W, Y MO S LO V BA 6 LA 4 AA 0 BC 0 MC {'X': 3} MF {'X': 0.23076923076923078} XX MM 1133.309 AI 82.308 II 24.046 HP 1.415 HM 0.177 IP 6.1 NC -0.002 SF 0.462, 0.308, 0 [Helix, Turn, Sheet] AR 0.231 ME 0, 0 MS 0 XX SC alpha XX TO MRSA USA300 (MIC = 16 μG/mL) XX XR PubMed: 28055186 XR CAMP R4: CAMPSQ16487 SQ SEQUENCE 1133.309 DA MW 13AA FXISFSSXFS VIX // ID AMRSAP663 PN Syn-BNP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 4, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 30%, 'G': 0%, 'H': 0%, 'I': 20%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 40%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, K, L, M, N, P, Q, R, T, W, Y MO S LO V BA 6 LA 4 AA 0 BC 0 MC {'X': 3} MF {'X': 0.23076923076923078} XX MM 1133.309 AI 82.308 II 24.046 HP 1.415 HM 0.177 IP 6.1 NC -0.002 SF 0.462, 0.308, 0 [Helix, Turn, Sheet] AR 0.231 ME 0, 0 MS 0 XX SC alpha XX TO MRSA USA300 (MIC = 128 μG/mL) XX XR PubMed: 28055186 XR CAMP R4: CAMPSQ16488 SQ SEQUENCE 1133.309 DA MW 13AA FXISFSSXFS VIX // ID AMRSAP664 PN Syn-BNP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 4, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 20%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 40%, 'T': 0%, 'V': 10%, 'W': 20%, 'Y': 0% MA A, C, D, E, G, H, K, L, M, N, P, Q, R, T, Y MO S LO F, V BA 6 LA 4 AA 0 BC 0 MC {'X': 3} MF {'X': 0.23076923076923078} XX MM 1211.382 AI 82.308 II 24.046 HP 0.846 HM 0.122 IP 6.1 NC -0.002 SF 0.462, 0.308, 0 [Helix, Turn, Sheet] AR 0.231 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA USA300 (MIC = 64 μG/mL) XX XR PubMed: 28055186 XR CAMP R4: CAMPSQ16489 SQ SEQUENCE 1211.382 DA MW 13AA FXISWSSXWS VIX // ID AMRSAP665 PN Syn-BNP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 4, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 20%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 40%, 'T': 0%, 'V': 30%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, K, L, M, N, P, Q, R, T, W, Y MO S LO F BA 6 LA 4 AA 0 BC 0 MC {'X': 3} MF {'X': 0.23076923076923078} XX MM 1037.221 AI 126.923 II 24.046 HP 1.631 HM 0.16 IP 6.1 NC -0.002 SF 0.462, 0.308, 0 [Helix, Turn, Sheet] AR 0.077 ME 0, 0 MS 0 XX SC beta XX TO MRSA USA300 (MIC >= 128 μG/mL) XX XR PubMed: 28055186 XR CAMP R4: CAMPSQ16490 SQ SEQUENCE 1037.221 DA MW 13AA FXISVSSXVS VIX // ID AMRSAP666 PN Meucin-22, MUC-22 SO Mesobuthus eupeus PL 22 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 4, 'G': 1, 'H': 1, 'I': 2, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.55%, 'C': 0%, 'D': 0%, 'E': 4.55%, 'F': 18.18%, 'G': 4.55%, 'H': 4.55%, 'I': 9.09%, 'K': 18.18%, 'L': 13.64%, AF 'M': 0%, 'N': 0%, 'P': 4.55%, 'Q': 4.55%, 'R': 4.55%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, M, N, V, W, Y MO F; K LO A, E, G, H, P, Q, R, S, T BA 12 LA 10 AA 1 BC 6 MC 0 MF 0 XX MM 2649.221 AI 93.182 II 2.441 HP -0.018 HM 0.606 IP 11.248 NC 4.089 SF 0.409, 0.136, 0.227 [Helix, Turn, Sheet] AR 0.182 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA P1374 (LC = 0.87 μM) XX XR PubMed: 29599756 XR CAMP R4: CAMPSQ16500 SQ SEQUENCE 2649.221 DA MW 22AA FFGHLFKLAT KIIPSLFQRK KE // ID AMRSAP667 PN Marcin-22, MAC-22 SO Mesobuthus martensii PL 22 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 1, 'H': 1, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 2, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 4.55%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.73%, 'G': 4.55%, 'H': 4.55%, 'I': 9.09%, 'K': 13.64%, 'L': 9.09%, AF 'M': 0%, 'N': 4.55%, 'P': 4.55%, 'Q': 4.55%, 'R': 9.09%, 'S': 4.55%, 'T': 4.55%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, V, W, Y MO F LO A, G, H, N, P, Q, S, T BA 12 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2696.239 AI 75.455 II 25.05 HP -0.091 HM 0.734 IP 12.546 NC 5.088 SF 0.409, 0.182, 0.136 [Helix, Turn, Sheet] AR 0.227 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA P1374 (LC = 1.35 μM) XX XR PubMed: 29599756 XR CAMP R4: CAMPSQ16501 SQ SEQUENCE 2696.239 DA MW 22AA FFGHLFKLAT KIIPSFFRRK NQ // ID AMRSAP668 PN Marmelittin, Peptide BmKb1 SO Mesobuthus martensii PL 26 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 3, 'G': 2, 'H': 0, 'I': 3, 'K': 2, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 4, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 3.85%, 'E': 0%, 'F': 11.54%, 'G': 7.69%, 'H': 0%, 'I': 11.54%, 'K': 7.69%, 'L': 15.38%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 11.54%, 'S': 15.38%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, E, H, M, Q, T, V, W, Y MO L; S LO D, N, P BA 15 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 2907.455 AI 112.692 II 41.438 HP 0.262 HM 0.442 IP 12.244 NC 3.998 SF 0.385, 0.308, 0.231 [Helix, Turn, Sheet] AR 0.115 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA P1374 (LC = 2.60 μM) XX XR PubMed: 29599756 XR CAMP R4: CAMPSQ16502 SQ SEQUENCE 2907.455 DA MW 26AA FLFSLIPSAI SGLISAFKGR RKRDLN // ID AMRSAP669 PN Venom antimicrobial peptide-10, MeuFSPL-2 SO Mesobuthus eupeus PL 18 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 3, 'K': 1, 'L': 3, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 3, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 16.67%, 'G': 5.56%, 'H': 0%, 'I': 16.67%, 'K': 5.56%, 'L': 16.67%, AF 'M': 0%, 'N': 5.56%, 'P': 5.56%, 'Q': 0%, 'R': 0%, 'S': 16.67%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, Q, R, T, V, W, Y MO F; I; L; S LO G, K, N, P BA 13 LA 5 AA 0 BC 1 MC 0 MF 0 XX MM 1938.34 AI 141.111 II 10.194 HP 1.394 HM 0.497 IP 9.7 NC 0.998 SF 0.5, 0.333, 0.278 [Helix, Turn, Sheet] AR 0.167 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA P1374 (LC = 3.61 μM) XX XR PubMed: 29599756 XR CAMP R4: CAMPSQ16503 SQ SEQUENCE 1938.34 DA MW 18AA FLFSLIPSAI SGLINAFK // ID AMRSAP670 PN Ac-FtsA10 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 20%, AF 'M': 0%, 'N': 10%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 10%, 'T': 0%, 'V': 0%, 'W': 10%, 'Y': 0% MA A, C, D, E, F, G, H, M, P, Q, T, V, Y MO K; L; R LO I, N, S, W BA 4 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1313.612 AI 117 II 64.71 HP -0.99 HM 0.809 IP 12.532 NC 3.997 SF 0.4, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Gentamicn resistant MRSA (MIC > 128 μM in NaCL TO MIC > 128 μM in CaCl2 TO MIC > 128 μM in MgCl2) XX XR PubMed: 30279152 XR CAMP R4: CAMPSQ16683 SQ SEQUENCE 1313.612 DA MW 10AA IKRLNSWLRK // ID AMRSAP671 PN Ac-FtsA11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 18.18%, 'S': 9.09%, 'T': 0%, 'V': 0%, 'W': 18.18%, 'Y': 0% MA A, C, D, E, F, G, H, M, P, Q, T, V, Y MO K; L; R; W LO I, N, S BA 5 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1499.825 AI 106.364 II 59.736 HP -0.982 HM 0.78 IP 12.532 NC 3.997 SF 0.455, 0.182, 0.182 [Helix, Turn, Sheet] AR 0.182 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Gentamicn resistant MRSA (MIC = 32 μM in NaCL TO MIC = 16 μM in CaCl2 TO MIC = 32 μM in MgCl2) XX XR PubMed: 30279152 XR CAMP R4: CAMPSQ16684 SQ SEQUENCE 1499.825 DA MW 11AA WIKRLNSWLR K // ID AMRSAP672 PN Ac-FtsA13 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 2, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.69%, 'H': 0%, 'I': 7.69%, 'K': 15.38%, 'L': 15.38%, AF 'M': 0%, 'N': 7.69%, 'P': 0%, 'Q': 0%, 'R': 15.38%, 'S': 15.38%, 'T': 0%, 'V': 0%, 'W': 15.38%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, T, V, Y MO K; L; R; S; W LO G, I, N BA 6 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 1643.955 AI 90 II 52.085 HP -0.923 HM 0.78 IP 12.532 NC 3.997 SF 0.385, 0.308, 0.154 [Helix, Turn, Sheet] AR 0.154 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Gentamicn resistant MRSA (MIC = 32 μM in NaCL TO MIC = 64 μM in CaCl2 TO MIC = 64 μM in MgCl2) XX XR PubMed: 30279152 XR CAMP R4: CAMPSQ16685 SQ SEQUENCE 1643.955 DA MW 13AA GSWIKRLNSW LRK // ID AMRSAP673 PN FtsA10 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 20%, AF 'M': 0%, 'N': 10%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 10%, 'T': 0%, 'V': 0%, 'W': 10%, 'Y': 0% MA A, C, D, E, F, G, H, M, P, Q, T, V, Y MO K; L; R LO I, N, S, W BA 4 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1313.612 AI 117 II 64.71 HP -0.99 HM 0.809 IP 12.532 NC 3.997 SF 0.4, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.1 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO Gentamicn resistant MRSA (MIC > 128 μM in NaCL TO MIC > 128 μM in CaCl2 TO MIC > 128 μM in MgCl2) XX XR PubMed: 30279152 XR CAMP R4: CAMPSQ16686 SQ SEQUENCE 1313.612 DA MW 10AA IKRLNSWLRK // ID AMRSAP674 PN FtsA11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 18.18%, 'S': 9.09%, 'T': 0%, 'V': 0%, 'W': 18.18%, 'Y': 0% MA A, C, D, E, F, G, H, M, P, Q, T, V, Y MO K; L; R; W LO I, N, S BA 5 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1499.825 AI 106.364 II 59.736 HP -0.982 HM 0.78 IP 12.532 NC 3.997 SF 0.455, 0.182, 0.182 [Helix, Turn, Sheet] AR 0.182 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Gentamicn resistant MRSA (MIC = 128 μM in NaCL TO MIC = 128 μM in CaCl2 TO MIC = 128 μM in MgCl2) XX XR PubMed: 30279152 XR CAMP R4: CAMPSQ16687 SQ SEQUENCE 1499.825 DA MW 11AA WIKRLNSWLR K // ID AMRSAP675 PN FtsA13 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 2, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.69%, 'H': 0%, 'I': 7.69%, 'K': 15.38%, 'L': 15.38%, AF 'M': 0%, 'N': 7.69%, 'P': 0%, 'Q': 0%, 'R': 15.38%, 'S': 15.38%, 'T': 0%, 'V': 0%, 'W': 15.38%, 'Y': 0% MA A, C, D, E, F, H, M, P, Q, T, V, Y MO K; L; R; S; W LO G, I, N BA 6 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 1643.955 AI 90 II 52.085 HP -0.923 HM 0.78 IP 12.532 NC 3.997 SF 0.385, 0.308, 0.154 [Helix, Turn, Sheet] AR 0.154 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Gentamicn resistant MRSA (MIC = 32 μM in NaCL TO MIC = 32 μM in CaCl2 TO MIC = 32 μM in MgCl2) XX XR PubMed: 30279152 XR CAMP R4: CAMPSQ16688 SQ SEQUENCE 1643.955 DA MW 13AA GSWIKRLNSW LRK // ID AMRSAP676 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 3, 'H': 0, 'I': 1, 'K': 6, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 17.65%, 'G': 17.65%, 'H': 0%, 'I': 5.88%, 'K': 35.29%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO I, L, V BA 11 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1867.354 AI 74.706 II -10.565 HP -0.006 HM 0.789 IP 11.5 NC 5.996 SF 0.353, 0.176, 0.176 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA (MIC = 64-128 μG/mL TO MBC = 256 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: CAMPSQ16711 SQ SEQUENCE 1867.354 DA MW 17AA GIGKFLKKAK KFGKAFV // ID AMRSAP677 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 2, 'H': 0, 'I': 1, 'K': 7, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 17.65%, 'G': 11.76%, 'H': 0%, 'I': 5.88%, 'K': 41.18%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO I, L, V BA 10 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1938.477 AI 74.706 II -7.265 HP -0.212 HM 0.789 IP 11.579 NC 6.996 SF 0.353, 0.118, 0.176 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 42.140903 XX SC alpha XX TO MRSA (MIC > 512 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: CAMPSQ16712 SQ SEQUENCE 1938.477 DA MW 17AA IGKFLKKAKK FGKAFVK // ID AMRSAP678 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 2, 'H': 0, 'I': 1, 'K': 7, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 17.65%, 'G': 11.76%, 'H': 0%, 'I': 5.88%, 'K': 41.18%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO I, L, V BA 10 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1938.477 AI 74.706 II -12.259 HP -0.212 HM 0.789 IP 11.579 NC 6.996 SF 0.353, 0.118, 0.176 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 42.140903 XX SC alpha XX TO MRSA (MIC = 512 μG/mL TO MBC > 512 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: CAMPSQ16713 SQ SEQUENCE 1938.477 DA MW 17AA GKFLKKAKKF GKAFVKI // ID AMRSAP679 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 17.65%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 41.18%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO G, I, V BA 10 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1994.584 AI 97.647 II -0.929 HP 0.035 HM 0.789 IP 11.579 NC 6.996 SF 0.412, 0.059, 0.235 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 42.140903 XX SC alpha XX TO S. aureus (MRSA) XX XR PubMed: 30136030 XR CAMP R4: CAMPSQ16715 SQ SEQUENCE 1994.584 DA MW 17AA FLKKAKKFGK AFVKILK // ID AMRSAP680 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 1, 'K': 8, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.76%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 47.06%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO G, I, V BA 9 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 1975.582 AI 97.647 II -0.929 HP -0.359 HM 0.789 IP 11.646 NC 7.996 SF 0.353, 0.059, 0.235 [Helix, Turn, Sheet] AR 0.118 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA (MIC > 512 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: CAMPSQ16716 SQ SEQUENCE 1975.582 DA MW 17AA LKKAKKFGKA FVKILKK // ID AMRSAP681 PN IB-200 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16824 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP682 PN IB-247 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16825 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP683 PN IB-367 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 0%, 'Y': 5.88% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G; R LO F, L, Y BA 8 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1905.305 AI 57.059 II -7.182 HP 0.241 HM 0.298 IP 9.077 NC 3.749 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16826 SQ SEQUENCE 1905.305 DA MW 17AA RGGLCYCRGR FCVCVGR // ID AMRSAP684 PN IB-370 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 5.56%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA D, E, H, I, K, M, N, P, Q, S, T, W MO R LO A, F, Y BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2131.627 AI 81.111 II 26.744 HP 0.333 HM 0.61 IP 9.716 NC 4.749 SF 0.333, 0.111, 0.167 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 30.100645 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16827 SQ SEQUENCE 2131.627 DA MW 18AA RLLRACYCRG RFCVCVGR // ID AMRSAP685 PN IB-226 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 22.22%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 11.11%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, Q, S, W MO G; R LO F, L, P, Y BA 9 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1998.355 AI 53.889 II 11.328 HP -0.217 HM 0.314 IP 10.999 NC 3.873 SF 0.278, 0.278, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1615 MS 24.080516 XX SC beta XX TO MRSA (MIC = 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16828 SQ SEQUENCE 1998.355 DA MW 18AA RGGGLCYTRP RFTVCVGR // ID AMRSAP686 PN IB-356 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 5, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 27.78%, 'H': 0%, 'I': 0%, 'K': 11.11%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 5.56%, 'Y': 5.56% MA A, D, E, H, I, L, M, N, P, Q, S, T MO G; R LO F, V, W, Y BA 8 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2142.536 AI 16.111 II -1.711 HP -1.25 HM 0.731 IP 11.971 NC 6.873 SF 0.222, 0.278, 0 [Helix, Turn, Sheet] AR 0.167 ME 6990, 7115 MS 42.140903 XX SC alpha XX TO MRSA (MIC = 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16829 SQ SEQUENCE 2142.536 DA MW 18AA RGWRGCYKRG RFKGCVGR // ID AMRSAP687 PN IB-786 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA C, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 11 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2032.388 AI 76.111 II 83.667 HP -0.406 HM 0.415 IP 12.802 NC 5.997 SF 0.278, 0.167, 0.278 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1490 MS 36.120774 XX SC beta XX TO MRSA (MIC >= 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16830 SQ SEQUENCE 2032.388 DA MW 18AA RGGRLAYARR RFAVAVGR // ID AMRSAP688 PN IB-573 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 3, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 16.67%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, G, H, I, K, M, N, P, Q, S, W MO R LO F, L, Y BA 4 LA 14 AA 0 BC 6 MC 0 MF 0 XX MM 2292.788 AI 53.889 II 59.994 HP -0.3 HM 0.412 IP 10.916 NC 5.749 SF 0.278, 0, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC alpha XX TO MRSA (MIC = 2 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16831 SQ SEQUENCE 2292.788 DA MW 18AA RTTRLCYCRR RFCVCVTR // ID AMRSAP689 PN IB-416 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC >= 32 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16832 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP690 PN IB-235 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA A, D, E, G, H, I, K, M, N, P, Q, S, T, W MO C LO F, L, Y BA 4 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 1520.91 AI 80.833 II 92.067 HP 0.85 HM 0.252 IP 8.683 NC 2.749 SF 0.417, 0, 0.083 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1740 MS 18.060387 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16833 SQ SEQUENCE 1520.91 DA MW 12AA LCYCRRRFCV CV // ID AMRSAP691 PN IB-315 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 8.33%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA D, E, G, H, I, K, L, M, N, P, Q, S, T, W MO C LO A, F, Y BA 4 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 1478.83 AI 56.667 II 128.683 HP 0.683 HM 0.231 IP 8.683 NC 2.749 SF 0.333, 0, 0.083 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1740 MS 18.060387 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16834 SQ SEQUENCE 1478.83 DA MW 12AA ACYCRRRFCV CV // ID AMRSAP692 PN IB-469 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 20%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 0%, 'Y': 6.67% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C LO F, L, Y BA 7 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 1692.066 AI 64.667 II -12.04 HP 0.6 HM 0.298 IP 8.683 NC 2.749 SF 0.333, 0.2, 0.067 [Helix, Turn, Sheet] AR 0.133 ME 1490, 1740 MS 18.060387 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16835 SQ SEQUENCE 1692.066 DA MW 15AA GLCYCRGRFC VCVGR // ID AMRSAP693 PN IB-481 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 40%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 10%, 'Y': 10% MA A, D, E, G, H, I, K, M, N, P, Q, R, S, T MO C LO F, L, W, Y BA 5 LA 5 AA 0 BC 0 MC {'O': 3} MF {'O': 0.23076923076923078} XX MM 1950.466 AI 74.615 II 7.123 HP 1.754 HM 0.118 IP 5.707 NC -0.251 SF 0.462, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 0 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16836 SQ SEQUENCE 1950.466 DA MW 13AA WLCYCOOOFC VCV // ID AMRSAP694 PN IB-504 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 36.36%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 9.09%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 18.18%, 'W': 9.09%, 'Y': 9.09% MA A, D, E, G, H, I, M, N, P, Q, R, S, T MO C LO F, K, L, W, Y BA 5 LA 6 AA 0 BC 1 MC {'O': 3} MF {'O': 0.21428571428571427} XX MM 2078.64 AI 69.286 II 7.329 HP 1.35 HM 0.333 IP 7.913 NC 0.749 SF 0.429, 0, 0.071 [Helix, Turn, Sheet] AR 0.214 ME 6990, 7240 MS 6.020129 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16837 SQ SEQUENCE 2078.64 DA MW 14AA KWLCYCOOOF CVCV // ID AMRSAP695 PN IB-506 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 40%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 10%, 'Y': 10% MA A, D, E, G, H, I, K, M, N, P, Q, R, S, T MO C; O LO F, L, W, Y, Z BA 5 LA 5 AA 0 BC 0 MC {'O': 4, 'Z': 1} MF {'O': 0.26666666666666666, 'Z': 0.06666666666666667} XX MM 2187.768 AI 64.667 II -0.72 HP 1.52 HM 0.12 IP 5.707 NC -0.251 SF 0.4, 0, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 0 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16838 SQ SEQUENCE 2187.768 DA MW 15AA WOLCYCOZOF CVCVO // ID AMRSAP696 PN IB-482 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 40%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 10%, 'Y': 10% MA A, D, E, G, H, I, K, M, N, P, Q, R, S, T MO C LO F, L, W, Y BA 5 LA 5 AA 0 BC 0 MC {'X': 3} MF {'X': 0.23076923076923078} XX MM 1238.561 AI 74.615 II 7.123 HP 1.754 HM 0.118 IP 5.707 NC -0.251 SF 0.462, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 0 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16839 SQ SEQUENCE 1238.561 DA MW 13AA WLCYCXXXFC VCV // ID AMRSAP697 PN IB-510 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 30.77%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 15.38%, 'W': 7.69%, 'Y': 7.69% MA A, D, E, G, H, I, M, N, P, Q, R, S, T MO C LO F, L, W, Y BA 5 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 1623.083 AI 74.615 II 7.123 HP 0.854 HM 0.206 IP 8.675 NC 2.748 SF 0.462, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 18.060387 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16840 SQ SEQUENCE 1623.083 DA MW 13AA WLCYCKKKFC VCV // ID AMRSAP698 PN IB-565 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 30.77%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 7.69%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 7.69%, 'Y': 7.69% MA A, D, E, G, I, K, M, N, P, Q, S, T MO C LO F, H, L, V, W, Y BA 4 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1745.132 AI 52.308 II 126.123 HP 0.146 HM 0.376 IP 8.685 NC 2.84 SF 0.385, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 18.060387 XX SC beta XX TO MRSA (MIC = 8 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16841 SQ SEQUENCE 1745.132 DA MW 13AA WLCYCRRRFC HCV // ID AMRSAP699 PN IB-566 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 30.77%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 7.69%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 7.69%, 'Y': 7.69% MA A, D, E, G, I, K, M, N, P, Q, S, T MO C LO F, H, L, V, W, Y BA 4 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1745.132 AI 52.308 II 126.123 HP 0.146 HM 0.267 IP 8.685 NC 2.84 SF 0.385, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 18.060387 XX SC beta XX TO MRSA (MIC = 32 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16842 SQ SEQUENCE 1745.132 DA MW 13AA WLCYCRRRFC VCH // ID AMRSAP700 PN IB-570 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 30.77%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 7.69%, 'P': 0%, 'Q': 0%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 7.69%, 'Y': 7.69% MA A, D, E, G, H, I, K, M, P, Q, S, T MO C LO F, L, N, V, W, Y BA 4 LA 9 AA 0 BC 3 MC 0 MF 0 XX MM 1722.095 AI 52.308 II 98.831 HP 0.123 HM 0.407 IP 8.683 NC 2.749 SF 0.385, 0.077, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 18.060387 XX SC beta XX TO MRSA (MIC = 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16843 SQ SEQUENCE 1722.095 DA MW 13AA WLCYCRRRFC NCV // ID AMRSAP701 PN IB-200 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16844 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP702 PN IB-367 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 0%, 'Y': 5.88% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G; R LO F, L, Y BA 8 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1905.305 AI 57.059 II -7.182 HP 0.241 HM 0.298 IP 9.077 NC 3.749 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16845 SQ SEQUENCE 1905.305 DA MW 17AA RGGLCYCRGR FCVCVGR // ID AMRSAP703 PN IB-625 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 0%, 'Y': 5.88% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G; R LO F, L, Y BA 8 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1905.305 AI 57.059 II -7.182 HP 0.241 HM 0.298 IP 9.077 NC 3.749 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 2 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16846 SQ SEQUENCE 1905.305 DA MW 17AA RGGLCYCRGR FCVCVGR // ID AMRSAP704 PN IB-699 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 25%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA A, D, E, H, I, K, M, N, P, Q, R, S, T, W MO O LO F, L, Y BA 7 LA 5 AA 0 BC 0 MC {'O': 6} MF {'O': 0.3333333333333333} XX MM 2647.314 AI 53.889 II 3.206 HP 1.25 HM 0.166 IP 5.707 NC -0.251 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 0 XX SC beta XX TO MRSA (MIC = 8 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16847 SQ SEQUENCE 2647.314 DA MW 18AA OGGOLCYCOO OFCVCVGO // ID AMRSAP705 PN IB-739 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 25%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA A, D, E, H, I, K, M, N, P, Q, R, S, T, W MO O LO F, L, Y BA 7 LA 5 AA 0 BC 0 MC {'O': 6} MF {'O': 0.3333333333333333} XX MM 2647.314 AI 53.889 II 3.206 HP 1.25 HM 0.166 IP 5.707 NC -0.251 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 0 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16848 SQ SEQUENCE 2647.314 DA MW 18AA OGGOLCYCOO OFCVCVGO // ID AMRSAP706 PN IB-481 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 40%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 10%, 'Y': 10% MA A, D, E, G, H, I, K, M, N, P, Q, R, S, T MO C LO F, L, W, Y BA 5 LA 5 AA 0 BC 0 MC {'O': 3} MF {'O': 0.23076923076923078} XX MM 1950.466 AI 74.615 II 7.123 HP 1.754 HM 0.118 IP 5.707 NC -0.251 SF 0.462, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 0 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16849 SQ SEQUENCE 1950.466 DA MW 13AA WLCYCOOOFC VCV // ID AMRSAP707 PN IB-513 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 40%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 10%, 'Y': 10% MA A, D, E, G, H, I, K, M, N, P, Q, R, S, T MO C LO F, L, W, Y BA 5 LA 5 AA 0 BC 0 MC {'O': 3} MF {'O': 0.23076923076923078} XX MM 1950.466 AI 74.615 II 7.123 HP 1.754 HM 0.118 IP 5.707 NC -0.251 SF 0.462, 0, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 6990, 7240 MS 0 XX SC beta XX TO MRSA (MIC = 0.25 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16850 SQ SEQUENCE 1950.466 DA MW 13AA WLCYCOOOFC VCV // ID AMRSAP708 PN IB-200 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16851 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP709 PN IB-445 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16852 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP710 PN IB-542 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 26.67%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 6.67% MA A, D, E, H, I, K, M, N, P, Q, S, T MO C; R LO F, G, L, W, Y BA 6 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1920.363 AI 64.667 II 78.22 HP 0.293 HM 0.393 IP 9.077 NC 3.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC = 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16853 SQ SEQUENCE 1920.363 DA MW 15AA WLCYCRRRFC VCVGR // ID AMRSAP711 PN IB-543 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 26.67%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 6.67% MA A, D, E, H, I, K, M, N, P, Q, S, T MO C; R LO F, G, L, W, Y BA 6 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1920.363 AI 64.667 II 78.22 HP 0.293 HM 0.393 IP 9.077 NC 3.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC = 2 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16854 SQ SEQUENCE 1920.363 DA MW 15AA WLCYCRRRFC VCVGR // ID AMRSAP712 PN IB-536 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 8.33%, 'Y': 8.33% MA A, D, E, G, H, I, K, M, N, Q, S, T MO C LO F, L, P, R, W, Y BA 6 LA 6 AA 0 BC 1 MC {'O': 3} MF {'O': 0.2} XX MM 2203.77 AI 64.667 II -0.72 HP 1.113 HM 0.304 IP 7.913 NC 0.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 6.020129 XX SC beta XX TO MRSA (MIC = 8 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16855 SQ SEQUENCE 2203.77 DA MW 15AA WOLCYCOPOF CVCVR // ID AMRSAP713 PN IB-537 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 8.33%, 'Y': 8.33% MA A, D, E, G, H, I, K, M, N, Q, S, T MO C LO F, L, P, R, W, Y BA 6 LA 6 AA 0 BC 1 MC {'O': 3} MF {'O': 0.2} XX MM 2203.77 AI 64.667 II -0.72 HP 1.113 HM 0.304 IP 7.913 NC 0.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 6.020129 XX SC beta XX TO MRSA (MIC = 4 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16856 SQ SEQUENCE 2203.77 DA MW 15AA WOLCYCOPOF CVCVR // ID AMRSAP714 PN IB-538 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 28.57%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 14.29%, 'W': 0%, 'Y': 7.14% MA A, D, E, G, H, I, K, M, N, P, Q, S, T, W MO C; R LO L, Y BA 5 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1824.274 AI 69.286 II 66.943 HP 0.607 HM 0.602 IP 9.077 NC 3.749 SF 0.429, 0, 0.071 [Helix, Turn, Sheet] AR 0.214 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 2 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16857 SQ SEQUENCE 1824.274 DA MW 14AA RFCYCLRRFC VCVR // ID AMRSAP715 PN IB-539 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 28.57%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 14.29%, 'W': 0%, 'Y': 7.14% MA A, D, E, G, H, I, K, M, N, P, Q, S, T, W MO C; R LO L, Y BA 5 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1824.274 AI 69.286 II 66.943 HP 0.607 HM 0.602 IP 9.077 NC 3.749 SF 0.429, 0, 0.071 [Helix, Turn, Sheet] AR 0.214 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16858 SQ SEQUENCE 1824.274 DA MW 14AA RFCYCLRRFC VCVR // ID AMRSAP716 PN IB-413 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 26.67%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 6.67% MA A, D, E, H, I, K, M, N, P, Q, S, T MO C; R LO F, G, L, W, Y BA 6 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1920.363 AI 64.667 II 78.22 HP 0.293 HM 0.393 IP 9.077 NC 3.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC = 13.3 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16859 SQ SEQUENCE 1920.363 DA MW 15AA WLCYCRRRFC VCVGR // ID AMRSAP717 PN IB-421 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 6.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 26.67%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 6.67% MA A, D, E, H, I, K, M, N, P, Q, S, T MO C; R LO F, G, L, W, Y BA 6 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1920.363 AI 64.667 II 78.22 HP 0.293 HM 0.393 IP 9.077 NC 3.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16860 SQ SEQUENCE 1920.363 DA MW 15AA WLCYCRRRFC VCVGR // ID AMRSAP718 PN IB-200 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16861 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP719 PN IB-367 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 0%, 'Y': 5.88% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G; R LO F, L, Y BA 8 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1905.305 AI 57.059 II -7.182 HP 0.241 HM 0.298 IP 9.077 NC 3.749 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 0.5 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16862 SQ SEQUENCE 1905.305 DA MW 17AA RGGLCYCRGR FCVCVGR // ID AMRSAP720 PN IB-549 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 6, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, M, N, P, Q, R, S, T, W MO K LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 1992.548 AI 53.889 II -15.661 HP -0.05 HM 0.272 IP 9.959 NC 5.747 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO MRSA (MIC = 32 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16863 SQ SEQUENCE 1992.548 DA MW 18AA KGGKLCYCKK KFCVCVGK // ID AMRSAP721 PN IB-699 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 25%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA A, D, E, H, I, K, M, N, P, Q, R, S, T, W MO O LO F, L, Y BA 7 LA 5 AA 0 BC 0 MC {'O': 6} MF {'O': 0.3333333333333333} XX MM 2647.314 AI 53.889 II 3.206 HP 1.25 HM 0.166 IP 5.707 NC -0.251 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 0 XX SC beta XX TO MRSA (MIC = 8 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16864 SQ SEQUENCE 2647.314 DA MW 18AA OGGOLCYCOO OFCVCVGO // ID AMRSAP722 PN IB-766 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 1, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 30.77%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 23.08%, 'H': 7.69%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 15.38%, 'V': 7.69%, 'W': 0%, 'Y': 7.69% MA A, D, E, I, K, L, M, N, P, Q, R, S, W MO O LO F, H, V, Y BA 5 LA 8 AA 0 BC 1 MC {'O': 5} MF {'O': 0.2777777777777778} XX MM 2537.072 AI 16.111 II 25.506 HP 0.55 HM 0.08 IP 7.121 NC -0.16 SF 0.167, 0.167, 0 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 0 XX SC beta XX TO MRSA (MIC >= 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16865 SQ SEQUENCE 2537.072 DA MW 18AA OGGOHCYCOT OFCVCTGO // ID AMRSAP723 PN IB-235 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA A, D, E, G, H, I, K, M, N, P, Q, S, T, W MO C LO F, L, Y BA 4 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 1520.91 AI 80.833 II 92.067 HP 0.85 HM 0.252 IP 8.683 NC 2.749 SF 0.417, 0, 0.083 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1740 MS 18.060387 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16866 SQ SEQUENCE 1520.91 DA MW 12AA LCYCRRRFCV CV // ID AMRSAP724 PN IB-241 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 8.33% MA A, D, E, G, H, I, K, M, N, Q, S, T, W MO C LO F, L, P, Y BA 5 LA 7 AA 0 BC 2 MC 0 MF 0 XX MM 1461.839 AI 80.833 II 6.367 HP 1.092 HM 0.055 IP 8.337 NC 1.749 SF 0.417, 0.083, 0.083 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1740 MS 12.040258 XX SC alpha+beta XX TO MRSA (MIC = 13.3 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16867 SQ SEQUENCE 1461.839 DA MW 12AA LCYCRPRFCV CV // ID AMRSAP725 PN IB-485 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 13.33%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 6.67%, 'Q': 0%, 'R': 13.33%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 6.67% MA A, D, E, G, H, I, M, N, Q, S, T MO C LO F, L, P, W, Y BA 6 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1904.401 AI 64.667 II 12.12 HP 0.293 HM 0.217 IP 9.061 NC 3.749 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC = 1 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16868 SQ SEQUENCE 1904.401 DA MW 15AA KWRLCYCRPK FCVCV // ID AMRSAP726 PN IB-484 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 26.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 0%, 'H': 6.67%, 'I': 0%, 'K': 6.67%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 6.67%, 'Q': 0%, 'R': 13.33%, 'S': 0%, 'T': 0%, 'V': 13.33%, 'W': 6.67%, 'Y': 6.67% MA A, D, E, G, I, M, N, Q, S, T MO C LO F, H, K, L, P, W, Y BA 6 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1913.368 AI 64.667 II 10.2 HP 0.34 HM 0.217 IP 8.683 NC 2.84 SF 0.4, 0.067, 0.067 [Helix, Turn, Sheet] AR 0.2 ME 6990, 7240 MS 18.060387 XX SC beta XX TO MRSA (MIC = 2 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16869 SQ SEQUENCE 1913.368 DA MW 15AA HWRLCYCRPK FCVCV // ID AMRSAP727 PN IB-576 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 28.57%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 7.14%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 21.43%, 'S': 0%, 'T': 0%, 'V': 14.29%, 'W': 7.14%, 'Y': 7.14% MA A, D, E, G, H, I, M, N, P, Q, S, T MO C LO F, K, L, W, Y BA 5 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1835.297 AI 69.286 II 89.157 HP 0.386 HM 0.479 IP 9.068 NC 3.749 SF 0.429, 0, 0.071 [Helix, Turn, Sheet] AR 0.214 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC = 1.7 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16870 SQ SEQUENCE 1835.297 DA MW 14AA KWLCYCRRRF CVCV // ID AMRSAP728 PN IB-571 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 28.57%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 14.29%, 'W': 7.14%, 'Y': 7.14% MA A, D, E, G, H, I, K, M, N, P, Q, S, T MO C; R LO F, L, W, Y BA 5 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1863.311 AI 69.286 II 89.157 HP 0.343 HM 0.464 IP 9.077 NC 3.749 SF 0.429, 0, 0.071 [Helix, Turn, Sheet] AR 0.214 ME 6990, 7240 MS 24.080516 XX SC beta XX TO MRSA (MIC >= 32 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16871 SQ SEQUENCE 1863.311 DA MW 14AA WLCYCRRRFC VCVR // ID AMRSAP729 PN IB-733 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 0%, 'Y': 5.88% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G; R LO F, L, Y BA 8 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1905.305 AI 57.059 II -7.182 HP 0.241 HM 0.298 IP 9.077 NC 3.749 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA (MIC = 8 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16872 SQ SEQUENCE 1905.305 DA MW 17AA RGGLCYCRGR FCVCVGR // ID AMRSAP730 PN IB-736 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 25%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 25%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 6.25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 18.75%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 0%, 'Y': 6.25% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G LO F, L, Y BA 8 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 1749.118 AI 60.625 II -8.256 HP 0.538 HM 0.204 IP 8.683 NC 2.749 SF 0.313, 0.25, 0.063 [Helix, Turn, Sheet] AR 0.125 ME 1490, 1740 MS 18.060387 XX SC beta XX TO MRSA (MIC >= 16 μG/mL) XX XR PubMed: 10931444 XR CAMP R4: CAMPSQ16873 SQ SEQUENCE 1749.118 DA MW 16AA RGGLCYCRGR FCVCVG // ID AMRSAP731 PN HG1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 26.32%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, Q, R, S, T, Y MO L LO C, V, W BA 12 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2058.475 AI 133.684 II 4.526 HP 0.432 HM 0.421 IP 9.678 NC 2.117 SF 0.368, 0.211, 0.421 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 12.040258 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 4 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16874 SQ SEQUENCE 2058.475 DA MW 19AA KWLNALLHHG LNCAKGVLA // ID AMRSAP732 PN L3Q SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, R, S, T, Y MO L LO C, Q, V, W BA 11 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 2073.446 AI 113.158 II -1.968 HP 0.047 HM 0.421 IP 9.678 NC 2.117 SF 0.316, 0.211, 0.368 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 12.040258 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 4 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16875 SQ SEQUENCE 2073.446 DA MW 19AA KWQNALLHHG LNCAKGVLA // ID AMRSAP733 PN L6Q SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, R, S, T, Y MO L LO C, Q, V, W BA 11 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 2073.446 AI 113.158 II 4.526 HP 0.047 HM 0.421 IP 9.678 NC 2.117 SF 0.316, 0.211, 0.368 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 12.040258 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC > 64 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16876 SQ SEQUENCE 2073.446 DA MW 19AA KWLNAQLHHG LNCAKGVLA // ID AMRSAP734 PN L7Q SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, R, S, T, Y MO L LO C, Q, V, W BA 11 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 2073.446 AI 113.158 II 21.684 HP 0.047 HM 0.393 IP 9.678 NC 2.117 SF 0.316, 0.211, 0.368 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 12.040258 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 64 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16877 SQ SEQUENCE 2073.446 DA MW 19AA KWLNALQHHG LNCAKGVLA // ID AMRSAP735 PN L11Q SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, R, S, T, Y MO L LO C, Q, V, W BA 11 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 2073.446 AI 113.158 II 4.526 HP 0.047 HM 0.482 IP 9.678 NC 2.117 SF 0.316, 0.211, 0.368 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 12.040258 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 8 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16878 SQ SEQUENCE 2073.446 DA MW 19AA KWLNALLHHG QNCAKGVLA // ID AMRSAP736 PN L18Q SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 2, 'L': 4, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, R, S, T, Y MO L LO C, Q, V, W BA 11 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 2073.446 AI 113.158 II 4.526 HP 0.047 HM 0.421 IP 9.678 NC 2.117 SF 0.316, 0.211, 0.368 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 12.040258 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 16 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16879 SQ SEQUENCE 2073.446 DA MW 19AA KWLNALLHHG LNCAKGVQA // ID AMRSAP737 PN Hgn SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 2, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 10.53%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 15.79%, 'L': 21.05%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, R, S, T, Y MO L LO C, Q, V, W BA 10 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2130.542 AI 107.895 II -6.437 HP -0.253 HM 0.495 IP 10.513 NC 3.117 SF 0.316, 0.211, 0.316 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 18.060387 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 4 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16880 SQ SEQUENCE 2130.542 DA MW 19AA KWQNALLHHG LNCAKGVLK // ID AMRSAP738 PN MSI-78 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 3, 'H': 0, 'I': 2, 'K': 9, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 13.64%, 'H': 0%, 'I': 9.09%, 'K': 40.91%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.55%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO V BA 13 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2478.195 AI 93.182 II -6.164 HP -0.159 HM 0.789 IP 11.703 NC 8.995 SF 0.364, 0.136, 0.182 [Helix, Turn, Sheet] AR 0.136 ME 0, 0 MS 54.181161 XX SC alpha XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 8 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16881 SQ SEQUENCE 2478.195 DA MW 22AA GIGKFLKKAK KFGKAFVKIL KK // ID AMRSAP739 PN IB-367 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 0%, 'Y': 5.88% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO C; G; R LO F, L, Y BA 8 LA 9 AA 0 BC 4 MC 0 MF 0 XX MM 1905.305 AI 57.059 II -7.182 HP 0.241 HM 0.298 IP 9.077 NC 3.749 SF 0.294, 0.235, 0.059 [Helix, Turn, Sheet] AR 0.118 ME 1490, 1740 MS 24.080516 XX SC beta XX TO MRSA Staphylococcus aureus CCARM 3696 (MIC = 4 μG/mL) XX XR PubMed: 25445605 XR CAMP R4: CAMPSQ16882 SQ SEQUENCE 1905.305 DA MW 17AA RGGLCYCRGR FCVCVGR // ID AMRSAP740 PN Temporin-1CEh SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 13.33%, 'G': 0%, 'H': 0%, 'I': 20%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 13.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 6.67%, 'W': 0%, 'Y': 0% MA C, E, G, H, M, P, Q, R, T, W, Y MO I LO A, D, S, V BA 9 LA 6 AA 1 BC 2 MC 0 MF 0 XX MM 1735.099 AI 156 II 30.127 HP 0.907 HM 0.711 IP 9.537 NC 0.998 SF 0.533, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.133 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA NCTC 12493 (MIC = 16 μM TO MBC = 16 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16956 SQ SEQUENCE 1735.099 DA MW 15AA FVDLKKIANI LNSIF // ID AMRSAP741 PN T1CEh-t SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 0%, 'D': 9.09%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA C, E, G, H, M, P, Q, R, S, T, W, Y MO I; K; L LO A, D, F, N, V BA 7 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1273.581 AI 177.273 II 37.445 HP 0.964 HM 0.435 IP 9.537 NC 0.998 SF 0.545, 0.091, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA NCTC 12494 (MIC > 512 μM TO MBC > 512 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16957 SQ SEQUENCE 1273.581 DA MW 11AA FVDLKKIANI L // ID AMRSAP742 PN T1CEa-t SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 0%, 'D': 9.09%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 27.27%, 'K': 18.18%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA C, E, G, H, M, P, Q, R, S, T, W, Y MO I LO A, D, F, L, N, V BA 7 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1273.581 AI 177.273 II 19.936 HP 1.027 HM 0.464 IP 9.537 NC 0.998 SF 0.545, 0.091, 0.182 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA NCTC 12494 (MIC > 512 μM TO MBC > 512 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16958 SQ SEQUENCE 1273.581 DA MW 11AA FVDLKKIANI I // ID AMRSAP743 PN T1CEh-KK SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 7.69%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 15.38%, 'K': 30.77%, 'L': 15.38%, AF 'M': 0%, 'N': 7.69%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 0%, 'Y': 0% MA C, E, G, H, M, P, Q, R, S, T, W, Y MO K LO A, D, F, N, V BA 7 LA 6 AA 1 BC 4 MC 0 MF 0 XX MM 1529.93 AI 150 II 33.223 HP 0.215 HM 0.435 IP 10.803 NC 2.997 SF 0.462, 0.077, 0.231 [Helix, Turn, Sheet] AR 0.077 ME 0, 0 MS 24.080516 XX SC alpha+beta XX TO MRSA NCTC 12494 (MIC > 512 μM TO MBC > 512 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16959 SQ SEQUENCE 1529.93 DA MW 13AA KKFVDLKKIA NIL // ID AMRSAP744 PN T1CEh-KKP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 15.38%, 'K': 30.77%, 'L': 15.38%, AF 'M': 0%, 'N': 7.69%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, M, Q, R, S, T, W, Y MO K LO A, F, N, P, V BA 8 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1511.958 AI 150 II 59.6 HP 0.362 HM 0.458 IP 11.278 NC 3.997 SF 0.462, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.077 ME 0, 0 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12497 (MIC = 256 μM TO MBC = 256 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16960 SQ SEQUENCE 1511.958 DA MW 13AA KKFVPLKKIA NIL // ID AMRSAP745 PN T1CEh-KKPW SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 15.38%, 'K': 30.77%, 'L': 15.38%, AF 'M': 0%, 'N': 7.69%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 7.69%, 'Y': 0% MA C, D, E, F, G, H, M, Q, R, S, T, Y MO K LO A, N, P, V, W BA 8 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1550.994 AI 150 II 53.069 HP 0.077 HM 0.46 IP 11.278 NC 3.997 SF 0.462, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.077 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12498 (MIC = 16 μM TO MBC = 64 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16961 SQ SEQUENCE 1550.994 DA MW 13AA KKWVPLKKIA NIL // ID AMRSAP746 PN T1CEh-KKPWW SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 15.38%, 'K': 30.77%, 'L': 7.69%, AF 'M': 0%, 'N': 7.69%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 15.38%, 'Y': 0% MA C, D, E, F, G, H, M, Q, R, S, T, Y MO K LO A, L, N, P, V BA 8 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1624.048 AI 120 II 57.385 HP -0.285 HM 0.441 IP 11.278 NC 3.997 SF 0.462, 0.154, 0.154 [Helix, Turn, Sheet] AR 0.154 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12499 (MIC = 32 μM TO MBC = 256 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16962 SQ SEQUENCE 1624.048 DA MW 13AA KKWVPWKKIA NIL // ID AMRSAP747 PN T1CEh-KKPWW2 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 15.38%, 'K': 30.77%, 'L': 7.69%, AF 'M': 0%, 'N': 7.69%, 'P': 7.69%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 15.38%, 'Y': 0% MA C, D, E, F, G, H, M, Q, R, S, T, Y MO K LO A, L, N, P, V BA 8 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1624.048 AI 120 II 57.385 HP -0.285 HM 0.441 IP 11.278 NC 3.997 SF 0.462, 0.154, 0.154 [Helix, Turn, Sheet] AR 0.154 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO MRSA NCTC 12500 (MIC = 8 μM TO MBC = 16 μM) XX XR PubMed: 35335979 XR CAMP R4: CAMPSQ16963 SQ SEQUENCE 1624.048 DA MW 13AA KKWVPWK2KI ANIL // ID AMRSAP748 PN Tritrpticin SO Sus scrofa PL 13 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 15.38%, 'Q': 0%, 'R': 30.77%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, G, H, I, K, M, N, Q, S, T, Y MO R LO L, V BA 9 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1902.283 AI 52.308 II 139.585 HP -0.792 HM 0.471 IP 12.977 NC 3.998 SF 0.538, 0.154, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 2 (MRSA 2) (MIC = 64 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: CAMPSQ170 SQ SEQUENCE 1902.283 DA MW 13AA VRRFPWWWPF LRR // ID AMRSAP749 PN Tritrpticin SO Sus scrofa PL 13 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 15.38%, 'Q': 0%, 'R': 30.77%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, G, H, I, K, M, N, Q, S, T, Y MO R LO L, V BA 9 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1902.283 AI 52.308 II 139.585 HP -0.792 HM 0.471 IP 12.977 NC 3.998 SF 0.538, 0.154, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 1 (MRSA 1) (MIC = 32 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: CAMPSQ170 SQ SEQUENCE 1902.283 DA MW 13AA VRRFPWWWPF LRR // ID AMRSAP750 PN N-terminal loop deleted Tenecin 1 SO Synthetic construct PL 27 TX Synthetic construct PE Predicted XX AC 'A': 4, 'C': 5, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 14.81%, 'C': 18.52%, 'D': 3.7%, 'E': 0%, 'F': 3.7%, 'G': 14.81%, 'H': 3.7%, 'I': 0%, 'K': 3.7%, 'L': 3.7%, AF 'M': 0%, 'N': 3.7%, 'P': 0%, 'Q': 0%, 'R': 14.81%, 'S': 3.7%, 'T': 0%, 'V': 7.41%, 'W': 0%, 'Y': 3.7% MA E, I, M, P, Q, T, W MO C LO D, F, H, K, L, N, S, Y BA 12 LA 15 AA 1 BC 6 MC 0 MF 0 XX MM 2874.345 AI 50.741 II 45.019 HP -0.041 HM 0.483 IP 8.801 NC 3.778 SF 0.185, 0.222, 0.185 [Helix, Turn, Sheet] AR 0.074 ME 1490, 1740 MS 30.100645 XX SC beta XX TO MRSA (Methicillin resistant S. aureus) (MIC > 100 μG/mL) XX XR PubMed: 9849873 XR CAMP R4: CAMPSQ17294 SQ SEQUENCE 2874.345 DA MW 27AA DAACAAHCLF RGRSGGYCNG KRVCVCR // ID AMRSAP751 PN HG34 SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 4, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 21.05%, 'L': 21.05%, AF 'M': 0%, 'N': 5.26%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, Q, R, S, T, Y MO K; L LO C, N, V, W BA 22 LA 16 AA 0 BC 12 MC 0 MF 0 XX MM 4157.105 AI 113.158 II -1.705 HP 0.005 HM 0.459 IP 11.024 NC 8.235 SF 0.316, 0.158, 0.368 [Helix, Turn, Sheet] AR 0.053 ME 11000, 11125 MS 48.161032 XX SC beta XX TO S. aureus strain CCARM 3696 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 20385874 XR CAMP R4: CAMPSQ17296 SQ SEQUENCE 4157.105 DA MW 38AA KWKKALLHHG LNCAKGVLAK WKKALLHHGL NCAKGVLA // ID AMRSAP752 PN PR-39 SO pig PL 39 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 4, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 19, 'Q': 0, 'R': 10, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 2.56%, 'F': 10.26%, 'G': 2.56%, 'H': 0%, 'I': 2.56%, 'K': 0%, 'L': 5.13%, AF 'M': 0%, 'N': 0%, 'P': 48.72%, 'Q': 0%, 'R': 25.64%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 2.56% MA A, C, D, H, K, M, N, Q, S, T, V, W MO P LO E, G, I, Y BA 27 LA 12 AA 1 BC 10 MC 0 MF 0 XX MM 4702.636 AI 30 II 118.677 HP -1.469 HM 0.622 IP 12.868 NC 8.999 SF 0.205, 0.513, 0.077 [Helix, Turn, Sheet] AR 0.128 ME 1490, 1490 MS 60.20129 XX SC alpha+beta XX TO MRSA (MIC > 40) XX XR PubMed: 24755622 XR CAMP R4: CAMPSQ17731 SQ SEQUENCE 4702.636 DA MW 39AA RRRPRPPYLP RPRPPPFFPP RLPPRIPPGF PPRFPPREP // ID AMRSAP753 PN Arenicin-3 SO Arenicola marina PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 3 AF 'A': 0%, 'C': 20%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 10%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 0%, 'V': 15%, 'W': 5%, 'Y': 15% MA A, D, E, H, I, K, L, M, P, Q, S, T MO C; R LO F, W BA 7 LA 13 AA 0 BC 4 MC 0 MF 0 XX MM 2517.947 AI 43.5 II 31.725 HP -0.26 HM 0.74 IP 9.009 NC 3.748 SF 0.4, 0.2, 0 [Helix, Turn, Sheet] AR 0.25 ME 9970, 10220 MS 24.080516 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC = 64 μGram/mL) XX XR PubMed: 27331141 XR CAMP R4: CAMPSQ17739 SQ SEQUENCE 2517.947 DA MW 20AA GFCWYVCYRN GVRVCYRRCN // ID AMRSAP754 PN Tachyplesin-1 SO Tachypleus tridentatus PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA A, D, E, H, L, M, N, P, Q, S, T MO R LO F, G, I, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2268.768 AI 40 II 13.224 HP -0.518 HM 0.652 IP 10.068 NC 5.748 SF 0.353, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC = 1 μGram/mL) XX XR PubMed: 27331141 XR CAMP R4: CAMPSQ17740 SQ SEQUENCE 2268.768 DA MW 17AA KWCFRVCYRG ICYRRCR // ID AMRSAP755 PN Polyphemusin-1 SO Limulus Polyphemus PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 5.56%, 'W': 5.56%, 'Y': 11.11% MA A, D, E, H, I, L, M, N, P, Q, S, T MO R LO G, K, V, W BA 5 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 2458.972 AI 16.111 II 49.583 HP -0.833 HM 0.707 IP 10.637 NC 6.748 SF 0.333, 0.056, 0 [Helix, Turn, Sheet] AR 0.278 ME 8480, 8730 MS 42.140903 XX SC alpha XX TO S. aureus ATCC 43300 (MRSA) (MIC = 2 μGram/mL) XX XR PubMed: 27331141 XR CAMP R4: CAMPSQ17741 SQ SEQUENCE 2458.972 DA MW 18AA RRWCFRVCYR GFCYRKCR // ID AMRSAP756 PN Gomesin SO Acanthoscurria gomesiana PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 5.88%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 0%, 'Y': 11.76% MA A, D, E, F, H, I, M, N, P, S, W MO R LO G, K, L, Q, T, V, Z BA 3 LA 14 AA 0 BC 6 MC {'Z': 1} MF {'Z': 0.05555555555555555} XX MM 2164.614 AI 37.778 II 40.8 HP -0.867 HM 0.47 IP 10.068 NC 5.748 SF 0.222, 0.056, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 2980, 3230 MS 36.120774 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC = 128 μGram/mL) XX XR PubMed: 27331141 XR CAMP R4: CAMPSQ17742 SQ SEQUENCE 2164.614 DA MW 18AA ZCRRLCYKQR CVTYCRGR // ID AMRSAP757 PN Protegrin-1 SO Porcine neutrophils PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 16.67%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 5.56% MA A, D, E, H, I, K, M, N, P, Q, S, T, W MO R LO F, L, Y BA 7 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2160.628 AI 53.889 II 62.133 HP -0.25 HM 0.393 IP 10.916 NC 5.749 SF 0.278, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1740 MS 36.120774 XX SC beta XX TO S. aureus ATCC 43300 (MRSA) (MIC = 4 μGram/mL) XX XR PubMed: 27331141 XR CAMP R4: CAMPSQ17743 SQ SEQUENCE 2160.628 DA MW 18AA RGGRLCYCRR RFCVCVGR // ID AMRSAP758 PN Thanatin SO Podisus maculiventris PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 0, AC 'M': 1, 'N': 1, 'P': 2, 'Q': 1, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 9.52%, 'H': 0%, 'I': 9.52%, 'K': 14.29%, 'L': 0%, AF 'M': 4.76%, 'N': 4.76%, 'P': 9.52%, 'Q': 4.76%, 'R': 14.29%, 'S': 4.76%, 'T': 4.76%, 'V': 4.76%, 'W': 0%, 'Y': 4.76% MA A, D, E, F, H, L, W MO K; R LO M, N, Q, S, T, V, Y BA 8 LA 13 AA 0 BC 6 MC 0 MF 0 XX MM 2435.953 AI 50.952 II 39.876 HP -0.9 HM 0.49 IP 11.093 NC 5.872 SF 0.19, 0.286, 0.048 [Helix, Turn, Sheet] AR 0.048 ME 1490, 1615 MS 36.120774 XX SC alpha+beta XX TO S. aureus ATCC 43300 (MRSA) (MIC = 256 μGram/mL) XX XR PubMed: 27331141 XR CAMP R4: CAMPSQ17744 SQ SEQUENCE 2435.953 DA MW 21AA GSKKPVPIIY CNRRTGKCQR M // ID AMRSAP759 PN PA 1 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17745 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP760 PN PA 1 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17745 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP761 PN PA 1 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17745 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP762 PN PA 2 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17746 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP763 PN PA 2 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = ne μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17746 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP764 PN PA 2 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17746 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP765 PN PA 3 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17747 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP766 PN PA 3 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = ne μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17747 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP767 PN PA 3 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 2 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17747 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP768 PN PA 4 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17748 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP769 PN PA 4 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17748 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP770 PN PA 4 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 1 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17748 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP771 PN PA 5 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17749 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP772 PN PA 5 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17749 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP773 PN PA 5 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 1 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17749 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP774 PN PA 6 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17750 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP775 PN PA 6 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17750 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP776 PN PA 6 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 658.886 AI 0 II 8 HP -3.9 HM 0.368 IP 11.403 NC 4.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17750 SQ SEQUENCE 658.886 DA MW 5AA KKKKK // ID AMRSAP777 PN PA 7 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17751 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP778 PN PA 7 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17751 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP779 PN PA 7 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 1 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17751 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP780 PN PA 8 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17752 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP781 PN PA 8 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17752 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP782 PN PA 8 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17752 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP783 PN PA 9 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17753 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP784 PN PA 9 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17753 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP785 PN PA 9 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17753 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP786 PN PA 10 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17754 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP787 PN PA 10 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17754 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP788 PN PA 10 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 787.06 AI 0 II 8.333 HP -3.9 HM 0.283 IP 11.5 NC 5.996 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17754 SQ SEQUENCE 787.06 DA MW 6AA KKKKKK // ID AMRSAP789 PN PA 11 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17755 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP790 PN PA 11 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17755 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP791 PN PA 11 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 1 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17755 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP792 PN PA 12 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 100%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO R LO R BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 798.953 AI 0 II 466.24 HP -4.5 HM 0.621 IP 13.102 NC 4.998 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17756 SQ SEQUENCE 798.953 DA MW 5AA RRRRR // ID AMRSAP793 PN PA 12 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 100%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO R LO R BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 798.953 AI 0 II 466.24 HP -4.5 HM 0.621 IP 13.102 NC 4.998 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17756 SQ SEQUENCE 798.953 DA MW 5AA RRRRR // ID AMRSAP794 PN PA 12 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 100%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO R LO R BA 0 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 798.953 AI 0 II 466.24 HP -4.5 HM 0.621 IP 13.102 NC 4.998 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17756 SQ SEQUENCE 798.953 DA MW 5AA RRRRR // ID AMRSAP795 PN PA 13 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 44.44%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 55.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO F BA 4 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1247.592 AI 0 II -7.811 HP -0.922 HM 0.213 IP 11.403 NC 4.997 SF 0.444, 0, 0 [Helix, Turn, Sheet] AR 0.444 ME 0, 0 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus�JE2 MRSA (MIC = 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17757 SQ SEQUENCE 1247.592 DA MW 9AA FFFFKKKKK // ID AMRSAP796 PN PA 13 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 44.44%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 55.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO F BA 4 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1247.592 AI 0 II -7.811 HP -0.922 HM 0.213 IP 11.403 NC 4.997 SF 0.444, 0, 0 [Helix, Turn, Sheet] AR 0.444 ME 0, 0 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus�LAC MRSA (MIC = 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17757 SQ SEQUENCE 1247.592 DA MW 9AA FFFFKKKKK // ID AMRSAP797 PN PA 13 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 44.44%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 55.56%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO F BA 4 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1247.592 AI 0 II -7.811 HP -0.922 HM 0.213 IP 11.403 NC 4.997 SF 0.444, 0, 0 [Helix, Turn, Sheet] AR 0.444 ME 0, 0 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 1 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17757 SQ SEQUENCE 1247.592 DA MW 9AA FFFFKKKKK // ID AMRSAP798 PN PA 14 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 50%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO F; K LO F, K BA 3 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 844.067 AI 0 II -16.717 HP -0.55 HM 0.149 IP 11.103 NC 2.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 0, 0 MS 18.060387 XX SC alpha XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17758 SQ SEQUENCE 844.067 DA MW 6AA FFFKKK // ID AMRSAP799 PN PA 14 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 50%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO F; K LO F, K BA 3 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 844.067 AI 0 II -16.717 HP -0.55 HM 0.149 IP 11.103 NC 2.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 0, 0 MS 18.060387 XX SC alpha XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17758 SQ SEQUENCE 844.067 DA MW 6AA FFFKKK // ID AMRSAP800 PN PA 14 SO Synthetic construct PL 6 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 50%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO F; K LO F, K BA 3 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 844.067 AI 0 II -16.717 HP -0.55 HM 0.149 IP 11.103 NC 2.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 0, 0 MS 18.060387 XX SC alpha XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17758 SQ SEQUENCE 844.067 DA MW 6AA FFFKKK // ID AMRSAP801 PN PA 15 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 62.5%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO K LO V BA 3 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 956.284 AI 108.75 II 5.15 HP -0.863 HM 0.303 IP 11.403 NC 4.997 SF 0.375, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17759 SQ SEQUENCE 956.284 DA MW 8AA VVVKKKKK // ID AMRSAP802 PN PA 15 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 62.5%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO K LO V BA 3 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 956.284 AI 108.75 II 5.15 HP -0.863 HM 0.303 IP 11.403 NC 4.997 SF 0.375, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17759 SQ SEQUENCE 956.284 DA MW 8AA VVVKKKKK // ID AMRSAP803 PN PA 15 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 62.5%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 37.5%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO K LO V BA 3 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 956.284 AI 108.75 II 5.15 HP -0.863 HM 0.303 IP 11.403 NC 4.997 SF 0.375, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 30.100645 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 16 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17759 SQ SEQUENCE 956.284 DA MW 8AA VVVKKKKK // ID AMRSAP804 PN PA 16 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 50%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO K; V LO K, V BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 927.242 AI 145 II -37.488 HP 0.15 HM 0.163 IP 11.278 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17760 SQ SEQUENCE 927.242 DA MW 8AA VKVKVKVK // ID AMRSAP805 PN PA 16 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 50%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO K; V LO K, V BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 927.242 AI 145 II -37.488 HP 0.15 HM 0.163 IP 11.278 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17760 SQ SEQUENCE 927.242 DA MW 8AA VKVKVKVK // ID AMRSAP806 PN PA 16 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 50%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO K; V LO K, V BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 927.242 AI 145 II -37.488 HP 0.15 HM 0.163 IP 11.278 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17760 SQ SEQUENCE 927.242 DA MW 8AA VKVKVKVK // ID AMRSAP807 PN PA 17 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 33.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO A; K; V LO A, K, V BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 913.172 AI 130 II 8.889 HP 0.7 HM 0.165 IP 11.103 NC 2.997 SF 0.333, 0, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17761 SQ SEQUENCE 913.172 DA MW 9AA VVVAAAKKK // ID AMRSAP808 PN PA 17 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 33.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO A; K; V LO A, K, V BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 913.172 AI 130 II 8.889 HP 0.7 HM 0.165 IP 11.103 NC 2.997 SF 0.333, 0, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO Staphylococcus aureus�LAC MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17761 SQ SEQUENCE 913.172 DA MW 9AA VVVAAAKKK // ID AMRSAP809 PN PA 17 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 33.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, W, Y MO A; K; V LO A, K, V BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 913.172 AI 130 II 8.889 HP 0.7 HM 0.165 IP 11.103 NC 2.997 SF 0.333, 0, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC > 32 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17761 SQ SEQUENCE 913.172 DA MW 9AA VVVAAAKKK // ID AMRSAP810 PN PA 18 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 402.538 AI 0 II 6.667 HP -3.9 HM 0.326 IP 11.103 NC 2.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC alpha+beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17762 SQ SEQUENCE 402.538 DA MW 3AA KKK // ID AMRSAP811 PN PA 18 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 402.538 AI 0 II 6.667 HP -3.9 HM 0.326 IP 11.103 NC 2.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC alpha+beta XX TO Staphylococcus aureus�LAC MRSA (MIC = 8 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17762 SQ SEQUENCE 402.538 DA MW 3AA KKK // ID AMRSAP812 PN PA 18 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 402.538 AI 0 II 6.667 HP -3.9 HM 0.326 IP 11.103 NC 2.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC alpha+beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 2 μGram/mL) XX XR PubMed: 30588791 XR CAMP R4: CAMPSQ17762 SQ SEQUENCE 402.538 DA MW 3AA KKK // ID AMRSAP813 PN USCL-K1 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 530.712 AI 0 II 7.5 HP -3.9 HM 0.167 IP 11.278 NC 3.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC alpha+beta XX TO MRSA ATCC 33592 (MIC = 16 [512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17772 SQ SEQUENCE 530.712 DA MW 4AA KKKK // ID AMRSAP814 PN USCL-Dab1 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO B LO B BA 0 LA 0 AA 0 BC 0 MC {'B': 4} MF {'B': 1.0} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 8 [512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17773 SQ SEQUENCE 18.015 DA MW 4AA BBBB // ID AMRSAP815 PN USCL-PCat1 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO X LO X BA 0 LA 0 AA 0 BC 0 MC {'X': 4} MF {'X': 1.0} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 32 [512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17774 SQ SEQUENCE 18.015 DA MW 4AA XXXX // ID AMRSAP816 PN USCL-K2 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 100%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO K LO K BA 0 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 530.712 AI 0 II 7.5 HP -3.9 HM 0.167 IP 11.278 NC 3.997 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC alpha+beta XX TO MRSA ATCC 33592 (MIC = 128 [512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17775 SQ SEQUENCE 530.712 DA MW 4AA KKKK // ID AMRSAP817 PN USCL-Dab2 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO B LO B BA 0 LA 0 AA 0 BC 0 MC {'B': 4} MF {'B': 1.0} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 64 [512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17776 SQ SEQUENCE 18.015 DA MW 4AA BBBB // ID AMRSAP818 PN USCL-PCat2 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO X LO X BA 0 LA 0 AA 0 BC 0 MC {'X': 4} MF {'X': 1.0} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 256 [>512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17777 SQ SEQUENCE 18.015 DA MW 4AA XXXX // ID AMRSAP819 PN USCL-Dab3 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO B; X LO B, X BA 0 LA 0 AA 0 BC 0 MC {'B': 2, 'X': 2} MF {'B': 0.5, 'X': 0.5} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 16 [>128] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17778 SQ SEQUENCE 18.015 DA MW 4AA BXXB // ID AMRSAP820 PN USCL-PCat3 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO B; X LO B, X BA 0 LA 0 AA 0 BC 0 MC {'B': 2, 'X': 2} MF {'B': 0.5, 'X': 0.5} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 64 [>512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17779 SQ SEQUENCE 18.015 DA MW 4AA XBBX // ID AMRSAP821 PN USCL-PCat4 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO B; X LO B, X BA 0 LA 0 AA 0 BC 0 MC {'B': 2, 'X': 2} MF {'B': 0.5, 'X': 0.5} XX MM 18.015 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA ATCC 33592 (MIC = 32 [512] μGram/mL) XX XR PubMed: 25069750 XR CAMP R4: CAMPSQ17780 SQ SEQUENCE 18.015 DA MW 4AA XBBX // ID AMRSAP822 PN LP1 SO Synthetic construct PL 1 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 1} MF {'O': 1.0} XX MM 255.317 AI 0 II 0 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17781 SQ SEQUENCE 255.317 DA MW 1AA O // ID AMRSAP823 PN LP2 SO Synthetic construct PL 1 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 1} MF {'O': 1.0} XX MM 255.317 AI 0 II 0 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17782 SQ SEQUENCE 255.317 DA MW 1AA O // ID AMRSAP824 PN LP3 SO Synthetic construct PL 1 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 1} MF {'O': 1.0} XX MM 255.317 AI 0 II 0 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17783 SQ SEQUENCE 255.317 DA MW 1AA O // ID AMRSAP825 PN LP4 SO Synthetic construct PL 1 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 1} MF {'O': 1.0} XX MM 255.317 AI 0 II 0 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17784 SQ SEQUENCE 255.317 DA MW 1AA O // ID AMRSAP826 PN LP5 SO Synthetic construct PL 1 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 1} MF {'O': 1.0} XX MM 255.317 AI 0 II 0 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17785 SQ SEQUENCE 255.317 DA MW 1AA O // ID AMRSAP827 PN LP6 SO Synthetic construct PL 1 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 1} MF {'O': 1.0} XX MM 255.317 AI 0 II 0 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17786 SQ SEQUENCE 255.317 DA MW 1AA O // ID AMRSAP828 PN LP7 SO Synthetic construct PL 2 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 2} MF {'O': 1.0} XX MM 492.619 AI 0 II 5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17787 SQ SEQUENCE 492.619 DA MW 2AA OO // ID AMRSAP829 PN LP8 SO Synthetic construct PL 2 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 2} MF {'O': 1.0} XX MM 492.619 AI 0 II 5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17788 SQ SEQUENCE 492.619 DA MW 2AA OO // ID AMRSAP830 PN LP9 SO Synthetic construct PL 2 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 2} MF {'O': 1.0} XX MM 492.619 AI 0 II 5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17789 SQ SEQUENCE 492.619 DA MW 2AA OO // ID AMRSAP831 PN LP10 SO Synthetic construct PL 2 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 2} MF {'O': 1.0} XX MM 492.619 AI 0 II 5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 50 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17790 SQ SEQUENCE 492.619 DA MW 2AA OO // ID AMRSAP832 PN LP11 SO Synthetic construct PL 2 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 2} MF {'O': 1.0} XX MM 492.619 AI 0 II 5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17791 SQ SEQUENCE 492.619 DA MW 2AA OO // ID AMRSAP833 PN LP12 SO Synthetic construct PL 2 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 2} MF {'O': 1.0} XX MM 492.619 AI 0 II 5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17792 SQ SEQUENCE 492.619 DA MW 2AA OO // ID AMRSAP834 PN LP13 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 3} MF {'O': 1.0} XX MM 729.921 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17793 SQ SEQUENCE 729.921 DA MW 3AA OOO // ID AMRSAP835 PN LP14 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 3} MF {'O': 1.0} XX MM 729.921 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17794 SQ SEQUENCE 729.921 DA MW 3AA OOO // ID AMRSAP836 PN LP15 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 3} MF {'O': 1.0} XX MM 729.921 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17795 SQ SEQUENCE 729.921 DA MW 3AA OOO // ID AMRSAP837 PN LP16 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 3} MF {'O': 1.0} XX MM 729.921 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17796 SQ SEQUENCE 729.921 DA MW 3AA OOO // ID AMRSAP838 PN LP17 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 3} MF {'O': 1.0} XX MM 729.921 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17797 SQ SEQUENCE 729.921 DA MW 3AA OOO // ID AMRSAP839 PN LP18 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 3} MF {'O': 1.0} XX MM 729.921 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17798 SQ SEQUENCE 729.921 DA MW 3AA OOO // ID AMRSAP840 PN LP19 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 4} MF {'O': 1.0} XX MM 967.222 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17799 SQ SEQUENCE 967.222 DA MW 4AA OOOO // ID AMRSAP841 PN LP20 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 4} MF {'O': 1.0} XX MM 967.222 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 50 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17800 SQ SEQUENCE 967.222 DA MW 4AA OOOO // ID AMRSAP842 PN LP21 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 4} MF {'O': 1.0} XX MM 967.222 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17801 SQ SEQUENCE 967.222 DA MW 4AA OOOO // ID AMRSAP843 PN LP22 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 4} MF {'O': 1.0} XX MM 967.222 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 6.25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17802 SQ SEQUENCE 967.222 DA MW 4AA OOOO // ID AMRSAP844 PN LP23 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 4} MF {'O': 1.0} XX MM 967.222 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17803 SQ SEQUENCE 967.222 DA MW 4AA OOOO // ID AMRSAP845 PN LP24 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 4} MF {'O': 1.0} XX MM 967.222 AI 0 II 7.5 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17804 SQ SEQUENCE 967.222 DA MW 4AA OOOO // ID AMRSAP846 PN LP25 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17805 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP847 PN LP26 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC >= 100 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17806 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP848 PN LP27 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17807 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP849 PN LP28 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 6.25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17808 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP850 PN LP29 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 12.5 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17809 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP851 PN LP30 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO O BA 0 LA 0 AA 0 BC 0 MC {'O': 5} MF {'O': 1.0} XX MM 1204.524 AI 0 II 8 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (ATCC BAA-1720) (MIC = 25 μGram/mL) XX XR PubMed: 23819506 XR CAMP R4: CAMPSQ17810 SQ SEQUENCE 1204.524 DA MW 5AA OOOOO // ID AMRSAP852 PN Temporin A SO Rana temporaria PL 14 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 1, 'I': 2, 'K': 0, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 7.14%, 'I': 14.29%, 'K': 0%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 7.14%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA A, C, D, E, K, M, N, Q, T, W, Y MO L LO F, H, P, R, S, V BA 11 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1534.908 AI 187.857 II 23.329 HP 1.45 HM 0.602 IP 10.552 NC 1.089 SF 0.571, 0.286, 0.286 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17824 SQ SEQUENCE 1534.908 DA MW 14AA H-FLPLIGRV LSGIL // ID AMRSAP853 PN Temporin B SO Rana temporaria PL 14 TX Animalia PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 7.14%, 'I': 7.14%, 'K': 7.14%, 'L': 42.86%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, M, Q, R, T, W, Y MO L LO G, H, I, K, N, P, S, V BA 10 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1529.929 AI 215.714 II -1.214 HP 1.293 HM 0.515 IP 9.702 NC 1.089 SF 0.571, 0.286, 0.429 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17825 SQ SEQUENCE 1529.929 DA MW 14AA H-LLPIVGNL LKSLL // ID AMRSAP854 PN Temporin B-Y SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.67%, 'H': 6.67%, 'I': 6.67%, 'K': 6.67%, 'L': 40%, AF 'M': 0%, 'N': 6.67%, 'P': 6.67%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 6.67%, 'W': 0%, 'Y': 6.67% MA A, C, D, E, F, M, Q, R, T, W MO L LO G, H, I, K, N, P, S, V, Y BA 10 LA 5 AA 0 BC 2 MC 0 MF 0 XX MM 1693.105 AI 201.333 II 28.827 HP 1.12 HM 0.508 IP 9.301 NC 1.088 SF 0.6, 0.267, 0.4 [Helix, Turn, Sheet] AR 0.067 ME 1490, 1490 MS 6.020129 XX SC alpha XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17826 SQ SEQUENCE 1693.105 DA MW 15AA H-YLLPIVGN LLKSLL // ID AMRSAP855 PN Temporin B-YK SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 6.25%, 'H': 0%, 'I': 6.25%, 'K': 18.75%, 'L': 37.5%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 6.25%, 'W': 0%, 'Y': 6.25% MA A, C, D, E, F, H, M, Q, R, T, W MO L LO G, I, N, P, S, V, Y BA 10 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 1812.313 AI 188.75 II 0.188 HP 0.763 HM 0.508 IP 10.643 NC 2.996 SF 0.563, 0.25, 0.375 [Helix, Turn, Sheet] AR 0.063 ME 1490, 1490 MS 18.060387 XX SC beta XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17827 SQ SEQUENCE 1812.313 DA MW 16AA KKYLLPIVGN LLKSLL // ID AMRSAP856 PN Temporin B-YKμA SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 3, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.26%, 'H': 5.26%, 'I': 5.26%, 'K': 15.79%, 'L': 31.58%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 0%, 'S': 5.26%, 'T': 0%, 'V': 5.26%, 'W': 0%, 'Y': 5.26% MA C, D, E, F, M, Q, R, T, W MO L LO G, H, I, N, P, S, V, Y BA 12 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2091.611 AI 169.474 II 1.737 HP 0.663 HM 0.508 IP 10.643 NC 3.087 SF 0.474, 0.211, 0.421 [Helix, Turn, Sheet] AR 0.053 ME 1490, 1490 MS 18.060387 XX SC beta XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17828 SQ SEQUENCE 2091.611 DA MW 19AA HAAKKYLLPI VGNLLKSLL // ID AMRSAP857 PN TA Rho SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 1, 'I': 2, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 10.53%, 'H': 5.26%, 'I': 10.53%, 'K': 10.53%, 'L': 21.05%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 0%, 'R': 10.53%, 'S': 5.26%, 'T': 0%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, Q, T, W, Y MO L LO F, H, O, P, S, V BA 13 LA 6 AA 0 BC 5 MC {'O': 1} MF {'O': 0.05} XX MM 2326.903 AI 141.5 II 34.145 HP 0.58 HM 0.734 IP 12.532 NC 4.088 SF 0.4, 0.2, 0.3 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17829 SQ SEQUENCE 2326.903 DA MW 20AA RHO-AAKKFL PLIGRVLSGI L // ID AMRSAP858 PN TB Fluo SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 7, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 5%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 35%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA C, D, E, H, M, Q, R, T, W MO L LO F, G, I, N, O, P, S, U, V, Y BA 14 LA 6 AA 0 BC 3 MC {'O': 1, 'U': 1} MF {'O': 0.045454545454545456, 'U': 0.045454545454545456} XX MM 2602.147 AI 164.091 II 2.864 HP 1.018 HM 0.508 IP 10.643 NC 2.996 SF 0.5, 0.182, 0.409 [Helix, Turn, Sheet] AR 0.091 ME 1490, 1490 MS 18.060387 XX SC beta XX TO MRSA XX XR PubMed: 19784377 XR CAMP R4: CAMPSQ17830 SQ SEQUENCE 2602.147 DA MW 22AA FLUO-AAKKY LLPIVGNLLK SLL // ID AMRSAP859 PN AMP2041 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 2, 'I': 1, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 11.76%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 11.76%, 'I': 5.88%, 'K': 23.53%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.88%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 5.88%, 'Y': 5.88% MA D, E, F, L, M, N, P, Q, S, T MO K LO G, I, R, W, Y BA 7 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2027.482 AI 68.824 II 6.665 HP -0.447 HM 0.463 IP 10.489 NC 5.054 SF 0.294, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.118 ME 6990, 7115 MS 30.100645 XX SC alpha XX TO MRSA ATCC 43400 (MBC = 1.11 μG/mL) XX XR PubMed: 23893489 XR CAMP R4: CAMPSQ17939 SQ SEQUENCE 2027.482 DA MW 17AA HKCAKIKWRG VHVKYCA // ID AMRSAP860 PN AMP72 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.76%, 'H': 0%, 'I': 0%, 'K': 23.53%, 'L': 17.65%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.88%, 'S': 0%, 'T': 5.88%, 'V': 17.65%, 'W': 0%, 'Y': 0% MA D, E, F, H, I, M, N, P, Q, S, W, Y MO K LO A, R, T BA 9 LA 8 AA 0 BC 5 MC 0 MF 0 XX MM 1816.34 AI 125.882 II -17.253 HP 0.541 HM 0.394 IP 10.799 NC 4.873 SF 0.353, 0.118, 0.235 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA ATCC 43400 (MBC = 0.94 μG/mL) XX XR PubMed: 23893489 XR CAMP R4: CAMPSQ17940 SQ SEQUENCE 1816.34 DA MW 17AA KGCALVKVRG LTLKVCK // ID AMRSAP861 PN AMP126 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 23.53%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 11.76%, 'S': 0%, 'T': 0%, 'V': 11.76%, 'W': 17.65%, 'Y': 0% MA A, D, E, H, L, M, N, P, S, T, Y MO K LO F, G, I, Q BA 8 LA 9 AA 0 BC 6 MC 0 MF 0 XX MM 2251.788 AI 57.059 II -6.706 HP -0.618 HM 0.569 IP 11.224 NC 5.873 SF 0.412, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 16500, 16625 MS 36.120774 XX SC alpha_beta XX TO MRSA ATCC 43400 (MBC = NA μG/mL) XX XR PubMed: 23893489 XR CAMP R4: CAMPSQ17941 SQ SEQUENCE 2251.788 DA MW 17AA KWCRKWQWRG VKFIKCV // ID AMRSAP862 PN 1 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 100%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, Y MO W LO X BA 2 LA 0 AA 0 BC 0 MC {'X': 1} MF {'X': 0.3333333333333333} XX MM 390.442 AI 0 II 6.667 HP -0.6 HM 0.347 IP 6.1 NC -0.002 SF 0.667, 0, 0 [Helix, Turn, Sheet] AR 0.667 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC = ND) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17963 SQ SEQUENCE 390.442 DA MW 3AA WW-X // ID AMRSAP863 PN 2 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 100%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, Y MO O; W; X LO O, W, X BA 1 LA 0 AA 0 BC 0 MC {'O': 1, 'X': 1} MF {'O': 0.3333333333333333, 'X': 0.3333333333333333} XX MM 441.53 AI 0 II 6.667 HP -0.3 HM 0.27 IP 6.1 NC -0.002 SF 0.333, 0, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC = ND) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17964 SQ SEQUENCE 441.53 DA MW 3AA WO-X // ID AMRSAP864 PN 3 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 0 [Only special amino acid(s) is/are present in this entry. Please see Special/Modified Amino Acids Frequencies Section (below in the same table)]: 0% AF MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO X BA 0 LA 0 AA 0 BC 0 MC {'O': 2, 'X': 1} MF {'O': 0.6666666666666666, 'X': 0.3333333333333333} XX MM 492.619 AI 0 II 6.667 HP 0 HM 0 IP 6.1 NC -0.002 SF 0, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (MIC = ND) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17965 SQ SEQUENCE 492.619 DA MW 3AA OO-X // ID AMRSAP865 PN 4 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 33.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO W LO N BA 2 LA 1 AA 0 BC 0 MC 0 MF 0 XX MM 504.545 AI 0 II -27.9 HP -1.767 HM 0.587 IP 6.1 NC -0.002 SF 0.667, 0.333, 0 [Helix, Turn, Sheet] AR 0.667 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC >= 227.2) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17966 SQ SEQUENCE 504.545 DA MW 3AA N-WW // ID AMRSAP866 PN 5 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 50%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO N; O; W LO N, O, W BA 1 LA 1 AA 0 BC 0 MC {'O': 1} MF {'O': 0.3333333333333333} XX MM 555.634 AI 0 II -27.9 HP -1.467 HM 0.406 IP 6.1 NC -0.002 SF 0.333, 0.333, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC >= 227.2) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17967 SQ SEQUENCE 555.634 DA MW 3AA N-WO // ID AMRSAP867 PN 6 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 33.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO W LO N BA 2 LA 1 AA 0 BC 0 MC 0 MF 0 XX MM 504.545 AI 0 II -27.9 HP -1.767 HM 0.587 IP 6.1 NC -0.002 SF 0.667, 0.333, 0 [Helix, Turn, Sheet] AR 0.667 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC >= 227.2) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17968 SQ SEQUENCE 504.545 DA MW 3AA N-WW // ID AMRSAP868 PN 7 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 50%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO N; O; W LO N, O, W BA 1 LA 1 AA 0 BC 0 MC {'O': 1} MF {'O': 0.3333333333333333} XX MM 555.634 AI 0 II -27.9 HP -1.467 HM 0.406 IP 6.1 NC -0.002 SF 0.333, 0.333, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC >= 227.2) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17969 SQ SEQUENCE 555.634 DA MW 3AA N-WO // ID AMRSAP869 PN 8 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 100%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, W, Y MO O LO N BA 0 LA 1 AA 0 BC 0 MC {'O': 2} MF {'O': 0.6666666666666666} XX MM 606.723 AI 0 II 6.667 HP -1.167 HM 0.26 IP 6.1 NC -0.002 SF 0, 0.333, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (MIC = 56.8) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17970 SQ SEQUENCE 606.723 DA MW 3AA N-OO // ID AMRSAP870 PN 9 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 33.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO W LO N BA 2 LA 1 AA 0 BC 0 MC 0 MF 0 XX MM 504.545 AI 0 II -27.9 HP -1.767 HM 0.587 IP 6.1 NC -0.002 SF 0.667, 0.333, 0 [Helix, Turn, Sheet] AR 0.667 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC = ND) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17971 SQ SEQUENCE 504.545 DA MW 3AA N-WW // ID AMRSAP871 PN 10 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 50%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO N; O; W LO N, O, W BA 1 LA 1 AA 0 BC 0 MC {'O': 1} MF {'O': 0.3333333333333333} XX MM 555.634 AI 0 II -27.9 HP -1.467 HM 0.406 IP 6.1 NC -0.002 SF 0.333, 0.333, 0 [Helix, Turn, Sheet] AR 0.333 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC = ND) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17972 SQ SEQUENCE 555.634 DA MW 3AA N-WO // ID AMRSAP872 PN 11 SO Synthetic construct PL 3 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 100%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, W, Y MO O LO N BA 0 LA 1 AA 0 BC 0 MC {'O': 2} MF {'O': 0.6666666666666666} XX MM 606.723 AI 0 II 6.667 HP -1.167 HM 0.26 IP 6.1 NC -0.002 SF 0, 0.333, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (MIC = 7.1) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17973 SQ SEQUENCE 606.723 DA MW 3AA N-OO // ID AMRSAP873 PN 12 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 33.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO W LO N, X BA 2 LA 1 AA 0 BC 0 MC {'X': 1} MF {'X': 0.25} XX MM 504.545 AI 0 II -18.425 HP -1.325 HM 0.44 IP 6.1 NC -0.002 SF 0.5, 0.25, 0 [Helix, Turn, Sheet] AR 0.5 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC = 56.8) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17974 SQ SEQUENCE 504.545 DA MW 4AA N-WW-X // ID AMRSAP874 PN 13 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 50%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO N; O; W; X LO N, O, W, X BA 1 LA 1 AA 0 BC 0 MC {'O': 1, 'X': 1} MF {'O': 0.25, 'X': 0.25} XX MM 555.634 AI 0 II -18.425 HP -1.1 HM 0.305 IP 6.1 NC -0.002 SF 0.25, 0.25, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC >= 227.2) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17975 SQ SEQUENCE 555.634 DA MW 4AA N-WO-X // ID AMRSAP875 PN 14 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 33.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO W LO N, X BA 2 LA 1 AA 0 BC 0 MC {'X': 1} MF {'X': 0.25} XX MM 504.545 AI 0 II -18.425 HP -1.325 HM 0.44 IP 6.1 NC -0.002 SF 0.5, 0.25, 0 [Helix, Turn, Sheet] AR 0.5 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC = 0.8) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17976 SQ SEQUENCE 504.545 DA MW 4AA N-WW-X // ID AMRSAP876 PN 15 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 50%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO N; O; W; X LO N, O, W, X BA 1 LA 1 AA 0 BC 0 MC {'O': 1, 'X': 1} MF {'O': 0.25, 'X': 0.25} XX MM 555.634 AI 0 II -18.425 HP -1.1 HM 0.305 IP 6.1 NC -0.002 SF 0.25, 0.25, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC = 0.8) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17977 SQ SEQUENCE 555.634 DA MW 4AA N-WO-X // ID AMRSAP877 PN 16 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 100%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, W, Y MO O LO N, X BA 0 LA 1 AA 0 BC 0 MC {'O': 2, 'X': 1} MF {'O': 0.5, 'X': 0.25} XX MM 606.723 AI 0 II 7.5 HP -0.875 HM 0.195 IP 6.1 NC -0.002 SF 0, 0.25, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (MIC = 3.5) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17978 SQ SEQUENCE 606.723 DA MW 4AA N-OO-X // ID AMRSAP878 PN 17 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 33.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 66.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO W LO N, X BA 2 LA 1 AA 0 BC 0 MC {'X': 1} MF {'X': 0.25} XX MM 504.545 AI 0 II -18.425 HP -1.325 HM 0.44 IP 6.1 NC -0.002 SF 0.5, 0.25, 0 [Helix, Turn, Sheet] AR 0.5 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO MRSA (MIC = 28.4) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17979 SQ SEQUENCE 504.545 DA MW 4AA N-WW-X // ID AMRSAP879 PN 18 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 50%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, Y MO N; O; W; X LO N, O, W, X BA 1 LA 1 AA 0 BC 0 MC {'O': 1, 'X': 1} MF {'O': 0.25, 'X': 0.25} XX MM 555.634 AI 0 II -18.425 HP -1.1 HM 0.305 IP 6.1 NC -0.002 SF 0.25, 0.25, 0 [Helix, Turn, Sheet] AR 0.25 ME 5500, 5500 MS 0 XX SC alpha_beta XX TO MRSA (MIC = 3.5) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17980 SQ SEQUENCE 555.634 DA MW 4AA N-WO-X // ID AMRSAP880 PN 19 SO Synthetic construct PL 4 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 100%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, P, Q, R, S, T, V, W, Y MO O LO N, X BA 0 LA 1 AA 0 BC 0 MC {'O': 2, 'X': 1} MF {'O': 0.5, 'X': 0.25} XX MM 606.723 AI 0 II 7.5 HP -0.875 HM 0.195 IP 6.1 NC -0.002 SF 0, 0.25, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC beta XX TO MRSA (MIC = 3.5) XX XR PubMed: 22986997 XR CAMP R4: CAMPSQ17981 SQ SEQUENCE 606.723 DA MW 4AA N-OO-X // ID AMRSAP881 PN ASP-2, WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18046 SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP882 PN ASP-2, WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA XX XR PubMed: 27405275 XR CAMP R4: CAMPSQ18046 SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP883 PN WR8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1387.618 AI 0 II 223.55 HP -2.7 HM 0.997 IP 12.977 NC 3.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18049 SQ SEQUENCE 1387.618 DA MW 8AA WWRRWWRR // ID AMRSAP884 PN WK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K; W LO K, W BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1275.564 AI 0 II 8.75 HP -2.4 HM 0.688 IP 11.278 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18050 SQ SEQUENCE 1275.564 DA MW 8AA WWKKWWKK // ID AMRSAP885 PN WR10 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 5 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1730.019 AI 0 II 238.12 HP -2.7 HM 1.073 IP 13.102 NC 4.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18051 SQ SEQUENCE 1730.019 DA MW 10AA WRWWRRWWRR // ID AMRSAP886 PN WK10 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K; W LO K, W BA 5 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1589.952 AI 0 II 9 HP -2.4 HM 0.722 IP 11.403 NC 4.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18052 SQ SEQUENCE 1589.952 DA MW 10AA WKWWKKWWKK // ID AMRSAP887 PN WR14 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 7, 'S': 0, 'T': 0, 'V': 0, 'W': 7, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 7 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2414.82 AI 0 II 254.771 HP -2.7 HM 1.113 IP 13.278 NC 6.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 38500, 38500 MS 42.140903 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18053 SQ SEQUENCE 2414.82 DA MW 14AA WRRWWRWWRR WWRR // ID AMRSAP888 PN WK14 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 7, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 7, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K; W LO K, W BA 7 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2218.726 AI 0 II 9.286 HP -2.4 HM 0.765 IP 11.579 NC 6.996 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 38500, 38500 MS 42.140903 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18054 SQ SEQUENCE 2218.726 DA MW 14AA WKKWWKWWKK WWKK // ID AMRSAP889 PN WR16 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 8, 'S': 0, 'T': 0, 'V': 0, 'W': 8, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2757.221 AI 0 II 259.975 HP -2.7 HM 1.113 IP 13.345 NC 7.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 44000, 44000 MS 48.161032 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18055 SQ SEQUENCE 2757.221 DA MW 16AA RWWRRWWRWW RRWWRR // ID AMRSAP890 PN WK16 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 8, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K; W LO K, W BA 8 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2533.114 AI 0 II 9.375 HP -2.4 HM 0.765 IP 11.646 NC 7.996 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 44000, 44000 MS 48.161032 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18056 SQ SEQUENCE 2533.114 DA MW 16AA KWWKKWWKWW KKWWKK // ID AMRSAP891 PN WR18 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 9, 'S': 0, 'T': 0, 'V': 0, 'W': 9, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 9 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 3099.622 AI 0 II 264.022 HP -2.7 HM 1.113 IP 13.403 NC 8.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 49500, 49500 MS 54.181161 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18057 SQ SEQUENCE 3099.622 DA MW 18AA WRRWWRRWWR WWRRWWRR // ID AMRSAP892 PN WK18 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 9, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 9, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K; W LO K, W BA 9 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2847.501 AI 0 II 9.444 HP -2.4 HM 0.765 IP 11.703 NC 8.995 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 49500, 49500 MS 54.181161 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18058 SQ SEQUENCE 2847.501 DA MW 18AA WKKWWKKWWK WWKKWWKK // ID AMRSAP893 PN WK12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K; W LO K, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1904.339 AI 0 II 9.167 HP -2.4 HM 0.765 IP 11.5 NC 5.996 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) USA300 XX XR PubMed: 27046192 XR CAMP R4: CAMPSQ18059 SQ SEQUENCE 1904.339 DA MW 12AA KWWKWWKKWW KK // ID AMRSAP894 PN Antibacterial peptide BMAP-27 SO Bos taurus PL 27 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 2, 'H': 1, 'I': 1, 'K': 7, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.81%, 'G': 7.41%, 'H': 3.7%, 'I': 3.7%, 'K': 25.93%, 'L': 18.52%, AF 'M': 0%, 'N': 0%, 'P': 7.41%, 'Q': 0%, 'R': 11.11%, 'S': 3.7%, 'T': 0%, 'V': 3.7%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, Q, T, W, Y MO K LO H, I, S, V BA 15 LA 12 AA 0 BC 11 MC 0 MF 0 XX MM 3283.148 AI 97.407 II 21.056 HP -0.367 HM 0.825 IP 12.843 NC 10.087 SF 0.407, 0.185, 0.185 [Helix, Turn, Sheet] AR 0.148 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA (MIC = 4 μM) XX XR PubMed: 8910461 XR CAMP R4: CAMPSQ196 SQ SEQUENCE 3283.148 DA MW 27AA GRFKRFRKKF KKLFKKLSPV IPLLHLG // ID AMRSAP895 PN Moronecidin SO Morone chrysops PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 4, 'I': 3, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.04%, 'G': 17.39%, 'H': 17.39%, 'I': 13.04%, 'K': 8.7%, 'L': 4.35%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.35%, 'S': 0%, 'T': 8.7%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, S, W, Y MO G; H LO L, R BA 14 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2601.098 AI 105.652 II 20.165 HP 0.443 HM 0.726 IP 11.823 NC 3.361 SF 0.435, 0.174, 0.043 [Helix, Turn, Sheet] AR 0.13 ME 0, 0 MS 18.060387 XX SC alpha XX TO S.aureus MRSA (MIC = 1.25-2.5 μM TO MBC = 1.25-2.5 μM) XX XR PubMed: 11739390 XR CAMP R4: CAMPSQ206 SQ SEQUENCE 2601.098 DA MW 23AA FFHHIFRGIV HVGKTIHKLV TGG // ID AMRSAP896 PN Moronecidin SO Morone saxatilis PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 4, 'I': 3, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.04%, 'G': 17.39%, 'H': 17.39%, 'I': 13.04%, 'K': 4.35%, 'L': 4.35%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.7%, 'S': 0%, 'T': 8.7%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, S, W, Y MO G; H LO K, L BA 14 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2629.112 AI 105.652 II 13.561 HP 0.417 HM 0.729 IP 12.516 NC 3.361 SF 0.435, 0.174, 0.043 [Helix, Turn, Sheet] AR 0.13 ME 0, 0 MS 18.060387 XX SC alpha XX TO S.aureus MRSA (MIC = 1.25-2.5 μM TO MBC = 1.25-2.5 μM) XX XR PubMed: 11739390 XR CAMP R4: CAMPSQ207 SQ SEQUENCE 2629.112 DA MW 23AA FFHHIFRGIV HVGKTIHRLV TGG // ID AMRSAP897 PN Moronecidin SO Morone chrysops PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 4, 'I': 3, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.04%, 'G': 17.39%, 'H': 17.39%, 'I': 13.04%, 'K': 4.35%, 'L': 4.35%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.7%, 'S': 0%, 'T': 8.7%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA A, C, D, E, M, N, P, Q, S, W, Y MO G; H LO K, L BA 14 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2629.112 AI 105.652 II 23.857 HP 0.417 HM 0.808 IP 12.516 NC 3.361 SF 0.435, 0.174, 0.043 [Helix, Turn, Sheet] AR 0.13 ME 0, 0 MS 18.060387 XX SC alpha XX TO S.aureus MRSA (MIC = 1.25-2.5 μM TO MBC = 1.25-2.5 μM) XX XR PubMed: 11739390 XR CAMP R4: CAMPSQ208 SQ SEQUENCE 2629.112 DA MW 23AA FFHHIFRGIV HVGRTIHKLV TGG // ID AMRSAP898 PN Moronecidin SO Morone saxatilis PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 4, 'I': 3, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.04%, 'G': 17.39%, 'H': 17.39%, 'I': 13.04%, 'K': 0%, 'L': 4.35%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 13.04%, 'S': 0%, 'T': 8.7%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA A, C, D, E, K, M, N, P, Q, S, W, Y MO G; H LO L BA 14 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2657.125 AI 105.652 II 17.252 HP 0.391 HM 0.819 IP 12.801 NC 3.362 SF 0.435, 0.174, 0.043 [Helix, Turn, Sheet] AR 0.13 ME 0, 0 MS 18.060387 XX SC alpha XX TO S.aureus MRSA (MIC = 1.25-2.5 μM TO MBC = 1.25-2.5 μM) XX XR PubMed: 11739390 XR CAMP R4: CAMPSQ209 SQ SEQUENCE 2657.125 DA MW 23AA FFHHIFRGIV HVGRTIHRLV TGG // ID AMRSAP899 PN PYLa/PGLa B SO Xenopus laevis PL 9 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 33.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 22.22%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 11.11%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, R, S, T, W, Y MO A LO I, V BA 7 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 926.211 AI 195.556 II -9.978 HP 1.544 HM 0.618 IP 10.805 NC 1.997 SF 0.444, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO Multidrug-resistant Meticillin-resistant S. aureus (MRSA) (MIC=67.8 μG/mL) XX XR PubMed: 6688991 XR CAMP R4: CAMPSQ2572 SQ SEQUENCE 926.211 DA MW 9AA IAKVALKAL // ID AMRSAP900 PN Imcroporin SO Isometrus maculatus PL 16 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 3, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 6.25%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 18.75%, 'T': 0%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, R, T, W, Y MO L LO A, F, K, P, V BA 12 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 1614.989 AI 170.625 II 35.856 HP 1.519 HM 0.431 IP 9.7 NC 0.998 SF 0.5, 0.375, 0.313 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA P1386 (MIC = 50 μG/mL) XX XR PubMed: 19451300 XR CAMP R4: CAMPSQ2579 SQ SEQUENCE 1614.989 DA MW 16AA FSLLPSLIGG LVSAIK // ID AMRSAP901 PN Imcroporin SO Isometrus maculatus PL 16 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 3, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 6.25%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 6.25%, 'Q': 0%, 'R': 0%, 'S': 18.75%, 'T': 0%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, R, T, W, Y MO L LO A, F, K, P, V BA 12 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 1614.989 AI 170.625 II 35.856 HP 1.519 HM 0.431 IP 9.7 NC 0.998 SF 0.5, 0.375, 0.313 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA P1374 (MIC = 50 μG/mL) XX XR PubMed: 19451300 XR CAMP R4: CAMPSQ2579 SQ SEQUENCE 1614.989 DA MW 16AA FSLLPSLIGG LVSAIK // ID AMRSAP902 PN Palustrin-2ISb precursor protein SO Odorrana ishikawae PL 35 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 2, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 0, 'R': 1, 'S': 2, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 5.71%, 'C': 5.71%, 'D': 5.71%, 'E': 2.86%, 'F': 2.86%, 'G': 8.57%, 'H': 0%, 'I': 8.57%, 'K': 17.14%, 'L': 8.57%, AF 'M': 0%, 'N': 5.71%, 'P': 2.86%, 'Q': 0%, 'R': 2.86%, 'S': 5.71%, 'T': 2.86%, 'V': 11.43%, 'W': 2.86%, 'Y': 0% MA H, M, Q, Y MO K LO E, F, P, R, T, W BA 18 LA 17 AA 3 BC 7 MC 0 MF 0 XX MM 3831.593 AI 105.714 II 16.951 HP 0.049 HM 0.65 IP 10.136 NC 3.875 SF 0.343, 0.229, 0.171 [Helix, Turn, Sheet] AR 0.057 ME 5500, 5625 MS 42.140903 XX SC beta XX TO MRSA (MIC = 100 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ2693 SQ SEQUENCE 3831.593 DA MW 35AA LWNSIKIAGK KLFVNVLDKI RCKVAGGCKT SPDVE // ID AMRSAP903 PN LP1A SO Manduca sexta PL 21 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 3, 'R': 3, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 9.52%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 9.52%, 'Q': 14.29%, 'R': 14.29%, 'S': 9.52%, 'T': 9.52%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, M, N, V, W, Y MO F; L; Q; R LO G BA 9 LA 12 AA 0 BC 5 MC 0 MF 0 XX MM 2535.978 AI 55.714 II 50.057 HP -0.886 HM 0.545 IP 12.814 NC 4.997 SF 0.286, 0.238, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 30.100645 XX SC alpha XX TO S. aureus MRSA 43300 (MIC = 100 μG/mL) XX XR PubMed: 20096726 XR CAMP R4: CAMPSQ2711 SQ SEQUENCE 2535.978 DA MW 21AA QRFSQPTFKL PQGRLTLSRK F // ID AMRSAP904 PN GLK-19 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 0, 'K': 7, 'L': 9, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15.79%, 'H': 0%, 'I': 0%, 'K': 36.84%, 'L': 47.37%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO G BA 12 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2104.824 AI 184.737 II -30.742 HP 0.3 HM 0.763 IP 11.579 NC 6.996 SF 0.474, 0.158, 0.474 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 42.140903 XX SC beta XX TO MRSA USA-300 (MIC = 160 μM) XX XR PubMed: 18957441 XR CAMP R4: CAMPSQ2732 SQ SEQUENCE 2104.824 DA MW 19AA GLKKLLGKLL KKLGKLLLK // ID AMRSAP905 PN rCRAMP SO Rattus norvegicus PL 39 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 5, 'F': 3, 'G': 5, 'H': 0, 'I': 4, 'K': 7, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 3, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5.13%, 'C': 0%, 'D': 0%, 'E': 12.82%, 'F': 7.69%, 'G': 12.82%, 'H': 0%, 'I': 10.26%, 'K': 17.95%, 'L': 12.82%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 7.69%, 'R': 7.69%, 'S': 2.56%, 'T': 0%, 'V': 2.56%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, P, T, W, Y MO K LO S, V BA 20 LA 19 AA 5 BC 10 MC 0 MF 0 XX MM 4487.358 AI 102.564 II 27 HP -0.472 HM 0.82 IP 10.907 NC 5.005 SF 0.333, 0.154, 0.308 [Helix, Turn, Sheet] AR 0.077 ME 0, 0 MS 60.20129 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 3.19 μM [Low] TO MIC > 20.1 []) XX XR PubMed: 10768969 XR CAMP R4: CAMPSQ2784 SQ SEQUENCE 4487.358 DA MW 39AA ISRLAGLVRK GGEKFGEKLR KIGQKIKEFF QKLALEIEQ // ID AMRSAP906 PN NRC-12 SO Hippoglossoides platessoides PL 25 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 0, 'K': 5, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 2, 'Y': 1 AF 'A': 8%, 'C': 0%, 'D': 4%, 'E': 0%, 'F': 4%, 'G': 16%, 'H': 4%, 'I': 0%, 'K': 20%, 'L': 8%, AF 'M': 0%, 'N': 4%, 'P': 0%, 'Q': 0%, 'R': 4%, 'S': 0%, 'T': 4%, 'V': 12%, 'W': 8%, 'Y': 4% MA C, E, I, M, P, Q, S MO K LO D, F, H, N, R, T, Y BA 14 LA 11 AA 1 BC 7 MC 0 MF 0 XX MM 2859.373 AI 74 II 17.452 HP -0.52 HM 0.724 IP 11.006 NC 5.087 SF 0.36, 0.2, 0.16 [Helix, Turn, Sheet] AR 0.16 ME 12490, 12490 MS 36.120774 XX SC alpha_beta XX TO MRSA C623 (MIC = 16μG/mL) XX XR PubMed: 9879502 XR CAMP R4: CAMPSQ2884 SQ SEQUENCE 2859.373 DA MW 25AA GWKKWFNRAK KVGKTVGGLA VDHYL // ID AMRSAP907 PN NRC-13 SO Glyptocephalus cynoglossus L. PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 8.7%, 'C': 0%, 'D': 0%, 'E': 4.35%, 'F': 0%, 'G': 8.7%, 'H': 4.35%, 'I': 0%, 'K': 21.74%, 'L': 21.74%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.35%, 'S': 0%, 'T': 8.7%, 'V': 8.7%, 'W': 4.35%, 'Y': 4.35% MA C, D, F, I, M, N, P, Q, S MO K; L LO E, H, R, W, Y BA 12 LA 11 AA 1 BC 7 MC 0 MF 0 XX MM 2653.253 AI 118.696 II 14.326 HP -0.178 HM 0.53 IP 11.006 NC 5.088 SF 0.391, 0.087, 0.348 [Helix, Turn, Sheet] AR 0.087 ME 6990, 6990 MS 36.120774 XX SC beta XX TO MRSA C623 (MIC = 4μG/mL) XX XR PubMed: 9879502 XR CAMP R4: CAMPSQ2885 SQ SEQUENCE 2653.253 DA MW 23AA GWRTLLKKAE VKTVGKLALK HYL // ID AMRSAP908 PN NRC-17 SO Glyptocephalus cynoglossus L. PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 1, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 17.39%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 17.39%, 'H': 4.35%, 'I': 4.35%, 'K': 21.74%, 'L': 13.04%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 4.35%, 'R': 4.35%, 'S': 4.35%, 'T': 0%, 'V': 0%, 'W': 8.7%, 'Y': 0% MA C, D, E, F, M, N, P, T, V, Y MO K LO H, I, Q, R, S BA 14 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2505.01 AI 85.217 II 13.904 HP -0.513 HM 0.778 IP 12.055 NC 6.087 SF 0.261, 0.217, 0.304 [Helix, Turn, Sheet] AR 0.087 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO MRSA C623 (MIC = 16μG/mL) XX XR PubMed: 9879502 XR CAMP R4: CAMPSQ2886 SQ SEQUENCE 2505.01 DA MW 23AA GWKKWLRKGA KHLGQAAIKG LAS // ID AMRSAP909 PN Siamycin I SO Streptomyces strain AA6532 PL 21 TX Monera PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 1, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 1 AF 'A': 9.52%, 'C': 19.05%, 'D': 4.76%, 'E': 0%, 'F': 9.52%, 'G': 19.05%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 0%, 'V': 14.29%, 'W': 4.76%, 'Y': 4.76% MA E, H, I, K, M, P, Q, R, T MO C; G LO D, L, N, S, W, Y BA 13 LA 8 AA 1 BC 0 MC 0 MF 0 XX MM 2171.506 AI 69.524 II 33.819 HP 1.143 HM 0.281 IP 3.75 NC -1.25 SF 0.381, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.19 ME 6990, 7240 MS 0 XX SC beta XX TO Staphylococcus aureus A15036 (MRSA) (MIC = 3.1 μG/mL) XX XR PubMed: 8557614 XR CAMP R4: CAMPSQ3068 SQ SEQUENCE 2171.506 DA MW 21AA CLGVGSCNDF AGCGYAVVCF W // ID AMRSAP910 PN Arminin-1a SO Hydra magnipapillata PL 31 TX Animalia (Hydrozoans) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 7, 'S': 0, 'T': 1, 'V': 5, 'W': 2, 'Y': 1 AF 'A': 6.45%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.45%, 'G': 3.23%, 'H': 0%, 'I': 6.45%, 'K': 16.13%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.68%, 'Q': 0%, 'R': 22.58%, 'S': 0%, 'T': 3.23%, 'V': 16.13%, 'W': 6.45%, 'Y': 3.23% MA C, D, E, H, L, M, N, Q, S MO R LO G, T, Y BA 17 LA 14 AA 0 BC 12 MC 0 MF 0 XX MM 3895.8 AI 78.387 II 64.1 HP -0.671 HM 0.864 IP 12.91 NC 11.996 SF 0.387, 0.129, 0.065 [Helix, Turn, Sheet] AR 0.161 ME 12490, 12490 MS 72.241548 XX SC alpha_beta XX TO MRSA ATCC 33393 (MBC = 0.4 μM TO LD90 = 0.20 μM) XX XR PubMed: 19770277 XR CAMP R4: CAMPSQ3325 SQ SEQUENCE 3895.8 DA MW 31AA KPWRFRRAIR RVRWRKVAPY IPFVVKTVGK K // ID AMRSAP911 PN Arminin-1a SO Hydra magnipapillata PL 31 TX Animalia (Hydrozoans) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 7, 'S': 0, 'T': 1, 'V': 5, 'W': 2, 'Y': 1 AF 'A': 6.45%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.45%, 'G': 3.23%, 'H': 0%, 'I': 6.45%, 'K': 16.13%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.68%, 'Q': 0%, 'R': 22.58%, 'S': 0%, 'T': 3.23%, 'V': 16.13%, 'W': 6.45%, 'Y': 3.23% MA C, D, E, H, L, M, N, Q, S MO R LO G, T, Y BA 17 LA 14 AA 0 BC 12 MC 0 MF 0 XX MM 3895.8 AI 78.387 II 64.1 HP -0.671 HM 0.864 IP 12.91 NC 11.996 SF 0.387, 0.129, 0.065 [Helix, Turn, Sheet] AR 0.161 ME 12490, 12490 MS 72.241548 XX SC alpha_beta XX TO MRSA ATCC 43300 (MBC = 0.4 μM TO LD90 = 0.20 μM) XX XR PubMed: 19770277 XR CAMP R4: CAMPSQ3325 SQ SEQUENCE 3895.8 DA MW 31AA KPWRFRRAIR RVRWRKVAPY IPFVVKTVGK K // ID AMRSAP912 PN Arminin-1a SO Hydra magnipapillata PL 31 TX Animalia (Hydrozoans) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 7, 'S': 0, 'T': 1, 'V': 5, 'W': 2, 'Y': 1 AF 'A': 6.45%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.45%, 'G': 3.23%, 'H': 0%, 'I': 6.45%, 'K': 16.13%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.68%, 'Q': 0%, 'R': 22.58%, 'S': 0%, 'T': 3.23%, 'V': 16.13%, 'W': 6.45%, 'Y': 3.23% MA C, D, E, H, L, M, N, Q, S MO R LO G, T, Y BA 17 LA 14 AA 0 BC 12 MC 0 MF 0 XX MM 3895.8 AI 78.387 II 64.1 HP -0.671 HM 0.864 IP 12.91 NC 11.996 SF 0.387, 0.129, 0.065 [Helix, Turn, Sheet] AR 0.161 ME 12490, 12490 MS 72.241548 XX SC alpha_beta XX TO MRSA 344 (MBC = 0.8 μM TO LD90 = 0.20 μM) XX XR PubMed: 19770277 XR CAMP R4: CAMPSQ3325 SQ SEQUENCE 3895.8 DA MW 31AA KPWRFRRAIR RVRWRKVAPY IPFVVKTVGK K // ID AMRSAP913 PN Arminin-1a SO Hydra magnipapillata PL 31 TX Animalia (Hydrozoans) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 7, 'S': 0, 'T': 1, 'V': 5, 'W': 2, 'Y': 1 AF 'A': 6.45%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.45%, 'G': 3.23%, 'H': 0%, 'I': 6.45%, 'K': 16.13%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.68%, 'Q': 0%, 'R': 22.58%, 'S': 0%, 'T': 3.23%, 'V': 16.13%, 'W': 6.45%, 'Y': 3.23% MA C, D, E, H, L, M, N, Q, S MO R LO G, T, Y BA 17 LA 14 AA 0 BC 12 MC 0 MF 0 XX MM 3895.8 AI 78.387 II 64.1 HP -0.671 HM 0.864 IP 12.91 NC 11.996 SF 0.387, 0.129, 0.065 [Helix, Turn, Sheet] AR 0.161 ME 12490, 12490 MS 72.241548 XX SC alpha_beta XX TO MRSA 355 (MBC = 0.4 μM TO LD90 = 0.20 μM) XX XR PubMed: 19770277 XR CAMP R4: CAMPSQ3325 SQ SEQUENCE 3895.8 DA MW 31AA KPWRFRRAIR RVRWRKVAPY IPFVVKTVGK K // ID AMRSAP914 PN Arminin-1a SO Hydra magnipapillata PL 31 TX Animalia (Hydrozoans) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 2, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 7, 'S': 0, 'T': 1, 'V': 5, 'W': 2, 'Y': 1 AF 'A': 6.45%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.45%, 'G': 3.23%, 'H': 0%, 'I': 6.45%, 'K': 16.13%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 9.68%, 'Q': 0%, 'R': 22.58%, 'S': 0%, 'T': 3.23%, 'V': 16.13%, 'W': 6.45%, 'Y': 3.23% MA C, D, E, H, L, M, N, Q, S MO R LO G, T, Y BA 17 LA 14 AA 0 BC 12 MC 0 MF 0 XX MM 3895.8 AI 78.387 II 64.1 HP -0.671 HM 0.864 IP 12.91 NC 11.996 SF 0.387, 0.129, 0.065 [Helix, Turn, Sheet] AR 0.161 ME 12490, 12490 MS 72.241548 XX SC alpha_beta XX TO MRSA 358 (MBC = 0.4 μM TO LD90 = 0.20 μM) XX XR PubMed: 19770277 XR CAMP R4: CAMPSQ3325 SQ SEQUENCE 3895.8 DA MW 31AA KPWRFRRAIR RVRWRKVAPY IPFVVKTVGK K // ID AMRSAP915 PN Hydramacin-1 SO Hydra magnipapillata PL 60 TX Animalia (Hydrozoans) PE Experimentally validated XX AC 'A': 1, 'C': 8, 'D': 2, 'E': 4, 'F': 0, 'G': 5, 'H': 0, 'I': 2, 'K': 7, 'L': 3, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 3, 'R': 5, 'S': 5, 'T': 5, 'V': 1, 'W': 5, 'Y': 1 AF 'A': 1.67%, 'C': 13.33%, 'D': 3.33%, 'E': 6.67%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 3.33%, 'K': 11.67%, 'L': 5%, AF 'M': 0%, 'N': 1.67%, 'P': 3.33%, 'Q': 5%, 'R': 8.33%, 'S': 8.33%, 'T': 8.33%, 'V': 1.67%, 'W': 8.33%, 'Y': 1.67% MA F, H, M MO C LO A, N, V, Y BA 19 LA 41 AA 6 BC 12 MC 0 MF 0 XX MM 7017.077 AI 39 II 39.207 HP -0.948 HM 0.635 IP 8.788 NC 5.507 SF 0.2, 0.217, 0.133 [Helix, Turn, Sheet] AR 0.1 ME 28990, 29490 MS 72.241548 XX SC beta XX TO Staphylococcus aureus ATCC 33593 (MRSA)(MBC > 14.3 μM TO LD90 > 14.3 μM) XX XR PubMed: 19019828 XR CAMP R4: CAMPSQ3331 SQ SEQUENCE 7017.077 DA MW 60AA QIVDCWETWS RCTKWSQGGT GTLWKSCNDR CKELGRKRGQ CEEKPSRCPL SKKAWTCICY // ID AMRSAP916 PN Sublancin 168, Sublancin SO Bacillus subtilis 168 PL 37 TX Monera PE Experimentally validated XX AC 'A': 6, 'C': 5, 'D': 0, 'E': 0, 'F': 1, 'G': 8, 'H': 0, 'I': 1, 'K': 1, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 4, 'R': 2, 'S': 1, 'T': 1, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 16.22%, 'C': 13.51%, 'D': 0%, 'E': 0%, 'F': 2.7%, 'G': 21.62%, 'H': 0%, 'I': 2.7%, 'K': 2.7%, 'L': 8.11%, AF 'M': 0%, 'N': 2.7%, 'P': 0%, 'Q': 10.81%, 'R': 5.41%, 'S': 2.7%, 'T': 2.7%, 'V': 2.7%, 'W': 2.7%, 'Y': 2.7% MA D, E, H, M, P MO G LO F, I, K, N, S, T, V, W, Y BA 21 LA 16 AA 0 BC 3 MC 0 MF 0 XX MM 3720.292 AI 66.216 II 35.757 HP 0.241 HM 0.644 IP 8.508 NC 2.687 SF 0.216, 0.27, 0.243 [Helix, Turn, Sheet] AR 0.081 ME 6990, 7240 MS 18.060387 XX SC beta XX TO MRSA ATCC43300 (MIC = 15 μM) XX XR PubMed: 28906115 XR CAMP R4: CAMPSQ3368 SQ SEQUENCE 3720.292 DA MW 37AA GLGKAQCAAL WLQCASGGTI GCGGGAVACQ NYRQFCR // ID AMRSAP917 PN PhTD1 SO Papio hamadryas PL 18 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 5.56%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA A, D, E, H, I, K, L, M, N, P, Q, S, W, Y MO C LO F, T BA 6 LA 12 AA 0 BC 5 MC 0 MF 0 XX MM 2077.569 AI 48.333 II 41.567 HP 0.356 HM 0.523 IP 8.912 NC 4.626 SF 0.222, 0.111, 0 [Helix, Turn, Sheet] AR 0.056 ME 0, 375 MS 30.100645 XX SC beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) ATCC 33591 XX XR PubMed: 20155756 XR CAMP R4: CAMPSQ3414 SQ SEQUENCE 2077.569 DA MW 18AA RCVCRRGVCR CVCTRGFC // ID AMRSAP918 PN PhTD3 SO Papio hamadryas PL 18 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 33.33%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 11.11%, 'V': 11.11%, 'W': 0%, 'Y': 0% MA A, D, E, H, I, K, L, M, N, P, Q, S, W, Y MO C LO F, G, T, V BA 6 LA 12 AA 0 BC 4 MC 0 MF 0 XX MM 2070.53 AI 32.222 II 27.856 HP 0.489 HM 0.617 IP 8.639 NC 3.626 SF 0.222, 0.111, 0 [Helix, Turn, Sheet] AR 0.111 ME 0, 375 MS 24.080516 XX SC beta XX TO Methicillin-resistant Staphylococcus aureus (MRSA) ATCC 33591 XX XR PubMed: 20155756 XR CAMP R4: CAMPSQ3415 SQ SEQUENCE 2070.53 DA MW 18AA RCVCTRGFCR CVCTRGFC // ID AMRSAP919 PN Esculentin-1ISa SO Odorrana ishikawae PL 46 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 2, 'E': 2, 'F': 2, 'G': 9, 'H': 0, 'I': 7, 'K': 8, 'L': 2, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 4.35%, 'C': 4.35%, 'D': 4.35%, 'E': 4.35%, 'F': 4.35%, 'G': 19.57%, 'H': 0%, 'I': 15.22%, 'K': 17.39%, 'L': 4.35%, AF 'M': 2.17%, 'N': 4.35%, 'P': 0%, 'Q': 0%, 'R': 2.17%, 'S': 2.17%, 'T': 2.17%, 'V': 8.7%, 'W': 0%, 'Y': 0% MA H, P, Q, W, Y MO G LO M, R, S, T BA 27 LA 19 AA 4 BC 9 MC 0 MF 0 XX MM 4806.808 AI 105.87 II 2.002 HP 0.222 HM 0.732 IP 10.334 NC 4.876 SF 0.326, 0.261, 0.152 [Helix, Turn, Sheet] AR 0.043 ME 0, 125 MS 54.181161 XX SC beta XX TO MRSA ATCC 43300 (MIC = 25 μM) XX XR PubMed: 21193000 XR CAMP R4: CAMPSQ3430 SQ SEQUENCE 4806.808 DA MW 46AA GIFSKFAGKG IKNLLVKGVK NIGKEVGMDV IRTGIDIAGC KIKGEC // ID AMRSAP920 PN Esculentin-1ISb SO Odorrana ishikawae PL 46 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 2, 'E': 2, 'F': 1, 'G': 8, 'H': 0, 'I': 9, 'K': 8, 'L': 2, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 4.35%, 'C': 4.35%, 'D': 4.35%, 'E': 4.35%, 'F': 2.17%, 'G': 17.39%, 'H': 0%, 'I': 19.57%, 'K': 17.39%, 'L': 4.35%, AF 'M': 2.17%, 'N': 4.35%, 'P': 0%, 'Q': 0%, 'R': 4.35%, 'S': 2.17%, 'T': 2.17%, 'V': 6.52%, 'W': 0%, 'Y': 0% MA H, P, Q, W, Y MO I LO F, M, S, T BA 26 LA 20 AA 4 BC 10 MC 0 MF 0 XX MM 4885.953 AI 116.522 II 8.278 HP 0.176 HM 0.778 IP 10.579 NC 5.876 SF 0.326, 0.239, 0.152 [Helix, Turn, Sheet] AR 0.022 ME 0, 125 MS 60.20129 XX SC beta XX TO MRSA ATCC 43300 (MIC = 12.5 μM) XX XR PubMed: 21193000 XR CAMP R4: CAMPSQ3431 SQ SEQUENCE 4885.953 DA MW 46AA RIFSKIGGKA IKNLILKGIK NIGKEVGMDV IRTGIDVAGC KIKGEC // ID AMRSAP921 PN Esculentin-2ISa SO Odorrana ishikawae PL 37 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 0, 'E': 2, 'F': 1, 'G': 4, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 4, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 13.51%, 'C': 5.41%, 'D': 0%, 'E': 5.41%, 'F': 2.7%, 'G': 10.81%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 2.7%, 'N': 2.7%, 'P': 0%, 'Q': 2.7%, 'R': 0%, 'S': 2.7%, 'T': 10.81%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA D, H, P, R, W, Y MO K LO F, M, N, Q, S BA 20 LA 17 AA 2 BC 6 MC 0 MF 0 XX MM 3837.653 AI 102.973 II -3.849 HP 0.357 HM 0.67 IP 10.138 NC 3.876 SF 0.27, 0.162, 0.324 [Helix, Turn, Sheet] AR 0.027 ME 0, 125 MS 36.120774 XX SC beta XX TO MRSA ATCC 43300 (MIC = 25 μM) XX XR PubMed: 21193000 XR CAMP R4: CAMPSQ3432 SQ SEQUENCE 3837.653 DA MW 37AA GIFSLIKGAA KLITKTVAKE AGKTGLELMA CKVTNQC // ID AMRSAP922 PN Brevinin-2ISa SO Odorrana ishikawae PL 33 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 5, AC 'M': 0, 'N': 3, 'P': 0, 'Q': 0, 'R': 1, 'S': 5, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 15.15%, 'C': 6.06%, 'D': 3.03%, 'E': 0%, 'F': 3.03%, 'G': 3.03%, 'H': 0%, 'I': 3.03%, 'K': 9.09%, 'L': 15.15%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 3.03%, 'S': 15.15%, 'T': 6.06%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA E, H, M, P, Q, W, Y MO A; L; S LO D, F, G, I, R BA 16 LA 17 AA 1 BC 4 MC 0 MF 0 XX MM 3395.981 AI 112.424 II 17.47 HP 0.512 HM 0.51 IP 9.666 NC 2.874 SF 0.303, 0.273, 0.303 [Helix, Turn, Sheet] AR 0.03 ME 0, 125 MS 24.080516 XX SC beta XX TO MRSA ATCC 43300 (MIC = 100 μM) XX XR PubMed: 21193000 XR CAMP R4: CAMPSQ3433 SQ SEQUENCE 3395.981 DA MW 33AA SLLDTFKNLA VNAAKSAGVS VLNALSCKIS RTC // ID AMRSAP923 PN Nigrocin-2ISa SO Odorrana ishikawae PL 21 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 23.81%, 'H': 0%, 'I': 9.52%, 'K': 9.52%, 'L': 9.52%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 9.52%, 'V': 9.52%, 'W': 0%, 'Y': 0% MA D, E, H, M, N, P, Q, R, W, Y MO G LO A, S BA 14 LA 7 AA 0 BC 2 MC 0 MF 0 XX MM 2071.524 AI 106.667 II -21.89 HP 1.21 HM 0.543 IP 8.822 NC 1.873 SF 0.381, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.095 ME 0, 125 MS 12.040258 XX SC alpha_beta XX TO MRSA ATCC 43300 (MIC = 12.5 μM) XX XR PubMed: 21193000 XR CAMP R4: CAMPSQ3436 SQ SEQUENCE 2071.524 DA MW 21AA GIFSTVFKAG KGIVCGLTGL C // ID AMRSAP924 PN Nigrocin-2ISb SO Odorrana ishikawae PL 21 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 6, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 28.57%, 'H': 0%, 'I': 9.52%, 'K': 9.52%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 9.52%, 'V': 9.52%, 'W': 0%, 'Y': 0% MA D, E, H, M, N, P, Q, R, S, W, Y MO G LO A, F BA 15 LA 6 AA 0 BC 2 MC 0 MF 0 XX MM 2007.48 AI 125.238 II -16.762 HP 1.276 HM 0.485 IP 8.822 NC 1.873 SF 0.381, 0.286, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 12.040258 XX SC beta XX TO MRSA ATCC 43300 (MIC = 12.5 μM) XX XR PubMed: 21193000 XR CAMP R4: CAMPSQ3437 SQ SEQUENCE 2007.48 DA MW 21AA GILGTVFKAG KGIVCGLTGL C // ID AMRSAP925 PN Entianin SO Bacillus subtilis DSM 15029T PL 32 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 5, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 0, 'S': 3, 'T': 5, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 15.63%, 'D': 0%, 'E': 3.13%, 'F': 3.13%, 'G': 6.25%, 'H': 0%, 'I': 6.25%, 'K': 9.38%, 'L': 9.38%, AF 'M': 0%, 'N': 3.13%, 'P': 3.13%, 'Q': 6.25%, 'R': 0%, 'S': 9.38%, 'T': 15.63%, 'V': 6.25%, 'W': 3.13%, 'Y': 0% MA A, D, H, M, R, Y MO C; T LO E, F, N, P, W BA 12 LA 20 AA 1 BC 3 MC 0 MF 0 XX MM 3493.145 AI 79.063 II 41.072 HP 0.288 HM 0.378 IP 8.213 NC 1.689 SF 0.281, 0.219, 0.125 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5750 MS 18.060387 XX SC beta XX TO MRSA ATCC 43300 (MIC = 8 μG/mL) XX XR PubMed: 21239550 XR CAMP R4: CAMPSQ3438 SQ SEQUENCE 3493.145 DA MW 32AA WKSESVCTPG CVTGLLQTCF LQTITCNCKI SK // ID AMRSAP926 PN PGLa-H SO Xenopus laevis PL 10 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 30%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10%, 'K': 30%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, R, S, T, W, Y MO A; K LO I, V BA 7 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1054.385 AI 176 II -16.47 HP 1 HM 0.675 IP 11.103 NC 2.997 SF 0.4, 0, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO Staphylococcus aureus (MRSA) (MIC=67.8 μG/mL) XX XR PubMed: 22014884 XR CAMP R4: CAMPSQ3525 SQ SEQUENCE 1054.385 DA MW 10AA KIAKVALKAL // ID AMRSAP927 PN Pleurocidin-like peptide AP1 SO Hippoglossoides platessoides PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 5, 'H': 1, 'I': 0, 'K': 5, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 3, 'W': 1, 'Y': 1 AF 'A': 7.69%, 'C': 0%, 'D': 3.85%, 'E': 0%, 'F': 3.85%, 'G': 19.23%, 'H': 3.85%, 'I': 0%, 'K': 19.23%, 'L': 11.54%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 3.85%, 'S': 3.85%, 'T': 3.85%, 'V': 11.54%, 'W': 3.85%, 'Y': 3.85% MA C, E, I, M, N, P, Q MO G; K LO D, F, H, R, S, T, W, Y BA 15 LA 11 AA 1 BC 7 MC 0 MF 0 XX MM 2816.345 AI 86.154 II 22.946 HP -0.231 HM 0.794 IP 11.006 NC 5.087 SF 0.346, 0.231, 0.192 [Helix, Turn, Sheet] AR 0.115 ME 6990, 6990 MS 36.120774 XX SC alpha_beta XX TO MRSA C623 (MIC >= 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ353 SQ SEQUENCE 2816.345 DA MW 26AA GWKSVFRKAK KVGKTVGGLA LDHYLG // ID AMRSAP928 PN Pleurocidin-like peptide AP2 SO Hippoglossoides platessoides PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 5, 'H': 1, 'I': 0, 'K': 5, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 2, 'Y': 1 AF 'A': 7.69%, 'C': 0%, 'D': 3.85%, 'E': 0%, 'F': 3.85%, 'G': 19.23%, 'H': 3.85%, 'I': 0%, 'K': 19.23%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 0%, 'Q': 0%, 'R': 3.85%, 'S': 0%, 'T': 3.85%, 'V': 11.54%, 'W': 7.69%, 'Y': 3.85% MA C, E, I, M, P, Q, S MO G; K LO D, F, H, N, R, T, Y BA 15 LA 11 AA 1 BC 7 MC 0 MF 0 XX MM 2916.425 AI 71.154 II 17.165 HP -0.515 HM 0.724 IP 11.006 NC 5.087 SF 0.346, 0.231, 0.154 [Helix, Turn, Sheet] AR 0.154 ME 12490, 12490 MS 36.120774 XX SC alpha_beta XX TO MRSA C623 (MIC = 16 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ354 SQ SEQUENCE 2916.425 DA MW 26AA GWKKWFNRAK KVGKTVGGLA VDHYLG // ID AMRSAP929 PN Pleurocidin-like peptide YT2 SO Limanda ferruginea PL 25 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 2, 'I': 0, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 2, 'W': 2, 'Y': 1 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4%, 'G': 12%, 'H': 8%, 'I': 0%, 'K': 20%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4%, 'S': 0%, 'T': 8%, 'V': 8%, 'W': 8%, 'Y': 4% MA C, D, E, I, M, N, P, Q, S MO K LO F, R, Y BA 14 LA 11 AA 0 BC 8 MC 0 MF 0 XX MM 2854.4 AI 70.4 II 5.372 HP -0.404 HM 0.697 IP 11.39 NC 6.177 SF 0.32, 0.12, 0.24 [Helix, Turn, Sheet] AR 0.16 ME 12490, 12490 MS 36.120774 XX SC alpha_beta XX TO MRSA C623 (MIC = 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ355 SQ SEQUENCE 2854.4 DA MW 25AA RWGKWFKKAT HVGKHVGKAA LTAYL // ID AMRSAP930 PN Pleurocidin-like peptide GcSc4C5 SO Glyptocephalus cynoglossus PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 1, 'E': 0, 'F': 3, 'G': 5, 'H': 3, 'I': 4, 'K': 3, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.54%, 'C': 0%, 'D': 3.85%, 'E': 0%, 'F': 11.54%, 'G': 19.23%, 'H': 11.54%, 'I': 15.38%, 'K': 11.54%, 'L': 0%, AF 'M': 0%, 'N': 3.85%, 'P': 0%, 'Q': 3.85%, 'R': 0%, 'S': 3.85%, 'T': 0%, 'V': 0%, 'W': 3.85%, 'Y': 0% MA C, E, L, M, P, R, T, V, Y MO G LO D, N, Q, S, W BA 16 LA 10 AA 1 BC 6 MC 0 MF 0 XX MM 2837.239 AI 71.538 II 15.781 HP -0.142 HM 0.7 IP 10.507 NC 2.27 SF 0.308, 0.269, 0.115 [Helix, Turn, Sheet] AR 0.154 ME 5500, 5500 MS 18.060387 XX SC alpha XX TO MRSA C623 (MIC = 16 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ356 SQ SEQUENCE 2837.239 DA MW 26AA GWGSIFKHIF KAGKFIHGAI QAHNDG // ID AMRSAP931 PN Pleurocidin-like peptide GcSc4B7 SO Glyptocephalus cynoglossus PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 5, 'H': 3, 'I': 1, 'K': 2, 'L': 6, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 23.81%, 'H': 14.29%, 'I': 4.76%, 'K': 9.52%, 'L': 28.57%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 4.76%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4.76%, 'Y': 0% MA A, C, D, E, N, P, R, S, T, V, Y MO L LO F, I, M, Q, W BA 15 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2355.875 AI 130 II 6.71 HP 0.39 HM 0.515 IP 10.806 NC 2.27 SF 0.429, 0.238, 0.333 [Helix, Turn, Sheet] AR 0.095 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA C623 (MIC = 4 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ357 SQ SEQUENCE 2355.875 DA MW 21AA FWGKLLKLGM HGIGLLHQHL G // ID AMRSAP932 PN Pleurocidin-like peptide GC3.2 SO Glyptocephalus cynoglossus PL 18 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 2, 'G': 2, 'H': 1, 'I': 0, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 2, 'S': 1, 'T': 1, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 5.56%, 'F': 11.11%, 'G': 11.11%, 'H': 5.56%, 'I': 0%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 11.11%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, I, M, N, P, V, Y MO K LO A, E, H, L, Q, S, T BA 8 LA 10 AA 1 BC 6 MC 0 MF 0 XX MM 2262.605 AI 27.222 II 23.033 HP -1.322 HM 0.707 IP 11.751 NC 4.09 SF 0.278, 0.167, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 30.100645 XX SC alpha_beta XX TO MRSA C623 (MIC >= 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ358 SQ SEQUENCE 2262.605 DA MW 18AA GWKKWFTKGE RLSQRHFA // ID AMRSAP933 PN Pleurocidin-like peptide Hb26 SO Hippoglossus hippoglossus PL 24 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 7, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 20.83%, 'H': 29.17%, 'I': 8.33%, 'K': 4.17%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 4.17%, 'Y': 0% MA A, C, D, E, M, N, P, Q, R, S, T, Y MO H LO K, W BA 16 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2749.225 AI 121.667 II -0.171 HP 0.375 HM 0.562 IP 9.714 NC 1.634 SF 0.458, 0.208, 0.167 [Helix, Turn, Sheet] AR 0.125 ME 5500, 5500 MS 6.020129 XX SC alpha XX TO MRSA C623 (MIC = 8 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ359 SQ SEQUENCE 2749.225 DA MW 24AA FLGLLFHGVH HVGKWIHGLI HGHH // ID AMRSAP934 PN Pleurocidin-like peptide Hb18 SO Hippoglossus hippoglossus PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 2, 'G': 4, 'H': 3, 'I': 1, 'K': 2, 'L': 3, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 1, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 3.85%, 'C': 0%, 'D': 0%, 'E': 3.85%, 'F': 7.69%, 'G': 15.38%, 'H': 11.54%, 'I': 3.85%, 'K': 7.69%, 'L': 11.54%, AF 'M': 3.85%, 'N': 3.85%, 'P': 0%, 'Q': 3.85%, 'R': 11.54%, 'S': 7.69%, 'T': 0%, 'V': 3.85%, 'W': 0%, 'Y': 0% MA C, D, P, T, W, Y MO G LO A, E, I, M, N, Q, V BA 13 LA 13 AA 1 BC 8 MC 0 MF 0 XX MM 2976.458 AI 75 II 64.658 HP -0.585 HM 0.427 IP 12.244 NC 4.272 SF 0.269, 0.269, 0.231 [Helix, Turn, Sheet] AR 0.077 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA C623 (MIC >= 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ360 SQ SEQUENCE 2976.458 DA MW 26AA GFLGILFHGV HHGRKKALQM NSERRS // ID AMRSAP935 PN Pleurocidin SO Pseudopleuronectes americanus PL 25 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 4, 'H': 3, 'I': 0, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 16%, 'H': 12%, 'I': 0%, 'K': 16%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4%, 'T': 4%, 'V': 8%, 'W': 4%, 'Y': 4% MA C, D, E, I, M, N, P, Q, R MO A; G; K LO S, T, W, Y BA 15 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2711.167 AI 70.4 II 4.972 HP -0.068 HM 0.593 IP 10.866 NC 4.269 SF 0.32, 0.2, 0.24 [Helix, Turn, Sheet] AR 0.16 ME 6990, 6990 MS 24.080516 XX SC alpha XX TO MRSA C623 (MIC = 8 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ374 SQ SEQUENCE 2711.167 DA MW 25AA GWGSFFKKAA HVGKHVGKAA LTHYL // ID AMRSAP936 PN RNase 8 SO Homo sapiens PL 127 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 5, 'C': 8, 'D': 5, 'E': 4, 'F': 3, 'G': 5, 'H': 6, 'I': 5, 'K': 11, 'L': 7, AC 'M': 4, 'N': 8, 'P': 13, 'Q': 8, 'R': 2, 'S': 11, 'T': 9, 'V': 7, 'W': 1, 'Y': 5 AF 'A': 3.94%, 'C': 6.3%, 'D': 3.94%, 'E': 3.15%, 'F': 2.36%, 'G': 3.94%, 'H': 4.72%, 'I': 3.94%, 'K': 8.66%, 'L': 5.51%, AF 'M': 3.15%, 'N': 6.3%, 'P': 10.24%, 'Q': 6.3%, 'R': 1.57%, 'S': 8.66%, 'T': 7.09%, 'V': 5.51%, 'W': 0.79%, 'Y': 3.94% MA MO P LO W BA 50 LA 77 AA 9 BC 19 MC 0 MF 0 XX MM 14209.254 AI 56.772 II 58.671 HP -0.633 HM 0.556 IP 8.401 NC 4.049 SF 0.22, 0.291, 0.157 [Helix, Turn, Sheet] AR 0.071 ME 12950, 13450 MS 78.261677 XX SC alpha XX TO Staphylococcus aureus ATCC 33593 (MRSA) (MBC = 1.8 μM TO LD90 = 0.4 μM) XX XR PubMed: 16940129 XR CAMP R4: CAMPSQ3755 SQ SEQUENCE 14209.254 DA MW 127AA KPKDMTSSQW FKTQHVQPSP QACNSAMSII NKYTERCKDL NTFLHEPFSS VAITCQTPNI ACKNSCKNCH QSHGPMSLTM GELTSGKYPN CRYKEKHLNT PYIVACDPPQ QGDPGYPLVP VHLDKVV // ID AMRSAP937 PN RNase 8 SO Homo sapiens PL 127 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 5, 'C': 8, 'D': 5, 'E': 4, 'F': 3, 'G': 5, 'H': 6, 'I': 5, 'K': 11, 'L': 7, AC 'M': 4, 'N': 8, 'P': 13, 'Q': 8, 'R': 2, 'S': 11, 'T': 9, 'V': 7, 'W': 1, 'Y': 5 AF 'A': 3.94%, 'C': 6.3%, 'D': 3.94%, 'E': 3.15%, 'F': 2.36%, 'G': 3.94%, 'H': 4.72%, 'I': 3.94%, 'K': 8.66%, 'L': 5.51%, AF 'M': 3.15%, 'N': 6.3%, 'P': 10.24%, 'Q': 6.3%, 'R': 1.57%, 'S': 8.66%, 'T': 7.09%, 'V': 5.51%, 'W': 0.79%, 'Y': 3.94% MA MO P LO W BA 50 LA 77 AA 9 BC 19 MC 0 MF 0 XX MM 14209.254 AI 56.772 II 58.671 HP -0.633 HM 0.556 IP 8.401 NC 4.049 SF 0.22, 0.291, 0.157 [Helix, Turn, Sheet] AR 0.071 ME 12950, 13450 MS 78.261677 XX SC alpha XX TO Staphylococcus aureus ATCC 43300 (MRSA) (MBC = 1.8 μM TO LD90 = 0.4 μM) XX XR PubMed: 16940129 XR CAMP R4: CAMPSQ3755 SQ SEQUENCE 14209.254 DA MW 127AA KPKDMTSSQW FKTQHVQPSP QACNSAMSII NKYTERCKDL NTFLHEPFSS VAITCQTPNI ACKNSCKNCH QSHGPMSLTM GELTSGKYPN CRYKEKHLNT PYIVACDPPQ QGDPGYPLVP VHLDKVV // ID AMRSAP938 PN Esculentin-2CHa SO Lithobates chiricahuensis PL 37 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 4, 'C': 2, 'D': 2, 'E': 0, 'F': 3, 'G': 5, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 4, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 10.81%, 'C': 5.41%, 'D': 5.41%, 'E': 0%, 'F': 8.11%, 'G': 13.51%, 'H': 0%, 'I': 5.41%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 2.7%, 'R': 2.7%, 'S': 10.81%, 'T': 0%, 'V': 8.11%, 'W': 0%, 'Y': 0% MA E, H, M, N, P, T, W, Y MO K LO Q, R BA 21 LA 16 AA 2 BC 7 MC 0 MF 0 XX MM 3843.604 AI 97.568 II 15.638 HP 0.373 HM 0.755 IP 10.506 NC 4.873 SF 0.324, 0.243, 0.216 [Helix, Turn, Sheet] AR 0.081 ME 0, 125 MS 42.140903 XX SC beta XX TO Staphylococcus aureus (MRSA) XX XR PubMed: 21262304 XR CAMP R4: CAMPSQ3767 SQ SEQUENCE 3843.604 DA MW 37AA GFSSIFRGVA KFASKGLGKD LAKLGVDLVA CKISKQC // ID AMRSAP939 PN Micasin SO Microsporum canis PL 38 TX Fungi PE Experimentally validated XX AC 'A': 3, 'C': 6, 'D': 0, 'E': 2, 'F': 4, 'G': 6, 'H': 2, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 1, 'R': 2, 'S': 1, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.89%, 'C': 15.79%, 'D': 0%, 'E': 5.26%, 'F': 10.53%, 'G': 15.79%, 'H': 5.26%, 'I': 2.63%, 'K': 5.26%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 2.63%, 'R': 5.26%, 'S': 2.63%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, M, V, W, Y MO C; G LO I, Q, S BA 18 LA 20 AA 2 BC 6 MC 0 MF 0 XX MM 4061.677 AI 38.684 II 60.495 HP -0.126 HM 0.45 IP 8.128 NC 1.811 SF 0.184, 0.289, 0.184 [Helix, Turn, Sheet] AR 0.105 ME 0, 375 MS 24.080516 XX SC beta XX TO Staphylococcus aureus MRSA P1386 (LC = 2.46 μM) XX XR PubMed: 22586077 XR CAMP R4: CAMPSQ3776 SQ SEQUENCE 4061.677 DA MW 38AA GFGCPFNENE CHAHCLSIGR KFGFCAGPLR ATCTCGKQ // ID AMRSAP940 PN Micasin SO Microsporum canis PL 38 TX Fungi PE Experimentally validated XX AC 'A': 3, 'C': 6, 'D': 0, 'E': 2, 'F': 4, 'G': 6, 'H': 2, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 1, 'R': 2, 'S': 1, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.89%, 'C': 15.79%, 'D': 0%, 'E': 5.26%, 'F': 10.53%, 'G': 15.79%, 'H': 5.26%, 'I': 2.63%, 'K': 5.26%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 2.63%, 'R': 5.26%, 'S': 2.63%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, M, V, W, Y MO C; G LO I, Q, S BA 18 LA 20 AA 2 BC 6 MC 0 MF 0 XX MM 4061.677 AI 38.684 II 60.495 HP -0.126 HM 0.45 IP 8.128 NC 1.811 SF 0.184, 0.289, 0.184 [Helix, Turn, Sheet] AR 0.105 ME 0, 375 MS 24.080516 XX SC beta XX TO Staphylococcus aureus MRSA P1374 (LC = 3.35 μM) XX XR PubMed: 22586077 XR CAMP R4: CAMPSQ3776 SQ SEQUENCE 4061.677 DA MW 38AA GFGCPFNENE CHAHCLSIGR KFGFCAGPLR ATCTCGKQ // ID AMRSAP941 PN Amythiamicin A SO Amycolatopsis sp. PL 14 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 3, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 42.86%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 21.43%, 'T': 0%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, I, K, L, M, Q, R, T, W, Y MO C LO G, N, P BA 4 LA 10 AA 0 BC 0 MC 0 MF 0 XX MM 1364.62 AI 41.429 II 79.8 HP 1.107 HM 0.219 IP 5.632 NC -0.374 SF 0.143, 0.429, 0 [Helix, Turn, Sheet] AR 0 ME 0, 375 MS 0 XX SC alpha+beta XX TO Staphylococcus aureus No.5 (MRSA) (MIC = 0.2 μG/mL) XX XR PubMed: 8040071 XR CAMP R4: CAMPSQ3870 SQ SEQUENCE 1364.62 DA MW 14AA SCNCVCGVCC SCSP // ID AMRSAP942 PN Amythiamicin A SO Amycolatopsis sp. PL 14 TX Monera PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 3, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 42.86%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 0%, 'R': 0%, 'S': 21.43%, 'T': 0%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, I, K, L, M, Q, R, T, W, Y MO C LO G, N, P BA 4 LA 10 AA 0 BC 0 MC 0 MF 0 XX MM 1364.62 AI 41.429 II 79.8 HP 1.107 HM 0.219 IP 5.632 NC -0.374 SF 0.143, 0.429, 0 [Helix, Turn, Sheet] AR 0 ME 0, 375 MS 0 XX SC alpha+beta XX TO Staphylococcus aureus No.17 (MRSA) (MIC = 0.2 μG/mL) XX XR PubMed: 8040071 XR CAMP R4: CAMPSQ3870 SQ SEQUENCE 1364.62 DA MW 14AA SCNCVCGVCC SCSP // ID AMRSAP943 PN Amphipathic peptide CT2 SO Scorpiops tibetanus PL 14 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 7.14%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 7.14%, 'K': 14.29%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 14.29%, 'Y': 0% MA C, D, H, M, N, P, Q, R, T, Y MO G LO A, E, F, I, L, S, V BA 10 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1577.846 AI 83.571 II 4.607 HP 0.143 HM 0.512 IP 9.537 NC 0.999 SF 0.429, 0.286, 0.214 [Helix, Turn, Sheet] AR 0.214 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (6.25-25 μG/mL) XX XR PubMed: 22542475 XR CAMP R4: CAMPSQ4029 SQ SEQUENCE 1577.846 DA MW 14AA GFWGKLWEGV KSAI // ID AMRSAP944 PN Venom antimicrobial peptide-9 SO Mesobuthus eupeus PL 18 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 1, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 5.56%, 'I': 11.11%, 'K': 11.11%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 5.56%, 'R': 0%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, R, V, W, Y MO F LO A, G, H, P, Q, S, T BA 12 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2107.569 AI 113.889 II 0.761 HP 0.856 HM 0.606 IP 10.805 NC 2.088 SF 0.5, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 12.040258 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus (MRSA) P1374 (MIC = 3.0μM) XX XR PubMed: 29896190 XR CAMP R4: CAMPSQ4134 SQ SEQUENCE 2107.569 DA MW 18AA FFGHLFKLAT KIIPSLFQ // ID AMRSAP945 PN Venom antimicrobial peptide-9 SO Mesobuthus eupeus PL 18 TX Animalia (Arachnida) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 1, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 5.56%, 'I': 11.11%, 'K': 11.11%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 5.56%, 'R': 0%, 'S': 5.56%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, R, V, W, Y MO F LO A, G, H, P, Q, S, T BA 12 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2107.569 AI 113.889 II 0.761 HP 0.856 HM 0.606 IP 10.805 NC 2.088 SF 0.5, 0.167, 0.222 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 12.040258 XX SC alpha XX TO Methicillin-resistant Staphylococcus aureus (MRSA) P1381 (MIC = 1.5μM) XX XR PubMed: 29896190 XR CAMP R4: CAMPSQ4134 SQ SEQUENCE 2107.569 DA MW 18AA FFGHLFKLAT KIIPSLFQ // ID AMRSAP946 PN Brevinin-1JDc SO Odorrana jingdongensis PL 24 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 5, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 8.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 4.17%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 0%, 'R': 4.17%, 'S': 4.17%, 'T': 4.17%, 'V': 20.83%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, N, Q, W, Y MO V LO I, R, S, T BA 16 LA 8 AA 0 BC 4 MC 0 MF 0 XX MM 2603.31 AI 137.917 II 46.171 HP 1.333 HM 0.633 IP 10.513 NC 3.873 SF 0.458, 0.125, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 125 MS 24.080516 XX SC beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 3 μG/mL) XX XR PubMed: 22917879 XR CAMP R4: CAMPSQ4142 SQ SEQUENCE 2603.31 DA MW 24AA FLPAVLRVAA KVVPTVFCLI SKKC // ID AMRSAP947 PN Brevinin-1JDa SO Odorrana jingdongensis PL 24 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 4, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 8.33%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 8.33%, 'L': 8.33%, AF 'M': 0%, 'N': 4.17%, 'P': 8.33%, 'Q': 0%, 'R': 4.17%, 'S': 4.17%, 'T': 4.17%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, Q, W, Y MO A; V LO N, R, S, T BA 16 LA 8 AA 0 BC 3 MC 0 MF 0 XX MM 2561.185 AI 130 II 33.658 HP 1.279 HM 0.585 IP 9.76 NC 2.873 SF 0.417, 0.167, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 125 MS 18.060387 XX SC beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 13 μG/mL) XX XR PubMed: 22917879 XR CAMP R4: CAMPSQ4143 SQ SEQUENCE 2561.185 DA MW 24AA FLPAVIRVAA NVLPTVFCAI SKKC // ID AMRSAP948 PN Brevinin-2JD SO Odorrana jingdongensis PL 33 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 4, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 4, 'L': 7, AC 'M': 0, 'N': 3, 'P': 0, 'Q': 0, 'R': 0, 'S': 5, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 12.12%, 'C': 6.06%, 'D': 3.03%, 'E': 0%, 'F': 3.03%, 'G': 6.06%, 'H': 0%, 'I': 0%, 'K': 12.12%, 'L': 21.21%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 15.15%, 'T': 6.06%, 'V': 6.06%, 'W': 0%, 'Y': 0% MA E, H, I, M, P, Q, R, W, Y MO L LO D, F BA 16 LA 17 AA 1 BC 4 MC 0 MF 0 XX MM 3367.967 AI 112.424 II 11.633 HP 0.43 HM 0.453 IP 9.601 NC 2.873 SF 0.303, 0.303, 0.333 [Helix, Turn, Sheet] AR 0.03 ME 0, 125 MS 24.080516 XX SC beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 19 μG/mL) XX XR PubMed: 22917879 XR CAMP R4: CAMPSQ4144 SQ SEQUENCE 3367.967 DA MW 33AA GLLDTFKNLA LNAAKSAGVS VLNSLSCKLS KTC // ID AMRSAP949 PN Nigrocin-2JDa SO Odorrana jingdongensis PL 21 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 6, 'H': 0, 'I': 2, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 28.57%, 'H': 0%, 'I': 9.52%, 'K': 14.29%, 'L': 19.05%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA D, E, H, M, N, P, Q, R, T, W, Y MO G LO A, F, S, V BA 15 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2034.549 AI 130 II -5.562 HP 1.1 HM 0.525 IP 9.668 NC 2.873 SF 0.381, 0.333, 0.238 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 18.060387 XX SC beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 22917879 XR CAMP R4: CAMPSQ4150 SQ SEQUENCE 2034.549 DA MW 21AA GIFGKILGAG KKVLCGLSGL C // ID AMRSAP950 PN Esculentin-2JDa SO Odorrana jingdongensis PL 37 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 0, 'E': 2, 'F': 1, 'G': 5, 'H': 0, 'I': 3, 'K': 6, 'L': 5, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 4, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.51%, 'C': 5.41%, 'D': 0%, 'E': 5.41%, 'F': 2.7%, 'G': 13.51%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 13.51%, AF 'M': 2.7%, 'N': 2.7%, 'P': 0%, 'Q': 2.7%, 'R': 0%, 'S': 0%, 'T': 10.81%, 'V': 2.7%, 'W': 0%, 'Y': 0% MA D, H, P, R, S, W, Y MO K LO F, M, N, Q, V BA 21 LA 16 AA 2 BC 6 MC 0 MF 0 XX MM 3821.654 AI 105.676 II -1.554 HP 0.357 HM 0.644 IP 10.138 NC 3.876 SF 0.27, 0.162, 0.351 [Helix, Turn, Sheet] AR 0.027 ME 0, 125 MS 36.120774 XX SC beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 22917879 XR CAMP R4: CAMPSQ4151 SQ SEQUENCE 3821.654 DA MW 37AA GLFTLIKGAA KLIGKTVAKE AGKTGLELMA CKITNQC // ID AMRSAP951 PN Nigrocin-2JDb SO Odorrana jingdongensis PL 21 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 6, 'H': 0, 'I': 2, 'K': 3, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 28.57%, 'H': 0%, 'I': 9.52%, 'K': 14.29%, 'L': 14.29%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 0%, 'V': 9.52%, 'W': 0%, 'Y': 0% MA A, D, E, H, N, P, Q, R, T, W, Y MO G LO F, M, S BA 15 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2080.636 AI 120.476 II -5.562 HP 1.124 HM 0.523 IP 9.668 NC 2.873 SF 0.381, 0.333, 0.19 [Helix, Turn, Sheet] AR 0.048 ME 0, 125 MS 18.060387 XX SC alpha XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 22917879 XR CAMP R4: CAMPSQ4152 SQ SEQUENCE 2080.636 DA MW 21AA GIFGKILGVG KKVLCGLSGM C // ID AMRSAP952 PN Siamycin II SO Streptomyces strain AA6532 PL 21 TX Monera PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 1, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 9.52%, 'C': 19.05%, 'D': 4.76%, 'E': 0%, 'F': 9.52%, 'G': 19.05%, 'H': 0%, 'I': 9.52%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 4.76%, 'T': 0%, 'V': 4.76%, 'W': 4.76%, 'Y': 4.76% MA E, H, K, M, P, Q, R, T MO C; G LO D, L, N, S, V, W, Y BA 13 LA 8 AA 1 BC 0 MC 0 MF 0 XX MM 2199.559 AI 79.048 II 29.776 HP 1.171 HM 0.3 IP 3.75 NC -1.25 SF 0.381, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.19 ME 6990, 7240 MS 0 XX SC beta XX TO Staphylococcus aureus A15036 (MRSA) (MIC = 3.1 μG/mL) XX XR PubMed: 8557614 XR CAMP R4: CAMPSQ4331 SQ SEQUENCE 2199.559 DA MW 21AA CLGIGSCNDF AGCGYAIVCF W // ID AMRSAP953 PN Caerin-1.1 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 3, 'I': 1, 'K': 1, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 6, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 0%, 'G': 8%, 'H': 12%, 'I': 4%, 'K': 4%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 8%, 'T': 0%, 'V': 24%, 'W': 0%, 'Y': 0% MA C, D, F, M, N, Q, R, T, W, Y MO V LO E, I, K BA 18 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2585.131 AI 171.2 II 29.696 HP 1.188 HM 0.471 IP 7.81 NC 0.272 SF 0.48, 0.24, 0.32 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ494 SQ SEQUENCE 2585.131 DA MW 25AA GLLSVLGSVA KHVLPHVVPV IAEHL // ID AMRSAP954 PN Caerin-1.1 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 3, 'I': 1, 'K': 1, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 6, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 0%, 'G': 8%, 'H': 12%, 'I': 4%, 'K': 4%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 8%, 'T': 0%, 'V': 24%, 'W': 0%, 'Y': 0% MA C, D, F, M, N, Q, R, T, W, Y MO V LO E, I, K BA 18 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2585.131 AI 171.2 II 29.696 HP 1.188 HM 0.471 IP 7.81 NC 0.272 SF 0.48, 0.24, 0.32 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA1 (Clincial isolate) (MIC = 60 μG/mL) XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ494 SQ SEQUENCE 2585.131 DA MW 25AA GLLSVLGSVA KHVLPHVVPV IAEHL // ID AMRSAP955 PN Caerin-1.1 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 3, 'I': 1, 'K': 1, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 6, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 0%, 'G': 8%, 'H': 12%, 'I': 4%, 'K': 4%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 8%, 'T': 0%, 'V': 24%, 'W': 0%, 'Y': 0% MA C, D, F, M, N, Q, R, T, W, Y MO V LO E, I, K BA 18 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2585.131 AI 171.2 II 29.696 HP 1.188 HM 0.471 IP 7.81 NC 0.272 SF 0.48, 0.24, 0.32 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA2 (Clincial isolate) (MIC = 15 μG/mL) XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ494 SQ SEQUENCE 2585.131 DA MW 25AA GLLSVLGSVA KHVLPHVVPV IAEHL // ID AMRSAP956 PN Caerin-1.1 SO Litoria splendida PL 25 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 3, 'I': 1, 'K': 1, 'L': 5, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 6, 'W': 0, 'Y': 0 AF 'A': 8%, 'C': 0%, 'D': 0%, 'E': 4%, 'F': 0%, 'G': 8%, 'H': 12%, 'I': 4%, 'K': 4%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 0%, 'S': 8%, 'T': 0%, 'V': 24%, 'W': 0%, 'Y': 0% MA C, D, F, M, N, Q, R, T, W, Y MO V LO E, I, K BA 18 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2585.131 AI 171.2 II 29.696 HP 1.188 HM 0.471 IP 7.81 NC 0.272 SF 0.48, 0.24, 0.32 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA3 (Clincial isolate) (MIC = 30 μG/mL) XX XR PubMed: 34259550 XR CAMP R4: CAMPSQ494 SQ SEQUENCE 2585.131 DA MW 25AA GLLSVLGSVA KHVLPHVVPV IAEHL // ID AMRSAP957 PN Pilosulin-1 SO Myrmecia pilosula PL 20 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 5%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, T, W, Y MO G LO A, F, K, P, S BA 15 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 2108.605 AI 146 II 13.445 HP 0.81 HM 0.916 IP 12.807 NC 3.998 SF 0.45, 0.3, 0.2 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) LT1338 (MIC = 3 μM) XX XR PubMed: 15639237 XR CAMP R4: CAMPSQ608 SQ SEQUENCE 2108.605 DA MW 20AA GLGSVFGRLA RILGRVIPKV // ID AMRSAP958 PN Pilosulin-1 SO Myrmecia pilosula PL 20 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 20%, 'H': 0%, 'I': 10%, 'K': 5%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, T, W, Y MO G LO A, F, K, P, S BA 15 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 2108.605 AI 146 II 13.445 HP 0.81 HM 0.916 IP 12.807 NC 3.998 SF 0.45, 0.3, 0.2 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) LT1334 (MIC = 1.5 μM) XX XR PubMed: 15639237 XR CAMP R4: CAMPSQ608 SQ SEQUENCE 2108.605 DA MW 20AA GLGSVFGRLA RILGRVIPKV // ID AMRSAP959 PN Cathelicidin SO Gallus gallus PL 26 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 2 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 3.85%, 'H': 0%, 'I': 11.54%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 3.85%, 'V': 15.38%, 'W': 3.85%, 'Y': 7.69% MA C, D, E, F, H, M, Q, S MO K; R; V LO G, N, P, T, W BA 14 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 3141.889 AI 127.308 II 8.012 HP -0.069 HM 0.785 IP 12.131 NC 7.995 SF 0.462, 0.115, 0.154 [Helix, Turn, Sheet] AR 0.115 ME 8480, 8480 MS 48.161032 XX SC beta XX TO S. aureus (MRSA) BAA-39 XX XR PubMed: 16326712 XR CAMP R4: CAMPSQ644 SQ SEQUENCE 3141.889 DA MW 26AA RVKRVWPLVI RTVIAGYNLY RAIKKK // ID AMRSAP960 PN Cathelicidin SO Gallus gallus PL 26 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 2 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 3.85%, 'H': 0%, 'I': 11.54%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 3.85%, 'V': 15.38%, 'W': 3.85%, 'Y': 7.69% MA C, D, E, F, H, M, Q, S MO K; R; V LO G, N, P, T, W BA 14 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 3141.889 AI 127.308 II 8.012 HP -0.069 HM 0.785 IP 12.131 NC 7.995 SF 0.462, 0.115, 0.154 [Helix, Turn, Sheet] AR 0.115 ME 8480, 8480 MS 48.161032 XX SC beta XX TO S. aureus (MRSA) 43300 XX XR PubMed: 16326712 XR CAMP R4: CAMPSQ644 SQ SEQUENCE 3141.889 DA MW 26AA RVKRVWPLVI RTVIAGYNLY RAIKKK // ID AMRSAP961 PN Pleurocidin-like peptide AP3 SO Hippoglossoides platessoides PL 23 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 8.7%, 'C': 0%, 'D': 0%, 'E': 4.35%, 'F': 0%, 'G': 8.7%, 'H': 4.35%, 'I': 0%, 'K': 21.74%, 'L': 21.74%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 4.35%, 'S': 0%, 'T': 8.7%, 'V': 8.7%, 'W': 4.35%, 'Y': 4.35% MA C, D, F, I, M, N, P, Q, S MO K; L LO E, H, R, W, Y BA 12 LA 11 AA 1 BC 7 MC 0 MF 0 XX MM 2653.253 AI 118.696 II 14.326 HP -0.178 HM 0.53 IP 11.006 NC 5.088 SF 0.391, 0.087, 0.348 [Helix, Turn, Sheet] AR 0.087 ME 6990, 6990 MS 36.120774 XX SC beta XX TO MRSA C623 (MIC = 4 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ675 SQ SEQUENCE 2653.253 DA MW 23AA GWRTLLKKAE VKTVGKLALK HYL // ID AMRSAP962 PN MBMAP28 SO Bos taurus PL 27 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 2, 'R': 4, 'S': 1, 'T': 2, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.81%, 'H': 0%, 'I': 3.7%, 'K': 11.11%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 7.41%, 'Q': 7.41%, 'R': 14.81%, 'S': 3.7%, 'T': 7.41%, 'V': 0%, 'W': 3.7%, 'Y': 3.7% MA C, D, E, F, H, M, N, V MO G; R LO I, S, W, Y BA 14 LA 13 AA 0 BC 7 MC 0 MF 0 XX MM 3010.542 AI 68.889 II 66.985 HP -0.911 HM 0.947 IP 12.526 NC 6.996 SF 0.222, 0.259, 0.222 [Helix, Turn, Sheet] AR 0.074 ME 6990, 6990 MS 42.140903 XX SC alpha_beta XX TO S. aureus MRSA (MIC >= 64 μM) XX XR PubMed: 8910461 XR CAMP R4: CAMPSQ679 SQ SEQUENCE 3010.542 DA MW 27AA GGLRSLGRKI LRAWKKYGPQ ATPATRQ // ID AMRSAP963 PN Cathelicidin-5 , Antibacterial peptide BMAP-28 , Myeloid antibacterial peptide 28 SO Bos taurus PL 28 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 0, 'I': 6, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 3.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 17.86%, 'H': 0%, 'I': 21.43%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 14.29%, 'S': 3.57%, 'T': 0%, 'V': 3.57%, 'W': 3.57%, 'Y': 3.57% MA C, D, E, F, H, M, N, Q, T MO I LO A, S, V, W, Y BA 19 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 3131.894 AI 139.286 II 48.161 HP 0.232 HM 0.947 IP 12.526 NC 6.996 SF 0.429, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 6990, 6990 MS 42.140903 XX SC alpha_beta XX TO S. aureus MRSA (MIC = 4 μM) XX XR PubMed: 8910461 XR CAMP R4: CAMPSQ687 SQ SEQUENCE 3131.894 DA MW 28AA GGLRSLGRKI LRAWKKYGPI IVPIIRIG // ID AMRSAP964 PN Cryptonin SO Cryptotympana dubia PL 24 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 4, 'L': 7, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 4.17%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.5%, 'H': 0%, 'I': 8.33%, 'K': 16.67%, 'L': 29.17%, AF 'M': 0%, 'N': 4.17%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, M, P, Q, S, T, V, W, Y MO L LO C, N BA 14 LA 10 AA 0 BC 8 MC 0 MF 0 XX MM 2704.452 AI 154.583 II 24.363 HP 0.142 HM 0.944 IP 12.532 NC 7.935 SF 0.375, 0.167, 0.375 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO Methicilin-resistant S.aureus (MRSA) (MIC = 25 μG/mL) XX XR PubMed: 18000874 XR CAMP R4: CAMPSQ735 SQ SEQUENCE 2704.452 DA MW 24AA GLLNGLALRL GKRALKKIIK RLCR // ID AMRSAP965 PN RL-37 SO Macaca mulatta PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 1, 'F': 3, 'G': 6, 'H': 0, 'I': 2, 'K': 7, 'L': 4, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 3, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 2.7%, 'C': 0%, 'D': 2.7%, 'E': 2.7%, 'F': 8.11%, 'G': 16.22%, 'H': 0%, 'I': 5.41%, 'K': 18.92%, 'L': 10.81%, AF 'M': 0%, 'N': 5.41%, 'P': 2.7%, 'Q': 2.7%, 'R': 8.11%, 'S': 2.7%, 'T': 2.7%, 'V': 8.11%, 'W': 0%, 'Y': 0% MA C, H, M, W, Y MO K LO A, D, E, P, Q, S, T BA 20 LA 17 AA 2 BC 10 MC 0 MF 0 XX MM 4100.913 AI 89.459 II -7.962 HP -0.454 HM 0.746 IP 11.861 NC 7.998 SF 0.324, 0.27, 0.162 [Helix, Turn, Sheet] AR 0.081 ME 0, 0 MS 60.20129 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 1.33 � 0.02 at 0 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: CAMPSQ780 SQ SEQUENCE 4100.913 DA MW 37AA RLGNFFRKVK EKIGGGLKKV GQKIKDFLGN LVPRTAS // ID AMRSAP966 PN RL-37 SO Macaca mulatta PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 1, 'F': 3, 'G': 6, 'H': 0, 'I': 2, 'K': 7, 'L': 4, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 3, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 2.7%, 'C': 0%, 'D': 2.7%, 'E': 2.7%, 'F': 8.11%, 'G': 16.22%, 'H': 0%, 'I': 5.41%, 'K': 18.92%, 'L': 10.81%, AF 'M': 0%, 'N': 5.41%, 'P': 2.7%, 'Q': 2.7%, 'R': 8.11%, 'S': 2.7%, 'T': 2.7%, 'V': 8.11%, 'W': 0%, 'Y': 0% MA C, H, M, W, Y MO K LO A, D, E, P, Q, S, T BA 20 LA 17 AA 2 BC 10 MC 0 MF 0 XX MM 4100.913 AI 89.459 II -7.962 HP -0.454 HM 0.746 IP 11.861 NC 7.998 SF 0.324, 0.27, 0.162 [Helix, Turn, Sheet] AR 0.081 ME 0, 0 MS 60.20129 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4.17 � 0.30 at 100 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: CAMPSQ780 SQ SEQUENCE 4100.913 DA MW 37AA RLGNFFRKVK EKIGGGLKKV GQKIKDFLGN LVPRTAS // ID AMRSAP967 PN RL-37 SO Macaca mulatta PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 1, 'F': 3, 'G': 6, 'H': 0, 'I': 2, 'K': 7, 'L': 4, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 3, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 2.7%, 'C': 0%, 'D': 2.7%, 'E': 2.7%, 'F': 8.11%, 'G': 16.22%, 'H': 0%, 'I': 5.41%, 'K': 18.92%, 'L': 10.81%, AF 'M': 0%, 'N': 5.41%, 'P': 2.7%, 'Q': 2.7%, 'R': 8.11%, 'S': 2.7%, 'T': 2.7%, 'V': 8.11%, 'W': 0%, 'Y': 0% MA C, H, M, W, Y MO K LO A, D, E, P, Q, S, T BA 20 LA 17 AA 2 BC 10 MC 0 MF 0 XX MM 4100.913 AI 89.459 II -7.962 HP -0.454 HM 0.746 IP 11.861 NC 7.998 SF 0.324, 0.27, 0.162 [Helix, Turn, Sheet] AR 0.081 ME 0, 0 MS 60.20129 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 11.6 � 0.90 at 175 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: CAMPSQ780 SQ SEQUENCE 4100.913 DA MW 37AA RLGNFFRKVK EKIGGGLKKV GQKIKDFLGN LVPRTAS // ID AMRSAP968 PN LL-37 pentamide SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 4, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.51%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 8.11%, AF 'M': 0%, 'N': 8.11%, 'P': 2.7%, 'Q': 10.81%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, W, Y MO K LO P, T BA 16 LA 21 AA 0 BC 11 MC 0 MF 0 XX MM 4522.418 AI 78.919 II 21.984 HP -0.751 HM 0.965 IP 13.118 NC 10.996 SF 0.351, 0.216, 0.081 [Helix, Turn, Sheet] AR 0.135 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 1.72 � 0.33 at 0 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: CAMPSQ781 SQ SEQUENCE 4522.418 DA MW 37AA LLGNFFRKSK QKIGKQFKRI VQRIKNFFRN LVPRTQS // ID AMRSAP969 PN LL-37 pentamide SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 4, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.51%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 8.11%, AF 'M': 0%, 'N': 8.11%, 'P': 2.7%, 'Q': 10.81%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, W, Y MO K LO P, T BA 16 LA 21 AA 0 BC 11 MC 0 MF 0 XX MM 4522.418 AI 78.919 II 21.984 HP -0.751 HM 0.965 IP 13.118 NC 10.996 SF 0.351, 0.216, 0.081 [Helix, Turn, Sheet] AR 0.135 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 186 � 16.7 at 100 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: CAMPSQ781 SQ SEQUENCE 4522.418 DA MW 37AA LLGNFFRKSK QKIGKQFKRI VQRIKNFFRN LVPRTQS // ID AMRSAP970 PN LL-37 pentamide SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 4, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.51%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 8.11%, AF 'M': 0%, 'N': 8.11%, 'P': 2.7%, 'Q': 10.81%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, W, Y MO K LO P, T BA 16 LA 21 AA 0 BC 11 MC 0 MF 0 XX MM 4522.418 AI 78.919 II 21.984 HP -0.751 HM 0.965 IP 13.118 NC 10.996 SF 0.351, 0.216, 0.081 [Helix, Turn, Sheet] AR 0.135 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC > 250 at 175 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: CAMPSQ781 SQ SEQUENCE 4522.418 DA MW 37AA LLGNFFRKSK QKIGKQFKRI VQRIKNFFRN LVPRTQS // ID AMRSAP971 PN OaBac5 SO Ovis aries PL 43 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 6, 'G': 1, 'H': 0, 'I': 4, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 20, 'Q': 0, 'R': 11, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.95%, 'G': 2.33%, 'H': 0%, 'I': 9.3%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 46.51%, 'Q': 0%, 'R': 25.58%, 'S': 0%, 'T': 0%, 'V': 2.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, L, M, N, Q, S, T, W, Y MO P LO G, V BA 32 LA 11 AA 0 BC 11 MC 0 MF 0 XX MM 5170.293 AI 43.023 II 135.065 HP -0.998 HM 0.715 IP 13.5 NC 10.998 SF 0.256, 0.488, 0 [Helix, Turn, Sheet] AR 0.14 ME 0, 0 MS 66.221419 XX SC alpha_beta XX TO S. aureus 1056 MRSA (MIC = 10 μG/mL at No NaCL) XX XR PubMed: 14651991 XR CAMP R4: CAMPSQ782 SQ SEQUENCE 5170.293 DA MW 43AA RFRPPIRRPP IRPPFRPPFR PPVRPPIRPP FRPPFRPPIG PFP // ID AMRSAP972 PN OaBac5 SO Ovis aries PL 43 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 6, 'G': 1, 'H': 0, 'I': 4, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 20, 'Q': 0, 'R': 11, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.95%, 'G': 2.33%, 'H': 0%, 'I': 9.3%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 46.51%, 'Q': 0%, 'R': 25.58%, 'S': 0%, 'T': 0%, 'V': 2.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, L, M, N, Q, S, T, W, Y MO P LO G, V BA 32 LA 11 AA 0 BC 11 MC 0 MF 0 XX MM 5170.293 AI 43.023 II 135.065 HP -0.998 HM 0.715 IP 13.5 NC 10.998 SF 0.256, 0.488, 0 [Helix, Turn, Sheet] AR 0.14 ME 0, 0 MS 66.221419 XX SC alpha_beta XX TO S. aureus 1056 MRSA (MIC > 30 μG/mL at 100 mM NaCL) XX XR PubMed: 14651991 XR CAMP R4: CAMPSQ782 SQ SEQUENCE 5170.293 DA MW 43AA RFRPPIRRPP IRPPFRPPFR PPVRPPIRPP FRPPFRPPIG PFP // ID AMRSAP973 PN OaBac7.5 SO Ovis aries PL 60 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 7, AC 'M': 0, 'N': 0, 'P': 22, 'Q': 3, 'R': 20, 'S': 1, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 0%, 'L': 11.67%, AF 'M': 0%, 'N': 0%, 'P': 36.67%, 'Q': 5%, 'R': 33.33%, 'S': 1.67%, 'T': 0%, 'V': 0%, 'W': 3.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, M, N, T, V, Y MO P LO S BA 36 LA 24 AA 0 BC 20 MC 0 MF 0 XX MM 7480.142 AI 78 II 111.717 HP -1.487 HM 0.767 IP 13.779 NC 19.998 SF 0.233, 0.383, 0.117 [Helix, Turn, Sheet] AR 0.033 ME 11000, 11000 MS 120.40258 XX SC alpha_beta XX TO S. aureus 1056 MRSA (MIC = 10 μG/mL at No NaCL) XX XR PubMed: 14651991 XR CAMP R4: CAMPSQ783 SQ SEQUENCE 7480.142 DA MW 60AA RRLRPRRPRL PRPRPRPRPR PRSLPLPRPQ PRRIPRPILL PWRPPRPIPR PQIQPIPRWL // ID AMRSAP974 PN OaBac7.5 SO Ovis aries PL 60 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 7, AC 'M': 0, 'N': 0, 'P': 22, 'Q': 3, 'R': 20, 'S': 1, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 0%, 'L': 11.67%, AF 'M': 0%, 'N': 0%, 'P': 36.67%, 'Q': 5%, 'R': 33.33%, 'S': 1.67%, 'T': 0%, 'V': 0%, 'W': 3.33%, 'Y': 0% MA A, C, D, E, F, G, H, K, M, N, T, V, Y MO P LO S BA 36 LA 24 AA 0 BC 20 MC 0 MF 0 XX MM 7480.142 AI 78 II 111.717 HP -1.487 HM 0.767 IP 13.779 NC 19.998 SF 0.233, 0.383, 0.117 [Helix, Turn, Sheet] AR 0.033 ME 11000, 11000 MS 120.40258 XX SC alpha_beta XX TO S. aureus 1056 MRSA (MIC > 30 μG/mL at 100 mM NaCl) XX XR PubMed: 14651991 XR CAMP R4: CAMPSQ783 SQ SEQUENCE 7480.142 DA MW 60AA RRLRPRRPRL PRPRPRPRPR PRSLPLPRPQ PRRIPRPILL PWRPPRPIPR PQIQPIPRWL // ID AMRSAP975 PN IN1 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 15.38%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 15.38%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, Q, S, T, V, Y MO W LO K, L, P, R BA 9 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1938.357 AI 60 II 63.677 HP -1.3 HM 0.42 IP 12.532 NC 3.997 SF 0.538, 0.154, 0.154 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 24.080516 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 31.25 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8207 SQ SEQUENCE 1938.357 DA MW 13AA LLPWKWPWWK WRR // ID AMRSAP976 PN IN2 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 38.46%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V, Y MO R; W LO P BA 8 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2021.369 AI 0 II 149.585 HP -2.446 HM 0.592 IP 13.102 NC 4.998 SF 0.385, 0.231, 0 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 30.100645 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 31.25 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8208 SQ SEQUENCE 2021.369 DA MW 13AA RRPWRWPWWP WRR // ID AMRSAP977 PN IN3 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 46.15%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 30.77%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V, Y MO R LO P BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1991.343 AI 0 II 190.062 HP -2.723 HM 0.714 IP 13.199 NC 5.998 SF 0.308, 0.231, 0 [Helix, Turn, Sheet] AR 0.308 ME 22000, 22000 MS 36.120774 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 31.25 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8209 SQ SEQUENCE 1991.343 DA MW 13AA RRPWRWPRWP WRR // ID AMRSAP978 PN IN4 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 46.15%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, Q, S, T, V, Y MO R LO L BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1918.289 AI 30 II 160.815 HP -2.362 HM 0.882 IP 13.199 NC 5.998 SF 0.308, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.231 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 62.5 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8210 SQ SEQUENCE 1918.289 DA MW 13AA RLPWRWPRRP WRR // ID AMRSAP979 PN RN1 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 3, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 15%, 'K': 15%, 'L': 10%, AF 'M': 5%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA D, E, H, N, Q, S, T, W, Y MO I; K LO F, M, P, R BA 14 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2160.812 AI 136.5 II 22.195 HP 1.21 HM 0.521 IP 10.513 NC 3.873 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 125 MS 24.080516 XX SC beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 250 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8211 SQ SEQUENCE 2160.812 DA MW 20AA FLGGLIKIVP AMICAVRKKC // ID AMRSAP980 PN RN2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 15%, 'L': 10%, AF 'M': 5%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA D, E, H, N, Q, S, T, W, Y MO K LO F, M, R BA 14 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2144.769 AI 117 II 36.545 HP 0.905 HM 0.443 IP 10.513 NC 3.873 SF 0.35, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 125 MS 24.080516 XX SC beta XX TO Methicillin resistant S.aureus (MRSA) (MIC >= 250 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8212 SQ SEQUENCE 2144.769 DA MW 20AA FLGGLIKPVP AMICAVRKKC // ID AMRSAP981 PN RN3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 15%, 'L': 10%, AF 'M': 5%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA D, E, H, N, Q, S, T, W, Y MO K LO F, M, P BA 13 LA 7 AA 0 BC 5 MC 0 MF 0 XX MM 2203.84 AI 117 II 46.985 HP 0.76 HM 0.506 IP 11.062 NC 4.873 SF 0.35, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 125 MS 30.100645 XX SC beta XX TO Methicillin resistant S.aureus (MRSA) (MIC >= 250 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8213 SQ SEQUENCE 2203.84 DA MW 20AA FLGGLIKRVP AMICAVRKKC // ID AMRSAP982 PN RN4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 15%, 'L': 10%, AF 'M': 5%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, H, N, Q, S, T, W, Y MO K LO F, M, V BA 13 LA 7 AA 0 BC 5 MC 0 MF 0 XX MM 2201.824 AI 102.5 II 56.615 HP 0.47 HM 0.432 IP 11.062 NC 4.873 SF 0.3, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 0, 125 MS 30.100645 XX SC alpha+beta XX TO Methicillin resistant S.aureus (MRSA) (MIC >= 250 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8214 SQ SEQUENCE 2201.824 DA MW 20AA FLGGLIKRPP AMICAVRKKC // ID AMRSAP983 PN RN7-IN10 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 11.76%, 'H': 0%, 'I': 5.88%, 'K': 11.76%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 11.76%, 'Q': 0%, 'R': 11.76%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 29.41%, 'Y': 0% MA A, C, D, E, H, M, N, Q, S, T, V, Y MO W LO F, I BA 13 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 2312.796 AI 68.824 II 41.982 HP -0.612 HM 0.37 IP 12.532 NC 3.997 SF 0.529, 0.235, 0.118 [Helix, Turn, Sheet] AR 0.353 ME 27500, 27500 MS 24.080516 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 7.81 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8215 SQ SEQUENCE 2312.796 DA MW 17AA FLGGLIKWKW PWWPWRR // ID AMRSAP984 PN RN7-IN9 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 12.5%, 'H': 0%, 'I': 6.25%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 12.5%, 'Q': 0%, 'R': 12.5%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, H, M, N, Q, S, T, V, Y MO W LO F, I BA 12 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 2126.583 AI 73.125 II 43.981 HP -0.594 HM 0.502 IP 12.532 NC 3.997 SF 0.5, 0.25, 0.125 [Helix, Turn, Sheet] AR 0.313 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 7.81 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8216 SQ SEQUENCE 2126.583 DA MW 16AA FLGGLIKKWP WWPWRR // ID AMRSAP985 PN RN7-IN8 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 13.33%, 'H': 0%, 'I': 6.67%, 'K': 6.67%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 13.33%, 'Q': 0%, 'R': 13.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 26.67%, 'Y': 0% MA A, C, D, E, H, M, N, Q, S, T, V, Y MO W LO F, I, K BA 12 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1998.409 AI 78 II 46.247 HP -0.373 HM 0.538 IP 12.516 NC 2.998 SF 0.533, 0.267, 0.133 [Helix, Turn, Sheet] AR 0.333 ME 22000, 22000 MS 18.060387 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 7.81 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8217 SQ SEQUENCE 1998.409 DA MW 15AA FLGGLIKWPW WPWRR // ID AMRSAP986 PN RN7-IN7 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 7.14%, 'K': 7.14%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 14.29%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 21.43%, 'Y': 0% MA A, C, D, E, H, M, N, Q, S, T, V, Y MO W LO F, I, K BA 11 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1812.196 AI 83.571 II 43.45 HP -0.336 HM 0.457 IP 12.516 NC 2.998 SF 0.5, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA) (MIC = 31.25 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8218 SQ SEQUENCE 1812.196 DA MW 14AA FLGGLIKPWW PWRR // ID AMRSAP987 PN RN7-IN6 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 15.38%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 7.69%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, H, M, N, Q, S, T, V, Y MO W LO F, I, K, P BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1715.079 AI 90 II 54.038 HP -0.238 HM 0.343 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.154 [Helix, Turn, Sheet] AR 0.308 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO Methicillin resistant S.aureus (MRSA)(MIC = 7.81 μG/mL) XX XR PubMed: 26046345 XR CAMP R4: CAMPSQ8219 SQ SEQUENCE 1715.079 DA MW 13AA FLGGLIKWWP WRR // ID AMRSAP988 PN OaBac5gamma SO Ovis aries PL 43 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 6, 'G': 1, 'H': 0, 'I': 4, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 20, 'Q': 0, 'R': 10, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.95%, 'G': 2.33%, 'H': 0%, 'I': 9.3%, 'K': 0%, 'L': 2.33%, AF 'M': 0%, 'N': 0%, 'P': 46.51%, 'Q': 0%, 'R': 23.26%, 'S': 0%, 'T': 0%, 'V': 2.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, Q, S, T, W, Y MO P LO G, L, V BA 33 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 5127.265 AI 52.093 II 130.702 HP -0.805 HM 0.719 IP 13.454 NC 9.998 SF 0.279, 0.488, 0.023 [Helix, Turn, Sheet] AR 0.14 ME 0, 0 MS 60.20129 XX SC alpha_beta XX TO S. aureus 1056 MRSA (MIC = 10 μG/mL at No NaCL) XX XR PubMed: 14651991 XR CAMP R4: CAMPSQ8253 SQ SEQUENCE 5127.265 DA MW 43AA RFRPPILRPP IRPPFRPPFR PPVRPPIRPP FRPPFRPPIG PFP // ID AMRSAP989 PN OaBac5gamma SO Ovis aries PL 43 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 6, 'G': 1, 'H': 0, 'I': 4, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 20, 'Q': 0, 'R': 10, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.95%, 'G': 2.33%, 'H': 0%, 'I': 9.3%, 'K': 0%, 'L': 2.33%, AF 'M': 0%, 'N': 0%, 'P': 46.51%, 'Q': 0%, 'R': 23.26%, 'S': 0%, 'T': 0%, 'V': 2.33%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, K, M, N, Q, S, T, W, Y MO P LO G, L, V BA 33 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 5127.265 AI 52.093 II 130.702 HP -0.805 HM 0.719 IP 13.454 NC 9.998 SF 0.279, 0.488, 0.023 [Helix, Turn, Sheet] AR 0.14 ME 0, 0 MS 60.20129 XX SC alpha_beta XX TO S. aureus 1056 MRSA (MIC > 150 μG/mL at 100 mM NaCL) XX XR PubMed: 14651991 XR CAMP R4: CAMPSQ8253 SQ SEQUENCE 5127.265 DA MW 43AA RFRPPILRPP IRPPFRPPFR PPVRPPIRPP FRPPFRPPIG PFP // ID AMRSAP990 PN CP26 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 4, 'T': 3, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 11.54%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 3.85%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 26.92%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 0%, 'R': 0%, 'S': 15.38%, 'T': 11.54%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, G, H, M, N, Q, R, Y MO K LO F, P, W BA 12 LA 14 AA 0 BC 7 MC 0 MF 0 XX MM 2861.508 AI 93.846 II 1.062 HP -0.073 HM 0.688 IP 11.579 NC 6.996 SF 0.308, 0.192, 0.192 [Helix, Turn, Sheet] AR 0.077 ME 5500, 5500 MS 42.140903 XX SC alpha_beta XX TO Staphylococcus aureus SAP0017 MRSAb (MIC = 64 μG/mL) XX XR PubMed: 10898680 XR CAMP R4: CAMPSQ8254 SQ SEQUENCE 2861.508 DA MW 26AA KWKSFIKKLT SAAKKVVTTA KPLISS // ID AMRSAP991 PN CP29 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 2, 'T': 4, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 3.85%, 'G': 3.85%, 'H': 0%, 'I': 7.69%, 'K': 23.08%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 0%, 'R': 0%, 'S': 7.69%, 'T': 15.38%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, H, M, N, Q, R, Y MO K LO F, G, P, W BA 14 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2872.574 AI 120 II 10.262 HP 0.319 HM 0.714 IP 11.5 NC 5.996 SF 0.385, 0.154, 0.231 [Helix, Turn, Sheet] AR 0.077 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus SAP0017 MRSAb (MIC = 8 μG/mL) XX XR PubMed: 10898680 XR CAMP R4: CAMPSQ8255 SQ SEQUENCE 2872.574 DA MW 26AA KWKSFIKKLT TAVKKVLTTG LPALIS // ID AMRSAP992 PN CP11CN SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 6.67%, 'I': 6.67%, 'K': 20%, 'L': 6.67%, AF 'M': 0%, 'N': 6.67%, 'P': 13.33%, 'Q': 0%, 'R': 13.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 26.67%, 'Y': 0% MA A, C, D, E, F, G, M, Q, S, T, V, Y MO W LO H, I, L, N BA 8 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2131.562 AI 52 II 50.86 HP -1.727 HM 0.482 IP 12.546 NC 5.088 SF 0.4, 0.2, 0.067 [Helix, Turn, Sheet] AR 0.267 ME 22000, 22000 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus SAP0017 MRSAb (MIC = 16 μG/mL) XX XR PubMed: 10898680 XR CAMP R4: CAMPSQ8256 SQ SEQUENCE 2131.562 DA MW 15AA ILKKWPWWPW RRK-NH2 // ID AMRSAP993 PN Bac2A-NH2 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 7.14%, 'I': 14.29%, 'K': 0%, 'L': 7.14%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 21.43%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, K, M, P, Q, S, T, W, Y MO R LO H, L, N BA 8 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 1673.044 AI 160 II 12.036 HP 0.307 HM 0.453 IP 12.977 NC 4.089 SF 0.429, 0.071, 0.214 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO Staphylococcus aureus SAP0017 MRSAb (MIC = 16 μG/mL) XX XR PubMed: 10898680 XR CAMP R4: CAMPSQ8257 SQ SEQUENCE 1673.044 DA MW 14AA RLARIVVIRV AR-NH2 // ID AMRSAP994 PN ARs-N-B SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 2 AF 'A': 8.33%, 'C': 8.33%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 8.33%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 8.33%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 16.67% MA D, E, F, G, I, K, L, M, P, Q, S, T MO V LO A, C, H, N, W BA 5 LA 7 AA 0 BC 3 MC 0 MF 0 XX MM 1565.816 AI 80.833 II 64.067 HP -0.192 HM 0.362 IP 9.326 NC 2.025 SF 0.5, 0.083, 0.083 [Helix, Turn, Sheet] AR 0.25 ME 8480, 8480 MS 12.040258 XX SC alpha XX TO MRSA ATCC 33591 (MIC= 8 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ8264 SQ SEQUENCE 1565.816 DA MW 12AA RWCVYAYVRV -NH2 // ID AMRSAP995 PN ARs-C-B SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 9.09%, 'I': 0%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 27.27%, 'S': 0%, 'T': 0%, 'V': 18.18%, 'W': 9.09%, 'Y': 9.09% MA A, D, E, F, G, I, K, M, P, Q, S, T MO R LO C, H, L, N, W, Y BA 4 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 1501.775 AI 88.182 II 38.936 HP -0.7 HM 0.522 IP 11.06 NC 3.026 SF 0.455, 0.091, 0.091 [Helix, Turn, Sheet] AR 0.182 ME 6990, 6990 MS 18.060387 XX SC beta XX TO MRSA ATCC 33591 (MIC= 8 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ8265 SQ SEQUENCE 1501.775 DA MW 11AA WCRRYRVLV- NH2 // ID AMRSAP996 PN AQ-1766 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA A, C, D, E, G, I, K, N, P, Q, R, S, V MO W LO F, H, L, M, T, Y BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1183.392 AI 48.75 II 98.088 HP 0.188 HM 0.172 IP 7.542 NC 0.088 SF 0.625, 0, 0.25 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 46 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8410 SQ SEQUENCE 1183.392 DA MW 8AA LWFYTMWH // ID AMRSAP997 PN AQ-2997 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 0, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA C, D, E, G, I, K, L, N, P, Q, R, S, V MO W LO A, F, H, M, T, Y BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1141.312 AI 12.5 II 68.488 HP -0.063 HM 0.227 IP 7.542 NC 0.088 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 46 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8411 SQ SEQUENCE 1141.312 DA MW 8AA AWFYTMWH // ID AMRSAP998 PN AQ-2998 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 12.5%, 'Y': 12.5% MA C, D, E, G, I, K, N, P, Q, R, S, V MO A; F; H; L; M; T; W; Y LO A, F, H, L, M, T, W, Y BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1068.258 AI 61.25 II 68.488 HP 0.525 HM 0.17 IP 7.542 NC 0.088 SF 0.5, 0, 0.375 [Helix, Turn, Sheet] AR 0.375 ME 6990, 6990 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC >= 50 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8412 SQ SEQUENCE 1068.258 DA MW 8AA LAFYTMWH // ID AMRSAP999 PN AQ-2999 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA C, D, E, F, G, I, K, N, P, Q, R, S, V MO W LO A, H, L, M, T, Y BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1107.295 AI 61.25 II 38.55 HP 0.063 HM 0.108 IP 7.542 NC 0.088 SF 0.5, 0, 0.375 [Helix, Turn, Sheet] AR 0.375 ME 12490, 12490 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC >= 50 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8413 SQ SEQUENCE 1107.295 DA MW 8AA LWAYTMWH // ID AMRSAP1000 PN AQ-3000 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 0% MA C, D, E, G, I, K, N, P, Q, R, S, V, Y MO W LO A, F, H, L, M, T BA 6 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 1091.295 AI 61.25 II 67.95 HP 0.575 HM 0.155 IP 7.55 NC 0.089 SF 0.5, 0, 0.375 [Helix, Turn, Sheet] AR 0.375 ME 11000, 11000 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 50 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8414 SQ SEQUENCE 1091.295 DA MW 8AA LWFATMWH // ID AMRSAP1001 PN AQ-3001 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA C, D, E, G, I, K, N, P, Q, R, S, T, V MO W LO A, F, H, L, M, Y BA 6 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 1153.366 AI 61.25 II 138.3 HP 0.5 HM 0.12 IP 7.542 NC 0.088 SF 0.625, 0, 0.375 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 43 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8415 SQ SEQUENCE 1153.366 DA MW 8AA LWFYAMWH // ID AMRSAP1002 PN AQ-3002 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA C, D, E, G, I, K, M, N, P, Q, R, S, V MO W LO A, F, H, L, T, Y BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1123.279 AI 61.25 II 98.088 HP 0.175 HM 0.17 IP 7.542 NC 0.088 SF 0.625, 0, 0.25 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 23 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8416 SQ SEQUENCE 1123.279 DA MW 8AA LWFYTAWH // ID AMRSAP1003 PN AQ-3003 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 12.5%, 'Y': 12.5% MA C, D, E, G, I, K, N, P, Q, R, S, V MO A; F; H; L; M; T; W; Y LO A, F, H, L, M, T, W, Y BA 5 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1068.258 AI 61.25 II 73.3 HP 0.525 HM 0.161 IP 7.542 NC 0.088 SF 0.5, 0, 0.375 [Helix, Turn, Sheet] AR 0.375 ME 6990, 6990 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC >= 50 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8417 SQ SEQUENCE 1068.258 DA MW 8AA LWFYTMAH // ID AMRSAP1004 PN AQ-3004 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA C, D, E, G, H, I, K, N, P, Q, R, S, V MO W LO A, F, L, M, T, Y BA 6 LA 2 AA 0 BC 0 MC 0 MF 0 XX MM 1117.33 AI 61.25 II 49.7 HP 0.813 HM 0.07 IP 6.093 NC -0.003 SF 0.625, 0, 0.375 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC >= 50 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8418 SQ SEQUENCE 1117.33 DA MW 8AA LWFYTMWA // ID AMRSAP1005 PN AQ-3369 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 1, 'L': 0, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 12.5%, 'L': 0%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA A, C, D, E, G, I, L, N, P, Q, R, S, V MO W LO F, H, K, M, T, Y BA 4 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1198.407 AI 0 II 68.488 HP -0.775 HM 0.492 IP 9.301 NC 1.088 SF 0.5, 0, 0.125 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 19 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8419 SQ SEQUENCE 1198.407 DA MW 8AA KWFYTMWH // ID AMRSAP1006 PN AQ-3370 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 12.5%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, G, I, N, P, Q, R, S, V, Y MO W LO F, H, K, L, M, T BA 5 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1148.391 AI 48.75 II 49.163 HP -0.138 HM 0.339 IP 9.702 NC 1.089 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.375 ME 11000, 11000 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 25 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8420 SQ SEQUENCE 1148.391 DA MW 8AA LWFKTMWH // ID AMRSAP1007 PN AQ-3371 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 12.5%, 'L': 12.5%, AF 'M': 12.5%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA A, C, D, E, G, I, N, P, Q, R, S, T, V MO W LO F, H, K, L, M, Y BA 5 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1210.461 AI 48.75 II 149.45 HP -0.213 HM 0.333 IP 9.301 NC 1.088 SF 0.625, 0, 0.25 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 30 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8421 SQ SEQUENCE 1210.461 DA MW 8AA LWFYKMWH // ID AMRSAP1008 PN AQ-3372 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 12.5%, 'I': 0%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 12.5%, 'V': 0%, 'W': 25%, 'Y': 12.5% MA A, C, D, E, G, I, M, N, P, Q, R, S, V MO W LO F, H, K, L, T, Y BA 4 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1180.374 AI 48.75 II 98.088 HP -0.538 HM 0.177 IP 9.301 NC 1.088 SF 0.625, 0, 0.125 [Helix, Turn, Sheet] AR 0.5 ME 12490, 12490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) (MIC = 44 μM) XX XR PubMed: 31374937 XR CAMP R4: CAMPSQ8422 SQ SEQUENCE 1180.374 DA MW 8AA LWFYTKWH // ID AMRSAP1009 PN MaeuCath7 SO Macropus eugenii PL 36 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 1, 'F': 2, 'G': 3, 'H': 0, 'I': 2, 'K': 6, 'L': 4, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 1, 'R': 5, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.56%, 'E': 2.78%, 'F': 5.56%, 'G': 8.33%, 'H': 0%, 'I': 5.56%, 'K': 16.67%, 'L': 11.11%, AF 'M': 0%, 'N': 5.56%, 'P': 5.56%, 'Q': 2.78%, 'R': 13.89%, 'S': 2.78%, 'T': 5.56%, 'V': 5.56%, 'W': 2.78%, 'Y': 0% MA A, C, H, M, Y MO K LO E, Q, S, W BA 16 LA 20 AA 3 BC 11 MC 0 MF 0 XX MM 4296.094 AI 81.111 II 44.056 HP -1.006 HM 0.789 IP 12.054 NC 7.999 SF 0.306, 0.222, 0.139 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 66.221419 XX SC alpha XX TO MRSA (MIC >= 14.8 μM) XX XR PubMed: 28949902 XR CAMP R4: CAMPSQ8424 SQ SEQUENCE 4296.094 DA MW 36AA KRGLWESLKR KVTKLGDDIR NTLRNFKIKF PVPRQG // ID AMRSAP1010 PN ModoCath4 SO Monodelphis domestica PL 27 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 2, 'G': 5, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 6, 'S': 2, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 3.7%, 'E': 0%, 'F': 7.41%, 'G': 18.52%, 'H': 0%, 'I': 3.7%, 'K': 14.81%, 'L': 11.11%, AF 'M': 0%, 'N': 3.7%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 7.41%, 'T': 3.7%, 'V': 0%, 'W': 3.7%, 'Y': 0% MA A, C, E, H, M, P, Q, V, Y MO R LO D, I, N, T, W BA 12 LA 15 AA 1 BC 10 MC 0 MF 0 XX MM 3190.754 AI 57.778 II 57.693 HP -1.233 HM 0.81 IP 12.814 NC 8.997 SF 0.259, 0.296, 0.111 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 60.20129 XX SC alpha+beta XX TO MRSA (MIC =10 μM) XX XR PubMed: 28949902 XR CAMP R4: CAMPSQ8429 SQ SEQUENCE 3190.754 DA MW 27AA SKTKRRSLLK RLGDGIRGFW NGFRGRK // ID AMRSAP1011 PN Taac-CATH1 SO Tachyglossus aculeatus PL 35 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 4, 'H': 0, 'I': 6, 'K': 7, 'L': 4, AC 'M': 0, 'N': 3, 'P': 2, 'Q': 0, 'R': 3, 'S': 0, 'T': 2, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 2.86%, 'E': 2.86%, 'F': 0%, 'G': 11.43%, 'H': 0%, 'I': 17.14%, 'K': 20%, 'L': 11.43%, AF 'M': 0%, 'N': 8.57%, 'P': 5.71%, 'Q': 0%, 'R': 8.57%, 'S': 0%, 'T': 5.71%, 'V': 2.86%, 'W': 2.86%, 'Y': 0% MA A, C, F, H, M, Q, S, Y MO K LO D, E, V, W BA 18 LA 17 AA 2 BC 10 MC 0 MF 0 XX MM 4011.903 AI 119.714 II 64.569 HP -0.543 HM 0.819 IP 11.861 NC 7.998 SF 0.343, 0.257, 0.143 [Helix, Turn, Sheet] AR 0.029 ME 5500, 5500 MS 60.20129 XX SC beta XX TO MRSA (MIC =3.9 μM) XX XR PubMed: 28949902 XR CAMP R4: CAMPSQ8436 SQ SEQUENCE 4011.903 DA MW 35AA PIRTKRRWKL IKKGGKIVKD LLTKNNIIIL PGGNE // ID AMRSAP1012 PN H5 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 0, 'H': 1, 'I': 2, 'K': 6, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 5.56%, 'F': 5.56%, 'G': 0%, 'H': 5.56%, 'I': 11.11%, 'K': 33.33%, 'L': 11.11%, AF 'M': 0%, 'N': 11.11%, 'P': 0%, 'Q': 0%, 'R': 5.56%, 'S': 0%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, G, M, P, Q, S, V, W MO K LO E, F, H, R, T, Y BA 5 LA 13 AA 1 BC 8 MC 0 MF 0 XX MM 2301.807 AI 86.667 II -6.322 HP -1.344 HM 0.752 IP 11.118 NC 6.088 SF 0.333, 0.111, 0.167 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8506 SQ SEQUENCE 2301.807 DA MW 18AA YEIKINRHFK TLKKNLKK // ID AMRSAP1013 PN P1 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 2, 'K': 6, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 5.56%, 'I': 11.11%, 'K': 33.33%, 'L': 11.11%, AF 'M': 0%, 'N': 11.11%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, E, G, M, P, Q, S, V, W MO K LO F, H, T, Y BA 5 LA 13 AA 0 BC 9 MC 0 MF 0 XX MM 2328.879 AI 86.667 II -8.117 HP -1.4 HM 0.932 IP 11.933 NC 8.086 SF 0.333, 0.111, 0.111 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1490 MS 48.161032 XX SC alpha XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8507 SQ SEQUENCE 2328.879 DA MW 18AA YIRKINRHFK TLKKNLKK // ID AMRSAP1014 PN P2 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 27.78%, 'L': 11.11%, AF 'M': 0%, 'N': 11.11%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 5.56%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, E, G, H, M, P, Q, S, V, W MO K LO T, Y BA 6 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 2366.928 AI 86.667 II 36.639 HP -1.1 HM 1.026 IP 12.3 NC 7.996 SF 0.389, 0.111, 0.111 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1490 MS 48.161032 XX SC alpha XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8508 SQ SEQUENCE 2366.928 DA MW 18AA YIRKIRRFFK TLNKNLKK // ID AMRSAP1015 PN P3 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 2, 'K': 6, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 33.33%, 'L': 11.11%, AF 'M': 0%, 'N': 11.11%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, E, G, H, M, P, Q, S, T, V, W MO K LO Y BA 6 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2393.997 AI 86.667 II 31.922 HP -1.278 HM 1.084 IP 12.314 NC 8.995 SF 0.389, 0.111, 0.111 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1490 MS 54.181161 XX SC alpha XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8509 SQ SEQUENCE 2393.997 DA MW 18AA YIRKIRRFFK KLNKNLKK // ID AMRSAP1016 PN P4 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 1, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 2, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 0%, 'H': 0%, 'I': 5.56%, 'K': 27.78%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 11.11%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, E, G, H, M, N, P, Q, S, V, W MO K LO I, Y BA 7 LA 11 AA 0 BC 8 MC 0 MF 0 XX MM 2421.019 AI 65 II 15.133 HP -0.689 HM 1.064 IP 12.3 NC 7.996 SF 0.444, 0, 0.111 [Helix, Turn, Sheet] AR 0.278 ME 1490, 1490 MS 48.161032 XX SC alpha XX TO MRSA 18466 (MIC = 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8510 SQ SEQUENCE 2421.019 DA MW 18AA YFRTIRRFFK KLFKTLKK // ID AMRSAP1017 PN P5 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 3, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 38.89%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, E, G, H, M, N, P, Q, S, T, V, W MO K LO Y BA 7 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2407.123 AI 108.333 II 20.033 HP -0.856 HM 1.084 IP 12.328 NC 9.995 SF 0.444, 0, 0.111 [Helix, Turn, Sheet] AR 0.167 ME 1490, 1490 MS 60.20129 XX SC alpha_beta XX TO MRSA 18466 (MIC = 8 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8511 SQ SEQUENCE 2407.123 DA MW 18AA YIRKIRRFFK KLKKILKK // ID AMRSAP1018 PN P6 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 0, 'H': 0, 'I': 2, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 33.33%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 27.78%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 5.56% MA A, C, D, E, G, H, L, M, N, P, Q, S, T, V, W MO K LO Y BA 6 LA 12 AA 0 BC 11 MC 0 MF 0 XX MM 2546.199 AI 43.333 II 37.961 HP -1.5 HM 1.012 IP 12.704 NC 10.995 SF 0.389, 0, 0 [Helix, Turn, Sheet] AR 0.278 ME 1490, 1490 MS 66.221419 XX SC alpha XX TO MRSA 18466 (MIC = 32 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8512 SQ SEQUENCE 2546.199 DA MW 18AA YIRKIRRFFK KRFKFRKK // ID AMRSAP1019 PN P7 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 7, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 5, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.89%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 27.78%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, Y MO K LO R, W BA 8 LA 10 AA 0 BC 10 MC 0 MF 0 XX MM 2438.099 AI 80.556 II 51.022 HP -1.25 HM 1.002 IP 12.843 NC 9.996 SF 0.444, 0, 0 [Helix, Turn, Sheet] AR 0.167 ME 16500, 16500 MS 60.20129 XX SC alpha_beta XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8513 SQ SEQUENCE 2438.099 DA MW 18AA WVRKVRRWWK KVKKVVKK // ID AMRSAP1020 PN P8 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 0, 'H': 1, 'I': 2, 'K': 7, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 5%, 'F': 5%, 'G': 0%, 'H': 5%, 'I': 10%, 'K': 35%, 'L': 10%, AF 'M': 0%, 'N': 10%, 'P': 0%, 'Q': 0%, 'R': 5%, 'S': 5%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA A, C, D, G, M, P, Q, V, W MO K LO E, F, H, R, S, T, Y BA 5 LA 15 AA 1 BC 9 MC 0 MF 0 XX MM 2517.059 AI 78 II -4.69 HP -1.445 HM 0.752 IP 11.206 NC 7.088 SF 0.3, 0.15, 0.15 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 48.161032 XX SC alpha XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8514 SQ SEQUENCE 2517.059 DA MW 20AA SYEIKINRHF KTLKKNLKKK // ID AMRSAP1021 PN P9 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 0, 'H': 1, 'I': 1, 'K': 7, 'L': 2, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 5%, 'F': 5%, 'G': 0%, 'H': 5%, 'I': 5%, 'K': 35%, 'L': 10%, AF 'M': 0%, 'N': 10%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 5%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA A, C, D, G, M, P, Q, V, W MO K LO E, F, H, I, S, T, Y BA 4 LA 16 AA 1 BC 10 MC 0 MF 0 XX MM 2560.087 AI 58.5 II -10.075 HP -1.895 HM 0.836 IP 11.508 NC 8.088 SF 0.25, 0.15, 0.15 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 54.181161 XX SC alpha XX TO MRSA 18466 (MIC = 16 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8515 SQ SEQUENCE 2560.087 DA MW 20AA SYERKINRHF KTLKKNLKKK // ID AMRSAP1022 PN P10 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 0, 'W': 2, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 5%, 'F': 5%, 'G': 5%, 'H': 0%, 'I': 5%, 'K': 25%, 'L': 15%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 0%, 'W': 10%, 'Y': 5% MA A, C, D, H, M, P, Q, T, V MO K LO E, F, G, I, N, S, Y BA 8 LA 12 AA 1 BC 8 MC 0 MF 0 XX MM 2650.214 AI 78 II -4.105 HP -1.28 HM 0.762 IP 11.788 NC 6.997 SF 0.4, 0.15, 0.2 [Helix, Turn, Sheet] AR 0.2 ME 12490, 12490 MS 48.161032 XX SC alpha_beta XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8516 SQ SEQUENCE 2650.214 DA MW 20AA WYERLINRKF KWLKGRLSKK // ID AMRSAP1023 PN P11 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 1, 'K': 9, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 10%, 'G': 0%, 'H': 0%, 'I': 5%, 'K': 45%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 10% MA A, C, D, E, G, H, M, N, P, Q, S, T, V, W MO K LO I BA 7 LA 13 AA 0 BC 11 MC 0 MF 0 XX MM 2670.459 AI 97.5 II 21.04 HP -1.07 HM 0.675 IP 11.623 NC 10.994 SF 0.45, 0, 0.2 [Helix, Turn, Sheet] AR 0.2 ME 2980, 2980 MS 66.221419 XX SC alpha_beta XX TO MRSA 18466 (MIC = 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8517 SQ SEQUENCE 2670.459 DA MW 20AA LYKRYILRKF KFLKKKLKKK // ID AMRSAP1024 PN P12 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 9, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 5, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 20%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, P, Q, S, T, Y MO K LO R BA 9 LA 11 AA 0 BC 11 MC 0 MF 0 XX MM 2724.473 AI 72.5 II 38.825 HP -1.335 HM 0.638 IP 12.618 NC 10.995 SF 0.45, 0, 0 [Helix, Turn, Sheet] AR 0.2 ME 22000, 22000 MS 66.221419 XX SC alpha_beta XX TO MRSA 18466 (MIC < 64 μG/mL) XX XR PubMed: 31520928 XR CAMP R4: CAMPSQ8518 SQ SEQUENCE 2724.473 DA MW 20AA VWKRWVVRKW KWVKKKVKKK // ID AMRSAP1025 PN DFT503 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 1, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15.38%, 'H': 0%, 'I': 0%, 'K': 7.69%, 'L': 61.54%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 15.38%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, T, V, W, Y MO L LO K BA 10 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1339.725 AI 240 II -3.831 HP 1.854 HM 0.355 IP 9.7 NC 0.998 SF 0.615, 0.308, 0.615 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO S. aureus M838-17 (MRSA) (MIC = 3.1 μM) XX XR PubMed: 31209048 XR CAMP R4: CAMPSQ8541 SQ SEQUENCE 1339.725 DA MW 13AA GLSLLLSLGL KLL // ID AMRSAP1026 PN DFT503d SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 1, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15.38%, 'H': 0%, 'I': 0%, 'K': 7.69%, 'L': 61.54%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 15.38%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, T, V, W, Y MO L LO K BA 10 LA 3 AA 0 BC 1 MC 0 MF 0 XX MM 1339.725 AI 240 II -3.831 HP 1.854 HM 0.355 IP 9.7 NC 0.998 SF 0.615, 0.308, 0.615 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 6.020129 XX SC alpha XX TO S. aureus M838-17 (MRSA) (MIC = 3.1 μM) XX XR PubMed: 31209048 XR CAMP R4: CAMPSQ8547 SQ SEQUENCE 1339.725 DA MW 13AA GLSLLLSLGL KLL // ID AMRSAP1027 PN DFT561 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 2, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15.38%, 'H': 0%, 'I': 0%, 'K': 15.38%, 'L': 61.54%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.69%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, T, V, W, Y MO L LO S BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1380.821 AI 240 II -16.892 HP 1.615 HM 0.442 IP 10.805 NC 1.997 SF 0.615, 0.231, 0.615 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO S. aureus M838-17 (MRSA) (MIC = 3.1 μM) XX XR PubMed: 31209048 XR CAMP R4: CAMPSQ8549 SQ SEQUENCE 1380.821 DA MW 13AA GLKLLLSLGL KLL // ID AMRSAP1028 PN DFT561d SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 2, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15.38%, 'H': 0%, 'I': 0%, 'K': 15.38%, 'L': 61.54%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.69%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, M, N, P, Q, R, T, V, W, Y MO L LO S BA 10 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1380.821 AI 240 II -16.892 HP 1.615 HM 0.442 IP 10.805 NC 1.997 SF 0.615, 0.231, 0.615 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO S. aureus M838-17 (MRSA) (MIC = 3.1 μM) XX XR PubMed: 31209048 XR CAMP R4: CAMPSQ8550 SQ SEQUENCE 1380.821 DA MW 13AA GLKLLLSLGL KLL // ID AMRSAP1029 PN Kunitzin-RE SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 2, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 23.53%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 11.76%, 'G': 0%, 'H': 0%, 'I': 11.76%, 'K': 17.65%, 'L': 5.88%, AF 'M': 0%, 'N': 5.88%, 'P': 5.88%, 'Q': 0%, 'R': 5.88%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, Q, S, T, V, W, Y MO A LO L, N, P, R BA 10 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 1894.37 AI 92.353 II 14.053 HP 0.547 HM 0.316 IP 10.513 NC 3.873 SF 0.294, 0.118, 0.294 [Helix, Turn, Sheet] AR 0.118 ME 0, 125 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC >= 128 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8555 SQ SEQUENCE 1894.37 DA MW 17AA AAKIILNPKF RCKAAFC // ID AMRSAP1030 PN OT SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 18.18%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 9.09%, 'Q': 0%, 'R': 9.09%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, M, Q, S, T, V, W, Y MO A; I; K LO F, L, N, P, R BA 7 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1270.584 AI 124.545 II 16.264 HP 0.164 HM 0.316 IP 11.823 NC 2.997 SF 0.364, 0.182, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 18.060387 XX SC alpha_beta XX TO MRSAc 43300 (MIC >= 128 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8556 SQ SEQUENCE 1270.584 DA MW 11AA AAKIILNPKF R // ID AMRSAP1031 PN P8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, Q, S, T, V, W, Y MO R LO F, L, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1368.694 AI 124.545 II 54.764 HP -0.036 HM 0.462 IP 12.977 NC 3.998 SF 0.364, 0.091, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC >= 128 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8557 SQ SEQUENCE 1368.694 DA MW 11AA AARIILRPRF R // ID AMRSAP1032 PN I8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 3, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 27.27%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO F, L BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1384.737 AI 160 II 44.109 HP 0.518 HM 0.509 IP 12.977 NC 3.998 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC = 2 μM) (MBC = 4 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8558 SQ SEQUENCE 1384.737 DA MW 11AA AARIILRIRF R // ID AMRSAP1033 PN G8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 9.09%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, H, K, M, N, P, Q, S, T, V, W, Y MO R LO F, G, L BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1328.63 AI 124.545 II 36.391 HP 0.073 HM 0.473 IP 12.977 NC 3.998 SF 0.364, 0.091, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC = 8 μM) (MBC = 8 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8559 SQ SEQUENCE 1328.63 DA MW 11AA AARIILRGRF R // ID AMRSAP1034 PN N8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 9.09%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, P, Q, S, T, V, W, Y MO R LO F, L, N BA 6 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1385.681 AI 124.545 II 55.327 HP -0.209 HM 0.443 IP 12.977 NC 3.998 SF 0.364, 0.091, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC >= 128 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8560 SQ SEQUENCE 1385.681 DA MW 11AA AARIILRNRF R // ID AMRSAP1035 PN T8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 9.09%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, V, W, Y MO R LO F, L, T BA 6 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1372.683 AI 124.545 II 44.109 HP 0.045 HM 0.457 IP 12.977 NC 3.998 SF 0.364, 0, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC = 16 μM) (MBC = 32 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8561 SQ SEQUENCE 1372.683 DA MW 11AA AARIILRTRF R // ID AMRSAP1036 PN Y8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 9.09% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, W MO R LO F, L, Y BA 6 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1434.754 AI 124.545 II 21.882 HP -0.009 HM 0.466 IP 12.502 NC 3.997 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 1490, 1490 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC = 4 μM) (MBC = 8 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8562 SQ SEQUENCE 1434.754 DA MW 11AA AARIILRYRF R // ID AMRSAP1037 PN A8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO F, L BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1342.656 AI 133.636 II 44.109 HP 0.273 HM 0.478 IP 12.977 NC 3.998 SF 0.364, 0, 0.364 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC = 2 μM) (MBC = 4 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8563 SQ SEQUENCE 1342.656 DA MW 11AA AARIILRARF R // ID AMRSAP1038 PN F8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO L BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1418.754 AI 124.545 II 44.109 HP 0.364 HM 0.501 IP 12.977 NC 3.998 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSAc 43300 (MIC = 2 μM) (MBC = 4 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8564 SQ SEQUENCE 1418.754 DA MW 11AA AARIILRFRF R // ID AMRSAP1039 PN L8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO F BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1384.737 AI 160 II 61.618 HP 0.455 HM 0.495 IP 12.977 NC 3.998 SF 0.455, 0, 0.364 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC = 2 μM) (MBC = 4 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8565 SQ SEQUENCE 1384.737 DA MW 11AA AARIILRLRF R // ID AMRSAP1040 PN D8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 9.09%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, E, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO D, F, L BA 6 LA 5 AA 1 BC 4 MC 0 MF 0 XX MM 1386.666 AI 124.545 II 37.255 HP -0.209 HM 0.442 IP 12.5 NC 2.998 SF 0.364, 0, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSAc 43300 (MIC >= 128 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8566 SQ SEQUENCE 1386.666 DA MW 11AA AARIILRDRF R // ID AMRSAP1041 PN R8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 45.45%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO F, L BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1427.765 AI 124.545 II 148.255 HP -0.3 HM 0.45 IP 13.102 NC 4.998 SF 0.364, 0, 0.273 [Helix, Turn, Sheet] AR 0.091 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSAc 43300 (MIC = 16 μM) (MBC = 64 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8567 SQ SEQUENCE 1427.765 DA MW 11AA AARIILRRRF R // ID AMRSAP1042 PN W8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, Y MO R LO F, L, W BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1457.791 AI 124.545 II 96.182 HP 0.027 HM 0.485 IP 12.977 NC 3.998 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 5500, 5500 MS 24.080516 XX SC alpha XX TO MRSAc 43300 (MIC = 1 μM) (MBC = 1 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8568 SQ SEQUENCE 1457.791 DA MW 11AA AARIILRWRF R // ID AMRSAP1043 PN TSW-1 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, Y MO R LO F, L, W BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1457.791 AI 124.545 II 148.255 HP 0.027 HM 1.026 IP 12.977 NC 3.998 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 5500, 5500 MS 24.080516 XX SC alpha XX TO MRSAc 43300 (MIC = 8 μM) (MBC = 8 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8569 SQ SEQUENCE 1457.791 DA MW 11AA AARRILRWIF R // ID AMRSAP1044 PN TSW-2 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 18.18%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.09%, 'G': 0%, 'H': 0%, 'I': 18.18%, 'K': 0%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA C, D, E, G, H, K, M, N, P, Q, S, T, V, Y MO R LO F, L, W BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1457.791 AI 124.545 II 148.255 HP 0.027 HM 1.002 IP 12.977 NC 3.998 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 5500, 5500 MS 24.080516 XX SC alpha XX TO MRSAc 43300 (MIC = 8 μM) (MBC = 8 μM) XX XR PubMed: 30958004 XR CAMP R4: CAMPSQ8570 SQ SEQUENCE 1457.791 DA MW 11AA AARIILRWFR R // ID AMRSAP1045 PN VCPP 0275 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 12, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 4 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 60%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 5%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 20% MA C, D, E, G, H, I, L, M, N, Q, S, T, V, W MO K LO A, F, P, R BA 3 LA 17 AA 0 BC 13 MC 0 MF 0 XX MM 2680.368 AI 5 II 18.26 HP -2.675 HM 0.414 IP 11.149 NC 12.991 SF 0.25, 0.05, 0.05 [Helix, Turn, Sheet] AR 0.25 ME 5960, 5960 MS 78.261677 XX SC beta XX TO MRSA (MIC = 50 μM) XX XR PubMed: 28522994 XR CAMP R4: CAMPSQ8571 SQ SEQUENCE 2680.368 DA MW 20AA KKRYKKKYKA YKPYKKKKKF // ID AMRSAP1046 PN VCPP 0769 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 9, 'S': 2, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5%, 'R': 45%, 'S': 10%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, I, K, M, N, P, V, W, Y MO R LO Q, T BA 7 LA 13 AA 0 BC 9 MC 0 MF 0 XX MM 2506.996 AI 97.5 II 213.19 HP -1.405 HM 0.601 IP 13.403 NC 8.998 SF 0.25, 0.2, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 54.181161 XX SC alpha XX TO MRSA (MIC = 3.13 μM) XX XR PubMed: 28522994 XR CAMP R4: CAMPSQ8572 SQ SEQUENCE 2506.996 DA MW 20AA RRLTLRQLLG LGSRRRRRSR // ID AMRSAP1047 PN VCPP 2319 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 15, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 75%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 15%, 'Y': 5% MA A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V MO R LO P, Y BA 4 LA 16 AA 0 BC 15 MC 0 MF 0 XX MM 3179.76 AI 0 II 346.815 HP -3.655 HM 0.749 IP 13.313 NC 14.997 SF 0.2, 0.05, 0 [Helix, Turn, Sheet] AR 0.2 ME 17990, 17990 MS 90.301935 XX SC alpha_beta XX TO MRSA (MIC = 1.56 μM) XX XR PubMed: 28522994 XR CAMP R4: CAMPSQ8573 SQ SEQUENCE 3179.76 DA MW 20AA WRRRYRRWRR RRRWRRRPRR // ID AMRSAP1048 PN VCPP 0417 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 4, 'Q': 1, 'R': 10, 'S': 4, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 20%, 'Q': 5%, 'R': 50%, 'S': 20%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, V, W, Y MO R LO Q, T BA 4 LA 16 AA 0 BC 10 MC 0 MF 0 XX MM 2545.906 AI 0 II 327.78 HP -2.94 HM 0.38 IP 13.454 NC 9.998 SF 0, 0.4, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 60.20129 XX SC alpha+beta XX TO MRSA (MIC >= 100 μM) XX XR PubMed: 28522994 XR CAMP R4: CAMPSQ8574 SQ SEQUENCE 2545.906 DA MW 20AA SPRRRTPSPR RRRSQSPRRR // ID AMRSAP1049 PN VCPP 1779 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 1, 'R': 10, 'S': 0, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 10%, 'P': 5%, 'Q': 5%, 'R': 50%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, I, K, L, M, S, V, W, Y MO R LO A, P, Q BA 5 LA 15 AA 0 BC 10 MC 0 MF 0 XX MM 2477.79 AI 5 II 186.435 HP -2.895 HM 0.741 IP 13.454 NC 9.998 SF 0, 0.3, 0.05 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 60.20129 XX SC beta XX TO MRSA (MIC >= 100 μM) XX XR PubMed: 28522994 XR CAMP R4: CAMPSQ8575 SQ SEQUENCE 2477.79 DA MW 20AA GRRGPRRANQ NGTRRRRRRT // ID AMRSAP1050 PN VCPP 0667 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 11, 'S': 0, 'T': 5, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5%, 'H': 0%, 'I': 5%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 55%, 'S': 0%, 'T': 25%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, K, L, M, N, Q, S, V, W, Y MO R LO A, G, I, P BA 4 LA 16 AA 0 BC 11 MC 0 MF 0 XX MM 2580.01 AI 24.5 II 207.35 HP -2.435 HM 0.579 IP 13.5 NC 10.998 SF 0.05, 0.1, 0.05 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 66.221419 XX SC beta XX TO MRSA (MIC = 100 μM) XX XR PubMed: 28522994 XR CAMP R4: CAMPSQ8576 SQ SEQUENCE 2580.01 DA MW 20AA RPRRRATTRR RITTGTRRRR // ID AMRSAP1051 PN Winter flounder 1 SO Pseudopleuronectes americanus PL 24 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 7, 'H': 1, 'I': 4, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 4.17%, 'E': 4.17%, 'F': 0%, 'G': 29.17%, 'H': 4.17%, 'I': 16.67%, 'K': 8.33%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4.17%, 'Y': 0% MA C, F, M, N, P, Q, S, T, V, Y MO G LO D, E, H, W BA 17 LA 7 AA 2 BC 5 MC 0 MF 0 XX MM 2487.934 AI 122.083 II 31.188 HP 0.096 HM 0.832 IP 10.774 NC 2.091 SF 0.333, 0.292, 0.25 [Helix, Turn, Sheet] AR 0.042 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO MRSA C623 (MIC >= 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ861 SQ SEQUENCE 2487.934 DA MW 24AA GKGRWLERIG KAGGIIIGGA LDHL // ID AMRSAP1052 PN Winter flounder 1a SO Pseudopleuronectes americanus PL 20 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 4, 'H': 1, 'I': 3, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 5%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 5%, 'I': 15%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 0%, 'V': 5%, 'W': 5%, 'Y': 0% MA C, E, F, M, N, P, Q, S, T, Y MO G LO D, H, V, W BA 14 LA 6 AA 1 BC 5 MC 0 MF 0 XX MM 2173.636 AI 141.5 II 41.69 HP 0.335 HM 0.814 IP 11.651 NC 3.089 SF 0.4, 0.2, 0.25 [Helix, Turn, Sheet] AR 0.05 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO MRSA C623 (MIC > 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ862 SQ SEQUENCE 2173.636 DA MW 20AA WLRRIGKGVK IIGGAALDHL // ID AMRSAP1053 PN Winter flounder 1a1 SO Pseudopleuronectes americanus PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 5, 'H': 1, 'I': 3, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 3.85%, 'E': 0%, 'F': 0%, 'G': 19.23%, 'H': 3.85%, 'I': 11.54%, 'K': 15.38%, 'L': 11.54%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 19.23%, 'S': 0%, 'T': 0%, 'V': 3.85%, 'W': 3.85%, 'Y': 0% MA C, E, F, M, N, P, Q, S, T, Y MO G; R LO D, H, V, W BA 15 LA 11 AA 1 BC 10 MC 0 MF 0 XX MM 2955.598 AI 108.846 II 68.946 HP -0.577 HM 0.96 IP 12.694 NC 8.088 SF 0.308, 0.192, 0.192 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 54.181161 XX SC alpha XX TO MRSA C623 (MIC = 8 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ863 SQ SEQUENCE 2955.598 DA MW 26AA GRRKRKWLRR IGKGVKIIGG AALDHL // ID AMRSAP1054 PN Winter flounder 3 SO Pseudopleuronectes americanus PL 24 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 4, 'I': 4, 'K': 1, 'L': 2, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 20.83%, 'H': 16.67%, 'I': 16.67%, 'K': 4.17%, 'L': 8.33%, AF 'M': 4.17%, 'N': 4.17%, 'P': 0%, 'Q': 4.17%, 'R': 4.17%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, P, S, T, V, W, Y MO G LO K, M, N, Q, R BA 16 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 2625.095 AI 105.833 II 2.217 HP 0.271 HM 0.598 IP 11.652 NC 2.361 SF 0.333, 0.25, 0.208 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA C623 (MIC = 32 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ864 SQ SEQUENCE 2625.095 DA MW 24AA FLGALIKGAI HGGRFIHGMI QNHH // ID AMRSAP1055 PN Winter flounder 4 SO Pseudopleuronectes americanus PL 25 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 5, 'I': 2, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 16%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4%, 'G': 16%, 'H': 20%, 'I': 8%, 'K': 8%, 'L': 4%, AF 'M': 0%, 'N': 4%, 'P': 0%, 'Q': 0%, 'R': 4%, 'S': 4%, 'T': 0%, 'V': 4%, 'W': 4%, 'Y': 4% MA C, D, E, M, P, Q, T MO H LO F, L, N, R, S, V, W, Y BA 14 LA 11 AA 0 BC 8 MC 0 MF 0 XX MM 2765.138 AI 74.4 II 43.084 HP -0.376 HM 0.664 IP 10.902 NC 3.451 SF 0.28, 0.24, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 6990, 6990 MS 18.060387 XX SC alpha XX TO MRSA C623 (MIC = 32 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ865 SQ SEQUENCE 2765.138 DA MW 25AA GWGSIFKHGR HAAKHIGHAA VNHYL // ID AMRSAP1056 PN Winter flounder Y SO Pseudopleuronectes americanus PL 19 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 0, 'K': 0, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.79%, 'G': 21.05%, 'H': 15.79%, 'I': 0%, 'K': 0%, 'L': 15.79%, AF 'M': 0%, 'N': 5.26%, 'P': 0%, 'Q': 0%, 'R': 5.26%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 0%, 'Y': 5.26% MA C, D, E, I, K, M, P, Q, S, T, W MO G LO N, R, V, Y BA 13 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2113.412 AI 87.368 II 7.079 HP 0.374 HM 0.591 IP 9.356 NC 1.27 SF 0.421, 0.263, 0.263 [Helix, Turn, Sheet] AR 0.211 ME 1490, 1490 MS 6.020129 XX SC alpha XX TO MRSA C623 (MIC >64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ866 SQ SEQUENCE 2113.412 DA MW 19AA FFRLLFHGVH HGGGYLNAA // ID AMRSAP1057 PN Winter flounder Z SO Pseudopleuronectes americanus PL 19 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 2, 'H': 3, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.79%, 'G': 10.53%, 'H': 15.79%, 'I': 5.26%, 'K': 10.53%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 5.26%, 'Q': 0%, 'R': 10.53%, 'S': 0%, 'T': 0%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, Q, S, T, W, Y MO F; H LO A, I, P BA 12 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 2259.734 AI 97.368 II -21.795 HP 0.1 HM 0.602 IP 12.532 NC 4.27 SF 0.421, 0.158, 0.158 [Helix, Turn, Sheet] AR 0.158 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA C623 (MIC = 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ867 SQ SEQUENCE 2259.734 DA MW 19AA FFRLLFHGVH HVGKIKPRA // ID AMRSAP1058 PN Witch flounder GcSc4C5 SO Glyptocephalus cynoglossus PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 1, 'E': 0, 'F': 3, 'G': 4, 'H': 3, 'I': 4, 'K': 3, 'L': 0, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 15.38%, 'C': 0%, 'D': 3.85%, 'E': 0%, 'F': 11.54%, 'G': 15.38%, 'H': 11.54%, 'I': 15.38%, 'K': 11.54%, 'L': 0%, AF 'M': 0%, 'N': 3.85%, 'P': 0%, 'Q': 3.85%, 'R': 0%, 'S': 3.85%, 'T': 0%, 'V': 0%, 'W': 3.85%, 'Y': 0% MA C, E, L, M, P, R, T, V, Y MO A; G; I LO D, N, Q, S, W BA 16 LA 10 AA 1 BC 6 MC 0 MF 0 XX MM 2851.266 AI 75.385 II 15.781 HP -0.058 HM 0.7 IP 10.507 NC 2.27 SF 0.308, 0.231, 0.154 [Helix, Turn, Sheet] AR 0.154 ME 5500, 5500 MS 18.060387 XX SC alpha XX TO MRSA C623 (MIC = 16 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ868 SQ SEQUENCE 2851.266 DA MW 26AA AGWGSIFKHI FKAGKFIHGA IQAHND // ID AMRSAP1059 PN Witch flounder GcSc4B7 SO Glyptocephalus cynoglossus PL 21 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 5, 'H': 3, 'I': 1, 'K': 2, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 23.81%, 'H': 14.29%, 'I': 4.76%, 'K': 9.52%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4.76%, 'Y': 0% MA A, C, D, E, M, N, P, Q, R, S, T, V, Y MO L LO I, W BA 16 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 2356.888 AI 148.571 II -23.681 HP 0.781 HM 0.528 IP 10.806 NC 2.27 SF 0.524, 0.238, 0.333 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 12.040258 XX SC alpha XX TO MRSA C623 (MIC = 4 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ869 SQ SEQUENCE 2356.888 DA MW 21AA GFWGKLFKLG LHGIGLLHLH L // ID AMRSAP1060 PN Witch flounder GC3.8-t SO Glyptocephalus cynoglossus PL 19 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 1, 'I': 1, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 15.79%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 15.79%, 'H': 5.26%, 'I': 5.26%, 'K': 26.32%, 'L': 10.53%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.26%, 'R': 5.26%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 10.53%, 'Y': 0% MA C, D, E, F, M, N, P, S, T, V, Y MO K LO H, I, Q, R BA 11 LA 8 AA 0 BC 7 MC 0 MF 0 XX MM 2176.642 AI 77.368 II 19.195 HP -0.853 HM 0.778 IP 12.055 NC 6.087 SF 0.263, 0.158, 0.263 [Helix, Turn, Sheet] AR 0.105 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO MRSA C623 (MIC = 32 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ870 SQ SEQUENCE 2176.642 DA MW 19AA GWKKWLRKGA KHLGQAAIK // ID AMRSAP1061 PN Halibut Hb18 SO Halibut PL 26 TX Animalia (Pisces) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 2, 'G': 4, 'H': 4, 'I': 1, 'K': 2, 'L': 3, AC 'M': 1, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 3.85%, 'C': 0%, 'D': 0%, 'E': 3.85%, 'F': 7.69%, 'G': 15.38%, 'H': 15.38%, 'I': 3.85%, 'K': 7.69%, 'L': 11.54%, AF 'M': 3.85%, 'N': 3.85%, 'P': 0%, 'Q': 0%, 'R': 11.54%, 'S': 7.69%, 'T': 0%, 'V': 3.85%, 'W': 0%, 'Y': 0% MA C, D, P, Q, T, W, Y MO G; H LO A, E, I, M, N, V BA 13 LA 13 AA 1 BC 9 MC 0 MF 0 XX MM 2985.468 AI 75 II 52.119 HP -0.573 HM 0.427 IP 12.244 NC 4.363 SF 0.269, 0.269, 0.231 [Helix, Turn, Sheet] AR 0.077 ME 0, 0 MS 30.100645 XX SC alpha XX TO MRSA C623 (MIC > 64 μG/mL) XX XR PubMed: 12878506 XR CAMP R4: CAMPSQ871 SQ SEQUENCE 2985.468 DA MW 26AA GFLGILFHGV HHGRKKALHM NSERRS // ID AMRSAP1062 PN Cathelin-related peptide SC5 SO Ovis aries PL 29 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 1, 'I': 4, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 6.9%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 17.24%, 'H': 3.45%, 'I': 13.79%, 'K': 10.34%, 'L': 10.34%, AF 'M': 0%, 'N': 0%, 'P': 3.45%, 'Q': 0%, 'R': 20.69%, 'S': 0%, 'T': 3.45%, 'V': 6.9%, 'W': 0%, 'Y': 3.45% MA C, D, E, F, M, N, Q, S, W MO R LO H, P, T, Y BA 17 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 3256 AI 121.034 II 26.41 HP -0.21 HM 1.071 IP 12.811 NC 9.087 SF 0.345, 0.207, 0.172 [Helix, Turn, Sheet] AR 0.034 ME 1490, 1490 MS 54.181161 XX SC beta XX TO MRSA ATCC 33591 (MIC = 1.24 μM) XX XR PubMed: 8549789 XR CAMP R4: CAMPSQ877 SQ SEQUENCE 3256 DA MW 29AA RGLRRLGRKI AHGVKKYGPT VLRIIRIAG // ID AMRSAP1063 PN K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO G; K LO F, S, V, W BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1545.931 AI 132.143 II 13.643 HP 0.643 HM 0.627 IP 11.103 NC 2.997 SF 0.5, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1381 (MIC = 6.25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8797 SQ SEQUENCE 1545.931 DA MW 14AA GILGKLWKGV KSIF // ID AMRSAP1064 PN K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO G; K LO F, S, V, W BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1545.931 AI 132.143 II 13.643 HP 0.643 HM 0.627 IP 11.103 NC 2.997 SF 0.5, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1374 (MIC = 6.25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8797 SQ SEQUENCE 1545.931 DA MW 14AA GILGKLWKGV KSIF // ID AMRSAP1065 PN L1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 21.43%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K; L LO F, S, V, W BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.039 AI 160 II 19.707 HP 0.943 HM 0.627 IP 11.103 NC 2.997 SF 0.571, 0.214, 0.214 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1381 (MIC = 25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8798 SQ SEQUENCE 1602.039 DA MW 14AA LILGKLWKGV KSIF // ID AMRSAP1066 PN L1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 21.43%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K; L LO F, S, V, W BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1602.039 AI 160 II 19.707 HP 0.943 HM 0.627 IP 11.103 NC 2.997 SF 0.571, 0.214, 0.214 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1374 (MIC = 6.25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8798 SQ SEQUENCE 1602.039 DA MW 14AA LILGKLWKGV KSIF // ID AMRSAP1067 PN S1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 14.29%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K LO F, V, W BA 9 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1575.958 AI 132.143 II 19.707 HP 0.614 HM 0.627 IP 11.103 NC 2.997 SF 0.5, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1381 (MIC = 12.5 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8799 SQ SEQUENCE 1575.958 DA MW 14AA SILGKLWKGV KSIF // ID AMRSAP1068 PN S1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 14.29%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K LO F, V, W BA 9 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1575.958 AI 132.143 II 19.707 HP 0.614 HM 0.627 IP 11.103 NC 2.997 SF 0.5, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1374 (MIC = 6.25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8799 SQ SEQUENCE 1575.958 DA MW 14AA SILGKLWKGV KSIF // ID AMRSAP1069 PN F1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K LO S, V, W BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1636.056 AI 132.143 II 19.707 HP 0.871 HM 0.627 IP 11.103 NC 2.997 SF 0.571, 0.214, 0.143 [Helix, Turn, Sheet] AR 0.214 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1381 (MIC = 12.5 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8800 SQ SEQUENCE 1636.056 DA MW 14AA FILGKLWKGV KSIF // ID AMRSAP1070 PN F1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 21.43%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K LO S, V, W BA 10 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1636.056 AI 132.143 II 19.707 HP 0.871 HM 0.627 IP 11.103 NC 2.997 SF 0.571, 0.214, 0.143 [Helix, Turn, Sheet] AR 0.214 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA P1374 (MIC = 12.5 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8800 SQ SEQUENCE 1636.056 DA MW 14AA FILGKLWKGV KSIF // ID AMRSAP1071 PN K1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 28.57%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K LO F, S, V, W BA 9 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1617.054 AI 132.143 II 13.643 HP 0.393 HM 0.71 IP 11.278 NC 3.997 SF 0.5, 0.214, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO S. aureus MRSA P1381 (MIC = 6.25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8801 SQ SEQUENCE 1617.054 DA MW 14AA KILGKLWKGV KSIF // ID AMRSAP1072 PN K1K8 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 28.57%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, E, H, M, N, P, Q, R, T, Y MO K LO F, S, V, W BA 9 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1617.054 AI 132.143 II 13.643 HP 0.393 HM 0.71 IP 11.278 NC 3.997 SF 0.5, 0.214, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO S. aureus MRSA P1374 (MIC = 6.25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: CAMPSQ8801 SQ SEQUENCE 1617.054 DA MW 14AA KILGKLWKGV KSIF // ID AMRSAP1073 PN IP SO Ixodes persulcatus PL 38 TX Animalia (Arthropoda) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-1 (MIC = 1.25 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: CAMPSQ8810 SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1074 PN IP SO Ixodes persulcatus PL 38 TX Animalia (Arthropoda) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-2 (MIC = 2.5 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: CAMPSQ8810 SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1075 PN BacSp222 SO Staphylococcus pseudintermedius PL 50 TX Monera (Bacteria) PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 4, 'F': 1, 'G': 5, 'H': 1, 'I': 2, 'K': 5, 'L': 7, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 1, 'R': 3, 'S': 3, 'T': 1, 'V': 2, 'W': 5, 'Y': 2 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 8%, 'F': 2%, 'G': 10%, 'H': 2%, 'I': 4%, 'K': 10%, 'L': 14%, AF 'M': 2%, 'N': 4%, 'P': 0%, 'Q': 2%, 'R': 6%, 'S': 6%, 'T': 2%, 'V': 4%, 'W': 10%, 'Y': 4% MA C, D, P MO L LO F, H, M, Q, T BA 28 LA 22 AA 4 BC 9 MC 0 MF 0 XX MM 5892.87 AI 91.8 II 9.21 HP -0.304 HM 0.581 IP 10.467 NC 4.093 SF 0.38, 0.2, 0.34 [Helix, Turn, Sheet] AR 0.16 ME 30480, 30480 MS 48.161032 XX SC alpha_beta XX TO Staphylococcus aureus MRSA USA300 strain FPR3757 (MIC = 0.89 � 0.00 μM) XX XR PubMed: 26411997 XR CAMP R4: CAMPSQ8859 SQ SEQUENCE 5892.87 DA MW 50AA MAGLLRFLLS KGRALYNWAK SHVGKVWEWL KSGATYEQIK EWIENALGWR // ID AMRSAP1076 PN RP435 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 5, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 5.26%, 'H': 0%, 'I': 10.53%, 'K': 26.32%, 'L': 15.79%, AF 'M': 5.26%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.79%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA C, D, E, H, N, P, Q, S, T, W, Y MO K LO F, G, M, V BA 11 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2269.957 AI 128.421 II -9.442 HP -0.026 HM 0.296 IP 12.831 NC 7.996 SF 0.368, 0.053, 0.316 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC > 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8863 SQ SEQUENCE 2269.957 DA MW 19AA MGFKLRAKIK VRLRAKIKL // ID AMRSAP1077 PN RP436 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 20%, 'D': 0%, 'E': 0%, 'F': 20%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 20%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA A, D, E, G, H, I, K, M, N, Q, R, S, T, W, Y MO C; F; L; O; P; V LO C, F, L, O, P, V BA 8 LA 2 AA 0 BC 0 MC {'O': 2} MF {'O': 0.16666666666666666} XX MM 1612.067 AI 113.333 II 44.75 HP 1.95 HM 0.098 IP 5.826 NC -0.126 SF 0.5, 0.167, 0.167 [Helix, Turn, Sheet] AR 0.167 ME 0, 125 MS 0 XX SC alpha+beta XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC > 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8864 SQ SEQUENCE 1612.067 DA MW 12AA CVOLFPVOLF PC // ID AMRSAP1078 PN RP437 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 12.5%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 12.5%, 'H': 0%, 'I': 6.25%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 6.25%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 6.25%, 'W': 0%, 'Y': 0% MA A, D, E, H, M, N, Q, S, T, W, Y MO R LO F, I, P, V BA 8 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 1902.399 AI 91.25 II 0.188 HP -0.256 HM 0.585 IP 12.079 NC 5.873 SF 0.313, 0.188, 0.125 [Helix, Turn, Sheet] AR 0.063 ME 0, 125 MS 36.120774 XX SC beta XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC > 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8865 SQ SEQUENCE 1902.399 DA MW 16AA CKLRFRGPGR IKVRLC // ID AMRSAP1079 PN RP438 SO Synthetic construct PL 52 TX Synthetic construct PE Experimentally validated XX AC 'A': 12, 'C': 2, 'D': 0, 'E': 0, 'F': 16, 'G': 2, 'H': 0, 'I': 0, 'K': 18, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 23.08%, 'C': 3.85%, 'D': 0%, 'E': 0%, 'F': 30.77%, 'G': 3.85%, 'H': 0%, 'I': 0%, 'K': 34.62%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, H, I, L, M, N, Q, R, S, T, V, W, Y MO K LO C, G, P BA 32 LA 20 AA 0 BC 18 MC 0 MF 0 XX MM 6047.535 AI 23.077 II 11.435 HP -0.054 HM 0.833 IP 11.5 NC 17.869 SF 0.308, 0.077, 0.231 [Helix, Turn, Sheet] AR 0.308 ME 0, 125 MS 108.362322 XX SC alpha XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC = 32 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8866 SQ SEQUENCE 6047.535 DA MW 52AA CPGFAKKFAK KFKKFAKKFA KFAFAFCPGF AKKFAKKFKK FAKKFAKFAF AF // ID AMRSAP1080 PN RP439 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 11.11%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 5.56%, 'H': 0%, 'I': 11.11%, 'K': 16.67%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, H, M, N, P, Q, S, T, V, W, Y MO R LO F, G BA 9 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2145.748 AI 119.444 II 16.694 HP 0.094 HM 0.493 IP 12.102 NC 6.873 SF 0.333, 0.056, 0.278 [Helix, Turn, Sheet] AR 0.056 ME 0, 125 MS 42.140903 XX SC beta XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC = 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8867 SQ SEQUENCE 2145.748 DA MW 18AA KIRAKLCLGR FCIRAKLR // ID AMRSAP1081 PN RP440 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 1, 'K': 8, 'L': 2, AC 'M': 0, 'N': 0, 'P': 12, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 3.85%, 'K': 30.77%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 46.15%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 3.85% MA A, C, D, E, G, H, M, N, Q, R, S, T, V, W MO P LO I, Y BA 17 LA 9 AA 0 BC 8 MC 0 MF 0 XX MM 3005.816 AI 45 II 58.154 HP -1.308 HM 0.261 IP 11.295 NC 7.995 SF 0.231, 0.462, 0.077 [Helix, Turn, Sheet] AR 0.115 ME 1490, 1490 MS 48.161032 XX SC alpha_beta XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC > 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8868 SQ SEQUENCE 3005.816 DA MW 26AA KKKPKPPYLP KPKPPPFFPP KLPPKI // ID AMRSAP1082 PN RP441 SO Synthetic construct PL 52 TX Synthetic construct PE Experimentally validated XX AC 'A': 12, 'C': 2, 'D': 0, 'E': 0, 'F': 16, 'G': 2, 'H': 0, 'I': 0, 'K': 18, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 23.08%, 'C': 3.85%, 'D': 0%, 'E': 0%, 'F': 30.77%, 'G': 3.85%, 'H': 0%, 'I': 0%, 'K': 34.62%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, H, I, L, M, N, Q, R, S, T, V, W, Y MO K LO C, G, P BA 32 LA 20 AA 0 BC 18 MC 0 MF 0 XX MM 6047.535 AI 23.077 II -21.996 HP -0.054 HM 0.833 IP 11.5 NC 17.869 SF 0.308, 0.077, 0.231 [Helix, Turn, Sheet] AR 0.308 ME 0, 125 MS 108.362322 XX SC alpha XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC > 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8869 SQ SEQUENCE 6047.535 DA MW 52AA FAFAFKAFKK AFKKFKKAFK KAFGPCFAFA FKAFKKAFKK FKKAFKKAFG PC // ID AMRSAP1083 PN RP442 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 8, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 36.36%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO F; K LO A BA 14 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2647.294 AI 27.273 II -17.782 HP 0.091 HM 0.833 IP 11.646 NC 7.996 SF 0.364, 0, 0.273 [Helix, Turn, Sheet] AR 0.364 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC = 16 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8870 SQ SEQUENCE 2647.294 DA MW 22AA FAFAFAFKKA FKKFKKAFKK AF // ID AMRSAP1084 PN RP443 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 8, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 42.86%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 57.14%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO A BA 14 LA 0 AA 0 BC 0 MC {'O': 9} MF {'O': 0.391304347826087} XX MM 3757.617 AI 26.087 II 9.565 HP 1.443 HM 0.366 IP 6.1 NC -0.002 SF 0.348, 0, 0.261 [Helix, Turn, Sheet] AR 0.348 ME 0, 0 MS 0 XX SC alpha XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC = 16 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8871 SQ SEQUENCE 3757.617 DA MW 23AA FAFAFOAFOO AFOOFOOAFO OAF // ID AMRSAP1085 PN RP444 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 8, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 42.86%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 57.14%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, K, L, M, N, P, Q, R, S, T, V, W, Y MO O LO A BA 14 LA 0 AA 0 BC 0 MC {'O': 9} MF {'O': 0.391304347826087} XX MM 3757.617 AI 26.087 II 9.565 HP 1.443 HM 0.366 IP 6.1 NC -0.002 SF 0.348, 0, 0.261 [Helix, Turn, Sheet] AR 0.348 ME 0, 0 MS 0 XX SC alpha XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC = 16 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8872 SQ SEQUENCE 3757.617 DA MW 23AA FAOOFAOOFO OFAOOFAOFA FAF // ID AMRSAP1086 PN RP445 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 8, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 36.36%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, W, Y MO F; K LO A BA 14 LA 8 AA 0 BC 8 MC 0 MF 0 XX MM 2647.294 AI 27.273 II 2.714 HP 0.091 HM 0.833 IP 11.646 NC 7.996 SF 0.364, 0, 0.273 [Helix, Turn, Sheet] AR 0.364 ME 0, 0 MS 48.161032 XX SC alpha XX TO MRSA (Methicillin-resistant Staphylococcus aureus) 33591 (MIC > 64 μG/mL) XX XR PubMed: 29242901 XR CAMP R4: CAMPSQ8873 SQ SEQUENCE 2647.294 DA MW 22AA FAKKFAKKFK KFAKKFAFAF AF // ID AMRSAP1087 PN Defensin SO Allomyrina dichotoma PL 43 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 6, 'C': 6, 'D': 1, 'E': 2, 'F': 2, 'G': 5, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 5, 'S': 3, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 13.95%, 'C': 13.95%, 'D': 2.33%, 'E': 4.65%, 'F': 4.65%, 'G': 11.63%, 'H': 4.65%, 'I': 4.65%, 'K': 2.33%, 'L': 9.3%, AF 'M': 0%, 'N': 2.33%, 'P': 0%, 'Q': 0%, 'R': 11.63%, 'S': 6.98%, 'T': 2.33%, 'V': 4.65%, 'W': 0%, 'Y': 0% MA M, P, Q, W, Y MO A; C LO D, K, N, T BA 21 LA 22 AA 3 BC 8 MC 0 MF 0 XX MM 4553.312 AI 81.86 II 45.947 HP 0.281 HM 0.558 IP 8.394 NC 2.812 SF 0.233, 0.209, 0.279 [Helix, Turn, Sheet] AR 0.047 ME 0, 375 MS 36.120774 XX SC beta XX TO MRSA XX XR PubMed: 8607799 XR CAMP R4: CAMPSQ893 SQ SEQUENCE 4553.312 DA MW 43AA VTCDLLSFEA KGFAANHSLC AAHCLAIGRR GGSCERGVCI CRR // ID AMRSAP1088 PN P3 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 0, 'K': 1, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 8.33%, 'I': 0%, 'K': 8.33%, 'L': 25%, AF 'M': 0%, 'N': 8.33%, 'P': 0%, 'Q': 8.33%, 'R': 8.33%, 'S': 8.33%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, I, M, P, T, Y MO L LO G, H, K, N, Q, R, S, V, W BA 6 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 1450.707 AI 121.667 II 18.142 HP -0.425 HM 0.49 IP 11.652 NC 2.089 SF 0.417, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8933 SQ SEQUENCE 1450.707 DA MW 12AA VGSNLRLLHQ WK // ID AMRSAP1089 PN P4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 1, 'S': 1, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 8.33%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 8.33%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 8.33%, 'Q': 16.67%, 'R': 8.33%, 'S': 8.33%, 'T': 0%, 'V': 8.33%, 'W': 25%, 'Y': 0% MA A, C, E, G, I, K, L, M, N, T, Y MO W LO D, F, H, P, R, S, V BA 6 LA 6 AA 1 BC 2 MC 0 MF 0 XX MM 1671.838 AI 24.167 II 48.633 HP -1.358 HM 0.455 IP 7.551 NC 0.089 SF 0.417, 0.167, 0 [Helix, Turn, Sheet] AR 0.333 ME 16500, 16500 MS 6.020129 XX SC alpha_beta XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8934 SQ SEQUENCE 1671.838 DA MW 12AA VHWDFRQWWQ PS // ID AMRSAP1090 PN P5 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 28.57%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 14.29%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 0%, 'W': 0%, 'Y': 14.29% MA A, D, E, F, G, H, I, M, N, Q, R, S, V, W MO C LO K, L, P, T, Y BA 2 LA 5 AA 0 BC 1 MC 0 MF 0 XX MM 827.024 AI 55.714 II 23.957 HP 0.186 HM 0.379 IP 8.221 NC 0.873 SF 0.286, 0.143, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 1490, 1615 MS 6.020129 XX SC beta XX TO MRSA ATCC 43300 (MIC > 256 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8935 SQ SEQUENCE 827.024 DA MW 7AA KCCYTLP // ID AMRSAP1091 PN P6 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 28.57%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, I, K, M, N, P, Q, S, W, Y MO C LO G, L, R, T, V BA 3 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 750.929 AI 97.143 II 8.571 HP 1.057 HM 0.465 IP 8.231 NC 0.874 SF 0.286, 0.143, 0.143 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 6.020129 XX SC beta XX TO MRSA ATCC 43300 (MIC > 256 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8936 SQ SEQUENCE 750.929 DA MW 7AA VLTRCCG // ID AMRSAP1092 PN P7 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 14.29%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 14.29%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 28.57%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, K, M, P, Q, R, S, W, Y MO V LO F, G, L, N, T BA 5 LA 2 AA 0 BC 0 MC 0 MF 0 XX MM 748.877 AI 138.571 II -3.557 HP 1.486 HM 0.229 IP 6.1 NC -0.002 SF 0.571, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 0 XX SC alpha XX TO MRSA ATCC 43300 (MIC > 256 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8937 SQ SEQUENCE 748.877 DA MW 7AA TGFLVNV // ID AMRSAP1093 PN P8 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 14.29%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 14.29%, 'I': 14.29%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 14.29%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 14.29%, 'Y': 14.29% MA A, C, E, G, K, L, M, N, P, Q, S, T, V MO D; F; H; I; R; W; Y LO D, F, H, I, R, W, Y BA 3 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1036.158 AI 55.714 II 142.4 HP -0.871 HM 0.147 IP 7.543 NC 0.088 SF 0.571, 0, 0 [Helix, Turn, Sheet] AR 0.429 ME 6990, 6990 MS 6.020129 XX SC alpha_beta XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8938 SQ SEQUENCE 1036.158 DA MW 7AA HYIDFRW // ID AMRSAP1094 PN P9 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 1, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 11.11%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA A, D, F, H, I, M, N, P, Q, R, S, T, V, Y MO C; K; L LO E, G, W BA 4 LA 5 AA 1 BC 2 MC 0 MF 0 XX MM 1079.34 AI 86.667 II 3.044 HP 0 HM 0.542 IP 8.228 NC 0.875 SF 0.333, 0.111, 0.333 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5625 MS 12.040258 XX SC beta XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8939 SQ SEQUENCE 1079.34 DA MW 9AA CLKLGEKWC // ID AMRSAP1095 PN P10 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 1, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 11.11%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 11.11%, 'N': 0%, 'P': 11.11%, 'Q': 0%, 'R': 11.11%, 'S': 11.11%, 'T': 11.11%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, I, K, L, N, Q, V, W, Y MO C LO A, G, M, P, R, S, T BA 4 LA 5 AA 0 BC 1 MC 0 MF 0 XX MM 925.104 AI 11.111 II 66.689 HP 0.078 HM 0.373 IP 8.231 NC 0.874 SF 0, 0.333, 0.222 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 6.020129 XX SC alpha XX TO MRSA ATCC 43300 (MIC = 128 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8940 SQ SEQUENCE 925.104 DA MW 9AA CRGATPMSC // ID AMRSAP1096 PN P11 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 11.11%, 'I': 11.11%, 'K': 0%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 33.33%, 'T': 11.11%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, F, G, K, M, N, P, Q, R, V, W, Y MO S LO H, I, L, T BA 2 LA 7 AA 0 BC 1 MC 0 MF 0 XX MM 950.092 AI 86.667 II 30.289 HP 0.778 HM 0.264 IP 7.253 NC -0.035 SF 0.222, 0.333, 0.111 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 0 XX SC alpha XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8941 SQ SEQUENCE 950.092 DA MW 9AA CSISSLTHC // ID AMRSAP1097 PN P12 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 11.11%, 'C': 22.22%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.11%, 'T': 22.22%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA D, E, F, H, I, K, M, N, P, Q, R, V, Y MO C; T LO A, G, L, S, W BA 4 LA 5 AA 0 BC 0 MC 0 MF 0 XX MM 941.085 AI 54.444 II 37.733 HP 0.789 HM 0.194 IP 5.826 NC -0.126 SF 0.222, 0.222, 0.222 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5625 MS 0 XX SC beta XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8942 SQ SEQUENCE 941.085 DA MW 9AA CLWSTGATC // ID AMRSAP1098 PN P13 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 1, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 22.22%, 'D': 11.11%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 0%, 'L': 0%, AF 'M': 11.11%, 'N': 11.11%, 'P': 11.11%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 11.11%, 'V': 11.11%, 'W': 0%, 'Y': 0% MA A, E, F, G, H, K, L, Q, R, S, W, Y MO C LO D, I, M, N, P, T, V BA 4 LA 5 AA 1 BC 0 MC 0 MF 0 XX MM 995.192 AI 75.556 II 97.311 HP 0.7 HM 0.419 IP 3.75 NC -1.126 SF 0.222, 0.222, 0.111 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 0 XX SC alpha_beta XX TO MRSA ATCC 43300 (MIC = 64 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8943 SQ SEQUENCE 995.192 DA MW 9AA CDNIMTPVC // ID AMRSAP1099 PN P14 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 3, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 1, 'S': 0, 'T': 2, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 27.27%, 'D': 9.09%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 18.18%, 'R': 9.09%, 'S': 0%, 'T': 18.18%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA A, E, F, G, H, K, L, M, N, P, S, W, Y MO C LO D, I, R, V BA 2 LA 9 AA 1 BC 1 MC 0 MF 0 XX MM 1269.471 AI 61.818 II -4.618 HP -0.018 HM 0.308 IP 5.998 NC -0.187 SF 0.182, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 6.020129 XX SC beta XX TO MRSA ATCC 43300 (MIC = 32 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8944 SQ SEQUENCE 1269.471 DA MW 11AA CQTDVCQRTI C // ID AMRSAP1100 PN P15 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 3, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 25%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 25%, 'H': 0%, 'I': 8.33%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 0%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, D, E, F, H, K, M, N, P, R, W, Y MO C; G LO I, L, Q, S, T, V BA 6 LA 6 AA 0 BC 0 MC 0 MF 0 XX MM 1140.353 AI 89.167 II -0.192 HP 1.15 HM 0.248 IP 5.759 NC -0.188 SF 0.25, 0.333, 0.083 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 0 XX SC beta XX TO MRSA ATCC 43300 (MIC = 32 μG/mL) XX XR PubMed: 31243959 XR CAMP R4: CAMPSQ8945 SQ SEQUENCE 1140.353 DA MW 12AA CSLITQCGGV GC // ID AMRSAP1101 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, K, L, M, N, P, Q, S, T MO R LO A, F, G, I, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2211.672 AI 45.882 II 13.224 HP -0.182 HM 0.599 IP 9.54 NC 4.748 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 0.5 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8979 SQ SEQUENCE 2211.672 DA MW 17AA AWCFRVCYRG ICYRRCR // ID AMRSAP1102 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T, W MO R LO A, F, G, I, K, V BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2153.633 AI 45.882 II 39.071 HP -0.359 HM 0.664 IP 10.068 NC 5.748 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.176 ME 2980, 3230 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8980 SQ SEQUENCE 2153.633 DA MW 17AA KACFRVCYRG ICYRRCR // ID AMRSAP1103 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 5.88%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, T MO R LO A, F, G, I, K, S, V, W BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2220.647 AI 45.882 II 41.559 HP -0.753 HM 0.679 IP 11.35 NC 5.872 SF 0.353, 0.118, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8605 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC >= 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8981 SQ SEQUENCE 2220.647 DA MW 17AA KWAFRVCYRG ICYRRSR // ID AMRSAP1104 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, F, H, L, M, N, P, Q, S, T MO R LO A, G, I, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2192.67 AI 45.882 II 13.224 HP -0.576 HM 0.637 IP 10.068 NC 5.748 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.176 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8982 SQ SEQUENCE 2192.67 DA MW 17AA KWCARVCYRG ICYRRCR // ID AMRSAP1105 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO C; R LO A, F, G, I, K, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2183.659 AI 45.882 II 13.224 HP -0.147 HM 0.373 IP 9.512 NC 4.748 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 0.5 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8983 SQ SEQUENCE 2183.659 DA MW 17AA KWCFAVCYRG ICYRRCR // ID AMRSAP1106 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T, V MO R LO A, F, G, I, K, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2240.714 AI 28.824 II 39.071 HP -0.659 HM 0.653 IP 10.068 NC 5.748 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8984 SQ SEQUENCE 2240.714 DA MW 17AA KWCFRACYRG ICYRRCR // ID AMRSAP1107 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 5.88%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, T MO R LO A, F, G, I, K, S, V, W BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2220.647 AI 45.882 II 13.224 HP -0.753 HM 0.682 IP 11.35 NC 5.872 SF 0.353, 0.118, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8605 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC = 2 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8985 SQ SEQUENCE 2220.647 DA MW 17AA KWCFRVAYRG ISYRRCR // ID AMRSAP1108 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA D, E, H, L, M, N, P, Q, S, T MO R LO A, F, G, I, K, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2176.671 AI 45.882 II 23.171 HP -0.335 HM 0.642 IP 10.462 NC 5.749 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.176 ME 6990, 7240 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8986 SQ SEQUENCE 2176.671 DA MW 17AA KWCFRVCARG ICYRRCR // ID AMRSAP1109 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO C; R LO A, F, G, I, K, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2183.659 AI 45.882 II 42.094 HP -0.147 HM 0.431 IP 9.512 NC 4.748 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 1 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8987 SQ SEQUENCE 2183.659 DA MW 17AA KWCFRVCYAG ICYRRCR // ID AMRSAP1110 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 0%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, G, H, L, M, N, P, Q, S, T MO R LO A, F, I, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2282.795 AI 45.882 II 23.212 HP -0.388 HM 0.661 IP 10.068 NC 5.748 SF 0.353, 0, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 0.5 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8988 SQ SEQUENCE 2282.795 DA MW 17AA KWCFRVCYRA ICYRRCR // ID AMRSAP1111 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, I, L, M, N, P, Q, S, T MO R LO A, F, G, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2226.687 AI 22.941 II 39.071 HP -0.676 HM 0.611 IP 10.068 NC 5.748 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 2 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8989 SQ SEQUENCE 2226.687 DA MW 17AA KWCFRVCYRG ACYRRCR // ID AMRSAP1112 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 5.88%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, T MO R LO A, F, G, I, K, S, V, W BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2220.647 AI 45.882 II 13.224 HP -0.753 HM 0.61 IP 11.35 NC 5.872 SF 0.353, 0.118, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8605 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8990 SQ SEQUENCE 2220.647 DA MW 17AA KWCFRVSYRG IAYRRCR // ID AMRSAP1113 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA D, E, H, L, M, N, P, Q, S, T MO R LO A, F, G, I, K, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2176.671 AI 45.882 II 23.171 HP -0.335 HM 0.652 IP 10.462 NC 5.749 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.176 ME 6990, 7240 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8991 SQ SEQUENCE 2176.671 DA MW 17AA KWCFRVCYRG ICARRCR // ID AMRSAP1114 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO C; R LO A, F, G, I, K, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2183.659 AI 45.882 II 3.406 HP -0.147 HM 0.652 IP 9.512 NC 4.748 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 0.5 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8992 SQ SEQUENCE 2183.659 DA MW 17AA KWCFRVCYRG ICYARCR // ID AMRSAP1115 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO C; R LO A, F, G, I, K, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2183.659 AI 45.882 II 5.376 HP -0.147 HM 0.652 IP 9.512 NC 4.748 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8993 SQ SEQUENCE 2183.659 DA MW 17AA KWCFRVCYRG ICYRACR // ID AMRSAP1116 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 5.88%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, T MO R LO A, F, G, I, K, S, V, W BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2220.647 AI 45.882 II 13.224 HP -0.753 HM 0.616 IP 11.35 NC 5.872 SF 0.353, 0.118, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8605 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8994 SQ SEQUENCE 2220.647 DA MW 17AA KWSFRVCYRG ICYRRAR // ID AMRSAP1117 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.53%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO C; R LO A, F, G, I, K, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2183.659 AI 45.882 II 13.224 HP -0.147 HM 0.652 IP 9.512 NC 4.748 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 0.5 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8995 SQ SEQUENCE 2183.659 DA MW 17AA KWCFRVCYRG ICYRRCA // ID AMRSAP1118 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 11.76%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO R LO F, G, I, K, V, W BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2204.648 AI 51.765 II 4.382 HP -0.6 HM 0.679 IP 11.35 NC 5.872 SF 0.353, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8605 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8996 SQ SEQUENCE 2204.648 DA MW 17AA KWAFRVCYRG ICYRRAR // ID AMRSAP1119 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 11.76%, 'C': 11.76%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO R LO F, G, I, K, V, W BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2204.648 AI 51.765 II 13.224 HP -0.6 HM 0.682 IP 11.35 NC 5.872 SF 0.353, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8605 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC = 2 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8997 SQ SEQUENCE 2204.648 DA MW 17AA KWCFRVAYRG IAYRRCR // ID AMRSAP1120 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 23.53%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA C, D, E, H, L, M, N, P, Q, S, T MO R LO F, G, I, K, V, W BA 9 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 2140.528 AI 63.529 II 4.382 HP -0.682 HM 0.708 IP 12.338 NC 5.996 SF 0.353, 0.059, 0.235 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8480 MS 36.120774 XX SC alpha XX TO S.aureus ATCC43300 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8998 SQ SEQUENCE 2140.528 DA MW 17AA KWAFRVAYRG IAYRRAR // ID AMRSAP1121 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 2 AF 'A': 5.88%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T, V MO R LO A, F, G, I, K, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2240.714 AI 28.824 II 75.788 HP -0.659 HM 0.47 IP 10.068 NC 5.748 SF 0.294, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC>16 = μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ8999 SQ SEQUENCE 2240.714 DA MW 17AA KWCFRRCYAG ICYRRCR // ID AMRSAP1122 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 35.29%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA A, D, E, H, K, L, M, N, P, Q, S, T MO R LO F, G, I, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2296.781 AI 40 II 46.918 HP -0.553 HM 0.717 IP 10.171 NC 5.748 SF 0.353, 0.059, 0 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 1 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9000 SQ SEQUENCE 2296.781 DA MW 17AA RWCFRVCYRG ICYRRCR // ID AMRSAP1123 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.76%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA A, D, E, F, H, L, M, N, P, Q, S, T MO R LO I, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2178.643 AI 40 II 13.224 HP -0.706 HM 0.634 IP 10.068 NC 5.748 SF 0.294, 0.118, 0 [Helix, Turn, Sheet] AR 0.176 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9001 SQ SEQUENCE 2178.643 DA MW 17AA KWCGRVCYRG ICYRRCR // ID AMRSAP1124 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 5.88%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA A, D, E, F, H, L, M, N, P, Q, T MO R LO G, I, K, S, V, W BA 4 LA 13 AA 0 BC 6 MC 0 MF 0 XX MM 2208.669 AI 40 II 24.553 HP -0.729 HM 0.622 IP 10.068 NC 5.748 SF 0.294, 0.118, 0 [Helix, Turn, Sheet] AR 0.176 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9002 SQ SEQUENCE 2208.669 DA MW 17AA KWCSRVCYRG ICYRRCR // ID AMRSAP1125 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 11.76%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA A, D, E, H, L, M, N, P, Q, S, T MO R LO F, I, K, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2162.644 AI 40 II 23.171 HP -0.465 HM 0.646 IP 10.462 NC 5.749 SF 0.294, 0.118, 0 [Helix, Turn, Sheet] AR 0.176 ME 6990, 7240 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9003 SQ SEQUENCE 2162.644 DA MW 17AA KWCFRVCGRG ICYRRCR // ID AMRSAP1126 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 11.76%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA A, D, E, H, I, L, M, N, P, Q, S, T MO R LO F, K, V, W BA 5 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2212.66 AI 17.059 II 25.476 HP -0.806 HM 0.604 IP 10.068 NC 5.748 SF 0.294, 0.118, 0 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9004 SQ SEQUENCE 2212.66 DA MW 17AA KWCFRVCYRG GCYRRCR // ID AMRSAP1127 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 17.65%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, Q, S, T MO R LO G, K, V, W, Y BA 6 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2058.492 AI 34.706 II 49.018 HP -0.553 HM 0.584 IP 10.462 NC 5.749 SF 0.176, 0.059, 0.176 [Helix, Turn, Sheet] AR 0.118 ME 6990, 7240 MS 36.120774 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC >= 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9005 SQ SEQUENCE 2058.492 DA MW 17AA KWCARVCARG ACYRRCR // ID AMRSAP1128 PN TP1 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 0%, 'C': 25%, 'D': 0%, 'E': 0%, 'F': 6.25%, 'G': 12.5%, 'H': 0%, 'I': 6.25%, 'K': 6.25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 18.75%, 'S': 0%, 'T': 0%, 'V': 6.25%, 'W': 6.25%, 'Y': 12.5% MA A, D, E, H, L, M, N, P, Q, S, T MO C LO F, I, K, V, W BA 6 LA 10 AA 0 BC 4 MC 0 MF 0 XX MM 2013.445 AI 42.5 II 13.425 HP -0.013 HM 0.425 IP 9.033 NC 3.748 SF 0.375, 0.125, 0 [Helix, Turn, Sheet] AR 0.25 ME 8480, 8730 MS 24.080516 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MCI >= 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9006 SQ SEQUENCE 2013.445 DA MW 16AA KWCFVCYRGI CYRRCG // ID AMRSAP1129 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 11.76%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, F, H, K, L, M, N, P, Q, S, T MO R LO G, I, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2135.575 AI 51.765 II 13.224 HP -0.241 HM 0.572 IP 9.54 NC 4.748 SF 0.294, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.176 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC >= 16 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9007 SQ SEQUENCE 2135.575 DA MW 17AA AWCARVCYRG ICYRRCR // ID AMRSAP1130 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 11.76%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 5.88% MA D, E, H, K, L, M, N, P, Q, S, T MO R LO F, G, I, V, W, Y BA 7 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2119.575 AI 51.765 II 23.171 HP 0 HM 0.597 IP 9.716 NC 4.749 SF 0.294, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.176 ME 6990, 7240 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9008 SQ SEQUENCE 2119.575 DA MW 17AA AWCFRVCARG ICYRRCR // ID AMRSAP1131 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 11.76%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 29.41%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, I, K, L, M, N, P, Q, S, T MO R LO F, G, V, W BA 6 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2169.592 AI 28.824 II 39.071 HP -0.341 HM 0.545 IP 9.54 NC 4.748 SF 0.294, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 30.100645 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 4 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9009 SQ SEQUENCE 2169.592 DA MW 17AA AWCFRVCYRG ACYRRCR // ID AMRSAP1132 PN TP1 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 4, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 2 AF 'A': 11.76%, 'C': 23.53%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 17.65%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 5.88%, 'Y': 11.76% MA D, E, H, L, M, N, P, Q, S, T MO C LO F, G, I, K, V, W BA 7 LA 10 AA 0 BC 4 MC 0 MF 0 XX MM 2098.55 AI 51.765 II 42.094 HP 0.224 HM 0.431 IP 9.033 NC 3.748 SF 0.353, 0.059, 0.118 [Helix, Turn, Sheet] AR 0.235 ME 8480, 8730 MS 24.080516 XX SC beta XX TO S.aureus ATCC43300 (MRSA) (MIC = 2 μG/mL) XX XR PubMed: 28960954 XR CAMP R4: CAMPSQ9010 SQ SEQUENCE 2098.55 DA MW 17AA KWCFRVCYAG ICYRRCA // ID AMRSAP1133 PN AMP-001/Cit 1.1 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1615.977 AI 158.125 II 14.188 HP 1.281 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9050 SQ SEQUENCE 1615.977 DA MW 16AA GLFDVIKKVA SVIGGL // ID AMRSAP1134 PN AMP-001/Cit 1.1 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1615.977 AI 158.125 II 14.188 HP 1.281 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9050 SQ SEQUENCE 1615.977 DA MW 16AA GLFDVIKKVA SVIGGL // ID AMRSAP1135 PN AMP-002 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 6.67%, 'G': 13.33%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO V LO A, D, F, S BA 11 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1558.925 AI 168.667 II 14.467 HP 1.393 HM 0.642 IP 9.537 NC 0.998 SF 0.533, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9051 SQ SEQUENCE 1558.925 DA MW 15AA LFDVIKKVAS VIGGL // ID AMRSAP1136 PN AMP-003 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1615.977 AI 158.125 II 14.188 HP 1.281 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 256 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9052 SQ SEQUENCE 1615.977 DA MW 16AA GLFDVIKKVA SVIGGL // ID AMRSAP1137 PN AMP-004 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G; V; X LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC {'X': 3} MF {'X': 0.15789473684210525} XX MM 1615.977 AI 133.158 II 13.526 HP 1.079 HM 0.642 IP 9.537 NC 0.998 SF 0.421, 0.211, 0.158 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 256 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9053 SQ SEQUENCE 1615.977 DA MW 19AA XXXGLFDVIK KVASVIGGL // ID AMRSAP1138 PN AMP-005 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 6.67%, 'G': 13.33%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO V LO A, D, F, S, X BA 11 LA 4 AA 1 BC 2 MC {'X': 1} MF {'X': 0.0625} XX MM 1558.925 AI 158.125 II 14.188 HP 1.306 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.188, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 256 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9054 SQ SEQUENCE 1558.925 DA MW 16AA XLFDVIKKVA SVIGGL // ID AMRSAP1139 PN AMP-006 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 7.14%, 'E': 0%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 21.43%, 'W': 0%, 'Y': 0% MA C, E, H, K, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 2 AA 1 BC 0 MC {'X': 2} MF {'X': 0.125} XX MM 1359.629 AI 158.125 II 24.8 HP 1.769 HM 0.467 IP 3.75 NC -1.002 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 64 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9055 SQ SEQUENCE 1359.629 DA MW 16AA GLFDVIXXVA SVIGGL // ID AMRSAP1140 PN AMP-006 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 7.14%, 'E': 0%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 21.43%, 'W': 0%, 'Y': 0% MA C, E, H, K, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 2 AA 1 BC 0 MC {'X': 2} MF {'X': 0.125} XX MM 1359.629 AI 158.125 II 24.8 HP 1.769 HM 0.467 IP 3.75 NC -1.002 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9055 SQ SEQUENCE 1359.629 DA MW 16AA GLFDVIXXVA SVIGGL // ID AMRSAP1141 PN AMP-007 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 7.14%, 'E': 0%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 21.43%, 'W': 0%, 'Y': 0% MA C, E, H, K, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 2 AA 1 BC 0 MC {'X': 2} MF {'X': 0.125} XX MM 1359.629 AI 158.125 II 24.8 HP 1.769 HM 0.467 IP 3.75 NC -1.002 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC >=32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9056 SQ SEQUENCE 1359.629 DA MW 16AA GLFDVIXXVA SVIGGL // ID AMRSAP1142 PN AMP-008 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 7.14%, 'E': 0%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 21.43%, 'W': 0%, 'Y': 0% MA C, E, H, K, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, S BA 12 LA 2 AA 1 BC 0 MC {'X': 2} MF {'X': 0.125} XX MM 1359.629 AI 158.125 II 24.8 HP 1.769 HM 0.467 IP 3.75 NC -1.002 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 0 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC >=32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9057 SQ SEQUENCE 1359.629 DA MW 16AA GLFDVIXXVA SVIGGL // ID AMRSAP1143 PN AMP-009 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 6.67%, 'G': 20%, 'H': 0%, 'I': 13.33%, 'K': 6.67%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, F, K, S, X BA 12 LA 3 AA 1 BC 1 MC {'X': 1} MF {'X': 0.0625} XX MM 1487.803 AI 158.125 II 19.494 HP 1.525 HM 0.568 IP 6.337 NC -0.002 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 6.020129 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 128 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9058 SQ SEQUENCE 1487.803 DA MW 16AA GLFDVIXKVA SVIGGL // ID AMRSAP1144 PN AMP-010 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO X LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC {'X': 9} MF {'X': 0.36} XX MM 1615.977 AI 101.2 II 16.076 HP 0.82 HM 0.542 IP 9.537 NC 0.998 SF 0.32, 0.16, 0.12 [Helix, Turn, Sheet] AR 0.04 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 256 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9059 SQ SEQUENCE 1615.977 DA MW 25AA XXXGLFDVIK XXXKXXXVAS VIGGL // ID AMRSAP1145 PN AMP-011 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO X LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC {'X': 6} MF {'X': 0.2727272727272727} XX MM 1615.977 AI 115 II 16.905 HP 0.932 HM 0.542 IP 9.537 NC 0.998 SF 0.364, 0.182, 0.136 [Helix, Turn, Sheet] AR 0.045 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 256 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9060 SQ SEQUENCE 1615.977 DA MW 22AA GLFDVIKXXX KXXXVASVIG GL // ID AMRSAP1146 PN AMP-012 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 0%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, K, M, N, P, Q, T, W, Y MO G; V LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1672.004 AI 158.125 II 60.6 HP 1.206 HM 0.763 IP 10.398 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9061 SQ SEQUENCE 1672.004 DA MW 16AA GLFDVIRRVA SVIGGL // ID AMRSAP1147 PN AMP-012 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 0%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, K, M, N, P, Q, T, W, Y MO G; V LO A, D, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1672.004 AI 158.125 II 60.6 HP 1.206 HM 0.763 IP 10.398 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 16 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9061 SQ SEQUENCE 1672.004 DA MW 16AA GLFDVIRRVA SVIGGL // ID AMRSAP1148 PN AMP-013 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 6.25%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.25%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, T, W, Y MO G; V LO A, D, F, K, R, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1643.99 AI 158.125 II 19.494 HP 1.244 HM 0.704 IP 9.695 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9062 SQ SEQUENCE 1643.99 DA MW 16AA GLFDVIRKVA SVIGGL // ID AMRSAP1149 PN AMP-014 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 0%, 'D': 5.88%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 11.76%, 'K': 11.76%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 5.88%, 'T': 0%, 'V': 17.65%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G LO A, D, F, S BA 13 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1673.029 AI 148.824 II 13.941 HP 1.182 HM 0.551 IP 9.537 NC 0.998 SF 0.471, 0.294, 0.176 [Helix, Turn, Sheet] AR 0.059 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 256 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9063 SQ SEQUENCE 1673.029 DA MW 17AA GLFDVIKKGV ASVIGGL // ID AMRSAP1150 PN AMP-014 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 0%, 'D': 5.88%, 'E': 0%, 'F': 5.88%, 'G': 23.53%, 'H': 0%, 'I': 11.76%, 'K': 11.76%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 5.88%, 'T': 0%, 'V': 17.65%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, P, Q, R, T, W, Y MO G LO A, D, F, S BA 13 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1673.029 AI 148.824 II 13.941 HP 1.182 HM 0.551 IP 9.537 NC 0.998 SF 0.471, 0.294, 0.176 [Helix, Turn, Sheet] AR 0.059 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 16 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9063 SQ SEQUENCE 1673.029 DA MW 17AA GLFDVIKKGV ASVIGGL // ID AMRSAP1151 PN AMP-015 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, P, Q, R, T, W, Y MO G; V LO A, E, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1630.004 AI 158.125 II 6.475 HP 1.281 HM 0.628 IP 9.537 NC 0.999 SF 0.5, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC alpha XX TO Staphylococcus aureus�JE2 MRSA (MIC = 64 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9064 SQ SEQUENCE 1630.004 DA MW 16AA GLFEVIKKVA SVIGGL // ID AMRSAP1152 PN AMP-015 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 6.25%, 'F': 6.25%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 0%, 'Y': 0% MA C, D, H, M, N, P, Q, R, T, W, Y MO G; V LO A, E, F, S BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1630.004 AI 158.125 II 6.475 HP 1.281 HM 0.628 IP 9.537 NC 0.999 SF 0.5, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.063 ME 0, 0 MS 12.040258 XX SC alpha XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 32 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9064 SQ SEQUENCE 1630.004 DA MW 16AA GLFEVIKKVA SVIGGL // ID AMRSAP1153 PN AMP-016 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 6.25%, 'Y': 0% MA C, E, F, H, M, N, P, Q, R, T, Y MO G; V LO A, D, S, W BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1655.013 AI 158.125 II 21.275 HP 1.05 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9065 SQ SEQUENCE 1655.013 DA MW 16AA GLWDVIKKVA SVIGGL // ID AMRSAP1154 PN AMP-016 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 6.25%, 'E': 0%, 'F': 0%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 6.25%, 'Y': 0% MA C, E, F, H, M, N, P, Q, R, T, Y MO G; V LO A, D, S, W BA 12 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1655.013 AI 158.125 II 21.275 HP 1.05 HM 0.642 IP 9.537 NC 0.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 4 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9065 SQ SEQUENCE 1655.013 DA MW 16AA GLWDVIKKVA SVIGGL // ID AMRSAP1155 PN AMP-017 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 6.25%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 6.25%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, T, Y MO G; V LO A, K, S, W BA 12 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1724.126 AI 158.125 II 26.581 HP 0.95 HM 0.851 IP 12.516 NC 2.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9066 SQ SEQUENCE 1724.126 DA MW 16AA GLWRVIRKVA SVIGGL // ID AMRSAP1156 PN AMP-017 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 18.75%, 'H': 0%, 'I': 12.5%, 'K': 6.25%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 12.5%, 'S': 6.25%, 'T': 0%, 'V': 18.75%, 'W': 6.25%, 'Y': 0% MA C, D, E, F, H, M, N, P, Q, T, Y MO G; V LO A, K, S, W BA 12 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1724.126 AI 158.125 II 26.581 HP 0.95 HM 0.851 IP 12.516 NC 2.998 SF 0.5, 0.25, 0.188 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 4 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9066 SQ SEQUENCE 1724.126 DA MW 16AA GLWRVIRKVA SVIGGL // ID AMRSAP1157 PN AMP-018 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 1 AF 'A': 5.56%, 'C': 0%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 16.67%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 0%, 'V': 16.67%, 'W': 5.56%, 'Y': 5.56% MA C, E, F, H, M, N, P, Q, T MO G; L; V LO A, D, K, R, S, W, Y BA 13 LA 5 AA 1 BC 2 MC 0 MF 0 XX MM 1959.362 AI 162.222 II 24.739 HP 1.039 HM 0.708 IP 9.297 NC 0.997 SF 0.556, 0.222, 0.222 [Helix, Turn, Sheet] AR 0.111 ME 6990, 6990 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 16 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9067 SQ SEQUENCE 1959.362 DA MW 18AA GLYLWDVIRK VASVIGGL // ID AMRSAP1158 PN AMP-018 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 1 AF 'A': 5.56%, 'C': 0%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 16.67%, 'H': 0%, 'I': 11.11%, 'K': 5.56%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 5.56%, 'S': 5.56%, 'T': 0%, 'V': 16.67%, 'W': 5.56%, 'Y': 5.56% MA C, E, F, H, M, N, P, Q, T MO G; L; V LO A, D, K, R, S, W, Y BA 13 LA 5 AA 1 BC 2 MC 0 MF 0 XX MM 1959.362 AI 162.222 II 24.739 HP 1.039 HM 0.708 IP 9.297 NC 0.997 SF 0.556, 0.222, 0.222 [Helix, Turn, Sheet] AR 0.111 ME 6990, 6990 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 8 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9067 SQ SEQUENCE 1959.362 DA MW 18AA GLYLWDVIRK VASVIGGL // ID AMRSAP1159 PN AMP-019 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, F, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, S, X BA 11 LA 4 AA 1 BC 2 MC {'X': 1} MF {'X': 0.0625} XX MM 1468.8 AI 158.125 II 6.475 HP 1.106 HM 0.648 IP 9.537 NC 0.998 SF 0.438, 0.25, 0.188 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9068 SQ SEQUENCE 1468.8 DA MW 16AA GLXDVIKKVA SVIGGL // ID AMRSAP1160 PN AMP-019 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, F, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, S, X BA 11 LA 4 AA 1 BC 2 MC {'X': 1} MF {'X': 0.0625} XX MM 1468.8 AI 158.125 II 6.475 HP 1.106 HM 0.648 IP 9.537 NC 0.998 SF 0.438, 0.25, 0.188 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 4 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9068 SQ SEQUENCE 1468.8 DA MW 16AA GLXDVIKKVA SVIGGL // ID AMRSAP1161 PN AMP-020 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, F, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, S, X BA 11 LA 4 AA 1 BC 2 MC {'X': 1} MF {'X': 0.0625} XX MM 1468.8 AI 158.125 II 6.475 HP 1.106 HM 0.648 IP 9.537 NC 0.998 SF 0.438, 0.25, 0.188 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�JE2 MRSA (MIC = 8 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9069 SQ SEQUENCE 1468.8 DA MW 16AA GLXDVIKKVA SVIGGL // ID AMRSAP1162 PN AMP-020 SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 20%, 'H': 0%, 'I': 13.33%, 'K': 13.33%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 0%, 'Y': 0% MA C, E, F, H, M, N, P, Q, R, T, W, Y MO G; V LO A, D, S, X BA 11 LA 4 AA 1 BC 2 MC {'X': 1} MF {'X': 0.0625} XX MM 1468.8 AI 158.125 II 6.475 HP 1.106 HM 0.648 IP 9.537 NC 0.998 SF 0.438, 0.25, 0.188 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 4 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9069 SQ SEQUENCE 1468.8 DA MW 16AA GLXDVIKKVA SVIGGL // ID AMRSAP1163 PN AMP-021 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.67%, 'C': 0%, 'D': 6.67%, 'E': 0%, 'F': 0%, 'G': 13.33%, 'H': 0%, 'I': 13.33%, 'K': 6.67%, 'L': 13.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 6.67%, 'S': 6.67%, 'T': 0%, 'V': 20%, 'W': 6.67%, 'Y': 0% MA C, E, F, H, M, N, P, Q, T, Y MO V LO A, D, K, R, S, W BA 11 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1625.975 AI 168.667 II 27.687 HP 1.107 HM 0.708 IP 9.695 NC 0.998 SF 0.533, 0.2, 0.2 [Helix, Turn, Sheet] AR 0.067 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO Staphylococcus aureus�ATCC 43300 MRSA (MIC = 8 μG/mL) XX XR PubMed: 31336137 XR CAMP R4: CAMPSQ9070 SQ SEQUENCE 1625.975 DA MW 15AA LWDVIRKVAS VIGGL // ID AMRSAP1164 PN Anoplin SO Anoplius samariensis PL 10 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, S, V, W, Y MO L LO G, I, R, T BA 6 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1154.505 AI 195 II 24.62 HP 0.63 HM 0.586 IP 11.823 NC 2.997 SF 0.5, 0.1, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 33591 (MIC = 32 μM) XX XR PubMed: 34180670 XR CAMP R4: CAMPSQ927 SQ SEQUENCE 1154.505 DA MW 10AA GLLKRIKTLL // ID AMRSAP1165 PN Anoplin SO Anoplius samariensis PL 10 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, S, V, W, Y MO L LO G, I, R, T BA 6 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1154.505 AI 195 II 24.62 HP 0.63 HM 0.586 IP 11.823 NC 2.997 SF 0.5, 0.1, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 48 (MIC = 32 μM) XX XR PubMed: 34180670 XR CAMP R4: CAMPSQ927 SQ SEQUENCE 1154.505 DA MW 10AA GLLKRIKTLL // ID AMRSAP1166 PN Anoplin SO Anoplius samariensis PL 10 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, S, V, W, Y MO L LO G, I, R, T BA 6 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1154.505 AI 195 II 24.62 HP 0.63 HM 0.586 IP 11.823 NC 2.997 SF 0.5, 0.1, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 52 (MIC = 64 μM) XX XR PubMed: 34180670 XR CAMP R4: CAMPSQ927 SQ SEQUENCE 1154.505 DA MW 10AA GLLKRIKTLL // ID AMRSAP1167 PN Anoplin SO Anoplius samariensis PL 10 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 2, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 10%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, H, M, N, P, Q, S, V, W, Y MO L LO G, I, R, T BA 6 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1154.505 AI 195 II 24.62 HP 0.63 HM 0.586 IP 11.823 NC 2.997 SF 0.5, 0.1, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO S. aureus�ATCC BAA1720 MRSA (MIC >= 64 μM) XX XR PubMed: 34966367 XR CAMP R4: CAMPSQ927 SQ SEQUENCE 1154.505 DA MW 10AA GLLKRIKTLL // ID AMRSAP1168 PN Synthetic 1 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 63.64%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 18.18%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, S, T, V, W, Y MO L LO K, R BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1378.854 AI 248.182 II 3.445 HP 0.891 HM 0.19 IP 12.532 NC 3.997 SF 0.636, 0, 0.636 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) (MIC = 30 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9271 SQ SEQUENCE 1378.854 DA MW 11AA RLKLLLLLRL K // ID AMRSAP1169 PN Synthetic 2 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 20%, 'L': 60%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, S, T, V, W, Y MO L LO K, R BA 6 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1265.695 AI 234 II 2.79 HP 0.6 HM 0.36 IP 12.532 NC 3.997 SF 0.6, 0, 0.6 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9272 SQ SEQUENCE 1265.695 DA MW 10AA RLKLLLLRLK // ID AMRSAP1170 PN Synthetic 3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, S, T, V, W, Y MO L LO K, R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1152.535 AI 216.667 II 1.989 HP 0.244 HM 0.295 IP 12.532 NC 3.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9273 SQ SEQUENCE 1152.535 DA MW 9AA RLKLLLRLK // ID AMRSAP1171 PN Synthetic 4 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 63.64%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO K BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1322.827 AI 248.182 II -37.218 HP 1 HM 0.102 IP 11.278 NC 3.997 SF 0.636, 0, 0.636 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) (MIC = 30 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9274 SQ SEQUENCE 1322.827 DA MW 11AA KLKLLLLLKL K // ID AMRSAP1172 PN Synthetic 5 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 63.64%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 36.36%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, W, Y MO L LO R BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1434.881 AI 248.182 II 61.618 HP 0.782 HM 0.152 IP 12.977 NC 3.998 SF 0.636, 0, 0.636 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC alpha XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9275 SQ SEQUENCE 1434.881 DA MW 11AA RLRLLLLLRL R // ID AMRSAP1173 PN Synthetic 6 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 4, 'I': 0, 'K': 0, 'L': 7, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 36.36%, 'I': 0%, 'K': 0%, 'L': 63.64%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, I, K, M, N, P, Q, R, S, T, V, W, Y MO L LO H BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1358.695 AI 248.182 II 9.091 HP 1.255 HM 0.049 IP 7.88 NC 0.362 SF 0.636, 0, 0.636 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 0 XX SC alpha XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9276 SQ SEQUENCE 1358.695 DA MW 11AA HLHLLLLLHL H // ID AMRSAP1174 PN Synthetic 7 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 44.44%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO K BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1096.509 AI 216.667 II -9.978 HP 0.378 HM 0.566 IP 11.278 NC 3.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9277 SQ SEQUENCE 1096.509 DA MW 9AA KKLLLLLKK // ID AMRSAP1175 PN Synthetic 8 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 28.57%, 'L': 71.43%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO K BA 5 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 840.16 AI 278.571 II -15.686 HP 1.6 HM 0.4 IP 10.805 NC 1.997 SF 0.714, 0, 0.714 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9278 SQ SEQUENCE 840.16 DA MW 7AA KLLLLLK // ID AMRSAP1176 PN Synthetic 9 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 75%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO K BA 6 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 953.32 AI 292.5 II -23.088 HP 1.875 HM 0.128 IP 10.805 NC 1.997 SF 0.75, 0, 0.75 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus (MRSA) (MIC >= 35 μG/mL) XX XR PubMed: 8093007 XR CAMP R4: CAMPSQ9279 SQ SEQUENCE 953.32 DA MW 8AA KLKLLLLL // ID AMRSAP1177 PN Pep-1-K SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.1%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Y MO K LO P, Q, R, S, V BA 7 LA 14 AA 0 BC 9 MC 0 MF 0 XX MM 2845.435 AI 13.81 II 17.876 HP -2.095 HM 0.424 IP 12.177 NC 8.996 SF 0.286, 0.095, 0 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 54.181161 XX SC alpha_beta XX TO MRSA 1 (CCARM 3001) (MIC=2.0 μM) XX XR PubMed: 16945333 XR CAMP R4: CAMPSQ9352 SQ SEQUENCE 2845.435 DA MW 21AA KKTWWKTWWT KWSQPKKKRK V // ID AMRSAP1178 PN Pep-1-K SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.1%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Y MO K LO P, Q, R, S, V BA 7 LA 14 AA 0 BC 9 MC 0 MF 0 XX MM 2845.435 AI 13.81 II 17.876 HP -2.095 HM 0.424 IP 12.177 NC 8.996 SF 0.286, 0.095, 0 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 54.181161 XX SC alpha_beta XX TO MRSA 2 (CCARM 3089) (MIC=2.0 μM) XX XR PubMed: 16945333 XR CAMP R4: CAMPSQ9352 SQ SEQUENCE 2845.435 DA MW 21AA KKTWWKTWWT KWSQPKKKRK V // ID AMRSAP1179 PN Pep-1-K SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.1%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Y MO K LO P, Q, R, S, V BA 7 LA 14 AA 0 BC 9 MC 0 MF 0 XX MM 2845.435 AI 13.81 II 17.876 HP -2.095 HM 0.424 IP 12.177 NC 8.996 SF 0.286, 0.095, 0 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 54.181161 XX SC alpha_beta XX TO MRSA 3 (CCARM 3543) (MIC=1.0 μM) XX XR PubMed: 16945333 XR CAMP R4: CAMPSQ9352 SQ SEQUENCE 2845.435 DA MW 21AA KKTWWKTWWT KWSQPKKKRK V // ID AMRSAP1180 PN Defensin precursor SO Oryctes rhinoceros PL 9 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 22.22%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 11.11%, 'I': 11.11%, 'K': 11.11%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 11.11%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, M, N, P, Q, S, T, V, W, Y MO A LO C, G, H, I, K, L, R BA 5 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 968.185 AI 108.889 II 20.856 HP 0.267 HM 0.307 IP 9.834 NC 2.027 SF 0.222, 0.111, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO S. aureus MRSA (MIC > 50 μG/mL) XX XR PubMed: 10561605 XR CAMP R4: CAMPSQ936 SQ SEQUENCE 968.185 DA MW 9AA AHCLAIGRK // ID AMRSAP1181 PN Modified defensin SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, W, Y MO R LO I, K BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1096.388 AI 152.222 II 66.511 HP -0.189 HM 0.367 IP 12.807 NC 3.998 SF 0.333, 0, 0.444 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO S. aureus MRSA (MIC > 48 μG/mL) XX XR PubMed: 10561605 XR CAMP R4: CAMPSQ937 SQ SEQUENCE 1096.388 DA MW 9AA ALRLAIRKR // ID AMRSAP1182 PN Modified defensin SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, W, Y MO L LO I, K BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1053.36 AI 195.556 II 45.111 HP 0.733 HM 0.193 IP 12.516 NC 2.998 SF 0.444, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO S. aureus MRSA (MIC = 40 μG/mL) XX XR PubMed: 10561605 XR CAMP R4: CAMPSQ938 SQ SEQUENCE 1053.36 DA MW 9AA ALLLAIRKR // ID AMRSAP1183 PN Modified defensin SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO A; L; R LO I, K, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1126.413 AI 152.222 II 58.822 HP 0.211 HM 0.171 IP 12.516 NC 2.998 SF 0.444, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA (MIC = 25 μG/mL) XX XR PubMed: 10561605 XR CAMP R4: CAMPSQ939 SQ SEQUENCE 1126.413 DA MW 9AA AWLLAIRKR // ID AMRSAP1184 PN Modified defensin SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 11.11% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, W MO A; L; R LO I, K, Y BA 5 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1103.376 AI 152.222 II 45.111 HP 0.167 HM 0.178 IP 11.531 NC 2.997 SF 0.444, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1490 MS 18.060387 XX SC beta XX TO S. aureus MRSA (MIC = 30 μG/mL) XX XR PubMed: 10561605 XR CAMP R4: CAMPSQ940 SQ SEQUENCE 1103.376 DA MW 9AA ALYLAIRKR // ID AMRSAP1185 PN Saha-CATH3 SO Sarcophilus harrisii PL 33 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 1, 'F': 3, 'G': 5, 'H': 1, 'I': 4, 'K': 4, 'L': 5, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 2, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 3.03%, 'C': 0%, 'D': 0%, 'E': 3.03%, 'F': 9.09%, 'G': 15.15%, 'H': 3.03%, 'I': 12.12%, 'K': 12.12%, 'L': 15.15%, AF 'M': 3.03%, 'N': 9.09%, 'P': 0%, 'Q': 6.06%, 'R': 6.06%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 3.03%, 'Y': 0% MA C, D, P, S, T, V, Y MO G; L LO A, E, H, M, W BA 20 LA 13 AA 1 BC 7 MC 0 MF 0 XX MM 3841.625 AI 109.394 II 27.194 HP -0.079 HM 0.776 IP 11.823 NC 5.089 SF 0.394, 0.242, 0.242 [Helix, Turn, Sheet] AR 0.121 ME 5500, 5500 MS 36.120774 XX SC alpha+beta XX TO Methicillin resistant S. aureus (MRSA) (MIC >= 64 μG/mL) XX XR PubMed: 27725697 XR CAMP R4: CAMPSQ9407 SQ SEQUENCE 3841.625 DA MW 33AA KRMGIFHLFW AGLRKLGNLI KNKIQQGIEN FLG // ID AMRSAP1186 PN Modified defensin SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 11.11%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO A; L; R LO I, K, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1126.413 AI 152.222 II 85.133 HP 0.211 HM 0.184 IP 12.516 NC 2.998 SF 0.444, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA (MIC = 40 μG/mL) XX XR PubMed: 10561605 XR CAMP R4: CAMPSQ941 SQ SEQUENCE 1126.413 DA MW 9AA ALWLAIRKR // ID AMRSAP1187 PN Pseudin-2 SO Pseudis paradoxa PL 24 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 2, 'H': 2, 'I': 3, 'K': 3, 'L': 3, AC 'M': 0, 'N': 3, 'P': 0, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 4.17%, 'F': 4.17%, 'G': 8.33%, 'H': 8.33%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 12.5%, 'P': 0%, 'Q': 8.33%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA C, D, M, P, R, S, T, W, Y MO I; K; L; N LO E, F BA 13 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 2685.168 AI 130 II -2.963 HP -0.008 HM 0.723 IP 10.507 NC 2.181 SF 0.375, 0.208, 0.25 [Helix, Turn, Sheet] AR 0.042 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC >= 250 μG/mL) (MBC >= 250 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9497 SQ SEQUENCE 2685.168 DA MW 24AA GLNALKKVFQ GIHEAIKLIN NHVQ // ID AMRSAP1188 PN Magainin-AM1 SO Xenopus amieti PL 23 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 3, 'G': 5, 'H': 1, 'I': 2, 'K': 3, 'L': 2, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 8.7%, 'C': 0%, 'D': 0%, 'E': 4.35%, 'F': 13.04%, 'G': 21.74%, 'H': 4.35%, 'I': 8.7%, 'K': 13.04%, 'L': 8.7%, AF 'M': 0%, 'N': 4.35%, 'P': 0%, 'Q': 4.35%, 'R': 0%, 'S': 4.35%, 'T': 0%, 'V': 4.35%, 'W': 0%, 'Y': 0% MA C, D, M, P, R, T, W, Y MO G LO E, H, N, Q, S, V BA 15 LA 8 AA 1 BC 4 MC 0 MF 0 XX MM 2418.824 AI 89.13 II -5.813 HP 0.2 HM 0.659 IP 10.507 NC 2.09 SF 0.348, 0.304, 0.217 [Helix, Turn, Sheet] AR 0.13 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 250 μG/mL) (MBC >= 250 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9500 SQ SEQUENCE 2418.824 DA MW 23AA GIKEFAHSLG KFGKAFVGGI LNQ // ID AMRSAP1189 PN PGLa-AM1 SO Xenopus amieti PL 22 TX Animalia PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 13.64%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 13.64%, AF 'M': 4.55%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 9.09%, 'T': 0%, 'V': 13.64%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, I, N, P, Q, R, T, W, Y MO A LO M BA 16 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 2070.565 AI 120 II -0.282 HP 0.832 HM 0.591 IP 11.278 NC 3.997 SF 0.273, 0.227, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC alpha XX TO S. aureus MRSA B33424 (MIC <=8 μG/mL) (MBC = 128 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9501 SQ SEQUENCE 2070.565 DA MW 22AA GMASKAGSVL GKVAKVALKA AL // ID AMRSAP1190 PN CPF-AM1 SO Xenopus amieti PL 17 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 1, 'K': 2, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 23.53%, 'H': 0%, 'I': 5.88%, 'K': 11.76%, 'L': 29.41%, AF 'M': 0%, 'N': 5.88%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 5.88%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, P, Q, R, T, W, Y MO L LO I, N, S, V BA 13 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1624 AI 166.471 II -10.565 HP 1.035 HM 0.521 IP 10.805 NC 1.997 SF 0.412, 0.353, 0.412 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus MRSA B33424 (MIC = 32 μG/mL) (MBC = 250 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9502 SQ SEQUENCE 1624 DA MW 17AA GLGSVLGKAL KIGANLL // ID AMRSAP1191 PN Alyteserin-1c SO Alytes obstetricans PL 23 TX Animalia PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 4, 'H': 1, 'I': 2, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 17.39%, 'C': 0%, 'D': 0%, 'E': 4.35%, 'F': 4.35%, 'G': 17.39%, 'H': 4.35%, 'I': 8.7%, 'K': 13.04%, 'L': 13.04%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 8.7%, 'T': 0%, 'V': 8.7%, 'W': 0%, 'Y': 0% MA C, D, M, N, P, Q, R, T, W, Y MO A; G LO E, F, H BA 16 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2266.712 AI 127.391 II -4.613 HP 0.748 HM 0.482 IP 10.507 NC 2.09 SF 0.348, 0.261, 0.348 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC <=8 μG/mL) (MBC = 32 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9503 SQ SEQUENCE 2266.712 DA MW 23AA GLKEIFKAGL GSLVKGIAAH VAS // ID AMRSAP1192 PN PGLa-LM1 SO X. laevis�נX. muelleri PL 21 TX Animalia PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 1, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 28.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 19.05%, 'H': 0%, 'I': 4.76%, 'K': 14.29%, 'L': 9.52%, AF 'M': 4.76%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 9.52%, 'T': 0%, 'V': 4.76%, 'W': 0%, 'Y': 0% MA C, D, E, H, N, P, Q, R, T, W, Y MO A LO F, I, M, V BA 16 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1948.354 AI 98.095 II 3.271 HP 0.805 HM 0.561 IP 11.103 NC 2.997 SF 0.238, 0.286, 0.429 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC <=8 μG/mL) (MBC = 128 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9504 SQ SEQUENCE 1948.354 DA MW 21AA GMASKAGSVA GKIAKFALGA L // ID AMRSAP1193 PN XT-7 SO Silurana tropicalis PL 18 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 1, 'K': 2, 'L': 6, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.11%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 16.67%, 'H': 0%, 'I': 5.56%, 'K': 11.11%, 'L': 33.33%, AF 'M': 0%, 'N': 5.56%, 'P': 5.56%, 'Q': 0%, 'R': 0%, 'S': 5.56%, 'T': 0%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA C, D, E, F, H, M, Q, R, T, W, Y MO L LO I, N, P, S, V BA 14 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1777.224 AI 178.889 II -9.422 HP 1.122 HM 0.551 IP 10.805 NC 1.997 SF 0.444, 0.333, 0.444 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO S. aureus MRSA B33424 (MIC = 8 μG/mL) (MBC = 32 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9505 SQ SEQUENCE 1777.224 DA MW 18AA GLLGPLLKIA AKVGSNLL // ID AMRSAP1194 PN Hymenochirin-2B SO Hymenochirus boettgeri PL 29 TX Animalia PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 1, 'E': 0, 'F': 2, 'G': 3, 'H': 0, 'I': 2, 'K': 5, 'L': 2, AC 'M': 1, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 2, 'T': 2, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 13.79%, 'C': 0%, 'D': 3.45%, 'E': 0%, 'F': 6.9%, 'G': 10.34%, 'H': 0%, 'I': 6.9%, 'K': 17.24%, 'L': 6.9%, AF 'M': 3.45%, 'N': 0%, 'P': 6.9%, 'Q': 0%, 'R': 0%, 'S': 6.9%, 'T': 6.9%, 'V': 10.34%, 'W': 0%, 'Y': 0% MA C, E, H, N, Q, R, W, Y MO K LO D, M BA 19 LA 10 AA 1 BC 5 MC 0 MF 0 XX MM 2975.626 AI 97.586 II -12.359 HP 0.466 HM 0.709 IP 10.978 NC 3.997 SF 0.31, 0.241, 0.241 [Helix, Turn, Sheet] AR 0.069 ME 0, 0 MS 30.100645 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 32 μG/mL) (MBC = 32 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9508 SQ SEQUENCE 2975.626 DA MW 29AA LKIPGFVKDT LKKVAKGIFS AVAGAMTPS // ID AMRSAP1195 PN Hymenochirin-4B SO Hymenochirus boettgeri PL 28 TX Animalia PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 3, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 0, 'S': 1, 'T': 2, 'V': 4, 'W': 0, 'Y': 0 AF 'A': 17.86%, 'C': 0%, 'D': 3.57%, 'E': 0%, 'F': 3.57%, 'G': 7.14%, 'H': 0%, 'I': 10.71%, 'K': 17.86%, 'L': 7.14%, AF 'M': 0%, 'N': 0%, 'P': 3.57%, 'Q': 3.57%, 'R': 0%, 'S': 3.57%, 'T': 7.14%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, E, H, M, N, R, W, Y MO A; K LO D, F, P, Q, S BA 18 LA 10 AA 1 BC 5 MC 0 MF 0 XX MM 2867.512 AI 128.929 II -11.789 HP 0.664 HM 0.69 IP 10.978 NC 3.997 SF 0.357, 0.143, 0.25 [Helix, Turn, Sheet] AR 0.036 ME 0, 0 MS 30.100645 XX SC beta XX TO S. aureus MRSA B33424 (MIC = 16 μG/mL) (MBC = 128 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9509 SQ SEQUENCE 2867.512 DA MW 28AA IKIPAFVKDT LKKVAKGVIS AVAGALTQ // ID AMRSAP1196 PN Temporin-1DRa SO Rana draytonii PL 14 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 2, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 7.14%, 'H': 7.14%, 'I': 7.14%, 'K': 14.29%, 'L': 28.57%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, M, P, Q, R, S, W, Y MO L LO A, F, G, H, I, N, T, V BA 9 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1566.95 AI 167.143 II 3.507 HP 0.921 HM 0.56 IP 10.805 NC 2.088 SF 0.5, 0.143, 0.357 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 12.040258 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 8 μG/mL) (MBC = 16 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9510 SQ SEQUENCE 1566.95 DA MW 14AA HFLGTLVNLA KKIL // ID AMRSAP1197 PN SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 0%, 'H': 7.14%, 'I': 7.14%, 'K': 21.43%, 'L': 28.57%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, G, M, P, Q, R, S, W, Y MO L LO A, F, H, I, N, T, V BA 8 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1638.073 AI 167.143 II 3.507 HP 0.671 HM 0.712 IP 11.103 NC 3.088 SF 0.5, 0.071, 0.357 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 4 μG/mL) (MBC = 16 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9511 SQ SEQUENCE 1638.073 DA MW 14AA HFLKTLVNLA KKIL // ID AMRSAP1198 PN SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 7.14%, 'H': 7.14%, 'I': 7.14%, 'K': 21.43%, 'L': 28.57%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, M, P, Q, R, S, T, W, Y MO L LO A, F, G, H, I, N, V BA 9 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1594.019 AI 167.143 II -2.557 HP 0.693 HM 0.631 IP 11.103 NC 3.088 SF 0.5, 0.143, 0.357 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 4 μG/mL) (MBC = 8 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9512 SQ SEQUENCE 1594.019 DA MW 14AA HFLGKLVNLA KKIL // ID AMRSAP1199 PN SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 1, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 0%, 'H': 7.14%, 'I': 7.14%, 'K': 21.43%, 'L': 28.57%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, G, M, P, Q, R, S, W, Y MO L LO A, F, H, I, N, T, V BA 8 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1638.073 AI 167.143 II 3.507 HP 0.671 HM 0.712 IP 11.103 NC 3.088 SF 0.5, 0.071, 0.357 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 16 μG/mL) (MBC = 64 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9513 SQ SEQUENCE 1638.073 DA MW 14AA HFLKTLVNLA KKIL // ID AMRSAP1200 PN SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 7.14%, 'H': 7.14%, 'I': 7.14%, 'K': 21.43%, 'L': 28.57%, AF 'M': 0%, 'N': 7.14%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, M, P, Q, R, S, T, W, Y MO L LO A, F, G, H, I, N, V BA 9 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1594.019 AI 167.143 II -2.557 HP 0.693 HM 0.631 IP 11.103 NC 3.088 SF 0.5, 0.143, 0.357 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 4 μG/mL) (MBC = 32 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9514 SQ SEQUENCE 1594.019 DA MW 14AA HFLGKLVNLA KKIL // ID AMRSAP1201 PN SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 1, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.14%, 'G': 7.14%, 'H': 7.14%, 'I': 7.14%, 'K': 21.43%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 7.14%, 'W': 0%, 'Y': 0% MA C, D, E, M, N, P, Q, R, S, W, Y MO L LO A, F, G, H, I, T, V BA 9 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1581.021 AI 167.143 II -4.614 HP 0.893 HM 0.626 IP 11.103 NC 3.088 SF 0.5, 0.071, 0.357 [Helix, Turn, Sheet] AR 0.071 ME 0, 0 MS 18.060387 XX SC alpha XX TO S. aureus MRSA B33424 (MIC = 4 μG/mL) (MBC = 32 μG/mL) XX XR PubMed: 31102497 XR CAMP R4: CAMPSQ9515 SQ SEQUENCE 1581.021 DA MW 14AA HFLGTLVKLA KKIL // ID AMRSAP1202 PN L5K5W1 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -18.282 HP -0.127 HM 0.779 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 8 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9640 SQ SEQUENCE 1410.896 DA MW 11AA WLKKLLKKLL K // ID AMRSAP1203 PN L5K5W2 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -10.564 HP -0.127 HM 0.777 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 8 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9641 SQ SEQUENCE 1410.896 DA MW 11AA KWLKKLLKKL L // ID AMRSAP1204 PN L5K5W3 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -18.282 HP -0.127 HM 0.81 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 8 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9642 SQ SEQUENCE 1410.896 DA MW 11AA LKWLKKLLKK L // ID AMRSAP1205 PN L5K5W4 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -10.564 HP -0.127 HM 0.8 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 16 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9643 SQ SEQUENCE 1410.896 DA MW 11AA LLKWLKKLLK K // ID AMRSAP1206 PN L5K5W5 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -18.282 HP -0.127 HM 0.842 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 8 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9644 SQ SEQUENCE 1410.896 DA MW 11AA KLLKWLKKLL K // ID AMRSAP1207 PN L5K5W7 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -18.282 HP -0.127 HM 0.84 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 16 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9699 SQ SEQUENCE 1410.896 DA MW 11AA LKKLLKWLKK L // ID AMRSAP1208 PN L5K5W8 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -10.564 HP -0.127 HM 0.814 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 16 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9700 SQ SEQUENCE 1410.896 DA MW 11AA LLKKLLKWLK K // ID AMRSAP1209 PN L5K5W9 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -18.282 HP -0.127 HM 0.839 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 8 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9701 SQ SEQUENCE 1410.896 DA MW 11AA KLLKKLLKWL K // ID AMRSAP1210 PN L5K5W10 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -10.564 HP -0.127 HM 0.795 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 4 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9702 SQ SEQUENCE 1410.896 DA MW 11AA KKLLKKLLKW L // ID AMRSAP1211 PN L5K5W11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 9.09%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; L LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1410.896 AI 177.273 II -29.5 HP -0.127 HM 0.804 IP 11.403 NC 4.997 SF 0.545, 0, 0.455 [Helix, Turn, Sheet] AR 0.091 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA-TK784 (MIC = 16 μG/mL) XX XR PubMed: 23344198 XR CAMP R4: CAMPSQ9703 SQ SEQUENCE 1410.896 DA MW 11AA LKKLLKKLLK W // ID AMRSAP1212 PN L2K3W2 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 42.86%, 'L': 28.57%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 28.57%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 4 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1001.283 AI 111.429 II 31.7 HP -0.843 HM 0.814 IP 11.103 NC 2.997 SF 0.571, 0, 0.286 [Helix, Turn, Sheet] AR 0.286 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9704 SQ SEQUENCE 1001.283 DA MW 7AA KWLKKWL // ID AMRSAP1213 PN L3K2W2 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 28.57%, 'L': 42.86%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 28.57%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO L LO K, W BA 5 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 986.268 AI 167.143 II 31.7 HP 0.257 HM 0.682 IP 10.805 NC 1.997 SF 0.714, 0, 0.429 [Helix, Turn, Sheet] AR 0.286 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9705 SQ SEQUENCE 986.268 DA MW 7AA KWLLKWL // ID AMRSAP1214 PN L2K5W2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 55.56%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 22.22%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 4 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1257.631 AI 86.667 II 17.444 HP -1.522 HM 0.804 IP 11.403 NC 4.997 SF 0.444, 0, 0.222 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 30.100645 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9706 SQ SEQUENCE 1257.631 DA MW 9AA KKWLKKWLK // ID AMRSAP1215 PN L3K4W2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 44.44%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 22.22%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO W BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1242.616 AI 130 II 8.011 HP -0.667 HM 0.809 IP 11.278 NC 3.997 SF 0.556, 0, 0.333 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9707 SQ SEQUENCE 1242.616 DA MW 9AA LKWLKKWLK // ID AMRSAP1216 PN L4K3W2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 44.44%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 22.22%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO L LO W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1227.602 AI 173.333 II 8.011 HP 0.189 HM 0.717 IP 11.103 NC 2.997 SF 0.667, 0, 0.444 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC = 20 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9708 SQ SEQUENCE 1227.602 DA MW 9AA LKWLLKWLK // ID AMRSAP1217 PN L5K2W2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 22.22%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO L LO K, W BA 7 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 1212.587 AI 216.667 II 17.444 HP 1.044 HM 0.538 IP 10.805 NC 1.997 SF 0.778, 0, 0.556 [Helix, Turn, Sheet] AR 0.222 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC = 2.5 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9709 SQ SEQUENCE 1212.587 DA MW 9AA LKWLLKWLL // ID AMRSAP1218 PN L3K6W2 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 54.55%, 'L': 27.27%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 18.18%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO W BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1498.964 AI 106.364 II 8.373 HP -1.255 HM 0.744 IP 11.5 NC 5.996 SF 0.455, 0, 0.273 [Helix, Turn, Sheet] AR 0.182 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9710 SQ SEQUENCE 1498.964 DA MW 11AA LKKWLKKWLK K // ID AMRSAP1219 PN L4K5W2 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 45.45%, 'L': 36.36%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 18.18%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO W BA 6 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1483.95 AI 141.818 II 8.373 HP -0.555 HM 0.785 IP 11.403 NC 4.997 SF 0.545, 0, 0.364 [Helix, Turn, Sheet] AR 0.182 ME 11000, 11000 MS 30.100645 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC = 40 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9711 SQ SEQUENCE 1483.95 DA MW 11AA LLKWLKKWLK K // ID AMRSAP1220 PN L5K4W2 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 18.18%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO L LO W BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1468.935 AI 177.273 II 8.373 HP 0.145 HM 0.732 IP 11.278 NC 3.997 SF 0.636, 0, 0.455 [Helix, Turn, Sheet] AR 0.182 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC = 5 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9712 SQ SEQUENCE 1468.935 DA MW 11AA LLKWLLKWLK K // ID AMRSAP1221 PN L6K3W2 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 6, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 27.27%, 'L': 54.55%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 18.18%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO L LO W BA 8 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1453.92 AI 212.727 II 8.373 HP 0.845 HM 0.593 IP 11.103 NC 2.997 SF 0.727, 0, 0.545 [Helix, Turn, Sheet] AR 0.182 ME 11000, 11000 MS 18.060387 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC = 5 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9713 SQ SEQUENCE 1453.92 DA MW 11AA LLKWLLKWLL K // ID AMRSAP1222 PN LK2W2 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 40%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 40%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K; W LO L BA 3 LA 2 AA 0 BC 2 MC 0 MF 0 XX MM 759.949 AI 78 II 15.7 HP -1.16 HM 0.775 IP 10.805 NC 1.997 SF 0.6, 0, 0.2 [Helix, Turn, Sheet] AR 0.4 ME 11000, 11000 MS 12.040258 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9714 SQ SEQUENCE 759.949 DA MW 5AA WLKKW // ID AMRSAP1223 PN L2KW2 SO Synthetic construct PL 5 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 20%, 'L': 40%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 40%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO L; W LO K BA 4 LA 1 AA 0 BC 1 MC 0 MF 0 XX MM 744.935 AI 156 II 15.7 HP 0.38 HM 0.51 IP 9.7 NC 0.998 SF 0.8, 0, 0.4 [Helix, Turn, Sheet] AR 0.4 ME 11000, 11000 MS 6.020129 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC > 80 μG/mL) XX XR PubMed: 20736034 XR CAMP R4: CAMPSQ9715 SQ SEQUENCE 744.935 DA MW 5AA WLLKW // ID AMRSAP1224 PN Ostricacin-1 SO Struthio camelus PL 36 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 1, 'E': 0, 'F': 4, 'G': 5, 'H': 2, 'I': 0, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 1, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 5.56%, 'C': 16.67%, 'D': 2.78%, 'E': 0%, 'F': 11.11%, 'G': 13.89%, 'H': 5.56%, 'I': 0%, 'K': 8.33%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 2.78%, 'T': 2.78%, 'V': 8.33%, 'W': 5.56%, 'Y': 0% MA E, I, M, N, Q, Y MO C LO D, S, T BA 20 LA 16 AA 1 BC 7 MC 0 MF 0 XX MM 4017.799 AI 51.389 II 37.894 HP 0.303 HM 0.536 IP 8.638 NC 3.808 SF 0.306, 0.222, 0.111 [Helix, Turn, Sheet] AR 0.167 ME 11000, 11375 MS 30.100645 XX SC alpha+beta XX TO S.aureus 1056 MRSA (MIC = 1.25 μG/mL) XX XR PubMed: 16459058 XR CAMP R4: CAMPSQ973 SQ SEQUENCE 4017.799 DA MW 36AA LFCRKGTCHF GGCPAHLVKV GSCFGFRACC KWPWDV // ID AMRSAP1225 PN 22A-30R-NH2 fragment 1 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 0%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, V, W, Y MO R LO I BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1124.401 AI 152.222 II 157.578 HP -0.256 HM 0.343 IP 12.977 NC 3.998 SF 0.333, 0, 0.444 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (MIC > 48 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9736 SQ SEQUENCE 1124.401 DA MW 9AA ALRLAIRRR // ID AMRSAP1226 PN 22A-30R-NH2 fragment 2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, V, W, Y MO L; R LO I BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1081.373 AI 195.556 II 136.178 HP 0.667 HM 0.3 IP 12.801 NC 2.998 SF 0.444, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (MIC = 32 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9737 SQ SEQUENCE 1081.373 DA MW 9AA ALLLAIRRR // ID AMRSAP1227 PN 22A-30R-NH2 fragment 3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 0%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, V, Y MO R LO I, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1154.427 AI 152.222 II 149.889 HP 0.144 HM 0.28 IP 12.801 NC 2.998 SF 0.444, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC beta XX TO MRSA (MIC = 20 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9738 SQ SEQUENCE 1154.427 DA MW 9AA AWLLAIRRR // ID AMRSAP1228 PN 22A-30R-NH2 fragment 4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 0%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 11.11% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, V, W MO R LO I, Y BA 5 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1131.39 AI 152.222 II 136.178 HP 0.1 HM 0.262 IP 12.204 NC 2.997 SF 0.444, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 1490, 1490 MS 18.060387 XX SC beta XX TO MRSA (MIC = 24 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9739 SQ SEQUENCE 1131.39 DA MW 9AA ALYLAIRRR // ID AMRSAP1229 PN Ostricacin-3 SO Struthio camelus PL 40 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 1, 'E': 0, 'F': 2, 'G': 4, 'H': 0, 'I': 4, 'K': 1, 'L': 1, AC 'M': 0, 'N': 2, 'P': 4, 'Q': 1, 'R': 7, 'S': 1, 'T': 2, 'V': 0, 'W': 1, 'Y': 2 AF 'A': 2.5%, 'C': 15%, 'D': 2.5%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 2.5%, 'L': 2.5%, AF 'M': 0%, 'N': 5%, 'P': 10%, 'Q': 2.5%, 'R': 17.5%, 'S': 2.5%, 'T': 5%, 'V': 0%, 'W': 2.5%, 'Y': 5% MA E, H, M, V MO R LO A, D, K, L, Q, S, W BA 17 LA 23 AA 1 BC 8 MC 0 MF 0 XX MM 4679.519 AI 51.25 II 35.145 HP -0.473 HM 0.659 IP 9.592 NC 6.625 SF 0.25, 0.275, 0.05 [Helix, Turn, Sheet] AR 0.125 ME 8480, 8855 MS 48.161032 XX SC beta XX TO S.aureus 1056 MRSA (MIC = 2.78 μG/mL) XX XR PubMed: 16459058 XR CAMP R4: CAMPSQ974 SQ SEQUENCE 4679.519 DA MW 40AA IPRPLDPCIA QNGRCFTGIC RYPYFWIGTC RNGKSCCRRR // ID AMRSAP1230 PN 22A-30R-NH2 fragment 5 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 22.22%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.11%, 'K': 0%, 'L': 22.22%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 11.11%, 'Y': 0% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, V, Y MO R LO I, W BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1154.427 AI 152.222 II 176.2 HP 0.144 HM 0.286 IP 12.801 NC 2.998 SF 0.444, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 5500, 5500 MS 18.060387 XX SC beta XX TO MRSA (MIC = 32 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9740 SQ SEQUENCE 1154.427 DA MW 9AA ALWLAIRRR // ID AMRSAP1231 PN 19L-30R-NH2 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 8.33%, 'I': 8.33%, 'K': 0%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, K, M, N, P, Q, S, T, V, W, Y MO A LO G, H, I BA 7 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1283.575 AI 122.5 II 65.875 HP 0.825 HM 0.371 IP 8.838 NC 1.965 SF 0.25, 0.083, 0.417 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 12.040258 XX SC alpha XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9741 SQ SEQUENCE 1283.575 DA MW 12AA LCAAHCLAIG RR // ID AMRSAP1232 PN 19L-30R-NH2 fragment 1 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 8.33%, 'I': 8.33%, 'K': 0%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, G, K, M, N, P, Q, S, T, V, W, Y MO A; R LO H, I BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1382.711 AI 122.5 II 113.608 HP 0.483 HM 0.308 IP 10.519 NC 2.965 SF 0.25, 0, 0.417 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 18.060387 XX SC alpha XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9742 SQ SEQUENCE 1382.711 DA MW 12AA LCAAHCLAIR RR // ID AMRSAP1233 PN 19L-30R-NH2 fragment 2 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 1, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 8.33%, 'I': 8.33%, 'K': 0%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, G, K, M, N, P, Q, S, T, V, W, Y MO A; L LO H, I BA 7 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1339.683 AI 155 II 97.975 HP 1.175 HM 0.421 IP 8.838 NC 1.965 SF 0.333, 0, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9743 SQ SEQUENCE 1339.683 DA MW 12AA LCAAHCLAIL RR // ID AMRSAP1234 PN 19L-30R-NH2 fragment 3 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 0%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, K, M, N, P, Q, S, T, V, W, Y MO A; R LO G, I BA 7 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1302.622 AI 122.5 II 72.95 HP 0.717 HM 0.499 IP 10.518 NC 2.874 SF 0.25, 0.083, 0.417 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 18.060387 XX SC beta XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9744 SQ SEQUENCE 1302.622 DA MW 12AA LCAARCLAIG RR // ID AMRSAP1235 PN 19L-30R-NH2 fragment 4 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 16.67%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 0%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, K, M, N, P, Q, S, T, V, W, Y MO A; L LO G, I BA 8 LA 4 AA 0 BC 2 MC 0 MF 0 XX MM 1259.594 AI 155 II 72.95 HP 1.408 HM 0.323 IP 8.835 NC 1.874 SF 0.333, 0.083, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 12.040258 XX SC beta XX TO MRSA (MIC = 48 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9745 SQ SEQUENCE 1259.594 DA MW 12AA LCAALCLAIG RR // ID AMRSAP1236 PN 19L-30R-NH2 fragment 5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 8.33%, 'I': 8.33%, 'K': 0%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, K, M, N, P, Q, S, T, V, W, Y MO R LO G, H, I BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1389.673 AI 122.5 II 65.875 HP -0.342 HM 0.317 IP 12.977 NC 4.089 SF 0.25, 0.083, 0.417 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (MIC = 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9746 SQ SEQUENCE 1389.673 DA MW 12AA LRAAHRLAIG RR // ID AMRSAP1237 PN 19L-30R-NH2 fragment 6 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 0, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 25%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 8.33%, 'I': 8.33%, 'K': 0%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, K, M, N, P, Q, S, T, V, W, Y MO L LO G, H, I BA 9 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1303.617 AI 187.5 II 49.825 HP 1.042 HM 0.478 IP 12.5 NC 2.089 SF 0.417, 0.083, 0.583 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC = 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9747 SQ SEQUENCE 1303.617 DA MW 12AA LLAAHLLAIG RR // ID AMRSAP1238 PN 19L-30R-NH2 fragment 7 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 30%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, K, M, N, P, Q, S, T, V, W, Y MO A LO C, G, H, I, L BA 6 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1067.277 AI 108 II 77.05 HP 0.36 HM 0.394 IP 10.527 NC 2.027 SF 0.2, 0.1, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9748 SQ SEQUENCE 1067.277 DA MW 10AA AAHCLAIGRR // ID AMRSAP1239 PN 22A-30R-NH2 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 22.22%, 'C': 11.11%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.11%, 'H': 11.11%, 'I': 11.11%, 'K': 0%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, K, M, N, P, Q, S, T, V, W, Y MO A; R LO C, G, H, I, L BA 5 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 996.198 AI 108.889 II 84.5 HP 0.2 HM 0.384 IP 10.527 NC 2.027 SF 0.222, 0.111, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9749 SQ SEQUENCE 996.198 DA MW 9AA AHCLAIGRR // ID AMRSAP1240 PN Ostricacin-4 SO Struthio camelus PL 42 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 0, 'E': 1, 'F': 2, 'G': 4, 'H': 1, 'I': 1, 'K': 0, 'L': 4, AC 'M': 0, 'N': 3, 'P': 3, 'Q': 2, 'R': 5, 'S': 2, 'T': 1, 'V': 4, 'W': 1, 'Y': 1 AF 'A': 2.38%, 'C': 14.29%, 'D': 0%, 'E': 2.38%, 'F': 4.76%, 'G': 9.52%, 'H': 2.38%, 'I': 2.38%, 'K': 0%, 'L': 9.52%, AF 'M': 0%, 'N': 7.14%, 'P': 7.14%, 'Q': 4.76%, 'R': 11.9%, 'S': 4.76%, 'T': 2.38%, 'V': 9.52%, 'W': 2.38%, 'Y': 2.38% MA D, K, M MO C LO A, E, H, I, T, W, Y BA 20 LA 22 AA 1 BC 6 MC 0 MF 0 XX MM 4754.583 AI 76.429 II 44.371 HP 0.031 HM 0.658 IP 8.633 NC 3.718 SF 0.31, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.095 ME 6990, 7365 MS 30.100645 XX SC beta XX TO S.aureus 1056 MRSA (MIC = 11.48 μG/mL) XX XR PubMed: 16459058 XR CAMP R4: CAMPSQ975 SQ SEQUENCE 4754.583 DA MW 42AA LPVNEAQCRQ VGGYCGLRIC NFPSRFLGLC TRNHPCCSRV WV // ID AMRSAP1241 PN 19L-30R-NH2 fragment 8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 1, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 12.5%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 12.5%, 'H': 12.5%, 'I': 12.5%, 'K': 0%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, K, M, N, P, Q, S, T, V, W, Y MO R LO A, C, G, H, I, L BA 4 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 925.12 AI 110 II 104.425 HP -0 HM 0.495 IP 10.527 NC 2.027 SF 0.25, 0.125, 0.25 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9750 SQ SEQUENCE 925.12 DA MW 8AA HCLAIGRR // ID AMRSAP1242 PN 19L-30R-NH2 fragment 9 SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 14.29%, 'C': 14.29%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 0%, 'I': 14.29%, 'K': 0%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, K, M, N, P, Q, S, T, V, W, Y MO R LO A, C, G, I, L BA 4 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 787.979 AI 125.714 II 117.914 HP 0.457 HM 0.545 IP 10.526 NC 1.936 SF 0.286, 0.143, 0.286 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (MIC > 64 μG/mL) XX XR PubMed: 9931294 XR CAMP R4: CAMPSQ9751 SQ SEQUENCE 787.979 DA MW 7AA CLAIGRR // ID AMRSAP1243 PN Cathelin-related antimicrobial peptide SO Mus musculus PL 38 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 3, 'F': 2, 'G': 5, 'H': 0, 'I': 4, 'K': 8, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 3, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 2.63%, 'C': 0%, 'D': 0%, 'E': 7.89%, 'F': 5.26%, 'G': 13.16%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 13.16%, AF 'M': 0%, 'N': 2.63%, 'P': 5.26%, 'Q': 7.89%, 'R': 5.26%, 'S': 2.63%, 'T': 0%, 'V': 2.63%, 'W': 0%, 'Y': 0% MA C, D, H, M, T, W, Y MO K LO A, N, S, V BA 20 LA 18 AA 3 BC 10 MC 0 MF 0 XX MM 4291.196 AI 102.632 II 17.103 HP -0.582 HM 0.76 IP 11.248 NC 7.001 SF 0.316, 0.237, 0.237 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 60.20129 XX SC alpha_beta XX TO Staphylococcus aureus (MRSA) (MIC >64 μM) XX XR PubMed: 9148921 XR CAMP R4: CAMPSQ979 SQ SEQUENCE 4291.196 DA MW 38AA ISRLAGLLRK GGEKIGEKLK KIGQKIKNFF QKLVPQPE // ID AMRSAP1244 PN Cathelin-related antimicrobial peptide SO Mus musculus PL 38 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 3, 'F': 2, 'G': 5, 'H': 0, 'I': 4, 'K': 8, 'L': 5, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 3, 'R': 2, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 2.63%, 'C': 0%, 'D': 0%, 'E': 7.89%, 'F': 5.26%, 'G': 13.16%, 'H': 0%, 'I': 10.53%, 'K': 21.05%, 'L': 13.16%, AF 'M': 0%, 'N': 2.63%, 'P': 5.26%, 'Q': 7.89%, 'R': 5.26%, 'S': 2.63%, 'T': 0%, 'V': 2.63%, 'W': 0%, 'Y': 0% MA C, D, H, M, T, W, Y MO K LO A, N, S, V BA 20 LA 18 AA 3 BC 10 MC 0 MF 0 XX MM 4291.196 AI 102.632 II 17.103 HP -0.582 HM 0.76 IP 11.248 NC 7.001 SF 0.316, 0.237, 0.237 [Helix, Turn, Sheet] AR 0.053 ME 0, 0 MS 60.20129 XX SC alpha_beta XX TO Staphylococcus aureus MRSA (MIC = 64 μM) XX XR PubMed: 9148921 XR CAMP R4: CAMPSQ979 SQ SEQUENCE 4291.196 DA MW 38AA ISRLAGLLRK GGEKIGEKLK KIGQKIKNFF QKLVPQPE // ID AMRSAP1245 PN Cathelin-related antimicrobial peptide SO Mus musculus PL 33 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 2, 'G': 5, 'H': 0, 'I': 3, 'K': 8, 'L': 4, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 3, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 9.09%, 'F': 6.06%, 'G': 15.15%, 'H': 0%, 'I': 9.09%, 'K': 24.24%, 'L': 12.12%, AF 'M': 0%, 'N': 3.03%, 'P': 6.06%, 'Q': 9.09%, 'R': 3.03%, 'S': 0%, 'T': 0%, 'V': 3.03%, 'W': 0%, 'Y': 0% MA A, C, D, H, M, S, T, W, Y MO K LO N, R, V BA 17 LA 16 AA 3 BC 9 MC 0 MF 0 XX MM 3750.532 AI 91.515 II 12.342 HP -0.815 HM 0.76 IP 11.015 NC 6.001 SF 0.303, 0.242, 0.212 [Helix, Turn, Sheet] AR 0.061 ME 0, 0 MS 54.181161 XX SC alpha_beta XX TO Staphylococcus aureus (MRSA) (MIC > 64 μM) XX XR PubMed: 9148921 XR CAMP R4: CAMPSQ980 SQ SEQUENCE 3750.532 DA MW 33AA GLLRKGGEKI GEKLKKIGQK IKNFFQKLVP QPE // ID AMRSAP1246 PN Cathelin-related antimicrobial peptide SO Mus musculus PL 33 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 2, 'G': 5, 'H': 0, 'I': 3, 'K': 8, 'L': 4, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 3, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 9.09%, 'F': 6.06%, 'G': 15.15%, 'H': 0%, 'I': 9.09%, 'K': 24.24%, 'L': 12.12%, AF 'M': 0%, 'N': 3.03%, 'P': 6.06%, 'Q': 9.09%, 'R': 3.03%, 'S': 0%, 'T': 0%, 'V': 3.03%, 'W': 0%, 'Y': 0% MA A, C, D, H, M, S, T, W, Y MO K LO N, R, V BA 17 LA 16 AA 3 BC 9 MC 0 MF 0 XX MM 3750.532 AI 91.515 II 12.342 HP -0.815 HM 0.76 IP 11.015 NC 6.001 SF 0.303, 0.242, 0.212 [Helix, Turn, Sheet] AR 0.061 ME 0, 0 MS 54.181161 XX SC alpha_beta XX TO Staphylococcus aureus MRSA (MIC = 64 μM) XX XR PubMed: 9148921 XR CAMP R4: CAMPSQ980 SQ SEQUENCE 3750.532 DA MW 33AA GLLRKGGEKI GEKLKKIGQK IKNFFQKLVP QPE // ID AMRSAP1247 PN Kn2-7 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 23.08%, 'K': 15.38%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, M, N, P, Q, S, T, V, W, Y MO I; R LO A BA 8 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1674.155 AI 157.692 II 36.062 HP 0.554 HM 1.097 IP 12.814 NC 4.997 SF 0.538, 0, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 30.100645 XX SC alpha XX TO Methicillin resistant S. aureus (MRSA) P1381 (MIC = 6.25 μG/mL) XX XR PubMed: 22792229 XR CAMP R4: CAMPSQ9805 SQ SEQUENCE 1674.155 DA MW 13AA FIKRIARLLR KIF // ID AMRSAP1248 PN Kn2-7 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 23.08%, 'K': 15.38%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, M, N, P, Q, S, T, V, W, Y MO I; R LO A BA 8 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1674.155 AI 157.692 II 36.062 HP 0.554 HM 1.097 IP 12.814 NC 4.997 SF 0.538, 0, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 30.100645 XX SC alpha XX TO Methicillin resistant S. aureus (MRSA) P1386 (MIC = 6.25 μG/mL) XX XR PubMed: 22792229 XR CAMP R4: CAMPSQ9805 SQ SEQUENCE 1674.155 DA MW 13AA FIKRIARLLR KIF // ID AMRSAP1249 PN Kn2-7 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 23.08%, 'K': 15.38%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 23.08%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, G, H, M, N, P, Q, S, T, V, W, Y MO I; R LO A BA 8 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1674.155 AI 157.692 II 36.062 HP 0.554 HM 1.097 IP 12.814 NC 4.997 SF 0.538, 0, 0.231 [Helix, Turn, Sheet] AR 0.154 ME 0, 0 MS 30.100645 XX SC alpha XX TO Methicillin resistant S. aureus (MRSA) P1374 (MIC = 3.13 μG/mL) XX XR PubMed: 22792229 XR CAMP R4: CAMPSQ9805 SQ SEQUENCE 1674.155 DA MW 13AA FIKRIARLLR KIF // ID AMRSAP1250 PN RIP-W SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 14.29%, 'P': 14.29%, 'Q': 0%, 'R': 0%, 'S': 14.29%, 'T': 14.29%, 'V': 0%, 'W': 14.29%, 'Y': 14.29% MA A, C, D, E, G, H, I, K, L, M, Q, R, V MO F; N; P; S; T; W; Y LO F, N, P, S, T, W, Y BA 3 LA 4 AA 0 BC 0 MC 0 MF 0 XX MM 913.985 AI 0 II 2.814 HP -0.857 HM 0.363 IP 6.093 NC -0.003 SF 0.429, 0.429, 0 [Helix, Turn, Sheet] AR 0.429 ME 6990, 6990 MS 0 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9818 SQ SEQUENCE 913.985 DA MW 7AA YSPWTNF // ID AMRSAP1251 PN RIP-I SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 14.29%, 'K': 14.29%, 'L': 0%, AF 'M': 0%, 'N': 14.29%, 'P': 14.29%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 0%, 'W': 0%, 'Y': 14.29% MA A, C, D, E, G, H, L, M, Q, R, S, V, W MO F; I; K; N; P; T; Y LO F, I, K, N, P, T, Y BA 3 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 882.027 AI 55.714 II -45.143 HP -0.529 HM 0.63 IP 9.298 NC 0.997 SF 0.429, 0.286, 0 [Helix, Turn, Sheet] AR 0.286 ME 1490, 1490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9819 SQ SEQUENCE 882.027 DA MW 7AA YKPITNF // ID AMRSAP1252 PN RIP-L SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 14.29%, 'P': 14.29%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 0%, 'W': 0%, 'Y': 14.29% MA A, C, D, E, G, H, I, M, Q, R, S, V, W MO F; K; L; N; P; T; Y LO F, K, L, N, P, T, Y BA 3 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 882.027 AI 55.714 II -45.143 HP -0.629 HM 0.586 IP 9.298 NC 0.997 SF 0.429, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.286 ME 1490, 1490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9820 SQ SEQUENCE 882.027 DA MW 7AA YKPLTNF // ID AMRSAP1253 PN RIP-V SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 0%, AF 'M': 0%, 'N': 14.29%, 'P': 14.29%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 14.29% MA A, C, D, E, G, H, I, L, M, Q, R, S, W MO F; K; N; P; T; V; Y LO F, K, N, P, T, V, Y BA 3 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 868 AI 41.429 II -29.757 HP -0.571 HM 0.589 IP 9.298 NC 0.997 SF 0.429, 0.286, 0 [Helix, Turn, Sheet] AR 0.286 ME 1490, 1490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9821 SQ SEQUENCE 868 DA MW 7AA YKPVTNF // ID AMRSAP1254 PN 7P-AC SO Synthetic construct PL 7 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 0%, AF 'M': 0%, 'N': 14.29%, 'P': 14.29%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 14.29%, 'V': 14.29%, 'W': 0%, 'Y': 14.29% MA A, C, D, E, G, H, I, L, M, Q, R, S, W MO F; K; N; P; T; V; Y LO F, K, N, P, T, V, Y BA 3 LA 4 AA 0 BC 1 MC 0 MF 0 XX MM 868 AI 41.429 II -29.757 HP -0.571 HM 0.589 IP 9.298 NC 0.997 SF 0.429, 0.286, 0 [Helix, Turn, Sheet] AR 0.286 ME 1490, 1490 MS 6.020129 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9822 SQ SEQUENCE 868 DA MW 7AA YKPVTNF // ID AMRSAP1255 PN 16P SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 3, 'V': 2, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 12.5%, 'L': 0%, AF 'M': 0%, 'N': 12.5%, 'P': 12.5%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 18.75%, 'V': 12.5%, 'W': 0%, 'Y': 12.5% MA A, C, D, E, G, H, I, L, M, Q, R, W MO T LO S BA 6 LA 10 AA 0 BC 2 MC 0 MF 0 XX MM 1906.168 AI 36.25 II -24.163 HP -0.594 HM 0.248 IP 9.93 NC 1.996 SF 0.375, 0.313, 0 [Helix, Turn, Sheet] AR 0.25 ME 2980, 2980 MS 12.040258 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9823 SQ SEQUENCE 1906.168 DA MW 16AA YKPVTNFSTY KPVTNF // ID AMRSAP1256 PN 16P-AC SO Synthetic construct PL 16 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 0, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 3, 'V': 2, 'W': 0, 'Y': 2 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 12.5%, 'L': 0%, AF 'M': 0%, 'N': 12.5%, 'P': 12.5%, 'Q': 0%, 'R': 0%, 'S': 6.25%, 'T': 18.75%, 'V': 12.5%, 'W': 0%, 'Y': 12.5% MA A, C, D, E, G, H, I, L, M, Q, R, W MO T LO S BA 6 LA 10 AA 0 BC 2 MC 0 MF 0 XX MM 1906.168 AI 36.25 II -24.163 HP -0.594 HM 0.248 IP 9.93 NC 1.996 SF 0.375, 0.313, 0 [Helix, Turn, Sheet] AR 0.25 ME 2980, 2980 MS 12.040258 XX SC alpha_beta XX TO Methicillin-resistant S. aureus (MRSA) XJ75302 XX XR PubMed: 26571297 XR CAMP R4: CAMPSQ9824 SQ SEQUENCE 1906.168 DA MW 16AA YKPVTNFSTY KPVTNF // ID AMRSAP1257 PN IDR-1018 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 25%, 'W': 8.33%, 'Y': 0% MA C, D, E, F, G, H, K, M, N, P, Q, S, T, Y MO R LO A, L, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1536.933 AI 178.333 II 49.825 HP 0.692 HM 0.529 IP 12.977 NC 3.998 SF 0.583, 0, 0.167 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 24.080516 XX SC beta XX TO S. aureus MRSA SAP0017 XX XR PubMed: 26525663 XR CAMP R4: CAMPSQ9836 SQ SEQUENCE 1536.933 DA MW 12AA VRLIVAVRIW RR // ID AMRSAP1258 PN OP-145 SO Synthetic construct PL 24 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 2, 'G': 1, 'H': 0, 'I': 3, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 12.5%, 'F': 8.33%, 'G': 4.17%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 0%, 'P': 4.17%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 0%, 'Y': 0% MA A, C, D, H, M, N, Q, S, T, W, Y MO R LO G, P BA 12 LA 12 AA 3 BC 9 MC 0 MF 0 XX MM 3052.752 AI 121.667 II 43.95 HP -0.513 HM 1.11 IP 12.233 NC 6.002 SF 0.417, 0.083, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 54.181161 XX SC beta XX TO MRSA XX XR PubMed: 28890511 XR CAMP R4: CAMPSQ9838 SQ SEQUENCE 3052.752 DA MW 24AA IGKEFKRIVE RIKRFLRELV RPLR // ID AMRSAP1259 PN Ala2Gly SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 5, 'T': 3, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 29.41%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 11.76%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 29.41%, 'T': 17.65%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, H, K, L, M, N, P, Q, R, V, W, Y MO C; S LO A, G BA 4 LA 13 AA 0 BC 0 MC 0 MF 0 XX MM 1626.865 AI 51.765 II 97.447 HP 0.988 HM 0.138 IP 5.667 NC -0.312 SF 0.118, 0.353, 0.059 [Helix, Turn, Sheet] AR 0 ME 0, 250 MS 0 XX SC beta XX TO (MRSA) Staphylococcus aureus ATCC 10537 (MIC = 0.012 μG/mL) XX XR PubMed: 26630475 XR CAMP R4: CAMPSQ9843 SQ SEQUENCE 1626.865 DA MW 17AA IGSASCTTCI CTCSCSS // ID AMRSAP1260 PN Ala2Met SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 5, 'T': 3, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 29.41%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.76%, 'K': 0%, 'L': 0%, AF 'M': 5.88%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 29.41%, 'T': 17.65%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, G, H, K, L, N, P, Q, R, V, W, Y MO C; S LO A, M BA 4 LA 13 AA 0 BC 0 MC 0 MF 0 XX MM 1701.006 AI 51.765 II 123.294 HP 1.124 HM 0.138 IP 5.667 NC -0.312 SF 0.118, 0.294, 0.118 [Helix, Turn, Sheet] AR 0 ME 0, 250 MS 0 XX SC beta XX TO (MRSA) Staphylococcus aureus ATCC 10537 (MIC = 0.014 μG/mL) XX XR PubMed: 26630475 XR CAMP R4: CAMPSQ9844 SQ SEQUENCE 1701.006 DA MW 17AA IMSASCTTCI CTCSCSS // ID AMRSAP1261 PN Ala2Phe SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 5, 'T': 3, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 5.88%, 'C': 29.41%, 'D': 0%, 'E': 0%, 'F': 5.88%, 'G': 0%, 'H': 0%, 'I': 11.76%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 29.41%, 'T': 17.65%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, G, H, K, L, M, N, P, Q, R, V, W, Y MO C; S LO A, F BA 4 LA 13 AA 0 BC 0 MC 0 MF 0 XX MM 1716.99 AI 51.765 II 97.447 HP 1.176 HM 0.15 IP 5.667 NC -0.312 SF 0.176, 0.294, 0.059 [Helix, Turn, Sheet] AR 0.059 ME 0, 250 MS 0 XX SC beta XX TO (MRSA) Staphylococcus aureus ATCC 10537 (MIC = 0.022 μG/mL) XX XR PubMed: 26630475 XR CAMP R4: CAMPSQ9845 SQ SEQUENCE 1716.99 DA MW 17AA IFSASCTTCI CTCSCSS // ID AMRSAP1262 PN Ala2Tyr SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 5, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 5, 'T': 3, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5.88%, 'C': 29.41%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.76%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 29.41%, 'T': 17.65%, 'V': 0%, 'W': 0%, 'Y': 5.88% MA D, E, F, G, H, K, L, M, N, P, Q, R, V, W MO C; S LO A, Y BA 3 LA 14 AA 0 BC 0 MC 0 MF 0 XX MM 1732.989 AI 51.765 II 97.447 HP 0.935 HM 0.138 IP 5.666 NC -0.313 SF 0.176, 0.294, 0.059 [Helix, Turn, Sheet] AR 0.059 ME 1490, 1740 MS 0 XX SC beta XX TO (MRSA) Staphylococcus aureus ATCC 10537 (MIC = 0.22 μG/mL) XX XR PubMed: 26630475 XR CAMP R4: CAMPSQ9846 SQ SEQUENCE 1732.989 DA MW 17AA IYSASCTTCI CTCSCSS // ID AMRSAP1263 PN Thiostrepton A SO Streptomyces laurentii ATCC 31255 PL 17 TX Monera PE Experimentally validated XX AC 'A': 2, 'C': 5, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 5, 'T': 3, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 29.41%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 11.76%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 29.41%, 'T': 17.65%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, F, G, H, K, L, M, N, P, Q, R, V, W, Y MO C; S LO A, I BA 4 LA 13 AA 0 BC 0 MC 0 MF 0 XX MM 1640.892 AI 57.647 II 97.447 HP 1.118 HM 0.138 IP 5.667 NC -0.312 SF 0.118, 0.294, 0.118 [Helix, Turn, Sheet] AR 0 ME 0, 250 MS 0 XX SC beta XX TO (MRSA) Staphylococcus aureus ATCC 10537 (MIC = 0.012 μG/mL) XX XR PubMed: 26630475 XR CAMP R4: CAMPSQ9847 SQ SEQUENCE 1640.892 DA MW 17AA IASASCTTCI CTCSCSS // ID AMRSAP1264 PN 3001 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 8.33%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 16.67%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 8.33%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, Y MO I; L LO A, R, V, W BA 9 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1465.932 AI 227.5 II 30.325 HP 1.475 HM 0.803 IP 11.823 NC 2.997 SF 0.667, 0, 0.333 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 1 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9856 SQ SEQUENCE 1465.932 DA MW 12AA VIKWLLKILR AI // ID AMRSAP1265 PN 3002 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 3, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 3, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 25%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, K, M, N, P, S, T, Y MO I; R; W LO L, Q, V BA 8 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1725.118 AI 154.167 II 120.683 HP 0.15 HM 0.476 IP 12.801 NC 2.998 SF 0.667, 0, 0.083 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 2 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9857 SQ SEQUENCE 1725.118 DA MW 12AA ILVRWIRWRI QW // ID AMRSAP1266 PN 3003 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 0, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 33.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 8.33%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, S, T, Y MO L LO Q, R, V BA 7 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1611.052 AI 154.167 II 32.467 HP -0.175 HM 0.551 IP 11.925 NC 3.997 SF 0.583, 0, 0.333 [Helix, Turn, Sheet] AR 0.167 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 4 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9858 SQ SEQUENCE 1611.052 DA MW 12AA WKKVQWLKRL LL // ID AMRSAP1267 PN 3004 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 0, 'V': 2, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 9.09%, 'K': 18.18%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 9.09%, 'S': 0%, 'T': 0%, 'V': 18.18%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, S, T, Y MO W LO I, L, Q, R BA 7 LA 4 AA 0 BC 3 MC 0 MF 0 XX MM 1541.905 AI 123.636 II 49.227 HP -0.164 HM 0.773 IP 11.823 NC 2.997 SF 0.636, 0, 0.091 [Helix, Turn, Sheet] AR 0.273 ME 16500, 16500 MS 18.060387 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 4 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9859 SQ SEQUENCE 1541.905 DA MW 11AA IQRWWKVWLK V // ID AMRSAP1268 PN Dermaseptin-01 SO Phyllomedusa oreades PL 29 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 10, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 4, 'H': 0, 'I': 2, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 2, 'R': 0, 'S': 1, 'T': 1, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 34.48%, 'C': 0%, 'D': 0%, 'E': 3.45%, 'F': 0%, 'G': 13.79%, 'H': 0%, 'I': 6.9%, 'K': 13.79%, 'L': 10.34%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 6.9%, 'R': 0%, 'S': 3.45%, 'T': 3.45%, 'V': 0%, 'W': 3.45%, 'Y': 0% MA C, D, F, H, M, N, P, R, V, Y MO A LO E, S, T, W BA 20 LA 9 AA 1 BC 4 MC 0 MF 0 XX MM 2795.278 AI 101.724 II 14.276 HP 0.286 HM 0.452 IP 10.803 NC 2.999 SF 0.207, 0.172, 0.483 [Helix, Turn, Sheet] AR 0.034 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO S. aureus MRSA (MIC = 12.83 μM) XX XR PubMed: 12379643 XR CAMP R4: CAMPSQ986 SQ SEQUENCE 2795.278 DA MW 29AA GLWSTIKQKG KEAAIAAAKA AGQAALGAL // ID AMRSAP1269 PN 3005 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 8.33%, 'H': 0%, 'I': 8.33%, 'K': 0%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 8.33%, 'R': 33.33%, 'S': 0%, 'T': 0%, 'V': 8.33%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, H, K, M, N, P, S, T, Y MO R LO G, I, L, Q, V BA 7 LA 5 AA 0 BC 4 MC 0 MF 0 XX MM 1712.039 AI 89.167 II 79.367 HP -1.008 HM 0.871 IP 12.977 NC 3.998 SF 0.5, 0.083, 0.083 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 4 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9860 SQ SEQUENCE 1712.039 DA MW 12AA RRQWRGWVRI WL // ID AMRSAP1270 PN 3006 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 8.33%, 'K': 25%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, S, T, Y MO K; L LO I, W BA 7 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1552.029 AI 178.333 II 41.442 HP 0.225 HM 0.481 IP 12.546 NC 4.997 SF 0.583, 0, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 4 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9861 SQ SEQUENCE 1552.029 DA MW 12AA IWLRLKVVLK RK // ID AMRSAP1271 PN 3007 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 16.67%, 'K': 33.33%, 'L': 8.33%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 33.33%, 'W': 8.33%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, R, S, T, Y MO K; V LO L, W BA 8 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1452.933 AI 194.167 II -38.083 HP 1.092 HM 0.219 IP 11.278 NC 3.997 SF 0.667, 0, 0.083 [Helix, Turn, Sheet] AR 0.083 ME 5500, 5500 MS 24.080516 XX SC alpha_beta XX TO S. aureus MRSA strain USA300 LAC (MIC = 16 μM) XX XR PubMed: 29382854 XR CAMP R4: CAMPSQ9862 SQ SEQUENCE 1452.933 DA MW 12AA VLKIKVKIWV VK // ID AMRSAP1272 PN Amurin SO Rana amurensis PL 20 TX Animalia PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 15%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 30%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA D, E, G, H, M, N, Q, R, T, V, W, Y MO L LO I, P, S BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2239.892 AI 151.5 II 17 HP 1.6 HM 0.563 IP 9.668 NC 2.873 SF 0.5, 0.1, 0.45 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC = 32 μM) XX XR PubMed: 29366784 XR CAMP R4: CAMPSQ9870 SQ SEQUENCE 2239.892 DA MW 20AA FLSLALAALP KLFCLIFKKC // ID AMRSAP1273 PN Amurin-2a SO Rana amurensis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 7, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 0%, 'I': 0%, 'K': 10%, 'L': 35%, AF 'M': 0%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, H, I, M, N, Q, R, T, W, Y MO L LO A, G, S, V BA 15 LA 5 AA 0 BC 2 MC 0 MF 0 XX MM 2222.862 AI 156 II 40.505 HP 1.69 HM 0.413 IP 8.822 NC 1.873 SF 0.55, 0.2, 0.4 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 12.040258 XX SC alpha_beta XX TO MRSA (MIC > 512 μM) XX XR PubMed: 29366784 XR CAMP R4: CAMPSQ9871 SQ SEQUENCE 2222.862 DA MW 20AA FLPLLLAGLP SFLCLVFKKC // ID AMRSAP1274 PN Amurin-2b SO Rana amurensis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 7, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 2, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 10%, 'L': 35%, AF 'M': 0%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 0%, 'S': 10%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, G, H, I, M, N, Q, R, T, W, Y MO L LO A, V BA 14 LA 6 AA 0 BC 2 MC 0 MF 0 XX MM 2252.888 AI 156 II 40.505 HP 1.67 HM 0.413 IP 8.822 NC 1.873 SF 0.55, 0.2, 0.4 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 12.040258 XX SC alpha_beta XX TO MRSA (MIC = 512 μM) XX XR PubMed: 29366784 XR CAMP R4: CAMPSQ9872 SQ SEQUENCE 2252.888 DA MW 20AA FLPLLLSALP SFLCLVFKKC // ID AMRSAP1275 PN Amurin-2c SO Rana amurensis PL 20 TX Animalia (Amphibia) PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 6, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 15%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 15%, 'L': 30%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, G, H, I, M, N, Q, R, T, W, Y MO L LO P, S, V BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2225.865 AI 146.5 II 21.245 HP 1.585 HM 0.533 IP 9.668 NC 2.873 SF 0.5, 0.1, 0.45 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC = 32 μM) XX XR PubMed: 29366784 XR CAMP R4: CAMPSQ9873 SQ SEQUENCE 2225.865 DA MW 20AA FLSLALAALP KFLCLVFKKC // ID AMRSAP1276 PN K 4 -Amurin-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 3, 'L': 6, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 0%, 'I': 0%, 'K': 15%, 'L': 30%, AF 'M': 0%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, H, I, M, N, Q, R, T, W, Y MO L LO A, G, S, V BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2237.876 AI 136.5 II 36.26 HP 1.305 HM 0.418 IP 9.668 NC 2.873 SF 0.5, 0.2, 0.35 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC = 8 μM) XX XR PubMed: 29366784 XR CAMP R4: CAMPSQ9874 SQ SEQUENCE 2237.876 DA MW 20AA FLPKLLAGLP SFLCLVFKKC // ID AMRSAP1277 PN K 11-Amurin-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 3, 'L': 7, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 5%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 0%, 'I': 0%, 'K': 15%, 'L': 35%, AF 'M': 0%, 'N': 0%, 'P': 10%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA D, E, H, I, M, N, Q, R, S, T, W, Y MO L LO A, G, V BA 15 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 2263.957 AI 156 II 30.875 HP 1.535 HM 0.533 IP 9.668 NC 2.873 SF 0.55, 0.15, 0.4 [Helix, Turn, Sheet] AR 0.15 ME 0, 125 MS 18.060387 XX SC alpha_beta XX TO MRSA (MIC = 16 μM) XX XR PubMed: 29366784 XR CAMP R4: CAMPSQ9875 SQ SEQUENCE 2263.957 DA MW 20AA FLPLLLAGLP KFLCLVFKKC // ID AMRSAP1278 PN A-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC = 2 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: CAMPSQ9889 SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1279 PN Ostricacin-2 SO Struthio camelus PL 41 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 3, 'F': 6, 'G': 4, 'H': 0, 'I': 1, 'K': 5, 'L': 1, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 0, 'R': 2, 'S': 3, 'T': 0, 'V': 2, 'W': 1, 'Y': 1 AF 'A': 4.88%, 'C': 14.63%, 'D': 0%, 'E': 7.32%, 'F': 14.63%, 'G': 9.76%, 'H': 0%, 'I': 2.44%, 'K': 12.2%, 'L': 2.44%, AF 'M': 0%, 'N': 4.88%, 'P': 4.88%, 'Q': 0%, 'R': 4.88%, 'S': 7.32%, 'T': 0%, 'V': 4.88%, 'W': 2.44%, 'Y': 2.44% MA D, H, M, Q, T MO C; F LO I, L, W, Y BA 19 LA 22 AA 3 BC 7 MC 0 MF 0 XX MM 4688.514 AI 38.049 II 45.402 HP -0.08 HM 0.451 IP 8.623 NC 3.629 SF 0.293, 0.268, 0.146 [Helix, Turn, Sheet] AR 0.195 ME 6990, 7365 MS 42.140903 XX SC alpha XX TO S.aureus 1056 MRSA (MIC = 1.25 μG/mL) XX XR PubMed: 16459058 XR CAMP R4: CAMPSQ989 SQ SEQUENCE 4688.514 DA MW 41AA APGNKAECER EKGYCGFLKC SFPFVVSGKC SRFFFCCKNI W // ID AMRSAP1280 PN Beta SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC > 256 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: CAMPSQ9890 SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1281 PN DA-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC = 16 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: CAMPSQ9891 SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1282 PN UNA-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA ATCC 33591 (MIC = 8 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: CAMPSQ9892 SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1283 PN AR SO Arenicola marina PL 21 TX Animalia PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 5, 'W': 2, 'Y': 3 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 23.81%, 'W': 9.52%, 'Y': 14.29% MA D, E, F, H, I, K, M, N, P, Q, S, T MO R LO A, G, L BA 10 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2760.325 AI 92.381 II 63.762 HP -0.071 HM 0.544 IP 11.147 NC 5.871 SF 0.524, 0.048, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 15470, 15595 MS 36.120774 XX SC beta XX TO MRSA ATCC 33591 (MIC = 4 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9922 SQ SEQUENCE 2760.325 DA MW 21AA RWCVYAYVRV RGVLVRYRRC W // ID AMRSAP1284 PN ARin-s SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 5, 'W': 2, 'Y': 3 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 23.81%, 'W': 9.52%, 'Y': 14.29% MA D, E, F, H, I, K, M, N, P, Q, S, T MO R LO A, G, L BA 10 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2760.325 AI 92.381 II 67.352 HP -0.071 HM 0.622 IP 11.147 NC 5.871 SF 0.524, 0.048, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 15470, 15595 MS 36.120774 XX SC beta XX TO MRSA ATCC 33591 (MIC >= 16 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9923 SQ SEQUENCE 2760.325 DA MW 21AA RWCRRYRVRV RGVLVYAYVC W // ID AMRSAP1285 PN ARs-N SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 5, 'S': 0, 'T': 0, 'V': 6, 'W': 2, 'Y': 4 AF 'A': 9.09%, 'C': 9.09%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 4.55%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 22.73%, 'S': 0%, 'T': 0%, 'V': 27.27%, 'W': 9.09%, 'Y': 18.18% MA D, E, F, H, I, K, L, M, N, P, Q, S, T MO V LO G BA 11 LA 11 AA 0 BC 5 MC 0 MF 0 XX MM 2824.366 AI 88.182 II 79.768 HP 0.177 HM 0.479 IP 10.124 NC 4.871 SF 0.545, 0.045, 0.091 [Helix, Turn, Sheet] AR 0.273 ME 16960, 17085 MS 30.100645 XX SC alpha XX TO MRSA ATCC 33591 (MIC >= 16 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9924 SQ SEQUENCE 2824.366 DA MW 22AA RRWCVYAYVR VRGVRVYAYV CW // ID AMRSAP1286 PN ARs-C SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 7, 'S': 0, 'T': 0, 'V': 4, 'W': 2, 'Y': 2 AF 'A': 0%, 'C': 10%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 35%, 'S': 0%, 'T': 0%, 'V': 20%, 'W': 10%, 'Y': 10% MA A, D, E, F, H, I, K, M, N, P, Q, S, T MO R LO G BA 9 LA 11 AA 0 BC 7 MC 0 MF 0 XX MM 2696.285 AI 97 II 49.925 HP -0.345 HM 0.694 IP 12.108 NC 6.872 SF 0.5, 0.05, 0.1 [Helix, Turn, Sheet] AR 0.2 ME 13980, 14105 MS 42.140903 XX SC beta XX TO MRSA ATCC 33591 (MIC = 4-8 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9925 SQ SEQUENCE 2696.285 DA MW 20AA WCRRYRVLVR GVLVRYRRCW // ID AMRSAP1287 PN AR K SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 6, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 5, 'W': 2, 'Y': 3 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 28.57%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 23.81%, 'W': 9.52%, 'Y': 14.29% MA D, E, F, H, I, M, N, P, Q, R, S, T MO K LO A, G, L BA 10 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2592.245 AI 92.381 II 12.695 HP 0.1 HM 0.372 IP 10.245 NC 5.87 SF 0.524, 0.048, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 15470, 15595 MS 36.120774 XX SC beta XX TO MRSA ATCC 33591 (MIC = 2 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9926 SQ SEQUENCE 2592.245 DA MW 21AA KWCVYAYVKV KGVLVKYKKC W // ID AMRSAP1288 PN AR F SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 5, 'W': 0, 'Y': 3 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 9.52%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 23.81%, 'W': 0%, 'Y': 14.29% MA D, E, H, I, K, M, N, P, Q, S, T, W MO R LO A, G, L BA 10 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2682.252 AI 92.381 II 25.21 HP 0.281 HM 0.544 IP 11.147 NC 5.871 SF 0.524, 0.048, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 4470, 4595 MS 36.120774 XX SC beta XX TO MRSA ATCC 33591 (MIC = 2 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9927 SQ SEQUENCE 2682.252 DA MW 21AA RFCVYAYVRV RGVLVRYRRC F // ID AMRSAP1289 PN Arcycl SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 5, 'W': 2, 'Y': 3 AF 'A': 4.76%, 'C': 9.52%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 4.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 28.57%, 'S': 0%, 'T': 0%, 'V': 23.81%, 'W': 9.52%, 'Y': 14.29% MA D, E, F, H, I, K, M, N, P, Q, S, T MO R LO A, G, L BA 10 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2760.325 AI 92.381 II 63.762 HP -0.071 HM 0.544 IP 11.147 NC 5.871 SF 0.524, 0.048, 0.095 [Helix, Turn, Sheet] AR 0.238 ME 15470, 15595 MS 36.120774 XX SC beta XX TO MRSA ATCC 33591 (MIC = 4 μM) XX XR PubMed: 31234579 XR CAMP R4: CAMPSQ9929 SQ SEQUENCE 2760.325 DA MW 21AA RWCVYAYVRV RGVLVRYRRC W // ID AMRSAP1290 PN Palustrin-2ISa SO Odorrana ishikawae PL 29 TX Animalia PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 2, 'E': 0, 'F': 1, 'G': 3, 'H': 0, 'I': 1, 'K': 5, 'L': 3, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 3, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 10.34%, 'C': 6.9%, 'D': 6.9%, 'E': 0%, 'F': 3.45%, 'G': 10.34%, 'H': 0%, 'I': 3.45%, 'K': 17.24%, 'L': 10.34%, AF 'M': 3.45%, 'N': 6.9%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.34%, 'V': 10.34%, 'W': 0%, 'Y': 0% MA E, H, P, Q, R, S, W, Y MO K LO F, I, M BA 15 LA 14 AA 2 BC 5 MC 0 MF 0 XX MM 3039.66 AI 94.138 II -8.838 HP 0.234 HM 0.612 IP 9.549 NC 2.873 SF 0.276, 0.172, 0.241 [Helix, Turn, Sheet] AR 0.034 ME 0, 125 MS 30.100645 XX SC beta XX TO S. aureus (MRSA) (MIC = 100 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9984 SQ SEQUENCE 3039.66 DA MW 29AA GFMDTAKNVA KNVAVTLLDK LKCKITGGC // ID AMRSAP1291 PN Palustrin-2ISb SO Odorrana ishikawae PL 36 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 2, 'E': 1, 'F': 1, 'G': 4, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 0, 'R': 1, 'S': 2, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 5.56%, 'C': 5.56%, 'D': 5.56%, 'E': 2.78%, 'F': 2.78%, 'G': 11.11%, 'H': 0%, 'I': 8.33%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 5.56%, 'P': 2.78%, 'Q': 0%, 'R': 2.78%, 'S': 5.56%, 'T': 2.78%, 'V': 11.11%, 'W': 2.78%, 'Y': 0% MA H, M, Q, Y MO K LO E, F, P, R, T, W BA 19 LA 17 AA 3 BC 7 MC 0 MF 0 XX MM 3888.645 AI 102.778 II 16.758 HP 0.036 HM 0.65 IP 10.136 NC 3.875 SF 0.333, 0.25, 0.167 [Helix, Turn, Sheet] AR 0.056 ME 5500, 5625 MS 42.140903 XX SC beta XX TO S. aureus (MRSA) (MIC = 100 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9985 SQ SEQUENCE 3888.645 DA MW 36AA GLWNSIKIAG KKLFVNVLDK IRCKVAGGCK TSPDVE // ID AMRSAP1292 PN Palustrin-2ISb + 3aa SO Synthetic construct PL 39 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 2, 'E': 1, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 7, 'L': 3, AC 'M': 0, 'N': 2, 'P': 1, 'Q': 0, 'R': 1, 'S': 2, 'T': 1, 'V': 4, 'W': 1, 'Y': 1 AF 'A': 5.13%, 'C': 5.13%, 'D': 5.13%, 'E': 2.56%, 'F': 2.56%, 'G': 10.26%, 'H': 2.56%, 'I': 7.69%, 'K': 17.95%, 'L': 7.69%, AF 'M': 0%, 'N': 5.13%, 'P': 2.56%, 'Q': 0%, 'R': 2.56%, 'S': 5.13%, 'T': 2.56%, 'V': 10.26%, 'W': 2.56%, 'Y': 2.56% MA M, Q MO K LO E, F, H, P, R, T, W, Y BA 19 LA 20 AA 3 BC 9 MC 0 MF 0 XX MM 4317.136 AI 94.872 II 25.474 HP -0.182 HM 0.65 IP 10.229 NC 4.965 SF 0.333, 0.231, 0.154 [Helix, Turn, Sheet] AR 0.077 ME 6990, 7115 MS 48.161032 XX SC beta XX TO S. aureus (MRSA) (MIC = 100 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9986 SQ SEQUENCE 4317.136 DA MW 39AA GLWNSIKIAG KKLFVNVLDK IRCKVAGGCK TSPDVEYHK // ID AMRSAP1293 PN Palustrin-2ISb-des-C7 SO Synthetic construct PL 29 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 3, 'K': 5, 'L': 3, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.9%, 'C': 6.9%, 'D': 3.45%, 'E': 0%, 'F': 3.45%, 'G': 13.79%, 'H': 0%, 'I': 10.34%, 'K': 17.24%, 'L': 10.34%, AF 'M': 0%, 'N': 6.9%, 'P': 0%, 'Q': 0%, 'R': 3.45%, 'S': 3.45%, 'T': 0%, 'V': 10.34%, 'W': 3.45%, 'Y': 0% MA E, H, M, P, Q, T, Y MO K LO D, F, R, S, W BA 17 LA 12 AA 1 BC 6 MC 0 MF 0 XX MM 3131.834 AI 117.586 II 5.838 HP 0.383 HM 0.65 IP 10.628 NC 4.873 SF 0.379, 0.241, 0.172 [Helix, Turn, Sheet] AR 0.069 ME 5500, 5625 MS 36.120774 XX SC beta XX TO S. aureus (MRSA) (MIC = 12.5 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9987 SQ SEQUENCE 3131.834 DA MW 29AA GLWNSIKIAG KKLFVNVLDK IRCKVAGGC // ID AMRSAP1294 PN Palustrin-2ISb-des-C7-4D SO Synthetic construct PL 29 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 2, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 3, 'K': 5, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.9%, 'C': 6.9%, 'D': 6.9%, 'E': 0%, 'F': 3.45%, 'G': 13.79%, 'H': 0%, 'I': 10.34%, 'K': 17.24%, 'L': 10.34%, AF 'M': 0%, 'N': 3.45%, 'P': 0%, 'Q': 0%, 'R': 3.45%, 'S': 3.45%, 'T': 0%, 'V': 10.34%, 'W': 3.45%, 'Y': 0% MA E, H, M, P, Q, T, Y MO K LO F, N, R, S, W BA 17 LA 12 AA 2 BC 6 MC 0 MF 0 XX MM 3132.819 AI 117.586 II 8.224 HP 0.383 HM 0.65 IP 10.227 NC 3.873 SF 0.379, 0.207, 0.172 [Helix, Turn, Sheet] AR 0.069 ME 5500, 5625 MS 36.120774 XX SC beta XX TO S. aureus (MRSA) (MIC = 12.5 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9988 SQ SEQUENCE 3132.819 DA MW 29AA GLWDSIKIAG KKLFVNVLDK IRCKVAGGC // ID AMRSAP1295 PN Palustrin-2ISb-des-C7-12N SO Synthetic construct PL 29 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 3, 'K': 4, 'L': 3, AC 'M': 0, 'N': 3, 'P': 0, 'Q': 0, 'R': 1, 'S': 1, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.9%, 'C': 6.9%, 'D': 3.45%, 'E': 0%, 'F': 3.45%, 'G': 13.79%, 'H': 0%, 'I': 10.34%, 'K': 13.79%, 'L': 10.34%, AF 'M': 0%, 'N': 10.34%, 'P': 0%, 'Q': 0%, 'R': 3.45%, 'S': 3.45%, 'T': 0%, 'V': 10.34%, 'W': 3.45%, 'Y': 0% MA E, H, M, P, Q, T, Y MO G; K LO D, F, R, S, W BA 17 LA 12 AA 1 BC 5 MC 0 MF 0 XX MM 3117.764 AI 117.586 II 8.766 HP 0.397 HM 0.585 IP 10.345 NC 3.873 SF 0.379, 0.276, 0.172 [Helix, Turn, Sheet] AR 0.069 ME 5500, 5625 MS 30.100645 XX SC beta XX TO S. aureus (MRSA) (MIC = 12.5 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9989 SQ SEQUENCE 3117.764 DA MW 29AA GLWNSIKIAG KNLFVNVLDK IRCKVAGGC // ID AMRSAP1296 PN Palustrin-2ISb-des-C7-23,29S SO Synthetic construct PL 29 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 4, 'H': 0, 'I': 3, 'K': 5, 'L': 3, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 1, 'S': 3, 'T': 0, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 6.9%, 'C': 0%, 'D': 3.45%, 'E': 0%, 'F': 3.45%, 'G': 13.79%, 'H': 0%, 'I': 10.34%, 'K': 17.24%, 'L': 10.34%, AF 'M': 0%, 'N': 6.9%, 'P': 0%, 'Q': 0%, 'R': 3.45%, 'S': 10.34%, 'T': 0%, 'V': 10.34%, 'W': 3.45%, 'Y': 0% MA C, E, H, M, P, Q, T, Y MO K LO D, F, R, W BA 17 LA 12 AA 1 BC 6 MC 0 MF 0 XX MM 3099.713 AI 117.586 II 20.99 HP 0.155 HM 0.65 IP 11.367 NC 4.997 SF 0.379, 0.31, 0.172 [Helix, Turn, Sheet] AR 0.069 ME 5500, 5500 MS 36.120774 XX SC alpha_beta XX TO S. aureus (MRSA) (MIC = 25 μM) XX XR PubMed: 21911019 XR CAMP R4: CAMPSQ9990 SQ SEQUENCE 3099.713 DA MW 29AA GLWNSIKIAG KKLFVNVLDK IRSKVAGGS // ID AMRSAP1297 PN BMAP-27- SO Bos taurus [Bovine] PL 18 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 4, 'G': 1, 'H': 0, 'I': 0, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 22.22%, 'G': 5.56%, 'H': 0%, 'I': 0%, 'K': 38.89%, 'L': 11.11%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 5.56%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, M, N, P, Q, T, V, W, Y MO K LO G, S BA 7 LA 11 AA 0 BC 10 MC 0 MF 0 XX MM 2342.952 AI 43.333 II -6.928 HP -1.289 HM 0.825 IP 12.843 NC 9.996 SF 0.333, 0.111, 0.111 [Helix, Turn, Sheet] AR 0.222 ME 0, 0 MS 60.20129 XX SC alpha XX TO S. aureus MRSA (MIC = 4 μM) XX XR PubMed: 8910461 XR CAMP R4: NA SQ SEQUENCE 2342.952 DA MW 18AA GRFKRFRKKF KKLFKKLS // ID AMRSAP1298 PN BMAP-28 SO Bos taurus [Bovine] PL 28 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 0, 'I': 6, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 3.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 17.86%, 'H': 0%, 'I': 21.43%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 14.29%, 'S': 3.57%, 'T': 0%, 'V': 3.57%, 'W': 3.57%, 'Y': 3.57% MA C, D, E, F, H, M, N, Q, T MO I LO A, S, V, W, Y BA 19 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 3131.894 AI 139.286 II 48.161 HP 0.232 HM 0.947 IP 12.526 NC 6.996 SF 0.429, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 6990, 6990 MS 42.140903 XX SC alpha_beta XX TO S. aureus MRSA (MIC = 4 μM) XX XR PubMed: 8910461 XR CAMP R4: NA SQ SEQUENCE 3131.894 DA MW 28AA GGLRSLGRKI LRAWKKYGPI IVPIIRIG // ID AMRSAP1299 PN BMAP-28- SO Bos taurus [Bovine] PL 18 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 5.56%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 22.22%, 'H': 0%, 'I': 5.56%, 'K': 16.67%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 16.67%, 'S': 5.56%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA C, D, E, F, H, M, N, P, Q, T, V MO G LO A, I, S, W, Y BA 10 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 2059.491 AI 92.222 II 63.378 HP -0.672 HM 0.947 IP 12.266 NC 5.996 SF 0.333, 0.278, 0.222 [Helix, Turn, Sheet] AR 0.111 ME 6990, 6990 MS 36.120774 XX SC alpha XX TO S. aureus MRSA (MIC = 4 μM) XX XR PubMed: 8910461 XR CAMP R4: NA SQ SEQUENCE 2059.491 DA MW 18AA GGLRSLGRKI LRAWKKYG // ID AMRSAP1300 PN BMAP-28 SO Bos taurus [Bovine] PL 28 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 0, 'I': 6, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 3.57%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 17.86%, 'H': 0%, 'I': 21.43%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 7.14%, 'Q': 0%, 'R': 14.29%, 'S': 3.57%, 'T': 0%, 'V': 3.57%, 'W': 3.57%, 'Y': 3.57% MA C, D, E, F, H, M, N, Q, T MO I LO A, S, V, W, Y BA 19 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 3131.894 AI 139.286 II 48.161 HP 0.232 HM 0.947 IP 12.526 NC 6.996 SF 0.429, 0.286, 0.143 [Helix, Turn, Sheet] AR 0.071 ME 6990, 6990 MS 42.140903 XX SC alpha_beta XX TO S. aureus MRSA (MIC = 2 μM) XX XR PubMed: 8910461 XR CAMP R4: NA SQ SEQUENCE 3131.894 DA MW 28AA GGLRSLGRKI LRAWKKYGPI IVPIIRIG // ID AMRSAP1301 PN Tenecin 1 SO Synthetic construct PL 43 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 6, 'D': 2, 'E': 1, 'F': 1, 'G': 5, 'H': 1, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 4, 'S': 2, 'T': 1, 'V': 5, 'W': 0, 'Y': 1 AF 'A': 11.63%, 'C': 13.95%, 'D': 4.65%, 'E': 2.33%, 'F': 2.33%, 'G': 11.63%, 'H': 2.33%, 'I': 2.33%, 'K': 6.98%, 'L': 6.98%, AF 'M': 0%, 'N': 4.65%, 'P': 0%, 'Q': 0%, 'R': 9.3%, 'S': 4.65%, 'T': 2.33%, 'V': 11.63%, 'W': 0%, 'Y': 2.33% MA M, P, Q, W MO C LO E, F, H, I, T, Y BA 20 LA 23 AA 3 BC 8 MC 0 MF 0 XX MM 4545.33 AI 81.628 II 34.353 HP 0.179 HM 0.483 IP 8.628 NC 3.718 SF 0.256, 0.209, 0.209 [Helix, Turn, Sheet] AR 0.047 ME 1490, 1865 MS 42.140903 XX SC beta XX TO MRSA (Methicillin resistant S. aureus) (MIC > 25 μG/mL) XX XR PubMed: 9849873 XR CAMP R4: NA SQ SEQUENCE 4545.33 DA MW 43AA VTCDILSVEA KGVKLNDAAC AAHCLFRGRS GGYCNGKRVC VCR // ID AMRSAP1302 PN Reduced tenecin 1 SO Synthetic construct PL 43 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 6, 'D': 2, 'E': 1, 'F': 1, 'G': 5, 'H': 1, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 2, 'P': 0, 'Q': 0, 'R': 4, 'S': 2, 'T': 1, 'V': 5, 'W': 0, 'Y': 1 AF 'A': 11.63%, 'C': 13.95%, 'D': 4.65%, 'E': 2.33%, 'F': 2.33%, 'G': 11.63%, 'H': 2.33%, 'I': 2.33%, 'K': 6.98%, 'L': 6.98%, AF 'M': 0%, 'N': 4.65%, 'P': 0%, 'Q': 0%, 'R': 9.3%, 'S': 4.65%, 'T': 2.33%, 'V': 11.63%, 'W': 0%, 'Y': 2.33% MA M, P, Q, W MO C LO E, F, H, I, T, Y BA 20 LA 23 AA 3 BC 8 MC 0 MF 0 XX MM 4545.33 AI 81.628 II 34.353 HP 0.179 HM 0.483 IP 8.628 NC 3.718 SF 0.256, 0.209, 0.209 [Helix, Turn, Sheet] AR 0.047 ME 1490, 1865 MS 42.140903 XX SC beta XX TO MRSA (Methicillin resistant S. aureus) (MIC > 100 μG/mL) XX XR PubMed: 9849873 XR CAMP R4: NA SQ SEQUENCE 4545.33 DA MW 43AA VTCDILSVEA KGVKLNDAAC AAHCLFRGRS GGYCNGKRVC VCR // ID AMRSAP1303 PN SMAP29 SO Ovis aries [Sheep] PL 29 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 5, 'H': 1, 'I': 4, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 6.9%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 17.24%, 'H': 3.45%, 'I': 13.79%, 'K': 10.34%, 'L': 10.34%, AF 'M': 0%, 'N': 0%, 'P': 3.45%, 'Q': 0%, 'R': 20.69%, 'S': 0%, 'T': 3.45%, 'V': 6.9%, 'W': 0%, 'Y': 3.45% MA C, D, E, F, M, N, Q, S, W MO R LO H, P, T, Y BA 17 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 3256 AI 121.034 II 26.41 HP -0.21 HM 1.071 IP 12.811 NC 9.087 SF 0.345, 0.207, 0.172 [Helix, Turn, Sheet] AR 0.034 ME 1490, 1490 MS 54.181161 XX SC beta XX TO MRSA ATCC 33591 (MIC = 1.24 μM [Low] TO MIC = 0.65 []) XX XR PubMed: 10768969 XR CAMP R4: NA SQ SEQUENCE 3256 DA MW 29AA RGLRRLGRKI AHGVKKYGPT VLRIIRIAG // ID AMRSAP1304 PN CAP18 SO Ovis aries [Sheep] PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 1, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 3, 'K': 9, 'L': 6, AC 'M': 0, 'N': 1, 'P': 2, 'Q': 2, 'R': 5, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 2.7%, 'C': 0%, 'D': 2.7%, 'E': 2.7%, 'F': 2.7%, 'G': 8.11%, 'H': 0%, 'I': 8.11%, 'K': 24.32%, 'L': 16.22%, AF 'M': 0%, 'N': 2.7%, 'P': 5.41%, 'Q': 5.41%, 'R': 13.51%, 'S': 0%, 'T': 2.7%, 'V': 0%, 'W': 0%, 'Y': 2.7% MA C, H, M, S, V, W MO K LO A, D, E, F, N, T, Y BA 16 LA 21 AA 2 BC 14 MC 0 MF 0 XX MM 4433.449 AI 97.568 II 30.997 HP -1.097 HM 0.672 IP 12.105 NC 11.997 SF 0.297, 0.162, 0.216 [Helix, Turn, Sheet] AR 0.054 ME 1490, 1490 MS 84.281806 XX SC alpha+beta XX TO MRSA ATCC 33591 (MIC = 1.24 μM [Low] TO MIC = 1.36 []) XX XR PubMed: 10768969 XR CAMP R4: NA SQ SEQUENCE 4433.449 DA MW 37AA GLRKRLRKFR NKIKEKLKKI GQKIQGLLPK LAPRTDY // ID AMRSAP1305 PN FALL39 SO Ovis aries [Sheep] PL 39 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 2, 'E': 3, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 2.56%, 'C': 0%, 'D': 5.13%, 'E': 7.69%, 'F': 12.82%, 'G': 5.13%, 'H': 0%, 'I': 7.69%, 'K': 15.38%, 'L': 10.26%, AF 'M': 0%, 'N': 2.56%, 'P': 2.56%, 'Q': 2.56%, 'R': 12.82%, 'S': 5.13%, 'T': 2.56%, 'V': 5.13%, 'W': 0%, 'Y': 0% MA C, H, M, W, Y MO K LO A, N, P, Q, T BA 18 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4711.58 AI 87.436 II 22.659 HP -0.569 HM 0.966 IP 11.347 NC 6.002 SF 0.359, 0.154, 0.205 [Helix, Turn, Sheet] AR 0.128 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 6.90 μM [Low] TO MIC > 16.8 []) XX XR PubMed: 10768969 XR CAMP R4: NA SQ SEQUENCE 4711.58 DA MW 39AA FALLGDFFRK SKEKIGKEFK RIVQRIKDFL RNLVPRTES // ID AMRSAP1306 PN LL37 SO Ovis aries [Sheep] PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 5.45 μM [Low] TO MIC = 30.8 []) XX XR PubMed: 10768969 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1307 PN Indolicidin SO Bos taurus [Bovine] PL 13 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus SAP0017 MRSAb (MIC = 8 μG/mL) XX XR PubMed: 10898680 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1308 PN CP10A SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 23.08%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1829.186 AI 83.077 II 44.985 HP -0.285 HM 0.546 IP 12.516 NC 2.998 SF 0.538, 0, 0.308 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO Staphylococcus aureus SAP0017 MRSAb (MIC = 4 μG/mL) XX XR PubMed: 10898680 XR CAMP R4: NA SQ SEQUENCE 1829.186 DA MW 13AA ILAWKWAWWA WRR // ID AMRSAP1309 PN LL-37 pentamide SO Macaca mulatta [Rhesus macaque] PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 4, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.51%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 8.11%, AF 'M': 0%, 'N': 8.11%, 'P': 2.7%, 'Q': 10.81%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, W, Y MO K LO P, T BA 16 LA 21 AA 0 BC 11 MC 0 MF 0 XX MM 4522.418 AI 78.919 II 21.984 HP -0.751 HM 0.965 IP 13.118 NC 10.996 SF 0.351, 0.216, 0.081 [Helix, Turn, Sheet] AR 0.135 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 2.52 � 0.17 at 0 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: NA SQ SEQUENCE 4522.418 DA MW 37AA LLGNFFRKSK QKIGKQFKRI VQRIKNFFRN LVPRTQS // ID AMRSAP1310 PN LL-37 pentamide SO Macaca mulatta [Rhesus macaque] PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 4, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.51%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 8.11%, AF 'M': 0%, 'N': 8.11%, 'P': 2.7%, 'Q': 10.81%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, W, Y MO K LO P, T BA 16 LA 21 AA 0 BC 11 MC 0 MF 0 XX MM 4522.418 AI 78.919 II 21.984 HP -0.751 HM 0.965 IP 13.118 NC 10.996 SF 0.351, 0.216, 0.081 [Helix, Turn, Sheet] AR 0.135 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 3.41 � 0.40 at 100 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: NA SQ SEQUENCE 4522.418 DA MW 37AA LLGNFFRKSK QKIGKQFKRI VQRIKNFFRN LVPRTQS // ID AMRSAP1311 PN LL-37 pentamide SO Macaca mulatta [Rhesus macaque] PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 3, AC 'M': 0, 'N': 3, 'P': 1, 'Q': 4, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.51%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 8.11%, AF 'M': 0%, 'N': 8.11%, 'P': 2.7%, 'Q': 10.81%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, M, W, Y MO K LO P, T BA 16 LA 21 AA 0 BC 11 MC 0 MF 0 XX MM 4522.418 AI 78.919 II 21.984 HP -0.751 HM 0.965 IP 13.118 NC 10.996 SF 0.351, 0.216, 0.081 [Helix, Turn, Sheet] AR 0.135 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4.96 � 1.32 at 175 mM NaCL) XX XR PubMed: 11557457 XR CAMP R4: NA SQ SEQUENCE 4522.418 DA MW 37AA LLGNFFRKSK QKIGKQFKRI VQRIKNFFRN LVPRTQS // ID AMRSAP1312 PN CP-11 SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 23.08%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 15.38%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 30.77%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, L BA 8 LA 5 AA 0 BC 5 MC 0 MF 0 XX MM 1880.318 AI 60 II 57.146 HP -1.477 HM 0.482 IP 12.546 NC 4.997 SF 0.462, 0.154, 0.077 [Helix, Turn, Sheet] AR 0.308 ME 22000, 22000 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus (MRSA) (MIC = 16 μG/mL) XX XR PubMed: 14640680 XR CAMP R4: NA SQ SEQUENCE 1880.318 DA MW 13AA ILKKWPWWPW RRK // ID AMRSAP1313 PN Pilosulin-P2 SO Myrmecia pilosula [Jack jumper ant] PL 20 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, T, W, Y MO L LO F, I, P, S BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2222.795 AI 136.5 II -0.43 HP 0.305 HM 1.026 IP 12.82 NC 5.997 SF 0.4, 0.2, 0.3 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus (MRSA) LT1338 (MIC = 4 μM) XX XR PubMed: 15639237 XR CAMP R4: NA SQ SEQUENCE 2222.795 DA MW 20AA GLLSKFGRLA RKLARVIPKV // ID AMRSAP1314 PN Pilosulin-P2 SO Myrmecia pilosula [Jack jumper ant] PL 20 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 5%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, Q, T, W, Y MO L LO F, I, P, S BA 13 LA 7 AA 0 BC 6 MC 0 MF 0 XX MM 2222.795 AI 136.5 II -0.43 HP 0.305 HM 1.026 IP 12.82 NC 5.997 SF 0.4, 0.2, 0.3 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 36.120774 XX SC beta XX TO S. aureus (MRSA) LT1334 (MIC = 3 μM) XX XR PubMed: 15639237 XR CAMP R4: NA SQ SEQUENCE 2222.795 DA MW 20AA GLLSKFGRLA RKLARVIPKV // ID AMRSAP1315 PN Fowlicidin-1 SO Gallus gallus [Chicken] PL 26 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 2 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 3.85%, 'H': 0%, 'I': 11.54%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 3.85%, 'V': 15.38%, 'W': 3.85%, 'Y': 7.69% MA C, D, E, F, H, M, Q, S MO K; R; V LO G, N, P, T, W BA 14 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 3141.889 AI 127.308 II 8.012 HP -0.069 HM 0.785 IP 12.131 NC 7.995 SF 0.462, 0.115, 0.154 [Helix, Turn, Sheet] AR 0.115 ME 8480, 8480 MS 48.161032 XX SC beta XX TO S. aureus MRSA ATCC BAA-39 (MIC = 0.40 μM at 0 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3141.889 DA MW 26AA RVKRVWPLVI RTVIAGYNLY RAIKKK // ID AMRSAP1316 PN Fowlicidin-1 SO Gallus gallus [Chicken] PL 26 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 2 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 3.85%, 'H': 0%, 'I': 11.54%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 3.85%, 'V': 15.38%, 'W': 3.85%, 'Y': 7.69% MA C, D, E, F, H, M, Q, S MO K; R; V LO G, N, P, T, W BA 14 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 3141.889 AI 127.308 II 8.012 HP -0.069 HM 0.785 IP 12.131 NC 7.995 SF 0.462, 0.115, 0.154 [Helix, Turn, Sheet] AR 0.115 ME 8480, 8480 MS 48.161032 XX SC beta XX TO S. aureus MRSA ATCC 43300 (MIC = 0.40 μM at 100 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3141.889 DA MW 26AA RVKRVWPLVI RTVIAGYNLY RAIKKK // ID AMRSAP1317 PN Fowlicidin-1 SO Gallus gallus [Chicken] PL 26 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 2 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 3.85%, 'H': 0%, 'I': 11.54%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 3.85%, 'V': 15.38%, 'W': 3.85%, 'Y': 7.69% MA C, D, E, F, H, M, Q, S MO K; R; V LO G, N, P, T, W BA 14 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 3141.889 AI 127.308 II 8.012 HP -0.069 HM 0.785 IP 12.131 NC 7.995 SF 0.462, 0.115, 0.154 [Helix, Turn, Sheet] AR 0.115 ME 8480, 8480 MS 48.161032 XX SC beta XX TO S. aureus MRSA ATCC BAA-39 (MIC = 0.80 μM at 0 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3141.889 DA MW 26AA RVKRVWPLVI RTVIAGYNLY RAIKKK // ID AMRSAP1318 PN Fowlicidin-1 SO Gallus gallus [Chicken] PL 26 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 3, 'K': 4, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 2 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 3.85%, 'H': 0%, 'I': 11.54%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 3.85%, 'P': 3.85%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 3.85%, 'V': 15.38%, 'W': 3.85%, 'Y': 7.69% MA C, D, E, F, H, M, Q, S MO K; R; V LO G, N, P, T, W BA 14 LA 12 AA 0 BC 8 MC 0 MF 0 XX MM 3141.889 AI 127.308 II 8.012 HP -0.069 HM 0.785 IP 12.131 NC 7.995 SF 0.462, 0.115, 0.154 [Helix, Turn, Sheet] AR 0.115 ME 8480, 8480 MS 48.161032 XX SC beta XX TO S. aureus MRSA ATCC 43300 (MIC = 0.40 μM at 100 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3141.889 DA MW 26AA RVKRVWPLVI RTVIAGYNLY RAIKKK // ID AMRSAP1319 PN SMAP-29 SO Gallus gallus [Chicken] PL 28 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 1, 'I': 4, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 3.57%, 'I': 14.29%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 3.57%, 'Q': 0%, 'R': 21.43%, 'S': 0%, 'T': 3.57%, 'V': 7.14%, 'W': 0%, 'Y': 3.57% MA C, D, E, F, M, N, Q, S, W MO R LO H, P, T, Y BA 16 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 3198.948 AI 125.357 II 26.996 HP -0.204 HM 1.071 IP 12.811 NC 9.087 SF 0.357, 0.179, 0.179 [Helix, Turn, Sheet] AR 0.036 ME 1490, 1490 MS 54.181161 XX SC beta XX TO S. aureus MRSA ATCC BAA-39 (MIC = 0.39 μM at 0 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3198.948 DA MW 28AA RGLRRLGRKI AHGVKKYGPT VLRIIRIA // ID AMRSAP1320 PN SMAP-29 SO Gallus gallus [Chicken] PL 28 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 1, 'I': 4, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 3.57%, 'I': 14.29%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 3.57%, 'Q': 0%, 'R': 21.43%, 'S': 0%, 'T': 3.57%, 'V': 7.14%, 'W': 0%, 'Y': 3.57% MA C, D, E, F, M, N, Q, S, W MO R LO H, P, T, Y BA 16 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 3198.948 AI 125.357 II 26.996 HP -0.204 HM 1.071 IP 12.811 NC 9.087 SF 0.357, 0.179, 0.179 [Helix, Turn, Sheet] AR 0.036 ME 1490, 1490 MS 54.181161 XX SC beta XX TO S. aureus MRSA ATCC 43300 (MIC = 0.39 μM at 100 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3198.948 DA MW 28AA RGLRRLGRKI AHGVKKYGPT VLRIIRIA // ID AMRSAP1321 PN SMAP-29 SO Gallus gallus [Chicken] PL 28 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 1, 'I': 4, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 3.57%, 'I': 14.29%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 3.57%, 'Q': 0%, 'R': 21.43%, 'S': 0%, 'T': 3.57%, 'V': 7.14%, 'W': 0%, 'Y': 3.57% MA C, D, E, F, M, N, Q, S, W MO R LO H, P, T, Y BA 16 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 3198.948 AI 125.357 II 26.996 HP -0.204 HM 1.071 IP 12.811 NC 9.087 SF 0.357, 0.179, 0.179 [Helix, Turn, Sheet] AR 0.036 ME 1490, 1490 MS 54.181161 XX SC beta XX TO S. aureus MRSA ATCC BAA-39 (MIC = 0.39 μM at 0 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3198.948 DA MW 28AA RGLRRLGRKI AHGVKKYGPT VLRIIRIA // ID AMRSAP1322 PN SMAP-29 SO Gallus gallus [Chicken] PL 28 TX Animalia (Aves) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 1, 'I': 4, 'K': 3, 'L': 3, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 7.14%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 14.29%, 'H': 3.57%, 'I': 14.29%, 'K': 10.71%, 'L': 10.71%, AF 'M': 0%, 'N': 0%, 'P': 3.57%, 'Q': 0%, 'R': 21.43%, 'S': 0%, 'T': 3.57%, 'V': 7.14%, 'W': 0%, 'Y': 3.57% MA C, D, E, F, M, N, Q, S, W MO R LO H, P, T, Y BA 16 LA 12 AA 0 BC 10 MC 0 MF 0 XX MM 3198.948 AI 125.357 II 26.996 HP -0.204 HM 1.071 IP 12.811 NC 9.087 SF 0.357, 0.179, 0.179 [Helix, Turn, Sheet] AR 0.036 ME 1490, 1490 MS 54.181161 XX SC beta XX TO S. aureus MRSA ATCC 43300 (MIC = 0.39 μM at 100 mM NaCL) XX XR PubMed: 16326712 XR CAMP R4: NA SQ SEQUENCE 3198.948 DA MW 28AA RGLRRLGRKI AHGVKKYGPT VLRIIRIA // ID AMRSAP1323 PN Indolicidin SO Bos taurus [Bovine] PL 13 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 1 (MRSA 1) (MIC = 16 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1324 PN Indolicidin SO Bos taurus [Bovine] PL 13 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 2 (MRSA 2) (MIC = 32 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1325 PN PSI10 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 20%, 'Q': 0%, 'R': 40%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 40%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V, Y MO R; W LO P BA 6 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1581.851 AI 0 II 175.08 HP -2.48 HM 0.47 IP 12.977 NC 3.998 SF 0.4, 0.2, 0 [Helix, Turn, Sheet] AR 0.4 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 1 (MRSA 1) (MIC = 4 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: NA SQ SEQUENCE 1581.851 DA MW 10AA RRWPWWPWRR // ID AMRSAP1326 PN PSI10 SO Synthetic construct PL 10 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 4, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 20%, 'Q': 0%, 'R': 40%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 40%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, Q, S, T, V, Y MO R; W LO P BA 6 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1581.851 AI 0 II 175.08 HP -2.48 HM 0.47 IP 12.977 NC 3.998 SF 0.4, 0.2, 0 [Helix, Turn, Sheet] AR 0.4 ME 22000, 22000 MS 24.080516 XX SC alpha_beta XX TO Methicillin-resistant Staphylococcus aureus 2 (MRSA 2) (MIC = 4 μG/mL) XX XR PubMed: 16563706 XR CAMP R4: NA SQ SEQUENCE 1581.851 DA MW 10AA RRWPWWPWRR // ID AMRSAP1327 PN Melittin SO Simian virus [Virus] PL 26 TX Virus PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 1 (CCARM 3001) (MIC = 1 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1328 PN Melittin SO Simian virus [Virus] PL 26 TX Virus PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 2 (CCARM 3089) (MIC = 2 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1329 PN Melittin SO Simian virus [Virus] PL 26 TX Virus PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 3 (CCARM 3543) (MIC = 1 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1330 PN Pep-1 SO Simian virus [Virus] PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 14.29%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.81%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, F, G, H, I, L, M, N, Y MO K; W LO P, Q, R, S, V BA 7 LA 14 AA 3 BC 6 MC 0 MF 0 XX MM 2848.259 AI 13.81 II 19.89 HP -2.038 HM 0.378 IP 10.623 NC 3.002 SF 0.286, 0.095, 0.143 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 1 (CCARM 2092) (MIC = 32 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2848.259 DA MW 21AA KETWWETWWT EWSQPKKKRK V // ID AMRSAP1331 PN Pep-1 SO Simian virus [Virus] PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 14.29%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.81%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, F, G, H, I, L, M, N, Y MO K; W LO P, Q, R, S, V BA 7 LA 14 AA 3 BC 6 MC 0 MF 0 XX MM 2848.259 AI 13.81 II 19.89 HP -2.038 HM 0.378 IP 10.623 NC 3.002 SF 0.286, 0.095, 0.143 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 2 (CCARM 2095) (MIC > 64 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2848.259 DA MW 21AA KETWWETWWT EWSQPKKKRK V // ID AMRSAP1332 PN Pep-1 SO Simian virus [Virus] PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 3, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 5, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 14.29%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.81%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, F, G, H, I, L, M, N, Y MO K; W LO P, Q, R, S, V BA 7 LA 14 AA 3 BC 6 MC 0 MF 0 XX MM 2848.259 AI 13.81 II 19.89 HP -2.038 HM 0.378 IP 10.623 NC 3.002 SF 0.286, 0.095, 0.143 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 3 (CCARM 2109) (MIC = 32 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2848.259 DA MW 21AA KETWWETWWT EWSQPKKKRK V // ID AMRSAP1333 PN Pep-1-K SO Simian virus [Virus] PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.1%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Y MO K LO P, Q, R, S, V BA 7 LA 14 AA 0 BC 9 MC 0 MF 0 XX MM 2845.435 AI 13.81 II 17.876 HP -2.095 HM 0.424 IP 12.177 NC 8.996 SF 0.286, 0.095, 0 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 54.181161 XX SC alpha_beta XX TO MRSA 1 (CCARM 2092) (MIC = 8 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2845.435 DA MW 21AA KKTWWKTWWT KWSQPKKKRK V // ID AMRSAP1334 PN Pep-1-K SO Simian virus [Virus] PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.1%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Y MO K LO P, Q, R, S, V BA 7 LA 14 AA 0 BC 9 MC 0 MF 0 XX MM 2845.435 AI 13.81 II 17.876 HP -2.095 HM 0.424 IP 12.177 NC 8.996 SF 0.286, 0.095, 0 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 54.181161 XX SC alpha_beta XX TO MRSA 2 (CCARM 2095) (MIC = 8 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2845.435 DA MW 21AA KKTWWKTWWT KWSQPKKKRK V // ID AMRSAP1335 PN Pep-1-K SO Simian virus [Virus] PL 21 TX Virus PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 0, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 1, 'R': 1, 'S': 1, 'T': 3, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 38.1%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 4.76%, 'Q': 4.76%, 'R': 4.76%, 'S': 4.76%, 'T': 14.29%, 'V': 4.76%, 'W': 23.81%, 'Y': 0% MA A, C, D, E, F, G, H, I, L, M, N, Y MO K LO P, Q, R, S, V BA 7 LA 14 AA 0 BC 9 MC 0 MF 0 XX MM 2845.435 AI 13.81 II 17.876 HP -2.095 HM 0.424 IP 12.177 NC 8.996 SF 0.286, 0.095, 0 [Helix, Turn, Sheet] AR 0.238 ME 27500, 27500 MS 54.181161 XX SC alpha_beta XX TO MRSA 3 (CCARM 2109) (MIC = 8 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2845.435 DA MW 21AA KKTWWKTWWT KWSQPKKKRK V // ID AMRSAP1336 PN Melittin SO Simian virus [Virus] PL 26 TX Virus PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 1 (CCARM 2092) (MIC = 16 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1337 PN Melittin SO Simian virus [Virus] PL 26 TX Virus PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 2 (CCARM 2095) (MIC = 8 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1338 PN Melittin SO Simian virus [Virus] PL 26 TX Virus PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 3 (CCARM 2109) (MIC = 8 μM) XX XR PubMed: 16945333 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1339 PN TP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 15.38%, 'Q': 0%, 'R': 30.77%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, G, H, I, K, M, N, Q, S, T, Y MO R LO L, V BA 9 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1902.283 AI 52.308 II 139.585 HP -0.792 HM 0.471 IP 12.977 NC 3.998 SF 0.538, 0.154, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO MRSA1 (CCARM 3001) (MIC = 2 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1902.283 DA MW 13AA VRRFPWWWPF LRR // ID AMRSAP1340 PN STP SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 18.18%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, Q, R, S, T, V, Y MO K LO F, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1577.938 AI 0 II 27.827 HP -1.445 HM 0.136 IP 11.278 NC 3.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO MRSA1 (CCARM 3001) (MIC = 1 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1577.938 DA MW 11AA KKFPWWWPFK K // ID AMRSAP1341 PN IN SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO MRSA1 (CCARM 3001) (MIC= 1 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1342 PN TP SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15.38%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 15.38%, 'Q': 0%, 'R': 30.77%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, G, H, I, K, M, N, Q, S, T, Y MO R LO L, V BA 9 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1902.283 AI 52.308 II 139.585 HP -0.792 HM 0.471 IP 12.977 NC 3.998 SF 0.538, 0.154, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO MRSA1 (CCARM 3543) (MIC= 2 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1902.283 DA MW 13AA VRRFPWWWPF LRR // ID AMRSAP1343 PN TPk SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 1, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 7.69%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 15.38%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 7.69%, 'Q': 0%, 'R': 30.77%, 'S': 0%, 'T': 0%, 'V': 7.69%, 'W': 23.08%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, Q, S, T, Y MO R LO F, L, P, V BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1914.338 AI 52.308 II 126.985 HP -1.485 HM 0.627 IP 12.985 NC 5.997 SF 0.462, 0.077, 0.077 [Helix, Turn, Sheet] AR 0.308 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA1 (CCARM 3543) (MIC= 0.5 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1914.338 DA MW 13AA VRRPKWWWKF LRR // ID AMRSAP1344 PN STP SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 0, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 36.36%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 18.18%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, Q, R, S, T, V, Y MO K LO F, P BA 7 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1577.938 AI 0 II 27.827 HP -1.445 HM 0.136 IP 11.278 NC 3.997 SF 0.455, 0.182, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 24.080516 XX SC alpha_beta XX TO MRSA1 (CCARM 3543) (MIC= 0.5 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1577.938 DA MW 11AA KKFPWWWPFK K // ID AMRSAP1345 PN STPk SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 18.18%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 54.55%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 27.27%, 'Y': 0% MA A, C, D, E, G, H, I, L, M, N, P, Q, R, S, T, V, Y MO K LO F BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1640.053 AI 0 II -18.236 HP -1.864 HM 0.413 IP 11.5 NC 5.996 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0.455 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO MRSA1 (CCARM 3543) (MIC= 0.5 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1640.053 DA MW 11AA KKFKWWWKFK K // ID AMRSAP1346 PN IN SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO MRSA1 (CCARM 3543) (MIC= 1 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1347 PN INk SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 4, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 30.77%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, P, Q, S, T, V, Y MO W LO I, L BA 7 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2000.471 AI 60 II 61.577 HP -1.6 HM 0.432 IP 12.56 NC 5.997 SF 0.538, 0, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA1 (CCARM 3543) (MIC= 1 μM) XX XR PubMed: 17604338 XR CAMP R4: NA SQ SEQUENCE 2000.471 DA MW 13AA ILKWKWKWWK WRR // ID AMRSAP1348 PN LP1 SO Manduca sexta [Tobacco hawkmoth] PL 22 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 3, 'R': 4, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 4.55%, 'H': 0%, 'I': 0%, 'K': 9.09%, 'L': 13.64%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 13.64%, 'R': 18.18%, 'S': 9.09%, 'T': 9.09%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, M, N, V, W, Y MO R LO G BA 9 LA 13 AA 0 BC 6 MC 0 MF 0 XX MM 2692.165 AI 53.182 II 48.236 HP -1.05 HM 0.545 IP 12.985 NC 5.997 SF 0.273, 0.227, 0.136 [Helix, Turn, Sheet] AR 0.136 ME 0, 0 MS 36.120774 XX SC alpha XX TO S. aureus MRSA BAA-39 (MIC = 100 μG/mL) XX XR PubMed: 20096726 XR CAMP R4: NA SQ SEQUENCE 2692.165 DA MW 22AA QRFSQPTFKL PQGRLTLSRK FR // ID AMRSAP1349 PN LP1A SO Manduca sexta [Tobacco hawkmoth] PL 21 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 3, 'R': 3, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 14.29%, 'G': 4.76%, 'H': 0%, 'I': 0%, 'K': 9.52%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 9.52%, 'Q': 14.29%, 'R': 14.29%, 'S': 9.52%, 'T': 9.52%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, M, N, V, W, Y MO F; L; Q; R LO G BA 9 LA 12 AA 0 BC 5 MC 0 MF 0 XX MM 2535.978 AI 55.714 II 50.057 HP -0.886 HM 0.545 IP 12.814 NC 4.997 SF 0.286, 0.238, 0.143 [Helix, Turn, Sheet] AR 0.143 ME 0, 0 MS 30.100645 XX SC alpha XX TO S. aureus MRSA 43300 (MIC = 100 μG/mL) XX XR PubMed: 20096726 XR CAMP R4: NA SQ SEQUENCE 2535.978 DA MW 21AA QRFSQPTFKL PQGRLTLSRK F // ID AMRSAP1350 PN LP1 SO Manduca sexta [Tobacco hawkmoth] PL 22 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 3, 'R': 4, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 4.55%, 'H': 0%, 'I': 0%, 'K': 9.09%, 'L': 13.64%, AF 'M': 0%, 'N': 0%, 'P': 9.09%, 'Q': 13.64%, 'R': 18.18%, 'S': 9.09%, 'T': 9.09%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, H, I, M, N, V, W, Y MO R LO G BA 9 LA 13 AA 0 BC 6 MC 0 MF 0 XX MM 2692.165 AI 53.182 II 48.236 HP -1.05 HM 0.545 IP 12.985 NC 5.997 SF 0.273, 0.227, 0.136 [Helix, Turn, Sheet] AR 0.136 ME 0, 0 MS 36.120774 XX SC alpha XX TO S. aureus MRSA BAA-39 (MIC = 100 μG/mL) XX XR PubMed: 20096726 XR CAMP R4: NA SQ SEQUENCE 2692.165 DA MW 22AA QRFSQPTFKL PQGRLTLSRK FR // ID AMRSAP1351 PN HG1 SO Synthetic construct PL 38 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 4, 'I': 0, 'K': 4, 'L': 10, AC 'M': 0, 'N': 4, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 2, 'Y': 0 AF 'A': 15.79%, 'C': 5.26%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 10.53%, 'I': 0%, 'K': 10.53%, 'L': 26.32%, AF 'M': 0%, 'N': 10.53%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 5.26%, 'Y': 0% MA D, E, F, I, M, P, Q, R, S, T, Y MO L LO C, V, W BA 24 LA 14 AA 0 BC 8 MC 0 MF 0 XX MM 4098.935 AI 133.684 II 4.789 HP 0.432 HM 0.5 IP 10.349 NC 4.236 SF 0.368, 0.211, 0.421 [Helix, Turn, Sheet] AR 0.053 ME 11000, 11125 MS 24.080516 XX SC beta XX TO MRSA CCARM 3696 (MIC = 4 μG/mL) XX XR PubMed: 20385874 XR CAMP R4: NA SQ SEQUENCE 4098.935 DA MW 38AA KWLNALLHHG LNCAKGVLA, KWLNALLHHG LNCAKGVLA // ID AMRSAP1352 PN Khal SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 4, 'H': 4, 'I': 0, 'K': 3, 'L': 9, AC 'M': 0, 'N': 3, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 17.65%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.76%, 'H': 11.76%, 'I': 0%, 'K': 8.82%, 'L': 26.47%, AF 'M': 0%, 'N': 8.82%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 2.94%, 'Y': 0% MA D, E, F, I, M, P, Q, R, S, T, Y MO L LO W BA 22 LA 12 AA 0 BC 7 MC 0 MF 0 XX MM 3557.284 AI 137.941 II 0.547 HP 0.615 HM 0.421 IP 9.671 NC 3.237 SF 0.353, 0.206, 0.441 [Helix, Turn, Sheet] AR 0.029 ME 5500, 5625 MS 18.060387 XX SC alpha XX TO MRSA CCARM 3696 (MIC = 8 μG/mL) XX XR PubMed: 20385874 XR CAMP R4: NA SQ SEQUENCE 3557.284 DA MW 34AA KWLNALLHHG LNCAKGVLA, ALLHHGLNCA KGVLA // ID AMRSAP1353 PN MSI-78 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 3, 'H': 0, 'I': 2, 'K': 9, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 13.64%, 'H': 0%, 'I': 9.09%, 'K': 40.91%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.55%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO V BA 13 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2478.195 AI 93.182 II -6.164 HP -0.159 HM 0.789 IP 11.703 NC 8.995 SF 0.364, 0.136, 0.182 [Helix, Turn, Sheet] AR 0.136 ME 0, 0 MS 54.181161 XX SC alpha XX TO MRSA CCARM 3696 (MIC = 16 μG/mL) XX XR PubMed: 20385874 XR CAMP R4: NA SQ SEQUENCE 2478.195 DA MW 22AA GIGKFLKKAK KFGKAFVKIL KK // ID AMRSAP1354 PN LL-37 SO Synthetic construct PL 37 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA CCARM 3696 (MIC > 64 μG/mL) XX XR PubMed: 20385874 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1355 PN Indolicidin SO Bos taurus [Bovine] PL 13 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO MRSA CCARM 3696 (MIC = 16 μG/mL) XX XR PubMed: 20385874 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1356 PN PGLa-H SO Likely of sticklefish origin PL 10 TX Animalia PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 30%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 10%, 'K': 30%, 'L': 20%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 10%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, M, N, P, Q, R, S, T, W, Y MO A; K LO I, V BA 7 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1054.385 AI 176 II -16.47 HP 1 HM 0.675 IP 11.103 NC 2.997 SF 0.4, 0, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (MIC = 67.8 μG/mL) XX XR PubMed: 22188679 XR CAMP R4: NA SQ SEQUENCE 1054.385 DA MW 10AA KIAKVALKAL // ID AMRSAP1357 PN MSI-78 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 3, 'H': 0, 'I': 2, 'K': 9, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 9.09%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 13.64%, 'G': 13.64%, 'H': 0%, 'I': 9.09%, 'K': 40.91%, 'L': 9.09%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 4.55%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO V BA 13 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2478.195 AI 93.182 II -6.164 HP -0.159 HM 0.789 IP 11.703 NC 8.995 SF 0.364, 0.136, 0.182 [Helix, Turn, Sheet] AR 0.136 ME 0, 0 MS 54.181161 XX SC alpha XX TO MRSA (MIC = 16-32(6.5-13) μG/mL TO MBC = 32 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: NA SQ SEQUENCE 2478.195 DA MW 22AA GIGKFLKKAK KFGKAFVKIL KK // ID AMRSAP1358 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 17.65%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 41.18%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO G, I, V BA 10 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1994.584 AI 97.647 II 4.065 HP 0.035 HM 0.789 IP 11.579 NC 6.996 SF 0.412, 0.059, 0.235 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 42.140903 XX SC alpha XX TO MRSA (MIC = 32(16) μG/mL TO MBC = 64 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: NA SQ SEQUENCE 1994.584 DA MW 17AA KFLKKAKKFG KAFVKIL // ID AMRSAP1359 PN MSI-78 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 0, 'I': 1, 'K': 7, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 11.76%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 17.65%, 'G': 5.88%, 'H': 0%, 'I': 5.88%, 'K': 41.18%, 'L': 11.76%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.88%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, Q, R, S, T, W, Y MO K LO G, I, V BA 10 LA 7 AA 0 BC 7 MC 0 MF 0 XX MM 1994.584 AI 97.647 II -0.929 HP 0.035 HM 0.789 IP 11.579 NC 6.996 SF 0.412, 0.059, 0.235 [Helix, Turn, Sheet] AR 0.176 ME 0, 0 MS 42.140903 XX SC alpha XX TO MRSA (MIC = 256 μG/mL TO MBC = 256-512 μG/mL) XX XR PubMed: 26066462 XR CAMP R4: NA SQ SEQUENCE 1994.584 DA MW 17AA FLKKAKKFGK AFVKILK // ID AMRSAP1360 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-3 (MIC = 2.5 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1361 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-4 (MIC = 0.625 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1362 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-5 (MIC = 1.25 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1363 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-6 (MIC = 2.5 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1364 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-7 (MIC = 1.25 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1365 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-8 (MIC = 2.5 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1366 PN IP SO Ixodes persulcatus (Hard tick) PL 38 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 6, 'D': 0, 'E': 0, 'F': 3, 'G': 7, 'H': 2, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 5, 'S': 2, 'T': 2, 'V': 0, 'W': 0, 'Y': 2 AF 'A': 5.26%, 'C': 15.79%, 'D': 0%, 'E': 0%, 'F': 7.89%, 'G': 18.42%, 'H': 5.26%, 'I': 2.63%, 'K': 2.63%, 'L': 2.63%, AF 'M': 0%, 'N': 2.63%, 'P': 2.63%, 'Q': 5.26%, 'R': 13.16%, 'S': 5.26%, 'T': 5.26%, 'V': 0%, 'W': 0%, 'Y': 5.26% MA D, E, M, V, W MO G LO I, K, L, N, P BA 15 LA 23 AA 0 BC 8 MC 0 MF 0 XX MM 4199.812 AI 25.789 II 82.205 HP -0.474 HM 0.791 IP 9.183 NC 5.806 SF 0.184, 0.289, 0.079 [Helix, Turn, Sheet] AR 0.132 ME 2980, 3355 MS 36.120774 XX SC beta XX TO MRSA MR-9 (MIC = 0.625 μG/mL) XX XR PubMed: 26873587 XR CAMP R4: NA SQ SEQUENCE 4199.812 DA MW 38AA GFGCPFNQGA CHRHCRSIGR RGGYCAGLFK QTCTCYSR // ID AMRSAP1367 PN Hp1404 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 7.14%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, H, M, N, P, Q, R, T, Y MO G LO E, F, S, V, W BA 10 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1546.873 AI 132.143 II 19.707 HP 0.671 HM 0.558 IP 9.537 NC 0.999 SF 0.5, 0.286, 0.214 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO S. aureus MRSA P1381 (MIC = 12.5 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: NA SQ SEQUENCE 1546.873 DA MW 14AA GILGKLWEGV KSIF // ID AMRSAP1368 PN Hp1404 SO Synthetic construct PL 14 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 1, 'F': 1, 'G': 3, 'H': 0, 'I': 2, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 7.14%, 'F': 7.14%, 'G': 21.43%, 'H': 0%, 'I': 14.29%, 'K': 14.29%, 'L': 14.29%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 7.14%, 'T': 0%, 'V': 7.14%, 'W': 7.14%, 'Y': 0% MA A, C, D, H, M, N, P, Q, R, T, Y MO G LO E, F, S, V, W BA 10 LA 4 AA 1 BC 2 MC 0 MF 0 XX MM 1546.873 AI 132.143 II 19.707 HP 0.671 HM 0.558 IP 9.537 NC 0.999 SF 0.5, 0.286, 0.214 [Helix, Turn, Sheet] AR 0.143 ME 5500, 5500 MS 12.040258 XX SC alpha_beta XX TO S. aureus MRSA P1374 (MIC = 25 μG/mL) XX XR PubMed: 26952110 XR CAMP R4: NA SQ SEQUENCE 1546.873 DA MW 14AA GILGKLWEGV KSIF // ID AMRSAP1369 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA100 (NRS382) (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1370 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA200 (NRS383) (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1371 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA300-0114 (NRS384) (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1372 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA400 (NRS123) (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1373 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA500 (NRS385) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1374 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA700 (NRS386) (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1375 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA800 (NRS387) (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1376 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA1000 (NRS483) (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1377 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain USA1100 (NRS484) (MIC = 1 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1378 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS194 (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1379 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS108 (MIC = 1 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1380 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS119 (LinR) (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1381 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain ATCC 43300 (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1382 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain ATCC BAA-44 (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1383 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS70 (MIC = 1 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1384 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS71 (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1385 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS100 (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1386 PN WR12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 6, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 50%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 50%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R; W LO R, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 2072.419 AI 0 II 247.833 HP -2.7 HM 1.113 IP 13.199 NC 5.998 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0.5 ME 33000, 33000 MS 36.120774 XX SC alpha_beta XX TO MRSA strain NRS123 (MIC = 2 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 2072.419 DA MW 12AA RWWRWWRRWW RR // ID AMRSAP1387 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA100 (NRS382) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1388 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA200 (NRS383) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1389 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA300-0114 (NRS384) (MIC = 16 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1390 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA400 (NRS123) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1391 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA500 (NRS385) (MIC = 16 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1392 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA700 (NRS386) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1393 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA800 (NRS387) (MIC = 16 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1394 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA1000 (NRS483) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1395 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain USA1100 (NRS484) (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1396 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS194 (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1397 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS108 (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1398 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS119 (LinR) (MIC = 16 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1399 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain ATCC 43300 (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1400 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain ATCC BAA-44 (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1401 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS70 (MIC = 4 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1402 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS71 (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1403 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS100 (MIC = 16 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1404 PN D-IK8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 4, 'K': 2, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 50%, 'K': 25%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, L, M, N, P, Q, S, T, V, W, Y MO I LO K, R BA 4 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1039.376 AI 195 II -23.088 HP 0.15 HM 0.395 IP 12.532 NC 3.997 SF 0.5, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA strain NRS123 (MIC = 8 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 1039.376 DA MW 8AA IRIKIRIK // ID AMRSAP1405 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA100 (NRS382) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1406 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA200 (NRS383) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1407 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA300-0114 (NRS384) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1408 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA400 (NRS123) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1409 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA500 (NRS385) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1410 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA700 (NRS386) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1411 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA800 (NRS387) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1412 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA1000 (NRS483) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1413 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain USA1100 (NRS484) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1414 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS194 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1415 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS108 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1416 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS119 (LinR) (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1417 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain ATCC 43300 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1418 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain ATCC BAA-44 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1419 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS70 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1420 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS71 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1421 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS100 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1422 PN LL-37 SO Homo sapiens (Human) PL 37 TX Animalia (Mammals) PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 2, 'E': 3, 'F': 4, 'G': 2, 'H': 0, 'I': 3, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 1, 'R': 5, 'S': 2, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.41%, 'E': 8.11%, 'F': 10.81%, 'G': 5.41%, 'H': 0%, 'I': 8.11%, 'K': 16.22%, 'L': 10.81%, AF 'M': 0%, 'N': 2.7%, 'P': 2.7%, 'Q': 2.7%, 'R': 13.51%, 'S': 5.41%, 'T': 2.7%, 'V': 5.41%, 'W': 0%, 'Y': 0% MA A, C, H, M, W, Y MO K LO N, P, Q, T BA 16 LA 21 AA 5 BC 11 MC 0 MF 0 XX MM 4493.325 AI 89.459 II 23.343 HP -0.724 HM 0.966 IP 11.347 NC 6.002 SF 0.351, 0.162, 0.189 [Helix, Turn, Sheet] AR 0.108 ME 0, 0 MS 66.221419 XX SC alpha XX TO MRSA strain NRS123 (MIC >=128 μM) XX XR PubMed: 27405275 XR CAMP R4: NA SQ SEQUENCE 4493.325 DA MW 37AA LLGDFFRKSK EKIGKEFKRI VQRIKDFLRN LVPRTES // ID AMRSAP1423 PN G13,18P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 8%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2972.587 AI 105.6 II 84.172 HP -0.096 HM 0.576 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700698 MRSA) (MIC = 3 μM) XX XR PubMed: 28611397 XR CAMP R4: NA SQ SEQUENCE 2972.587 DA MW 25AA FFGWLIKGAI HAPKAIHPLI HRRRH // ID AMRSAP1424 PN G13,18P-Chr-1 SO Synthetic construct PL 25 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 2, 'H': 4, 'I': 4, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 3, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 12%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8%, 'G': 8%, 'H': 16%, 'I': 16%, 'K': 8%, 'L': 8%, AF 'M': 0%, 'N': 0%, 'P': 8%, 'Q': 0%, 'R': 12%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 4%, 'Y': 0% MA C, D, E, M, N, Q, S, T, V, Y MO H; I LO W BA 16 LA 9 AA 0 BC 9 MC 0 MF 0 XX MM 2972.587 AI 105.6 II 84.172 HP -0.096 HM 0.576 IP 12.814 NC 5.361 SF 0.36, 0.16, 0.2 [Helix, Turn, Sheet] AR 0.12 ME 5500, 5500 MS 30.100645 XX SC alpha XX TO Staphylococcus aureus (ATCC 700699 MRSA) (MIC = 3 μM) XX XR PubMed: 28611397 XR CAMP R4: NA SQ SEQUENCE 2972.587 DA MW 25AA FFGWLIKGAI HAPKAIHPLI HRRRH // ID AMRSAP1425 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22424 (MIC = 13.9 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1426 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22111 (MIC = 13.9 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1427 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22360 (MIC = 1.4 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1428 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22354 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1429 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M21756 (MIC = 11.1 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1430 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22130 (MIC = 11.1 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1431 PN D33 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -6.712 HP 0.169 HM 0.687 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22224 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS KAKAAKLKTL LKALSK // ID AMRSAP1432 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22424 (MIC = 34.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1433 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22111 (MIC = 17.4 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1434 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22360 (MIC = 1.4 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1435 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22354 (MIC = 44.5 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1436 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M21756 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1437 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22130 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1438 PN D34 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.537 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22224 (MIC = 44.5 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLKTLS AAKKKKLATL LKALSK // ID AMRSAP1439 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22424 (MIC = 13.9 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1440 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22111 (MIC = 27.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1441 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22360 (MIC = 0.7 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1442 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22354 (MIC = 44.5 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1443 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M21756 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1444 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22130 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1445 PN D35 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -0.181 HP 0.169 HM 0.499 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22224 (MIC = 22.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALKSLLATLS KAKKKKLKTL LAALSK // ID AMRSAP1446 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22424 (MIC = 4.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1447 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22111 (MIC = 4.3 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1448 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22360 (MIC = 1.4 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1449 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22354 (MIC = 5.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1450 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M21756 (MIC = 5.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1451 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22130 (MIC = 5.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1452 PN D36 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 8, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 19.23%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 30.77%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO K; L LO T BA 13 LA 13 AA 0 BC 8 MC 0 MF 0 XX MM 2767.522 AI 139.231 II -3.446 HP 0.169 HM 0.616 IP 11.646 NC 7.996 SF 0.308, 0.115, 0.5 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 48.161032 XX SC beta XX TO MRSA strain M22224 (MIC = 5.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2767.522 DA MW 26AA ALASLLKTLS KAKKKKLKTL LKALSA // ID AMRSAP1453 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22424 (MIC = 14.5 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1454 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22111 (MIC = 14.5 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1455 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22360 (MIC = 2.9 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1456 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22354 (MIC = 23.2 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1457 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M21756 (MIC = 23.2 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1458 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22130 (MIC = 11.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1459 PN D38 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.557 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22224 (MIC = 11.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLKTLS AAAKKALATL LKALSK // ID AMRSAP1460 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22424 (MIC = 7.2 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1461 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22111 (MIC = 7.2 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1462 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22360 (MIC = 2.9 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1463 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22354 (MIC = 5.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1464 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M21756 (MIC = 2.9 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1465 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22130 (MIC = 5.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1466 PN D39 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II 3.085 HP 0.608 HM 0.69 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22224 (MIC = 5.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALKSLLATLS KAAKKALKTL LAALSK // ID AMRSAP1467 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22424 (MIC = 9.1 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1468 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22111 (MIC = 9.1 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1469 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22360 (MIC = 5.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1470 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22354 (MIC = 11.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1471 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M21756 (MIC = 11.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1472 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22130 (MIC = 5.8 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1473 PN D40 SO Synthetic construct PL 26 TX Synthetic construct PE Experimentally validated XX AC 'A': 7, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 8, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 3, 'T': 2, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 26.92%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 23.08%, 'L': 30.77%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 11.54%, 'T': 7.69%, 'V': 0%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, Q, R, V, W, Y MO L LO T BA 15 LA 11 AA 0 BC 6 MC 0 MF 0 XX MM 2653.331 AI 146.923 II -0.181 HP 0.608 HM 0.723 IP 11.5 NC 5.996 SF 0.308, 0.115, 0.577 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA strain M22224 (MIC = 11.6 μM) XX XR PubMed: 28636788 XR CAMP R4: NA SQ SEQUENCE 2653.331 DA MW 26AA ALASLLKTLS KAAKKALKTL LKALSA // ID AMRSAP1474 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA-15 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1475 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA-15 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1476 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA-15 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1477 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA-15 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1478 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA-15 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1479 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA-15 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1480 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA-15 (MIC = 250 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1481 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA-15 (MIC = 250 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1482 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA-15 (MIC = 250 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1483 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA-15 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1484 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA ATCC 33591 (MIC = 16 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1485 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA ATCC 33591 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1486 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA ATCC 33591 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1487 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA ATCC 33591 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1488 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA ATCC 33592 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1489 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA ATCC 33593 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1490 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA ATCC 33594 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1491 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA ATCC 33595 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1492 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA ATCC 33596 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1493 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA ATCC 33597 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1494 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA USA300 BAA-1717 (MIC = 8 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1495 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA USA300 BAA-1717 (MIC = 256 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1496 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA USA300 BAA-1717 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1497 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA USA300 BAA-1717 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1498 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA USA300 BAA-1718 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1499 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA USA300 BAA-1719 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1500 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA USA300 BAA-1720 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1501 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA USA300 BAA-1721 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1502 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA USA300 BAA-1722 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1503 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA USA300 BAA-1723 XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1504 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1505 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1506 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0320 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1507 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0320 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1508 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1509 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1510 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1511 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1512 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0320 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1513 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0320 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1514 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1515 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1516 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1517 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0325 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1518 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1519 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1520 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1521 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1522 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1523 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0325 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1524 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1525 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1526 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0352 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1527 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0352 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1528 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1529 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1530 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1531 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1532 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0352 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1533 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0352 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1534 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1535 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1536 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0390 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1537 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0390 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1538 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1539 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC = 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1540 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1541 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1542 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA Q14-0390 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1543 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA Q14-0390 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1544 PN Lynronne-1 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 3, 'L': 1, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 3, 'S': 2, 'T': 1, 'V': 3, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 15.79%, 'L': 5.26%, AF 'M': 0%, 'N': 5.26%, 'P': 5.26%, 'Q': 0%, 'R': 15.79%, 'S': 10.53%, 'T': 5.26%, 'V': 15.79%, 'W': 10.53%, 'Y': 0% MA A, C, D, E, G, H, M, Q, Y MO K; R; V LO F, I, L, N, P, T BA 9 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2400.902 AI 86.842 II 69.026 HP -0.563 HM 0.76 IP 12.82 NC 5.997 SF 0.421, 0.211, 0.053 [Helix, Turn, Sheet] AR 0.158 ME 11000, 11000 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 16 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2400.902 DA MW 19AA LPRRNRWSKI WKKVVTVFS // ID AMRSAP1545 PN Lynronne-2 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 2, 'I': 2, 'K': 1, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 1 AF 'A': 5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 10%, 'I': 10%, 'K': 5%, 'L': 20%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 0%, 'T': 5%, 'V': 0%, 'W': 0%, 'Y': 5% MA C, D, E, M, P, Q, S, V, W MO L; R LO A, F, K, N, T, Y BA 10 LA 10 AA 0 BC 7 MC 0 MF 0 XX MM 2434.922 AI 122 II 56.54 HP -0.29 HM 0.989 IP 12.51 NC 5.179 SF 0.4, 0.15, 0.25 [Helix, Turn, Sheet] AR 0.1 ME 1490, 1490 MS 30.100645 XX SC beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2434.922 DA MW 20AA HLRRINKLLT RIGLYRHAFG // ID AMRSAP1546 PN Lynronne-3 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 3, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 2, 'R': 6, 'S': 0, 'T': 2, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 5%, 'C': 5%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 10%, AF 'M': 0%, 'N': 5%, 'P': 5%, 'Q': 10%, 'R': 30%, 'S': 0%, 'T': 10%, 'V': 0%, 'W': 5%, 'Y': 0% MA D, E, G, H, I, K, M, S, V, Y MO R LO A, C, N, P, W BA 8 LA 12 AA 0 BC 6 MC 0 MF 0 XX MM 2653.112 AI 44 II 68.49 HP -1.055 HM 0.661 IP 12.801 NC 5.936 SF 0.3, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 5500, 5500 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2653.112 DA MW 20AA NRFTARFRRT PWRLCLQFRQ // ID AMRSAP1547 PN P4 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 3, 'G': 1, 'H': 3, 'I': 0, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 15%, 'G': 5%, 'H': 15%, 'I': 0%, 'K': 10%, 'L': 15%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 20%, 'S': 5%, 'T': 5%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, C, D, E, I, M, N, P, Q, W MO R LO G, S, T, V, Y BA 8 LA 12 AA 0 BC 9 MC 0 MF 0 XX MM 2599.089 AI 73 II 36.685 HP -0.73 HM 0.786 IP 12.518 NC 6.269 SF 0.4, 0.1, 0.15 [Helix, Turn, Sheet] AR 0.2 ME 1490, 1490 MS 36.120774 XX SC alpha XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2599.089 DA MW 20AA VLHTGYRKFL HRSKRFFHLR // ID AMRSAP1548 PN P5 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 1, 'N': 0, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 1, 'V': 1, 'W': 2, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 8.33%, 'L': 8.33%, AF 'M': 8.33%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 25%, 'S': 8.33%, 'T': 8.33%, 'V': 8.33%, 'W': 16.67%, 'Y': 0% MA A, C, D, E, G, H, I, N, P, Q, Y MO R LO F, K, L, M, S, T, V BA 6 LA 6 AA 0 BC 4 MC 0 MF 0 XX MM 1666.023 AI 56.667 II 102.492 HP -0.667 HM 0.542 IP 12.807 NC 3.998 SF 0.417, 0.083, 0.167 [Helix, Turn, Sheet] AR 0.25 ME 11000, 11000 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 1666.023 DA MW 12AA TMSLRFWRWK VR // ID AMRSAP1549 PN P8 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 4, 'S': 3, 'T': 0, 'V': 1, 'W': 3, 'Y': 0 AF 'A': 11.11%, 'C': 5.56%, 'D': 0%, 'E': 0%, 'F': 5.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 5.56%, 'L': 5.56%, AF 'M': 0%, 'N': 5.56%, 'P': 0%, 'Q': 0%, 'R': 22.22%, 'S': 16.67%, 'T': 0%, 'V': 5.56%, 'W': 16.67%, 'Y': 0% MA D, E, G, H, I, M, P, Q, T, Y MO R LO C, F, K, L, N, V BA 8 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2309.682 AI 48.889 II 105.489 HP -0.756 HM 0.547 IP 12.508 NC 4.936 SF 0.333, 0.222, 0.167 [Helix, Turn, Sheet] AR 0.222 ME 16500, 16500 MS 30.100645 XX SC alpha_beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2309.682 DA MW 18AA AWRWKAFRNC WRVRSSSL // ID AMRSAP1550 PN P10 SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 1, 'K': 0, 'L': 1, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 0, 'R': 7, 'S': 1, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5.26%, 'G': 0%, 'H': 0%, 'I': 5.26%, 'K': 0%, 'L': 5.26%, AF 'M': 0%, 'N': 0%, 'P': 10.53%, 'Q': 0%, 'R': 36.84%, 'S': 5.26%, 'T': 5.26%, 'V': 21.05%, 'W': 5.26%, 'Y': 0% MA A, C, D, E, G, H, K, M, N, Q, Y MO R LO F, I, L, S, T, W BA 10 LA 9 AA 0 BC 7 MC 0 MF 0 XX MM 2449.983 AI 102.105 II 163.589 HP -0.484 HM 0.309 IP 13.278 NC 6.998 SF 0.421, 0.158, 0.053 [Helix, Turn, Sheet] AR 0.105 ME 5500, 5500 MS 42.140903 XX SC beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC > 128 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2449.983 DA MW 19AA RSITRPVLVR RRWRVRPVF // ID AMRSAP1551 PN P11 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 2, 'G': 1, 'H': 1, 'I': 4, 'K': 3, 'L': 1, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 2, 'T': 0, 'V': 0, 'W': 1, 'Y': 1 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 5.56%, 'H': 5.56%, 'I': 22.22%, 'K': 16.67%, 'L': 5.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 11.11%, 'T': 0%, 'V': 0%, 'W': 5.56%, 'Y': 5.56% MA A, C, D, E, M, N, P, T, V MO I LO G, H, L, Q, R, W, Y BA 9 LA 9 AA 0 BC 5 MC 0 MF 0 XX MM 2264.745 AI 108.333 II 23.772 HP 0.017 HM 0.367 IP 11.132 NC 4.087 SF 0.5, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.222 ME 6990, 6990 MS 24.080516 XX SC alpha_beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 32 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2264.745 DA MW 18AA SIKILKIYFI QGKRHWSF // ID AMRSAP1552 PN P12 SO Synthetic construct PL 17 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 1, 'D': 0, 'E': 0, 'F': 0, 'G': 1, 'H': 0, 'I': 0, 'K': 1, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 5, 'S': 0, 'T': 1, 'V': 1, 'W': 4, 'Y': 1 AF 'A': 5.88%, 'C': 5.88%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 5.88%, 'H': 0%, 'I': 0%, 'K': 5.88%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.88%, 'R': 29.41%, 'S': 0%, 'T': 5.88%, 'V': 5.88%, 'W': 23.53%, 'Y': 5.88% MA D, E, F, H, I, L, M, N, P, S MO R LO A, C, G, K, Q, T, V, Y BA 7 LA 10 AA 0 BC 6 MC 0 MF 0 XX MM 2394.794 AI 22.941 II 46.888 HP -1.612 HM 0.855 IP 12.336 NC 5.935 SF 0.353, 0.059, 0.059 [Helix, Turn, Sheet] AR 0.294 ME 23490, 23490 MS 36.120774 XX SC alpha_beta XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 16 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2394.794 DA MW 17AA QVRWWGRYWR RKWATCR // ID AMRSAP1553 PN P15s SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 1, 'E': 0, 'F': 2, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 3, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 5%, 'D': 5%, 'E': 0%, 'F': 10%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 5%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 0%, 'R': 15%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 5% MA A, E, H, M, P, Q, T, W MO K LO C, D, L, N, S, V, Y BA 8 LA 12 AA 1 BC 7 MC 0 MF 0 XX MM 2428.927 AI 73 II -4.13 HP -0.695 HM 0.412 IP 11.232 NC 5.934 SF 0.35, 0.2, 0.05 [Helix, Turn, Sheet] AR 0.15 ME 1490, 1490 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus MRSA NCTC 12493 (MIC = 64 μG/mL) XX XR PubMed: 29214045 XR CAMP R4: NA SQ SEQUENCE 2428.927 DA MW 20AA KFVRLKIYCR DKNKGRGISF // ID AMRSAP1554 PN A-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO Ciprofloxacin resistant MRSA ATCC BAA-44 (MIC = 4 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: NA SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1555 PN μA-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO Ciprofloxacin resistant MRSA ATCC BAA-44 (MIC > 256 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: NA SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1556 PN DA-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO Ciprofloxacin resistant MRSA ATCC BAA-44 (MIC = 32 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: NA SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1557 PN UNA-12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 6, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 3, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 50%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 25%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, Y MO K LO L, W BA 6 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1685.178 AI 97.5 II 18.792 HP -1.225 HM 0.805 IP 11.5 NC 5.996 SF 0.5, 0, 0.25 [Helix, Turn, Sheet] AR 0.25 ME 16500, 16500 MS 36.120774 XX SC alpha_beta XX TO Ciprofloxacin resistant MRSA ATCC BAA-44 (MIC = 8 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: NA SQ SEQUENCE 1685.178 DA MW 12AA KWLKKWLKWL KK // ID AMRSAP1558 PN IL SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO Ciprofloxacin resistant MRSA ATCC BAA-44 (MIC = 16 μG/mL) XX XR PubMed: 29310083 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1559 PN IL SO Synthetic construct PL 13 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 0, 'P': 3, 'Q': 0, 'R': 2, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 7.69%, 'K': 7.69%, 'L': 7.69%, AF 'M': 0%, 'N': 0%, 'P': 23.08%, 'Q': 0%, 'R': 15.38%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 38.46%, 'Y': 0% MA A, C, D, E, F, G, H, M, N, Q, S, T, V, Y MO W LO I, K, L BA 10 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1907.299 AI 60 II 76.277 HP -1.069 HM 0.449 IP 12.516 NC 2.998 SF 0.538, 0.231, 0.077 [Helix, Turn, Sheet] AR 0.385 ME 27500, 27500 MS 18.060387 XX SC alpha_beta XX TO MRSA ATCC 33591 XX XR PubMed: 29310083 XR CAMP R4: NA SQ SEQUENCE 1907.299 DA MW 13AA ILPWKWPWWP WRR // ID AMRSAP1560 PN L4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, W, Y MO L LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1208.562 AI 216.667 II 73.089 HP 0.111 HM 0.292 IP 12.977 NC 3.998 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1208.562 DA MW 9AA RLRLLLRLR // ID AMRSAP1561 PN L4pf.d SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, W, Y MO L LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1208.562 AI 216.667 II 178.978 HP 0.111 HM 1.042 IP 12.977 NC 3.998 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA 43300 (MIC = 8 �M TO MBC = 16 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1208.562 DA MW 9AA LLRRLRRLL // ID AMRSAP1562 PN F4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 55.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO F LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1378.648 AI 0 II 8.889 HP -0.444 HM 0.316 IP 12.977 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.556 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1378.648 DA MW 9AA RFRFFFRFR // ID AMRSAP1563 PN F4pf. SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 55.56%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO F LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1378.648 AI 0 II 136.178 HP -0.444 HM 1.093 IP 12.977 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.556 ME 0, 0 MS 24.080516 XX SC alpha XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1378.648 DA MW 9AA FFRRFRRFF // ID AMRSAP1564 PN I4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 55.56%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, W, Y MO I LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1208.562 AI 216.667 II 8.889 HP 0.5 HM 0.351 IP 12.977 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1208.562 DA MW 9AA RIRIIIRIR // ID AMRSAP1565 PN I4pf. SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 55.56%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, W, Y MO I LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1208.562 AI 216.667 II 136.178 HP 0.5 HM 1.168 IP 12.977 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA 43300 (MIC = 64 �M TO MBC > 64 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1208.562 DA MW 9AA IIRRIRRII // ID AMRSAP1566 PN W4 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 55.56%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1573.831 AI 0 II 199.822 HP -2.5 HM 0.246 IP 12.977 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.556 ME 27500, 27500 MS 24.080516 XX SC alpha_beta XX TO MRSA 43300 (MIC = 2 �M TO MBC = 2 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1573.831 DA MW 9AA RWRWWWRWR // ID AMRSAP1567 PN W4pf. SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 44.44%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 55.56%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO W LO R BA 5 LA 4 AA 0 BC 4 MC 0 MF 0 XX MM 1573.831 AI 0 II 263.467 HP -2.5 HM 0.944 IP 12.977 NC 3.998 SF 0.556, 0, 0 [Helix, Turn, Sheet] AR 0.556 ME 27500, 27500 MS 24.080516 XX SC alpha_beta XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1573.831 DA MW 9AA WWRRWRRWW // ID AMRSAP1568 PN L6 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, W, Y MO R LO L BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1520.937 AI 177.273 II 165.764 HP -0.727 HM 0.592 IP 13.199 NC 5.998 SF 0.455, 0, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA 43300 (MIC = 8 �M TO MBC = 16 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1520.937 DA MW 11AA RRLRLLLRLR R // ID AMRSAP1569 PN L6pf. SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 45.45%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, M, N, P, Q, S, T, V, W, Y MO R LO L BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1520.937 AI 177.273 II 165.764 HP -0.727 HM 1.205 IP 13.199 NC 5.998 SF 0.455, 0, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA 43300 (MIC = 8 �M TO MBC = 16 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1520.937 DA MW 11AA RLLRRLRRLL R // ID AMRSAP1570 PN F6 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 45.45%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO R LO F BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1691.023 AI 0 II 113.236 HP -1.182 HM 0.611 IP 13.199 NC 5.998 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0.455 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA 43300 (MIC = 4 �M TO MBC = 8 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1691.023 DA MW 11AA RRFRFFFRFR R // ID AMRSAP1571 PN F6pf. SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 5, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 45.45%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, K, L, M, N, P, Q, S, T, V, W, Y MO R LO F BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1691.023 AI 0 II 113.236 HP -1.182 HM 1.247 IP 13.199 NC 5.998 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0.455 ME 0, 0 MS 36.120774 XX SC alpha XX TO MRSA 43300 (MIC = 4 �M TO MBC = 8 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1691.023 DA MW 11AA RFFRRFRRFF R // ID AMRSAP1572 PN I6 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 45.45%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, W, Y MO R LO I BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1520.937 AI 177.273 II 113.236 HP -0.409 HM 0.64 IP 13.199 NC 5.998 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1520.937 DA MW 11AA RRIRIIIRIR R // ID AMRSAP1573 PN I6pf. SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 5, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 45.45%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, K, L, M, N, P, Q, S, T, V, W, Y MO R LO I BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1520.937 AI 177.273 II 113.236 HP -0.409 HM 1.308 IP 13.199 NC 5.998 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA 43300 (MIC = 16 �M TO MBC = 16 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1520.937 DA MW 11AA RIIRRIRRII R // ID AMRSAP1574 PN W6 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 45.45%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO W BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1886.206 AI 0 II 269.455 HP -2.864 HM 0.554 IP 13.199 NC 5.998 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0.455 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 43300 (MIC = 4 �M TO MBC = 8 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1886.206 DA MW 11AA RRWRWWWRWR R // ID AMRSAP1575 PN W6pf. SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 0, 'V': 0, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 54.55%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 45.45%, 'Y': 0% MA A, C, D, E, F, G, H, I, K, L, M, N, P, Q, S, T, V, Y MO R LO W BA 5 LA 6 AA 0 BC 6 MC 0 MF 0 XX MM 1886.206 AI 0 II 269.455 HP -2.864 HM 1.125 IP 13.199 NC 5.998 SF 0.455, 0, 0 [Helix, Turn, Sheet] AR 0.455 ME 27500, 27500 MS 36.120774 XX SC alpha_beta XX TO MRSA 43300 (MIC = 4 �M TO MBC = 8 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1886.206 DA MW 11AA RWWRRWRRWW R // ID AMRSAP1576 PN FITC-I6 SO Synthetic construct PL 15 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 1, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 6, 'K': 0, 'L': 0, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 6, 'S': 0, 'T': 1, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 6.67%, 'D': 0%, 'E': 0%, 'F': 6.67%, 'G': 0%, 'H': 0%, 'I': 40%, 'K': 0%, 'L': 0%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 40%, 'S': 0%, 'T': 6.67%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, D, E, G, H, K, L, M, N, P, Q, S, V, W, Y MO I; R LO C, F, T BA 7 LA 8 AA 0 BC 6 MC 0 MF 0 XX MM 1985.517 AI 156 II 85.707 HP 0.307 HM 0.698 IP 12.801 NC 5.936 SF 0.467, 0, 0 [Helix, Turn, Sheet] AR 0.067 ME 0, 0 MS 36.120774 XX SC beta XX TO MRSA 43300 (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 29648811 XR CAMP R4: NA SQ SEQUENCE 1985.517 DA MW 15AA FITCRRIRII IRIRR // ID AMRSAP1577 PN R2PLx-22 SO Synthetic construct PL 22 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 2, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 4, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 13.64%, 'C': 0%, 'D': 9.09%, 'E': 0%, 'F': 0%, 'G': 9.09%, 'H': 0%, 'I': 4.55%, 'K': 18.18%, 'L': 18.18%, AF 'M': 4.55%, 'N': 9.09%, 'P': 0%, 'Q': 4.55%, 'R': 0%, 'S': 0%, 'T': 4.55%, 'V': 4.55%, 'W': 0%, 'Y': 0% MA C, E, F, H, P, R, S, W, Y MO K; L LO I, M, Q, T, V BA 12 LA 10 AA 2 BC 4 MC 0 MF 0 XX MM 2341.795 AI 115.455 II -14.032 HP -0.155 HM 0.636 IP 10.333 NC 1.998 SF 0.273, 0.182, 0.364 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (ATCC 12493) (MIC > 512 μM) XX XR PubMed: 30279210 XR CAMP R4: NA SQ SEQUENCE 2341.795 DA MW 22AA GIMDTVKNAA KNLAGQLLDK LK // ID AMRSAP1578 PN Melittin SO Apis mellifera PL 26 TX Animalia (Insects) PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 3, 'H': 0, 'I': 3, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 1, 'Q': 2, 'R': 2, 'S': 1, 'T': 2, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.69%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 11.54%, 'H': 0%, 'I': 11.54%, 'K': 11.54%, 'L': 15.38%, AF 'M': 0%, 'N': 0%, 'P': 3.85%, 'Q': 7.69%, 'R': 7.69%, 'S': 3.85%, 'T': 7.69%, 'V': 7.69%, 'W': 3.85%, 'Y': 0% MA C, D, E, F, H, M, N, Y MO L LO P, S, W BA 16 LA 10 AA 0 BC 5 MC 0 MF 0 XX MM 2847.487 AI 135 II 44.731 HP 0.273 HM 0.568 IP 12.546 NC 4.997 SF 0.385, 0.192, 0.231 [Helix, Turn, Sheet] AR 0.038 ME 5500, 5500 MS 30.100645 XX SC alpha_beta XX TO MRSA 3126 (MIC = 2 μM) XX XR PubMed: 30846839 XR CAMP R4: NA SQ SEQUENCE 2847.487 DA MW 26AA GIGAVLKVLT TGLPALISWI KRKRQQ // ID AMRSAP1579 PN Danalexin SO Rana catesbeiana (American bullfrog) PL 19 TX Animalia PE Experimentally validated XX AC 'A': 2, 'C': 2, 'D': 0, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 3, 'K': 3, 'L': 2, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 0, 'S': 0, 'T': 1, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 10.53%, 'C': 10.53%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 15.79%, 'K': 15.79%, 'L': 10.53%, AF 'M': 5.26%, 'N': 0%, 'P': 5.26%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 5.26%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA D, E, F, H, N, Q, R, S, W, Y MO I; K LO M, P, T BA 13 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 1958.553 AI 143.684 II 18.368 HP 1.326 HM 0.396 IP 9.668 NC 2.873 SF 0.368, 0.158, 0.263 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 18.060387 XX SC beta XX TO S. aureus NCTC 10442 MRSA (MIC = 3.8 μM) XX XR PubMed: 31426494 XR CAMP R4: NA SQ SEQUENCE 1958.553 DA MW 19AA LGGLIKIVPA MICAVTKKC // ID AMRSAP1580 PN DPH SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 2, 'F': 0, 'G': 1, 'H': 0, 'I': 1, 'K': 3, 'L': 4, AC 'M': 0, 'N': 4, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 17.39%, 'C': 0%, 'D': 0%, 'E': 8.7%, 'F': 0%, 'G': 4.35%, 'H': 0%, 'I': 4.35%, 'K': 13.04%, 'L': 17.39%, AF 'M': 0%, 'N': 17.39%, 'P': 0%, 'Q': 4.35%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 8.7%, 'W': 4.35%, 'Y': 0% MA C, D, F, H, M, P, R, S, T, Y MO A; L; N LO G, I, Q, W BA 13 LA 10 AA 2 BC 3 MC 0 MF 0 XX MM 2536.957 AI 127.391 II 20.852 HP -0.096 HM 0.659 IP 9.442 NC 1.001 SF 0.348, 0.217, 0.435 [Helix, Turn, Sheet] AR 0.043 ME 5500, 5500 MS 18.060387 XX SC beta XX TO MRSA NCTC 12493 (MIC > 512 μM TO MBC > 512 μM) XX XR PubMed: 31635388 XR CAMP R4: NA SQ SEQUENCE 2536.957 DA MW 23AA ALWKEVLKNA GKAALNEINN LVQ // ID AMRSAP1581 PN DCA1 SO Synthetic construct PL 28 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 2, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 5, 'L': 4, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 4, 'W': 1, 'Y': 0 AF 'A': 14.29%, 'C': 0%, 'D': 7.14%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 17.86%, 'L': 14.29%, AF 'M': 3.57%, 'N': 10.71%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 0%, 'T': 3.57%, 'V': 14.29%, 'W': 3.57%, 'Y': 0% MA C, E, F, H, I, P, R, S, Y MO K LO M, Q, T, W BA 16 LA 12 AA 2 BC 5 MC 0 MF 0 XX MM 3025.603 AI 111.429 II 5.671 HP -0.064 HM 0.711 IP 10.627 NC 2.997 SF 0.321, 0.179, 0.321 [Helix, Turn, Sheet] AR 0.036 ME 5500, 5500 MS 30.100645 XX SC beta XX TO MRSA NCTC 12493 (MIC = 8 μM TO MBC = 32 μM) XX XR PubMed: 31635388 XR CAMP R4: NA SQ SEQUENCE 3025.603 DA MW 28AA ALWKDLLKNV GKAAGKAVLN KVTDMVNQ // ID AMRSAP1582 PN DDU1 SO Synthetic construct PL 28 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 2, 'H': 0, 'I': 0, 'K': 4, 'L': 4, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 1, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 21.43%, 'C': 0%, 'D': 3.57%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 0%, 'I': 0%, 'K': 14.29%, 'L': 14.29%, AF 'M': 3.57%, 'N': 10.71%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 3.57%, 'T': 3.57%, 'V': 10.71%, 'W': 3.57%, 'Y': 0% MA C, E, F, H, I, P, R, Y MO A LO D, M, Q, S, T, W BA 17 LA 11 AA 1 BC 4 MC 0 MF 0 XX MM 2912.443 AI 108.214 II 0.246 HP 0.15 HM 0.659 IP 10.803 NC 2.997 SF 0.286, 0.214, 0.393 [Helix, Turn, Sheet] AR 0.036 ME 5500, 5500 MS 24.080516 XX SC beta XX TO MRSA NCTC 12493 (MIC = 4 μM TO MBC = 16 μM) XX XR PubMed: 31635388 XR CAMP R4: NA SQ SEQUENCE 2912.443 DA MW 28AA ALWKSLLKNV GKAAGKAALN AVTDMVNQ // ID AMRSAP1583 PN DPS4 SO Synthetic construct PL 28 TX Synthetic construct PE Experimentally validated XX AC 'A': 6, 'C': 0, 'D': 1, 'E': 0, 'F': 0, 'G': 2, 'H': 1, 'I': 0, 'K': 4, 'L': 4, AC 'M': 1, 'N': 2, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 2, 'V': 3, 'W': 1, 'Y': 0 AF 'A': 21.43%, 'C': 0%, 'D': 3.57%, 'E': 0%, 'F': 0%, 'G': 7.14%, 'H': 3.57%, 'I': 0%, 'K': 14.29%, 'L': 14.29%, AF 'M': 3.57%, 'N': 7.14%, 'P': 0%, 'Q': 3.57%, 'R': 0%, 'S': 0%, 'T': 7.14%, 'V': 10.71%, 'W': 3.57%, 'Y': 0% MA C, E, F, I, P, R, S, Y MO A LO D, H, M, Q, W BA 17 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 2949.508 AI 108.214 II 0.246 HP 0.164 HM 0.645 IP 10.803 NC 3.088 SF 0.286, 0.143, 0.393 [Helix, Turn, Sheet] AR 0.036 ME 5500, 5500 MS 24.080516 XX SC beta XX TO MRSA NCTC 12493 (MIC = 8 μM) XX XR PubMed: 31635388 XR CAMP R4: NA SQ SEQUENCE 2949.508 DA MW 28AA ALWKTLLKHV GKAAGKAALN AVTDMVNQ // ID AMRSAP1584 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus ATCC 33591 (MRSA) (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAP1585 PN Nisin SO Lactococcus lactis subsp. PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO Staphylococcus aureus ATCC 43300 (MRSA) (MIC = 8 μM) XX XR PubMed: 33427970 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK // ID AMRSAP1586 PN Am2HR SO Synthetic construct PL 32 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 1, 'E': 1, 'F': 0, 'G': 1, 'H': 2, 'I': 3, 'K': 2, 'L': 0, AC 'M': 0, 'N': 2, 'P': 2, 'Q': 0, 'R': 5, 'S': 1, 'T': 2, 'V': 1, 'W': 1, 'Y': 1 AF 'A': 3.13%, 'C': 18.75%, 'D': 3.13%, 'E': 3.13%, 'F': 0%, 'G': 3.13%, 'H': 6.25%, 'I': 9.38%, 'K': 6.25%, 'L': 0%, AF 'M': 0%, 'N': 6.25%, 'P': 6.25%, 'Q': 0%, 'R': 15.63%, 'S': 3.13%, 'T': 6.25%, 'V': 3.13%, 'W': 3.13%, 'Y': 3.13% MA F, L, M, Q MO C LO A, D, E, G, S, V, W, Y BA 9 LA 23 AA 2 BC 9 MC 0 MF 0 XX MM 3820.48 AI 48.75 II 33.156 HP -0.756 HM 0.618 IP 8.89 NC 4.809 SF 0.188, 0.188, 0.063 [Helix, Turn, Sheet] AR 0.063 ME 6990, 7365 MS 42.140903 XX SC beta XX TO MRSA SAP0017 (MIC > 64 μG/mL) XX XR PubMed: 33865931 XR CAMP R4: NA SQ SEQUENCE 3820.48 DA MW 32AA HCKRNDRNCR HTPCKPAERI IGWCISTYVC CR // ID AMRSAP1587 PN Am11RR SO Synthetic construct PL 30 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 1, 'F': 1, 'G': 4, 'H': 1, 'I': 2, 'K': 4, 'L': 2, AC 'M': 0, 'N': 0, 'P': 2, 'Q': 1, 'R': 4, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 20%, 'D': 0%, 'E': 3.33%, 'F': 3.33%, 'G': 13.33%, 'H': 3.33%, 'I': 6.67%, 'K': 13.33%, 'L': 6.67%, AF 'M': 0%, 'N': 0%, 'P': 6.67%, 'Q': 3.33%, 'R': 13.33%, 'S': 0%, 'T': 3.33%, 'V': 3.33%, 'W': 0%, 'Y': 0% MA A, D, M, N, S, W, Y MO C LO E, F, H, Q, T, V BA 12 LA 18 AA 1 BC 9 MC 0 MF 0 XX MM 3391.175 AI 61.667 II 11.503 HP -0.357 HM 0.422 IP 9.783 NC 6.718 SF 0.2, 0.2, 0.1 [Helix, Turn, Sheet] AR 0.033 ME 0, 375 MS 48.161032 XX SC beta XX TO MRSA SAP0017 (MIC = 32 μG/mL) XX XR PubMed: 33865931 XR CAMP R4: NA SQ SEQUENCE 3391.175 DA MW 30AA RCRKGLFCRP KCGQKEHVIG TCPKGLICCR // ID AMRSAP1588 PN Am17RV SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 1, 'F': 0, 'G': 3, 'H': 3, 'I': 2, 'K': 1, 'L': 5, AC 'M': 0, 'N': 3, 'P': 0, 'Q': 0, 'R': 5, 'S': 1, 'T': 1, 'V': 2, 'W': 0, 'Y': 1 AF 'A': 0%, 'C': 17.65%, 'D': 0%, 'E': 2.94%, 'F': 0%, 'G': 8.82%, 'H': 8.82%, 'I': 5.88%, 'K': 2.94%, 'L': 14.71%, AF 'M': 0%, 'N': 8.82%, 'P': 0%, 'Q': 0%, 'R': 14.71%, 'S': 2.94%, 'T': 2.94%, 'V': 5.88%, 'W': 0%, 'Y': 2.94% MA A, D, F, M, P, Q, W MO C LO E, K, S, T, Y BA 12 LA 22 AA 1 BC 9 MC 0 MF 0 XX MM 3941.706 AI 97.353 II 31.641 HP -0.076 HM 0.783 IP 8.895 NC 4.899 SF 0.294, 0.206, 0.176 [Helix, Turn, Sheet] AR 0.029 ME 1490, 1865 MS 36.120774 XX SC alpha XX TO MRSA SAP0017 (MIC = 64 μG/mL) XX XR PubMed: 33865931 XR CAMP R4: NA SQ SEQUENCE 3941.706 DA MW 34AA RCINLLNGVC RHTLCHSLEK YIGRCHRGLR NCCV // ID AMRSAP1589 PN Am23SK SO Synthetic construct PL 34 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 6, 'D': 0, 'E': 1, 'F': 3, 'G': 3, 'H': 1, 'I': 1, 'K': 2, 'L': 2, AC 'M': 0, 'N': 1, 'P': 1, 'Q': 0, 'R': 5, 'S': 3, 'T': 0, 'V': 1, 'W': 2, 'Y': 1 AF 'A': 2.94%, 'C': 17.65%, 'D': 0%, 'E': 2.94%, 'F': 8.82%, 'G': 8.82%, 'H': 2.94%, 'I': 2.94%, 'K': 5.88%, 'L': 5.88%, AF 'M': 0%, 'N': 2.94%, 'P': 2.94%, 'Q': 0%, 'R': 14.71%, 'S': 8.82%, 'T': 0%, 'V': 2.94%, 'W': 5.88%, 'Y': 2.94% MA D, M, Q, T MO C LO A, E, H, I, N, P, V, Y BA 14 LA 20 AA 1 BC 8 MC 0 MF 0 XX MM 4070.823 AI 45.882 II 51.797 HP -0.215 HM 0.412 IP 9.214 NC 5.717 SF 0.294, 0.235, 0.118 [Helix, Turn, Sheet] AR 0.176 ME 12490, 12865 MS 42.140903 XX SC beta XX TO MRSA SAP0017 (MIC = 16 μG/mL) XX XR PubMed: 33865931 XR CAMP R4: NA SQ SEQUENCE 4070.823 DA MW 34AA SCRFSGGYCI WNWERCRSGH FLVALCPFRK RCCK // ID AMRSAP1590 PN Cp13QK SO Synthetic construct PL 32 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 6, 'D': 0, 'E': 1, 'F': 1, 'G': 4, 'H': 5, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 4, 'P': 0, 'Q': 3, 'R': 4, 'S': 0, 'T': 0, 'V': 0, 'W': 1, 'Y': 0 AF 'A': 0%, 'C': 18.75%, 'D': 0%, 'E': 3.13%, 'F': 3.13%, 'G': 12.5%, 'H': 15.63%, 'I': 3.13%, 'K': 3.13%, 'L': 3.13%, AF 'M': 0%, 'N': 12.5%, 'P': 0%, 'Q': 9.38%, 'R': 12.5%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 3.13%, 'Y': 0% MA A, D, M, P, S, T, V, Y MO C LO E, F, I, K, L, W BA 8 LA 24 AA 1 BC 10 MC 0 MF 0 XX MM 3833.317 AI 24.375 II 24.038 HP -1.322 HM 0.545 IP 8.646 NC 4.082 SF 0.125, 0.25, 0.063 [Helix, Turn, Sheet] AR 0.063 ME 5500, 5875 MS 30.100645 XX SC beta XX TO MRSA SAP0017 (MIC > 64 μG/mL) XX XR PubMed: 33865931 XR CAMP R4: NA SQ SEQUENCE 3833.317 DA MW 32AA QCRNNHGHCR RLC3FHGEQW IGNCNGRHQH CCK // ID AMRSAP1591 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA ATCC 33591 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1592 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 48 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1593 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 54 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1594 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 936 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1595 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 52 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1596 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 74 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1597 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 23 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1598 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 75 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1599 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 113 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1600 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 51 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1601 PN Feleucin-K3 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 11.11%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 33.33%, 'L': 55.56%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F BA 6 LA 3 AA 0 BC 3 MC 0 MF 0 XX MM 1115.511 AI 216.667 II -28.844 HP 1.122 HM 0.803 IP 11.103 NC 2.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 71 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1115.511 DA MW 9AA FLKLLKKLL // ID AMRSAP1602 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA ATCC 33591 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1603 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 48 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1604 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 54 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1605 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 936 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1606 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 52 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1607 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 74 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1608 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 23 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1609 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 75 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1610 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 113 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1611 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 51 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1612 PN Feleucin-K65 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, F, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 968.335 AI 216.667 II -28.844 HP 0.811 HM 0.679 IP 11.103 NC 2.997 SF 0.556, 0, 0.556 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA 71 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 968.335 DA MW 9AA XLKLLKKLL // ID AMRSAP1613 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1614 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 48 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1615 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 54 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1616 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 936 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1617 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 52 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1618 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 74 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1619 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 23 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1620 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 75 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1621 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 113 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1622 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 51 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1623 PN Feleucin-K67 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.793 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 71 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FXKLLKKLL // ID AMRSAP1624 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1625 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 48 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1626 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 54 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1627 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 936 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1628 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 52 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1629 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 74 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1630 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 23 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1631 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 75 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1632 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 113 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1633 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 51 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1634 PN Feleucin-K68 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.694 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 71 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLXKKLL // ID AMRSAP1635 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1636 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 48 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1637 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 54 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1638 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 936 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1639 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 52 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1640 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 74 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1641 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 23 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1642 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 75 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1643 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 113 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1644 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 51 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1645 PN Feleucin-K69 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -19.411 HP 0.7 HM 0.715 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 71 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKXL // ID AMRSAP1646 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1647 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 48 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1648 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 54 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1649 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 936 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1650 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 52 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1651 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 74 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1652 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 23 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1653 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 75 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1654 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 113 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1655 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 51 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1656 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA 71 (MIC = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1657 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1658 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 48 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1659 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 54 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1660 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 936 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1661 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 52 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1662 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 74 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1663 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 23 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1664 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 75 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1665 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 113 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1666 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 51 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1667 PN Feleucin-K71 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 25%, 'L': 62.5%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 6 LA 2 AA 0 BC 2 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 987.337 AI 216.667 II -19.411 HP 1.556 HM 0.731 IP 10.805 NC 1.997 SF 0.667, 0, 0.556 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA 71 (MIC = 4 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 987.337 DA MW 9AA FLKLLXKLL // ID AMRSAP1668 PN Feleucin-K70 SO Synthetic construct PL 9 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 0, 'H': 0, 'I': 0, 'K': 3, 'L': 4, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 0, 'W': 0, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 37.5%, 'L': 50%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 0%, 'W': 0%, 'Y': 0% MA A, C, D, E, G, H, I, M, N, P, Q, R, S, T, V, W, Y MO L LO F, X BA 5 LA 3 AA 0 BC 3 MC {'X': 1} MF {'X': 0.1111111111111111} XX MM 1002.352 AI 173.333 II -28.844 HP 0.7 HM 0.753 IP 11.103 NC 2.997 SF 0.556, 0, 0.444 [Helix, Turn, Sheet] AR 0.111 ME 0, 0 MS 18.060387 XX SC alpha XX TO MRSA ATCC 33591 (MIC = 8 �G/mL TO MBIC50 = 4 �G/mL TO MBIC90 = 8 �G/mL) XX XR PubMed: 34069651 XR CAMP R4: NA SQ SEQUENCE 1002.352 DA MW 9AA FLKLLKKLX // ID AMRSAP1669 PN PinA SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 0, 'C': 0, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 0, 'K': 3, 'L': 0, AC 'M': 1, 'N': 0, 'P': 1, 'Q': 0, 'R': 1, 'S': 0, 'T': 2, 'V': 1, 'W': 5, 'Y': 0 AF 'A': 0%, 'C': 0%, 'D': 5.56%, 'E': 0%, 'F': 5.56%, 'G': 11.11%, 'H': 0%, 'I': 0%, 'K': 16.67%, 'L': 0%, AF 'M': 5.56%, 'N': 0%, 'P': 5.56%, 'Q': 0%, 'R': 5.56%, 'S': 0%, 'T': 11.11%, 'V': 5.56%, 'W': 27.78%, 'Y': 0% MA A, C, E, H, I, L, N, Q, S, Y MO W LO D, F, M, P, R, V BA 11 LA 7 AA 1 BC 4 MC 0 MF 0 XX MM 2395.812 AI 16.111 II 47.55 HP -1.061 HM 0.502 IP 11.08 NC 2.998 SF 0.389, 0.167, 0.056 [Helix, Turn, Sheet] AR 0.333 ME 27500, 27500 MS 24.080516 XX SC alpha_beta XX TO MRSA (MIC = 256 μG/mL) XX XR PubMed: 34276635 XR CAMP R4: NA SQ SEQUENCE 2395.812 DA MW 18AA TMKDFPVTWR WWKWWKGG // ID AMRSAP1670 PN tB2U-μ SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 5.26%, 'E': 5.26%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 10.53%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.53%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, F, H, M, N, P, Q, R, S, W, Y MO A LO D, E BA 13 LA 6 AA 2 BC 2 MC 0 MF 0 XX MM 1883.259 AI 154.211 II -11.842 HP 1 HM 0.549 IP 6.493 NC -0 SF 0.368, 0.105, 0.421 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: NA SQ SEQUENCE 1883.259 DA MW 19AA GVIIDTLKGA AKTVAAELL // ID AMRSAP1671 PN tB2U-μ SO Synthetic construct PL 19 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 1, 'E': 1, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 2, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 2, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 21.05%, 'C': 0%, 'D': 5.26%, 'E': 5.26%, 'F': 0%, 'G': 10.53%, 'H': 0%, 'I': 10.53%, 'K': 10.53%, 'L': 15.79%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 10.53%, 'V': 10.53%, 'W': 0%, 'Y': 0% MA C, F, H, M, N, P, Q, R, S, W, Y MO A LO D, E BA 13 LA 6 AA 2 BC 2 MC 0 MF 0 XX MM 1883.259 AI 154.211 II -11.842 HP 1 HM 0.549 IP 6.493 NC -0 SF 0.368, 0.105, 0.421 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 12.040258 XX SC beta XX TO MRSA (B042 V2E1 A) (MIC > 512 μM) XX XR PubMed: 34438945 XR CAMP R4: NA SQ SEQUENCE 1883.259 DA MW 19AA GVIIDTLKGA AKTVAAELL // ID AMRSAP1672 PN GV30 SO Synthetic construct PL 30 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 6.67%, 'D': 3.33%, 'E': 0%, 'F': 3.33%, 'G': 6.67%, 'H': 0%, 'I': 3.33%, 'K': 20%, 'L': 13.33%, AF 'M': 0%, 'N': 3.33%, 'P': 0%, 'Q': 3.33%, 'R': 3.33%, 'S': 3.33%, 'T': 3.33%, 'V': 10%, 'W': 0%, 'Y': 0% MA E, H, M, P, W, Y MO K LO D, F, I, N, Q, R, S, T BA 16 LA 14 AA 1 BC 7 MC 0 MF 0 XX MM 3174.901 AI 110.667 II 6.383 HP 0.28 HM 0.597 IP 10.799 NC 5.873 SF 0.3, 0.133, 0.3 [Helix, Turn, Sheet] AR 0.033 ME 0, 125 MS 42.140903 XX SC beta XX TO MRSA (NCTC 12493) (MIC = 2 �M TO MBC = 4 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 3174.901 DA MW 30AA GVIFNALKGV AKTVAAQLLK KARCKLDKSC // ID AMRSAP1673 PN GV23 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 21.74%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.35%, 'G': 8.7%, 'H': 0%, 'I': 4.35%, 'K': 17.39%, 'L': 13.04%, AF 'M': 0%, 'N': 4.35%, 'P': 0%, 'Q': 4.35%, 'R': 4.35%, 'S': 0%, 'T': 4.35%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, S, W, Y MO A LO F, I, N, Q, R, T BA 15 LA 8 AA 0 BC 5 MC 0 MF 0 XX MM 2396.949 AI 127.391 II -1.509 HP 0.509 HM 0.597 IP 11.997 NC 4.997 SF 0.348, 0.13, 0.348 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA (NCTC 12493) (MIC = 2 �M TO MBC = 2 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2396.949 DA MW 23AA GVIFNALKGV AKTVAAQLLK KAR // ID AMRSAP1674 PN GV21 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 19.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 19.05%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 4.76%, 'R': 0%, 'S': 0%, 'T': 4.76%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A; K LO F, I, N, Q, T BA 14 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2169.682 AI 134.762 II -2.605 HP 0.686 HM 0.597 IP 11.278 NC 3.997 SF 0.381, 0.143, 0.333 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (NCTC 12493) (MIC = 4 �M TO MBC = 4 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2169.682 DA MW 21AA GVIFNALKGV AKTVAAQLLK K // ID AMRSAP1675 PN GV20 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 15%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 5%, 'R': 0%, 'S': 0%, 'T': 5%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A LO F, I, N, Q, T BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2041.508 AI 141.5 II -3.235 HP 0.915 HM 0.597 IP 11.103 NC 2.997 SF 0.4, 0.15, 0.35 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (NCTC 12493) (MIC = 8 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2041.508 DA MW 20AA GVIFNALKGV AKTVAAQLLK // ID AMRSAP1676 PN GV12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 16.67%, 'H': 0%, 'I': 8.33%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 8.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; G; K; V LO F, I, L, N BA 9 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1216.489 AI 130 II -4.983 HP 0.917 HM 0.582 IP 10.805 NC 1.997 SF 0.417, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (NCTC 12493) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1216.489 DA MW 12AA GVIFNALKGV AK // ID AMRSAP1677 PN GV8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 12.5%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; F; G; I; K; L; N; V LO A, F, G, I, K, L, N, V BA 6 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 861.052 AI 146.25 II -1.863 HP 1.163 HM 0.444 IP 9.7 NC 0.998 SF 0.5, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (NCTC 12493) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 861.052 DA MW 8AA GVIFNALK // ID AMRSAP1678 PN GV18 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 11.11%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA E, F, G, H, I, M, N, P, W, Y MO K LO D, Q, R, S, T, V BA 7 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 1976.427 AI 97.778 II 13.406 HP -0.144 HM 0.496 IP 10.345 NC 3.873 SF 0.222, 0.056, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA (NCTC 12493) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1976.427 DA MW 18AA TVAAQLLKKA RCKLDKSC // ID AMRSAP1679 PN GV11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 9.09%, 'S': 0%, 'T': 9.09%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, S, W, Y MO A LO Q, R, T, V BA 6 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1198.475 AI 124.545 II 1.373 HP 0.064 HM 0.485 IP 11.823 NC 2.997 SF 0.273, 0, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (NCTC 12493) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1198.475 DA MW 11AA TVAAQLLKKA R // ID AMRSAP1680 PN GV30 SO Synthetic construct PL 30 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 6.67%, 'D': 3.33%, 'E': 0%, 'F': 3.33%, 'G': 6.67%, 'H': 0%, 'I': 3.33%, 'K': 20%, 'L': 13.33%, AF 'M': 0%, 'N': 3.33%, 'P': 0%, 'Q': 3.33%, 'R': 3.33%, 'S': 3.33%, 'T': 3.33%, 'V': 10%, 'W': 0%, 'Y': 0% MA E, H, M, P, W, Y MO K LO D, F, I, N, Q, R, S, T BA 16 LA 14 AA 1 BC 7 MC 0 MF 0 XX MM 3174.901 AI 110.667 II 6.383 HP 0.28 HM 0.597 IP 10.799 NC 5.873 SF 0.3, 0.133, 0.3 [Helix, Turn, Sheet] AR 0.033 ME 0, 125 MS 42.140903 XX SC beta XX TO MRSA (BO38 V1S1 A) (MIC = 2 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 3174.901 DA MW 30AA GVIFNALKGV AKTVAAQLLK KARCKLDKSC // ID AMRSAP1681 PN GV23 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 21.74%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.35%, 'G': 8.7%, 'H': 0%, 'I': 4.35%, 'K': 17.39%, 'L': 13.04%, AF 'M': 0%, 'N': 4.35%, 'P': 0%, 'Q': 4.35%, 'R': 4.35%, 'S': 0%, 'T': 4.35%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, S, W, Y MO A LO F, I, N, Q, R, T BA 15 LA 8 AA 0 BC 5 MC 0 MF 0 XX MM 2396.949 AI 127.391 II -1.509 HP 0.509 HM 0.597 IP 11.997 NC 4.997 SF 0.348, 0.13, 0.348 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA (BO38 V1S1 A) (MIC = 2 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2396.949 DA MW 23AA GVIFNALKGV AKTVAAQLLK KAR // ID AMRSAP1682 PN GV21 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 19.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 19.05%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 4.76%, 'R': 0%, 'S': 0%, 'T': 4.76%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A; K LO F, I, N, Q, T BA 14 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2169.682 AI 134.762 II -2.605 HP 0.686 HM 0.597 IP 11.278 NC 3.997 SF 0.381, 0.143, 0.333 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (BO38 V1S1 A) (MIC = 8 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2169.682 DA MW 21AA GVIFNALKGV AKTVAAQLLK K // ID AMRSAP1683 PN GV20 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 15%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 5%, 'R': 0%, 'S': 0%, 'T': 5%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A LO F, I, N, Q, T BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2041.508 AI 141.5 II -3.235 HP 0.915 HM 0.597 IP 11.103 NC 2.997 SF 0.4, 0.15, 0.35 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (BO38 V1S1 A) (MIC = 16 �M TO MBC = 32 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2041.508 DA MW 20AA GVIFNALKGV AKTVAAQLLK // ID AMRSAP1684 PN GV12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 16.67%, 'H': 0%, 'I': 8.33%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 8.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; G; K; V LO F, I, L, N BA 9 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1216.489 AI 130 II -4.983 HP 0.917 HM 0.582 IP 10.805 NC 1.997 SF 0.417, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (BO38 V1S1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1216.489 DA MW 12AA GVIFNALKGV AK // ID AMRSAP1685 PN GV8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 12.5%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; F; G; I; K; L; N; V LO A, F, G, I, K, L, N, V BA 6 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 861.052 AI 146.25 II -1.863 HP 1.163 HM 0.444 IP 9.7 NC 0.998 SF 0.5, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (BO38 V1S1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 861.052 DA MW 8AA GVIFNALK // ID AMRSAP1686 PN GV18 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 11.11%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA E, F, G, H, I, M, N, P, W, Y MO K LO D, Q, R, S, T, V BA 7 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 1976.427 AI 97.778 II 13.406 HP -0.144 HM 0.496 IP 10.345 NC 3.873 SF 0.222, 0.056, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA (BO38 V1S1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1976.427 DA MW 18AA TVAAQLLKKA RCKLDKSC // ID AMRSAP1687 PN GV11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 9.09%, 'S': 0%, 'T': 9.09%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, S, W, Y MO A LO Q, R, T, V BA 6 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1198.475 AI 124.545 II 1.373 HP 0.064 HM 0.485 IP 11.823 NC 2.997 SF 0.273, 0, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (BO38 V1S1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1198.475 DA MW 11AA TVAAQLLKKA R // ID AMRSAP1688 PN GV30 SO Synthetic construct PL 30 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 6.67%, 'D': 3.33%, 'E': 0%, 'F': 3.33%, 'G': 6.67%, 'H': 0%, 'I': 3.33%, 'K': 20%, 'L': 13.33%, AF 'M': 0%, 'N': 3.33%, 'P': 0%, 'Q': 3.33%, 'R': 3.33%, 'S': 3.33%, 'T': 3.33%, 'V': 10%, 'W': 0%, 'Y': 0% MA E, H, M, P, W, Y MO K LO D, F, I, N, Q, R, S, T BA 16 LA 14 AA 1 BC 7 MC 0 MF 0 XX MM 3174.901 AI 110.667 II 6.383 HP 0.28 HM 0.597 IP 10.799 NC 5.873 SF 0.3, 0.133, 0.3 [Helix, Turn, Sheet] AR 0.033 ME 0, 125 MS 42.140903 XX SC beta XX TO MRSA (BO42 V2E1 A) (MIC = 4 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 3174.901 DA MW 30AA GVIFNALKGV AKTVAAQLLK KARCKLDKSC // ID AMRSAP1689 PN GV23 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 21.74%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.35%, 'G': 8.7%, 'H': 0%, 'I': 4.35%, 'K': 17.39%, 'L': 13.04%, AF 'M': 0%, 'N': 4.35%, 'P': 0%, 'Q': 4.35%, 'R': 4.35%, 'S': 0%, 'T': 4.35%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, S, W, Y MO A LO F, I, N, Q, R, T BA 15 LA 8 AA 0 BC 5 MC 0 MF 0 XX MM 2396.949 AI 127.391 II -1.509 HP 0.509 HM 0.597 IP 11.997 NC 4.997 SF 0.348, 0.13, 0.348 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA (BO42 V2E1 A) (MIC = 8 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2396.949 DA MW 23AA GVIFNALKGV AKTVAAQLLK KAR // ID AMRSAP1690 PN GV21 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 19.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 19.05%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 4.76%, 'R': 0%, 'S': 0%, 'T': 4.76%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A; K LO F, I, N, Q, T BA 14 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2169.682 AI 134.762 II -2.605 HP 0.686 HM 0.597 IP 11.278 NC 3.997 SF 0.381, 0.143, 0.333 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (BO42 V2E1 A) (MIC = 8 �M TO MBC = 16 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2169.682 DA MW 21AA GVIFNALKGV AKTVAAQLLK K // ID AMRSAP1691 PN GV20 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 15%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 5%, 'R': 0%, 'S': 0%, 'T': 5%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A LO F, I, N, Q, T BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2041.508 AI 141.5 II -3.235 HP 0.915 HM 0.597 IP 11.103 NC 2.997 SF 0.4, 0.15, 0.35 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (BO42 V2E1 A) (MIC = 32 �M TO MBC = 64 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2041.508 DA MW 20AA GVIFNALKGV AKTVAAQLLK // ID AMRSAP1692 PN GV12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 16.67%, 'H': 0%, 'I': 8.33%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 8.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; G; K; V LO F, I, L, N BA 9 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1216.489 AI 130 II -4.983 HP 0.917 HM 0.582 IP 10.805 NC 1.997 SF 0.417, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (BO42 V2E1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1216.489 DA MW 12AA GVIFNALKGV AK // ID AMRSAP1693 PN GV8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 12.5%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; F; G; I; K; L; N; V LO A, F, G, I, K, L, N, V BA 6 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 861.052 AI 146.25 II -1.863 HP 1.163 HM 0.444 IP 9.7 NC 0.998 SF 0.5, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (BO42 V2E1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 861.052 DA MW 8AA GVIFNALK // ID AMRSAP1694 PN GV18 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 11.11%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA E, F, G, H, I, M, N, P, W, Y MO K LO D, Q, R, S, T, V BA 7 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 1976.427 AI 97.778 II 13.406 HP -0.144 HM 0.496 IP 10.345 NC 3.873 SF 0.222, 0.056, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA (BO42 V2E1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1976.427 DA MW 18AA TVAAQLLKKA RCKLDKSC // ID AMRSAP1695 PN GV11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 9.09%, 'S': 0%, 'T': 9.09%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, S, W, Y MO A LO Q, R, T, V BA 6 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1198.475 AI 124.545 II 1.373 HP 0.064 HM 0.485 IP 11.823 NC 2.997 SF 0.273, 0, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (BO42 V2E1 A) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1198.475 DA MW 11AA TVAAQLLKKA R // ID AMRSAP1696 PN GV30 SO Synthetic construct PL 30 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 2, 'D': 1, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 6, 'L': 4, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 6.67%, 'D': 3.33%, 'E': 0%, 'F': 3.33%, 'G': 6.67%, 'H': 0%, 'I': 3.33%, 'K': 20%, 'L': 13.33%, AF 'M': 0%, 'N': 3.33%, 'P': 0%, 'Q': 3.33%, 'R': 3.33%, 'S': 3.33%, 'T': 3.33%, 'V': 10%, 'W': 0%, 'Y': 0% MA E, H, M, P, W, Y MO K LO D, F, I, N, Q, R, S, T BA 16 LA 14 AA 1 BC 7 MC 0 MF 0 XX MM 3174.901 AI 110.667 II 6.383 HP 0.28 HM 0.597 IP 10.799 NC 5.873 SF 0.3, 0.133, 0.3 [Helix, Turn, Sheet] AR 0.033 ME 0, 125 MS 42.140903 XX SC beta XX TO MRSA (ATCC BAA 1707) (MIC = 8 �M TO MBC = 16 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 3174.901 DA MW 30AA GVIFNALKGV AKTVAAQLLK KARCKLDKSC // ID AMRSAP1697 PN GV23 SO Synthetic construct PL 23 TX Synthetic construct PE Experimentally validated XX AC 'A': 5, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 21.74%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.35%, 'G': 8.7%, 'H': 0%, 'I': 4.35%, 'K': 17.39%, 'L': 13.04%, AF 'M': 0%, 'N': 4.35%, 'P': 0%, 'Q': 4.35%, 'R': 4.35%, 'S': 0%, 'T': 4.35%, 'V': 13.04%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, S, W, Y MO A LO F, I, N, Q, R, T BA 15 LA 8 AA 0 BC 5 MC 0 MF 0 XX MM 2396.949 AI 127.391 II -1.509 HP 0.509 HM 0.597 IP 11.997 NC 4.997 SF 0.348, 0.13, 0.348 [Helix, Turn, Sheet] AR 0.043 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA (ATCC BAA 1707) (MIC = 8 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2396.949 DA MW 23AA GVIFNALKGV AKTVAAQLLK KAR // ID AMRSAP1698 PN GV21 SO Synthetic construct PL 21 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 4, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 19.05%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 4.76%, 'G': 9.52%, 'H': 0%, 'I': 4.76%, 'K': 19.05%, 'L': 14.29%, AF 'M': 0%, 'N': 4.76%, 'P': 0%, 'Q': 4.76%, 'R': 0%, 'S': 0%, 'T': 4.76%, 'V': 14.29%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A; K LO F, I, N, Q, T BA 14 LA 7 AA 0 BC 4 MC 0 MF 0 XX MM 2169.682 AI 134.762 II -2.605 HP 0.686 HM 0.597 IP 11.278 NC 3.997 SF 0.381, 0.143, 0.333 [Helix, Turn, Sheet] AR 0.048 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (ATCC BAA 1707) (MIC = 4 �M TO MBC = 8 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2169.682 DA MW 21AA GVIFNALKGV AKTVAAQLLK K // ID AMRSAP1699 PN GV20 SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 4, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 3, 'L': 3, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 1, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 20%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 5%, 'K': 15%, 'L': 15%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 5%, 'R': 0%, 'S': 0%, 'T': 5%, 'V': 15%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, R, S, W, Y MO A LO F, I, N, Q, T BA 14 LA 6 AA 0 BC 3 MC 0 MF 0 XX MM 2041.508 AI 141.5 II -3.235 HP 0.915 HM 0.597 IP 11.103 NC 2.997 SF 0.4, 0.15, 0.35 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (ATCC BAA 1707) (MIC = 16 �M TO MBC = 32 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 2041.508 DA MW 20AA GVIFNALKGV AKTVAAQLLK // ID AMRSAP1700 PN GV12 SO Synthetic construct PL 12 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 1, 'K': 2, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 8.33%, 'G': 16.67%, 'H': 0%, 'I': 8.33%, 'K': 16.67%, 'L': 8.33%, AF 'M': 0%, 'N': 8.33%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 16.67%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; G; K; V LO F, I, L, N BA 9 LA 3 AA 0 BC 2 MC 0 MF 0 XX MM 1216.489 AI 130 II -4.983 HP 0.917 HM 0.582 IP 10.805 NC 1.997 SF 0.417, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.083 ME 0, 0 MS 12.040258 XX SC alpha XX TO MRSA (ATCC BAA 1707) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1216.489 DA MW 12AA GVIFNALKGV AK // ID AMRSAP1701 PN GV8 SO Synthetic construct PL 8 TX Synthetic construct PE Experimentally validated XX AC 'A': 1, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 1, 'H': 0, 'I': 1, 'K': 1, 'L': 1, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 0, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 12.5%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 12.5%, 'G': 12.5%, 'H': 0%, 'I': 12.5%, 'K': 12.5%, 'L': 12.5%, AF 'M': 0%, 'N': 12.5%, 'P': 0%, 'Q': 0%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 12.5%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, P, Q, R, S, T, W, Y MO A; F; G; I; K; L; N; V LO A, F, G, I, K, L, N, V BA 6 LA 2 AA 0 BC 1 MC 0 MF 0 XX MM 861.052 AI 146.25 II -1.863 HP 1.163 HM 0.444 IP 9.7 NC 0.998 SF 0.5, 0.25, 0.25 [Helix, Turn, Sheet] AR 0.125 ME 0, 0 MS 6.020129 XX SC alpha XX TO MRSA (ATCC BAA 1707) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 861.052 DA MW 8AA GVIFNALK // ID AMRSAP1702 PN GV18 SO Synthetic construct PL 18 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 2, 'D': 1, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 4, 'L': 3, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 1, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 16.67%, 'C': 11.11%, 'D': 5.56%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 22.22%, 'L': 16.67%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5.56%, 'R': 5.56%, 'S': 5.56%, 'T': 5.56%, 'V': 5.56%, 'W': 0%, 'Y': 0% MA E, F, G, H, I, M, N, P, W, Y MO K LO D, Q, R, S, T, V BA 7 LA 11 AA 1 BC 5 MC 0 MF 0 XX MM 1976.427 AI 97.778 II 13.406 HP -0.144 HM 0.496 IP 10.345 NC 3.873 SF 0.222, 0.056, 0.333 [Helix, Turn, Sheet] AR 0 ME 0, 125 MS 30.100645 XX SC beta XX TO MRSA (ATCC BAA 1707) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1976.427 DA MW 18AA TVAAQLLKKA RCKLDKSC // ID AMRSAP1703 PN GV11 SO Synthetic construct PL 11 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 0, 'G': 0, 'H': 0, 'I': 0, 'K': 2, 'L': 2, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 1, 'S': 0, 'T': 1, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 27.27%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 0%, 'G': 0%, 'H': 0%, 'I': 0%, 'K': 18.18%, 'L': 18.18%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 9.09%, 'R': 9.09%, 'S': 0%, 'T': 9.09%, 'V': 9.09%, 'W': 0%, 'Y': 0% MA C, D, E, F, G, H, I, M, N, P, S, W, Y MO A LO Q, R, T, V BA 6 LA 5 AA 0 BC 3 MC 0 MF 0 XX MM 1198.475 AI 124.545 II 1.373 HP 0.064 HM 0.485 IP 11.823 NC 2.997 SF 0.273, 0, 0.455 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 18.060387 XX SC beta XX TO MRSA (ATCC BAA 1707) (MIC > 512 �M TO MBC > 512 �M) XX XR PubMed: 34584638 XR CAMP R4: NA SQ SEQUENCE 1198.475 DA MW 11AA TVAAQLLKKA R // ID AMRSAP1704 PN CeHS-1 SO Heterometrus laoticus PL 38 TX Animalia (Arthropoda) PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 1, 'E': 4, 'F': 1, 'G': 5, 'H': 1, 'I': 5, 'K': 7, 'L': 2, AC 'M': 1, 'N': 3, 'P': 0, 'Q': 2, 'R': 0, 'S': 0, 'T': 0, 'V': 2, 'W': 1, 'Y': 0 AF 'A': 7.89%, 'C': 0%, 'D': 2.63%, 'E': 10.53%, 'F': 2.63%, 'G': 13.16%, 'H': 2.63%, 'I': 13.16%, 'K': 18.42%, 'L': 5.26%, AF 'M': 2.63%, 'N': 7.89%, 'P': 0%, 'Q': 5.26%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5.26%, 'W': 2.63%, 'Y': 0% MA C, P, R, S, T, Y MO K LO D, F, H, M, W BA 20 LA 18 AA 5 BC 8 MC 0 MF 0 XX MM 4235.958 AI 95 II 35.532 HP -0.521 HM 0.589 IP 10.04 NC 2.094 SF 0.289, 0.211, 0.263 [Helix, Turn, Sheet] AR 0.053 ME 5500, 5500 MS 42.140903 XX SC alpha_beta XX TO MRSA (MIC = 128 μG/mL TO MBC = 128 μG/mL) XX XR PubMed: 34641415 XR CAMP R4: NA SQ SEQUENCE 4235.958 DA MW 38AA GWINEEKIQK KIDEKIGNNI LGGMA KAVV HKLAKGEFQ // ID AMRSAP1705 PN AK-N SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 3, 'C': 0, 'D': 0, 'E': 0, 'F': 1, 'G': 2, 'H': 0, 'I': 2, 'K': 5, 'L': 5, AC 'M': 0, 'N': 0, 'P': 0, 'Q': 1, 'R': 0, 'S': 0, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 15%, 'C': 0%, 'D': 0%, 'E': 0%, 'F': 5%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 25%, 'L': 25%, AF 'M': 0%, 'N': 0%, 'P': 0%, 'Q': 5%, 'R': 0%, 'S': 0%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA C, D, E, H, M, N, P, R, S, T, W, Y MO K; L LO F, Q, V BA 14 LA 6 AA 0 BC 5 MC 0 MF 0 XX MM 2152.782 AI 166 II -23.485 HP 0.83 HM 0.607 IP 11.403 NC 4.997 SF 0.45, 0.1, 0.4 [Helix, Turn, Sheet] AR 0.05 ME 0, 0 MS 30.100645 XX SC beta XX TO MRSA (MIC = 2 μM) XX XR PubMed: 35432369 XR CAMP R4: NA SQ SEQUENCE 2152.782 DA MW 20AA FKGLAKLLKI GLKALAKVIQ // ID AMRSAP1706 PN AK-Nm SO Synthetic construct PL 20 TX Synthetic construct PE Experimentally validated XX AC 'A': 2, 'C': 0, 'D': 0, 'E': 1, 'F': 0, 'G': 2, 'H': 0, 'I': 2, 'K': 4, 'L': 5, AC 'M': 0, 'N': 1, 'P': 0, 'Q': 1, 'R': 0, 'S': 1, 'T': 0, 'V': 1, 'W': 0, 'Y': 0 AF 'A': 10%, 'C': 0%, 'D': 0%, 'E': 5%, 'F': 0%, 'G': 10%, 'H': 0%, 'I': 10%, 'K': 20%, 'L': 25%, AF 'M': 0%, 'N': 5%, 'P': 0%, 'Q': 5%, 'R': 0%, 'S': 5%, 'T': 0%, 'V': 5%, 'W': 0%, 'Y': 0% MA C, D, F, H, M, P, R, T, W, Y MO L LO E, N, Q, S, V BA 12 LA 8 AA 1 BC 4 MC 0 MF 0 XX MM 2136.65 AI 161 II 9.745 HP 0.405 HM 0.643 IP 10.803 NC 2.999 SF 0.4, 0.2, 0.4 [Helix, Turn, Sheet] AR 0 ME 0, 0 MS 24.080516 XX SC beta XX TO MRSA (MIC = 32 μM) XX XR PubMed: 35432369 XR CAMP R4: NA SQ SEQUENCE 2136.65 DA MW 20AA NKGLAKLLKI GLKALESVIQ // ID AMRSAP1707 PN Nisin SO Lactococcus and Streptococcus species PL 57 TX Bacteria PE Experimentally validated XX AC 'A': 3, 'C': 5, 'D': 3, 'E': 0, 'F': 1, 'G': 4, 'H': 1, 'I': 3, 'K': 6, 'L': 4, AC 'M': 3, 'N': 3, 'P': 2, 'Q': 0, 'R': 1, 'S': 9, 'T': 6, 'V': 3, 'W': 0, 'Y': 0 AF 'A': 5.26%, 'C': 8.77%, 'D': 5.26%, 'E': 0%, 'F': 1.75%, 'G': 7.02%, 'H': 1.75%, 'I': 5.26%, 'K': 10.53%, 'L': 7.02%, AF 'M': 5.26%, 'N': 5.26%, 'P': 3.51%, 'Q': 0%, 'R': 1.75%, 'S': 15.79%, 'T': 10.53%, 'V': 5.26%, 'W': 0%, 'Y': 0% MA E, Q, W, Y MO S LO F, H, R BA 23 LA 34 AA 3 BC 8 MC 0 MF 0 XX MM 5939.939 AI 68.421 II 28.886 HP -0.011 HM 0.313 IP 8.8 NC 3.779 SF 0.193, 0.316, 0.175 [Helix, Turn, Sheet] AR 0.018 ME 0, 250 MS 42.140903 XX SC alpha XX TO MR-1 (MRSA) (MIC = 8 μG/mL) XX XR PubMed: 27531221 XR CAMP R4: NA SQ SEQUENCE 5939.939 DA MW 57AA MSTKDFNLDL VSVSKKDSGA SPRITSISLC TPGCKTGALM GCNMKTATCN CSIHVSK //